data_1m3c_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1m3c _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . 0.463 ' HB3' ' O ' ' A' ' 161' ' ' ILE . 0.3 OUTLIER . . . . . 0 N--CA 1.453 -0.275 0 N-CA-C 110.283 -0.265 . . . . 0.0 110.283 . . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . 0.812 ' CD1' ' CG ' ' A' ' 190' ' ' TYR . 1.9 t80 -112.49 128.77 56.43 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.482 1.113 . . . . 0.0 110.965 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.559 HG12 ' CG2' ' A' ' 187' ' ' VAL . 10.5 t -139.61 141.48 34.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 O-C-N 124.534 1.146 . . . . 0.0 109.306 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . 0.467 ' N ' HG11 ' A' ' 137' ' ' VAL . 0.5 OUTLIER -112.18 139.18 47.93 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.44 1.087 . . . . 0.0 110.287 -179.987 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . 0.504 ' HB1' ' CD1' ' A' ' 159' ' ' LEU . . . -95.17 114.5 26.3 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.468 1.105 . . . . 0.0 109.318 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.453 ' O ' ' CB ' ' A' ' 155' ' ' LYS . 0.5 OUTLIER -87.26 -22.83 24.95 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.498 1.124 . . . . 0.0 109.277 -179.984 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 20.2 m-85 -101.67 167.58 10.02 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.474 1.109 . . . . 0.0 110.995 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 1.9 p30 . . . . . 0 C--N 1.325 -0.484 0 O-C-N 124.504 1.127 . . . . 0.0 109.309 -179.992 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . 0.515 ' CE2' HG13 ' A' ' 182' ' ' ILE . 12.8 p90 . . . . . 0 N--CA 1.453 -0.296 0 CA-C-O 120.468 0.175 . . . . 0.0 110.999 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 8.6 tttt -126.56 -167.22 1.69 Allowed 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.556 1.16 . . . . 0.0 109.284 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.453 ' CB ' ' O ' ' A' ' 140' ' ' LEU . 2.9 ptmt -91.29 106.84 18.79 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.532 1.145 . . . . 0.0 109.257 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . 0.417 ' HA2' ' NE ' ' A' ' 138' ' ' ARG . . . 105.14 27.2 5.98 Favored Glycine 0 CA--C 1.531 1.033 0 O-C-N 124.505 1.128 . . . . 0.0 111.03 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . 0.401 ' OD2' ' HG ' ' A' ' 159' ' ' LEU . 32.2 t70 -92.34 161.46 14.66 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.502 0.766 . . . . 0.0 109.32 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . 0.588 ' CG2' ' CZ ' ' A' ' 136' ' ' TYR . 6.5 mm -111.76 128.1 68.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 O-C-N 124.474 1.109 . . . . 0.0 109.312 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . 0.504 ' CD1' ' HB1' ' A' ' 139' ' ' ALA . 1.7 mp -142.19 127.55 18.8 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.48 1.112 . . . . 0.0 109.292 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . 0.41 ' HG2' ' O ' ' A' ' 135' ' ' GLU . 4.4 mtt180 -86.53 143.56 27.65 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.497 1.123 . . . . 0.0 110.333 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . 0.477 ' CD1' HG23 ' A' ' 137' ' ' VAL . 0.9 OUTLIER -86.81 116.15 28.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 O-C-N 124.542 1.151 . . . . 0.0 109.275 -179.969 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . 0.401 ' NH1' ' OE2' ' A' ' 173' ' ' GLU . 3.1 tpt180 -97.7 -69.27 0.76 Allowed 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.49 1.119 . . . . 0.0 110.285 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -134.42 173.43 11.64 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.422 1.076 . . . . 0.0 109.316 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . 0.535 ' HG2' ' CD2' ' A' ' 170' ' ' TRP . 0.0 OUTLIER -135.1 87.32 29.3 Favored Pre-proline 0 C--N 1.325 -0.47 0 O-C-N 124.515 1.135 . . . . 0.0 109.316 -179.958 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -74.97 -25.21 12.13 Favored 'Trans proline' 0 C--N 1.361 1.192 0 O-C-N 124.486 1.782 . . . . 0.0 111.001 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 6.7 mt-10 -125.22 167.36 14.97 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.551 1.157 . . . . 0.0 110.302 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -87.62 -18.82 28.78 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.497 1.123 . . . . 0.0 110.274 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 12.0 mt-30 -103.28 -53.44 2.81 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.491 1.119 . . . . 0.0 110.31 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 169' ' ' TRP . . . . . . . . . . . . . 7.0 m95 -100.7 133.58 44.94 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.504 1.127 . . . . 0.0 107.999 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 170' ' ' TRP . . . . . 0.564 ' CE3' HG23 ' A' ' 184' ' ' VAL . 54.7 m0 -116.63 155.09 29.38 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.553 1.158 . . . . 0.0 107.983 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 171' ' ' ASN . . . . . 0.471 ' HA ' ' O ' ' A' ' 180' ' ' GLY . 19.5 t30 -86.5 97.48 10.52 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.495 1.122 . . . . 0.0 109.31 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -109.91 166.59 10.81 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.556 1.16 . . . . 0.0 109.308 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . 0.401 ' OE2' ' NH1' ' A' ' 162' ' ' ARG . 23.1 mt-10 -116.18 112.92 22.35 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.463 1.102 . . . . 0.0 110.273 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . 0.492 ' CB ' HD23 ' A' ' 159' ' ' LEU . 0.0 OUTLIER -68.63 -177.38 0.95 Allowed 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.427 1.08 . . . . 0.0 109.335 179.955 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 73.0 p -77.32 57.71 1.53 Allowed 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.506 1.129 . . . . 0.0 110.03 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . 0.409 ' O ' ' HD2' ' A' ' 178' ' ' LYS . 2.7 mt-10 -175.35 22.68 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.519 1.137 . . . . 0.0 110.284 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 55.57 29.18 53.34 Favored Glycine 0 CA--C 1.53 1.004 0 O-C-N 124.522 1.139 . . . . 0.0 110.991 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 178' ' ' LYS . . . . . 0.422 ' O ' ' OD1' ' A' ' 174' ' ' ASP . 0.0 OUTLIER -96.7 110.99 23.32 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.429 0.723 . . . . 0.0 109.308 179.982 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 3.4 ttp180 -91.1 120.5 32.1 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.523 1.139 . . . . 0.0 110.237 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . 0.471 ' O ' ' HA ' ' A' ' 171' ' ' ASN . . . -149.84 172.54 29.75 Favored Glycine 0 CA--C 1.53 0.998 0 O-C-N 124.483 1.114 . . . . 0.0 111.001 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 181' ' ' MET . . . . . 0.45 ' HA ' ' O ' ' A' ' 170' ' ' TRP . 20.7 mtp -86.94 92.55 9.06 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.497 0.763 . . . . 0.0 110.998 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . 0.581 ' CG1' ' HD2' ' A' ' 183' ' ' PRO . 6.6 tt -89.87 144.88 32.24 Favored Pre-proline 0 C--N 1.326 -0.455 0 O-C-N 124.495 1.122 . . . . 0.0 109.32 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 183' ' ' PRO . . . . . 0.674 ' HG2' ' HB2' ' A' ' 186' ' ' TYR . 18.4 Cg_endo -74.97 132.13 15.1 Favored 'Trans proline' 0 C--N 1.36 1.148 0 O-C-N 124.479 1.778 . . . . 0.0 111.028 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . 0.821 ' N ' ' CD ' ' A' ' 185' ' ' PRO . 28.1 t -74.48 -30.68 1.1 Allowed Pre-proline 0 C--N 1.325 -0.489 0 O-C-N 124.522 1.139 . . . . 0.0 109.303 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 185' ' ' PRO . . . . . 0.821 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.3 Cg_endo -74.92 -10.86 21.54 Favored 'Trans proline' 0 C--N 1.36 1.153 0 O-C-N 124.559 1.82 . . . . 0.0 111.025 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 186' ' ' TYR . . . . . 0.674 ' HB2' ' HG2' ' A' ' 183' ' ' PRO . 3.7 m-30 -101.61 -19.47 15.44 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.513 1.133 . . . . 0.0 111.018 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 187' ' ' VAL . . . . . 0.559 ' CG2' HG12 ' A' ' 137' ' ' VAL . 13.8 m -115.5 175.9 2.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 O-C-N 124.457 1.098 . . . . 0.0 109.311 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 188' ' ' GLU . . . . . 0.417 ' O ' HG11 ' A' ' 137' ' ' VAL . 0.0 OUTLIER -135.97 168.08 20.02 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 124.481 1.113 . . . . 0.0 110.311 -179.988 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . 0.464 ' HD2' ' CG2' ' A' ' 137' ' ' VAL . 5.8 mmmt -94.69 141.09 29.02 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.536 1.148 . . . . 0.0 109.31 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 190' ' ' TYR . . . . . 0.812 ' CG ' ' CD1' ' A' ' 136' ' ' TYR . 0.2 OUTLIER . . . . . 0 C--N 1.325 -0.47 0 O-C-N 124.459 1.1 . . . . 0.0 111.059 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . 0.447 ' O ' ' HA ' ' A' ' 160' ' ' ARG . 0.7 OUTLIER . . . . . 0 N--CA 1.454 -0.266 0 N-CA-C 110.311 -0.255 . . . . 0.0 110.311 . . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . 0.443 ' CD1' ' C ' ' A' ' 135' ' ' GLU . 1.9 m-85 -121.17 132.77 55.04 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.562 1.164 . . . . 0.0 110.975 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.509 ' CG2' HD13 ' A' ' 161' ' ' ILE . 22.4 m -129.6 162.31 37.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 O-C-N 124.58 1.175 . . . . 0.0 109.294 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.25 125.04 48.19 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.505 1.128 . . . . 0.0 110.341 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . 0.612 ' O ' ' N ' ' A' ' 156' ' ' GLY . . . -89.1 107.09 18.85 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.497 1.123 . . . . 0.0 109.284 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.41 ' O ' ' CG ' ' A' ' 155' ' ' LYS . 0.1 OUTLIER -88.68 -29.86 19.57 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.571 1.169 . . . . 0.0 109.349 -179.998 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . 0.494 ' C ' ' O ' ' A' ' 154' ' ' LYS . 47.2 m-85 -91.2 153.55 19.93 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.523 1.14 . . . . 0.0 110.989 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . 0.414 ' OD1' ' O ' ' A' ' 153' ' ' PHE . 4.2 t70 . . . . . 0 C--N 1.325 -0.467 0 O-C-N 124.475 1.11 . . . . 0.0 109.361 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . 0.414 ' O ' ' OD1' ' A' ' 142' ' ' ASP . 10.7 p90 . . . . . 0 N--CA 1.453 -0.285 0 CA-C-O 120.501 0.191 . . . . 0.0 111.004 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . 0.494 ' O ' ' C ' ' A' ' 141' ' ' PHE . 0.1 OUTLIER -121.27 -90.77 0.57 Allowed 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.492 1.12 . . . . 0.0 109.363 179.954 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.41 ' CG ' ' O ' ' A' ' 140' ' ' LEU . 10.3 ttpp -157.45 118.28 3.55 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.534 1.146 . . . . 0.0 109.28 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . 0.612 ' N ' ' O ' ' A' ' 139' ' ' ALA . . . 98.42 16.36 32.23 Favored Glycine 0 CA--C 1.531 1.033 0 O-C-N 124.544 1.153 . . . . 0.0 111.0 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -81.31 156.67 25.4 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.519 0.776 . . . . 0.0 109.3 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 5.1 mm -110.68 138.62 37.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 O-C-N 124.485 1.116 . . . . 0.0 109.347 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . 0.484 ' CD1' ' HB3' ' A' ' 139' ' ' ALA . 1.5 mp -141.19 136.3 31.65 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.506 1.129 . . . . 0.0 109.272 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . 0.547 ' O ' ' CA ' ' A' ' 172' ' ' ALA . 0.0 OUTLIER -99.46 129.52 45.65 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.476 1.11 . . . . 0.0 110.313 179.981 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . 0.509 HD13 ' CG2' ' A' ' 137' ' ' VAL . 1.7 mp -83.76 122.08 37.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 O-C-N 124.516 1.135 . . . . 0.0 109.286 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -122.65 -42.44 2.32 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.505 1.128 . . . . 0.0 110.261 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -135.06 170.81 15.34 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.491 1.119 . . . . 0.0 109.295 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . 0.566 ' HB2' ' CD1' ' A' ' 170' ' ' TRP . 0.6 OUTLIER -164.74 84.98 1.13 Allowed Pre-proline 0 C--N 1.325 -0.458 0 O-C-N 124.505 1.128 . . . . 0.0 109.3 179.928 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.08 -27.52 9.82 Favored 'Trans proline' 0 C--N 1.36 1.17 0 O-C-N 124.51 1.795 . . . . 0.0 110.983 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -118.54 168.94 10.21 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.539 1.15 . . . . 0.0 110.299 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -93.27 -19.67 21.17 Favored 'General case' 0 C--N 1.326 -0.441 0 O-C-N 124.522 1.139 . . . . 0.0 110.333 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -85.58 -57.12 3.19 Favored 'General case' 0 C--N 1.326 -0.422 0 O-C-N 124.506 1.129 . . . . 0.0 110.336 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 169' ' ' TRP . . . . . . . . . . . . . 10.6 m95 -107.18 150.62 26.41 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.549 1.156 . . . . 0.0 108.04 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 170' ' ' TRP . . . . . 0.566 ' CD1' ' HB2' ' A' ' 164' ' ' LYS . 37.5 m0 -127.51 151.6 48.66 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.549 1.155 . . . . 0.0 108.0 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -87.37 99.14 11.78 Favored 'General case' 0 C--N 1.324 -0.532 0 O-C-N 124.468 1.105 . . . . 0.0 109.283 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . 0.547 ' CA ' ' O ' ' A' ' 160' ' ' ARG . . . -119.05 -178.43 3.56 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.476 1.11 . . . . 0.0 109.303 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . 0.437 ' CG ' ' HG3' ' A' ' 179' ' ' ARG . 34.0 mt-10 -119.73 121.15 38.55 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.47 1.106 . . . . 0.0 110.27 -179.898 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -72.44 -164.22 0.14 Allowed 'General case' 0 C--N 1.323 -0.547 0 O-C-N 124.594 1.184 . . . . 0.0 109.259 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 52.6 p -87.53 56.94 4.15 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.465 1.103 . . . . 0.0 109.999 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -177.22 28.45 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.532 1.145 . . . . 0.0 110.189 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 53.23 24.69 23.06 Favored Glycine 0 CA--C 1.531 1.078 0 O-C-N 124.562 1.164 . . . . 0.0 111.003 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 3.1 mtpm? -90.93 108.89 20.15 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.503 0.767 . . . . 0.0 109.355 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 179' ' ' ARG . . . . . 0.437 ' HG3' ' CG ' ' A' ' 173' ' ' GLU . 0.0 OUTLIER -90.7 114.97 27.42 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.499 1.125 . . . . 0.0 110.34 179.955 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -150.79 174.31 30.13 Favored Glycine 0 CA--C 1.53 1.013 0 O-C-N 124.486 1.116 . . . . 0.0 111.01 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 181' ' ' MET . . . . . . . . . . . . . 33.5 mtp -88.04 106.19 17.98 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.537 0.786 . . . . 0.0 110.99 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 6.8 pt -106.65 159.38 30.06 Favored Pre-proline 0 C--N 1.325 -0.496 0 O-C-N 124.505 1.128 . . . . 0.0 109.36 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 183' ' ' PRO . . . . . 0.565 ' HG2' ' CB ' ' A' ' 186' ' ' TYR . 18.1 Cg_endo -75.02 127.5 10.72 Favored 'Trans proline' 0 C--N 1.36 1.174 0 O-C-N 124.418 1.746 . . . . 0.0 111.013 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . 0.758 ' N ' ' CD ' ' A' ' 185' ' ' PRO . 21.8 t -76.17 -34.92 1.51 Allowed Pre-proline 0 C--N 1.325 -0.49 0 O-C-N 124.514 1.134 . . . . 0.0 109.334 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 185' ' ' PRO . . . . . 0.758 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.4 Cg_endo -74.95 -9.73 20.98 Favored 'Trans proline' 0 C--N 1.36 1.162 0 O-C-N 124.51 1.795 . . . . 0.0 110.988 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 186' ' ' TYR . . . . . 0.565 ' CB ' ' HG2' ' A' ' 183' ' ' PRO . 3.2 m-85 -95.95 -5.92 40.23 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.464 1.103 . . . . 0.0 110.962 -179.897 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 7.6 m -129.33 175.47 10.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 O-C-N 124.391 1.057 . . . . 0.0 109.282 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -131.63 173.26 11.31 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.534 1.147 . . . . 0.0 110.297 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.05 119.43 28.41 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.502 1.126 . . . . 0.0 109.273 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 1.6 t80 . . . . . 0 C--N 1.324 -0.507 0 O-C-N 124.448 1.092 . . . . 0.0 110.92 -179.991 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . 0.433 ' HB3' ' O ' ' A' ' 161' ' ' ILE . 0.8 OUTLIER . . . . . 0 N--CA 1.452 -0.344 0 N-CA-C 110.351 -0.24 . . . . 0.0 110.351 . . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -124.46 114.5 19.54 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.496 1.123 . . . . 0.0 111.038 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.492 HG23 ' CG2' ' A' ' 187' ' ' VAL . 0.4 OUTLIER -113.06 132.22 62.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 O-C-N 124.419 1.074 . . . . 0.0 109.282 -179.993 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . 0.501 ' HG3' ' N ' ' A' ' 139' ' ' ALA . 2.7 ttm180 -101.09 142.85 31.95 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.462 1.101 . . . . 0.0 110.259 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . 0.515 ' O ' ' N ' ' A' ' 156' ' ' GLY . . . -105.85 109.08 20.91 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.564 1.165 . . . . 0.0 109.345 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.511 ' O ' ' CG ' ' A' ' 155' ' ' LYS . 0.3 OUTLIER -87.36 -22.42 25.08 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.496 1.123 . . . . 0.0 109.272 -179.944 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . 0.408 ' CD1' ' N ' ' A' ' 141' ' ' PHE . 0.6 OUTLIER -108.99 146.9 33.13 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.487 1.117 . . . . 0.0 111.013 179.972 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 5.7 t70 . . . . . 0 C--N 1.325 -0.489 0 O-C-N 124.537 1.148 . . . . 0.0 109.296 -179.997 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . 0.596 ' CZ ' ' CD ' ' A' ' 183' ' ' PRO . 0.4 OUTLIER . . . . . 0 N--CA 1.453 -0.307 0 CA-C-O 120.542 0.211 . . . . 0.0 111.018 . . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -127.13 -164.91 1.4 Allowed 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.458 1.099 . . . . 0.0 109.315 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.511 ' CG ' ' O ' ' A' ' 140' ' ' LEU . 1.5 tttp -97.08 99.16 10.68 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.475 1.109 . . . . 0.0 109.317 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . 0.515 ' N ' ' O ' ' A' ' 139' ' ' ALA . . . 116.08 29.54 2.34 Favored Glycine 0 CA--C 1.53 1.008 0 O-C-N 124.534 1.146 . . . . 0.0 111.01 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . 0.415 ' C ' ' CD1' ' A' ' 158' ' ' ILE . 12.4 t70 -102.9 166.81 10.25 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.607 0.828 . . . . 0.0 109.305 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . 0.475 ' N ' ' CD1' ' A' ' 158' ' ' ILE . 1.9 mp -123.56 146.28 29.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 O-C-N 124.476 1.11 . . . . 0.0 109.344 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . 0.452 ' N ' HG23 ' A' ' 158' ' ' ILE . 0.8 OUTLIER -144.11 128.85 18.27 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.513 1.133 . . . . 0.0 109.314 -179.98 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . 0.505 ' O ' ' HA ' ' A' ' 172' ' ' ALA . 2.0 tmt_? -87.72 127.77 35.3 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.458 1.099 . . . . 0.0 110.292 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . 0.456 ' O ' ' NE ' ' A' ' 160' ' ' ARG . 1.7 mp -84.96 130.85 35.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.455 1.097 . . . . 0.0 109.288 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . 0.466 ' HD3' ' CZ ' ' A' ' 179' ' ' ARG . 33.7 ttt85 -127.3 -46.44 1.49 Allowed 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.46 1.1 . . . . 0.0 110.314 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . 0.48 ' CB ' ' HB3' ' A' ' 171' ' ' ASN . 0.2 OUTLIER -123.7 161.4 25.19 Favored 'General case' 0 C--N 1.326 -0.433 0 O-C-N 124.508 1.13 . . . . 0.0 109.281 179.991 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . 0.513 ' O ' ' CG ' ' A' ' 164' ' ' LYS . 0.1 OUTLIER -165.23 64.14 1.0 Allowed Pre-proline 0 C--N 1.327 -0.391 0 O-C-N 124.463 1.102 . . . . 0.0 109.261 179.98 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' PRO . . . . . 0.423 ' HD3' ' N ' ' A' ' 164' ' ' LYS . 18.1 Cg_endo -75.03 -49.18 0.15 Allowed 'Trans proline' 0 C--N 1.359 1.089 0 O-C-N 124.547 1.814 . . . . 0.0 110.977 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -66.14 167.57 9.86 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.499 1.124 . . . . 0.0 110.244 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 5.3 mp0 -110.87 40.91 1.91 Allowed 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.448 1.093 . . . . 0.0 110.309 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 5.4 mt-30 -159.44 -57.82 0.06 Allowed 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.553 1.158 . . . . 0.0 110.263 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 169' ' ' TRP . . . . . . . . . . . . . 10.4 m95 -102.04 144.45 30.62 Favored 'General case' 0 C--N 1.324 -0.523 0 O-C-N 124.567 1.167 . . . . 0.0 107.972 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 170' ' ' TRP . . . . . 0.578 ' CD2' ' CG2' ' A' ' 184' ' ' VAL . 50.8 m0 -116.28 146.88 42.06 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 171' ' ' ASN . . . . . 0.499 ' OD1' ' CD ' ' A' ' 179' ' ' ARG . 18.7 t-20 -87.72 99.88 12.42 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.505 1.128 . . . . 0.0 109.288 180.0 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . 0.505 ' HA ' ' O ' ' A' ' 160' ' ' ARG . . . -119.87 168.77 10.77 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.484 1.115 . . . . 0.0 109.267 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . 0.485 ' HG3' ' CB ' ' A' ' 179' ' ' ARG . 1.8 mt-10 -113.92 124.12 51.41 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.53 1.144 . . . . 0.0 110.292 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . 0.435 ' CA ' HD23 ' A' ' 159' ' ' LEU . 0.2 OUTLIER -73.99 -168.5 0.62 Allowed 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.47 1.106 . . . . 0.0 109.309 179.97 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 10.5 t -81.17 58.31 3.48 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 124.404 1.065 . . . . 0.0 110.024 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -175.11 16.85 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.449 1.093 . . . . 0.0 110.317 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 177' ' ' GLY . . . . . 0.405 ' C ' ' HG2' ' A' ' 173' ' ' GLU . . . 64.12 17.36 61.2 Favored Glycine 0 CA--C 1.529 0.951 0 O-C-N 124.562 1.164 . . . . 0.0 111.005 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -85.95 102.09 13.45 Favored 'General case' 0 C--N 1.326 -0.441 0 O-C-N 124.472 0.748 . . . . 0.0 109.307 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 179' ' ' ARG . . . . . 0.499 ' CD ' ' OD1' ' A' ' 171' ' ' ASN . 20.1 ttm-85 -88.15 120.35 29.42 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.464 1.102 . . . . 0.0 110.328 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . 0.405 ' O ' ' HA ' ' A' ' 171' ' ' ASN . . . -152.36 172.45 31.56 Favored Glycine 0 CA--C 1.53 1.013 0 O-C-N 124.554 1.159 . . . . 0.0 110.953 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 181' ' ' MET . . . . . 0.406 ' HA ' ' O ' ' A' ' 170' ' ' TRP . 35.7 mtp -86.96 99.82 12.15 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.46 0.741 . . . . 0.0 111.009 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . 0.416 ' HB ' ' HD2' ' A' ' 183' ' ' PRO . 5.7 pt -99.38 160.6 27.1 Favored Pre-proline 0 C--N 1.325 -0.46 0 O-C-N 124.454 1.096 . . . . 0.0 109.381 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 183' ' ' PRO . . . . . 0.74 ' HG2' ' HB2' ' A' ' 186' ' ' TYR . 18.5 Cg_endo -75.05 135.16 18.61 Favored 'Trans proline' 0 C--N 1.359 1.1 0 O-C-N 124.462 1.77 . . . . 0.0 111.019 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . 0.851 ' N ' ' CD ' ' A' ' 185' ' ' PRO . 42.9 t -80.07 -30.16 0.59 Allowed Pre-proline 0 C--N 1.325 -0.493 0 O-C-N 124.522 1.139 . . . . 0.0 109.321 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 185' ' ' PRO . . . . . 0.851 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.4 Cg_endo -75.02 -21.42 15.83 Favored 'Trans proline' 0 C--N 1.36 1.155 0 O-C-N 124.532 1.806 . . . . 0.0 110.963 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 186' ' ' TYR . . . . . 0.74 ' HB2' ' HG2' ' A' ' 183' ' ' PRO . 4.1 m-85 -94.42 15.52 17.51 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.52 1.138 . . . . 0.0 111.001 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 187' ' ' VAL . . . . . 0.492 ' CG2' HG23 ' A' ' 137' ' ' VAL . 27.4 m -143.37 171.83 8.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 O-C-N 124.453 1.096 . . . . 0.0 109.294 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 188' ' ' GLU . . . . . 0.475 ' N ' ' O ' ' A' ' 138' ' ' ARG . 0.0 OUTLIER -131.75 169.65 15.92 Favored 'General case' 0 C--N 1.326 -0.442 0 O-C-N 124.462 1.102 . . . . 0.0 110.257 179.999 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -88.15 127.9 35.43 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.427 1.079 . . . . 0.0 109.304 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.325 -0.498 0 O-C-N 124.481 1.113 . . . . 0.0 111.053 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . 0.411 ' CB ' ' HB ' ' A' ' 161' ' ' ILE . 0.4 OUTLIER . . . . . 0 N--CA 1.452 -0.334 0 N-CA-C 110.286 -0.264 . . . . 0.0 110.286 . . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 8.6 m-85 -130.95 99.97 5.09 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.522 1.139 . . . . 0.0 110.94 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.587 HG23 ' CG2' ' A' ' 187' ' ' VAL . 11.8 p -102.22 130.66 51.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 O-C-N 124.55 1.156 . . . . 0.0 109.289 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . 0.495 ' O ' ' N ' ' A' ' 188' ' ' GLU . 13.7 ttm180 -97.59 151.55 19.95 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.502 1.126 . . . . 0.0 110.339 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . 0.487 ' CB ' ' OD2' ' A' ' 157' ' ' ASP . . . -120.63 106.34 11.65 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.467 1.104 . . . . 0.0 109.259 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.477 ' O ' ' CG ' ' A' ' 155' ' ' LYS . 0.0 OUTLIER -91.14 -22.97 20.41 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.561 1.163 . . . . 0.0 109.331 179.944 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . 0.484 ' CD2' ' HA ' ' A' ' 186' ' ' TYR . 97.1 m-85 -85.66 161.38 19.27 Favored 'General case' 0 C--N 1.326 -0.418 0 O-C-N 124.44 1.088 . . . . 0.0 110.98 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . 0.498 ' CA ' ' O ' ' A' ' 154' ' ' LYS . 0.5 OUTLIER . . . . . 0 C--N 1.324 -0.507 0 O-C-N 124.508 1.13 . . . . 0.0 109.272 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 1.2 p90 . . . . . 0 N--CA 1.454 -0.253 0 CA-C-O 120.502 0.191 . . . . 0.0 110.955 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . 0.498 ' O ' ' CA ' ' A' ' 142' ' ' ASP . 32.2 tttt -121.6 -82.26 0.65 Allowed 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.498 1.124 . . . . 0.0 109.348 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.477 ' CG ' ' O ' ' A' ' 140' ' ' LEU . 0.0 OUTLIER -175.25 108.63 0.1 Allowed 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.499 1.124 . . . . 0.0 109.326 179.973 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . 0.434 ' N ' ' O ' ' A' ' 139' ' ' ALA . . . 104.83 16.1 18.27 Favored Glycine 0 CA--C 1.529 0.964 0 O-C-N 124.493 1.12 . . . . 0.0 111.05 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . 0.487 ' OD2' ' CB ' ' A' ' 139' ' ' ALA . 2.3 p-10 -88.2 144.51 26.42 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.494 0.761 . . . . 0.0 109.327 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . 0.623 ' N ' ' CD1' ' A' ' 158' ' ' ILE . 1.1 mp -95.93 150.02 4.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 O-C-N 124.438 1.086 . . . . 0.0 109.314 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . 0.425 ' O ' HG12 ' A' ' 137' ' ' VAL . 5.3 mt -145.65 133.77 21.55 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.542 1.151 . . . . 0.0 109.28 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . 0.454 ' O ' ' CA ' ' A' ' 172' ' ' ALA . 2.0 ttt180 -90.28 129.48 36.51 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.51 1.131 . . . . 0.0 110.322 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . 0.448 ' CD1' HG11 ' A' ' 137' ' ' VAL . 24.1 mm -85.23 124.2 39.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 O-C-N 124.517 1.136 . . . . 0.0 109.253 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -119.39 -62.96 1.44 Allowed 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.507 1.129 . . . . 0.0 110.336 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -111.31 157.03 20.65 Favored 'General case' 0 C--N 1.324 -0.522 0 O-C-N 124.498 1.124 . . . . 0.0 109.333 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . 0.537 ' HG3' ' CE2' ' A' ' 170' ' ' TRP . 0.0 OUTLIER -157.81 63.08 2.67 Favored Pre-proline 0 C--N 1.324 -0.506 0 O-C-N 124.469 1.105 . . . . 0.0 109.306 -179.989 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' PRO . . . . . 0.441 ' HD3' ' N ' ' A' ' 164' ' ' LYS . 18.2 Cg_endo -75.05 -58.89 0.04 OUTLIER 'Trans proline' 0 C--N 1.36 1.148 0 O-C-N 124.445 1.761 . . . . 0.0 111.005 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -62.01 167.26 3.98 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.509 1.131 . . . . 0.0 110.248 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 6.5 mt-10 -106.99 45.77 0.97 Allowed 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.501 1.126 . . . . 0.0 110.349 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -167.03 -59.53 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.535 1.147 . . . . 0.0 110.346 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 169' ' ' TRP . . . . . . . . . . . . . 25.4 m95 -102.69 135.2 44.76 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.553 1.158 . . . . 0.0 107.966 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 170' ' ' TRP . . . . . 0.587 ' CE2' ' CG2' ' A' ' 184' ' ' VAL . 27.8 m0 -117.31 151.65 36.54 Favored 'General case' 0 C--N 1.324 -0.533 0 O-C-N 124.551 1.157 . . . . 0.0 108.048 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 171' ' ' ASN . . . . . 0.403 ' HA ' ' O ' ' A' ' 180' ' ' GLY . 2.8 t-20 -86.23 102.98 14.42 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.432 1.083 . . . . 0.0 109.268 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . 0.466 ' CB ' HD11 ' A' ' 182' ' ' ILE . . . -113.1 179.89 3.83 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.488 1.117 . . . . 0.0 109.309 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . 0.473 ' CG ' ' HG3' ' A' ' 179' ' ' ARG . 28.0 mt-10 -125.34 125.91 44.23 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.5 1.125 . . . . 0.0 110.271 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -74.6 -163.92 0.24 Allowed 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.477 1.111 . . . . 0.0 109.307 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -89.32 47.04 1.43 Allowed 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.582 1.177 . . . . 0.0 110.019 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -169.68 24.51 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.546 1.154 . . . . 0.0 110.287 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 62.57 20.51 61.57 Favored Glycine 0 CA--C 1.53 0.976 0 O-C-N 124.441 1.088 . . . . 0.0 111.004 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 4.8 tptt -81.21 104.26 11.56 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.524 0.779 . . . . 0.0 109.285 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 179' ' ' ARG . . . . . 0.473 ' HG3' ' CG ' ' A' ' 173' ' ' GLU . 0.0 OUTLIER -89.26 116.92 27.84 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.427 1.079 . . . . 0.0 110.373 179.946 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . 0.403 ' O ' ' HA ' ' A' ' 171' ' ' ASN . . . -151.46 173.39 30.83 Favored Glycine 0 CA--C 1.53 0.979 0 O-C-N 124.452 1.095 . . . . 0.0 111.007 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 181' ' ' MET . . . . . 0.413 ' HA ' ' O ' ' A' ' 170' ' ' TRP . 12.9 mmm -86.14 103.6 14.94 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.461 0.742 . . . . 0.0 110.986 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . 0.517 ' CG2' ' HD2' ' A' ' 183' ' ' PRO . 4.1 mp -94.5 145.27 29.37 Favored Pre-proline 0 C--N 1.324 -0.509 0 O-C-N 124.563 1.164 . . . . 0.0 109.289 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 183' ' ' PRO . . . . . 0.773 ' HG2' ' HB2' ' A' ' 186' ' ' TYR . 18.3 Cg_endo -75.01 133.63 16.81 Favored 'Trans proline' 0 C--N 1.36 1.164 0 O-C-N 124.448 1.762 . . . . 0.0 110.977 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . 0.814 ' N ' ' CD ' ' A' ' 185' ' ' PRO . 25.2 t -78.62 -31.14 0.73 Allowed Pre-proline 0 C--N 1.325 -0.469 0 O-C-N 124.509 1.131 . . . . 0.0 109.309 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 185' ' ' PRO . . . . . 0.814 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.1 Cg_endo -75.09 -25.96 11.23 Favored 'Trans proline' 0 C--N 1.359 1.123 0 O-C-N 124.474 1.776 . . . . 0.0 110.932 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 186' ' ' TYR . . . . . 0.773 ' HB2' ' HG2' ' A' ' 183' ' ' PRO . 4.1 m-85 -95.91 15.54 20.18 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.475 1.109 . . . . 0.0 110.994 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 187' ' ' VAL . . . . . 0.587 ' CG2' HG23 ' A' ' 137' ' ' VAL . 24.4 m -139.59 173.96 10.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 O-C-N 124.451 1.094 . . . . 0.0 109.278 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 188' ' ' GLU . . . . . 0.495 ' N ' ' O ' ' A' ' 138' ' ' ARG . 0.0 OUTLIER -135.18 172.31 13.2 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.448 1.093 . . . . 0.0 110.353 179.966 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . 0.45 ' HD2' ' N ' ' A' ' 189' ' ' LYS . 0.0 OUTLIER -95.63 114.19 25.91 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.545 1.153 . . . . 0.0 109.267 -179.96 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 15.6 t80 . . . . . 0 C--N 1.325 -0.482 0 O-C-N 124.507 1.129 . . . . 0.0 110.962 -179.991 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . 0.459 ' O ' ' HG2' ' A' ' 160' ' ' ARG . 0.2 OUTLIER . . . . . 0 N--CA 1.452 -0.366 0 N-CA-C 110.32 -0.252 . . . . 0.0 110.32 . . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . 0.433 ' O ' ' HB3' ' A' ' 190' ' ' TYR . 0.4 OUTLIER -135.64 141.74 45.09 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.473 1.108 . . . . 0.0 111.003 179.993 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 34.3 m -133.66 157.51 42.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 O-C-N 124.476 1.11 . . . . 0.0 109.322 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . 0.483 ' HB3' ' CG ' ' A' ' 188' ' ' GLU . 4.2 tpp85 -127.3 127.07 43.73 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.436 1.085 . . . . 0.0 110.241 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . 0.698 ' O ' ' N ' ' A' ' 156' ' ' GLY . . . -88.41 106.93 18.58 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.432 1.083 . . . . 0.0 109.323 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -87.29 -5.14 59.03 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.538 1.149 . . . . 0.0 109.336 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . 0.463 ' CD1' ' HA ' ' A' ' 186' ' ' TYR . 6.2 m-85 -123.32 151.92 41.97 Favored 'General case' 0 C--N 1.326 -0.443 0 O-C-N 124.486 1.116 . . . . 0.0 111.028 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 3.5 t70 . . . . . 0 C--N 1.326 -0.454 0 O-C-N 124.506 1.129 . . . . 0.0 109.345 179.96 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 6.5 p90 . . . . . 0 N--CA 1.453 -0.296 0 CA-C-O 120.469 0.176 . . . . 0.0 111.049 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.56 -164.42 1.38 Allowed 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.472 1.107 . . . . 0.0 109.305 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -96.4 96.29 8.63 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.534 1.147 . . . . 0.0 109.288 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . 0.698 ' N ' ' O ' ' A' ' 139' ' ' ALA . . . 122.63 29.81 1.24 Allowed Glycine 0 CA--C 1.53 0.981 0 O-C-N 124.487 1.117 . . . . 0.0 111.002 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -97.9 159.43 14.94 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.449 0.734 . . . . 0.0 109.298 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . 0.455 ' CD1' ' HD3' ' A' ' 138' ' ' ARG . 6.5 mm -115.04 147.37 18.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 O-C-N 124.533 1.146 . . . . 0.0 109.359 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . 0.471 HD22 HG21 ' A' ' 182' ' ' ILE . 1.1 mt -149.21 138.79 21.73 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.531 1.144 . . . . 0.0 109.371 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . 0.567 ' O ' ' HA ' ' A' ' 172' ' ' ALA . 0.0 OUTLIER -95.71 134.22 38.89 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.543 1.152 . . . . 0.0 110.349 -179.983 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . 0.422 ' HB ' ' CG ' ' A' ' 135' ' ' GLU . 15.4 mm -84.43 118.41 31.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 O-C-N 124.424 1.077 . . . . 0.0 109.264 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -112.36 -51.57 2.83 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.469 1.106 . . . . 0.0 110.285 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -138.86 168.39 19.93 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.495 1.122 . . . . 0.0 109.325 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . 0.581 ' HB3' ' CD1' ' A' ' 170' ' ' TRP . 27.4 mtmt -148.93 85.97 5.85 Favored Pre-proline 0 C--N 1.324 -0.513 0 O-C-N 124.499 1.124 . . . . 0.0 109.341 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.03 -30.57 6.98 Favored 'Trans proline' 0 C--N 1.36 1.138 0 O-C-N 124.498 1.788 . . . . 0.0 111.012 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -128.92 153.99 46.97 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.554 1.159 . . . . 0.0 110.272 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -77.75 -23.62 49.24 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.497 1.123 . . . . 0.0 110.265 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -75.9 -57.06 4.1 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.487 1.117 . . . . 0.0 110.329 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 169' ' ' TRP . . . . . . . . . . . . . 14.0 m95 -111.33 156.22 21.88 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.547 1.154 . . . . 0.0 107.995 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 170' ' ' TRP . . . . . 0.581 ' CD1' ' HB3' ' A' ' 164' ' ' LYS . 23.6 m0 -131.46 148.53 52.65 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.477 1.111 . . . . 0.0 108.017 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 171' ' ' ASN . . . . . 0.53 ' OD1' ' HG2' ' A' ' 179' ' ' ARG . 6.2 t-20 -87.26 98.98 11.63 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.503 1.127 . . . . 0.0 109.306 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . 0.567 ' HA ' ' O ' ' A' ' 160' ' ' ARG . . . -118.86 175.59 5.68 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.456 1.097 . . . . 0.0 109.327 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . 0.557 ' HG3' ' HG3' ' A' ' 179' ' ' ARG . 1.5 tt0 -118.02 118.26 31.44 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.441 1.088 . . . . 0.0 110.324 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . 0.46 ' CA ' HD21 ' A' ' 159' ' ' LEU . 0.9 OUTLIER -66.43 -174.73 0.3 Allowed 'General case' 0 C--N 1.326 -0.434 0 O-C-N 124.461 1.101 . . . . 0.0 109.308 -179.947 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -78.72 53.16 1.3 Allowed 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.461 1.1 . . . . 0.0 110.018 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -172.21 11.25 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.446 1.091 . . . . 0.0 110.323 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 177' ' ' GLY . . . . . 0.491 ' C ' ' HG2' ' A' ' 173' ' ' GLU . . . 73.27 18.02 79.09 Favored Glycine 0 CA--C 1.53 0.978 0 O-C-N 124.509 1.131 . . . . 0.0 111.008 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -79.66 103.85 9.86 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.54 0.788 . . . . 0.0 109.349 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 179' ' ' ARG . . . . . 0.557 ' HG3' ' HG3' ' A' ' 173' ' ' GLU . 0.0 OUTLIER -87.65 113.21 23.12 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.434 1.084 . . . . 0.0 110.296 179.985 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -152.2 172.89 31.43 Favored Glycine 0 CA--C 1.53 0.977 0 O-C-N 124.428 1.08 . . . . 0.0 111.026 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 181' ' ' MET . . . . . 0.405 ' HA ' ' O ' ' A' ' 170' ' ' TRP . 3.0 mmm -87.7 97.49 10.92 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.492 0.76 . . . . 0.0 111.017 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . 0.471 HG21 HD22 ' A' ' 159' ' ' LEU . 3.4 pt -90.78 157.69 43.37 Favored Pre-proline 0 C--N 1.325 -0.498 0 O-C-N 124.498 1.124 . . . . 0.0 109.323 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 183' ' ' PRO . . . . . 0.74 ' HG2' ' HB2' ' A' ' 186' ' ' TYR . 18.3 Cg_endo -75.06 136.86 20.84 Favored 'Trans proline' 0 C--N 1.36 1.164 0 O-C-N 124.557 1.819 . . . . 0.0 111.012 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . 0.838 ' N ' ' CD ' ' A' ' 185' ' ' PRO . 92.2 t -82.08 -31.07 0.54 Allowed Pre-proline 0 C--N 1.325 -0.474 0 O-C-N 124.527 1.142 . . . . 0.0 109.37 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 185' ' ' PRO . . . . . 0.838 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.4 Cg_endo -74.99 -27.71 9.81 Favored 'Trans proline' 0 C--N 1.36 1.184 0 O-C-N 124.458 1.767 . . . . 0.0 111.012 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 186' ' ' TYR . . . . . 0.74 ' HB2' ' HG2' ' A' ' 183' ' ' PRO . 5.1 m-85 -91.37 15.17 12.7 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.493 1.12 . . . . 0.0 110.997 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 187' ' ' VAL . . . . . 0.415 ' HA ' ' HA ' ' A' ' 139' ' ' ALA . 34.5 m -143.22 167.32 13.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 O-C-N 124.504 1.127 . . . . 0.0 109.261 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 188' ' ' GLU . . . . . 0.483 ' CG ' ' HB3' ' A' ' 138' ' ' ARG . 0.0 OUTLIER -126.3 168.03 14.68 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 124.487 1.117 . . . . 0.0 110.329 179.943 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 12.3 mmmm -89.25 129.88 35.74 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.511 1.132 . . . . 0.0 109.274 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 190' ' ' TYR . . . . . 0.433 ' HB3' ' O ' ' A' ' 136' ' ' TYR . 0.8 OUTLIER . . . . . 0 C--N 1.324 -0.512 0 O-C-N 124.48 1.112 . . . . 0.0 110.963 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . 0.521 ' O ' ' HG2' ' A' ' 160' ' ' ARG . 0.1 OUTLIER . . . . . 0 N--CA 1.454 -0.262 0 N-CA-C 110.266 -0.272 . . . . 0.0 110.266 . . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . 0.44 ' CE1' ' HG3' ' A' ' 160' ' ' ARG . 0.7 OUTLIER -129.19 132.4 47.28 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.432 1.083 . . . . 0.0 110.963 179.963 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 3.4 m -128.15 164.51 29.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 O-C-N 124.449 1.093 . . . . 0.0 109.297 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . 0.405 ' O ' ' HA ' ' A' ' 187' ' ' VAL . 0.5 OUTLIER -123.57 126.32 46.45 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.482 1.114 . . . . 0.0 110.308 179.975 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -89.8 103.9 16.51 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.559 1.162 . . . . 0.0 109.258 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.457 ' CD1' ' HG2' ' A' ' 188' ' ' GLU . 0.2 OUTLIER -87.94 12.62 12.79 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.498 1.123 . . . . 0.0 109.231 -179.99 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . 0.471 ' O ' ' O ' ' A' ' 154' ' ' LYS . 23.7 m-85 -146.69 154.99 42.08 Favored 'General case' 0 C--N 1.324 -0.532 0 O-C-N 124.577 1.173 . . . . 0.0 111.041 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . 0.469 ' CB ' ' HA ' ' A' ' 154' ' ' LYS . 7.2 p-10 . . . . . 0 C--N 1.325 -0.457 0 O-C-N 124.51 1.131 . . . . 0.0 109.237 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . 0.457 ' C ' ' CD1' ' A' ' 153' ' ' PHE . 7.3 p90 . . . . . 0 N--CA 1.453 -0.308 0 CA-C-O 120.482 0.182 . . . . 0.0 110.981 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . 0.471 ' O ' ' O ' ' A' ' 141' ' ' PHE . 3.8 tttt -135.61 -156.1 0.69 Allowed 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.562 1.164 . . . . 0.0 109.232 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 4.4 ptpp? -99.84 106.74 18.63 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.494 1.121 . . . . 0.0 109.334 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 108.88 27.65 4.8 Favored Glycine 0 CA--C 1.53 1.018 0 O-C-N 124.499 1.125 . . . . 0.0 110.953 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . 0.406 ' OD2' ' HG ' ' A' ' 159' ' ' LEU . 13.4 t70 -101.04 162.05 13.16 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.46 0.741 . . . . 0.0 109.306 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 19.6 mm -114.0 142.34 26.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 O-C-N 124.621 1.201 . . . . 0.0 109.327 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . 0.406 ' HG ' ' OD2' ' A' ' 157' ' ' ASP . 2.2 mt -142.41 135.19 28.28 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.486 1.116 . . . . 0.0 109.328 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . 0.521 ' HG2' ' O ' ' A' ' 135' ' ' GLU . 8.2 ttm-85 -97.59 134.72 40.43 Favored 'General case' 0 C--N 1.324 -0.531 0 O-C-N 124.493 1.121 . . . . 0.0 110.303 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . 0.413 ' CB ' ' HB2' ' A' ' 135' ' ' GLU . 1.2 mp -82.65 119.39 32.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 O-C-N 124.537 1.148 . . . . 0.0 109.23 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . 0.427 ' HB3' ' NH1' ' A' ' 162' ' ' ARG . 2.8 mmm180 -110.49 -59.19 1.98 Allowed 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.49 1.119 . . . . 0.0 110.332 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -129.23 163.84 24.75 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.456 1.097 . . . . 0.0 109.288 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . 0.426 ' HG3' ' NE1' ' A' ' 170' ' ' TRP . 0.3 OUTLIER -139.91 76.19 28.79 Favored Pre-proline 0 C--N 1.325 -0.489 0 O-C-N 124.537 1.148 . . . . 0.0 109.329 -179.951 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.97 -30.73 6.91 Favored 'Trans proline' 0 C--N 1.36 1.165 0 O-C-N 124.469 1.773 . . . . 0.0 111.038 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -113.4 169.68 8.78 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.519 1.137 . . . . 0.0 110.303 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -96.85 -27.92 14.47 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 124.47 1.106 . . . . 0.0 110.33 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -84.51 -55.94 3.88 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.47 1.107 . . . . 0.0 110.308 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 169' ' ' TRP . . . . . 0.436 ' CD1' ' N ' ' A' ' 169' ' ' TRP . 2.7 m95 -111.17 145.68 38.22 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.496 1.122 . . . . 0.0 107.99 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 170' ' ' TRP . . . . . 0.582 ' CZ3' HG11 ' A' ' 184' ' ' VAL . 50.3 m0 -122.09 156.78 32.87 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.509 1.131 . . . . 0.0 108.0 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 171' ' ' ASN . . . . . 0.413 ' OD1' ' C ' ' A' ' 171' ' ' ASN . 33.0 t-20 -86.92 98.63 11.34 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.522 1.139 . . . . 0.0 109.351 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . 0.521 ' CA ' ' O ' ' A' ' 160' ' ' ARG . . . -113.87 176.19 5.14 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.483 1.114 . . . . 0.0 109.28 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . 0.492 ' CG ' ' HG3' ' A' ' 179' ' ' ARG . 9.6 mt-10 -112.75 127.71 56.22 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 124.354 1.033 . . . . 0.0 110.237 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 6.2 p30 -83.78 -170.73 3.22 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.483 1.114 . . . . 0.0 109.327 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 1.1 t -79.53 68.06 5.46 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.493 1.121 . . . . 0.0 109.999 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 176.86 -4.39 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.473 1.108 . . . . 0.0 110.28 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 81.61 21.27 62.22 Favored Glycine 0 CA--C 1.53 1.012 0 O-C-N 124.542 1.151 . . . . 0.0 110.98 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 12.9 mtpt -92.04 118.67 31.02 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.483 0.754 . . . . 0.0 109.306 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 179' ' ' ARG . . . . . 0.492 ' HG3' ' CG ' ' A' ' 173' ' ' GLU . 61.0 mtt180 -89.92 121.92 32.47 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.443 1.089 . . . . 0.0 110.237 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . 0.402 ' O ' ' HA ' ' A' ' 171' ' ' ASN . . . -150.77 166.93 30.4 Favored Glycine 0 CA--C 1.53 0.994 0 O-C-N 124.456 1.097 . . . . 0.0 111.0 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 181' ' ' MET . . . . . 0.436 ' HA ' ' O ' ' A' ' 170' ' ' TRP . 11.0 mtp -87.16 104.23 16.16 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.488 0.758 . . . . 0.0 110.921 -179.935 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . 0.414 ' HB ' ' HD2' ' A' ' 183' ' ' PRO . 1.4 pp -106.9 159.99 27.95 Favored Pre-proline 0 C--N 1.324 -0.527 0 O-C-N 124.587 1.18 . . . . 0.0 109.292 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 183' ' ' PRO . . . . . 0.627 ' HG2' ' HB2' ' A' ' 186' ' ' TYR . 18.5 Cg_endo -74.89 131.1 14.04 Favored 'Trans proline' 0 C--N 1.36 1.18 0 O-C-N 124.55 1.816 . . . . 0.0 111.066 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . 0.764 ' N ' ' CD ' ' A' ' 185' ' ' PRO . 93.4 t -77.87 -33.99 1.06 Allowed Pre-proline 0 C--N 1.324 -0.506 0 O-C-N 124.54 1.15 . . . . 0.0 109.351 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 185' ' ' PRO . . . . . 0.764 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.3 Cg_endo -75.02 -11.44 21.45 Favored 'Trans proline' 0 C--N 1.361 1.199 0 O-C-N 124.41 1.742 . . . . 0.0 111.028 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 186' ' ' TYR . . . . . 0.627 ' HB2' ' HG2' ' A' ' 183' ' ' PRO . 6.7 m-85 -97.01 5.98 49.44 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.586 1.179 . . . . 0.0 110.996 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 187' ' ' VAL . . . . . 0.405 ' HA ' ' O ' ' A' ' 138' ' ' ARG . 8.4 m -137.74 173.32 13.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 O-C-N 124.507 1.13 . . . . 0.0 109.245 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 188' ' ' GLU . . . . . 0.457 ' HG2' ' CD1' ' A' ' 140' ' ' LEU . 0.0 OUTLIER -129.61 174.64 9.49 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.468 1.105 . . . . 0.0 110.253 -179.972 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 12.2 mmmm -86.98 117.19 25.54 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.472 1.108 . . . . 0.0 109.296 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 5.1 t80 . . . . . 0 C--N 1.325 -0.492 0 O-C-N 124.483 1.114 . . . . 0.0 111.014 179.962 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . 0.53 ' HB2' ' O ' ' A' ' 161' ' ' ILE . 1.6 pm0 . . . . . 0 N--CA 1.453 -0.301 0 N-CA-C 110.278 -0.268 . . . . 0.0 110.278 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . 0.797 ' CE1' ' CD2' ' A' ' 190' ' ' TYR . 1.4 t80 -122.29 131.13 53.76 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.476 1.11 . . . . 0.0 110.952 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.555 ' CG1' ' HB ' ' A' ' 187' ' ' VAL . 3.8 t -132.55 162.16 40.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 O-C-N 124.497 1.123 . . . . 0.0 109.326 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . 0.476 ' N ' ' CG1' ' A' ' 137' ' ' VAL . 2.2 tpp85 -136.14 135.28 39.12 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.494 1.121 . . . . 0.0 110.31 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . 0.538 ' O ' ' N ' ' A' ' 156' ' ' GLY . . . -98.57 109.51 22.25 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.506 1.129 . . . . 0.0 109.332 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.509 ' CD1' ' HG2' ' A' ' 188' ' ' GLU . 1.2 mt -88.71 -4.22 58.59 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.435 1.084 . . . . 0.0 109.263 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -133.28 154.46 50.67 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.536 1.147 . . . . 0.0 110.951 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . 0.409 ' CB ' ' HA ' ' A' ' 154' ' ' LYS . 7.6 t70 . . . . . 0 C--N 1.326 -0.427 0 O-C-N 124.484 1.115 . . . . 0.0 109.293 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . 0.466 ' CE2' ' CG ' ' A' ' 183' ' ' PRO . 18.9 p90 . . . . . 0 N--CA 1.453 -0.318 0 CA-C-O 120.472 0.177 . . . . 0.0 111.031 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . 0.409 ' HA ' ' CB ' ' A' ' 142' ' ' ASP . 0.1 OUTLIER -125.9 -164.04 1.27 Allowed 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.504 1.127 . . . . 0.0 109.282 -179.993 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -99.7 103.28 14.94 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.48 1.112 . . . . 0.0 109.267 -179.932 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . 0.538 ' N ' ' O ' ' A' ' 139' ' ' ALA . . . 114.76 23.42 4.68 Favored Glycine 0 CA--C 1.529 0.964 0 O-C-N 124.434 1.084 . . . . 0.0 111.013 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -101.69 170.0 8.46 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.454 0.738 . . . . 0.0 109.295 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . 0.618 ' CG2' ' CE1' ' A' ' 136' ' ' TYR . 3.6 mp -120.62 146.17 25.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 O-C-N 124.413 1.071 . . . . 0.0 109.257 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . 0.475 ' CD2' ' HA ' ' A' ' 174' ' ' ASP . 0.9 OUTLIER -140.13 125.54 18.97 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.435 1.084 . . . . 0.0 109.313 179.973 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . 0.538 ' O ' ' CB ' ' A' ' 172' ' ' ALA . 1.1 ttp85 -88.04 130.89 34.85 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.554 1.159 . . . . 0.0 110.291 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . 0.53 ' O ' ' HB2' ' A' ' 135' ' ' GLU . 8.7 mm -83.3 125.88 40.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 O-C-N 124.518 1.136 . . . . 0.0 109.283 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.32 -58.85 1.89 Allowed 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.495 1.122 . . . . 0.0 110.34 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . 0.422 ' CB ' ' HB3' ' A' ' 171' ' ' ASN . 0.1 OUTLIER -115.37 154.65 28.81 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.5 1.125 . . . . 0.0 109.313 179.948 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . 0.543 ' HG3' ' CD1' ' A' ' 170' ' ' TRP . 28.9 tttm -146.47 66.64 11.15 Favored Pre-proline 0 C--N 1.325 -0.476 0 O-C-N 124.552 1.157 . . . . 0.0 109.241 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -74.99 -33.08 4.86 Favored 'Trans proline' 0 C--N 1.36 1.133 0 O-C-N 124.522 1.801 . . . . 0.0 111.019 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -104.48 171.02 7.56 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.498 1.124 . . . . 0.0 110.289 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 21.5 mt-10 -101.4 -30.08 11.66 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.504 1.128 . . . . 0.0 110.31 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 28.3 tt0 -74.47 -61.11 1.98 Allowed 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.559 1.162 . . . . 0.0 110.292 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 169' ' ' TRP . . . . . 0.562 ' CZ2' ' HB3' ' A' ' 183' ' ' PRO . 13.3 m95 -114.35 160.54 18.99 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.481 1.113 . . . . 0.0 108.001 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 170' ' ' TRP . . . . . 0.611 ' CE2' HG21 ' A' ' 184' ' ' VAL . 10.6 m0 -134.19 156.95 47.44 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.53 1.144 . . . . 0.0 108.011 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 171' ' ' ASN . . . . . 0.459 ' HA ' ' O ' ' A' ' 180' ' ' GLY . 40.5 t30 -87.42 102.48 14.58 Favored 'General case' 0 C--N 1.324 -0.522 0 O-C-N 124.523 1.14 . . . . 0.0 109.291 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . 0.538 ' CB ' ' O ' ' A' ' 160' ' ' ARG . . . -118.35 -178.19 3.46 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.521 1.138 . . . . 0.0 109.367 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 -114.76 118.52 33.82 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.527 1.142 . . . . 0.0 110.227 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . 0.475 ' HA ' ' CD2' ' A' ' 159' ' ' LEU . 0.2 OUTLIER -73.43 -171.53 1.0 Allowed 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.522 1.139 . . . . 0.0 109.285 -179.998 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 29.1 t -80.07 56.56 2.43 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.546 1.154 . . . . 0.0 110.0 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -173.82 27.05 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.402 1.064 . . . . 0.0 110.392 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 50.47 22.53 5.46 Favored Glycine 0 CA--C 1.53 0.999 0 O-C-N 124.51 1.131 . . . . 0.0 110.992 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 2.7 ptpt -92.86 122.28 35.08 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.515 0.773 . . . . 0.0 109.352 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 40.6 mtt85 -91.16 115.4 27.99 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.467 1.104 . . . . 0.0 110.312 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . 0.459 ' O ' ' HA ' ' A' ' 171' ' ' ASN . . . -150.38 179.51 27.05 Favored Glycine 0 CA--C 1.531 1.05 0 O-C-N 124.595 1.185 . . . . 0.0 110.998 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 181' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -85.33 107.35 17.29 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.576 0.81 . . . . 0.0 110.971 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -98.0 144.14 27.49 Favored Pre-proline 0 C--N 1.325 -0.496 0 O-C-N 124.541 1.151 . . . . 0.0 109.262 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 183' ' ' PRO . . . . . 0.725 ' HG2' ' HB2' ' A' ' 186' ' ' TYR . 18.5 Cg_endo -75.01 136.48 20.44 Favored 'Trans proline' 0 C--N 1.36 1.18 0 O-C-N 124.476 1.777 . . . . 0.0 111.021 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . 0.815 ' N ' ' CD ' ' A' ' 185' ' ' PRO . 44.3 t -82.03 -32.59 0.6 Allowed Pre-proline 0 C--N 1.326 -0.447 0 O-C-N 124.478 1.111 . . . . 0.0 109.305 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 185' ' ' PRO . . . . . 0.815 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.5 Cg_endo -75.0 -31.46 6.19 Favored 'Trans proline' 0 C--N 1.36 1.163 0 O-C-N 124.48 1.779 . . . . 0.0 111.024 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 186' ' ' TYR . . . . . 0.725 ' HB2' ' HG2' ' A' ' 183' ' ' PRO . 3.8 m-85 -90.8 19.39 5.55 Favored 'General case' 0 C--N 1.326 -0.428 0 O-C-N 124.483 1.114 . . . . 0.0 111.005 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 187' ' ' VAL . . . . . 0.555 ' HB ' ' CG1' ' A' ' 137' ' ' VAL . 11.3 m -149.64 179.49 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 O-C-N 124.44 1.088 . . . . 0.0 109.371 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 188' ' ' GLU . . . . . 0.509 ' HG2' ' CD1' ' A' ' 140' ' ' LEU . 0.0 OUTLIER -139.54 166.33 24.86 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.496 1.122 . . . . 0.0 110.37 -179.994 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.64 129.74 39.81 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.478 1.111 . . . . 0.0 109.325 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 190' ' ' TYR . . . . . 0.797 ' CD2' ' CE1' ' A' ' 136' ' ' TYR . 0.2 OUTLIER . . . . . 0 C--N 1.326 -0.456 0 O-C-N 124.495 1.122 . . . . 0.0 111.045 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . 0.417 ' CD ' ' O ' ' A' ' 161' ' ' ILE . 1.9 pt-20 . . . . . 0 N--CA 1.453 -0.319 0 N-CA-C 110.292 -0.262 . . . . 0.0 110.292 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -111.35 135.17 52.29 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.546 1.154 . . . . 0.0 110.987 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.519 ' CG2' ' O ' ' A' ' 188' ' ' GLU . 0.5 OUTLIER -126.01 157.03 36.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 O-C-N 124.498 1.124 . . . . 0.0 109.254 -179.933 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . 0.483 ' O ' ' N ' ' A' ' 188' ' ' GLU . 1.4 ttm180 -126.22 139.48 53.31 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.513 1.133 . . . . 0.0 110.263 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . 0.411 ' N ' ' HG3' ' A' ' 138' ' ' ARG . . . -103.61 106.23 16.68 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 124.523 1.14 . . . . 0.0 109.306 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.444 ' O ' ' CG ' ' A' ' 155' ' ' LYS . 0.2 OUTLIER -87.32 -1.39 57.88 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.513 1.133 . . . . 0.0 109.327 179.965 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . 0.402 ' O ' ' O ' ' A' ' 154' ' ' LYS . 35.1 m-85 -128.14 159.63 34.54 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.488 1.118 . . . . 0.0 110.96 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . 0.451 ' CB ' ' HA ' ' A' ' 154' ' ' LYS . 45.2 p-10 . . . . . 0 C--N 1.324 -0.509 0 O-C-N 124.531 1.145 . . . . 0.0 109.278 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 15.3 p90 . . . . . 0 N--CA 1.452 -0.33 0 CA-C-O 120.447 0.165 . . . . 0.0 111.035 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . 0.451 ' HA ' ' CB ' ' A' ' 142' ' ' ASP . 0.0 OUTLIER -130.54 -162.2 1.19 Allowed 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.537 1.148 . . . . 0.0 109.294 179.98 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.444 ' CG ' ' O ' ' A' ' 140' ' ' LEU . 2.9 tmtt? -94.47 107.51 19.48 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.495 1.122 . . . . 0.0 109.335 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . 0.453 ' HA2' ' CZ ' ' A' ' 138' ' ' ARG . . . 112.29 23.15 5.58 Favored Glycine 0 CA--C 1.529 0.949 0 O-C-N 124.529 1.143 . . . . 0.0 111.049 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -93.76 170.2 9.74 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.434 0.726 . . . . 0.0 109.296 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . 0.43 ' C ' ' HG ' ' A' ' 159' ' ' LEU . 3.0 mp -132.63 147.85 31.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 O-C-N 124.514 1.134 . . . . 0.0 109.234 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . 0.495 ' HB2' ' CG1' ' A' ' 137' ' ' VAL . 12.0 mt -147.67 131.82 17.36 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.483 1.114 . . . . 0.0 109.335 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . 0.552 ' O ' ' HA ' ' A' ' 172' ' ' ALA . 0.5 OUTLIER -86.85 139.38 30.72 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.457 1.098 . . . . 0.0 110.31 -179.975 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . 0.465 ' CD1' ' HB ' ' A' ' 137' ' ' VAL . 1.4 mp -84.02 116.44 27.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 O-C-N 124.48 1.112 . . . . 0.0 109.287 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.92 -58.28 2.0 Allowed 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.499 1.124 . . . . 0.0 110.222 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . 0.442 ' OD1' ' N ' ' A' ' 164' ' ' LYS . 0.6 OUTLIER -136.47 161.37 36.02 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.484 1.115 . . . . 0.0 109.307 -179.918 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . 0.442 ' N ' ' OD1' ' A' ' 163' ' ' ASP . 0.0 OUTLIER -143.1 84.62 10.29 Favored Pre-proline 0 C--N 1.325 -0.48 0 O-C-N 124.489 1.118 . . . . 0.0 109.298 179.925 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' PRO . . . . . 0.485 ' CD ' ' HE3' ' A' ' 181' ' ' MET . 18.4 Cg_endo -75.04 -39.04 1.31 Allowed 'Trans proline' 0 C--N 1.36 1.174 0 O-C-N 124.385 1.729 . . . . 0.0 111.029 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . 0.463 ' O ' ' NE1' ' A' ' 170' ' ' TRP . 3.9 mm-40 -111.36 178.24 4.4 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.532 1.145 . . . . 0.0 110.345 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.82 -22.02 14.45 Favored 'General case' 0 C--N 1.323 -0.546 0 O-C-N 124.51 1.131 . . . . 0.0 110.31 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 168' ' ' GLN . . . . . 0.443 ' HB3' ' CD1' ' A' ' 169' ' ' TRP . 0.0 OUTLIER -83.89 -57.89 3.02 Favored 'General case' 0 C--N 1.324 -0.523 0 O-C-N 124.527 1.142 . . . . 0.0 110.273 -179.996 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 169' ' ' TRP . . . . . 0.443 ' CD1' ' HB3' ' A' ' 168' ' ' GLN . 11.7 m95 -108.03 149.98 27.73 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.51 1.131 . . . . 0.0 107.994 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 170' ' ' TRP . . . . . 0.595 ' CE3' HG12 ' A' ' 184' ' ' VAL . 26.6 m0 -131.3 151.59 51.36 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.486 1.116 . . . . 0.0 108.015 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 171' ' ' ASN . . . . . 0.421 ' CA ' ' HE2' ' A' ' 181' ' ' MET . 1.0 OUTLIER -87.64 98.89 11.67 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.548 1.155 . . . . 0.0 109.229 -179.913 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . 0.552 ' HA ' ' O ' ' A' ' 160' ' ' ARG . . . -112.46 166.17 11.56 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.434 1.084 . . . . 0.0 109.286 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . 0.42 ' HG2' ' CA ' ' A' ' 179' ' ' ARG . 18.9 mt-10 -116.13 120.87 40.43 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.523 1.139 . . . . 0.0 110.256 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -74.77 -173.4 1.84 Allowed 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.521 1.138 . . . . 0.0 109.321 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 22.6 t -79.83 63.24 4.32 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.507 1.129 . . . . 0.0 110.048 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -174.25 9.78 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.553 1.158 . . . . 0.0 110.309 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 68.69 19.49 73.2 Favored Glycine 0 CA--C 1.531 1.08 0 O-C-N 124.57 1.169 . . . . 0.0 110.986 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 178' ' ' LYS . . . . . 0.412 ' O ' ' HA ' ' A' ' 173' ' ' GLU . 0.1 OUTLIER -94.29 112.32 24.11 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 124.583 0.813 . . . . 0.0 109.228 -179.945 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 179' ' ' ARG . . . . . 0.447 ' HA ' ' O ' ' A' ' 172' ' ' ALA . 0.1 OUTLIER -96.69 124.6 40.73 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.548 1.155 . . . . 0.0 110.324 179.915 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -149.9 164.87 29.65 Favored Glycine 0 CA--C 1.531 1.092 0 O-C-N 124.531 1.144 . . . . 0.0 110.947 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 181' ' ' MET . . . . . 0.485 ' HE3' ' CD ' ' A' ' 165' ' ' PRO . 0.3 OUTLIER -88.98 100.98 13.63 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.57 0.806 . . . . 0.0 111.005 179.992 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . 0.482 HG12 ' N ' ' A' ' 183' ' ' PRO . 0.2 OUTLIER -108.52 174.09 2.64 Favored Pre-proline 0 C--N 1.325 -0.488 0 O-C-N 124.436 1.085 . . . . 0.0 109.311 -179.999 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 183' ' ' PRO . . . . . 0.601 ' HB2' ' CD1' ' A' ' 186' ' ' TYR . 18.5 Cg_endo -74.95 129.21 12.17 Favored 'Trans proline' 0 C--N 1.36 1.132 0 O-C-N 124.535 1.808 . . . . 0.0 111.014 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . 0.816 ' N ' ' CD ' ' A' ' 185' ' ' PRO . 38.7 t -78.91 -32.94 0.83 Allowed Pre-proline 0 C--N 1.325 -0.459 0 O-C-N 124.473 1.108 . . . . 0.0 109.358 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 185' ' ' PRO . . . . . 0.816 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.6 Cg_endo -75.02 -13.84 21.25 Favored 'Trans proline' 0 C--N 1.361 1.189 0 O-C-N 124.45 1.763 . . . . 0.0 111.033 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 186' ' ' TYR . . . . . 0.601 ' CD1' ' HB2' ' A' ' 183' ' ' PRO . 7.9 m-85 -93.93 10.59 32.74 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.514 1.134 . . . . 0.0 110.985 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 187' ' ' VAL . . . . . 0.48 ' HA ' ' O ' ' A' ' 138' ' ' ARG . 20.3 m -143.12 165.01 15.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 O-C-N 124.503 1.127 . . . . 0.0 109.311 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 188' ' ' GLU . . . . . 0.519 ' O ' ' CG2' ' A' ' 137' ' ' VAL . 0.0 OUTLIER -120.42 159.61 24.76 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.512 1.132 . . . . 0.0 110.303 -179.995 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -86.59 134.17 33.66 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.519 1.137 . . . . 0.0 109.292 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.325 -0.475 0 O-C-N 124.53 1.144 . . . . 0.0 111.028 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . 0.526 ' O ' ' HG2' ' A' ' 160' ' ' ARG . 0.4 OUTLIER . . . . . 0 N--CA 1.453 -0.293 0 N-CA-C 110.285 -0.265 . . . . 0.0 110.285 . . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 39.2 m-85 -128.82 126.91 40.85 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.459 1.099 . . . . 0.0 110.984 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.452 ' HA ' ' O ' ' A' ' 188' ' ' GLU . 28.5 m -121.06 170.03 11.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 O-C-N 124.535 1.147 . . . . 0.0 109.334 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . 0.447 ' O ' ' HA ' ' A' ' 187' ' ' VAL . 5.1 ttm180 -133.91 127.64 32.91 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.498 1.124 . . . . 0.0 110.306 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . 0.597 ' O ' ' N ' ' A' ' 156' ' ' GLY . . . -93.5 115.58 28.1 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.582 1.176 . . . . 0.0 109.27 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.52 ' O ' ' CB ' ' A' ' 155' ' ' LYS . 0.2 OUTLIER -95.22 -19.58 19.92 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.545 1.153 . . . . 0.0 109.338 179.908 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . 0.444 ' O ' ' O ' ' A' ' 154' ' ' LYS . 5.8 m-85 -114.45 147.52 39.16 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.45 1.094 . . . . 0.0 110.96 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . 0.447 ' N ' ' OD1' ' A' ' 142' ' ' ASP . 0.0 OUTLIER . . . . . 0 C--N 1.325 -0.49 0 O-C-N 124.476 1.11 . . . . 0.0 109.275 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . 0.496 ' CE2' ' HD2' ' A' ' 183' ' ' PRO . 20.9 p90 . . . . . 0 N--CA 1.454 -0.248 0 CA-C-O 120.581 0.229 . . . . 0.0 110.947 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . 0.447 ' HG3' ' CG ' ' A' ' 142' ' ' ASP . 3.4 tttt -130.0 -120.92 0.22 Allowed 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.46 1.1 . . . . 0.0 109.317 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.52 ' CB ' ' O ' ' A' ' 140' ' ' LEU . 0.3 OUTLIER -126.65 118.22 24.34 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.559 1.162 . . . . 0.0 109.315 179.976 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . 0.597 ' N ' ' O ' ' A' ' 139' ' ' ALA . . . 98.16 19.61 23.18 Favored Glycine 0 CA--C 1.53 1.004 0 O-C-N 124.513 1.133 . . . . 0.0 111.012 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -91.45 157.04 17.28 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.54 0.788 . . . . 0.0 109.291 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 12.8 mm -113.19 141.04 30.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 O-C-N 124.486 1.116 . . . . 0.0 109.298 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . 0.427 HD21 ' C ' ' A' ' 173' ' ' GLU . 7.2 mt -145.3 124.95 13.26 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.503 1.127 . . . . 0.0 109.316 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . 0.528 ' O ' ' HA ' ' A' ' 172' ' ' ALA . 0.0 OUTLIER -87.68 135.21 33.46 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.42 1.075 . . . . 0.0 110.342 179.99 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . 0.419 ' CD1' HG23 ' A' ' 137' ' ' VAL . 1.4 mp -83.0 119.37 32.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 O-C-N 124.428 1.08 . . . . 0.0 109.286 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.56 -46.35 2.58 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.573 1.17 . . . . 0.0 110.309 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . 0.457 ' CB ' ' HB3' ' A' ' 171' ' ' ASN . 0.1 OUTLIER -134.94 179.59 6.22 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.564 1.165 . . . . 0.0 109.264 179.998 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . 0.598 ' HB2' ' CD1' ' A' ' 170' ' ' TRP . 0.0 OUTLIER -170.82 91.97 0.46 Allowed Pre-proline 0 C--N 1.326 -0.432 0 O-C-N 124.462 1.101 . . . . 0.0 109.311 -179.994 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.03 -26.35 10.95 Favored 'Trans proline' 0 C--N 1.362 1.239 0 O-C-N 124.513 1.796 . . . . 0.0 111.023 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -126.26 166.27 17.42 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.508 1.13 . . . . 0.0 110.24 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -86.54 -26.09 24.72 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.501 1.126 . . . . 0.0 110.299 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 4.4 mt-30 -78.02 -56.58 4.37 Favored 'General case' 0 C--N 1.324 -0.524 0 O-C-N 124.568 1.167 . . . . 0.0 110.316 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 169' ' ' TRP . . . . . . . . . . . . . 9.2 m95 -104.87 145.83 29.85 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 170' ' ' TRP . . . . . 0.598 ' CD1' ' HB2' ' A' ' 164' ' ' LYS . 30.8 m0 -122.44 151.43 41.28 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.564 1.165 . . . . 0.0 108.034 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 171' ' ' ASN . . . . . 0.457 ' HB3' ' CB ' ' A' ' 163' ' ' ASP . 2.7 t30 -86.44 96.19 9.95 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.544 1.153 . . . . 0.0 109.289 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . 0.528 ' HA ' ' O ' ' A' ' 160' ' ' ARG . . . -107.26 166.65 10.48 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.496 1.123 . . . . 0.0 109.259 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . 0.449 ' HA ' ' O ' ' A' ' 178' ' ' LYS . 34.3 mt-10 -126.03 126.25 43.95 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.503 1.127 . . . . 0.0 110.31 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . 0.493 ' HB2' ' CG ' ' A' ' 178' ' ' LYS . 1.1 m-20 -79.48 -174.57 4.3 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.521 1.138 . . . . 0.0 109.277 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 38.4 t -77.74 56.27 1.48 Allowed 'General case' 0 C--N 1.324 -0.528 0 O-C-N 124.584 1.178 . . . . 0.0 109.964 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . 0.459 ' CB ' ' HD2' ' A' ' 178' ' ' LYS . 0.0 OUTLIER -167.68 16.68 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.466 1.104 . . . . 0.0 110.298 179.925 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 62.57 15.13 52.73 Favored Glycine 0 CA--C 1.53 0.983 0 O-C-N 124.503 1.127 . . . . 0.0 110.992 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 178' ' ' LYS . . . . . 0.493 ' CG ' ' HB2' ' A' ' 174' ' ' ASP . 1.5 ptmm? -86.04 108.15 18.12 Favored 'General case' 0 C--N 1.326 -0.429 0 O-C-N 124.469 0.747 . . . . 0.0 109.334 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 179' ' ' ARG . . . . . 0.435 ' HA ' ' O ' ' A' ' 172' ' ' ALA . 0.0 OUTLIER -96.11 127.82 42.47 Favored 'General case' 0 C--N 1.324 -0.523 0 O-C-N 124.51 1.131 . . . . 0.0 110.284 -179.961 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -152.27 165.84 30.94 Favored Glycine 0 CA--C 1.53 0.993 0 O-C-N 124.511 1.132 . . . . 0.0 111.021 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 181' ' ' MET . . . . . 0.436 ' HA ' ' O ' ' A' ' 170' ' ' TRP . 25.4 mtp -88.41 105.32 17.52 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.488 0.758 . . . . 0.0 110.98 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . 0.485 ' C ' ' CD1' ' A' ' 182' ' ' ILE . 0.0 OUTLIER -110.15 164.11 15.6 Favored Pre-proline 0 C--N 1.324 -0.536 0 O-C-N 124.514 1.134 . . . . 0.0 109.359 179.956 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 183' ' ' PRO . . . . . 0.637 ' HG2' ' HB2' ' A' ' 186' ' ' TYR . 18.3 Cg_endo -74.99 128.85 11.82 Favored 'Trans proline' 0 C--N 1.36 1.169 0 O-C-N 124.51 1.795 . . . . 0.0 111.048 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . 0.812 ' N ' ' CD ' ' A' ' 185' ' ' PRO . 59.8 t -76.87 -32.96 1.06 Allowed Pre-proline 0 C--N 1.324 -0.506 0 O-C-N 124.576 1.173 . . . . 0.0 109.266 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 185' ' ' PRO . . . . . 0.812 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.5 Cg_endo -74.99 -14.57 21.13 Favored 'Trans proline' 0 C--N 1.36 1.15 0 O-C-N 124.485 1.782 . . . . 0.0 111.048 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 186' ' ' TYR . . . . . 0.637 ' HB2' ' HG2' ' A' ' 183' ' ' PRO . 6.3 m-85 -96.26 5.01 51.93 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.522 1.139 . . . . 0.0 111.001 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 187' ' ' VAL . . . . . 0.447 ' HA ' ' O ' ' A' ' 138' ' ' ARG . 12.6 m -135.81 165.02 30.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 O-C-N 124.499 1.124 . . . . 0.0 109.248 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 188' ' ' GLU . . . . . 0.481 ' OE2' ' CD2' ' A' ' 140' ' ' LEU . 0.3 OUTLIER -115.03 153.22 31.07 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.475 1.11 . . . . 0.0 110.277 -179.984 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.54 137.01 32.7 Favored 'General case' 0 C--N 1.326 -0.436 0 O-C-N 124.505 1.128 . . . . 0.0 109.334 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 . . . . . 0 C--N 1.326 -0.456 0 O-C-N 124.57 1.169 . . . . 0.0 110.987 179.99 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . 0.523 ' CB ' ' O ' ' A' ' 161' ' ' ILE . 25.3 mp0 . . . . . 0 N--CA 1.453 -0.279 0 N-CA-C 110.379 -0.23 . . . . 0.0 110.379 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 76.0 m-85 -126.66 125.07 41.27 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.512 1.133 . . . . 0.0 111.021 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.485 ' CG2' HD13 ' A' ' 161' ' ' ILE . 7.5 m -131.84 141.26 46.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 O-C-N 124.533 1.145 . . . . 0.0 109.336 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . 0.546 ' HD2' ' CE1' ' A' ' 190' ' ' TYR . 0.8 OUTLIER -115.58 137.5 52.0 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.57 1.169 . . . . 0.0 110.261 -179.956 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . 0.645 ' O ' ' N ' ' A' ' 156' ' ' GLY . . . -92.56 115.6 28.25 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.501 1.126 . . . . 0.0 109.273 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.57 ' HB2' ' CE1' ' A' ' 141' ' ' PHE . 0.2 OUTLIER -87.44 -8.41 56.53 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.495 1.122 . . . . 0.0 109.331 179.993 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . 0.57 ' CE1' ' HB2' ' A' ' 140' ' ' LEU . 0.4 OUTLIER -128.04 144.31 51.1 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.494 1.121 . . . . 0.0 111.004 179.991 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.325 -0.494 0 O-C-N 124.55 1.156 . . . . 0.0 109.242 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . 0.573 ' CE1' ' CG ' ' A' ' 183' ' ' PRO . 24.4 p90 . . . . . 0 N--CA 1.452 -0.363 0 CA-C-O 120.491 0.186 . . . . 0.0 111.046 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . 0.414 ' O ' ' OD1' ' A' ' 157' ' ' ASP . 0.6 OUTLIER -119.76 -155.56 0.62 Allowed 'General case' 0 C--N 1.326 -0.438 0 O-C-N 124.479 1.112 . . . . 0.0 109.296 -179.992 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 1.1 tttp -111.96 98.78 7.6 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.473 1.108 . . . . 0.0 109.314 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . 0.645 ' N ' ' O ' ' A' ' 139' ' ' ALA . . . 115.55 25.75 3.62 Favored Glycine 0 CA--C 1.529 0.967 0 O-C-N 124.525 1.141 . . . . 0.0 111.038 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . 0.414 ' OD1' ' O ' ' A' ' 154' ' ' LYS . 3.4 p-10 -99.13 166.85 11.05 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.438 0.728 . . . . 0.0 109.28 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . 0.471 ' N ' ' CD1' ' A' ' 158' ' ' ILE . 2.1 mp -122.5 150.88 26.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 O-C-N 124.422 1.076 . . . . 0.0 109.268 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . 0.481 ' CD2' HG23 ' A' ' 182' ' ' ILE . 0.4 OUTLIER -151.94 134.84 15.65 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.482 1.114 . . . . 0.0 109.336 179.988 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . 0.465 ' HG2' ' O ' ' A' ' 135' ' ' GLU . 0.1 OUTLIER -93.53 127.56 39.25 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.431 1.082 . . . . 0.0 110.314 -179.981 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . 0.523 ' O ' ' CB ' ' A' ' 135' ' ' GLU . 1.6 mp -85.67 121.49 37.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 O-C-N 124.48 1.112 . . . . 0.0 109.362 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . 0.429 ' CD ' ' HB2' ' A' ' 163' ' ' ASP . 0.2 OUTLIER -119.99 -32.21 4.26 Favored 'General case' 0 C--N 1.326 -0.431 0 O-C-N 124.425 1.078 . . . . 0.0 110.289 -179.976 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . 0.448 ' CB ' ' HB3' ' A' ' 171' ' ' ASN . 0.4 OUTLIER -139.8 171.34 14.36 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.554 1.159 . . . . 0.0 109.299 179.985 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . 0.573 ' HB2' ' CD1' ' A' ' 170' ' ' TRP . 0.5 OUTLIER -156.8 82.62 3.26 Favored Pre-proline 0 C--N 1.325 -0.476 0 O-C-N 124.496 1.123 . . . . 0.0 109.312 -179.939 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -74.9 -25.71 11.83 Favored 'Trans proline' 0 C--N 1.359 1.129 0 O-C-N 124.438 1.757 . . . . 0.0 111.075 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 9.6 mt-10 -111.64 169.01 9.11 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.464 1.102 . . . . 0.0 110.317 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -90.98 -32.04 16.1 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.544 1.153 . . . . 0.0 110.296 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 168' ' ' GLN . . . . . 0.437 ' HB3' ' CD1' ' A' ' 169' ' ' TRP . 6.6 mt-30 -87.3 -53.45 4.83 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.552 1.158 . . . . 0.0 110.31 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 169' ' ' TRP . . . . . 0.473 ' N ' ' CD1' ' A' ' 169' ' ' TRP . 1.6 m95 -104.8 148.18 26.91 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.546 1.154 . . . . 0.0 107.972 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 170' ' ' TRP . . . . . 0.647 ' CE3' HG21 ' A' ' 184' ' ' VAL . 36.9 m0 -125.38 159.67 31.26 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.558 1.161 . . . . 0.0 108.05 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 171' ' ' ASN . . . . . 0.448 ' HB3' ' CB ' ' A' ' 163' ' ' ASP . 23.6 t-20 -86.14 109.5 18.92 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.511 1.132 . . . . 0.0 109.289 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . 0.449 ' CA ' ' O ' ' A' ' 160' ' ' ARG . . . -122.82 176.92 5.71 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.457 1.098 . . . . 0.0 109.323 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . 0.501 ' CG ' ' HG2' ' A' ' 179' ' ' ARG . 7.1 mt-10 -116.36 119.74 36.64 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.453 1.096 . . . . 0.0 110.357 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . 0.496 ' HB2' ' CG ' ' A' ' 178' ' ' LYS . 1.7 m-20 -74.66 -175.93 2.62 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.508 1.13 . . . . 0.0 109.361 179.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 98.2 p -76.74 58.93 1.49 Allowed 'General case' 0 C--N 1.324 -0.531 0 O-C-N 124.506 1.129 . . . . 0.0 109.99 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -170.93 -2.22 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.52 0 O-C-N 124.515 1.134 . . . . 0.0 110.333 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 79.16 19.58 71.9 Favored Glycine 0 CA--C 1.53 1.012 0 O-C-N 124.524 1.14 . . . . 0.0 111.037 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 178' ' ' LYS . . . . . 0.496 ' CG ' ' HB2' ' A' ' 174' ' ' ASP . 2.1 ptpp? -91.88 121.26 33.31 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.499 0.764 . . . . 0.0 109.331 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 179' ' ' ARG . . . . . 0.501 ' HG2' ' CG ' ' A' ' 173' ' ' GLU . 21.1 mtt85 -89.81 122.44 32.88 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.475 1.109 . . . . 0.0 110.275 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . 0.414 ' O ' ' HA ' ' A' ' 171' ' ' ASN . . . -152.02 167.04 31.11 Favored Glycine 0 CA--C 1.531 1.037 0 O-C-N 124.486 1.117 . . . . 0.0 110.972 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 181' ' ' MET . . . . . 0.45 ' HA ' ' O ' ' A' ' 170' ' ' TRP . 33.8 mtp -87.97 103.5 15.75 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.471 0.748 . . . . 0.0 110.988 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . 0.481 HG23 ' CD2' ' A' ' 159' ' ' LEU . 8.2 pt -98.7 157.12 34.79 Favored Pre-proline 0 C--N 1.324 -0.528 0 O-C-N 124.526 1.141 . . . . 0.0 109.281 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 183' ' ' PRO . . . . . 0.716 ' HG2' ' HB2' ' A' ' 186' ' ' TYR . 18.4 Cg_endo -75.0 135.27 18.85 Favored 'Trans proline' 0 C--N 1.36 1.148 0 O-C-N 124.495 1.787 . . . . 0.0 111.029 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . 0.816 ' N ' ' CD ' ' A' ' 185' ' ' PRO . 62.8 t -81.74 -32.45 0.61 Allowed Pre-proline 0 C--N 1.324 -0.501 0 O-C-N 124.547 1.155 . . . . 0.0 109.359 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 185' ' ' PRO . . . . . 0.816 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.5 Cg_endo -74.98 -25.35 11.97 Favored 'Trans proline' 0 C--N 1.36 1.159 0 O-C-N 124.508 1.794 . . . . 0.0 111.011 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 186' ' ' TYR . . . . . 0.716 ' HB2' ' HG2' ' A' ' 183' ' ' PRO . 3.8 m-85 -93.48 14.43 18.69 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.504 1.127 . . . . 0.0 111.068 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 187' ' ' VAL . . . . . 0.519 ' CG2' ' HA ' ' A' ' 184' ' ' VAL . 21.4 m -138.22 163.69 28.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 O-C-N 124.525 1.14 . . . . 0.0 109.272 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 188' ' ' GLU . . . . . 0.467 ' O ' ' HA ' ' A' ' 137' ' ' VAL . 0.0 OUTLIER -126.07 167.62 15.1 Favored 'General case' 0 C--N 1.326 -0.416 0 O-C-N 124.431 1.082 . . . . 0.0 110.335 179.958 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -87.5 125.39 34.28 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.508 1.13 . . . . 0.0 109.251 -179.9 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 190' ' ' TYR . . . . . 0.546 ' CE1' ' HD2' ' A' ' 138' ' ' ARG . 0.1 OUTLIER . . . . . 0 C--N 1.325 -0.472 0 O-C-N 124.444 1.09 . . . . 0.0 111.034 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . 0.442 ' HB2' ' HB ' ' A' ' 161' ' ' ILE . 0.2 OUTLIER . . . . . 0 N--CA 1.452 -0.328 0 N-CA-C 110.294 -0.262 . . . . 0.0 110.294 . . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . 0.582 ' C ' ' CD1' ' A' ' 136' ' ' TYR . 0.4 OUTLIER -121.97 143.0 49.73 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.493 1.121 . . . . 0.0 110.978 179.998 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.508 ' CG2' ' O ' ' A' ' 159' ' ' LEU . 35.1 m -145.03 137.45 21.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 O-C-N 124.431 1.082 . . . . 0.0 109.243 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . 0.445 ' HB3' ' HG3' ' A' ' 188' ' ' GLU . 0.6 OUTLIER -105.07 133.98 48.93 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.466 1.104 . . . . 0.0 110.285 -179.993 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . 0.499 ' O ' ' N ' ' A' ' 156' ' ' GLY . . . -95.97 112.57 24.27 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.56 1.163 . . . . 0.0 109.305 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.551 ' CD1' ' HG2' ' A' ' 188' ' ' GLU . 0.2 OUTLIER -98.5 -9.48 24.97 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.561 1.163 . . . . 0.0 109.325 -179.971 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . 0.495 ' C ' ' O ' ' A' ' 154' ' ' LYS . 14.3 m-85 -109.22 152.02 25.74 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.448 1.093 . . . . 0.0 111.062 179.906 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . 0.502 ' CA ' ' O ' ' A' ' 154' ' ' LYS . 3.3 t70 . . . . . 0 C--N 1.325 -0.495 0 O-C-N 124.551 1.157 . . . . 0.0 109.353 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 11.7 p90 . . . . . 0 N--CA 1.454 -0.263 0 CA-C-O 120.576 0.227 . . . . 0.0 110.922 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . 0.502 ' O ' ' CA ' ' A' ' 142' ' ' ASP . 0.0 OUTLIER -127.02 -80.73 0.6 Allowed 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.484 1.115 . . . . 0.0 109.303 -179.979 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -165.77 115.51 1.01 Allowed 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.538 1.149 . . . . 0.0 109.34 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . 0.499 ' N ' ' O ' ' A' ' 139' ' ' ALA . . . 100.38 20.83 14.27 Favored Glycine 0 CA--C 1.53 1.017 0 O-C-N 124.437 1.086 . . . . 0.0 111.049 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . 0.407 ' HB3' ' HB3' ' A' ' 139' ' ' ALA . 23.1 t70 -84.59 155.23 22.14 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.488 0.757 . . . . 0.0 109.32 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 13.1 mm -105.1 133.78 48.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 O-C-N 124.417 1.073 . . . . 0.0 109.342 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . 0.508 ' O ' ' CG2' ' A' ' 137' ' ' VAL . 0.4 OUTLIER -142.96 124.93 15.19 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.538 1.149 . . . . 0.0 109.286 -179.976 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . 0.62 ' O ' ' HA ' ' A' ' 172' ' ' ALA . 0.0 OUTLIER -94.65 141.01 29.11 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.529 1.143 . . . . 0.0 110.271 179.992 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . 0.442 ' HB ' ' HB2' ' A' ' 135' ' ' GLU . 19.9 mm -84.28 114.71 25.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 O-C-N 124.533 1.145 . . . . 0.0 109.313 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.47 -52.59 2.75 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.491 1.119 . . . . 0.0 110.293 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 11.8 t0 -136.34 174.7 10.33 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.451 1.094 . . . . 0.0 109.284 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . 0.565 ' HB2' ' CD1' ' A' ' 170' ' ' TRP . 0.0 OUTLIER -167.1 89.16 0.75 Allowed Pre-proline 0 C--N 1.325 -0.499 0 O-C-N 124.472 1.108 . . . . 0.0 109.299 -179.99 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.04 -34.2 3.97 Favored 'Trans proline' 0 C--N 1.36 1.166 0 O-C-N 124.532 1.806 . . . . 0.0 110.952 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -107.8 170.13 8.18 Favored 'General case' 0 C--N 1.324 -0.532 0 O-C-N 124.542 1.151 . . . . 0.0 110.28 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 18.7 pt-20 -95.36 -15.56 22.98 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.471 1.107 . . . . 0.0 110.355 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 168' ' ' GLN . . . . . 0.446 ' HG2' ' CD1' ' A' ' 169' ' ' TRP . 20.5 tt0 -92.41 -56.29 3.09 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.502 1.126 . . . . 0.0 110.333 179.952 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 169' ' ' TRP . . . . . 0.446 ' CD1' ' HG2' ' A' ' 168' ' ' GLN . 32.4 m95 -105.61 140.34 38.83 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.449 1.093 . . . . 0.0 108.064 179.934 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 170' ' ' TRP . . . . . 0.607 ' CZ3' HG12 ' A' ' 184' ' ' VAL . 53.1 m0 -120.02 152.78 36.99 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.523 1.139 . . . . 0.0 107.98 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 171' ' ' ASN . . . . . 0.436 ' HA ' ' O ' ' A' ' 180' ' ' GLY . 0.1 OUTLIER -88.04 97.34 10.91 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.493 1.121 . . . . 0.0 109.268 179.976 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . 0.62 ' HA ' ' O ' ' A' ' 160' ' ' ARG . . . -107.47 173.17 6.44 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.51 1.131 . . . . 0.0 109.342 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . 0.428 ' N ' ' O ' ' A' ' 160' ' ' ARG . 18.1 mt-10 -118.94 120.08 36.21 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.517 1.136 . . . . 0.0 110.329 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -74.34 -169.92 0.89 Allowed 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.468 1.105 . . . . 0.0 109.297 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 72.6 p -81.3 59.79 4.11 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.441 1.088 . . . . 0.0 110.004 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 177.61 25.48 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.484 1.115 . . . . 0.0 110.266 -179.974 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 57.79 19.2 35.2 Favored Glycine 0 CA--C 1.531 1.043 0 O-C-N 124.534 1.146 . . . . 0.0 110.997 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 6.6 mtmt -81.28 104.06 11.49 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.504 0.767 . . . . 0.0 109.293 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 179' ' ' ARG . . . . . 0.434 ' HA ' ' O ' ' A' ' 172' ' ' ALA . 4.7 ttp180 -90.46 118.75 30.18 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.528 1.143 . . . . 0.0 110.288 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . 0.436 ' O ' ' HA ' ' A' ' 171' ' ' ASN . . . -152.25 168.86 31.47 Favored Glycine 0 CA--C 1.531 1.032 0 O-C-N 124.612 1.195 . . . . 0.0 111.04 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 181' ' ' MET . . . . . 0.442 ' HA ' ' O ' ' A' ' 170' ' ' TRP . 1.5 mmm -85.98 106.76 17.38 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.546 0.792 . . . . 0.0 110.961 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . 0.475 ' HB ' ' HD2' ' A' ' 183' ' ' PRO . 1.4 pp -110.41 162.12 21.81 Favored Pre-proline 0 C--N 1.326 -0.446 0 O-C-N 124.515 1.134 . . . . 0.0 109.278 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 183' ' ' PRO . . . . . 0.706 ' HG2' ' HB2' ' A' ' 186' ' ' TYR . 18.6 Cg_endo -74.99 132.56 15.58 Favored 'Trans proline' 0 C--N 1.36 1.162 0 O-C-N 124.508 1.794 . . . . 0.0 111.05 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . 0.807 ' N ' ' CD ' ' A' ' 185' ' ' PRO . 62.1 t -78.94 -32.45 0.79 Allowed Pre-proline 0 C--N 1.324 -0.527 0 O-C-N 124.568 1.168 . . . . 0.0 109.332 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 185' ' ' PRO . . . . . 0.807 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.4 Cg_endo -74.96 -17.44 19.65 Favored 'Trans proline' 0 C--N 1.36 1.156 0 O-C-N 124.438 1.757 . . . . 0.0 111.006 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 186' ' ' TYR . . . . . 0.706 ' HB2' ' HG2' ' A' ' 183' ' ' PRO . 3.5 m-30 -97.25 17.7 16.72 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.496 1.123 . . . . 0.0 110.972 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 187' ' ' VAL . . . . . 0.42 HG11 ' O ' ' A' ' 183' ' ' PRO . 16.7 m -145.44 173.61 3.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 O-C-N 124.515 1.134 . . . . 0.0 109.359 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 188' ' ' GLU . . . . . 0.551 ' HG2' ' CD1' ' A' ' 140' ' ' LEU . 0.1 OUTLIER -127.95 159.6 34.47 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.504 1.127 . . . . 0.0 110.245 -179.962 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 7.4 mmmm -88.18 135.84 33.25 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.433 1.083 . . . . 0.0 109.306 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 8.9 t80 . . . . . 0 C--N 1.326 -0.452 0 O-C-N 124.456 1.098 . . . . 0.0 111.02 179.987 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . 0.459 ' CB ' ' HB ' ' A' ' 161' ' ' ILE . 1.5 mt-10 . . . . . 0 N--CA 1.453 -0.301 0 N-CA-C 110.248 -0.279 . . . . 0.0 110.248 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . 0.513 ' CE1' ' HB2' ' A' ' 160' ' ' ARG . 26.0 m-85 -86.86 106.55 17.82 Favored 'General case' 0 C--N 1.324 -0.527 0 O-C-N 124.491 1.119 . . . . 0.0 110.946 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.555 ' HA ' ' O ' ' A' ' 188' ' ' GLU . 19.8 m -117.19 138.39 48.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 O-C-N 124.502 1.126 . . . . 0.0 109.301 179.943 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . 0.43 ' HG2' ' CG ' ' A' ' 188' ' ' GLU . 0.0 OUTLIER -108.27 147.01 32.03 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.532 1.145 . . . . 0.0 110.275 -179.956 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . 0.663 ' O ' ' N ' ' A' ' 156' ' ' GLY . . . -93.88 119.89 33.41 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.506 1.128 . . . . 0.0 109.336 179.955 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.429 ' CD1' ' HG2' ' A' ' 188' ' ' GLU . 1.1 mt -88.51 -3.46 58.81 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.472 1.108 . . . . 0.0 109.281 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 13.8 m-85 -139.96 154.34 47.16 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.433 1.083 . . . . 0.0 110.984 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . 0.471 ' CB ' ' HA ' ' A' ' 154' ' ' LYS . 10.8 p-10 . . . . . 0 C--N 1.325 -0.485 0 O-C-N 124.495 1.122 . . . . 0.0 109.285 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . 0.596 ' CZ ' ' CG ' ' A' ' 183' ' ' PRO . 30.0 p90 . . . . . 0 N--CA 1.453 -0.298 0 CA-C-O 120.504 0.193 . . . . 0.0 111.072 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . 0.471 ' HA ' ' CB ' ' A' ' 142' ' ' ASP . 0.1 OUTLIER -126.1 -166.64 1.59 Allowed 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.453 1.096 . . . . 0.0 109.331 -179.985 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 6.4 ptpt -95.65 105.63 17.64 Favored 'General case' 0 C--N 1.324 -0.531 0 O-C-N 124.545 1.153 . . . . 0.0 109.329 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . 0.663 ' N ' ' O ' ' A' ' 139' ' ' ALA . . . 106.75 27.72 5.34 Favored Glycine 0 CA--C 1.53 0.999 0 O-C-N 124.434 1.084 . . . . 0.0 110.993 -180.0 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -97.45 165.9 11.78 Favored 'General case' 0 C--N 1.324 -0.522 0 O-C-N 124.482 0.754 . . . . 0.0 109.27 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -123.96 138.83 52.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 O-C-N 124.507 1.13 . . . . 0.0 109.268 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . 0.451 ' CD2' HD11 ' A' ' 182' ' ' ILE . 0.7 OUTLIER -147.13 130.28 16.46 Favored 'General case' 0 C--N 1.324 -0.54 0 O-C-N 124.579 1.174 . . . . 0.0 109.326 179.971 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . 0.513 ' HB2' ' CE1' ' A' ' 136' ' ' TYR . 0.0 OUTLIER -93.91 132.63 38.16 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.476 1.11 . . . . 0.0 110.308 179.982 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . 0.465 ' CD1' ' CG2' ' A' ' 137' ' ' VAL . 1.6 mp -89.09 132.59 33.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 O-C-N 124.519 1.137 . . . . 0.0 109.327 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -127.01 -36.59 2.16 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.522 1.139 . . . . 0.0 110.263 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -132.68 169.66 16.34 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.455 1.097 . . . . 0.0 109.242 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . 0.588 ' HB2' ' CD1' ' A' ' 170' ' ' TRP . 0.0 OUTLIER -163.36 84.48 1.38 Allowed Pre-proline 0 C--N 1.326 -0.454 0 O-C-N 124.423 1.077 . . . . 0.0 109.334 -179.988 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.94 -25.54 11.9 Favored 'Trans proline' 0 C--N 1.361 1.194 0 O-C-N 124.56 1.821 . . . . 0.0 111.022 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -113.6 174.77 5.76 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.487 1.117 . . . . 0.0 110.292 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -99.71 -19.66 16.65 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.546 1.154 . . . . 0.0 110.317 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 3.6 mt-30 -88.18 -66.69 0.89 Allowed 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.41 1.069 . . . . 0.0 110.326 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 169' ' ' TRP . . . . . . . . . . . . . 6.5 m95 -95.49 153.17 17.83 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.537 1.148 . . . . 0.0 108.025 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 170' ' ' TRP . . . . . 0.588 ' CD1' ' HB2' ' A' ' 164' ' ' LYS . 43.2 m0 -126.03 153.93 43.7 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 -179.925 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 171' ' ' ASN . . . . . 0.403 ' HA ' ' O ' ' A' ' 180' ' ' GLY . 0.6 OUTLIER -86.97 104.23 16.08 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.459 1.099 . . . . 0.0 109.325 179.952 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . 0.413 ' HA ' ' O ' ' A' ' 160' ' ' ARG . . . -123.0 170.74 9.84 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.514 1.134 . . . . 0.0 109.319 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -115.93 126.48 53.95 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.505 1.128 . . . . 0.0 110.319 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . 0.438 ' N ' HD23 ' A' ' 159' ' ' LEU . 0.9 OUTLIER -78.34 -174.18 3.62 Favored 'General case' 0 C--N 1.324 -0.543 0 O-C-N 124.491 1.12 . . . . 0.0 109.298 179.986 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 80.7 p -76.19 64.48 2.01 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.514 1.134 . . . . 0.0 109.932 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -177.27 0.22 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.453 1.096 . . . . 0.0 110.345 -179.974 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 79.12 12.59 83.87 Favored Glycine 0 CA--C 1.53 1.006 0 O-C-N 124.575 1.172 . . . . 0.0 110.931 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.91 109.4 17.57 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.554 0.797 . . . . 0.0 109.272 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 179' ' ' ARG . . . . . 0.413 ' HA ' ' O ' ' A' ' 172' ' ' ALA . 2.1 ttp85 -87.99 123.19 32.45 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.495 1.122 . . . . 0.0 110.242 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . 0.403 ' O ' ' HA ' ' A' ' 171' ' ' ASN . . . -151.25 172.03 30.83 Favored Glycine 0 CA--C 1.53 1.022 0 O-C-N 124.486 1.116 . . . . 0.0 110.96 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 181' ' ' MET . . . . . 0.435 ' HA ' ' O ' ' A' ' 170' ' ' TRP . 0.9 OUTLIER -87.73 93.77 9.54 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.507 0.769 . . . . 0.0 111.001 -179.987 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . 0.526 ' CG1' ' HD2' ' A' ' 183' ' ' PRO . 0.0 OUTLIER -91.79 158.17 40.45 Favored Pre-proline 0 C--N 1.325 -0.497 0 O-C-N 124.459 1.099 . . . . 0.0 109.316 179.969 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 183' ' ' PRO . . . . . 0.69 ' HG2' ' HB2' ' A' ' 186' ' ' TYR . 18.2 Cg_endo -74.97 131.44 14.33 Favored 'Trans proline' 0 C--N 1.361 1.206 0 O-C-N 124.438 1.757 . . . . 0.0 111.026 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . 0.813 ' N ' ' CD ' ' A' ' 185' ' ' PRO . 85.9 t -79.96 -31.91 0.69 Allowed Pre-proline 0 C--N 1.325 -0.46 0 O-C-N 124.435 1.084 . . . . 0.0 109.265 180.0 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 185' ' ' PRO . . . . . 0.813 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.3 Cg_endo -74.99 -25.2 12.12 Favored 'Trans proline' 0 C--N 1.359 1.103 0 O-C-N 124.526 1.803 . . . . 0.0 111.002 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 186' ' ' TYR . . . . . 0.69 ' HB2' ' HG2' ' A' ' 183' ' ' PRO . 7.9 m-85 -92.83 16.64 12.01 Favored 'General case' 0 C--N 1.326 -0.431 0 O-C-N 124.498 1.124 . . . . 0.0 111.038 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 187' ' ' VAL . . . . . 0.429 ' HA ' ' HA ' ' A' ' 139' ' ' ALA . 27.4 m -141.78 170.57 12.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 O-C-N 124.535 1.147 . . . . 0.0 109.317 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 188' ' ' GLU . . . . . 0.565 ' OE2' ' CE1' ' A' ' 190' ' ' TYR . 0.0 OUTLIER -131.76 155.91 46.89 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.53 1.144 . . . . 0.0 110.295 -179.997 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.62 132.36 34.59 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.513 1.133 . . . . 0.0 109.21 -179.956 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 190' ' ' TYR . . . . . 0.565 ' CE1' ' OE2' ' A' ' 188' ' ' GLU . 0.1 OUTLIER . . . . . 0 C--N 1.325 -0.474 0 O-C-N 124.502 1.126 . . . . 0.0 110.977 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . 0.432 ' HB3' ' O ' ' A' ' 161' ' ' ILE . 2.4 mp0 . . . . . 0 N--CA 1.453 -0.284 0 N-CA-C 110.303 -0.258 . . . . 0.0 110.303 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 31.7 m-85 -126.11 131.93 51.98 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.434 1.084 . . . . 0.0 111.078 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.515 ' CG2' ' CG2' ' A' ' 187' ' ' VAL . 0.7 OUTLIER -132.68 127.82 56.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 O-C-N 124.516 1.135 . . . . 0.0 109.329 -179.931 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . 0.466 ' HB3' ' HG3' ' A' ' 188' ' ' GLU . 0.0 OUTLIER -96.03 134.15 39.41 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.501 1.126 . . . . 0.0 110.371 -179.988 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . 0.494 ' O ' ' N ' ' A' ' 156' ' ' GLY . . . -96.35 109.47 21.98 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.52 1.138 . . . . 0.0 109.279 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.451 ' CD1' ' HG2' ' A' ' 188' ' ' GLU . 0.2 OUTLIER -89.91 -31.79 17.13 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.483 1.115 . . . . 0.0 109.284 179.996 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . 0.505 ' O ' ' CD1' ' A' ' 153' ' ' PHE . 71.2 m-85 -88.53 152.62 21.74 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.529 1.143 . . . . 0.0 111.007 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . 0.536 ' HA ' ' O ' ' A' ' 154' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--N 1.325 -0.497 0 O-C-N 124.497 1.123 . . . . 0.0 109.36 179.942 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . 0.505 ' CD1' ' O ' ' A' ' 141' ' ' PHE . 28.9 p90 . . . . . 0 N--CA 1.452 -0.327 0 CA-C-O 120.401 0.143 . . . . 0.0 111.055 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . 0.536 ' O ' ' HA ' ' A' ' 142' ' ' ASP . 5.6 ttmt -127.25 -99.51 0.37 Allowed 'General case' 0 C--N 1.324 -0.53 0 O-C-N 124.554 1.159 . . . . 0.0 109.301 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 17.2 ttpp -156.09 118.82 4.16 Favored 'General case' 0 C--N 1.326 -0.443 0 O-C-N 124.445 1.09 . . . . 0.0 109.353 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . 0.494 ' N ' ' O ' ' A' ' 139' ' ' ALA . . . 97.46 15.06 39.04 Favored Glycine 0 CA--C 1.53 1.023 0 O-C-N 124.572 1.17 . . . . 0.0 110.948 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . 0.416 ' O ' ' HA ' ' A' ' 138' ' ' ARG . 8.9 t0 -83.83 163.28 20.22 Favored 'General case' 0 C--N 1.324 -0.523 0 O-C-N 124.479 0.752 . . . . 0.0 109.254 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . 0.411 HD13 ' C ' ' A' ' 157' ' ' ASP . 3.5 mp -119.01 148.74 21.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 O-C-N 124.473 1.108 . . . . 0.0 109.29 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . 0.417 ' HA ' ' O ' ' A' ' 173' ' ' GLU . 0.7 OUTLIER -147.43 130.88 16.69 Favored 'General case' 0 C--N 1.326 -0.443 0 O-C-N 124.468 1.105 . . . . 0.0 109.303 -179.953 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . 0.637 ' O ' ' HA ' ' A' ' 172' ' ' ALA . 3.7 tpp180 -87.45 127.37 35.23 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.523 1.14 . . . . 0.0 110.273 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . 0.432 ' O ' ' HB3' ' A' ' 135' ' ' GLU . 1.5 mp -82.37 119.23 31.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 O-C-N 124.434 1.084 . . . . 0.0 109.305 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . 0.484 ' NH1' ' OD2' ' A' ' 163' ' ' ASP . 1.0 OUTLIER -115.25 -48.89 2.79 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.467 1.105 . . . . 0.0 110.345 179.952 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . 0.484 ' OD2' ' NH1' ' A' ' 162' ' ' ARG . 67.4 m-20 -141.54 171.34 14.2 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.485 1.116 . . . . 0.0 109.291 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . 0.59 ' HB3' ' CD1' ' A' ' 170' ' ' TRP . 14.5 mtmm -138.71 58.46 13.84 Favored Pre-proline 0 C--N 1.325 -0.486 0 O-C-N 124.521 1.138 . . . . 0.0 109.309 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 165' ' ' PRO . . . . . 0.541 ' HD3' ' N ' ' A' ' 164' ' ' LYS . 18.5 Cg_endo -74.99 76.41 3.4 Favored 'Trans proline' 0 C--N 1.36 1.163 0 O-C-N 124.455 1.766 . . . . 0.0 111.02 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . 0.47 ' CB ' ' O ' ' A' ' 165' ' ' PRO . 1.5 mt-10 162.77 177.24 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.547 1.155 . . . . 0.0 110.296 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -117.08 42.68 2.47 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.433 1.083 . . . . 0.0 110.277 -179.923 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER 178.29 -51.53 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.493 1.121 . . . . 0.0 110.306 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 169' ' ' TRP . . . . . . . . . . . . . 7.2 m95 -95.29 144.05 26.18 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 170' ' ' TRP . . . . . 0.59 ' CD1' ' HB3' ' A' ' 164' ' ' LYS . 48.6 m0 -120.45 149.82 41.78 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.474 1.109 . . . . 0.0 108.02 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 171' ' ' ASN . . . . . 0.408 ' HA ' ' O ' ' A' ' 180' ' ' GLY . 1.2 t-20 -86.6 98.99 11.4 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.428 1.08 . . . . 0.0 109.322 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . 0.637 ' HA ' ' O ' ' A' ' 160' ' ' ARG . . . -116.04 171.41 7.81 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.474 1.109 . . . . 0.0 109.239 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . 0.483 ' HG3' ' CG ' ' A' ' 179' ' ' ARG . 5.2 mt-10 -115.89 117.4 30.08 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.493 1.12 . . . . 0.0 110.326 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -68.28 -164.28 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.559 1.162 . . . . 0.0 109.355 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 88.1 p -85.09 60.03 5.99 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.444 1.09 . . . . 0.0 109.905 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -178.95 18.62 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.418 1.074 . . . . 0.0 110.286 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 63.54 14.96 56.52 Favored Glycine 0 CA--C 1.531 1.038 0 O-C-N 124.605 1.19 . . . . 0.0 110.999 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 178' ' ' LYS . . . . . 0.4 ' O ' ' HA ' ' A' ' 173' ' ' GLU . 1.5 mttt -80.51 105.59 11.87 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.495 0.762 . . . . 0.0 109.255 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 179' ' ' ARG . . . . . 0.483 ' CG ' ' HG3' ' A' ' 173' ' ' GLU . 0.0 OUTLIER -89.58 118.29 29.1 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.488 1.118 . . . . 0.0 110.243 -179.997 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . 0.408 ' O ' ' HA ' ' A' ' 171' ' ' ASN . . . -151.55 171.09 31.09 Favored Glycine 0 CA--C 1.53 1.026 0 O-C-N 124.54 1.15 . . . . 0.0 111.004 179.938 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 181' ' ' MET . . . . . 0.45 ' CE ' ' HD2' ' A' ' 165' ' ' PRO . 0.4 OUTLIER -88.81 103.73 16.26 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.524 0.779 . . . . 0.0 110.926 -179.926 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -107.36 165.72 12.31 Favored Pre-proline 0 C--N 1.325 -0.495 0 O-C-N 124.49 1.119 . . . . 0.0 109.298 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 183' ' ' PRO . . . . . 0.599 ' HG2' ' HB2' ' A' ' 186' ' ' TYR . 18.3 Cg_endo -75.02 131.38 14.2 Favored 'Trans proline' 0 C--N 1.359 1.088 0 O-C-N 124.534 1.807 . . . . 0.0 110.984 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . 0.803 ' N ' ' CD ' ' A' ' 185' ' ' PRO . 90.5 t -79.92 -33.64 0.8 Allowed Pre-proline 0 C--N 1.326 -0.447 0 O-C-N 124.529 1.143 . . . . 0.0 109.28 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 185' ' ' PRO . . . . . 0.803 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.3 Cg_endo -74.93 -13.87 21.46 Favored 'Trans proline' 0 C--N 1.361 1.194 0 O-C-N 124.517 1.798 . . . . 0.0 111.054 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 186' ' ' TYR . . . . . 0.599 ' HB2' ' HG2' ' A' ' 183' ' ' PRO . 8.8 m-85 -95.96 4.98 52.26 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.458 1.098 . . . . 0.0 110.983 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 187' ' ' VAL . . . . . 0.515 ' CG2' ' CG2' ' A' ' 137' ' ' VAL . 25.0 m -136.18 170.25 19.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 O-C-N 124.424 1.078 . . . . 0.0 109.319 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 188' ' ' GLU . . . . . 0.466 ' HG3' ' HB3' ' A' ' 138' ' ' ARG . 0.0 OUTLIER -121.82 155.27 35.69 Favored 'General case' 0 C--N 1.326 -0.432 0 O-C-N 124.426 1.079 . . . . 0.0 110.26 -179.994 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.44 126.75 35.07 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.527 1.142 . . . . 0.0 109.259 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.324 -0.521 0 O-C-N 124.455 1.097 . . . . 0.0 111.017 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . 0.441 ' O ' ' HG2' ' A' ' 160' ' ' ARG . 0.4 OUTLIER . . . . . 0 N--CA 1.453 -0.301 0 N-CA-C 110.33 -0.248 . . . . 0.0 110.33 . . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . 0.418 ' CE1' ' HG3' ' A' ' 160' ' ' ARG . 0.1 OUTLIER -127.72 113.8 16.48 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.416 1.072 . . . . 0.0 111.012 -179.973 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.462 HG23 ' CD1' ' A' ' 161' ' ' ILE . 16.0 m -108.17 137.18 40.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 O-C-N 124.539 1.149 . . . . 0.0 109.275 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . 0.412 ' O ' ' N ' ' A' ' 188' ' ' GLU . 6.4 ttm180 -101.89 128.83 48.1 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.529 1.143 . . . . 0.0 110.3 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . 0.568 ' O ' ' N ' ' A' ' 156' ' ' GLY . . . -88.52 103.69 16.12 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 124.557 1.16 . . . . 0.0 109.267 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.427 ' CD1' ' HB3' ' A' ' 188' ' ' GLU . 0.2 OUTLIER -90.41 -29.06 18.23 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.464 1.102 . . . . 0.0 109.26 179.984 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . 0.498 ' C ' ' O ' ' A' ' 154' ' ' LYS . 27.0 m-85 -92.16 151.22 20.49 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.498 1.124 . . . . 0.0 110.951 -179.907 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . 0.4 ' HA ' ' O ' ' A' ' 154' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--N 1.325 -0.499 0 O-C-N 124.508 1.13 . . . . 0.0 109.322 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 20.5 p90 . . . . . 0 N--CA 1.454 -0.255 0 CA-C-O 120.537 0.208 . . . . 0.0 110.95 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . 0.498 ' O ' ' C ' ' A' ' 141' ' ' PHE . 1.2 ttmm -127.32 -83.73 0.61 Allowed 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.471 1.107 . . . . 0.0 109.364 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -161.46 113.52 1.81 Allowed 'General case' 0 C--N 1.326 -0.431 0 O-C-N 124.378 1.048 . . . . 0.0 109.312 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . 0.568 ' N ' ' O ' ' A' ' 139' ' ' ALA . . . 108.38 16.08 12.79 Favored Glycine 0 CA--C 1.53 1.022 0 O-C-N 124.435 1.084 . . . . 0.0 111.041 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . 0.53 ' OD2' ' CD2' ' A' ' 159' ' ' LEU . 24.6 t70 -81.27 158.06 24.93 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.55 0.794 . . . . 0.0 109.336 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . 0.467 ' C ' ' HG ' ' A' ' 159' ' ' LEU . 7.5 mm -119.35 133.21 66.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 O-C-N 124.468 1.105 . . . . 0.0 109.328 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . 0.53 ' CD2' ' OD2' ' A' ' 157' ' ' ASP . 0.1 OUTLIER -138.07 128.71 26.61 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.48 1.113 . . . . 0.0 109.316 -179.953 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . 0.539 ' O ' ' HA ' ' A' ' 172' ' ' ALA . 1.5 ttp180 -90.1 131.18 36.1 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.426 1.079 . . . . 0.0 110.271 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . 0.462 ' CD1' HG23 ' A' ' 137' ' ' VAL . 1.3 mp -82.82 120.7 34.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 O-C-N 124.482 1.114 . . . . 0.0 109.353 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 3.5 mtp180 -114.41 -56.91 2.34 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.494 1.122 . . . . 0.0 110.245 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -123.83 161.41 25.34 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.478 1.111 . . . . 0.0 109.295 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . 0.628 ' CD ' ' CE2' ' A' ' 170' ' ' TRP . 2.6 ttpt -144.95 76.0 13.92 Favored Pre-proline 0 C--N 1.326 -0.451 0 O-C-N 124.506 1.128 . . . . 0.0 109.33 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.96 -33.07 4.91 Favored 'Trans proline' 0 C--N 1.36 1.145 0 O-C-N 124.527 1.804 . . . . 0.0 111.0 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . 0.406 ' O ' ' CD1' ' A' ' 170' ' ' TRP . 2.9 mt-10 -114.18 163.8 14.73 Favored 'General case' 0 C--N 1.324 -0.536 0 O-C-N 124.569 1.168 . . . . 0.0 110.282 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -88.64 -23.35 23.07 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.446 1.092 . . . . 0.0 110.283 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 3.9 mt-30 -87.03 -69.92 0.65 Allowed 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.499 1.125 . . . . 0.0 110.331 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 169' ' ' TRP . . . . . . . . . . . . . 5.8 m95 -94.1 141.35 28.64 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 170' ' ' TRP . . . . . 0.628 ' CE2' ' CD ' ' A' ' 164' ' ' LYS . 50.8 m0 -120.15 153.24 36.49 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.517 1.135 . . . . 0.0 107.957 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 171' ' ' ASN . . . . . 0.401 ' HA ' ' O ' ' A' ' 180' ' ' GLY . 1.3 t-20 -86.67 92.63 8.99 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.503 1.127 . . . . 0.0 109.334 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . 0.539 ' HA ' ' O ' ' A' ' 160' ' ' ARG . . . -109.21 176.66 5.01 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.507 1.129 . . . . 0.0 109.317 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -123.06 123.4 40.77 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.496 1.122 . . . . 0.0 110.331 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -73.79 -171.46 1.07 Allowed 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.475 1.109 . . . . 0.0 109.369 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -83.21 64.48 7.74 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.458 1.099 . . . . 0.0 110.063 179.958 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -176.22 8.25 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.559 1.162 . . . . 0.0 110.279 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 69.03 29.26 72.41 Favored Glycine 0 CA--C 1.53 0.985 0 O-C-N 124.453 1.095 . . . . 0.0 111.03 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 8.4 mtpt -103.86 115.27 30.15 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.518 0.775 . . . . 0.0 109.346 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 179' ' ' ARG . . . . . 0.448 ' HA ' ' O ' ' A' ' 172' ' ' ALA . 8.9 ttp180 -88.95 128.03 35.68 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.5 1.125 . . . . 0.0 110.316 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . 0.401 ' O ' ' HA ' ' A' ' 171' ' ' ASN . . . -151.71 170.34 31.18 Favored Glycine 0 CA--C 1.53 1.025 0 O-C-N 124.527 1.142 . . . . 0.0 110.991 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 181' ' ' MET . . . . . 0.425 ' HA ' ' O ' ' A' ' 170' ' ' TRP . 0.2 OUTLIER -92.13 99.47 12.27 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.49 0.759 . . . . 0.0 111.039 179.987 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . 0.658 ' CG1' ' HD2' ' A' ' 183' ' ' PRO . 0.6 OUTLIER -103.78 151.64 38.85 Favored Pre-proline 0 C--N 1.324 -0.504 0 O-C-N 124.482 1.114 . . . . 0.0 109.311 -179.976 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 183' ' ' PRO . . . . . 0.658 ' HD2' ' CG1' ' A' ' 182' ' ' ILE . 18.4 Cg_endo -74.99 134.19 17.53 Favored 'Trans proline' 0 C--N 1.359 1.109 0 O-C-N 124.441 1.759 . . . . 0.0 110.979 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . 0.858 ' N ' ' CD ' ' A' ' 185' ' ' PRO . 21.6 t -75.8 -29.14 0.79 Allowed Pre-proline 0 C--N 1.326 -0.441 0 O-C-N 124.398 1.061 . . . . 0.0 109.286 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 185' ' ' PRO . . . . . 0.858 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.5 Cg_endo -74.87 -13.68 21.65 Favored 'Trans proline' 0 C--N 1.36 1.146 0 O-C-N 124.477 1.777 . . . . 0.0 111.037 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 186' ' ' TYR . . . . . 0.634 ' HB2' ' HG2' ' A' ' 183' ' ' PRO . 8.2 m-85 -98.54 4.56 48.21 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.476 1.11 . . . . 0.0 111.009 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 19.2 m -137.05 171.09 16.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 O-C-N 124.547 1.154 . . . . 0.0 109.312 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 188' ' ' GLU . . . . . 0.427 ' HB3' ' CD1' ' A' ' 140' ' ' LEU . 1.5 pp20? -125.89 176.76 6.74 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.458 1.099 . . . . 0.0 110.259 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -93.44 112.39 24.28 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.522 1.139 . . . . 0.0 109.335 179.958 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 190' ' ' TYR . . . . . 0.45 ' CD1' ' C ' ' A' ' 190' ' ' TYR . 0.8 OUTLIER . . . . . 0 C--N 1.325 -0.491 0 O-C-N 124.53 1.144 . . . . 0.0 111.027 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . 0.46 ' CB ' HG22 ' A' ' 161' ' ' ILE . 5.1 pt-20 . . . . . 0 N--CA 1.453 -0.293 0 N-CA-C 110.262 -0.273 . . . . 0.0 110.262 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -123.81 118.9 28.19 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.487 1.117 . . . . 0.0 110.99 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.464 HG23 ' CG2' ' A' ' 187' ' ' VAL . 0.9 OUTLIER -121.83 123.04 68.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 O-C-N 124.543 1.152 . . . . 0.0 109.275 -179.969 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . 0.52 ' O ' ' N ' ' A' ' 188' ' ' GLU . 12.1 ttm180 -87.45 150.29 23.87 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.489 1.118 . . . . 0.0 110.299 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . 0.463 ' N ' ' HG3' ' A' ' 138' ' ' ARG . . . -113.75 108.48 17.16 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.499 1.125 . . . . 0.0 109.317 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.498 ' O ' ' CB ' ' A' ' 155' ' ' LYS . 0.0 OUTLIER -93.5 -7.56 43.98 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.607 1.192 . . . . 0.0 109.262 -179.991 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 59.9 m-85 -113.78 164.11 14.16 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.554 1.159 . . . . 0.0 110.955 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . 0.462 ' N ' ' OD1' ' A' ' 142' ' ' ASP . 0.0 OUTLIER . . . . . 0 C--N 1.325 -0.462 0 O-C-N 124.493 1.121 . . . . 0.0 109.299 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 21.8 p90 . . . . . 0 N--CA 1.453 -0.324 0 CA-C-O 120.466 0.175 . . . . 0.0 111.028 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . 0.411 ' HA ' ' HA ' ' A' ' 142' ' ' ASP . 1.6 tttm -132.09 -169.36 2.2 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.549 1.155 . . . . 0.0 109.319 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.498 ' CB ' ' O ' ' A' ' 140' ' ' LEU . 9.6 ptpt -89.31 111.17 21.94 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.517 1.136 . . . . 0.0 109.301 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 117.3 8.24 11.58 Favored Glycine 0 CA--C 1.529 0.96 0 O-C-N 124.486 1.116 . . . . 0.0 111.05 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . 0.432 ' CG ' ' N ' ' A' ' 158' ' ' ILE . 14.5 t0 -91.12 172.63 8.42 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.512 0.772 . . . . 0.0 109.277 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . 0.433 ' C ' ' HG ' ' A' ' 159' ' ' LEU . 3.2 mt -140.27 142.55 31.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 O-C-N 124.547 1.154 . . . . 0.0 109.332 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . 0.464 ' CD2' ' OD1' ' A' ' 174' ' ' ASP . 0.1 OUTLIER -136.93 141.23 42.67 Favored 'General case' 0 C--N 1.324 -0.533 0 O-C-N 124.555 1.159 . . . . 0.0 109.328 179.997 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . 0.437 ' O ' ' HB2' ' A' ' 172' ' ' ALA . 15.2 ttm105 -87.86 134.91 33.6 Favored 'General case' 0 C--N 1.326 -0.437 0 O-C-N 124.581 1.176 . . . . 0.0 110.333 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . 0.46 HG22 ' CB ' ' A' ' 135' ' ' GLU . 1.0 OUTLIER -83.53 109.81 17.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 O-C-N 124.536 1.148 . . . . 0.0 109.321 179.969 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . 0.452 ' HG3' ' CG ' ' A' ' 179' ' ' ARG . 20.8 mmm180 -90.68 -59.34 2.2 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.546 1.154 . . . . 0.0 110.303 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . 0.515 ' N ' ' OD1' ' A' ' 171' ' ' ASN . 0.7 OUTLIER -151.34 144.53 24.69 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.481 1.113 . . . . 0.0 109.32 179.963 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . 0.598 ' CB ' ' CG ' ' A' ' 170' ' ' TRP . 0.6 OUTLIER -128.02 78.38 75.36 Favored Pre-proline 0 C--N 1.325 -0.475 0 O-C-N 124.494 1.121 . . . . 0.0 109.307 -179.942 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.03 -48.08 0.18 Allowed 'Trans proline' 0 C--N 1.359 1.116 0 O-C-N 124.51 1.795 . . . . 0.0 110.914 -179.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 13.7 mp0 -69.68 176.23 3.7 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.402 1.064 . . . . 0.0 110.322 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -115.24 51.44 0.92 Allowed 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.547 1.154 . . . . 0.0 110.29 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 168' ' ' GLN . . . . . 0.476 ' HB3' ' CD1' ' A' ' 169' ' ' TRP . 3.3 mt-30 -179.25 -55.58 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.582 1.176 . . . . 0.0 110.278 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 169' ' ' TRP . . . . . 0.476 ' CD1' ' HB3' ' A' ' 168' ' ' GLN . 12.2 m95 -108.91 133.05 53.44 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.491 1.12 . . . . 0.0 107.995 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 170' ' ' TRP . . . . . 0.605 ' CE3' HG21 ' A' ' 184' ' ' VAL . 26.6 m0 -120.8 154.66 35.43 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 171' ' ' ASN . . . . . 0.515 ' OD1' ' N ' ' A' ' 163' ' ' ASP . 6.0 p30 -87.16 108.9 19.11 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.46 1.1 . . . . 0.0 109.265 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . 0.494 ' O ' ' HA ' ' A' ' 179' ' ' ARG . . . -117.35 174.63 6.02 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.511 1.132 . . . . 0.0 109.331 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -116.34 116.69 28.19 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.406 1.066 . . . . 0.0 110.278 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . 0.464 ' OD1' ' CD2' ' A' ' 159' ' ' LEU . 0.4 OUTLIER -74.43 -176.88 2.86 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.56 1.163 . . . . 0.0 109.316 -179.993 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 37.6 t -76.01 61.91 1.58 Allowed 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.53 1.144 . . . . 0.0 109.969 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -173.79 8.11 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.415 1.072 . . . . 0.0 110.319 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 67.88 20.91 72.94 Favored Glycine 0 CA--C 1.53 1.014 0 O-C-N 124.58 1.175 . . . . 0.0 110.998 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.06 115.63 27.68 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.481 0.754 . . . . 0.0 109.329 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 179' ' ' ARG . . . . . 0.494 ' HA ' ' O ' ' A' ' 172' ' ' ALA . 0.1 OUTLIER -90.13 122.53 33.17 Favored 'General case' 0 C--N 1.326 -0.442 0 O-C-N 124.459 1.099 . . . . 0.0 110.286 -179.958 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . 0.476 ' O ' ' HA ' ' A' ' 171' ' ' ASN . . . -151.34 165.9 30.5 Favored Glycine 0 CA--C 1.53 0.971 0 O-C-N 124.487 1.117 . . . . 0.0 111.001 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 181' ' ' MET . . . . . 0.419 ' HA ' ' O ' ' A' ' 170' ' ' TRP . 0.4 OUTLIER -84.5 103.7 13.86 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.503 0.766 . . . . 0.0 111.035 179.943 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . 0.451 ' HB ' ' HD2' ' A' ' 183' ' ' PRO . 2.2 pp -106.93 161.11 23.94 Favored Pre-proline 0 C--N 1.325 -0.493 0 O-C-N 124.498 1.124 . . . . 0.0 109.267 -179.952 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 183' ' ' PRO . . . . . 0.642 ' HG2' ' HB2' ' A' ' 186' ' ' TYR . 18.4 Cg_endo -74.98 135.37 19.02 Favored 'Trans proline' 0 C--N 1.361 1.214 0 O-C-N 124.505 1.792 . . . . 0.0 110.989 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . 0.843 ' N ' ' CD ' ' A' ' 185' ' ' PRO . 58.0 t -80.1 -30.28 0.6 Allowed Pre-proline 0 C--N 1.326 -0.427 0 O-C-N 124.467 1.105 . . . . 0.0 109.28 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 185' ' ' PRO . . . . . 0.843 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.2 Cg_endo -75.05 -15.53 20.58 Favored 'Trans proline' 0 C--N 1.36 1.154 0 O-C-N 124.482 1.78 . . . . 0.0 110.973 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 186' ' ' TYR . . . . . 0.642 ' HB2' ' HG2' ' A' ' 183' ' ' PRO . 4.5 m-85 -94.95 5.91 50.58 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.492 1.12 . . . . 0.0 111.056 179.923 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 187' ' ' VAL . . . . . 0.483 ' HA ' ' O ' ' A' ' 138' ' ' ARG . 35.4 m -136.94 164.48 30.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 O-C-N 124.475 1.11 . . . . 0.0 109.314 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 188' ' ' GLU . . . . . 0.52 ' N ' ' O ' ' A' ' 138' ' ' ARG . 0.0 OUTLIER -120.49 165.75 14.54 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.487 1.117 . . . . 0.0 110.262 -180.0 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . 0.442 ' CD ' ' H ' ' A' ' 189' ' ' LYS . 0.0 OUTLIER -89.33 126.54 35.57 Favored 'General case' 0 C--N 1.326 -0.439 0 O-C-N 124.455 1.097 . . . . 0.0 109.366 179.969 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 190' ' ' TYR . . . . . 0.436 ' CD1' ' OE1' ' A' ' 188' ' ' GLU . 0.1 OUTLIER . . . . . 0 C--N 1.326 -0.449 0 O-C-N 124.528 1.143 . . . . 0.0 110.98 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.453 -0.299 0 N-CA-C 110.321 -0.252 . . . . 0.0 110.321 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . 0.528 ' CE2' ' HD2' ' A' ' 160' ' ' ARG . 36.6 m-85 -126.62 130.88 51.33 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.547 1.154 . . . . 0.0 110.982 -179.969 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.544 ' CG2' ' O ' ' A' ' 188' ' ' GLU . 2.9 p -125.75 155.83 35.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 O-C-N 124.491 1.119 . . . . 0.0 109.273 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . 0.457 ' HB3' ' HG3' ' A' ' 188' ' ' GLU . 0.0 OUTLIER -126.08 133.03 51.8 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.501 1.125 . . . . 0.0 110.338 179.98 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . 0.409 ' N ' ' HG3' ' A' ' 138' ' ' ARG . . . -97.06 110.64 23.14 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.514 1.134 . . . . 0.0 109.316 -179.965 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.475 ' CD1' ' HG2' ' A' ' 188' ' ' GLU . 0.2 OUTLIER -95.33 -22.39 17.78 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.555 1.159 . . . . 0.0 109.344 179.948 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . 0.476 ' C ' ' O ' ' A' ' 154' ' ' LYS . 12.1 m-85 -94.62 150.31 20.36 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.474 1.109 . . . . 0.0 111.031 179.939 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . 0.441 ' HA ' ' O ' ' A' ' 154' ' ' LYS . 0.1 OUTLIER . . . . . 0 C--N 1.324 -0.502 0 O-C-N 124.538 1.149 . . . . 0.0 109.322 -179.969 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 14.9 p90 . . . . . 0 N--CA 1.454 -0.273 0 CA-C-O 120.558 0.218 . . . . 0.0 111.006 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . 0.476 ' O ' ' C ' ' A' ' 141' ' ' PHE . 0.0 OUTLIER -125.86 -84.99 0.63 Allowed 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.488 1.118 . . . . 0.0 109.233 -179.984 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -165.58 113.14 0.96 Allowed 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.501 1.126 . . . . 0.0 109.252 -179.949 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 108.84 14.07 16.47 Favored Glycine 0 CA--C 1.53 1.003 0 O-C-N 124.391 1.057 . . . . 0.0 111.016 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . 0.441 ' OD1' ' N ' ' A' ' 158' ' ' ILE . 6.9 t0 -82.72 158.26 22.96 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.532 0.783 . . . . 0.0 109.27 -179.974 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . 0.441 ' N ' ' OD1' ' A' ' 157' ' ' ASP . 3.9 mp -119.79 141.19 41.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 O-C-N 124.571 1.169 . . . . 0.0 109.266 -179.945 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . 0.523 ' HB2' ' CG1' ' A' ' 137' ' ' VAL . 2.9 mp -142.04 126.79 18.07 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.42 1.075 . . . . 0.0 109.345 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . 0.635 ' O ' ' HA ' ' A' ' 172' ' ' ALA . 0.0 OUTLIER -88.26 132.87 34.21 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.545 1.153 . . . . 0.0 110.328 179.997 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 14.3 mm -82.15 117.14 27.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 O-C-N 124.42 1.075 . . . . 0.0 109.312 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . 0.469 ' HG3' ' N ' ' A' ' 163' ' ' ASP . 0.8 OUTLIER -118.22 -32.58 4.65 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.537 1.148 . . . . 0.0 110.368 179.943 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . 0.469 ' N ' ' HG3' ' A' ' 162' ' ' ARG . 0.9 OUTLIER -146.35 155.25 42.48 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.486 1.116 . . . . 0.0 109.338 179.949 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . 0.576 ' HB3' ' CD1' ' A' ' 170' ' ' TRP . 1.4 mtmp? -148.25 71.93 11.01 Favored Pre-proline 0 C--N 1.324 -0.519 0 O-C-N 124.522 1.139 . . . . 0.0 109.234 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.96 -29.06 8.7 Favored 'Trans proline' 0 C--N 1.359 1.105 0 O-C-N 124.539 1.81 . . . . 0.0 110.999 179.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . 0.517 ' O ' ' CD1' ' A' ' 170' ' ' TRP . 3.0 mm-40 -105.26 166.02 10.7 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.446 1.091 . . . . 0.0 110.296 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 13.3 mt-10 -96.38 -27.82 14.75 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.463 1.102 . . . . 0.0 110.309 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 11.4 tt0 -82.35 -58.68 2.83 Favored 'General case' 0 C--N 1.324 -0.536 0 O-C-N 124.533 1.146 . . . . 0.0 110.284 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 169' ' ' TRP . . . . . 0.58 ' CZ3' ' HD3' ' A' ' 183' ' ' PRO . 9.9 m0 -109.7 163.26 13.66 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.501 1.126 . . . . 0.0 107.968 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 170' ' ' TRP . . . . . 0.587 ' CZ3' ' CG1' ' A' ' 184' ' ' VAL . 30.9 m0 -139.57 157.11 46.36 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.525 1.141 . . . . 0.0 107.951 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 4.6 t30 -88.55 107.6 18.98 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.472 1.107 . . . . 0.0 109.291 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . 0.635 ' HA ' ' O ' ' A' ' 160' ' ' ARG . . . -121.78 178.45 4.85 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.454 1.096 . . . . 0.0 109.312 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . 0.471 ' CG ' ' HG3' ' A' ' 179' ' ' ARG . 17.9 mt-10 -116.49 115.95 26.74 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.548 1.155 . . . . 0.0 110.201 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -64.51 -164.91 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.498 1.124 . . . . 0.0 109.239 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -88.36 60.0 5.48 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.439 1.087 . . . . 0.0 110.016 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 174.16 22.58 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.455 1.097 . . . . 0.0 110.362 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 67.75 15.52 66.77 Favored Glycine 0 CA--C 1.531 1.035 0 O-C-N 124.464 1.102 . . . . 0.0 111.023 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 8.0 mttt -70.9 101.77 2.23 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.505 0.768 . . . . 0.0 109.325 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 179' ' ' ARG . . . . . 0.471 ' HG3' ' CG ' ' A' ' 173' ' ' GLU . 11.3 mtt85 -87.68 105.76 17.58 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.494 1.121 . . . . 0.0 110.255 -179.914 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -151.87 169.45 31.26 Favored Glycine 0 CA--C 1.53 0.983 0 O-C-N 124.507 1.129 . . . . 0.0 111.033 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 181' ' ' MET . . . . . 0.414 ' HA ' ' O ' ' A' ' 170' ' ' TRP . 4.9 mmm -87.68 116.89 26.13 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.52 0.776 . . . . 0.0 111.064 179.904 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . 0.436 ' HB ' ' HD2' ' A' ' 183' ' ' PRO . 1.0 OUTLIER -112.91 161.85 24.62 Favored Pre-proline 0 C--N 1.325 -0.484 0 O-C-N 124.504 1.127 . . . . 0.0 109.252 -179.967 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 183' ' ' PRO . . . . . 0.737 ' HG2' ' HB2' ' A' ' 186' ' ' TYR . 18.2 Cg_endo -75.0 134.05 17.35 Favored 'Trans proline' 0 C--N 1.36 1.151 0 O-C-N 124.502 1.79 . . . . 0.0 110.979 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . 0.834 ' N ' ' CD ' ' A' ' 185' ' ' PRO . 38.7 t -79.96 -31.1 0.64 Allowed Pre-proline 0 C--N 1.325 -0.467 0 O-C-N 124.429 1.081 . . . . 0.0 109.275 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 185' ' ' PRO . . . . . 0.834 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.5 Cg_endo -74.99 -25.26 12.06 Favored 'Trans proline' 0 C--N 1.36 1.135 0 O-C-N 124.504 1.792 . . . . 0.0 111.059 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 186' ' ' TYR . . . . . 0.737 ' HB2' ' HG2' ' A' ' 183' ' ' PRO . 3.5 m-85 -93.82 22.84 5.23 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.522 1.139 . . . . 0.0 110.988 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 187' ' ' VAL . . . . . 0.473 ' CG2' HG23 ' A' ' 137' ' ' VAL . 26.2 m -146.53 169.52 5.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 O-C-N 124.475 1.109 . . . . 0.0 109.369 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 188' ' ' GLU . . . . . 0.544 ' O ' ' CG2' ' A' ' 137' ' ' VAL . 0.0 OUTLIER -126.82 160.47 30.81 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.543 1.152 . . . . 0.0 110.255 -179.976 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 24.6 mmmt -85.04 127.19 34.11 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.573 1.171 . . . . 0.0 109.259 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.326 -0.451 0 O-C-N 124.516 1.135 . . . . 0.0 111.012 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . 0.51 ' O ' ' HG2' ' A' ' 160' ' ' ARG . 0.7 OUTLIER . . . . . 0 N--CA 1.453 -0.3 0 N-CA-C 110.282 -0.266 . . . . 0.0 110.282 . . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -112.03 128.71 56.26 Favored 'General case' 0 C--N 1.324 -0.522 0 O-C-N 124.531 1.145 . . . . 0.0 111.037 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.478 ' CG2' ' O ' ' A' ' 188' ' ' GLU . 0.4 OUTLIER -119.35 174.98 4.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 O-C-N 124.471 1.107 . . . . 0.0 109.332 179.988 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . 0.549 ' O ' ' HA ' ' A' ' 187' ' ' VAL . 14.0 ttm180 -144.69 146.73 32.36 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.535 1.147 . . . . 0.0 110.289 -179.958 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . 0.438 ' N ' ' HG3' ' A' ' 138' ' ' ARG . . . -107.72 109.83 21.52 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.456 1.098 . . . . 0.0 109.306 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.482 ' CD1' ' HG2' ' A' ' 188' ' ' GLU . 1.0 OUTLIER -88.86 -7.15 56.66 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.52 1.138 . . . . 0.0 109.361 179.977 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 18.6 m-85 -120.67 158.24 27.86 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.576 1.173 . . . . 0.0 110.966 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . 0.487 ' HB3' ' HG2' ' A' ' 154' ' ' LYS . 2.0 p-10 . . . . . 0 C--N 1.326 -0.453 0 O-C-N 124.492 1.12 . . . . 0.0 109.339 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 13.4 p90 . . . . . 0 N--CA 1.453 -0.281 0 CA-C-O 120.529 0.204 . . . . 0.0 111.064 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . 0.487 ' HG2' ' HB3' ' A' ' 142' ' ' ASP . 1.0 OUTLIER -127.98 -158.86 0.9 Allowed 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.434 1.084 . . . . 0.0 109.255 -179.937 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.43 108.31 20.98 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.466 1.104 . . . . 0.0 109.29 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 114.51 17.9 6.85 Favored Glycine 0 CA--C 1.53 0.974 0 O-C-N 124.433 1.083 . . . . 0.0 111.041 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . 0.446 ' C ' ' CD1' ' A' ' 158' ' ' ILE . 8.9 t70 -87.5 168.68 12.87 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.488 0.758 . . . . 0.0 109.366 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . 0.485 ' N ' HD13 ' A' ' 158' ' ' ILE . 2.3 mp -128.56 143.98 39.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 O-C-N 124.559 1.162 . . . . 0.0 109.31 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . 0.465 HD21 ' N ' ' A' ' 174' ' ' ASP . 0.3 OUTLIER -149.27 128.47 12.84 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.467 1.104 . . . . 0.0 109.29 -179.913 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . 0.526 ' O ' ' HA ' ' A' ' 172' ' ' ALA . 0.0 OUTLIER -84.57 138.32 32.81 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.515 1.134 . . . . 0.0 110.26 -179.994 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . 0.463 ' HB ' ' HB2' ' A' ' 135' ' ' GLU . 43.9 mm -84.77 112.65 22.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 O-C-N 124.482 1.114 . . . . 0.0 109.306 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.45 -56.0 2.4 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.424 1.077 . . . . 0.0 110.309 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -134.88 167.01 21.69 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.464 1.103 . . . . 0.0 109.282 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . 0.584 ' HB3' ' CD1' ' A' ' 170' ' ' TRP . 23.3 mtmt -144.44 83.13 10.06 Favored Pre-proline 0 C--N 1.325 -0.492 0 O-C-N 124.531 1.144 . . . . 0.0 109.296 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.03 -27.48 9.93 Favored 'Trans proline' 0 C--N 1.36 1.152 0 O-C-N 124.523 1.802 . . . . 0.0 110.99 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . 0.492 ' O ' ' CD1' ' A' ' 170' ' ' TRP . 2.7 mt-10 -121.03 172.75 7.72 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.501 1.126 . . . . 0.0 110.284 -179.941 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -95.56 -29.8 14.16 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.516 1.135 . . . . 0.0 110.319 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 168' ' ' GLN . . . . . 0.403 ' O ' ' CG2' ' A' ' 184' ' ' VAL . 6.8 tt0 -79.11 -60.19 2.47 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.473 1.108 . . . . 0.0 110.287 -179.954 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 169' ' ' TRP . . . . . 0.42 ' O ' ' CD1' ' A' ' 170' ' ' TRP . 11.2 m0 -104.96 157.74 17.01 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 170' ' ' TRP . . . . . 0.64 ' CZ3' HG12 ' A' ' 184' ' ' VAL . 39.9 m0 -136.13 155.61 49.92 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.467 1.104 . . . . 0.0 108.055 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 171' ' ' ASN . . . . . 0.405 ' HA ' ' O ' ' A' ' 180' ' ' GLY . 42.1 t-20 -88.37 99.2 12.08 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.525 1.141 . . . . 0.0 109.266 -179.947 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . 0.526 ' HA ' ' O ' ' A' ' 160' ' ' ARG . . . -109.41 174.77 5.72 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.514 1.134 . . . . 0.0 109.342 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . 0.403 ' OE2' ' HD3' ' A' ' 179' ' ' ARG . 8.0 mt-10 -119.39 117.19 27.84 Favored 'General case' 0 C--N 1.326 -0.437 0 O-C-N 124.475 1.109 . . . . 0.0 110.315 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . 0.465 ' N ' HD21 ' A' ' 159' ' ' LEU . 3.7 m-20 -67.2 -176.39 0.55 Allowed 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.471 1.107 . . . . 0.0 109.273 -179.952 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 73.4 p -79.24 60.17 3.0 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.528 1.142 . . . . 0.0 110.002 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -176.54 7.56 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.428 0 O-C-N 124.485 1.116 . . . . 0.0 110.292 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 75.66 18.23 79.81 Favored Glycine 0 CA--C 1.529 0.959 0 O-C-N 124.495 1.122 . . . . 0.0 110.985 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 14.1 mtmm -83.92 106.25 15.44 Favored 'General case' 0 C--N 1.326 -0.435 0 O-C-N 124.41 0.712 . . . . 0.0 109.277 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 179' ' ' ARG . . . . . 0.403 ' HD3' ' OE2' ' A' ' 173' ' ' GLU . 4.1 ttp180 -88.51 118.04 27.88 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.444 1.09 . . . . 0.0 110.265 -179.936 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . 0.405 ' O ' ' HA ' ' A' ' 171' ' ' ASN . . . -151.57 166.86 30.83 Favored Glycine 0 CA--C 1.53 1.002 0 O-C-N 124.501 1.126 . . . . 0.0 110.979 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 181' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -87.61 114.43 24.22 Favored 'General case' 0 C--N 1.324 -0.528 0 O-C-N 124.497 0.763 . . . . 0.0 110.939 -179.957 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . 0.441 ' HB ' ' HD2' ' A' ' 183' ' ' PRO . 2.1 pt -116.02 163.44 21.35 Favored Pre-proline 0 C--N 1.325 -0.487 0 O-C-N 124.492 1.12 . . . . 0.0 109.256 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 183' ' ' PRO . . . . . 0.774 ' HG2' ' HB2' ' A' ' 186' ' ' TYR . 18.0 Cg_endo -75.02 135.63 19.3 Favored 'Trans proline' 0 C--N 1.361 1.199 0 O-C-N 124.52 1.8 . . . . 0.0 110.946 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . 0.82 ' N ' ' CD ' ' A' ' 185' ' ' PRO . 50.6 t -80.17 -31.98 0.68 Allowed Pre-proline 0 C--N 1.325 -0.469 0 O-C-N 124.486 1.117 . . . . 0.0 109.299 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 185' ' ' PRO . . . . . 0.82 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.3 Cg_endo -75.0 -23.09 14.13 Favored 'Trans proline' 0 C--N 1.361 1.214 0 O-C-N 124.541 1.811 . . . . 0.0 110.985 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 186' ' ' TYR . . . . . 0.774 ' HB2' ' HG2' ' A' ' 183' ' ' PRO . 3.8 m-85 -93.66 16.02 14.86 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.503 1.127 . . . . 0.0 111.037 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 187' ' ' VAL . . . . . 0.549 ' HA ' ' O ' ' A' ' 138' ' ' ARG . 6.0 m -145.49 165.58 10.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 O-C-N 124.449 1.093 . . . . 0.0 109.305 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 188' ' ' GLU . . . . . 0.485 ' N ' ' O ' ' A' ' 138' ' ' ARG . 0.0 OUTLIER -130.16 166.05 21.05 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.47 1.106 . . . . 0.0 110.371 -179.971 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.65 121.85 32.92 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.462 1.101 . . . . 0.0 109.369 179.911 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 2.6 t80 . . . . . 0 C--N 1.325 -0.487 0 O-C-N 124.543 1.152 . . . . 0.0 110.991 -179.913 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.453 -0.287 0 N-CA-C 110.301 -0.259 . . . . 0.0 110.301 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -128.08 116.68 20.35 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 124.518 1.136 . . . . 0.0 110.967 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.477 HG13 ' CD1' ' A' ' 161' ' ' ILE . 32.4 m -107.77 165.02 4.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 O-C-N 124.542 1.151 . . . . 0.0 109.36 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . 0.461 ' HD3' ' O ' ' A' ' 157' ' ' ASP . 2.7 tpp85 -125.12 132.18 53.15 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.445 1.091 . . . . 0.0 110.306 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . 0.578 ' O ' ' N ' ' A' ' 156' ' ' GLY . . . -98.22 112.94 24.74 Favored 'General case' 0 C--N 1.326 -0.444 0 O-C-N 124.474 1.109 . . . . 0.0 109.307 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.484 ' CD1' ' HG2' ' A' ' 188' ' ' GLU . 0.1 OUTLIER -92.71 -12.02 32.5 Favored 'General case' 0 C--N 1.326 -0.437 0 O-C-N 124.448 1.092 . . . . 0.0 109.302 -179.953 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -121.73 156.69 32.56 Favored 'General case' 0 C--N 1.326 -0.416 0 O-C-N 124.507 1.129 . . . . 0.0 110.966 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . 0.464 ' OD1' ' N ' ' A' ' 155' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--N 1.326 -0.454 0 O-C-N 124.439 1.087 . . . . 0.0 109.316 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 52.2 p90 . . . . . 0 N--CA 1.453 -0.306 0 CA-C-O 120.475 0.179 . . . . 0.0 110.967 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . 0.421 ' HA ' ' HA ' ' A' ' 142' ' ' ASP . 2.9 tttm -128.92 -161.75 1.14 Allowed 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.528 1.143 . . . . 0.0 109.273 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.464 ' N ' ' OD1' ' A' ' 142' ' ' ASP . 0.0 OUTLIER -91.64 101.12 13.74 Favored 'General case' 0 C--N 1.324 -0.522 0 O-C-N 124.507 1.129 . . . . 0.0 109.302 -179.987 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . 0.578 ' N ' ' O ' ' A' ' 139' ' ' ALA . . . 114.47 27.64 3.27 Favored Glycine 0 CA--C 1.53 0.981 0 O-C-N 124.491 1.12 . . . . 0.0 111.023 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . 0.461 ' O ' ' HD3' ' A' ' 138' ' ' ARG . 2.5 t70 -105.08 163.47 12.53 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.555 0.797 . . . . 0.0 109.299 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . 0.432 HG12 ' HD3' ' A' ' 138' ' ' ARG . 4.4 mt -119.59 149.08 22.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 O-C-N 124.47 1.107 . . . . 0.0 109.297 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . 0.425 ' CD1' ' N ' ' A' ' 159' ' ' LEU . 0.0 OUTLIER -147.5 137.45 22.93 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 124.515 1.135 . . . . 0.0 109.279 -179.969 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . 0.602 ' O ' ' CB ' ' A' ' 172' ' ' ALA . 7.3 ttt180 -88.25 136.29 33.05 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.522 1.139 . . . . 0.0 110.325 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . 0.477 ' CD1' HG13 ' A' ' 137' ' ' VAL . 0.9 OUTLIER -83.68 110.3 18.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 O-C-N 124.44 1.087 . . . . 0.0 109.324 -179.948 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . 0.43 ' HB3' ' ND2' ' A' ' 171' ' ' ASN . 2.5 tpt85 -88.33 -59.6 2.19 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.483 1.114 . . . . 0.0 110.353 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . 0.43 ' O ' ' HB3' ' A' ' 170' ' ' TRP . 20.3 t0 -149.19 149.68 31.4 Favored 'General case' 0 C--N 1.324 -0.526 0 O-C-N 124.515 1.134 . . . . 0.0 109.34 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . 0.542 ' HB2' ' CE2' ' A' ' 170' ' ' TRP . 0.4 OUTLIER -132.76 76.51 70.9 Favored Pre-proline 0 C--N 1.325 -0.496 0 O-C-N 124.474 1.109 . . . . 0.0 109.324 -179.987 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -75.14 -44.89 0.3 Allowed 'Trans proline' 0 C--N 1.361 1.207 0 O-C-N 124.426 1.75 . . . . 0.0 110.959 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 -78.97 175.5 10.51 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.457 1.098 . . . . 0.0 110.303 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 32.6 mm-40 -114.03 54.12 0.76 Allowed 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.464 1.102 . . . . 0.0 110.322 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 168' ' ' GLN . . . . . 0.421 ' O ' ' CG2' ' A' ' 184' ' ' VAL . 0.0 OUTLIER -178.5 -57.63 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.432 0 O-C-N 124.464 1.103 . . . . 0.0 110.261 -179.971 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 169' ' ' TRP . . . . . 0.565 ' CZ3' ' HA ' ' A' ' 182' ' ' ILE . 14.0 m95 -109.8 142.13 41.49 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 107.961 -1.125 . . . . 0.0 107.961 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 170' ' ' TRP . . . . . 0.607 ' CZ3' HG11 ' A' ' 184' ' ' VAL . 22.8 m0 -133.91 161.39 34.91 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.518 1.136 . . . . 0.0 108.011 179.964 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 171' ' ' ASN . . . . . 0.468 ' HA ' ' HA ' ' A' ' 181' ' ' MET . 5.3 p-10 -94.08 111.26 22.96 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.556 1.16 . . . . 0.0 109.296 179.986 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . 0.602 ' CB ' ' O ' ' A' ' 160' ' ' ARG . . . -117.34 -176.79 3.08 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.499 1.125 . . . . 0.0 109.308 179.991 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . 0.435 ' OE2' ' CD ' ' A' ' 179' ' ' ARG . 40.2 mt-10 -128.09 124.27 36.59 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.439 1.087 . . . . 0.0 110.338 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -75.99 -172.65 2.06 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.407 1.067 . . . . 0.0 109.278 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 1.4 m -82.35 61.59 5.62 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.55 1.156 . . . . 0.0 110.028 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -177.16 9.95 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.451 1.094 . . . . 0.0 110.312 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 74.07 17.25 79.45 Favored Glycine 0 CA--C 1.531 1.034 0 O-C-N 124.51 1.132 . . . . 0.0 111.029 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 178' ' ' LYS . . . . . 0.4 ' O ' ' HA ' ' A' ' 173' ' ' GLU . 0.8 OUTLIER -82.8 101.38 10.9 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.544 0.79 . . . . 0.0 109.262 -179.97 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 179' ' ' ARG . . . . . 0.499 ' HA ' ' O ' ' A' ' 172' ' ' ALA . 0.0 OUTLIER -91.42 115.42 28.02 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.528 1.142 . . . . 0.0 110.275 -179.968 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -150.96 169.0 30.7 Favored Glycine 0 CA--C 1.53 1.005 0 O-C-N 124.457 1.098 . . . . 0.0 110.998 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 181' ' ' MET . . . . . 0.495 ' HG3' ' HB3' ' A' ' 169' ' ' TRP . 1.4 ttm -87.75 111.95 21.88 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.44 0.729 . . . . 0.0 110.99 -179.978 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . 0.565 ' HA ' ' CZ3' ' A' ' 169' ' ' TRP . 1.5 pp -115.27 166.88 10.94 Favored Pre-proline 0 C--N 1.325 -0.472 0 O-C-N 124.538 1.149 . . . . 0.0 109.263 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 183' ' ' PRO . . . . . 0.607 ' HG2' ' CB ' ' A' ' 186' ' ' TYR . 18.3 Cg_endo -75.02 135.11 18.61 Favored 'Trans proline' 0 C--N 1.36 1.145 0 O-C-N 124.471 1.774 . . . . 0.0 110.973 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . 0.811 ' N ' ' CD ' ' A' ' 185' ' ' PRO . 86.9 t -79.98 -32.3 0.71 Allowed Pre-proline 0 C--N 1.325 -0.467 0 O-C-N 124.482 1.114 . . . . 0.0 109.293 179.986 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 185' ' ' PRO . . . . . 0.811 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.3 Cg_endo -74.99 -11.38 21.49 Favored 'Trans proline' 0 C--N 1.359 1.124 0 O-C-N 124.48 1.779 . . . . 0.0 110.999 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 186' ' ' TYR . . . . . 0.607 ' CB ' ' HG2' ' A' ' 183' ' ' PRO . 6.8 m-85 -93.97 -1.98 53.82 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.501 1.126 . . . . 0.0 111.022 -179.979 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 187' ' ' VAL . . . . . 0.425 ' HA ' ' O ' ' A' ' 138' ' ' ARG . 14.4 m -133.22 174.03 13.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 O-C-N 124.477 1.111 . . . . 0.0 109.307 179.963 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 188' ' ' GLU . . . . . 0.484 ' HG2' ' CD1' ' A' ' 140' ' ' LEU . 0.0 OUTLIER -135.53 172.51 12.9 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.457 1.098 . . . . 0.0 110.307 179.991 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.8 126.07 34.8 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.454 1.096 . . . . 0.0 109.288 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 72.2 t80 . . . . . 0 C--N 1.325 -0.484 0 O-C-N 124.47 1.106 . . . . 0.0 110.953 -179.977 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . 0.442 ' HB2' ' O ' ' A' ' 161' ' ' ILE . 1.2 pt-20 . . . . . 0 N--CA 1.452 -0.354 0 N-CA-C 110.32 -0.252 . . . . 0.0 110.32 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 7.3 m-85 -124.19 117.06 23.75 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.489 1.118 . . . . 0.0 110.957 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.516 ' CG2' ' O ' ' A' ' 188' ' ' GLU . 0.4 OUTLIER -119.41 132.54 68.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 O-C-N 124.544 1.153 . . . . 0.0 109.309 179.973 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . 0.499 ' CZ ' ' OH ' ' A' ' 190' ' ' TYR . 12.7 ttm180 -95.2 148.37 22.47 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.525 1.14 . . . . 0.0 110.373 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . 0.51 ' O ' ' N ' ' A' ' 156' ' ' GLY . . . -105.91 110.66 23.01 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.512 1.132 . . . . 0.0 109.268 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.511 ' O ' ' CD ' ' A' ' 155' ' ' LYS . 0.3 OUTLIER -93.89 -7.9 41.82 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.456 1.098 . . . . 0.0 109.274 179.965 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . 0.456 ' C ' ' O ' ' A' ' 154' ' ' LYS . 14.7 m-85 -104.61 158.73 16.3 Favored 'General case' 0 C--N 1.324 -0.524 0 O-C-N 124.525 1.141 . . . . 0.0 110.976 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . 0.57 ' CA ' ' O ' ' A' ' 154' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--N 1.325 -0.461 0 O-C-N 124.449 1.093 . . . . 0.0 109.276 -179.942 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . 0.565 ' CD1' ' N ' ' A' ' 153' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.454 -0.251 0 CA-C-O 120.496 0.188 . . . . 0.0 110.971 . . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . 0.57 ' O ' ' CA ' ' A' ' 142' ' ' ASP . 0.0 OUTLIER -127.0 -75.37 0.58 Allowed 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.5 1.125 . . . . 0.0 109.258 179.97 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.511 ' CD ' ' O ' ' A' ' 140' ' ' LEU . 0.0 OUTLIER -165.26 109.64 0.88 Allowed 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.54 1.15 . . . . 0.0 109.278 -179.97 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . 0.51 ' N ' ' O ' ' A' ' 139' ' ' ALA . . . 93.45 29.88 9.7 Favored Glycine 0 CA--C 1.531 1.042 0 O-C-N 124.593 1.183 . . . . 0.0 110.98 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . 0.492 ' OD1' ' N ' ' A' ' 158' ' ' ILE . 0.4 OUTLIER -88.66 158.65 18.16 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.482 0.754 . . . . 0.0 109.285 179.995 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . 0.529 ' N ' ' CD1' ' A' ' 158' ' ' ILE . 1.5 mp -116.38 136.34 53.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 O-C-N 124.492 1.12 . . . . 0.0 109.278 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . 0.41 ' HG ' ' C ' ' A' ' 158' ' ' ILE . 0.6 OUTLIER -138.09 126.22 22.9 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.51 1.131 . . . . 0.0 109.3 -179.971 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . 0.478 ' O ' ' HA ' ' A' ' 172' ' ' ALA . 0.0 OUTLIER -86.84 126.28 34.54 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.535 1.147 . . . . 0.0 110.299 -179.98 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . 0.457 HG23 ' CE ' ' A' ' 164' ' ' LYS . 12.4 mm -81.77 122.56 36.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 O-C-N 124.502 1.127 . . . . 0.0 109.336 179.998 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . 0.463 ' HG3' ' N ' ' A' ' 163' ' ' ASP . 0.0 OUTLIER -122.53 -29.55 4.06 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.526 1.141 . . . . 0.0 110.276 179.989 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . 0.463 ' N ' ' HG3' ' A' ' 162' ' ' ARG . 0.8 OUTLIER -135.99 146.0 46.73 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.477 1.111 . . . . 0.0 109.312 -179.949 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . 0.62 ' CE ' ' CE3' ' A' ' 170' ' ' TRP . 15.9 mtpt -146.84 62.64 7.7 Favored Pre-proline 0 C--N 1.324 -0.506 0 O-C-N 124.459 1.099 . . . . 0.0 109.342 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 165' ' ' PRO . . . . . 0.442 ' HD3' ' N ' ' A' ' 164' ' ' LYS . 18.1 Cg_endo -75.04 -73.54 0.01 OUTLIER 'Trans proline' 0 C--N 1.361 1.218 0 O-C-N 124.474 1.776 . . . . 0.0 110.976 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -50.69 160.06 0.47 Allowed 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.523 1.139 . . . . 0.0 110.293 -179.967 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -100.91 35.21 2.25 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.477 1.11 . . . . 0.0 110.271 -179.938 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -157.75 -51.35 0.07 Allowed 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.417 1.073 . . . . 0.0 110.353 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 169' ' ' TRP . . . . . . . . . . . . . 13.0 m95 -103.79 140.53 37.5 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.607 1.192 . . . . 0.0 108.039 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 170' ' ' TRP . . . . . 0.62 ' CE3' ' CE ' ' A' ' 164' ' ' LYS . 50.5 m0 -121.0 147.35 45.61 Favored 'General case' 0 C--N 1.324 -0.53 0 O-C-N 124.511 1.132 . . . . 0.0 107.975 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 16.4 t30 -87.47 98.06 11.18 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.473 1.108 . . . . 0.0 109.233 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . 0.478 ' HA ' ' O ' ' A' ' 160' ' ' ARG . . . -107.77 173.54 6.28 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.43 1.081 . . . . 0.0 109.334 179.909 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . 0.511 ' CG ' ' HG2' ' A' ' 179' ' ' ARG . 23.9 mt-10 -118.95 120.24 36.7 Favored 'General case' 0 C--N 1.326 -0.439 0 O-C-N 124.479 1.112 . . . . 0.0 110.268 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -73.92 -169.55 0.76 Allowed 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.489 1.118 . . . . 0.0 109.307 179.944 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 27.6 t -83.69 63.98 7.73 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.496 1.122 . . . . 0.0 110.038 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -176.33 7.23 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.511 1.132 . . . . 0.0 110.341 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 70.68 22.46 78.04 Favored Glycine 0 CA--C 1.53 0.984 0 O-C-N 124.492 1.12 . . . . 0.0 111.005 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 4.6 ptpp? -94.4 115.45 27.66 Favored 'General case' 0 C--N 1.324 -0.53 0 O-C-N 124.454 0.738 . . . . 0.0 109.29 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 179' ' ' ARG . . . . . 0.511 ' HG2' ' CG ' ' A' ' 173' ' ' GLU . 1.3 mtt180 -92.87 123.63 36.27 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.579 1.175 . . . . 0.0 110.331 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -151.04 160.49 28.66 Favored Glycine 0 CA--C 1.53 1.001 0 O-C-N 124.48 1.112 . . . . 0.0 110.996 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 181' ' ' MET . . . . . 0.421 ' HA ' ' O ' ' A' ' 170' ' ' TRP . 4.7 mmm -88.6 107.13 18.75 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.472 0.748 . . . . 0.0 110.997 -179.966 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . 0.553 ' CG2' ' CE2' ' A' ' 153' ' ' PHE . 1.0 OUTLIER -112.32 170.12 5.62 Favored Pre-proline 0 C--N 1.325 -0.474 0 O-C-N 124.41 1.069 . . . . 0.0 109.338 179.969 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 183' ' ' PRO . . . . . 0.598 ' HG2' ' CB ' ' A' ' 186' ' ' TYR . 18.5 Cg_endo -74.98 132.82 15.88 Favored 'Trans proline' 0 C--N 1.36 1.132 0 O-C-N 124.425 1.75 . . . . 0.0 111.022 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . 0.819 ' N ' ' CD ' ' A' ' 185' ' ' PRO . 84.5 t -76.62 -31.68 0.96 Allowed Pre-proline 0 C--N 1.326 -0.456 0 O-C-N 124.577 1.173 . . . . 0.0 109.282 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 185' ' ' PRO . . . . . 0.819 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.4 Cg_endo -74.9 -8.72 20.44 Favored 'Trans proline' 0 C--N 1.36 1.153 0 O-C-N 124.454 1.765 . . . . 0.0 111.057 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 186' ' ' TYR . . . . . 0.598 ' CB ' ' HG2' ' A' ' 183' ' ' PRO . 3.4 m-85 -99.7 6.68 45.53 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.459 1.1 . . . . 0.0 110.941 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 187' ' ' VAL . . . . . 0.452 ' HB ' ' O ' ' A' ' 138' ' ' ARG . 34.5 m -136.92 174.5 11.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 O-C-N 124.506 1.129 . . . . 0.0 109.252 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 188' ' ' GLU . . . . . 0.516 ' O ' ' CG2' ' A' ' 137' ' ' VAL . 0.0 OUTLIER -131.58 163.69 27.5 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.558 1.161 . . . . 0.0 110.302 179.986 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.53 124.14 35.47 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.461 1.101 . . . . 0.0 109.288 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 190' ' ' TYR . . . . . 0.499 ' OH ' ' CZ ' ' A' ' 138' ' ' ARG . 0.1 OUTLIER . . . . . 0 C--N 1.325 -0.493 0 O-C-N 124.448 1.093 . . . . 0.0 111.049 179.967 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . 0.436 ' HB3' ' O ' ' A' ' 161' ' ' ILE . 5.5 mp0 . . . . . 0 N--CA 1.453 -0.315 0 N-CA-C 110.268 -0.271 . . . . 0.0 110.268 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . 0.584 ' CD1' ' HG2' ' A' ' 160' ' ' ARG . 86.2 m-85 -128.33 140.11 52.04 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.549 1.155 . . . . 0.0 110.956 -179.965 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.533 ' CG2' HD11 ' A' ' 161' ' ' ILE . 29.1 m -138.1 149.64 24.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 124.514 1.134 . . . . 0.0 109.335 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . 0.434 ' HB3' ' CD ' ' A' ' 188' ' ' GLU . 1.2 ttm180 -107.54 130.02 54.91 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.495 1.122 . . . . 0.0 110.275 -179.948 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . 0.659 ' O ' ' N ' ' A' ' 156' ' ' GLY . . . -89.25 103.37 16.0 Favored 'General case' 0 C--N 1.326 -0.443 0 O-C-N 124.461 1.1 . . . . 0.0 109.281 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -86.85 -2.8 58.86 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.521 1.138 . . . . 0.0 109.345 179.933 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 46.7 m-85 -128.92 157.63 41.06 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.5 1.125 . . . . 0.0 111.009 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . 0.424 ' HB2' ' HA ' ' A' ' 154' ' ' LYS . 1.5 t70 . . . . . 0 C--N 1.325 -0.458 0 O-C-N 124.388 1.055 . . . . 0.0 109.266 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 8.4 p90 . . . . . 0 N--CA 1.454 -0.272 0 CA-C-O 120.51 0.195 . . . . 0.0 111.003 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . 0.424 ' HA ' ' HB2' ' A' ' 142' ' ' ASP . 6.8 tttt -128.49 -164.9 1.43 Allowed 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.441 1.088 . . . . 0.0 109.272 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 35.4 tttt -92.94 106.47 18.43 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.483 1.114 . . . . 0.0 109.293 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . 0.659 ' N ' ' O ' ' A' ' 139' ' ' ALA . . . 109.86 29.01 3.97 Favored Glycine 0 CA--C 1.531 1.034 0 O-C-N 124.496 1.123 . . . . 0.0 111.004 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -97.39 167.05 11.24 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.482 0.754 . . . . 0.0 109.352 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . 0.421 ' C ' ' HG ' ' A' ' 159' ' ' LEU . 18.0 mm -121.46 136.78 57.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 O-C-N 124.52 1.137 . . . . 0.0 109.306 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . 0.421 ' HG ' ' C ' ' A' ' 158' ' ' ILE . 0.8 OUTLIER -141.48 136.63 31.44 Favored 'General case' 0 C--N 1.326 -0.427 0 O-C-N 124.495 1.122 . . . . 0.0 109.325 -179.97 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . 0.584 ' HG2' ' CD1' ' A' ' 136' ' ' TYR . 0.0 OUTLIER -97.33 134.98 39.88 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.528 1.143 . . . . 0.0 110.347 179.96 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . 0.533 HD11 ' CG2' ' A' ' 137' ' ' VAL . 1.7 mp -87.19 125.22 41.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 O-C-N 124.501 1.126 . . . . 0.0 109.346 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . 0.482 ' CG ' ' N ' ' A' ' 163' ' ' ASP . 0.8 OUTLIER -118.63 -41.03 2.83 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 124.5 1.125 . . . . 0.0 110.291 -179.953 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . 0.482 ' N ' ' CG ' ' A' ' 162' ' ' ARG . 13.7 m-20 -148.78 176.99 9.91 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.492 1.12 . . . . 0.0 109.34 -179.987 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . 0.591 ' HB3' ' CD1' ' A' ' 170' ' ' TRP . 6.9 mtmm -144.88 65.45 12.24 Favored Pre-proline 0 C--N 1.325 -0.478 0 O-C-N 124.564 1.165 . . . . 0.0 109.283 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 165' ' ' PRO . . . . . 0.514 ' O ' ' CB ' ' A' ' 166' ' ' GLU . 18.5 Cg_endo -74.92 73.29 4.32 Favored 'Trans proline' 0 C--N 1.361 1.212 0 O-C-N 124.507 1.793 . . . . 0.0 110.997 179.966 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . 0.514 ' CB ' ' O ' ' A' ' 165' ' ' PRO . 2.5 mt-10 159.93 179.35 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.528 1.142 . . . . 0.0 110.325 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -118.16 46.11 1.85 Allowed 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.513 1.133 . . . . 0.0 110.318 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -178.83 -54.35 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.484 1.115 . . . . 0.0 110.322 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 169' ' ' TRP . . . . . . . . . . . . . 10.2 m95 -95.52 144.35 26.07 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.539 1.149 . . . . 0.0 107.991 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 170' ' ' TRP . . . . . 0.591 ' CD1' ' HB3' ' A' ' 164' ' ' LYS . 53.2 m0 -118.71 148.38 42.83 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 -179.963 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 171' ' ' ASN . . . . . 0.459 ' HB2' ' CD ' ' A' ' 165' ' ' PRO . 5.4 t-20 -87.58 107.73 18.73 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.555 1.16 . . . . 0.0 109.366 179.903 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . 0.528 ' CA ' ' O ' ' A' ' 160' ' ' ARG . . . -119.28 174.88 6.09 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.511 1.132 . . . . 0.0 109.31 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . 0.515 ' HG3' ' CG ' ' A' ' 179' ' ' ARG . 3.8 mt-10 -118.17 119.92 36.16 Favored 'General case' 0 C--N 1.326 -0.427 0 O-C-N 124.543 1.152 . . . . 0.0 110.262 -179.947 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . 0.4 ' OD1' ' HB3' ' A' ' 178' ' ' LYS . 0.8 OUTLIER -76.19 -173.7 2.5 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.411 1.069 . . . . 0.0 109.319 -179.943 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 40.6 t -75.82 63.89 1.73 Allowed 'General case' 0 C--N 1.324 -0.539 0 O-C-N 124.591 1.182 . . . . 0.0 110.079 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . 0.42 ' H ' ' H ' ' A' ' 177' ' ' GLY . 0.9 OUTLIER -177.56 1.53 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.55 1.156 . . . . 0.0 110.276 -179.921 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 177' ' ' GLY . . . . . 0.42 ' H ' ' H ' ' A' ' 176' ' ' GLU . . . 74.94 15.47 80.98 Favored Glycine 0 CA--C 1.53 0.998 0 O-C-N 124.522 1.139 . . . . 0.0 111.019 -179.954 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 178' ' ' LYS . . . . . 0.4 ' HB3' ' OD1' ' A' ' 174' ' ' ASP . 0.0 OUTLIER -84.91 117.59 24.01 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.506 0.768 . . . . 0.0 109.38 179.986 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 179' ' ' ARG . . . . . 0.515 ' CG ' ' HG3' ' A' ' 173' ' ' GLU . 3.3 mtt85 -90.18 123.34 33.92 Favored 'General case' 0 C--N 1.326 -0.441 0 O-C-N 124.498 1.124 . . . . 0.0 110.294 -179.949 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . 0.427 ' O ' ' HA ' ' A' ' 171' ' ' ASN . . . -152.21 164.57 30.56 Favored Glycine 0 CA--C 1.53 1.011 0 O-C-N 124.471 1.107 . . . . 0.0 111.017 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 181' ' ' MET . . . . . 0.401 ' HA ' ' O ' ' A' ' 170' ' ' TRP . 21.7 mtp -86.37 101.77 13.41 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.528 0.781 . . . . 0.0 110.95 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 23.3 pt -99.2 158.12 32.82 Favored Pre-proline 0 C--N 1.326 -0.452 0 O-C-N 124.492 1.12 . . . . 0.0 109.301 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 183' ' ' PRO . . . . . 0.753 ' HG2' ' HB2' ' A' ' 186' ' ' TYR . 18.4 Cg_endo -74.96 134.13 17.5 Favored 'Trans proline' 0 C--N 1.36 1.159 0 O-C-N 124.404 1.739 . . . . 0.0 110.947 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . 0.807 ' N ' ' CD ' ' A' ' 185' ' ' PRO . 73.9 t -77.43 -33.36 1.04 Allowed Pre-proline 0 C--N 1.325 -0.46 0 O-C-N 124.578 1.174 . . . . 0.0 109.271 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 185' ' ' PRO . . . . . 0.807 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.3 Cg_endo -74.96 -14.7 21.15 Favored 'Trans proline' 0 C--N 1.361 1.191 0 O-C-N 124.5 1.789 . . . . 0.0 111.026 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 186' ' ' TYR . . . . . 0.753 ' HB2' ' HG2' ' A' ' 183' ' ' PRO . 3.3 m-85 -96.59 0.31 49.78 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.508 1.13 . . . . 0.0 111.057 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 4.1 m -135.4 164.49 32.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 O-C-N 124.463 1.102 . . . . 0.0 109.271 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 188' ' ' GLU . . . . . 0.434 ' CD ' ' HB3' ' A' ' 138' ' ' ARG . 0.0 OUTLIER -122.46 166.92 13.99 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.52 1.137 . . . . 0.0 110.293 179.963 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -87.69 135.59 33.31 Favored 'General case' 0 C--N 1.326 -0.422 0 O-C-N 124.492 1.12 . . . . 0.0 109.288 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.326 -0.423 0 O-C-N 124.447 1.092 . . . . 0.0 110.948 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' CYS . . . . . . . . . . . . . 3.9 m . . . . . 0 N--CA 1.452 -0.329 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 143.58 -35.34 1.64 Allowed Glycine 0 CA--C 1.53 1.026 0 O-C-N 124.463 1.102 . . . . 0.0 111.009 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -74.76 59.63 0.88 Allowed 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.504 0.767 . . . . 0.0 109.293 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . 0.463 ' HB3' ' O ' ' A' ' 161' ' ' ILE . 0.3 OUTLIER 39.05 69.02 0.3 Allowed 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.529 1.143 . . . . 0.0 110.283 -179.981 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . 0.812 ' CD1' ' CG ' ' A' ' 190' ' ' TYR . 1.9 t80 -112.49 128.77 56.43 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.482 1.113 . . . . 0.0 110.965 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.559 HG12 ' CG2' ' A' ' 187' ' ' VAL . 10.5 t -139.61 141.48 34.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 O-C-N 124.534 1.146 . . . . 0.0 109.306 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . 0.467 ' N ' HG11 ' A' ' 137' ' ' VAL . 0.5 OUTLIER -112.18 139.18 47.93 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.44 1.087 . . . . 0.0 110.287 -179.987 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . 0.504 ' HB1' ' CD1' ' A' ' 159' ' ' LEU . . . -95.17 114.5 26.3 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.468 1.105 . . . . 0.0 109.318 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.453 ' O ' ' CB ' ' A' ' 155' ' ' LYS . 0.5 OUTLIER -87.26 -22.83 24.95 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.498 1.124 . . . . 0.0 109.277 -179.984 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 20.2 m-85 -101.67 167.58 10.02 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.474 1.109 . . . . 0.0 110.995 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . 0.404 ' O ' ' HB2' ' A' ' 143' ' ' PHE . 1.9 p30 -120.26 147.55 44.82 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.504 1.127 . . . . 0.0 109.309 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' PHE . . . . . 0.558 ' HB3' ' CZ ' ' A' ' 153' ' ' PHE . 85.5 t80 179.0 59.82 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.494 1.121 . . . . 0.0 110.992 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . 0.454 ' O ' ' O ' ' A' ' 145' ' ' GLY . 20.1 t-20 -55.22 -15.85 2.73 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.474 1.109 . . . . 0.0 109.293 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . 0.454 ' O ' ' O ' ' A' ' 144' ' ' ASN . . . -51.82 -168.89 0.01 OUTLIER Glycine 0 CA--C 1.53 1.001 0 O-C-N 124.466 1.104 . . . . 0.0 111.001 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 2.6 p30 -167.53 66.28 0.08 Allowed 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.478 0.752 . . . . 0.0 109.31 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 24.3 m-20 -41.22 -57.22 2.16 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.501 1.126 . . . . 0.0 109.277 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -130.7 58.82 1.68 Allowed 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.517 1.136 . . . . 0.0 110.285 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER 66.24 36.2 5.58 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.543 1.152 . . . . 0.0 110.3 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . 0.631 ' OD2' ' CZ3' ' A' ' 169' ' ' TRP . 0.1 OUTLIER -68.67 179.85 1.61 Allowed 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.507 1.129 . . . . 0.0 109.251 -179.994 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.584 ' O ' ' CE2' ' A' ' 153' ' ' PHE . 14.7 tp -103.36 130.3 23.84 Favored Pre-proline 0 C--N 1.325 -0.465 0 O-C-N 124.533 1.146 . . . . 0.0 109.285 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 151' ' ' LEU . 18.3 Cg_endo -75.01 152.59 40.89 Favored 'Trans proline' 0 C--N 1.359 1.131 0 O-C-N 124.531 1.806 . . . . 0.0 110.972 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . 0.584 ' CE2' ' O ' ' A' ' 151' ' ' LEU . 12.8 p90 -179.48 168.98 1.43 Allowed 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.521 1.138 . . . . 0.0 110.999 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 8.6 tttt -126.56 -167.22 1.69 Allowed 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.556 1.16 . . . . 0.0 109.284 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.453 ' CB ' ' O ' ' A' ' 140' ' ' LEU . 2.9 ptmt -91.29 106.84 18.79 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.532 1.145 . . . . 0.0 109.257 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . 0.417 ' HA2' ' NE ' ' A' ' 138' ' ' ARG . . . 105.14 27.2 5.98 Favored Glycine 0 CA--C 1.531 1.033 0 O-C-N 124.505 1.128 . . . . 0.0 111.03 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . 0.401 ' OD2' ' HG ' ' A' ' 159' ' ' LEU . 32.2 t70 -92.34 161.46 14.66 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.502 0.766 . . . . 0.0 109.32 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . 0.588 ' CG2' ' CZ ' ' A' ' 136' ' ' TYR . 6.5 mm -111.76 128.1 68.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 O-C-N 124.474 1.109 . . . . 0.0 109.312 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.504 ' CD1' ' HB1' ' A' ' 139' ' ' ALA . 1.7 mp -142.19 127.55 18.8 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.48 1.112 . . . . 0.0 109.292 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . 0.41 ' HG2' ' O ' ' A' ' 135' ' ' GLU . 4.4 mtt180 -86.53 143.56 27.65 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.497 1.123 . . . . 0.0 110.333 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . 0.477 ' CD1' HG23 ' A' ' 137' ' ' VAL . 0.9 OUTLIER -86.81 116.15 28.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 O-C-N 124.542 1.151 . . . . 0.0 109.275 -179.969 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . 0.401 ' NH1' ' OE2' ' A' ' 173' ' ' GLU . 3.1 tpt180 -97.7 -69.27 0.76 Allowed 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.49 1.119 . . . . 0.0 110.285 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -134.42 173.43 11.64 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.422 1.076 . . . . 0.0 109.316 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . 0.535 ' HG2' ' CD2' ' A' ' 170' ' ' TRP . 0.0 OUTLIER -135.1 87.32 29.3 Favored Pre-proline 0 C--N 1.325 -0.47 0 O-C-N 124.515 1.135 . . . . 0.0 109.316 -179.958 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -74.97 -25.21 12.13 Favored 'Trans proline' 0 C--N 1.361 1.192 0 O-C-N 124.486 1.782 . . . . 0.0 111.001 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 6.7 mt-10 -125.22 167.36 14.97 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.551 1.157 . . . . 0.0 110.302 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -87.62 -18.82 28.78 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.497 1.123 . . . . 0.0 110.274 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 12.0 mt-30 -103.28 -53.44 2.81 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.491 1.119 . . . . 0.0 110.31 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' TRP . . . . . 0.631 ' CZ3' ' OD2' ' A' ' 150' ' ' ASP . 7.0 m95 -100.7 133.58 44.94 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.504 1.127 . . . . 0.0 107.999 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' TRP . . . . . 0.564 ' CE3' HG23 ' A' ' 184' ' ' VAL . 54.7 m0 -116.63 155.09 29.38 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.553 1.158 . . . . 0.0 107.983 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' ASN . . . . . 0.471 ' HA ' ' O ' ' A' ' 180' ' ' GLY . 19.5 t30 -86.5 97.48 10.52 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.495 1.122 . . . . 0.0 109.31 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -109.91 166.59 10.81 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.556 1.16 . . . . 0.0 109.308 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . 0.401 ' OE2' ' NH1' ' A' ' 162' ' ' ARG . 23.1 mt-10 -116.18 112.92 22.35 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.463 1.102 . . . . 0.0 110.273 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . 0.522 ' OD1' ' CD2' ' A' ' 151' ' ' LEU . 0.0 OUTLIER -68.63 -177.38 0.95 Allowed 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.427 1.08 . . . . 0.0 109.335 179.955 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 73.0 p -77.32 57.71 1.53 Allowed 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.506 1.129 . . . . 0.0 110.03 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . 0.409 ' O ' ' HD2' ' A' ' 178' ' ' LYS . 2.7 mt-10 -175.35 22.68 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.519 1.137 . . . . 0.0 110.284 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 55.57 29.18 53.34 Favored Glycine 0 CA--C 1.53 1.004 0 O-C-N 124.522 1.139 . . . . 0.0 110.991 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' LYS . . . . . 0.422 ' O ' ' OD1' ' A' ' 174' ' ' ASP . 0.0 OUTLIER -96.7 110.99 23.32 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.429 0.723 . . . . 0.0 109.308 179.982 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 3.4 ttp180 -91.1 120.5 32.1 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.523 1.139 . . . . 0.0 110.237 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . 0.471 ' O ' ' HA ' ' A' ' 171' ' ' ASN . . . -149.84 172.54 29.75 Favored Glycine 0 CA--C 1.53 0.998 0 O-C-N 124.483 1.114 . . . . 0.0 111.001 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' MET . . . . . 0.45 ' HA ' ' O ' ' A' ' 170' ' ' TRP . 20.7 mtp -86.94 92.55 9.06 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.497 0.763 . . . . 0.0 110.998 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . 0.581 ' CG1' ' HD2' ' A' ' 183' ' ' PRO . 6.6 tt -89.87 144.88 32.24 Favored Pre-proline 0 C--N 1.326 -0.455 0 O-C-N 124.495 1.122 . . . . 0.0 109.32 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' PRO . . . . . 0.674 ' HG2' ' HB2' ' A' ' 186' ' ' TYR . 18.4 Cg_endo -74.97 132.13 15.1 Favored 'Trans proline' 0 C--N 1.36 1.148 0 O-C-N 124.479 1.778 . . . . 0.0 111.028 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . 0.821 ' N ' ' CD ' ' A' ' 185' ' ' PRO . 28.1 t -74.48 -30.68 1.1 Allowed Pre-proline 0 C--N 1.325 -0.489 0 O-C-N 124.522 1.139 . . . . 0.0 109.303 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 185' ' ' PRO . . . . . 0.821 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.3 Cg_endo -74.92 -10.86 21.54 Favored 'Trans proline' 0 C--N 1.36 1.153 0 O-C-N 124.559 1.82 . . . . 0.0 111.025 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 186' ' ' TYR . . . . . 0.674 ' HB2' ' HG2' ' A' ' 183' ' ' PRO . 3.7 m-30 -101.61 -19.47 15.44 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.513 1.133 . . . . 0.0 111.018 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 187' ' ' VAL . . . . . 0.559 ' CG2' HG12 ' A' ' 137' ' ' VAL . 13.8 m -115.5 175.9 2.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 O-C-N 124.457 1.098 . . . . 0.0 109.311 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . 0.417 ' O ' HG11 ' A' ' 137' ' ' VAL . 0.0 OUTLIER -135.97 168.08 20.02 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 124.481 1.113 . . . . 0.0 110.311 -179.988 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . 0.464 ' HD2' ' CG2' ' A' ' 137' ' ' VAL . 5.8 mmmt -94.69 141.09 29.02 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.536 1.148 . . . . 0.0 109.31 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 190' ' ' TYR . . . . . 0.812 ' CG ' ' CD1' ' A' ' 136' ' ' TYR . 0.2 OUTLIER -93.18 172.86 8.03 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.459 1.1 . . . . 0.0 111.059 179.972 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.981 0 O-C-N 124.528 1.143 . . . . 0.0 110.999 -179.993 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' CYS . . . . . 0.437 ' O ' ' O ' ' A' ' 191' ' ' GLY . 90.0 m . . . . . 0 N--CA 1.452 -0.345 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -61.45 -161.16 0.14 Allowed Glycine 0 CA--C 1.53 0.986 0 O-C-N 124.419 1.075 . . . . 0.0 111.002 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . 0.461 ' HB2' ' CZ ' ' A' ' 136' ' ' TYR . . . 68.4 -159.64 0.2 Allowed 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.437 0.728 . . . . 0.0 109.325 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . 0.447 ' O ' ' HA ' ' A' ' 160' ' ' ARG . 0.7 OUTLIER -148.58 67.83 1.07 Allowed 'General case' 0 C--N 1.326 -0.442 0 O-C-N 124.446 1.091 . . . . 0.0 110.311 -179.98 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . 0.461 ' CZ ' ' HB2' ' A' ' 134' ' ' ALA . 1.9 m-85 -121.17 132.77 55.04 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.562 1.164 . . . . 0.0 110.975 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.509 ' CG2' HD13 ' A' ' 161' ' ' ILE . 22.4 m -129.6 162.31 37.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 O-C-N 124.58 1.175 . . . . 0.0 109.294 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.25 125.04 48.19 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.505 1.128 . . . . 0.0 110.341 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . 0.612 ' O ' ' N ' ' A' ' 156' ' ' GLY . . . -89.1 107.09 18.85 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.497 1.123 . . . . 0.0 109.284 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.41 ' O ' ' CG ' ' A' ' 155' ' ' LYS . 0.1 OUTLIER -88.68 -29.86 19.57 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.571 1.169 . . . . 0.0 109.349 -179.998 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . 0.494 ' C ' ' O ' ' A' ' 154' ' ' LYS . 47.2 m-85 -91.2 153.55 19.93 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.523 1.14 . . . . 0.0 110.989 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . 0.414 ' OD1' ' O ' ' A' ' 153' ' ' PHE . 4.2 t70 -106.86 153.64 22.21 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.475 1.11 . . . . 0.0 109.361 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' PHE . . . . . 0.588 ' HB3' ' CZ ' ' A' ' 153' ' ' PHE . 19.6 t80 -179.36 34.73 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.5 1.125 . . . . 0.0 110.967 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . 0.458 ' C ' ' ND2' ' A' ' 144' ' ' ASN . 0.9 OUTLIER -45.18 137.85 4.25 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.472 1.108 . . . . 0.0 109.229 -179.931 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . 0.41 ' O ' ' ND2' ' A' ' 144' ' ' ASN . . . -103.59 -116.96 4.27 Favored Glycine 0 CA--C 1.53 0.981 0 O-C-N 124.597 1.186 . . . . 0.0 110.984 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 7.5 p-10 -177.74 -50.19 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.443 0 O-C-N 124.461 0.742 . . . . 0.0 109.346 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -42.1 154.82 0.05 OUTLIER 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.511 1.132 . . . . 0.0 109.285 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 9.5 tt0 -90.94 46.21 1.31 Allowed 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.485 1.116 . . . . 0.0 110.31 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -144.2 -46.52 0.26 Allowed 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.455 1.097 . . . . 0.0 110.288 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 2.6 p-10 -70.52 168.22 16.73 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.472 1.107 . . . . 0.0 109.307 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.557 ' CB ' ' CG2' ' A' ' 182' ' ' ILE . 1.3 mp -113.72 107.59 52.59 Favored Pre-proline 0 C--N 1.325 -0.458 0 O-C-N 124.514 1.134 . . . . 0.0 109.321 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . 0.4 ' CB ' ' OD1' ' A' ' 144' ' ' ASN . 18.5 Cg_endo -74.95 136.04 19.96 Favored 'Trans proline' 0 C--N 1.36 1.171 0 O-C-N 124.429 1.752 . . . . 0.0 111.015 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . 0.588 ' CZ ' ' HB3' ' A' ' 143' ' ' PHE . 10.7 p90 -148.29 166.94 26.48 Favored 'General case' 0 C--N 1.326 -0.427 0 O-C-N 124.5 1.125 . . . . 0.0 111.004 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . 0.494 ' O ' ' C ' ' A' ' 141' ' ' PHE . 0.1 OUTLIER -121.27 -90.77 0.57 Allowed 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.492 1.12 . . . . 0.0 109.363 179.954 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.41 ' CG ' ' O ' ' A' ' 140' ' ' LEU . 10.3 ttpp -157.45 118.28 3.55 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.534 1.146 . . . . 0.0 109.28 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . 0.612 ' N ' ' O ' ' A' ' 139' ' ' ALA . . . 98.42 16.36 32.23 Favored Glycine 0 CA--C 1.531 1.033 0 O-C-N 124.544 1.153 . . . . 0.0 111.0 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -81.31 156.67 25.4 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.519 0.776 . . . . 0.0 109.3 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 5.1 mm -110.68 138.62 37.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 O-C-N 124.485 1.116 . . . . 0.0 109.347 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.484 ' CD1' ' HB3' ' A' ' 139' ' ' ALA . 1.5 mp -141.19 136.3 31.65 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.506 1.129 . . . . 0.0 109.272 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . 0.547 ' O ' ' CA ' ' A' ' 172' ' ' ALA . 0.0 OUTLIER -99.46 129.52 45.65 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.476 1.11 . . . . 0.0 110.313 179.981 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . 0.509 HD13 ' CG2' ' A' ' 137' ' ' VAL . 1.7 mp -83.76 122.08 37.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 O-C-N 124.516 1.135 . . . . 0.0 109.286 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -122.65 -42.44 2.32 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.505 1.128 . . . . 0.0 110.261 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -135.06 170.81 15.34 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.491 1.119 . . . . 0.0 109.295 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . 0.566 ' HB2' ' CD1' ' A' ' 170' ' ' TRP . 0.6 OUTLIER -164.74 84.98 1.13 Allowed Pre-proline 0 C--N 1.325 -0.458 0 O-C-N 124.505 1.128 . . . . 0.0 109.3 179.928 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.08 -27.52 9.82 Favored 'Trans proline' 0 C--N 1.36 1.17 0 O-C-N 124.51 1.795 . . . . 0.0 110.983 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -118.54 168.94 10.21 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.539 1.15 . . . . 0.0 110.299 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -93.27 -19.67 21.17 Favored 'General case' 0 C--N 1.326 -0.441 0 O-C-N 124.522 1.139 . . . . 0.0 110.333 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -85.58 -57.12 3.19 Favored 'General case' 0 C--N 1.326 -0.422 0 O-C-N 124.506 1.129 . . . . 0.0 110.336 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' TRP . . . . . . . . . . . . . 10.6 m95 -107.18 150.62 26.41 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.549 1.156 . . . . 0.0 108.04 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' TRP . . . . . 0.566 ' CD1' ' HB2' ' A' ' 164' ' ' LYS . 37.5 m0 -127.51 151.6 48.66 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.549 1.155 . . . . 0.0 108.0 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -87.37 99.14 11.78 Favored 'General case' 0 C--N 1.324 -0.532 0 O-C-N 124.468 1.105 . . . . 0.0 109.283 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . 0.547 ' CA ' ' O ' ' A' ' 160' ' ' ARG . . . -119.05 -178.43 3.56 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.476 1.11 . . . . 0.0 109.303 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . 0.437 ' CG ' ' HG3' ' A' ' 179' ' ' ARG . 34.0 mt-10 -119.73 121.15 38.55 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.47 1.106 . . . . 0.0 110.27 -179.898 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . 0.467 ' CB ' HD21 ' A' ' 151' ' ' LEU . 0.2 OUTLIER -72.44 -164.22 0.14 Allowed 'General case' 0 C--N 1.323 -0.547 0 O-C-N 124.594 1.184 . . . . 0.0 109.259 -179.998 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 52.6 p -87.53 56.94 4.15 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.465 1.103 . . . . 0.0 109.999 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -177.22 28.45 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.532 1.145 . . . . 0.0 110.189 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 53.23 24.69 23.06 Favored Glycine 0 CA--C 1.531 1.078 0 O-C-N 124.562 1.164 . . . . 0.0 111.003 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 3.1 mtpm? -90.93 108.89 20.15 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.503 0.767 . . . . 0.0 109.355 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 179' ' ' ARG . . . . . 0.437 ' HG3' ' CG ' ' A' ' 173' ' ' GLU . 0.0 OUTLIER -90.7 114.97 27.42 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.499 1.125 . . . . 0.0 110.34 179.955 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -150.79 174.31 30.13 Favored Glycine 0 CA--C 1.53 1.013 0 O-C-N 124.486 1.116 . . . . 0.0 111.01 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 181' ' ' MET . . . . . . . . . . . . . 33.5 mtp -88.04 106.19 17.98 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.537 0.786 . . . . 0.0 110.99 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . 0.557 ' CG2' ' CB ' ' A' ' 151' ' ' LEU . 6.8 pt -106.65 159.38 30.06 Favored Pre-proline 0 C--N 1.325 -0.496 0 O-C-N 124.505 1.128 . . . . 0.0 109.36 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 183' ' ' PRO . . . . . 0.565 ' HG2' ' CB ' ' A' ' 186' ' ' TYR . 18.1 Cg_endo -75.02 127.5 10.72 Favored 'Trans proline' 0 C--N 1.36 1.174 0 O-C-N 124.418 1.746 . . . . 0.0 111.013 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . 0.758 ' N ' ' CD ' ' A' ' 185' ' ' PRO . 21.8 t -76.17 -34.92 1.51 Allowed Pre-proline 0 C--N 1.325 -0.49 0 O-C-N 124.514 1.134 . . . . 0.0 109.334 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 185' ' ' PRO . . . . . 0.758 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.4 Cg_endo -74.95 -9.73 20.98 Favored 'Trans proline' 0 C--N 1.36 1.162 0 O-C-N 124.51 1.795 . . . . 0.0 110.988 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 186' ' ' TYR . . . . . 0.565 ' CB ' ' HG2' ' A' ' 183' ' ' PRO . 3.2 m-85 -95.95 -5.92 40.23 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.464 1.103 . . . . 0.0 110.962 -179.897 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 7.6 m -129.33 175.47 10.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 O-C-N 124.391 1.057 . . . . 0.0 109.282 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -131.63 173.26 11.31 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.534 1.147 . . . . 0.0 110.297 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.05 119.43 28.41 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.502 1.126 . . . . 0.0 109.273 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -78.05 -45.01 24.77 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.448 1.092 . . . . 0.0 110.92 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . 0.437 ' O ' ' O ' ' A' ' 132' ' ' CYS . . . . . . . . 0 CA--C 1.531 1.032 0 O-C-N 124.496 1.123 . . . . 0.0 111.014 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' CYS . . . . . . . . . . . . . 1.9 m . . . . . 0 N--CA 1.452 -0.363 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . 0.497 ' O ' ' CE1' ' A' ' 136' ' ' TYR . . . -121.3 31.3 5.13 Favored Glycine 0 CA--C 1.529 0.965 0 O-C-N 124.47 1.106 . . . . 0.0 111.038 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . 0.428 ' O ' ' O ' ' A' ' 133' ' ' GLY . . . 56.54 109.61 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.432 0 O-C-N 124.454 0.737 . . . . 0.0 109.26 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . 0.433 ' HB3' ' O ' ' A' ' 161' ' ' ILE . 0.8 OUTLIER 57.02 69.12 0.77 Allowed 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.546 1.154 . . . . 0.0 110.351 -179.988 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . 0.497 ' CE1' ' O ' ' A' ' 133' ' ' GLY . 2.0 m-85 -124.46 114.5 19.54 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.496 1.123 . . . . 0.0 111.038 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.492 HG23 ' CG2' ' A' ' 187' ' ' VAL . 0.4 OUTLIER -113.06 132.22 62.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 O-C-N 124.419 1.074 . . . . 0.0 109.282 -179.993 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . 0.501 ' HG3' ' N ' ' A' ' 139' ' ' ALA . 2.7 ttm180 -101.09 142.85 31.95 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.462 1.101 . . . . 0.0 110.259 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . 0.515 ' O ' ' N ' ' A' ' 156' ' ' GLY . . . -105.85 109.08 20.91 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.564 1.165 . . . . 0.0 109.345 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.511 ' O ' ' CG ' ' A' ' 155' ' ' LYS . 0.3 OUTLIER -87.36 -22.42 25.08 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.496 1.123 . . . . 0.0 109.272 -179.944 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . 0.408 ' CD1' ' N ' ' A' ' 141' ' ' PHE . 0.6 OUTLIER -108.99 146.9 33.13 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.487 1.117 . . . . 0.0 111.013 179.972 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -101.1 156.25 17.52 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.537 1.148 . . . . 0.0 109.296 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' PHE . . . . . 0.592 ' CE2' ' O ' ' A' ' 144' ' ' ASN . 0.0 OUTLIER -149.03 -42.35 0.15 Allowed 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.434 1.083 . . . . 0.0 111.042 179.97 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . 0.592 ' O ' ' CE2' ' A' ' 143' ' ' PHE . 2.3 t30 58.61 169.39 0.06 Allowed 'General case' 0 C--N 1.326 -0.437 0 O-C-N 124.476 1.11 . . . . 0.0 109.309 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . 0.496 ' H ' ' ND2' ' A' ' 144' ' ' ASN . . . -177.24 -176.83 45.66 Favored Glycine 0 CA--C 1.531 1.043 0 O-C-N 124.502 1.126 . . . . 0.0 111.037 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 6.5 m120 -157.42 57.33 0.5 Allowed 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.568 0.805 . . . . 0.0 109.276 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -121.23 161.73 21.42 Favored 'General case' 0 C--N 1.326 -0.443 0 O-C-N 124.446 1.091 . . . . 0.0 109.26 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 17.3 tt0 -101.67 58.01 0.84 Allowed 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.511 1.132 . . . . 0.0 110.282 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -179.51 -43.74 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.523 0 O-C-N 124.505 1.128 . . . . 0.0 110.247 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -74.26 170.73 14.97 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.498 1.124 . . . . 0.0 109.398 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.494 ' O ' ' CE2' ' A' ' 153' ' ' PHE . 57.4 tp -132.72 110.99 13.45 Favored Pre-proline 0 C--N 1.326 -0.451 0 O-C-N 124.464 1.102 . . . . 0.0 109.307 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . 0.465 ' HB3' ' N ' ' A' ' 145' ' ' GLY . 18.4 Cg_endo -74.96 174.4 12.84 Favored 'Trans proline' 0 C--N 1.36 1.158 0 O-C-N 124.431 1.753 . . . . 0.0 110.997 180.0 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . 0.596 ' CZ ' ' CD ' ' A' ' 183' ' ' PRO . 0.4 OUTLIER -169.25 173.83 6.47 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.54 1.15 . . . . 0.0 111.018 179.979 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -127.13 -164.91 1.4 Allowed 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.458 1.099 . . . . 0.0 109.315 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.511 ' CG ' ' O ' ' A' ' 140' ' ' LEU . 1.5 tttp -97.08 99.16 10.68 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.475 1.109 . . . . 0.0 109.317 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . 0.515 ' N ' ' O ' ' A' ' 139' ' ' ALA . . . 116.08 29.54 2.34 Favored Glycine 0 CA--C 1.53 1.008 0 O-C-N 124.534 1.146 . . . . 0.0 111.01 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . 0.415 ' C ' ' CD1' ' A' ' 158' ' ' ILE . 12.4 t70 -102.9 166.81 10.25 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.607 0.828 . . . . 0.0 109.305 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . 0.475 ' N ' ' CD1' ' A' ' 158' ' ' ILE . 1.9 mp -123.56 146.28 29.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 O-C-N 124.476 1.11 . . . . 0.0 109.344 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.488 ' CD2' HD23 ' A' ' 151' ' ' LEU . 0.8 OUTLIER -144.11 128.85 18.27 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.513 1.133 . . . . 0.0 109.314 -179.98 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . 0.505 ' O ' ' HA ' ' A' ' 172' ' ' ALA . 2.0 tmt_? -87.72 127.77 35.3 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.458 1.099 . . . . 0.0 110.292 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . 0.456 ' O ' ' NE ' ' A' ' 160' ' ' ARG . 1.7 mp -84.96 130.85 35.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.455 1.097 . . . . 0.0 109.288 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . 0.466 ' HD3' ' CZ ' ' A' ' 179' ' ' ARG . 33.7 ttt85 -127.3 -46.44 1.49 Allowed 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.46 1.1 . . . . 0.0 110.314 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . 0.48 ' CB ' ' HB3' ' A' ' 171' ' ' ASN . 0.2 OUTLIER -123.7 161.4 25.19 Favored 'General case' 0 C--N 1.326 -0.433 0 O-C-N 124.508 1.13 . . . . 0.0 109.281 179.991 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . 0.513 ' O ' ' CG ' ' A' ' 164' ' ' LYS . 0.1 OUTLIER -165.23 64.14 1.0 Allowed Pre-proline 0 C--N 1.327 -0.391 0 O-C-N 124.463 1.102 . . . . 0.0 109.261 179.98 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . 0.423 ' HD3' ' N ' ' A' ' 164' ' ' LYS . 18.1 Cg_endo -75.03 -49.18 0.15 Allowed 'Trans proline' 0 C--N 1.359 1.089 0 O-C-N 124.547 1.814 . . . . 0.0 110.977 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -66.14 167.57 9.86 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.499 1.124 . . . . 0.0 110.244 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 5.3 mp0 -110.87 40.91 1.91 Allowed 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.448 1.093 . . . . 0.0 110.309 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 5.4 mt-30 -159.44 -57.82 0.06 Allowed 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.553 1.158 . . . . 0.0 110.263 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' TRP . . . . . . . . . . . . . 10.4 m95 -102.04 144.45 30.62 Favored 'General case' 0 C--N 1.324 -0.523 0 O-C-N 124.567 1.167 . . . . 0.0 107.972 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' TRP . . . . . 0.578 ' CD2' ' CG2' ' A' ' 184' ' ' VAL . 50.8 m0 -116.28 146.88 42.06 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' ASN . . . . . 0.499 ' OD1' ' CD ' ' A' ' 179' ' ' ARG . 18.7 t-20 -87.72 99.88 12.42 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.505 1.128 . . . . 0.0 109.288 180.0 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . 0.505 ' HA ' ' O ' ' A' ' 160' ' ' ARG . . . -119.87 168.77 10.77 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.484 1.115 . . . . 0.0 109.267 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . 0.485 ' HG3' ' CB ' ' A' ' 179' ' ' ARG . 1.8 mt-10 -113.92 124.12 51.41 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.53 1.144 . . . . 0.0 110.292 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . 0.435 ' CA ' HD23 ' A' ' 159' ' ' LEU . 0.2 OUTLIER -73.99 -168.5 0.62 Allowed 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.47 1.106 . . . . 0.0 109.309 179.97 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 10.5 t -81.17 58.31 3.48 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 124.404 1.065 . . . . 0.0 110.024 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -175.11 16.85 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.449 1.093 . . . . 0.0 110.317 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . 0.405 ' C ' ' HG2' ' A' ' 173' ' ' GLU . . . 64.12 17.36 61.2 Favored Glycine 0 CA--C 1.529 0.951 0 O-C-N 124.562 1.164 . . . . 0.0 111.005 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -85.95 102.09 13.45 Favored 'General case' 0 C--N 1.326 -0.441 0 O-C-N 124.472 0.748 . . . . 0.0 109.307 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 179' ' ' ARG . . . . . 0.499 ' CD ' ' OD1' ' A' ' 171' ' ' ASN . 20.1 ttm-85 -88.15 120.35 29.42 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.464 1.102 . . . . 0.0 110.328 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . 0.405 ' O ' ' HA ' ' A' ' 171' ' ' ASN . . . -152.36 172.45 31.56 Favored Glycine 0 CA--C 1.53 1.013 0 O-C-N 124.554 1.159 . . . . 0.0 110.953 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 181' ' ' MET . . . . . 0.406 ' HA ' ' O ' ' A' ' 170' ' ' TRP . 35.7 mtp -86.96 99.82 12.15 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.46 0.741 . . . . 0.0 111.009 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . 0.416 ' HB ' ' HD2' ' A' ' 183' ' ' PRO . 5.7 pt -99.38 160.6 27.1 Favored Pre-proline 0 C--N 1.325 -0.46 0 O-C-N 124.454 1.096 . . . . 0.0 109.381 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 183' ' ' PRO . . . . . 0.74 ' HG2' ' HB2' ' A' ' 186' ' ' TYR . 18.5 Cg_endo -75.05 135.16 18.61 Favored 'Trans proline' 0 C--N 1.359 1.1 0 O-C-N 124.462 1.77 . . . . 0.0 111.019 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . 0.851 ' N ' ' CD ' ' A' ' 185' ' ' PRO . 42.9 t -80.07 -30.16 0.59 Allowed Pre-proline 0 C--N 1.325 -0.493 0 O-C-N 124.522 1.139 . . . . 0.0 109.321 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 185' ' ' PRO . . . . . 0.851 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.4 Cg_endo -75.02 -21.42 15.83 Favored 'Trans proline' 0 C--N 1.36 1.155 0 O-C-N 124.532 1.806 . . . . 0.0 110.963 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 186' ' ' TYR . . . . . 0.74 ' HB2' ' HG2' ' A' ' 183' ' ' PRO . 4.1 m-85 -94.42 15.52 17.51 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.52 1.138 . . . . 0.0 111.001 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 187' ' ' VAL . . . . . 0.492 ' CG2' HG23 ' A' ' 137' ' ' VAL . 27.4 m -143.37 171.83 8.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 O-C-N 124.453 1.096 . . . . 0.0 109.294 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . 0.475 ' N ' ' O ' ' A' ' 138' ' ' ARG . 0.0 OUTLIER -131.75 169.65 15.92 Favored 'General case' 0 C--N 1.326 -0.442 0 O-C-N 124.462 1.102 . . . . 0.0 110.257 179.999 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -88.15 127.9 35.43 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.427 1.079 . . . . 0.0 109.304 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -99.75 -58.5 1.91 Allowed 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.481 1.113 . . . . 0.0 111.053 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.041 0 O-C-N 124.54 1.15 . . . . 0.0 110.971 179.976 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' CYS . . . . . . . . . . . . . 4.5 t . . . . . 0 N--CA 1.453 -0.32 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 164.87 -107.97 0.31 Allowed Glycine 0 CA--C 1.532 1.146 0 O-C-N 124.435 1.085 . . . . 0.0 110.978 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -168.59 77.96 0.13 Allowed 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.607 0.827 . . . . 0.0 109.256 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . 0.411 ' CB ' ' HB ' ' A' ' 161' ' ' ILE . 0.4 OUTLIER 46.66 75.54 0.12 Allowed 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.416 1.073 . . . . 0.0 110.286 179.949 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 8.6 m-85 -130.95 99.97 5.09 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.522 1.139 . . . . 0.0 110.94 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.587 HG23 ' CG2' ' A' ' 187' ' ' VAL . 11.8 p -102.22 130.66 51.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 O-C-N 124.55 1.156 . . . . 0.0 109.289 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . 0.495 ' O ' ' N ' ' A' ' 188' ' ' GLU . 13.7 ttm180 -97.59 151.55 19.95 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.502 1.126 . . . . 0.0 110.339 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . 0.487 ' CB ' ' OD2' ' A' ' 157' ' ' ASP . . . -120.63 106.34 11.65 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.467 1.104 . . . . 0.0 109.259 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.477 ' O ' ' CG ' ' A' ' 155' ' ' LYS . 0.0 OUTLIER -91.14 -22.97 20.41 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.561 1.163 . . . . 0.0 109.331 179.944 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . 0.484 ' CD2' ' HA ' ' A' ' 186' ' ' TYR . 97.1 m-85 -85.66 161.38 19.27 Favored 'General case' 0 C--N 1.326 -0.418 0 O-C-N 124.44 1.088 . . . . 0.0 110.98 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . 0.498 ' CA ' ' O ' ' A' ' 154' ' ' LYS . 0.5 OUTLIER -115.17 142.8 46.17 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.508 1.13 . . . . 0.0 109.272 -179.984 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' PHE . . . . . 0.633 ' HB3' ' CE1' ' A' ' 153' ' ' PHE . 33.9 t80 -170.09 29.22 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.532 1.145 . . . . 0.0 110.961 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . 0.526 ' HA ' ' CB ' ' A' ' 152' ' ' PRO . 2.3 t30 -47.25 169.73 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.512 1.133 . . . . 0.0 109.315 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 164.21 -98.12 0.15 Allowed Glycine 0 CA--C 1.53 0.998 0 O-C-N 124.419 1.074 . . . . 0.0 111.012 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' ASN . . . . . 0.433 ' O ' ' CG ' ' A' ' 147' ' ' ASP . 1.6 p30 -176.87 -53.68 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.495 0.762 . . . . 0.0 109.326 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . 0.47 ' CG ' ' CB ' ' A' ' 150' ' ' ASP . 2.6 p30 46.04 -171.77 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.49 1.119 . . . . 0.0 109.3 -179.962 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -124.45 -33.94 2.96 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.47 1.106 . . . . 0.0 110.295 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -131.06 31.47 4.43 Favored 'General case' 0 C--N 1.323 -0.545 0 O-C-N 124.485 1.116 . . . . 0.0 110.345 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . 0.47 ' CB ' ' CG ' ' A' ' 147' ' ' ASP . 0.1 OUTLIER -127.95 176.28 7.72 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.521 1.138 . . . . 0.0 109.301 179.98 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.561 ' O ' ' CD2' ' A' ' 153' ' ' PHE . 2.5 tp -129.27 113.59 18.35 Favored Pre-proline 0 C--N 1.326 -0.435 0 O-C-N 124.467 1.104 . . . . 0.0 109.324 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . 0.526 ' CB ' ' HA ' ' A' ' 144' ' ' ASN . 18.0 Cg_endo -75.03 126.74 10.15 Favored 'Trans proline' 0 C--N 1.36 1.135 0 O-C-N 124.43 1.753 . . . . 0.0 110.945 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . 0.633 ' CE1' ' HB3' ' A' ' 143' ' ' PHE . 1.2 p90 -129.57 -179.49 5.2 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.547 1.155 . . . . 0.0 110.955 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . 0.498 ' O ' ' CA ' ' A' ' 142' ' ' ASP . 32.2 tttt -121.6 -82.26 0.65 Allowed 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.498 1.124 . . . . 0.0 109.348 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.477 ' CG ' ' O ' ' A' ' 140' ' ' LEU . 0.0 OUTLIER -175.25 108.63 0.1 Allowed 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.499 1.124 . . . . 0.0 109.326 179.973 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . 0.434 ' N ' ' O ' ' A' ' 139' ' ' ALA . . . 104.83 16.1 18.27 Favored Glycine 0 CA--C 1.529 0.964 0 O-C-N 124.493 1.12 . . . . 0.0 111.05 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . 0.487 ' OD2' ' CB ' ' A' ' 139' ' ' ALA . 2.3 p-10 -88.2 144.51 26.42 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.494 0.761 . . . . 0.0 109.327 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . 0.623 ' N ' ' CD1' ' A' ' 158' ' ' ILE . 1.1 mp -95.93 150.02 4.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 O-C-N 124.438 1.086 . . . . 0.0 109.314 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.496 ' CD2' ' CD2' ' A' ' 151' ' ' LEU . 5.3 mt -145.65 133.77 21.55 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.542 1.151 . . . . 0.0 109.28 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . 0.454 ' O ' ' CA ' ' A' ' 172' ' ' ALA . 2.0 ttt180 -90.28 129.48 36.51 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.51 1.131 . . . . 0.0 110.322 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . 0.448 ' CD1' HG11 ' A' ' 137' ' ' VAL . 24.1 mm -85.23 124.2 39.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 O-C-N 124.517 1.136 . . . . 0.0 109.253 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -119.39 -62.96 1.44 Allowed 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.507 1.129 . . . . 0.0 110.336 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -111.31 157.03 20.65 Favored 'General case' 0 C--N 1.324 -0.522 0 O-C-N 124.498 1.124 . . . . 0.0 109.333 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . 0.537 ' HG3' ' CE2' ' A' ' 170' ' ' TRP . 0.0 OUTLIER -157.81 63.08 2.67 Favored Pre-proline 0 C--N 1.324 -0.506 0 O-C-N 124.469 1.105 . . . . 0.0 109.306 -179.989 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . 0.441 ' HD3' ' N ' ' A' ' 164' ' ' LYS . 18.2 Cg_endo -75.05 -58.89 0.04 OUTLIER 'Trans proline' 0 C--N 1.36 1.148 0 O-C-N 124.445 1.761 . . . . 0.0 111.005 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -62.01 167.26 3.98 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.509 1.131 . . . . 0.0 110.248 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 6.5 mt-10 -106.99 45.77 0.97 Allowed 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.501 1.126 . . . . 0.0 110.349 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -167.03 -59.53 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.535 1.147 . . . . 0.0 110.346 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' TRP . . . . . . . . . . . . . 25.4 m95 -102.69 135.2 44.76 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.553 1.158 . . . . 0.0 107.966 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' TRP . . . . . 0.587 ' CE2' ' CG2' ' A' ' 184' ' ' VAL . 27.8 m0 -117.31 151.65 36.54 Favored 'General case' 0 C--N 1.324 -0.533 0 O-C-N 124.551 1.157 . . . . 0.0 108.048 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' ASN . . . . . 0.403 ' HA ' ' O ' ' A' ' 180' ' ' GLY . 2.8 t-20 -86.23 102.98 14.42 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.432 1.083 . . . . 0.0 109.268 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . 0.466 ' CB ' HD11 ' A' ' 182' ' ' ILE . . . -113.1 179.89 3.83 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.488 1.117 . . . . 0.0 109.309 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . 0.473 ' CG ' ' HG3' ' A' ' 179' ' ' ARG . 28.0 mt-10 -125.34 125.91 44.23 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.5 1.125 . . . . 0.0 110.271 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . 0.484 ' HB2' ' CD2' ' A' ' 151' ' ' LEU . 2.9 t70 -74.6 -163.92 0.24 Allowed 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.477 1.111 . . . . 0.0 109.307 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -89.32 47.04 1.43 Allowed 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.582 1.177 . . . . 0.0 110.019 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -169.68 24.51 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.546 1.154 . . . . 0.0 110.287 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 62.57 20.51 61.57 Favored Glycine 0 CA--C 1.53 0.976 0 O-C-N 124.441 1.088 . . . . 0.0 111.004 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' LYS . . . . . 0.453 ' CG ' HD11 ' A' ' 151' ' ' LEU . 4.8 tptt -81.21 104.26 11.56 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.524 0.779 . . . . 0.0 109.285 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 179' ' ' ARG . . . . . 0.473 ' HG3' ' CG ' ' A' ' 173' ' ' GLU . 0.0 OUTLIER -89.26 116.92 27.84 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.427 1.079 . . . . 0.0 110.373 179.946 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . 0.403 ' O ' ' HA ' ' A' ' 171' ' ' ASN . . . -151.46 173.39 30.83 Favored Glycine 0 CA--C 1.53 0.979 0 O-C-N 124.452 1.095 . . . . 0.0 111.007 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 181' ' ' MET . . . . . 0.413 ' HA ' ' O ' ' A' ' 170' ' ' TRP . 12.9 mmm -86.14 103.6 14.94 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.461 0.742 . . . . 0.0 110.986 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . 0.517 ' CG2' ' HD2' ' A' ' 183' ' ' PRO . 4.1 mp -94.5 145.27 29.37 Favored Pre-proline 0 C--N 1.324 -0.509 0 O-C-N 124.563 1.164 . . . . 0.0 109.289 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 183' ' ' PRO . . . . . 0.773 ' HG2' ' HB2' ' A' ' 186' ' ' TYR . 18.3 Cg_endo -75.01 133.63 16.81 Favored 'Trans proline' 0 C--N 1.36 1.164 0 O-C-N 124.448 1.762 . . . . 0.0 110.977 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . 0.814 ' N ' ' CD ' ' A' ' 185' ' ' PRO . 25.2 t -78.62 -31.14 0.73 Allowed Pre-proline 0 C--N 1.325 -0.469 0 O-C-N 124.509 1.131 . . . . 0.0 109.309 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 185' ' ' PRO . . . . . 0.814 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.1 Cg_endo -75.09 -25.96 11.23 Favored 'Trans proline' 0 C--N 1.359 1.123 0 O-C-N 124.474 1.776 . . . . 0.0 110.932 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 186' ' ' TYR . . . . . 0.773 ' HB2' ' HG2' ' A' ' 183' ' ' PRO . 4.1 m-85 -95.91 15.54 20.18 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.475 1.109 . . . . 0.0 110.994 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 187' ' ' VAL . . . . . 0.587 ' CG2' HG23 ' A' ' 137' ' ' VAL . 24.4 m -139.59 173.96 10.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 O-C-N 124.451 1.094 . . . . 0.0 109.278 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . 0.495 ' N ' ' O ' ' A' ' 138' ' ' ARG . 0.0 OUTLIER -135.18 172.31 13.2 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.448 1.093 . . . . 0.0 110.353 179.966 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . 0.45 ' HD2' ' N ' ' A' ' 189' ' ' LYS . 0.0 OUTLIER -95.63 114.19 25.91 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.545 1.153 . . . . 0.0 109.267 -179.96 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 15.6 t80 -60.06 -45.18 93.75 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.507 1.129 . . . . 0.0 110.962 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.977 0 O-C-N 124.461 1.1 . . . . 0.0 111.023 179.99 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' CYS . . . . . 0.436 ' O ' ' O ' ' A' ' 133' ' ' GLY . 3.0 t . . . . . 0 N--CA 1.453 -0.311 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . 0.436 ' O ' ' O ' ' A' ' 132' ' ' CYS . . . -55.39 -114.23 0.01 OUTLIER Glycine 0 CA--C 1.53 1.003 0 O-C-N 124.515 1.134 . . . . 0.0 110.996 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -163.64 124.03 2.21 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.448 0.734 . . . . 0.0 109.259 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . 0.459 ' O ' ' HG2' ' A' ' 160' ' ' ARG . 0.2 OUTLIER 39.14 74.88 0.08 Allowed 'General case' 0 C--N 1.326 -0.443 0 O-C-N 124.477 1.111 . . . . 0.0 110.32 179.988 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . 0.433 ' O ' ' HB3' ' A' ' 190' ' ' TYR . 0.4 OUTLIER -135.64 141.74 45.09 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.473 1.108 . . . . 0.0 111.003 179.993 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 34.3 m -133.66 157.51 42.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 O-C-N 124.476 1.11 . . . . 0.0 109.322 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . 0.483 ' HB3' ' CG ' ' A' ' 188' ' ' GLU . 4.2 tpp85 -127.3 127.07 43.73 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.436 1.085 . . . . 0.0 110.241 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . 0.698 ' O ' ' N ' ' A' ' 156' ' ' GLY . . . -88.41 106.93 18.58 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.432 1.083 . . . . 0.0 109.323 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -87.29 -5.14 59.03 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.538 1.149 . . . . 0.0 109.336 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . 0.463 ' CD1' ' HA ' ' A' ' 186' ' ' TYR . 6.2 m-85 -123.32 151.92 41.97 Favored 'General case' 0 C--N 1.326 -0.443 0 O-C-N 124.486 1.116 . . . . 0.0 111.028 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -102.7 157.06 17.21 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.506 1.129 . . . . 0.0 109.345 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' PHE . . . . . 0.646 ' HB3' ' CZ ' ' A' ' 153' ' ' PHE . 28.1 t80 -179.14 36.09 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.523 1.139 . . . . 0.0 110.983 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . 0.505 ' HA ' ' CB ' ' A' ' 152' ' ' PRO . 17.2 p-10 -40.99 107.36 0.07 Allowed 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.436 1.085 . . . . 0.0 109.281 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . 0.435 ' N ' ' HB3' ' A' ' 152' ' ' PRO . . . -92.99 -125.02 3.75 Favored Glycine 0 CA--C 1.53 0.974 0 O-C-N 124.538 1.149 . . . . 0.0 111.031 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 6.5 m120 -174.39 -51.56 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.509 0.77 . . . . 0.0 109.313 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -40.54 154.4 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.503 1.127 . . . . 0.0 109.282 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.03 -20.71 48.29 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.451 1.094 . . . . 0.0 110.267 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 13.1 tt0 -63.88 -39.7 94.81 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.475 1.11 . . . . 0.0 110.255 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . 0.42 ' OD1' ' CZ3' ' A' ' 169' ' ' TRP . 0.2 OUTLIER -122.26 153.18 39.23 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.519 1.137 . . . . 0.0 109.315 179.996 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.545 ' CD1' ' OD2' ' A' ' 174' ' ' ASP . 3.4 pp -108.06 142.77 25.99 Favored Pre-proline 0 C--N 1.326 -0.45 0 O-C-N 124.468 1.105 . . . . 0.0 109.295 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . 0.505 ' CB ' ' HA ' ' A' ' 144' ' ' ASN . 18.3 Cg_endo -75.05 134.04 17.25 Favored 'Trans proline' 0 C--N 1.359 1.121 0 O-C-N 124.604 1.844 . . . . 0.0 110.985 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . 0.646 ' CZ ' ' HB3' ' A' ' 143' ' ' PHE . 6.5 p90 -141.31 175.58 9.54 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.487 1.117 . . . . 0.0 111.049 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.56 -164.42 1.38 Allowed 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.472 1.107 . . . . 0.0 109.305 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -96.4 96.29 8.63 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.534 1.147 . . . . 0.0 109.288 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . 0.698 ' N ' ' O ' ' A' ' 139' ' ' ALA . . . 122.63 29.81 1.24 Allowed Glycine 0 CA--C 1.53 0.981 0 O-C-N 124.487 1.117 . . . . 0.0 111.002 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -97.9 159.43 14.94 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.449 0.734 . . . . 0.0 109.298 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . 0.455 ' CD1' ' HD3' ' A' ' 138' ' ' ARG . 6.5 mm -115.04 147.37 18.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 O-C-N 124.533 1.146 . . . . 0.0 109.359 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.471 HD22 HG21 ' A' ' 182' ' ' ILE . 1.1 mt -149.21 138.79 21.73 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.531 1.144 . . . . 0.0 109.371 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . 0.567 ' O ' ' HA ' ' A' ' 172' ' ' ALA . 0.0 OUTLIER -95.71 134.22 38.89 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.543 1.152 . . . . 0.0 110.349 -179.983 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . 0.422 ' HB ' ' CG ' ' A' ' 135' ' ' GLU . 15.4 mm -84.43 118.41 31.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 O-C-N 124.424 1.077 . . . . 0.0 109.264 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -112.36 -51.57 2.83 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.469 1.106 . . . . 0.0 110.285 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -138.86 168.39 19.93 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.495 1.122 . . . . 0.0 109.325 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . 0.581 ' HB3' ' CD1' ' A' ' 170' ' ' TRP . 27.4 mtmt -148.93 85.97 5.85 Favored Pre-proline 0 C--N 1.324 -0.513 0 O-C-N 124.499 1.124 . . . . 0.0 109.341 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.03 -30.57 6.98 Favored 'Trans proline' 0 C--N 1.36 1.138 0 O-C-N 124.498 1.788 . . . . 0.0 111.012 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -128.92 153.99 46.97 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.554 1.159 . . . . 0.0 110.272 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -77.75 -23.62 49.24 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.497 1.123 . . . . 0.0 110.265 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -75.9 -57.06 4.1 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.487 1.117 . . . . 0.0 110.329 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' TRP . . . . . 0.42 ' CZ3' ' OD1' ' A' ' 150' ' ' ASP . 14.0 m95 -111.33 156.22 21.88 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.547 1.154 . . . . 0.0 107.995 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' TRP . . . . . 0.581 ' CD1' ' HB3' ' A' ' 164' ' ' LYS . 23.6 m0 -131.46 148.53 52.65 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.477 1.111 . . . . 0.0 108.017 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' ASN . . . . . 0.53 ' OD1' ' HG2' ' A' ' 179' ' ' ARG . 6.2 t-20 -87.26 98.98 11.63 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.503 1.127 . . . . 0.0 109.306 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . 0.567 ' HA ' ' O ' ' A' ' 160' ' ' ARG . . . -118.86 175.59 5.68 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.456 1.097 . . . . 0.0 109.327 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . 0.557 ' HG3' ' HG3' ' A' ' 179' ' ' ARG . 1.5 tt0 -118.02 118.26 31.44 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.441 1.088 . . . . 0.0 110.324 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . 0.545 ' OD2' ' CD1' ' A' ' 151' ' ' LEU . 0.9 OUTLIER -66.43 -174.73 0.3 Allowed 'General case' 0 C--N 1.326 -0.434 0 O-C-N 124.461 1.101 . . . . 0.0 109.308 -179.947 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -78.72 53.16 1.3 Allowed 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.461 1.1 . . . . 0.0 110.018 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -172.21 11.25 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.446 1.091 . . . . 0.0 110.323 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . 0.491 ' C ' ' HG2' ' A' ' 173' ' ' GLU . . . 73.27 18.02 79.09 Favored Glycine 0 CA--C 1.53 0.978 0 O-C-N 124.509 1.131 . . . . 0.0 111.008 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -79.66 103.85 9.86 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.54 0.788 . . . . 0.0 109.349 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 179' ' ' ARG . . . . . 0.557 ' HG3' ' HG3' ' A' ' 173' ' ' GLU . 0.0 OUTLIER -87.65 113.21 23.12 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.434 1.084 . . . . 0.0 110.296 179.985 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -152.2 172.89 31.43 Favored Glycine 0 CA--C 1.53 0.977 0 O-C-N 124.428 1.08 . . . . 0.0 111.026 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 181' ' ' MET . . . . . 0.405 ' HA ' ' O ' ' A' ' 170' ' ' TRP . 3.0 mmm -87.7 97.49 10.92 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.492 0.76 . . . . 0.0 111.017 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . 0.493 HG22 ' CD1' ' A' ' 151' ' ' LEU . 3.4 pt -90.78 157.69 43.37 Favored Pre-proline 0 C--N 1.325 -0.498 0 O-C-N 124.498 1.124 . . . . 0.0 109.323 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 183' ' ' PRO . . . . . 0.74 ' HG2' ' HB2' ' A' ' 186' ' ' TYR . 18.3 Cg_endo -75.06 136.86 20.84 Favored 'Trans proline' 0 C--N 1.36 1.164 0 O-C-N 124.557 1.819 . . . . 0.0 111.012 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . 0.838 ' N ' ' CD ' ' A' ' 185' ' ' PRO . 92.2 t -82.08 -31.07 0.54 Allowed Pre-proline 0 C--N 1.325 -0.474 0 O-C-N 124.527 1.142 . . . . 0.0 109.37 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 185' ' ' PRO . . . . . 0.838 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.4 Cg_endo -74.99 -27.71 9.81 Favored 'Trans proline' 0 C--N 1.36 1.184 0 O-C-N 124.458 1.767 . . . . 0.0 111.012 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 186' ' ' TYR . . . . . 0.74 ' HB2' ' HG2' ' A' ' 183' ' ' PRO . 5.1 m-85 -91.37 15.17 12.7 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.493 1.12 . . . . 0.0 110.997 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 187' ' ' VAL . . . . . 0.415 ' HA ' ' HA ' ' A' ' 139' ' ' ALA . 34.5 m -143.22 167.32 13.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 O-C-N 124.504 1.127 . . . . 0.0 109.261 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . 0.483 ' CG ' ' HB3' ' A' ' 138' ' ' ARG . 0.0 OUTLIER -126.3 168.03 14.68 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 124.487 1.117 . . . . 0.0 110.329 179.943 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 12.3 mmmm -89.25 129.88 35.74 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.511 1.132 . . . . 0.0 109.274 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 190' ' ' TYR . . . . . 0.498 ' CG ' ' N ' ' A' ' 191' ' ' GLY . 0.8 OUTLIER -61.57 -149.89 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.48 1.112 . . . . 0.0 110.963 179.991 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . 0.498 ' N ' ' CG ' ' A' ' 190' ' ' TYR . . . . . . . . 0 CA--C 1.53 1.02 0 O-C-N 124.567 1.167 . . . . 0.0 110.988 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' CYS . . . . . . . . . . . . . 1.1 m . . . . . 0 N--CA 1.453 -0.316 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . 0.407 ' O ' ' HB1' ' A' ' 134' ' ' ALA . . . -77.25 56.99 3.67 Favored Glycine 0 CA--C 1.529 0.96 0 O-C-N 124.497 1.123 . . . . 0.0 111.022 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . 0.407 ' HB1' ' O ' ' A' ' 133' ' ' GLY . . . 179.39 -159.17 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.434 0 O-C-N 124.436 0.727 . . . . 0.0 109.248 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . 0.521 ' O ' ' HG2' ' A' ' 160' ' ' ARG . 0.1 OUTLIER -131.17 64.78 1.57 Allowed 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.485 1.116 . . . . 0.0 110.266 179.969 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . 0.44 ' CE1' ' HG3' ' A' ' 160' ' ' ARG . 0.7 OUTLIER -129.19 132.4 47.28 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.432 1.083 . . . . 0.0 110.963 179.963 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 3.4 m -128.15 164.51 29.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 O-C-N 124.449 1.093 . . . . 0.0 109.297 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . 0.405 ' O ' ' HA ' ' A' ' 187' ' ' VAL . 0.5 OUTLIER -123.57 126.32 46.45 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.482 1.114 . . . . 0.0 110.308 179.975 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -89.8 103.9 16.51 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.559 1.162 . . . . 0.0 109.258 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.457 ' CD1' ' HG2' ' A' ' 188' ' ' GLU . 0.2 OUTLIER -87.94 12.62 12.79 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.498 1.123 . . . . 0.0 109.231 -179.99 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . 0.471 ' O ' ' O ' ' A' ' 154' ' ' LYS . 23.7 m-85 -146.69 154.99 42.08 Favored 'General case' 0 C--N 1.324 -0.532 0 O-C-N 124.577 1.173 . . . . 0.0 111.041 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . 0.469 ' CB ' ' HA ' ' A' ' 154' ' ' LYS . 7.2 p-10 -103.19 139.74 38.27 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.51 1.131 . . . . 0.0 109.237 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' PHE . . . . . 0.648 ' O ' ' CE2' ' A' ' 153' ' ' PHE . 0.2 OUTLIER 166.55 81.87 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.444 0 O-C-N 124.507 1.129 . . . . 0.0 111.044 -179.992 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . 0.446 ' OD1' ' N ' ' A' ' 145' ' ' GLY . 51.9 t-20 -39.58 154.58 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.539 1.149 . . . . 0.0 109.314 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . 0.446 ' N ' ' OD1' ' A' ' 144' ' ' ASN . . . -74.8 -156.77 5.33 Favored Glycine 0 CA--C 1.53 1.001 0 O-C-N 124.563 1.164 . . . . 0.0 110.988 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' ASN . . . . . 0.401 ' OD1' ' C ' ' A' ' 145' ' ' GLY . 6.7 p-10 166.39 76.56 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.493 0.761 . . . . 0.0 109.271 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -159.72 -81.4 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.423 1.077 . . . . 0.0 109.265 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . 0.646 ' O ' ' CB ' ' A' ' 149' ' ' GLU . 9.8 mm-40 -113.95 74.24 0.86 Allowed 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.555 1.159 . . . . 0.0 110.277 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . 0.646 ' CB ' ' O ' ' A' ' 148' ' ' GLU . 5.8 tt0 98.42 -29.26 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.442 0 O-C-N 124.535 1.147 . . . . 0.0 110.311 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . 0.446 ' O ' ' O ' ' A' ' 149' ' ' GLU . 0.3 OUTLIER 60.68 136.43 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.509 1.131 . . . . 0.0 109.228 179.975 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.551 ' HB3' ' CG2' ' A' ' 182' ' ' ILE . 2.4 tp -118.32 111.83 38.08 Favored Pre-proline 0 C--N 1.326 -0.429 0 O-C-N 124.445 1.091 . . . . 0.0 109.288 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -75.01 117.47 4.92 Favored 'Trans proline' 0 C--N 1.359 1.127 0 O-C-N 124.535 1.808 . . . . 0.0 110.988 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . 0.648 ' CE2' ' O ' ' A' ' 143' ' ' PHE . 7.3 p90 -130.95 174.87 9.56 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.445 1.091 . . . . 0.0 110.981 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . 0.471 ' O ' ' O ' ' A' ' 141' ' ' PHE . 3.8 tttt -135.61 -156.1 0.69 Allowed 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.562 1.164 . . . . 0.0 109.232 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 4.4 ptpp? -99.84 106.74 18.63 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.494 1.121 . . . . 0.0 109.334 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 108.88 27.65 4.8 Favored Glycine 0 CA--C 1.53 1.018 0 O-C-N 124.499 1.125 . . . . 0.0 110.953 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . 0.406 ' OD2' ' HG ' ' A' ' 159' ' ' LEU . 13.4 t70 -101.04 162.05 13.16 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.46 0.741 . . . . 0.0 109.306 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 19.6 mm -114.0 142.34 26.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 O-C-N 124.621 1.201 . . . . 0.0 109.327 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.406 ' HG ' ' OD2' ' A' ' 157' ' ' ASP . 2.2 mt -142.41 135.19 28.28 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.486 1.116 . . . . 0.0 109.328 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . 0.521 ' HG2' ' O ' ' A' ' 135' ' ' GLU . 8.2 ttm-85 -97.59 134.72 40.43 Favored 'General case' 0 C--N 1.324 -0.531 0 O-C-N 124.493 1.121 . . . . 0.0 110.303 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . 0.413 ' CB ' ' HB2' ' A' ' 135' ' ' GLU . 1.2 mp -82.65 119.39 32.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 O-C-N 124.537 1.148 . . . . 0.0 109.23 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . 0.427 ' HB3' ' NH1' ' A' ' 162' ' ' ARG . 2.8 mmm180 -110.49 -59.19 1.98 Allowed 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.49 1.119 . . . . 0.0 110.332 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -129.23 163.84 24.75 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.456 1.097 . . . . 0.0 109.288 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . 0.426 ' HG3' ' NE1' ' A' ' 170' ' ' TRP . 0.3 OUTLIER -139.91 76.19 28.79 Favored Pre-proline 0 C--N 1.325 -0.489 0 O-C-N 124.537 1.148 . . . . 0.0 109.329 -179.951 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.97 -30.73 6.91 Favored 'Trans proline' 0 C--N 1.36 1.165 0 O-C-N 124.469 1.773 . . . . 0.0 111.038 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -113.4 169.68 8.78 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.519 1.137 . . . . 0.0 110.303 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -96.85 -27.92 14.47 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 124.47 1.106 . . . . 0.0 110.33 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -84.51 -55.94 3.88 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.47 1.107 . . . . 0.0 110.308 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' TRP . . . . . 0.436 ' CD1' ' N ' ' A' ' 169' ' ' TRP . 2.7 m95 -111.17 145.68 38.22 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.496 1.122 . . . . 0.0 107.99 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' TRP . . . . . 0.582 ' CZ3' HG11 ' A' ' 184' ' ' VAL . 50.3 m0 -122.09 156.78 32.87 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.509 1.131 . . . . 0.0 108.0 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' ASN . . . . . 0.413 ' OD1' ' C ' ' A' ' 171' ' ' ASN . 33.0 t-20 -86.92 98.63 11.34 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.522 1.139 . . . . 0.0 109.351 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . 0.521 ' CA ' ' O ' ' A' ' 160' ' ' ARG . . . -113.87 176.19 5.14 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.483 1.114 . . . . 0.0 109.28 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . 0.492 ' CG ' ' HG3' ' A' ' 179' ' ' ARG . 9.6 mt-10 -112.75 127.71 56.22 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 124.354 1.033 . . . . 0.0 110.237 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . 0.445 ' N ' HD21 ' A' ' 151' ' ' LEU . 6.2 p30 -83.78 -170.73 3.22 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.483 1.114 . . . . 0.0 109.327 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 1.1 t -79.53 68.06 5.46 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.493 1.121 . . . . 0.0 109.999 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 176.86 -4.39 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.473 1.108 . . . . 0.0 110.28 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 81.61 21.27 62.22 Favored Glycine 0 CA--C 1.53 1.012 0 O-C-N 124.542 1.151 . . . . 0.0 110.98 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 12.9 mtpt -92.04 118.67 31.02 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.483 0.754 . . . . 0.0 109.306 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 179' ' ' ARG . . . . . 0.492 ' HG3' ' CG ' ' A' ' 173' ' ' GLU . 61.0 mtt180 -89.92 121.92 32.47 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.443 1.089 . . . . 0.0 110.237 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . 0.402 ' O ' ' HA ' ' A' ' 171' ' ' ASN . . . -150.77 166.93 30.4 Favored Glycine 0 CA--C 1.53 0.994 0 O-C-N 124.456 1.097 . . . . 0.0 111.0 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 181' ' ' MET . . . . . 0.436 ' HA ' ' O ' ' A' ' 170' ' ' TRP . 11.0 mtp -87.16 104.23 16.16 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.488 0.758 . . . . 0.0 110.921 -179.935 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . 0.551 ' CG2' ' HB3' ' A' ' 151' ' ' LEU . 1.4 pp -106.9 159.99 27.95 Favored Pre-proline 0 C--N 1.324 -0.527 0 O-C-N 124.587 1.18 . . . . 0.0 109.292 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 183' ' ' PRO . . . . . 0.627 ' HG2' ' HB2' ' A' ' 186' ' ' TYR . 18.5 Cg_endo -74.89 131.1 14.04 Favored 'Trans proline' 0 C--N 1.36 1.18 0 O-C-N 124.55 1.816 . . . . 0.0 111.066 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . 0.764 ' N ' ' CD ' ' A' ' 185' ' ' PRO . 93.4 t -77.87 -33.99 1.06 Allowed Pre-proline 0 C--N 1.324 -0.506 0 O-C-N 124.54 1.15 . . . . 0.0 109.351 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 185' ' ' PRO . . . . . 0.764 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.3 Cg_endo -75.02 -11.44 21.45 Favored 'Trans proline' 0 C--N 1.361 1.199 0 O-C-N 124.41 1.742 . . . . 0.0 111.028 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 186' ' ' TYR . . . . . 0.627 ' HB2' ' HG2' ' A' ' 183' ' ' PRO . 6.7 m-85 -97.01 5.98 49.44 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.586 1.179 . . . . 0.0 110.996 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 187' ' ' VAL . . . . . 0.405 ' HA ' ' O ' ' A' ' 138' ' ' ARG . 8.4 m -137.74 173.32 13.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 O-C-N 124.507 1.13 . . . . 0.0 109.245 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . 0.457 ' HG2' ' CD1' ' A' ' 140' ' ' LEU . 0.0 OUTLIER -129.61 174.64 9.49 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.468 1.105 . . . . 0.0 110.253 -179.972 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 12.2 mmmm -86.98 117.19 25.54 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.472 1.108 . . . . 0.0 109.296 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 5.1 t80 -55.47 -41.8 73.46 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.483 1.114 . . . . 0.0 111.014 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.953 0 O-C-N 124.443 1.089 . . . . 0.0 111.007 179.967 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' CYS . . . . . 0.422 ' O ' ' SG ' ' A' ' 132' ' ' CYS . 32.1 p . . . . . 0 N--CA 1.453 -0.323 0 N-CA-C 108.334 -0.988 . . . . 0.0 108.334 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -173.07 -100.38 0.13 Allowed Glycine 0 CA--C 1.531 1.032 0 O-C-N 124.439 1.087 . . . . 0.0 110.988 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . 0.478 ' O ' ' C ' ' A' ' 135' ' ' GLU . . . -158.38 85.79 0.86 Allowed 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.523 0.778 . . . . 0.0 109.323 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . 0.53 ' HB2' ' O ' ' A' ' 161' ' ' ILE . 1.6 pm0 30.87 68.68 0.1 Allowed 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.485 1.116 . . . . 0.0 110.278 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . 0.797 ' CE1' ' CD2' ' A' ' 190' ' ' TYR . 1.4 t80 -122.29 131.13 53.76 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.476 1.11 . . . . 0.0 110.952 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.555 ' CG1' ' HB ' ' A' ' 187' ' ' VAL . 3.8 t -132.55 162.16 40.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 O-C-N 124.497 1.123 . . . . 0.0 109.326 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . 0.476 ' N ' ' CG1' ' A' ' 137' ' ' VAL . 2.2 tpp85 -136.14 135.28 39.12 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.494 1.121 . . . . 0.0 110.31 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . 0.538 ' O ' ' N ' ' A' ' 156' ' ' GLY . . . -98.57 109.51 22.25 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.506 1.129 . . . . 0.0 109.332 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.509 ' CD1' ' HG2' ' A' ' 188' ' ' GLU . 1.2 mt -88.71 -4.22 58.59 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.435 1.084 . . . . 0.0 109.263 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -133.28 154.46 50.67 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.536 1.147 . . . . 0.0 110.951 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . 0.409 ' CB ' ' HA ' ' A' ' 154' ' ' LYS . 7.6 t70 -100.27 152.88 19.78 Favored 'General case' 0 C--N 1.326 -0.427 0 O-C-N 124.484 1.115 . . . . 0.0 109.293 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' PHE . . . . . 0.604 ' HB3' ' CZ ' ' A' ' 153' ' ' PHE . 1.7 t80 177.46 59.84 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.422 0 O-C-N 124.479 1.112 . . . . 0.0 110.986 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . 0.433 ' HA ' ' HA ' ' A' ' 152' ' ' PRO . 0.4 OUTLIER -41.87 144.4 0.43 Allowed 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.51 1.131 . . . . 0.0 109.293 -179.999 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -89.15 -179.89 45.43 Favored Glycine 0 CA--C 1.53 0.984 0 O-C-N 124.534 1.146 . . . . 0.0 111.033 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' ASN . . . . . 0.417 ' O ' ' O ' ' A' ' 147' ' ' ASP . 3.8 t30 175.3 -35.74 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.515 0.774 . . . . 0.0 109.322 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . 0.417 ' O ' ' O ' ' A' ' 146' ' ' ASN . 68.9 m-20 -41.52 -91.78 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.549 1.156 . . . . 0.0 109.33 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 175.72 39.35 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.481 1.113 . . . . 0.0 110.305 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 170.48 46.31 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.452 1.095 . . . . 0.0 110.319 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . 0.607 ' OD2' ' CH2' ' A' ' 169' ' ' TRP . 0.3 OUTLIER -155.47 133.06 11.14 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.547 1.154 . . . . 0.0 109.283 179.992 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.464 ' CD2' HD13 ' A' ' 182' ' ' ILE . 5.4 tp -89.72 138.11 28.21 Favored Pre-proline 0 C--N 1.324 -0.507 0 O-C-N 124.475 1.109 . . . . 0.0 109.312 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . 0.433 ' HA ' ' HA ' ' A' ' 144' ' ' ASN . 18.3 Cg_endo -75.03 137.36 21.54 Favored 'Trans proline' 0 C--N 1.361 1.19 0 O-C-N 124.466 1.772 . . . . 0.0 110.989 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . 0.604 ' CZ ' ' HB3' ' A' ' 143' ' ' PHE . 18.9 p90 -154.65 170.35 21.73 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.445 1.091 . . . . 0.0 111.031 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . 0.409 ' HA ' ' CB ' ' A' ' 142' ' ' ASP . 0.1 OUTLIER -125.9 -164.04 1.27 Allowed 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.504 1.127 . . . . 0.0 109.282 -179.993 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -99.7 103.28 14.94 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.48 1.112 . . . . 0.0 109.267 -179.932 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . 0.538 ' N ' ' O ' ' A' ' 139' ' ' ALA . . . 114.76 23.42 4.68 Favored Glycine 0 CA--C 1.529 0.964 0 O-C-N 124.434 1.084 . . . . 0.0 111.013 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -101.69 170.0 8.46 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.454 0.738 . . . . 0.0 109.295 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . 0.618 ' CG2' ' CE1' ' A' ' 136' ' ' TYR . 3.6 mp -120.62 146.17 25.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 O-C-N 124.413 1.071 . . . . 0.0 109.257 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.475 ' CD2' ' HA ' ' A' ' 174' ' ' ASP . 0.9 OUTLIER -140.13 125.54 18.97 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.435 1.084 . . . . 0.0 109.313 179.973 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . 0.538 ' O ' ' CB ' ' A' ' 172' ' ' ALA . 1.1 ttp85 -88.04 130.89 34.85 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.554 1.159 . . . . 0.0 110.291 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . 0.53 ' O ' ' HB2' ' A' ' 135' ' ' GLU . 8.7 mm -83.3 125.88 40.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 O-C-N 124.518 1.136 . . . . 0.0 109.283 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.32 -58.85 1.89 Allowed 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.495 1.122 . . . . 0.0 110.34 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . 0.422 ' CB ' ' HB3' ' A' ' 171' ' ' ASN . 0.1 OUTLIER -115.37 154.65 28.81 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.5 1.125 . . . . 0.0 109.313 179.948 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . 0.543 ' HG3' ' CD1' ' A' ' 170' ' ' TRP . 28.9 tttm -146.47 66.64 11.15 Favored Pre-proline 0 C--N 1.325 -0.476 0 O-C-N 124.552 1.157 . . . . 0.0 109.241 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -74.99 -33.08 4.86 Favored 'Trans proline' 0 C--N 1.36 1.133 0 O-C-N 124.522 1.801 . . . . 0.0 111.019 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -104.48 171.02 7.56 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.498 1.124 . . . . 0.0 110.289 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 21.5 mt-10 -101.4 -30.08 11.66 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.504 1.128 . . . . 0.0 110.31 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 28.3 tt0 -74.47 -61.11 1.98 Allowed 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.559 1.162 . . . . 0.0 110.292 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' TRP . . . . . 0.607 ' CH2' ' OD2' ' A' ' 150' ' ' ASP . 13.3 m95 -114.35 160.54 18.99 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.481 1.113 . . . . 0.0 108.001 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' TRP . . . . . 0.611 ' CE2' HG21 ' A' ' 184' ' ' VAL . 10.6 m0 -134.19 156.95 47.44 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.53 1.144 . . . . 0.0 108.011 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' ASN . . . . . 0.459 ' HA ' ' O ' ' A' ' 180' ' ' GLY . 40.5 t30 -87.42 102.48 14.58 Favored 'General case' 0 C--N 1.324 -0.522 0 O-C-N 124.523 1.14 . . . . 0.0 109.291 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . 0.538 ' CB ' ' O ' ' A' ' 160' ' ' ARG . . . -118.35 -178.19 3.46 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.521 1.138 . . . . 0.0 109.367 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 -114.76 118.52 33.82 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.527 1.142 . . . . 0.0 110.227 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . 0.475 ' HA ' ' CD2' ' A' ' 159' ' ' LEU . 0.2 OUTLIER -73.43 -171.53 1.0 Allowed 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.522 1.139 . . . . 0.0 109.285 -179.998 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 29.1 t -80.07 56.56 2.43 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.546 1.154 . . . . 0.0 110.0 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -173.82 27.05 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.402 1.064 . . . . 0.0 110.392 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 50.47 22.53 5.46 Favored Glycine 0 CA--C 1.53 0.999 0 O-C-N 124.51 1.131 . . . . 0.0 110.992 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 178' ' ' LYS . . . . . 0.416 ' O ' HD21 ' A' ' 151' ' ' LEU . 2.7 ptpt -92.86 122.28 35.08 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.515 0.773 . . . . 0.0 109.352 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 40.6 mtt85 -91.16 115.4 27.99 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.467 1.104 . . . . 0.0 110.312 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . 0.459 ' O ' ' HA ' ' A' ' 171' ' ' ASN . . . -150.38 179.51 27.05 Favored Glycine 0 CA--C 1.531 1.05 0 O-C-N 124.595 1.185 . . . . 0.0 110.998 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 181' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -85.33 107.35 17.29 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.576 0.81 . . . . 0.0 110.971 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . 0.464 HD13 ' CD2' ' A' ' 151' ' ' LEU . 0.9 OUTLIER -98.0 144.14 27.49 Favored Pre-proline 0 C--N 1.325 -0.496 0 O-C-N 124.541 1.151 . . . . 0.0 109.262 -179.982 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 183' ' ' PRO . . . . . 0.725 ' HG2' ' HB2' ' A' ' 186' ' ' TYR . 18.5 Cg_endo -75.01 136.48 20.44 Favored 'Trans proline' 0 C--N 1.36 1.18 0 O-C-N 124.476 1.777 . . . . 0.0 111.021 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . 0.815 ' N ' ' CD ' ' A' ' 185' ' ' PRO . 44.3 t -82.03 -32.59 0.6 Allowed Pre-proline 0 C--N 1.326 -0.447 0 O-C-N 124.478 1.111 . . . . 0.0 109.305 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 185' ' ' PRO . . . . . 0.815 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.5 Cg_endo -75.0 -31.46 6.19 Favored 'Trans proline' 0 C--N 1.36 1.163 0 O-C-N 124.48 1.779 . . . . 0.0 111.024 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 186' ' ' TYR . . . . . 0.725 ' HB2' ' HG2' ' A' ' 183' ' ' PRO . 3.8 m-85 -90.8 19.39 5.55 Favored 'General case' 0 C--N 1.326 -0.428 0 O-C-N 124.483 1.114 . . . . 0.0 111.005 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 187' ' ' VAL . . . . . 0.555 ' HB ' ' CG1' ' A' ' 137' ' ' VAL . 11.3 m -149.64 179.49 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 O-C-N 124.44 1.088 . . . . 0.0 109.371 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . 0.509 ' HG2' ' CD1' ' A' ' 140' ' ' LEU . 0.0 OUTLIER -139.54 166.33 24.86 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.496 1.122 . . . . 0.0 110.37 -179.994 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.64 129.74 39.81 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.478 1.111 . . . . 0.0 109.325 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 190' ' ' TYR . . . . . 0.797 ' CD2' ' CE1' ' A' ' 136' ' ' TYR . 0.2 OUTLIER -85.02 -47.61 10.05 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.495 1.122 . . . . 0.0 111.045 179.976 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.94 0 O-C-N 124.503 1.127 . . . . 0.0 111.038 179.954 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' CYS . . . . . 0.403 ' O ' ' C ' ' A' ' 133' ' ' GLY . 1.6 m . . . . . 0 N--CA 1.453 -0.32 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . 0.403 ' C ' ' O ' ' A' ' 132' ' ' CYS . . . -36.52 -81.97 0.02 OUTLIER Glycine 0 CA--C 1.531 1.032 0 O-C-N 124.491 1.12 . . . . 0.0 110.977 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . 179.96 -98.89 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.489 0.758 . . . . 0.0 109.256 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . 0.417 ' CD ' ' O ' ' A' ' 161' ' ' ILE . 1.9 pt-20 -105.91 59.01 0.66 Allowed 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.575 1.172 . . . . 0.0 110.292 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -111.35 135.17 52.29 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.546 1.154 . . . . 0.0 110.987 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.519 ' CG2' ' O ' ' A' ' 188' ' ' GLU . 0.5 OUTLIER -126.01 157.03 36.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 O-C-N 124.498 1.124 . . . . 0.0 109.254 -179.933 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . 0.483 ' O ' ' N ' ' A' ' 188' ' ' GLU . 1.4 ttm180 -126.22 139.48 53.31 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.513 1.133 . . . . 0.0 110.263 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . 0.411 ' N ' ' HG3' ' A' ' 138' ' ' ARG . . . -103.61 106.23 16.68 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 124.523 1.14 . . . . 0.0 109.306 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.444 ' O ' ' CG ' ' A' ' 155' ' ' LYS . 0.2 OUTLIER -87.32 -1.39 57.88 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.513 1.133 . . . . 0.0 109.327 179.965 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . 0.402 ' O ' ' O ' ' A' ' 154' ' ' LYS . 35.1 m-85 -128.14 159.63 34.54 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.488 1.118 . . . . 0.0 110.96 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . 0.451 ' CB ' ' HA ' ' A' ' 154' ' ' LYS . 45.2 p-10 -112.66 145.45 40.4 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.531 1.145 . . . . 0.0 109.278 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' PHE . . . . . 0.572 ' HB3' ' CZ ' ' A' ' 153' ' ' PHE . 36.3 t80 -179.88 69.29 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.549 1.156 . . . . 0.0 111.033 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . 0.44 ' HA ' ' HA ' ' A' ' 152' ' ' PRO . 23.0 p-10 -39.93 145.91 0.13 Allowed 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.525 1.141 . . . . 0.0 109.332 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . 0.429 ' C ' ' N ' ' A' ' 147' ' ' ASP . . . -96.7 -97.49 1.88 Allowed Glycine 0 CA--C 1.53 0.99 0 O-C-N 124.442 1.089 . . . . 0.0 111.005 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' ASN . . . . . 0.428 ' CG ' ' O ' ' A' ' 145' ' ' GLY . 13.6 p30 45.42 25.94 0.26 Allowed 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.502 0.766 . . . . 0.0 109.276 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . 0.429 ' N ' ' C ' ' A' ' 145' ' ' GLY . 49.4 m-20 -119.13 -63.83 1.35 Allowed 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.543 1.152 . . . . 0.0 109.274 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . 0.438 ' C ' ' N ' ' A' ' 150' ' ' ASP . 0.9 OUTLIER -115.72 69.47 0.73 Allowed 'General case' 0 C--N 1.326 -0.426 0 O-C-N 124.434 1.084 . . . . 0.0 110.258 -179.929 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . 0.534 ' O ' ' CG ' ' A' ' 149' ' ' GLU . 1.0 OUTLIER 42.34 25.04 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.534 1.146 . . . . 0.0 110.33 179.998 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . 0.438 ' N ' ' C ' ' A' ' 148' ' ' GLU . 70.5 m-20 -90.32 166.49 13.28 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.542 1.151 . . . . 0.0 109.303 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.511 ' CD1' ' OD2' ' A' ' 174' ' ' ASP . 3.9 tp -105.23 132.84 20.52 Favored Pre-proline 0 C--N 1.325 -0.484 0 O-C-N 124.519 1.137 . . . . 0.0 109.287 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . 0.44 ' HA ' ' HA ' ' A' ' 144' ' ' ASN . 18.3 Cg_endo -75.0 143.63 29.28 Favored 'Trans proline' 0 C--N 1.36 1.146 0 O-C-N 124.59 1.837 . . . . 0.0 110.969 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . 0.572 ' CZ ' ' HB3' ' A' ' 143' ' ' PHE . 15.3 p90 -151.01 172.62 15.44 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.447 1.092 . . . . 0.0 111.035 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . 0.451 ' HA ' ' CB ' ' A' ' 142' ' ' ASP . 0.0 OUTLIER -130.54 -162.2 1.19 Allowed 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.537 1.148 . . . . 0.0 109.294 179.98 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.444 ' CG ' ' O ' ' A' ' 140' ' ' LEU . 2.9 tmtt? -94.47 107.51 19.48 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.495 1.122 . . . . 0.0 109.335 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . 0.453 ' HA2' ' CZ ' ' A' ' 138' ' ' ARG . . . 112.29 23.15 5.58 Favored Glycine 0 CA--C 1.529 0.949 0 O-C-N 124.529 1.143 . . . . 0.0 111.049 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -93.76 170.2 9.74 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.434 0.726 . . . . 0.0 109.296 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . 0.43 ' C ' ' HG ' ' A' ' 159' ' ' LEU . 3.0 mp -132.63 147.85 31.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 O-C-N 124.514 1.134 . . . . 0.0 109.234 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.495 ' HB2' ' CG1' ' A' ' 137' ' ' VAL . 12.0 mt -147.67 131.82 17.36 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.483 1.114 . . . . 0.0 109.335 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . 0.552 ' O ' ' HA ' ' A' ' 172' ' ' ALA . 0.5 OUTLIER -86.85 139.38 30.72 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.457 1.098 . . . . 0.0 110.31 -179.975 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . 0.465 ' CD1' ' HB ' ' A' ' 137' ' ' VAL . 1.4 mp -84.02 116.44 27.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 O-C-N 124.48 1.112 . . . . 0.0 109.287 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.92 -58.28 2.0 Allowed 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.499 1.124 . . . . 0.0 110.222 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . 0.442 ' OD1' ' N ' ' A' ' 164' ' ' LYS . 0.6 OUTLIER -136.47 161.37 36.02 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.484 1.115 . . . . 0.0 109.307 -179.918 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . 0.442 ' N ' ' OD1' ' A' ' 163' ' ' ASP . 0.0 OUTLIER -143.1 84.62 10.29 Favored Pre-proline 0 C--N 1.325 -0.48 0 O-C-N 124.489 1.118 . . . . 0.0 109.298 179.925 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . 0.485 ' CD ' ' HE3' ' A' ' 181' ' ' MET . 18.4 Cg_endo -75.04 -39.04 1.31 Allowed 'Trans proline' 0 C--N 1.36 1.174 0 O-C-N 124.385 1.729 . . . . 0.0 111.029 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . 0.463 ' O ' ' NE1' ' A' ' 170' ' ' TRP . 3.9 mm-40 -111.36 178.24 4.4 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.532 1.145 . . . . 0.0 110.345 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.82 -22.02 14.45 Favored 'General case' 0 C--N 1.323 -0.546 0 O-C-N 124.51 1.131 . . . . 0.0 110.31 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . 0.443 ' HB3' ' CD1' ' A' ' 169' ' ' TRP . 0.0 OUTLIER -83.89 -57.89 3.02 Favored 'General case' 0 C--N 1.324 -0.523 0 O-C-N 124.527 1.142 . . . . 0.0 110.273 -179.996 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' TRP . . . . . 0.443 ' CD1' ' HB3' ' A' ' 168' ' ' GLN . 11.7 m95 -108.03 149.98 27.73 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.51 1.131 . . . . 0.0 107.994 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' TRP . . . . . 0.595 ' CE3' HG12 ' A' ' 184' ' ' VAL . 26.6 m0 -131.3 151.59 51.36 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.486 1.116 . . . . 0.0 108.015 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' ASN . . . . . 0.421 ' CA ' ' HE2' ' A' ' 181' ' ' MET . 1.0 OUTLIER -87.64 98.89 11.67 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.548 1.155 . . . . 0.0 109.229 -179.913 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . 0.552 ' HA ' ' O ' ' A' ' 160' ' ' ARG . . . -112.46 166.17 11.56 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.434 1.084 . . . . 0.0 109.286 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . 0.42 ' HG2' ' CA ' ' A' ' 179' ' ' ARG . 18.9 mt-10 -116.13 120.87 40.43 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.523 1.139 . . . . 0.0 110.256 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . 0.511 ' OD2' ' CD1' ' A' ' 151' ' ' LEU . 1.1 p30 -74.77 -173.4 1.84 Allowed 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.521 1.138 . . . . 0.0 109.321 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 22.6 t -79.83 63.24 4.32 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.507 1.129 . . . . 0.0 110.048 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -174.25 9.78 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.553 1.158 . . . . 0.0 110.309 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 68.69 19.49 73.2 Favored Glycine 0 CA--C 1.531 1.08 0 O-C-N 124.57 1.169 . . . . 0.0 110.986 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 178' ' ' LYS . . . . . 0.412 ' O ' ' HA ' ' A' ' 173' ' ' GLU . 0.1 OUTLIER -94.29 112.32 24.11 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 124.583 0.813 . . . . 0.0 109.228 -179.945 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 179' ' ' ARG . . . . . 0.447 ' HA ' ' O ' ' A' ' 172' ' ' ALA . 0.1 OUTLIER -96.69 124.6 40.73 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.548 1.155 . . . . 0.0 110.324 179.915 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -149.9 164.87 29.65 Favored Glycine 0 CA--C 1.531 1.092 0 O-C-N 124.531 1.144 . . . . 0.0 110.947 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 181' ' ' MET . . . . . 0.485 ' HE3' ' CD ' ' A' ' 165' ' ' PRO . 0.3 OUTLIER -88.98 100.98 13.63 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.57 0.806 . . . . 0.0 111.005 179.992 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . 0.482 HG12 ' N ' ' A' ' 183' ' ' PRO . 0.2 OUTLIER -108.52 174.09 2.64 Favored Pre-proline 0 C--N 1.325 -0.488 0 O-C-N 124.436 1.085 . . . . 0.0 109.311 -179.999 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 183' ' ' PRO . . . . . 0.601 ' HB2' ' CD1' ' A' ' 186' ' ' TYR . 18.5 Cg_endo -74.95 129.21 12.17 Favored 'Trans proline' 0 C--N 1.36 1.132 0 O-C-N 124.535 1.808 . . . . 0.0 111.014 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . 0.816 ' N ' ' CD ' ' A' ' 185' ' ' PRO . 38.7 t -78.91 -32.94 0.83 Allowed Pre-proline 0 C--N 1.325 -0.459 0 O-C-N 124.473 1.108 . . . . 0.0 109.358 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 185' ' ' PRO . . . . . 0.816 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.6 Cg_endo -75.02 -13.84 21.25 Favored 'Trans proline' 0 C--N 1.361 1.189 0 O-C-N 124.45 1.763 . . . . 0.0 111.033 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 186' ' ' TYR . . . . . 0.601 ' CD1' ' HB2' ' A' ' 183' ' ' PRO . 7.9 m-85 -93.93 10.59 32.74 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.514 1.134 . . . . 0.0 110.985 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 187' ' ' VAL . . . . . 0.48 ' HA ' ' O ' ' A' ' 138' ' ' ARG . 20.3 m -143.12 165.01 15.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 O-C-N 124.503 1.127 . . . . 0.0 109.311 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . 0.519 ' O ' ' CG2' ' A' ' 137' ' ' VAL . 0.0 OUTLIER -120.42 159.61 24.76 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.512 1.132 . . . . 0.0 110.303 -179.995 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -86.59 134.17 33.66 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.519 1.137 . . . . 0.0 109.292 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -111.53 86.41 2.33 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.53 1.144 . . . . 0.0 111.028 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 1.0 0 O-C-N 124.501 1.126 . . . . 0.0 110.993 -179.989 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' CYS . . . . . 0.475 ' N ' ' O ' ' A' ' 190' ' ' TYR . 26.9 p . . . . . 0 N--CA 1.453 -0.319 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 96.9 -49.57 1.56 Allowed Glycine 0 CA--C 1.529 0.963 0 O-C-N 124.505 1.128 . . . . 0.0 110.988 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -61.32 -150.52 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.454 0.737 . . . . 0.0 109.243 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . 0.526 ' O ' ' HG2' ' A' ' 160' ' ' ARG . 0.4 OUTLIER -142.63 73.16 1.39 Allowed 'General case' 0 C--N 1.326 -0.427 0 O-C-N 124.424 1.078 . . . . 0.0 110.285 -179.979 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 39.2 m-85 -128.82 126.91 40.85 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.459 1.099 . . . . 0.0 110.984 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.452 ' HA ' ' O ' ' A' ' 188' ' ' GLU . 28.5 m -121.06 170.03 11.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 O-C-N 124.535 1.147 . . . . 0.0 109.334 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . 0.447 ' O ' ' HA ' ' A' ' 187' ' ' VAL . 5.1 ttm180 -133.91 127.64 32.91 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.498 1.124 . . . . 0.0 110.306 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . 0.597 ' O ' ' N ' ' A' ' 156' ' ' GLY . . . -93.5 115.58 28.1 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.582 1.176 . . . . 0.0 109.27 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.52 ' O ' ' CB ' ' A' ' 155' ' ' LYS . 0.2 OUTLIER -95.22 -19.58 19.92 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.545 1.153 . . . . 0.0 109.338 179.908 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . 0.444 ' O ' ' O ' ' A' ' 154' ' ' LYS . 5.8 m-85 -114.45 147.52 39.16 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.45 1.094 . . . . 0.0 110.96 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . 0.447 ' N ' ' OD1' ' A' ' 142' ' ' ASP . 0.0 OUTLIER -89.5 138.84 31.11 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.476 1.11 . . . . 0.0 109.275 179.991 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' PHE . . . . . 0.69 ' O ' ' CZ ' ' A' ' 153' ' ' PHE . 0.1 OUTLIER 172.17 82.04 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.575 1.172 . . . . 0.0 110.962 179.966 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 33.3 p-10 -43.54 163.9 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.518 1.136 . . . . 0.0 109.317 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . 0.454 ' N ' ' OD1' ' A' ' 150' ' ' ASP . . . -77.47 -156.79 8.27 Favored Glycine 0 CA--C 1.53 0.996 0 O-C-N 124.521 1.138 . . . . 0.0 111.067 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 22.2 t-20 177.24 72.08 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.547 0.792 . . . . 0.0 109.285 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . 0.429 ' N ' ' OD1' ' A' ' 147' ' ' ASP . 0.0 OUTLIER -163.14 -162.07 0.73 Allowed 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.453 1.096 . . . . 0.0 109.295 179.992 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . 0.444 ' O ' ' CB ' ' A' ' 149' ' ' GLU . 0.6 OUTLIER -70.73 52.1 0.14 Allowed 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.436 1.085 . . . . 0.0 110.278 179.994 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . 0.458 ' O ' ' O ' ' A' ' 150' ' ' ASP . 0.2 OUTLIER 164.41 -58.59 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.462 1.101 . . . . 0.0 110.291 -179.958 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . 0.458 ' O ' ' O ' ' A' ' 149' ' ' GLU . 1.4 t0 60.22 134.15 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.587 1.179 . . . . 0.0 109.261 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.519 ' HB3' ' CG2' ' A' ' 182' ' ' ILE . 1.0 OUTLIER -119.79 103.82 45.38 Favored Pre-proline 0 C--N 1.325 -0.467 0 O-C-N 124.481 1.113 . . . . 0.0 109.339 179.985 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -75.04 117.95 5.08 Favored 'Trans proline' 0 C--N 1.36 1.146 0 O-C-N 124.559 1.82 . . . . 0.0 111.041 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . 0.69 ' CZ ' ' O ' ' A' ' 143' ' ' PHE . 20.9 p90 -137.91 169.87 17.03 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.561 1.163 . . . . 0.0 110.947 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . 0.447 ' HG3' ' CG ' ' A' ' 142' ' ' ASP . 3.4 tttt -130.0 -120.92 0.22 Allowed 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.46 1.1 . . . . 0.0 109.317 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.52 ' CB ' ' O ' ' A' ' 140' ' ' LEU . 0.3 OUTLIER -126.65 118.22 24.34 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.559 1.162 . . . . 0.0 109.315 179.976 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . 0.597 ' N ' ' O ' ' A' ' 139' ' ' ALA . . . 98.16 19.61 23.18 Favored Glycine 0 CA--C 1.53 1.004 0 O-C-N 124.513 1.133 . . . . 0.0 111.012 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -91.45 157.04 17.28 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.54 0.788 . . . . 0.0 109.291 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 12.8 mm -113.19 141.04 30.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 O-C-N 124.486 1.116 . . . . 0.0 109.298 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.427 HD21 ' C ' ' A' ' 173' ' ' GLU . 7.2 mt -145.3 124.95 13.26 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.503 1.127 . . . . 0.0 109.316 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . 0.528 ' O ' ' HA ' ' A' ' 172' ' ' ALA . 0.0 OUTLIER -87.68 135.21 33.46 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.42 1.075 . . . . 0.0 110.342 179.99 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . 0.419 ' CD1' HG23 ' A' ' 137' ' ' VAL . 1.4 mp -83.0 119.37 32.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 O-C-N 124.428 1.08 . . . . 0.0 109.286 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.56 -46.35 2.58 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.573 1.17 . . . . 0.0 110.309 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . 0.457 ' CB ' ' HB3' ' A' ' 171' ' ' ASN . 0.1 OUTLIER -134.94 179.59 6.22 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.564 1.165 . . . . 0.0 109.264 179.998 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . 0.598 ' HB2' ' CD1' ' A' ' 170' ' ' TRP . 0.0 OUTLIER -170.82 91.97 0.46 Allowed Pre-proline 0 C--N 1.326 -0.432 0 O-C-N 124.462 1.101 . . . . 0.0 109.311 -179.994 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.03 -26.35 10.95 Favored 'Trans proline' 0 C--N 1.362 1.239 0 O-C-N 124.513 1.796 . . . . 0.0 111.023 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -126.26 166.27 17.42 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.508 1.13 . . . . 0.0 110.24 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -86.54 -26.09 24.72 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.501 1.126 . . . . 0.0 110.299 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 4.4 mt-30 -78.02 -56.58 4.37 Favored 'General case' 0 C--N 1.324 -0.524 0 O-C-N 124.568 1.167 . . . . 0.0 110.316 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' TRP . . . . . . . . . . . . . 9.2 m95 -104.87 145.83 29.85 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' TRP . . . . . 0.598 ' CD1' ' HB2' ' A' ' 164' ' ' LYS . 30.8 m0 -122.44 151.43 41.28 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.564 1.165 . . . . 0.0 108.034 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' ASN . . . . . 0.457 ' HB3' ' CB ' ' A' ' 163' ' ' ASP . 2.7 t30 -86.44 96.19 9.95 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.544 1.153 . . . . 0.0 109.289 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . 0.528 ' HA ' ' O ' ' A' ' 160' ' ' ARG . . . -107.26 166.65 10.48 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.496 1.123 . . . . 0.0 109.259 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . 0.449 ' HA ' ' O ' ' A' ' 178' ' ' LYS . 34.3 mt-10 -126.03 126.25 43.95 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.503 1.127 . . . . 0.0 110.31 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . 0.507 ' OD2' ' CD1' ' A' ' 151' ' ' LEU . 1.1 m-20 -79.48 -174.57 4.3 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.521 1.138 . . . . 0.0 109.277 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 38.4 t -77.74 56.27 1.48 Allowed 'General case' 0 C--N 1.324 -0.528 0 O-C-N 124.584 1.178 . . . . 0.0 109.964 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . 0.459 ' CB ' ' HD2' ' A' ' 178' ' ' LYS . 0.0 OUTLIER -167.68 16.68 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.466 1.104 . . . . 0.0 110.298 179.925 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 62.57 15.13 52.73 Favored Glycine 0 CA--C 1.53 0.983 0 O-C-N 124.503 1.127 . . . . 0.0 110.992 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 178' ' ' LYS . . . . . 0.493 ' CG ' ' HB2' ' A' ' 174' ' ' ASP . 1.5 ptmm? -86.04 108.15 18.12 Favored 'General case' 0 C--N 1.326 -0.429 0 O-C-N 124.469 0.747 . . . . 0.0 109.334 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 179' ' ' ARG . . . . . 0.435 ' HA ' ' O ' ' A' ' 172' ' ' ALA . 0.0 OUTLIER -96.11 127.82 42.47 Favored 'General case' 0 C--N 1.324 -0.523 0 O-C-N 124.51 1.131 . . . . 0.0 110.284 -179.961 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -152.27 165.84 30.94 Favored Glycine 0 CA--C 1.53 0.993 0 O-C-N 124.511 1.132 . . . . 0.0 111.021 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 181' ' ' MET . . . . . 0.436 ' HA ' ' O ' ' A' ' 170' ' ' TRP . 25.4 mtp -88.41 105.32 17.52 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.488 0.758 . . . . 0.0 110.98 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . 0.519 ' CG2' ' HB3' ' A' ' 151' ' ' LEU . 0.0 OUTLIER -110.15 164.11 15.6 Favored Pre-proline 0 C--N 1.324 -0.536 0 O-C-N 124.514 1.134 . . . . 0.0 109.359 179.956 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 183' ' ' PRO . . . . . 0.637 ' HG2' ' HB2' ' A' ' 186' ' ' TYR . 18.3 Cg_endo -74.99 128.85 11.82 Favored 'Trans proline' 0 C--N 1.36 1.169 0 O-C-N 124.51 1.795 . . . . 0.0 111.048 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . 0.812 ' N ' ' CD ' ' A' ' 185' ' ' PRO . 59.8 t -76.87 -32.96 1.06 Allowed Pre-proline 0 C--N 1.324 -0.506 0 O-C-N 124.576 1.173 . . . . 0.0 109.266 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 185' ' ' PRO . . . . . 0.812 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.5 Cg_endo -74.99 -14.57 21.13 Favored 'Trans proline' 0 C--N 1.36 1.15 0 O-C-N 124.485 1.782 . . . . 0.0 111.048 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 186' ' ' TYR . . . . . 0.637 ' HB2' ' HG2' ' A' ' 183' ' ' PRO . 6.3 m-85 -96.26 5.01 51.93 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.522 1.139 . . . . 0.0 111.001 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 187' ' ' VAL . . . . . 0.447 ' HA ' ' O ' ' A' ' 138' ' ' ARG . 12.6 m -135.81 165.02 30.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 O-C-N 124.499 1.124 . . . . 0.0 109.248 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . 0.481 ' OE2' ' CD2' ' A' ' 140' ' ' LEU . 0.3 OUTLIER -115.03 153.22 31.07 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.475 1.11 . . . . 0.0 110.277 -179.984 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.54 137.01 32.7 Favored 'General case' 0 C--N 1.326 -0.436 0 O-C-N 124.505 1.128 . . . . 0.0 109.334 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 190' ' ' TYR . . . . . 0.565 ' O ' ' C ' ' A' ' 191' ' ' GLY . 3.4 m-85 -136.81 -86.22 0.32 Allowed 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.57 1.169 . . . . 0.0 110.987 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . 0.565 ' C ' ' O ' ' A' ' 190' ' ' TYR . . . . . . . . 0 CA--C 1.53 1.01 0 O-C-N 124.627 1.204 . . . . 0.0 111.077 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' CYS . . . . . 0.466 ' O ' ' O ' ' A' ' 191' ' ' GLY . 15.5 p . . . . . 0 N--CA 1.452 -0.339 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -65.9 -149.45 0.09 OUTLIER Glycine 0 CA--C 1.53 0.994 0 O-C-N 124.541 1.151 . . . . 0.0 110.994 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . 0.435 ' C ' ' CD ' ' A' ' 135' ' ' GLU . . . 71.97 -157.13 0.1 Allowed 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.454 0.738 . . . . 0.0 109.317 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . 0.523 ' CB ' ' O ' ' A' ' 161' ' ' ILE . 25.3 mp0 -148.6 76.41 1.35 Allowed 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.481 1.113 . . . . 0.0 110.379 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 76.0 m-85 -126.66 125.07 41.27 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.512 1.133 . . . . 0.0 111.021 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.485 ' CG2' HD13 ' A' ' 161' ' ' ILE . 7.5 m -131.84 141.26 46.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 O-C-N 124.533 1.145 . . . . 0.0 109.336 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . 0.546 ' HD2' ' CE1' ' A' ' 190' ' ' TYR . 0.8 OUTLIER -115.58 137.5 52.0 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.57 1.169 . . . . 0.0 110.261 -179.956 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . 0.645 ' O ' ' N ' ' A' ' 156' ' ' GLY . . . -92.56 115.6 28.25 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.501 1.126 . . . . 0.0 109.273 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.57 ' HB2' ' CE1' ' A' ' 141' ' ' PHE . 0.2 OUTLIER -87.44 -8.41 56.53 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.495 1.122 . . . . 0.0 109.331 179.993 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . 0.57 ' CE1' ' HB2' ' A' ' 140' ' ' LEU . 0.4 OUTLIER -128.04 144.31 51.1 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.494 1.121 . . . . 0.0 111.004 179.991 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -93.3 157.39 16.27 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.55 1.156 . . . . 0.0 109.242 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' PHE . . . . . 0.575 ' HB3' ' CZ ' ' A' ' 153' ' ' PHE . 0.0 OUTLIER -149.43 -40.03 0.15 Allowed 'General case' 0 C--N 1.326 -0.42 0 O-C-N 124.479 1.112 . . . . 0.0 111.008 -179.987 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . 0.479 ' O ' ' CE1' ' A' ' 143' ' ' PHE . 37.4 m-80 55.42 175.0 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.435 0 O-C-N 124.418 1.074 . . . . 0.0 109.295 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . 0.44 ' N ' ' HB3' ' A' ' 152' ' ' PRO . . . 162.32 -170.09 37.83 Favored Glycine 0 CA--C 1.53 0.979 0 O-C-N 124.426 1.079 . . . . 0.0 111.035 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 12.2 p-10 171.17 74.02 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.47 0.747 . . . . 0.0 109.3 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -97.3 -84.67 0.37 Allowed 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.445 1.091 . . . . 0.0 109.32 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 177.51 36.73 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.49 1.119 . . . . 0.0 110.308 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 170.07 -39.04 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.476 1.11 . . . . 0.0 110.334 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -52.18 167.37 0.13 Allowed 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.478 1.112 . . . . 0.0 109.314 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.567 ' CD2' ' OD1' ' A' ' 174' ' ' ASP . 12.5 tp -130.55 107.34 15.77 Favored Pre-proline 0 C--N 1.324 -0.51 0 O-C-N 124.496 1.122 . . . . 0.0 109.265 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . 0.44 ' HB3' ' N ' ' A' ' 145' ' ' GLY . 18.3 Cg_endo -75.0 172.02 17.18 Favored 'Trans proline' 0 C--N 1.36 1.166 0 O-C-N 124.552 1.817 . . . . 0.0 111.012 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . 0.575 ' CZ ' ' HB3' ' A' ' 143' ' ' PHE . 24.4 p90 -169.5 176.7 4.92 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.516 1.135 . . . . 0.0 111.046 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . 0.414 ' O ' ' OD1' ' A' ' 157' ' ' ASP . 0.6 OUTLIER -119.76 -155.56 0.62 Allowed 'General case' 0 C--N 1.326 -0.438 0 O-C-N 124.479 1.112 . . . . 0.0 109.296 -179.992 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 1.1 tttp -111.96 98.78 7.6 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.473 1.108 . . . . 0.0 109.314 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . 0.645 ' N ' ' O ' ' A' ' 139' ' ' ALA . . . 115.55 25.75 3.62 Favored Glycine 0 CA--C 1.529 0.967 0 O-C-N 124.525 1.141 . . . . 0.0 111.038 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . 0.414 ' OD1' ' O ' ' A' ' 154' ' ' LYS . 3.4 p-10 -99.13 166.85 11.05 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.438 0.728 . . . . 0.0 109.28 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . 0.471 ' N ' ' CD1' ' A' ' 158' ' ' ILE . 2.1 mp -122.5 150.88 26.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 O-C-N 124.422 1.076 . . . . 0.0 109.268 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.481 ' CD2' HG23 ' A' ' 182' ' ' ILE . 0.4 OUTLIER -151.94 134.84 15.65 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.482 1.114 . . . . 0.0 109.336 179.988 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . 0.465 ' HG2' ' O ' ' A' ' 135' ' ' GLU . 0.1 OUTLIER -93.53 127.56 39.25 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.431 1.082 . . . . 0.0 110.314 -179.981 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . 0.523 ' O ' ' CB ' ' A' ' 135' ' ' GLU . 1.6 mp -85.67 121.49 37.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 O-C-N 124.48 1.112 . . . . 0.0 109.362 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . 0.429 ' CD ' ' HB2' ' A' ' 163' ' ' ASP . 0.2 OUTLIER -119.99 -32.21 4.26 Favored 'General case' 0 C--N 1.326 -0.431 0 O-C-N 124.425 1.078 . . . . 0.0 110.289 -179.976 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . 0.448 ' CB ' ' HB3' ' A' ' 171' ' ' ASN . 0.4 OUTLIER -139.8 171.34 14.36 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.554 1.159 . . . . 0.0 109.299 179.985 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . 0.573 ' HB2' ' CD1' ' A' ' 170' ' ' TRP . 0.5 OUTLIER -156.8 82.62 3.26 Favored Pre-proline 0 C--N 1.325 -0.476 0 O-C-N 124.496 1.123 . . . . 0.0 109.312 -179.939 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -74.9 -25.71 11.83 Favored 'Trans proline' 0 C--N 1.359 1.129 0 O-C-N 124.438 1.757 . . . . 0.0 111.075 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 9.6 mt-10 -111.64 169.01 9.11 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.464 1.102 . . . . 0.0 110.317 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -90.98 -32.04 16.1 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.544 1.153 . . . . 0.0 110.296 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . 0.437 ' HB3' ' CD1' ' A' ' 169' ' ' TRP . 6.6 mt-30 -87.3 -53.45 4.83 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.552 1.158 . . . . 0.0 110.31 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' TRP . . . . . 0.473 ' N ' ' CD1' ' A' ' 169' ' ' TRP . 1.6 m95 -104.8 148.18 26.91 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.546 1.154 . . . . 0.0 107.972 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' TRP . . . . . 0.647 ' CE3' HG21 ' A' ' 184' ' ' VAL . 36.9 m0 -125.38 159.67 31.26 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.558 1.161 . . . . 0.0 108.05 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' ASN . . . . . 0.448 ' HB3' ' CB ' ' A' ' 163' ' ' ASP . 23.6 t-20 -86.14 109.5 18.92 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.511 1.132 . . . . 0.0 109.289 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . 0.449 ' CA ' ' O ' ' A' ' 160' ' ' ARG . . . -122.82 176.92 5.71 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.457 1.098 . . . . 0.0 109.323 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . 0.501 ' CG ' ' HG2' ' A' ' 179' ' ' ARG . 7.1 mt-10 -116.36 119.74 36.64 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.453 1.096 . . . . 0.0 110.357 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . 0.567 ' OD1' ' CD2' ' A' ' 151' ' ' LEU . 1.7 m-20 -74.66 -175.93 2.62 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.508 1.13 . . . . 0.0 109.361 179.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 98.2 p -76.74 58.93 1.49 Allowed 'General case' 0 C--N 1.324 -0.531 0 O-C-N 124.506 1.129 . . . . 0.0 109.99 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -170.93 -2.22 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.52 0 O-C-N 124.515 1.134 . . . . 0.0 110.333 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 79.16 19.58 71.9 Favored Glycine 0 CA--C 1.53 1.012 0 O-C-N 124.524 1.14 . . . . 0.0 111.037 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 178' ' ' LYS . . . . . 0.496 ' CG ' ' HB2' ' A' ' 174' ' ' ASP . 2.1 ptpp? -91.88 121.26 33.31 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.499 0.764 . . . . 0.0 109.331 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 179' ' ' ARG . . . . . 0.501 ' HG2' ' CG ' ' A' ' 173' ' ' GLU . 21.1 mtt85 -89.81 122.44 32.88 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.475 1.109 . . . . 0.0 110.275 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . 0.437 ' C ' HD21 ' A' ' 151' ' ' LEU . . . -152.02 167.04 31.11 Favored Glycine 0 CA--C 1.531 1.037 0 O-C-N 124.486 1.117 . . . . 0.0 110.972 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 181' ' ' MET . . . . . 0.45 ' HA ' ' O ' ' A' ' 170' ' ' TRP . 33.8 mtp -87.97 103.5 15.75 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.471 0.748 . . . . 0.0 110.988 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . 0.502 HG22 ' CD2' ' A' ' 151' ' ' LEU . 8.2 pt -98.7 157.12 34.79 Favored Pre-proline 0 C--N 1.324 -0.528 0 O-C-N 124.526 1.141 . . . . 0.0 109.281 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 183' ' ' PRO . . . . . 0.716 ' HG2' ' HB2' ' A' ' 186' ' ' TYR . 18.4 Cg_endo -75.0 135.27 18.85 Favored 'Trans proline' 0 C--N 1.36 1.148 0 O-C-N 124.495 1.787 . . . . 0.0 111.029 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . 0.816 ' N ' ' CD ' ' A' ' 185' ' ' PRO . 62.8 t -81.74 -32.45 0.61 Allowed Pre-proline 0 C--N 1.324 -0.501 0 O-C-N 124.547 1.155 . . . . 0.0 109.359 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 185' ' ' PRO . . . . . 0.816 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.5 Cg_endo -74.98 -25.35 11.97 Favored 'Trans proline' 0 C--N 1.36 1.159 0 O-C-N 124.508 1.794 . . . . 0.0 111.011 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 186' ' ' TYR . . . . . 0.716 ' HB2' ' HG2' ' A' ' 183' ' ' PRO . 3.8 m-85 -93.48 14.43 18.69 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.504 1.127 . . . . 0.0 111.068 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 187' ' ' VAL . . . . . 0.519 ' CG2' ' HA ' ' A' ' 184' ' ' VAL . 21.4 m -138.22 163.69 28.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 O-C-N 124.525 1.14 . . . . 0.0 109.272 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . 0.467 ' O ' ' HA ' ' A' ' 137' ' ' VAL . 0.0 OUTLIER -126.07 167.62 15.1 Favored 'General case' 0 C--N 1.326 -0.416 0 O-C-N 124.431 1.082 . . . . 0.0 110.335 179.958 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -87.5 125.39 34.28 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.508 1.13 . . . . 0.0 109.251 -179.9 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 190' ' ' TYR . . . . . 0.546 ' CE1' ' HD2' ' A' ' 138' ' ' ARG . 0.1 OUTLIER -109.32 81.61 1.47 Allowed 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.444 1.09 . . . . 0.0 111.034 179.948 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . 0.466 ' O ' ' O ' ' A' ' 132' ' ' CYS . . . . . . . . 0 CA--C 1.531 1.048 0 O-C-N 124.443 1.089 . . . . 0.0 110.93 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' CYS . . . . . . . . . . . . . 5.8 t . . . . . 0 N--CA 1.452 -0.342 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -127.4 149.88 17.98 Favored Glycine 0 CA--C 1.53 1.022 0 O-C-N 124.474 1.109 . . . . 0.0 110.976 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . 48.73 -157.2 0.07 Allowed 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.449 0.735 . . . . 0.0 109.297 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . 0.442 ' HB2' ' HB ' ' A' ' 161' ' ' ILE . 0.2 OUTLIER -120.16 60.65 0.87 Allowed 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.492 1.12 . . . . 0.0 110.294 179.981 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . 0.582 ' C ' ' CD1' ' A' ' 136' ' ' TYR . 0.4 OUTLIER -121.97 143.0 49.73 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.493 1.121 . . . . 0.0 110.978 179.998 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.508 ' CG2' ' O ' ' A' ' 159' ' ' LEU . 35.1 m -145.03 137.45 21.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 O-C-N 124.431 1.082 . . . . 0.0 109.243 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . 0.445 ' HB3' ' HG3' ' A' ' 188' ' ' GLU . 0.6 OUTLIER -105.07 133.98 48.93 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.466 1.104 . . . . 0.0 110.285 -179.993 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . 0.499 ' O ' ' N ' ' A' ' 156' ' ' GLY . . . -95.97 112.57 24.27 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.56 1.163 . . . . 0.0 109.305 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.551 ' CD1' ' HG2' ' A' ' 188' ' ' GLU . 0.2 OUTLIER -98.5 -9.48 24.97 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.561 1.163 . . . . 0.0 109.325 -179.971 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . 0.495 ' C ' ' O ' ' A' ' 154' ' ' LYS . 14.3 m-85 -109.22 152.02 25.74 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.448 1.093 . . . . 0.0 111.062 179.906 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . 0.502 ' CA ' ' O ' ' A' ' 154' ' ' LYS . 3.3 t70 -106.9 149.53 27.36 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.551 1.157 . . . . 0.0 109.353 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' PHE . . . . . 0.58 ' HB3' ' CZ ' ' A' ' 153' ' ' PHE . 8.0 t80 -174.28 25.4 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.419 1.074 . . . . 0.0 110.965 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . 0.473 ' OD1' ' N ' ' A' ' 145' ' ' GLY . 16.9 p30 36.67 -157.5 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.563 1.165 . . . . 0.0 109.279 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . 0.473 ' N ' ' OD1' ' A' ' 144' ' ' ASN . . . 164.2 112.77 0.28 Allowed Glycine 0 CA--C 1.53 0.987 0 O-C-N 124.564 1.165 . . . . 0.0 110.988 -179.956 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 -159.97 52.4 0.33 Allowed 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.459 0.74 . . . . 0.0 109.316 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 60.5 m-20 -162.49 149.16 13.14 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.503 1.127 . . . . 0.0 109.336 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 42.41 35.49 0.64 Allowed 'General case' 0 C--N 1.326 -0.447 0 O-C-N 124.43 1.081 . . . . 0.0 110.344 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 60.7 47.97 7.62 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.54 1.15 . . . . 0.0 110.268 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -84.54 146.97 27.28 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.446 1.091 . . . . 0.0 109.32 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.505 ' HB2' ' CG2' ' A' ' 182' ' ' ILE . 1.1 mp -92.16 112.7 56.33 Favored Pre-proline 0 C--N 1.325 -0.487 0 O-C-N 124.499 1.124 . . . . 0.0 109.328 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . 0.46 ' HA ' ' C ' ' A' ' 144' ' ' ASN . 18.4 Cg_endo -74.98 138.88 23.65 Favored 'Trans proline' 0 C--N 1.359 1.104 0 O-C-N 124.505 1.792 . . . . 0.0 110.977 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . 0.58 ' CZ ' ' HB3' ' A' ' 143' ' ' PHE . 11.7 p90 -151.82 170.2 20.37 Favored 'General case' 0 C--N 1.326 -0.437 0 O-C-N 124.441 1.088 . . . . 0.0 110.922 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . 0.502 ' O ' ' CA ' ' A' ' 142' ' ' ASP . 0.0 OUTLIER -127.02 -80.73 0.6 Allowed 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.484 1.115 . . . . 0.0 109.303 -179.979 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -165.77 115.51 1.01 Allowed 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.538 1.149 . . . . 0.0 109.34 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . 0.499 ' N ' ' O ' ' A' ' 139' ' ' ALA . . . 100.38 20.83 14.27 Favored Glycine 0 CA--C 1.53 1.017 0 O-C-N 124.437 1.086 . . . . 0.0 111.049 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . 0.407 ' HB3' ' HB3' ' A' ' 139' ' ' ALA . 23.1 t70 -84.59 155.23 22.14 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.488 0.757 . . . . 0.0 109.32 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 13.1 mm -105.1 133.78 48.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 O-C-N 124.417 1.073 . . . . 0.0 109.342 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.508 ' O ' ' CG2' ' A' ' 137' ' ' VAL . 0.4 OUTLIER -142.96 124.93 15.19 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.538 1.149 . . . . 0.0 109.286 -179.976 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . 0.62 ' O ' ' HA ' ' A' ' 172' ' ' ALA . 0.0 OUTLIER -94.65 141.01 29.11 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.529 1.143 . . . . 0.0 110.271 179.992 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . 0.442 ' HB ' ' HB2' ' A' ' 135' ' ' GLU . 19.9 mm -84.28 114.71 25.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 O-C-N 124.533 1.145 . . . . 0.0 109.313 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.47 -52.59 2.75 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.491 1.119 . . . . 0.0 110.293 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 11.8 t0 -136.34 174.7 10.33 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.451 1.094 . . . . 0.0 109.284 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . 0.565 ' HB2' ' CD1' ' A' ' 170' ' ' TRP . 0.0 OUTLIER -167.1 89.16 0.75 Allowed Pre-proline 0 C--N 1.325 -0.499 0 O-C-N 124.472 1.108 . . . . 0.0 109.299 -179.99 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.04 -34.2 3.97 Favored 'Trans proline' 0 C--N 1.36 1.166 0 O-C-N 124.532 1.806 . . . . 0.0 110.952 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -107.8 170.13 8.18 Favored 'General case' 0 C--N 1.324 -0.532 0 O-C-N 124.542 1.151 . . . . 0.0 110.28 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 18.7 pt-20 -95.36 -15.56 22.98 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.471 1.107 . . . . 0.0 110.355 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . 0.446 ' HG2' ' CD1' ' A' ' 169' ' ' TRP . 20.5 tt0 -92.41 -56.29 3.09 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.502 1.126 . . . . 0.0 110.333 179.952 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 169' ' ' TRP . . . . . 0.446 ' CD1' ' HG2' ' A' ' 168' ' ' GLN . 32.4 m95 -105.61 140.34 38.83 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.449 1.093 . . . . 0.0 108.064 179.934 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 170' ' ' TRP . . . . . 0.607 ' CZ3' HG12 ' A' ' 184' ' ' VAL . 53.1 m0 -120.02 152.78 36.99 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.523 1.139 . . . . 0.0 107.98 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 171' ' ' ASN . . . . . 0.436 ' HA ' ' O ' ' A' ' 180' ' ' GLY . 0.1 OUTLIER -88.04 97.34 10.91 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.493 1.121 . . . . 0.0 109.268 179.976 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . 0.62 ' HA ' ' O ' ' A' ' 160' ' ' ARG . . . -107.47 173.17 6.44 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.51 1.131 . . . . 0.0 109.342 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . 0.428 ' N ' ' O ' ' A' ' 160' ' ' ARG . 18.1 mt-10 -118.94 120.08 36.21 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.517 1.136 . . . . 0.0 110.329 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . 0.402 ' OD1' HD22 ' A' ' 151' ' ' LEU . 0.1 OUTLIER -74.34 -169.92 0.89 Allowed 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.468 1.105 . . . . 0.0 109.297 -179.952 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 72.6 p -81.3 59.79 4.11 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.441 1.088 . . . . 0.0 110.004 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 177.61 25.48 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.484 1.115 . . . . 0.0 110.266 -179.974 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 57.79 19.2 35.2 Favored Glycine 0 CA--C 1.531 1.043 0 O-C-N 124.534 1.146 . . . . 0.0 110.997 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 6.6 mtmt -81.28 104.06 11.49 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.504 0.767 . . . . 0.0 109.293 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 179' ' ' ARG . . . . . 0.434 ' HA ' ' O ' ' A' ' 172' ' ' ALA . 4.7 ttp180 -90.46 118.75 30.18 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.528 1.143 . . . . 0.0 110.288 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . 0.436 ' O ' ' HA ' ' A' ' 171' ' ' ASN . . . -152.25 168.86 31.47 Favored Glycine 0 CA--C 1.531 1.032 0 O-C-N 124.612 1.195 . . . . 0.0 111.04 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 181' ' ' MET . . . . . 0.442 ' HA ' ' O ' ' A' ' 170' ' ' TRP . 1.5 mmm -85.98 106.76 17.38 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.546 0.792 . . . . 0.0 110.961 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . 0.505 ' CG2' ' HB2' ' A' ' 151' ' ' LEU . 1.4 pp -110.41 162.12 21.81 Favored Pre-proline 0 C--N 1.326 -0.446 0 O-C-N 124.515 1.134 . . . . 0.0 109.278 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 183' ' ' PRO . . . . . 0.706 ' HG2' ' HB2' ' A' ' 186' ' ' TYR . 18.6 Cg_endo -74.99 132.56 15.58 Favored 'Trans proline' 0 C--N 1.36 1.162 0 O-C-N 124.508 1.794 . . . . 0.0 111.05 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . 0.807 ' N ' ' CD ' ' A' ' 185' ' ' PRO . 62.1 t -78.94 -32.45 0.79 Allowed Pre-proline 0 C--N 1.324 -0.527 0 O-C-N 124.568 1.168 . . . . 0.0 109.332 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 185' ' ' PRO . . . . . 0.807 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.4 Cg_endo -74.96 -17.44 19.65 Favored 'Trans proline' 0 C--N 1.36 1.156 0 O-C-N 124.438 1.757 . . . . 0.0 111.006 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 186' ' ' TYR . . . . . 0.706 ' HB2' ' HG2' ' A' ' 183' ' ' PRO . 3.5 m-30 -97.25 17.7 16.72 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.496 1.123 . . . . 0.0 110.972 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 187' ' ' VAL . . . . . 0.42 HG11 ' O ' ' A' ' 183' ' ' PRO . 16.7 m -145.44 173.61 3.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 O-C-N 124.515 1.134 . . . . 0.0 109.359 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . 0.551 ' HG2' ' CD1' ' A' ' 140' ' ' LEU . 0.1 OUTLIER -127.95 159.6 34.47 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.504 1.127 . . . . 0.0 110.245 -179.962 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 7.4 mmmm -88.18 135.84 33.25 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.433 1.083 . . . . 0.0 109.306 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 8.9 t80 -38.54 -62.8 0.56 Allowed 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.456 1.098 . . . . 0.0 111.02 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.977 0 O-C-N 124.531 1.144 . . . . 0.0 110.962 179.981 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' CYS . . . . . . . . . . . . . 52.4 m . . . . . 0 N--CA 1.452 -0.364 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -147.04 -90.31 0.09 OUTLIER Glycine 0 CA--C 1.53 1.01 0 O-C-N 124.485 1.116 . . . . 0.0 111.022 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . 0.419 ' C ' ' HG2' ' A' ' 135' ' ' GLU . . . -156.14 -78.13 0.09 Allowed 'General case' 0 C--N 1.326 -0.443 0 O-C-N 124.558 0.799 . . . . 0.0 109.299 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . 0.459 ' CB ' ' HB ' ' A' ' 161' ' ' ILE . 1.5 mt-10 -145.16 44.03 1.32 Allowed 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.49 1.119 . . . . 0.0 110.248 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . 0.513 ' CE1' ' HB2' ' A' ' 160' ' ' ARG . 26.0 m-85 -86.86 106.55 17.82 Favored 'General case' 0 C--N 1.324 -0.527 0 O-C-N 124.491 1.119 . . . . 0.0 110.946 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.555 ' HA ' ' O ' ' A' ' 188' ' ' GLU . 19.8 m -117.19 138.39 48.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 O-C-N 124.502 1.126 . . . . 0.0 109.301 179.943 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . 0.43 ' HG2' ' CG ' ' A' ' 188' ' ' GLU . 0.0 OUTLIER -108.27 147.01 32.03 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.532 1.145 . . . . 0.0 110.275 -179.956 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . 0.663 ' O ' ' N ' ' A' ' 156' ' ' GLY . . . -93.88 119.89 33.41 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.506 1.128 . . . . 0.0 109.336 179.955 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.429 ' CD1' ' HG2' ' A' ' 188' ' ' GLU . 1.1 mt -88.51 -3.46 58.81 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.472 1.108 . . . . 0.0 109.281 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 13.8 m-85 -139.96 154.34 47.16 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.433 1.083 . . . . 0.0 110.984 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . 0.471 ' CB ' ' HA ' ' A' ' 154' ' ' LYS . 10.8 p-10 -97.36 147.48 24.14 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.495 1.122 . . . . 0.0 109.285 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' PHE . . . . . 0.568 ' HB3' ' CZ ' ' A' ' 153' ' ' PHE . 1.7 t80 177.85 67.82 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.516 1.135 . . . . 0.0 111.001 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . 0.425 ' HA ' ' HA ' ' A' ' 152' ' ' PRO . 76.6 m-20 -38.71 154.69 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.484 1.115 . . . . 0.0 109.295 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -47.19 -98.05 0.01 OUTLIER Glycine 0 CA--C 1.53 1.018 0 O-C-N 124.488 1.118 . . . . 0.0 111.045 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 9.3 p-10 -170.67 -51.1 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.474 0.749 . . . . 0.0 109.283 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -122.83 -59.59 1.59 Allowed 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.471 1.107 . . . . 0.0 109.325 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 179.29 -36.02 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.535 1.147 . . . . 0.0 110.245 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -50.91 -34.25 27.67 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.549 1.156 . . . . 0.0 110.385 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -87.23 168.69 12.99 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.479 1.112 . . . . 0.0 109.312 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.505 ' HB3' ' CD1' ' A' ' 182' ' ' ILE . 8.4 tp -105.12 112.37 65.12 Favored Pre-proline 0 C--N 1.325 -0.468 0 O-C-N 124.425 1.078 . . . . 0.0 109.324 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . 0.425 ' HA ' ' HA ' ' A' ' 144' ' ' ASN . 18.4 Cg_endo -74.96 148.82 36.01 Favored 'Trans proline' 0 C--N 1.36 1.149 0 O-C-N 124.506 1.792 . . . . 0.0 110.996 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . 0.596 ' CZ ' ' CG ' ' A' ' 183' ' ' PRO . 30.0 p90 -150.45 172.36 15.57 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.512 1.132 . . . . 0.0 111.072 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . 0.471 ' HA ' ' CB ' ' A' ' 142' ' ' ASP . 0.1 OUTLIER -126.1 -166.64 1.59 Allowed 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.453 1.096 . . . . 0.0 109.331 -179.985 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 6.4 ptpt -95.65 105.63 17.64 Favored 'General case' 0 C--N 1.324 -0.531 0 O-C-N 124.545 1.153 . . . . 0.0 109.329 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . 0.663 ' N ' ' O ' ' A' ' 139' ' ' ALA . . . 106.75 27.72 5.34 Favored Glycine 0 CA--C 1.53 0.999 0 O-C-N 124.434 1.084 . . . . 0.0 110.993 -180.0 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -97.45 165.9 11.78 Favored 'General case' 0 C--N 1.324 -0.522 0 O-C-N 124.482 0.754 . . . . 0.0 109.27 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -123.96 138.83 52.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 O-C-N 124.507 1.13 . . . . 0.0 109.268 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.462 ' CD2' HD22 ' A' ' 151' ' ' LEU . 0.7 OUTLIER -147.13 130.28 16.46 Favored 'General case' 0 C--N 1.324 -0.54 0 O-C-N 124.579 1.174 . . . . 0.0 109.326 179.971 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . 0.513 ' HB2' ' CE1' ' A' ' 136' ' ' TYR . 0.0 OUTLIER -93.91 132.63 38.16 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.476 1.11 . . . . 0.0 110.308 179.982 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . 0.465 ' CD1' ' CG2' ' A' ' 137' ' ' VAL . 1.6 mp -89.09 132.59 33.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 O-C-N 124.519 1.137 . . . . 0.0 109.327 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -127.01 -36.59 2.16 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.522 1.139 . . . . 0.0 110.263 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -132.68 169.66 16.34 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.455 1.097 . . . . 0.0 109.242 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . 0.588 ' HB2' ' CD1' ' A' ' 170' ' ' TRP . 0.0 OUTLIER -163.36 84.48 1.38 Allowed Pre-proline 0 C--N 1.326 -0.454 0 O-C-N 124.423 1.077 . . . . 0.0 109.334 -179.988 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.94 -25.54 11.9 Favored 'Trans proline' 0 C--N 1.361 1.194 0 O-C-N 124.56 1.821 . . . . 0.0 111.022 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -113.6 174.77 5.76 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.487 1.117 . . . . 0.0 110.292 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -99.71 -19.66 16.65 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.546 1.154 . . . . 0.0 110.317 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 3.6 mt-30 -88.18 -66.69 0.89 Allowed 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.41 1.069 . . . . 0.0 110.326 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 169' ' ' TRP . . . . . . . . . . . . . 6.5 m95 -95.49 153.17 17.83 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.537 1.148 . . . . 0.0 108.025 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 170' ' ' TRP . . . . . 0.588 ' CD1' ' HB2' ' A' ' 164' ' ' LYS . 43.2 m0 -126.03 153.93 43.7 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 -179.925 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 171' ' ' ASN . . . . . 0.403 ' HA ' ' O ' ' A' ' 180' ' ' GLY . 0.6 OUTLIER -86.97 104.23 16.08 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.459 1.099 . . . . 0.0 109.325 179.952 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . 0.413 ' HA ' ' O ' ' A' ' 160' ' ' ARG . . . -123.0 170.74 9.84 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.514 1.134 . . . . 0.0 109.319 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -115.93 126.48 53.95 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.505 1.128 . . . . 0.0 110.319 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . 0.438 ' N ' HD23 ' A' ' 159' ' ' LEU . 0.9 OUTLIER -78.34 -174.18 3.62 Favored 'General case' 0 C--N 1.324 -0.543 0 O-C-N 124.491 1.12 . . . . 0.0 109.298 179.986 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 80.7 p -76.19 64.48 2.01 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.514 1.134 . . . . 0.0 109.932 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -177.27 0.22 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.453 1.096 . . . . 0.0 110.345 -179.974 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 79.12 12.59 83.87 Favored Glycine 0 CA--C 1.53 1.006 0 O-C-N 124.575 1.172 . . . . 0.0 110.931 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.91 109.4 17.57 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.554 0.797 . . . . 0.0 109.272 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 179' ' ' ARG . . . . . 0.413 ' HA ' ' O ' ' A' ' 172' ' ' ALA . 2.1 ttp85 -87.99 123.19 32.45 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.495 1.122 . . . . 0.0 110.242 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . 0.403 ' O ' ' HA ' ' A' ' 171' ' ' ASN . . . -151.25 172.03 30.83 Favored Glycine 0 CA--C 1.53 1.022 0 O-C-N 124.486 1.116 . . . . 0.0 110.96 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 181' ' ' MET . . . . . 0.435 ' HA ' ' O ' ' A' ' 170' ' ' TRP . 0.9 OUTLIER -87.73 93.77 9.54 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.507 0.769 . . . . 0.0 111.001 -179.987 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . 0.526 ' CG1' ' HD2' ' A' ' 183' ' ' PRO . 0.0 OUTLIER -91.79 158.17 40.45 Favored Pre-proline 0 C--N 1.325 -0.497 0 O-C-N 124.459 1.099 . . . . 0.0 109.316 179.969 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 183' ' ' PRO . . . . . 0.69 ' HG2' ' HB2' ' A' ' 186' ' ' TYR . 18.2 Cg_endo -74.97 131.44 14.33 Favored 'Trans proline' 0 C--N 1.361 1.206 0 O-C-N 124.438 1.757 . . . . 0.0 111.026 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . 0.813 ' N ' ' CD ' ' A' ' 185' ' ' PRO . 85.9 t -79.96 -31.91 0.69 Allowed Pre-proline 0 C--N 1.325 -0.46 0 O-C-N 124.435 1.084 . . . . 0.0 109.265 180.0 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 185' ' ' PRO . . . . . 0.813 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.3 Cg_endo -74.99 -25.2 12.12 Favored 'Trans proline' 0 C--N 1.359 1.103 0 O-C-N 124.526 1.803 . . . . 0.0 111.002 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 186' ' ' TYR . . . . . 0.69 ' HB2' ' HG2' ' A' ' 183' ' ' PRO . 7.9 m-85 -92.83 16.64 12.01 Favored 'General case' 0 C--N 1.326 -0.431 0 O-C-N 124.498 1.124 . . . . 0.0 111.038 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 187' ' ' VAL . . . . . 0.429 ' HA ' ' HA ' ' A' ' 139' ' ' ALA . 27.4 m -141.78 170.57 12.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 O-C-N 124.535 1.147 . . . . 0.0 109.317 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . 0.565 ' OE2' ' CE1' ' A' ' 190' ' ' TYR . 0.0 OUTLIER -131.76 155.91 46.89 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.53 1.144 . . . . 0.0 110.295 -179.997 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.62 132.36 34.59 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.513 1.133 . . . . 0.0 109.21 -179.956 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 190' ' ' TYR . . . . . 0.565 ' CE1' ' OE2' ' A' ' 188' ' ' GLU . 0.1 OUTLIER -109.15 -61.46 1.62 Allowed 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.502 1.126 . . . . 0.0 110.977 179.964 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.919 0 O-C-N 124.533 1.146 . . . . 0.0 110.998 -179.962 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' CYS . . . . . . . . . . . . . 1.7 t . . . . . 0 N--CA 1.453 -0.322 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 150.68 -118.53 0.93 Allowed Glycine 0 CA--C 1.529 0.928 0 O-C-N 124.418 1.073 . . . . 0.0 110.996 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -168.97 -64.06 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.492 0.76 . . . . 0.0 109.275 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . 0.432 ' HB3' ' O ' ' A' ' 161' ' ' ILE . 2.4 mp0 -153.69 76.31 1.07 Allowed 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.455 1.097 . . . . 0.0 110.303 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 31.7 m-85 -126.11 131.93 51.98 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.434 1.084 . . . . 0.0 111.078 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.515 ' CG2' ' CG2' ' A' ' 187' ' ' VAL . 0.7 OUTLIER -132.68 127.82 56.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 O-C-N 124.516 1.135 . . . . 0.0 109.329 -179.931 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . 0.466 ' HB3' ' HG3' ' A' ' 188' ' ' GLU . 0.0 OUTLIER -96.03 134.15 39.41 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.501 1.126 . . . . 0.0 110.371 -179.988 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . 0.494 ' O ' ' N ' ' A' ' 156' ' ' GLY . . . -96.35 109.47 21.98 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.52 1.138 . . . . 0.0 109.279 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.451 ' CD1' ' HG2' ' A' ' 188' ' ' GLU . 0.2 OUTLIER -89.91 -31.79 17.13 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.483 1.115 . . . . 0.0 109.284 179.996 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . 0.505 ' O ' ' CD1' ' A' ' 153' ' ' PHE . 71.2 m-85 -88.53 152.62 21.74 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.529 1.143 . . . . 0.0 111.007 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . 0.536 ' HA ' ' O ' ' A' ' 154' ' ' LYS . 0.0 OUTLIER -105.86 141.44 37.27 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.497 1.123 . . . . 0.0 109.36 179.942 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' PHE . . . . . 0.644 ' HB3' ' CZ ' ' A' ' 153' ' ' PHE . 5.5 t80 179.73 57.31 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.502 1.126 . . . . 0.0 111.01 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . 0.459 ' HA ' ' CA ' ' A' ' 152' ' ' PRO . 15.9 p-10 -36.96 -49.03 0.8 Allowed 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.5 1.125 . . . . 0.0 109.294 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 91.03 -110.4 3.82 Favored Glycine 0 CA--C 1.53 1.023 0 O-C-N 124.515 1.135 . . . . 0.0 110.977 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 9.1 t30 177.08 51.5 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.498 0.764 . . . . 0.0 109.331 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . 0.416 ' O ' ' CB ' ' A' ' 148' ' ' GLU . 5.1 p-10 45.12 -161.07 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.469 1.106 . . . . 0.0 109.332 -179.92 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . 0.416 ' CB ' ' O ' ' A' ' 147' ' ' ASP . 0.0 OUTLIER 79.68 50.98 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.527 1.142 . . . . 0.0 110.315 -179.998 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 76.75 40.79 0.19 Allowed 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.495 1.122 . . . . 0.0 110.334 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 34.0 m-20 -154.96 115.17 3.82 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.442 1.089 . . . . 0.0 109.243 -179.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.494 ' CD2' ' HB2' ' A' ' 174' ' ' ASP . 1.3 mp -78.39 119.81 78.71 Favored Pre-proline 0 C--N 1.323 -0.553 0 O-C-N 124.595 1.184 . . . . 0.0 109.264 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . 0.459 ' CA ' ' HA ' ' A' ' 144' ' ' ASN . 18.0 Cg_endo -75.07 133.8 16.91 Favored 'Trans proline' 0 C--N 1.359 1.131 0 O-C-N 124.533 1.807 . . . . 0.0 110.986 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . 0.644 ' CZ ' ' HB3' ' A' ' 143' ' ' PHE . 28.9 p90 -134.86 179.12 6.5 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.426 1.079 . . . . 0.0 111.055 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . 0.536 ' O ' ' HA ' ' A' ' 142' ' ' ASP . 5.6 ttmt -127.25 -99.51 0.37 Allowed 'General case' 0 C--N 1.324 -0.53 0 O-C-N 124.554 1.159 . . . . 0.0 109.301 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 17.2 ttpp -156.09 118.82 4.16 Favored 'General case' 0 C--N 1.326 -0.443 0 O-C-N 124.445 1.09 . . . . 0.0 109.353 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . 0.494 ' N ' ' O ' ' A' ' 139' ' ' ALA . . . 97.46 15.06 39.04 Favored Glycine 0 CA--C 1.53 1.023 0 O-C-N 124.572 1.17 . . . . 0.0 110.948 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . 0.416 ' O ' ' HA ' ' A' ' 138' ' ' ARG . 8.9 t0 -83.83 163.28 20.22 Favored 'General case' 0 C--N 1.324 -0.523 0 O-C-N 124.479 0.752 . . . . 0.0 109.254 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . 0.411 HD13 ' C ' ' A' ' 157' ' ' ASP . 3.5 mp -119.01 148.74 21.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 O-C-N 124.473 1.108 . . . . 0.0 109.29 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.417 ' HA ' ' O ' ' A' ' 173' ' ' GLU . 0.7 OUTLIER -147.43 130.88 16.69 Favored 'General case' 0 C--N 1.326 -0.443 0 O-C-N 124.468 1.105 . . . . 0.0 109.303 -179.953 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . 0.637 ' O ' ' HA ' ' A' ' 172' ' ' ALA . 3.7 tpp180 -87.45 127.37 35.23 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.523 1.14 . . . . 0.0 110.273 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . 0.432 ' O ' ' HB3' ' A' ' 135' ' ' GLU . 1.5 mp -82.37 119.23 31.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 O-C-N 124.434 1.084 . . . . 0.0 109.305 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . 0.484 ' NH1' ' OD2' ' A' ' 163' ' ' ASP . 1.0 OUTLIER -115.25 -48.89 2.79 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.467 1.105 . . . . 0.0 110.345 179.952 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . 0.484 ' OD2' ' NH1' ' A' ' 162' ' ' ARG . 67.4 m-20 -141.54 171.34 14.2 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.485 1.116 . . . . 0.0 109.291 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . 0.59 ' HB3' ' CD1' ' A' ' 170' ' ' TRP . 14.5 mtmm -138.71 58.46 13.84 Favored Pre-proline 0 C--N 1.325 -0.486 0 O-C-N 124.521 1.138 . . . . 0.0 109.309 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . 0.541 ' HD3' ' N ' ' A' ' 164' ' ' LYS . 18.5 Cg_endo -74.99 76.41 3.4 Favored 'Trans proline' 0 C--N 1.36 1.163 0 O-C-N 124.455 1.766 . . . . 0.0 111.02 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . 0.47 ' CB ' ' O ' ' A' ' 165' ' ' PRO . 1.5 mt-10 162.77 177.24 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.547 1.155 . . . . 0.0 110.296 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -117.08 42.68 2.47 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.433 1.083 . . . . 0.0 110.277 -179.923 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER 178.29 -51.53 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.493 1.121 . . . . 0.0 110.306 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 169' ' ' TRP . . . . . . . . . . . . . 7.2 m95 -95.29 144.05 26.18 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 170' ' ' TRP . . . . . 0.59 ' CD1' ' HB3' ' A' ' 164' ' ' LYS . 48.6 m0 -120.45 149.82 41.78 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.474 1.109 . . . . 0.0 108.02 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 171' ' ' ASN . . . . . 0.408 ' HA ' ' O ' ' A' ' 180' ' ' GLY . 1.2 t-20 -86.6 98.99 11.4 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.428 1.08 . . . . 0.0 109.322 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . 0.637 ' HA ' ' O ' ' A' ' 160' ' ' ARG . . . -116.04 171.41 7.81 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.474 1.109 . . . . 0.0 109.239 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . 0.483 ' HG3' ' CG ' ' A' ' 179' ' ' ARG . 5.2 mt-10 -115.89 117.4 30.08 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.493 1.12 . . . . 0.0 110.326 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . 0.494 ' HB2' ' CD2' ' A' ' 151' ' ' LEU . 0.1 OUTLIER -68.28 -164.28 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.559 1.162 . . . . 0.0 109.355 179.969 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 88.1 p -85.09 60.03 5.99 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.444 1.09 . . . . 0.0 109.905 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -178.95 18.62 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.418 1.074 . . . . 0.0 110.286 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 63.54 14.96 56.52 Favored Glycine 0 CA--C 1.531 1.038 0 O-C-N 124.605 1.19 . . . . 0.0 110.999 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 178' ' ' LYS . . . . . 0.4 ' O ' ' HA ' ' A' ' 173' ' ' GLU . 1.5 mttt -80.51 105.59 11.87 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.495 0.762 . . . . 0.0 109.255 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 179' ' ' ARG . . . . . 0.483 ' CG ' ' HG3' ' A' ' 173' ' ' GLU . 0.0 OUTLIER -89.58 118.29 29.1 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.488 1.118 . . . . 0.0 110.243 -179.997 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . 0.411 ' HA3' ' CD1' ' A' ' 151' ' ' LEU . . . -151.55 171.09 31.09 Favored Glycine 0 CA--C 1.53 1.026 0 O-C-N 124.54 1.15 . . . . 0.0 111.004 179.938 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 181' ' ' MET . . . . . 0.45 ' CE ' ' HD2' ' A' ' 165' ' ' PRO . 0.4 OUTLIER -88.81 103.73 16.26 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.524 0.779 . . . . 0.0 110.926 -179.926 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -107.36 165.72 12.31 Favored Pre-proline 0 C--N 1.325 -0.495 0 O-C-N 124.49 1.119 . . . . 0.0 109.298 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 183' ' ' PRO . . . . . 0.599 ' HG2' ' HB2' ' A' ' 186' ' ' TYR . 18.3 Cg_endo -75.02 131.38 14.2 Favored 'Trans proline' 0 C--N 1.359 1.088 0 O-C-N 124.534 1.807 . . . . 0.0 110.984 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . 0.803 ' N ' ' CD ' ' A' ' 185' ' ' PRO . 90.5 t -79.92 -33.64 0.8 Allowed Pre-proline 0 C--N 1.326 -0.447 0 O-C-N 124.529 1.143 . . . . 0.0 109.28 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 185' ' ' PRO . . . . . 0.803 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.3 Cg_endo -74.93 -13.87 21.46 Favored 'Trans proline' 0 C--N 1.361 1.194 0 O-C-N 124.517 1.798 . . . . 0.0 111.054 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 186' ' ' TYR . . . . . 0.599 ' HB2' ' HG2' ' A' ' 183' ' ' PRO . 8.8 m-85 -95.96 4.98 52.26 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.458 1.098 . . . . 0.0 110.983 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 187' ' ' VAL . . . . . 0.515 ' CG2' ' CG2' ' A' ' 137' ' ' VAL . 25.0 m -136.18 170.25 19.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 O-C-N 124.424 1.078 . . . . 0.0 109.319 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . 0.466 ' HG3' ' HB3' ' A' ' 138' ' ' ARG . 0.0 OUTLIER -121.82 155.27 35.69 Favored 'General case' 0 C--N 1.326 -0.432 0 O-C-N 124.426 1.079 . . . . 0.0 110.26 -179.994 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.44 126.75 35.07 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.527 1.142 . . . . 0.0 109.259 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -120.66 106.94 12.21 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.455 1.097 . . . . 0.0 111.017 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 1.005 0 O-C-N 124.551 1.157 . . . . 0.0 111.015 179.962 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.453 -0.315 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 178.96 110.38 0.28 Allowed Glycine 0 CA--C 1.53 1.001 0 O-C-N 124.493 1.121 . . . . 0.0 110.98 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -175.78 -156.98 0.05 Allowed 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.513 0.772 . . . . 0.0 109.309 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . 0.441 ' O ' ' HG2' ' A' ' 160' ' ' ARG . 0.4 OUTLIER -119.1 63.06 0.79 Allowed 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.455 1.097 . . . . 0.0 110.33 179.978 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . 0.418 ' CE1' ' HG3' ' A' ' 160' ' ' ARG . 0.1 OUTLIER -127.72 113.8 16.48 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.416 1.072 . . . . 0.0 111.012 -179.973 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.462 HG23 ' CD1' ' A' ' 161' ' ' ILE . 16.0 m -108.17 137.18 40.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 O-C-N 124.539 1.149 . . . . 0.0 109.275 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . 0.412 ' O ' ' N ' ' A' ' 188' ' ' GLU . 6.4 ttm180 -101.89 128.83 48.1 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.529 1.143 . . . . 0.0 110.3 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . 0.568 ' O ' ' N ' ' A' ' 156' ' ' GLY . . . -88.52 103.69 16.12 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 124.557 1.16 . . . . 0.0 109.267 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.427 ' CD1' ' HB3' ' A' ' 188' ' ' GLU . 0.2 OUTLIER -90.41 -29.06 18.23 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.464 1.102 . . . . 0.0 109.26 179.984 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . 0.498 ' C ' ' O ' ' A' ' 154' ' ' LYS . 27.0 m-85 -92.16 151.22 20.49 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.498 1.124 . . . . 0.0 110.951 -179.907 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . 0.4 ' HA ' ' O ' ' A' ' 154' ' ' LYS . 0.0 OUTLIER -98.37 143.19 29.1 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.508 1.13 . . . . 0.0 109.322 -179.99 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' PHE . . . . . 0.629 ' HB3' ' CE1' ' A' ' 153' ' ' PHE . 0.3 OUTLIER -132.32 -33.92 1.26 Allowed 'General case' 0 C--N 1.324 -0.523 0 O-C-N 124.442 1.089 . . . . 0.0 111.002 -179.978 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . 0.401 ' O ' ' O ' ' A' ' 143' ' ' PHE . 40.0 t-20 62.15 134.83 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.452 1.095 . . . . 0.0 109.313 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . 0.438 ' N ' ' HB3' ' A' ' 152' ' ' PRO . . . -157.74 -179.54 32.71 Favored Glycine 0 CA--C 1.53 1.009 0 O-C-N 124.486 1.116 . . . . 0.0 110.97 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' ASN . . . . . 0.436 ' CB ' ' O ' ' A' ' 145' ' ' GLY . 3.9 m-20 161.37 66.31 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.439 0.729 . . . . 0.0 109.354 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -119.22 -85.76 0.65 Allowed 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.469 1.106 . . . . 0.0 109.275 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 168.36 46.36 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.537 1.148 . . . . 0.0 110.256 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 179.45 -46.21 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.511 1.132 . . . . 0.0 110.321 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -67.05 164.31 18.1 Favored 'General case' 0 C--N 1.326 -0.415 0 O-C-N 124.444 1.09 . . . . 0.0 109.316 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.543 ' HB2' ' CD1' ' A' ' 182' ' ' ILE . 0.6 OUTLIER -114.2 103.92 54.93 Favored Pre-proline 0 C--N 1.326 -0.434 0 O-C-N 124.557 1.161 . . . . 0.0 109.288 179.996 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . 0.438 ' HB3' ' N ' ' A' ' 145' ' ' GLY . 18.3 Cg_endo -74.93 132.72 15.85 Favored 'Trans proline' 0 C--N 1.36 1.163 0 O-C-N 124.497 1.788 . . . . 0.0 110.986 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . 0.629 ' CE1' ' HB3' ' A' ' 143' ' ' PHE . 20.5 p90 -149.04 174.92 11.79 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.551 1.157 . . . . 0.0 110.95 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . 0.498 ' O ' ' C ' ' A' ' 141' ' ' PHE . 1.2 ttmm -127.32 -83.73 0.61 Allowed 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.471 1.107 . . . . 0.0 109.364 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -161.46 113.52 1.81 Allowed 'General case' 0 C--N 1.326 -0.431 0 O-C-N 124.378 1.048 . . . . 0.0 109.312 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . 0.568 ' N ' ' O ' ' A' ' 139' ' ' ALA . . . 108.38 16.08 12.79 Favored Glycine 0 CA--C 1.53 1.022 0 O-C-N 124.435 1.084 . . . . 0.0 111.041 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . 0.53 ' OD2' ' CD2' ' A' ' 159' ' ' LEU . 24.6 t70 -81.27 158.06 24.93 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.55 0.794 . . . . 0.0 109.336 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . 0.467 ' C ' ' HG ' ' A' ' 159' ' ' LEU . 7.5 mm -119.35 133.21 66.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 O-C-N 124.468 1.105 . . . . 0.0 109.328 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.53 ' CD2' ' OD2' ' A' ' 157' ' ' ASP . 0.1 OUTLIER -138.07 128.71 26.61 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.48 1.113 . . . . 0.0 109.316 -179.953 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . 0.539 ' O ' ' HA ' ' A' ' 172' ' ' ALA . 1.5 ttp180 -90.1 131.18 36.1 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.426 1.079 . . . . 0.0 110.271 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . 0.462 ' CD1' HG23 ' A' ' 137' ' ' VAL . 1.3 mp -82.82 120.7 34.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 O-C-N 124.482 1.114 . . . . 0.0 109.353 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 3.5 mtp180 -114.41 -56.91 2.34 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.494 1.122 . . . . 0.0 110.245 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -123.83 161.41 25.34 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.478 1.111 . . . . 0.0 109.295 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . 0.628 ' CD ' ' CE2' ' A' ' 170' ' ' TRP . 2.6 ttpt -144.95 76.0 13.92 Favored Pre-proline 0 C--N 1.326 -0.451 0 O-C-N 124.506 1.128 . . . . 0.0 109.33 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.96 -33.07 4.91 Favored 'Trans proline' 0 C--N 1.36 1.145 0 O-C-N 124.527 1.804 . . . . 0.0 111.0 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . 0.406 ' O ' ' CD1' ' A' ' 170' ' ' TRP . 2.9 mt-10 -114.18 163.8 14.73 Favored 'General case' 0 C--N 1.324 -0.536 0 O-C-N 124.569 1.168 . . . . 0.0 110.282 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -88.64 -23.35 23.07 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.446 1.092 . . . . 0.0 110.283 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 3.9 mt-30 -87.03 -69.92 0.65 Allowed 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.499 1.125 . . . . 0.0 110.331 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 169' ' ' TRP . . . . . . . . . . . . . 5.8 m95 -94.1 141.35 28.64 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 170' ' ' TRP . . . . . 0.628 ' CE2' ' CD ' ' A' ' 164' ' ' LYS . 50.8 m0 -120.15 153.24 36.49 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.517 1.135 . . . . 0.0 107.957 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 171' ' ' ASN . . . . . 0.401 ' HA ' ' O ' ' A' ' 180' ' ' GLY . 1.3 t-20 -86.67 92.63 8.99 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.503 1.127 . . . . 0.0 109.334 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . 0.539 ' HA ' ' O ' ' A' ' 160' ' ' ARG . . . -109.21 176.66 5.01 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.507 1.129 . . . . 0.0 109.317 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -123.06 123.4 40.77 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.496 1.122 . . . . 0.0 110.331 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . 0.513 ' OD2' ' CD2' ' A' ' 151' ' ' LEU . 1.4 p30 -73.79 -171.46 1.07 Allowed 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.475 1.109 . . . . 0.0 109.369 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -83.21 64.48 7.74 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.458 1.099 . . . . 0.0 110.063 179.958 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -176.22 8.25 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.559 1.162 . . . . 0.0 110.279 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 69.03 29.26 72.41 Favored Glycine 0 CA--C 1.53 0.985 0 O-C-N 124.453 1.095 . . . . 0.0 111.03 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 8.4 mtpt -103.86 115.27 30.15 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.518 0.775 . . . . 0.0 109.346 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 179' ' ' ARG . . . . . 0.448 ' HA ' ' O ' ' A' ' 172' ' ' ALA . 8.9 ttp180 -88.95 128.03 35.68 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.5 1.125 . . . . 0.0 110.316 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . 0.471 ' CA ' ' CD1' ' A' ' 151' ' ' LEU . . . -151.71 170.34 31.18 Favored Glycine 0 CA--C 1.53 1.025 0 O-C-N 124.527 1.142 . . . . 0.0 110.991 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 181' ' ' MET . . . . . 0.425 ' HA ' ' O ' ' A' ' 170' ' ' TRP . 0.2 OUTLIER -92.13 99.47 12.27 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.49 0.759 . . . . 0.0 111.039 179.987 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . 0.658 ' CG1' ' HD2' ' A' ' 183' ' ' PRO . 0.6 OUTLIER -103.78 151.64 38.85 Favored Pre-proline 0 C--N 1.324 -0.504 0 O-C-N 124.482 1.114 . . . . 0.0 109.311 -179.976 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 183' ' ' PRO . . . . . 0.658 ' HD2' ' CG1' ' A' ' 182' ' ' ILE . 18.4 Cg_endo -74.99 134.19 17.53 Favored 'Trans proline' 0 C--N 1.359 1.109 0 O-C-N 124.441 1.759 . . . . 0.0 110.979 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . 0.858 ' N ' ' CD ' ' A' ' 185' ' ' PRO . 21.6 t -75.8 -29.14 0.79 Allowed Pre-proline 0 C--N 1.326 -0.441 0 O-C-N 124.398 1.061 . . . . 0.0 109.286 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 185' ' ' PRO . . . . . 0.858 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.5 Cg_endo -74.87 -13.68 21.65 Favored 'Trans proline' 0 C--N 1.36 1.146 0 O-C-N 124.477 1.777 . . . . 0.0 111.037 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 186' ' ' TYR . . . . . 0.634 ' HB2' ' HG2' ' A' ' 183' ' ' PRO . 8.2 m-85 -98.54 4.56 48.21 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.476 1.11 . . . . 0.0 111.009 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 19.2 m -137.05 171.09 16.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 O-C-N 124.547 1.154 . . . . 0.0 109.312 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . 0.427 ' HB3' ' CD1' ' A' ' 140' ' ' LEU . 1.5 pp20? -125.89 176.76 6.74 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.458 1.099 . . . . 0.0 110.259 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -93.44 112.39 24.28 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.522 1.139 . . . . 0.0 109.335 179.958 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 190' ' ' TYR . . . . . 0.45 ' CD1' ' C ' ' A' ' 190' ' ' TYR . 0.8 OUTLIER -48.22 -77.96 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.53 1.144 . . . . 0.0 111.027 -179.99 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.993 0 O-C-N 124.472 1.108 . . . . 0.0 110.997 -179.963 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' CYS . . . . . 0.453 ' O ' ' O ' ' A' ' 191' ' ' GLY . 7.6 m . . . . . 0 N--CA 1.452 -0.364 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -138.32 71.87 0.45 Allowed Glycine 0 CA--C 1.53 0.993 0 O-C-N 124.466 1.104 . . . . 0.0 110.964 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . 0.458 ' HB2' ' CE2' ' A' ' 136' ' ' TYR . . . -115.93 -74.72 0.6 Allowed 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.415 0.715 . . . . 0.0 109.33 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . 0.46 ' CB ' HG22 ' A' ' 161' ' ' ILE . 5.1 pt-20 169.76 61.37 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.502 1.126 . . . . 0.0 110.262 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . 0.458 ' CE2' ' HB2' ' A' ' 134' ' ' ALA . 95.6 m-85 -123.81 118.9 28.19 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.487 1.117 . . . . 0.0 110.99 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.464 HG23 ' CG2' ' A' ' 187' ' ' VAL . 0.9 OUTLIER -121.83 123.04 68.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 O-C-N 124.543 1.152 . . . . 0.0 109.275 -179.969 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . 0.52 ' O ' ' N ' ' A' ' 188' ' ' GLU . 12.1 ttm180 -87.45 150.29 23.87 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.489 1.118 . . . . 0.0 110.299 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . 0.463 ' N ' ' HG3' ' A' ' 138' ' ' ARG . . . -113.75 108.48 17.16 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.499 1.125 . . . . 0.0 109.317 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.498 ' O ' ' CB ' ' A' ' 155' ' ' LYS . 0.0 OUTLIER -93.5 -7.56 43.98 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.607 1.192 . . . . 0.0 109.262 -179.991 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 59.9 m-85 -113.78 164.11 14.16 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.554 1.159 . . . . 0.0 110.955 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . 0.462 ' N ' ' OD1' ' A' ' 142' ' ' ASP . 0.0 OUTLIER -115.01 148.46 38.8 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.493 1.121 . . . . 0.0 109.299 179.942 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' PHE . . . . . 0.596 ' HB3' ' CZ ' ' A' ' 153' ' ' PHE . 16.1 t80 -167.86 30.32 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.51 1.131 . . . . 0.0 111.024 -179.955 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 14.8 p-10 -58.07 119.64 7.16 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.391 1.057 . . . . 0.0 109.351 180.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 101.18 99.0 2.35 Favored Glycine 0 CA--C 1.53 0.994 0 O-C-N 124.473 1.108 . . . . 0.0 111.038 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' ASN . . . . . 0.536 ' CG ' ' CE2' ' A' ' 143' ' ' PHE . 11.4 m-20 -146.16 -49.18 0.21 Allowed 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.479 0.752 . . . . 0.0 109.267 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 28.0 m-20 -165.09 164.72 20.32 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.588 1.18 . . . . 0.0 109.325 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -65.85 -20.12 66.13 Favored 'General case' 0 C--N 1.323 -0.557 0 O-C-N 124.571 1.169 . . . . 0.0 110.312 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -96.36 -32.19 12.49 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.462 1.101 . . . . 0.0 110.263 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . 0.465 ' CB ' ' HB2' ' A' ' 146' ' ' ASN . 0.2 OUTLIER -61.3 167.46 3.19 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.527 1.142 . . . . 0.0 109.272 179.952 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.506 ' CD2' ' OD1' ' A' ' 174' ' ' ASP . 1.2 tp -120.44 119.21 30.61 Favored Pre-proline 0 C--N 1.325 -0.474 0 O-C-N 124.535 1.147 . . . . 0.0 109.361 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -74.98 137.36 21.66 Favored 'Trans proline' 0 C--N 1.359 1.131 0 O-C-N 124.509 1.794 . . . . 0.0 110.959 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . 0.596 ' CZ ' ' HB3' ' A' ' 143' ' ' PHE . 21.8 p90 -150.41 173.75 13.68 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.49 1.119 . . . . 0.0 111.028 179.899 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . 0.411 ' HA ' ' HA ' ' A' ' 142' ' ' ASP . 1.6 tttm -132.09 -169.36 2.2 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.549 1.155 . . . . 0.0 109.319 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.498 ' CB ' ' O ' ' A' ' 140' ' ' LEU . 9.6 ptpt -89.31 111.17 21.94 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.517 1.136 . . . . 0.0 109.301 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 117.3 8.24 11.58 Favored Glycine 0 CA--C 1.529 0.96 0 O-C-N 124.486 1.116 . . . . 0.0 111.05 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . 0.432 ' CG ' ' N ' ' A' ' 158' ' ' ILE . 14.5 t0 -91.12 172.63 8.42 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.512 0.772 . . . . 0.0 109.277 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . 0.433 ' C ' ' HG ' ' A' ' 159' ' ' LEU . 3.2 mt -140.27 142.55 31.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 O-C-N 124.547 1.154 . . . . 0.0 109.332 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.464 ' CD2' ' OD1' ' A' ' 174' ' ' ASP . 0.1 OUTLIER -136.93 141.23 42.67 Favored 'General case' 0 C--N 1.324 -0.533 0 O-C-N 124.555 1.159 . . . . 0.0 109.328 179.997 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . 0.437 ' O ' ' HB2' ' A' ' 172' ' ' ALA . 15.2 ttm105 -87.86 134.91 33.6 Favored 'General case' 0 C--N 1.326 -0.437 0 O-C-N 124.581 1.176 . . . . 0.0 110.333 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . 0.46 HG22 ' CB ' ' A' ' 135' ' ' GLU . 1.0 OUTLIER -83.53 109.81 17.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 O-C-N 124.536 1.148 . . . . 0.0 109.321 179.969 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . 0.452 ' HG3' ' CG ' ' A' ' 179' ' ' ARG . 20.8 mmm180 -90.68 -59.34 2.2 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.546 1.154 . . . . 0.0 110.303 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . 0.515 ' N ' ' OD1' ' A' ' 171' ' ' ASN . 0.7 OUTLIER -151.34 144.53 24.69 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.481 1.113 . . . . 0.0 109.32 179.963 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . 0.598 ' CB ' ' CG ' ' A' ' 170' ' ' TRP . 0.6 OUTLIER -128.02 78.38 75.36 Favored Pre-proline 0 C--N 1.325 -0.475 0 O-C-N 124.494 1.121 . . . . 0.0 109.307 -179.942 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.03 -48.08 0.18 Allowed 'Trans proline' 0 C--N 1.359 1.116 0 O-C-N 124.51 1.795 . . . . 0.0 110.914 -179.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 13.7 mp0 -69.68 176.23 3.7 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.402 1.064 . . . . 0.0 110.322 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -115.24 51.44 0.92 Allowed 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.547 1.154 . . . . 0.0 110.29 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . 0.476 ' HB3' ' CD1' ' A' ' 169' ' ' TRP . 3.3 mt-30 -179.25 -55.58 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.582 1.176 . . . . 0.0 110.278 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 169' ' ' TRP . . . . . 0.476 ' CD1' ' HB3' ' A' ' 168' ' ' GLN . 12.2 m95 -108.91 133.05 53.44 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.491 1.12 . . . . 0.0 107.995 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 170' ' ' TRP . . . . . 0.605 ' CE3' HG21 ' A' ' 184' ' ' VAL . 26.6 m0 -120.8 154.66 35.43 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 171' ' ' ASN . . . . . 0.515 ' OD1' ' N ' ' A' ' 163' ' ' ASP . 6.0 p30 -87.16 108.9 19.11 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.46 1.1 . . . . 0.0 109.265 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . 0.494 ' O ' ' HA ' ' A' ' 179' ' ' ARG . . . -117.35 174.63 6.02 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.511 1.132 . . . . 0.0 109.331 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -116.34 116.69 28.19 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.406 1.066 . . . . 0.0 110.278 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . 0.506 ' OD1' ' CD2' ' A' ' 151' ' ' LEU . 0.4 OUTLIER -74.43 -176.88 2.86 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.56 1.163 . . . . 0.0 109.316 -179.993 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 37.6 t -76.01 61.91 1.58 Allowed 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.53 1.144 . . . . 0.0 109.969 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -173.79 8.11 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.415 1.072 . . . . 0.0 110.319 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 67.88 20.91 72.94 Favored Glycine 0 CA--C 1.53 1.014 0 O-C-N 124.58 1.175 . . . . 0.0 110.998 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.06 115.63 27.68 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.481 0.754 . . . . 0.0 109.329 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 179' ' ' ARG . . . . . 0.494 ' HA ' ' O ' ' A' ' 172' ' ' ALA . 0.1 OUTLIER -90.13 122.53 33.17 Favored 'General case' 0 C--N 1.326 -0.442 0 O-C-N 124.459 1.099 . . . . 0.0 110.286 -179.958 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . 0.476 ' O ' ' HA ' ' A' ' 171' ' ' ASN . . . -151.34 165.9 30.5 Favored Glycine 0 CA--C 1.53 0.971 0 O-C-N 124.487 1.117 . . . . 0.0 111.001 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 181' ' ' MET . . . . . 0.419 ' HA ' ' O ' ' A' ' 170' ' ' TRP . 0.4 OUTLIER -84.5 103.7 13.86 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.503 0.766 . . . . 0.0 111.035 179.943 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . 0.451 ' HB ' ' HD2' ' A' ' 183' ' ' PRO . 2.2 pp -106.93 161.11 23.94 Favored Pre-proline 0 C--N 1.325 -0.493 0 O-C-N 124.498 1.124 . . . . 0.0 109.267 -179.952 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 183' ' ' PRO . . . . . 0.642 ' HG2' ' HB2' ' A' ' 186' ' ' TYR . 18.4 Cg_endo -74.98 135.37 19.02 Favored 'Trans proline' 0 C--N 1.361 1.214 0 O-C-N 124.505 1.792 . . . . 0.0 110.989 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . 0.843 ' N ' ' CD ' ' A' ' 185' ' ' PRO . 58.0 t -80.1 -30.28 0.6 Allowed Pre-proline 0 C--N 1.326 -0.427 0 O-C-N 124.467 1.105 . . . . 0.0 109.28 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 185' ' ' PRO . . . . . 0.843 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.2 Cg_endo -75.05 -15.53 20.58 Favored 'Trans proline' 0 C--N 1.36 1.154 0 O-C-N 124.482 1.78 . . . . 0.0 110.973 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 186' ' ' TYR . . . . . 0.642 ' HB2' ' HG2' ' A' ' 183' ' ' PRO . 4.5 m-85 -94.95 5.91 50.58 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.492 1.12 . . . . 0.0 111.056 179.923 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 187' ' ' VAL . . . . . 0.483 ' HA ' ' O ' ' A' ' 138' ' ' ARG . 35.4 m -136.94 164.48 30.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 O-C-N 124.475 1.11 . . . . 0.0 109.314 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . 0.52 ' N ' ' O ' ' A' ' 138' ' ' ARG . 0.0 OUTLIER -120.49 165.75 14.54 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.487 1.117 . . . . 0.0 110.262 -180.0 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . 0.442 ' CD ' ' H ' ' A' ' 189' ' ' LYS . 0.0 OUTLIER -89.33 126.54 35.57 Favored 'General case' 0 C--N 1.326 -0.439 0 O-C-N 124.455 1.097 . . . . 0.0 109.366 179.969 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 190' ' ' TYR . . . . . 0.436 ' CD1' ' OE1' ' A' ' 188' ' ' GLU . 0.1 OUTLIER -120.38 179.49 4.29 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.528 1.143 . . . . 0.0 110.98 -179.968 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . 0.453 ' O ' ' O ' ' A' ' 132' ' ' CYS . . . . . . . . 0 CA--C 1.531 1.038 0 O-C-N 124.494 1.121 . . . . 0.0 110.994 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' CYS . . . . . 0.418 ' O ' ' C ' ' A' ' 133' ' ' GLY . 28.5 p . . . . . 0 N--CA 1.452 -0.338 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . 0.418 ' C ' ' O ' ' A' ' 132' ' ' CYS . . . 35.2 86.05 0.01 OUTLIER Glycine 0 CA--C 1.53 0.983 0 O-C-N 124.471 1.107 . . . . 0.0 111.019 -179.941 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -175.17 -149.8 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.468 0.746 . . . . 0.0 109.354 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -137.43 70.56 1.4 Allowed 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.454 1.097 . . . . 0.0 110.321 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . 0.528 ' CE2' ' HD2' ' A' ' 160' ' ' ARG . 36.6 m-85 -126.62 130.88 51.33 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.547 1.154 . . . . 0.0 110.982 -179.969 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.544 ' CG2' ' O ' ' A' ' 188' ' ' GLU . 2.9 p -125.75 155.83 35.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 O-C-N 124.491 1.119 . . . . 0.0 109.273 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . 0.457 ' HB3' ' HG3' ' A' ' 188' ' ' GLU . 0.0 OUTLIER -126.08 133.03 51.8 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.501 1.125 . . . . 0.0 110.338 179.98 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . 0.409 ' N ' ' HG3' ' A' ' 138' ' ' ARG . . . -97.06 110.64 23.14 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.514 1.134 . . . . 0.0 109.316 -179.965 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.475 ' CD1' ' HG2' ' A' ' 188' ' ' GLU . 0.2 OUTLIER -95.33 -22.39 17.78 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.555 1.159 . . . . 0.0 109.344 179.948 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . 0.476 ' C ' ' O ' ' A' ' 154' ' ' LYS . 12.1 m-85 -94.62 150.31 20.36 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.474 1.109 . . . . 0.0 111.031 179.939 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . 0.441 ' HA ' ' O ' ' A' ' 154' ' ' LYS . 0.1 OUTLIER -103.48 145.8 29.47 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.538 1.149 . . . . 0.0 109.322 -179.969 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' PHE . . . . . 0.618 ' HB3' ' CE1' ' A' ' 153' ' ' PHE . 54.9 t80 -151.85 -43.94 0.11 Allowed 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.51 1.131 . . . . 0.0 111.008 -179.949 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . 0.423 ' O ' ' O ' ' A' ' 143' ' ' PHE . 8.3 t-20 51.4 100.44 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.411 0 O-C-N 124.435 1.085 . . . . 0.0 109.352 -179.93 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -174.01 108.07 0.26 Allowed Glycine 0 CA--C 1.529 0.926 0 O-C-N 124.479 1.112 . . . . 0.0 111.024 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' ASN . . . . . 0.499 ' O ' ' N ' ' A' ' 148' ' ' GLU . 1.2 p30 -104.52 -50.81 3.22 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.459 0.741 . . . . 0.0 109.343 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 66.64 -66.26 0.18 Allowed 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.575 1.172 . . . . 0.0 109.309 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . 0.499 ' N ' ' O ' ' A' ' 146' ' ' ASN . 0.1 OUTLIER 169.91 40.51 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.454 1.097 . . . . 0.0 110.277 179.994 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 172.71 -33.29 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.561 1.163 . . . . 0.0 110.289 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -74.49 171.75 13.22 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.484 1.115 . . . . 0.0 109.328 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.489 ' CB ' ' CG2' ' A' ' 182' ' ' ILE . 1.4 tp -125.66 119.04 24.39 Favored Pre-proline 0 C--N 1.325 -0.493 0 O-C-N 124.577 1.173 . . . . 0.0 109.347 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -74.97 142.96 28.6 Favored 'Trans proline' 0 C--N 1.361 1.208 0 O-C-N 124.434 1.755 . . . . 0.0 111.004 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . 0.618 ' CE1' ' HB3' ' A' ' 143' ' ' PHE . 14.9 p90 -151.64 173.12 15.05 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.42 1.075 . . . . 0.0 111.006 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . 0.476 ' O ' ' C ' ' A' ' 141' ' ' PHE . 0.0 OUTLIER -125.86 -84.99 0.63 Allowed 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.488 1.118 . . . . 0.0 109.233 -179.984 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -165.58 113.14 0.96 Allowed 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.501 1.126 . . . . 0.0 109.252 -179.949 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 108.84 14.07 16.47 Favored Glycine 0 CA--C 1.53 1.003 0 O-C-N 124.391 1.057 . . . . 0.0 111.016 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . 0.441 ' OD1' ' N ' ' A' ' 158' ' ' ILE . 6.9 t0 -82.72 158.26 22.96 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.532 0.783 . . . . 0.0 109.27 -179.974 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . 0.441 ' N ' ' OD1' ' A' ' 157' ' ' ASP . 3.9 mp -119.79 141.19 41.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 O-C-N 124.571 1.169 . . . . 0.0 109.266 -179.945 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.523 ' HB2' ' CG1' ' A' ' 137' ' ' VAL . 2.9 mp -142.04 126.79 18.07 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.42 1.075 . . . . 0.0 109.345 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . 0.635 ' O ' ' HA ' ' A' ' 172' ' ' ALA . 0.0 OUTLIER -88.26 132.87 34.21 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.545 1.153 . . . . 0.0 110.328 179.997 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 14.3 mm -82.15 117.14 27.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 O-C-N 124.42 1.075 . . . . 0.0 109.312 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . 0.469 ' HG3' ' N ' ' A' ' 163' ' ' ASP . 0.8 OUTLIER -118.22 -32.58 4.65 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.537 1.148 . . . . 0.0 110.368 179.943 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . 0.469 ' N ' ' HG3' ' A' ' 162' ' ' ARG . 0.9 OUTLIER -146.35 155.25 42.48 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.486 1.116 . . . . 0.0 109.338 179.949 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . 0.576 ' HB3' ' CD1' ' A' ' 170' ' ' TRP . 1.4 mtmp? -148.25 71.93 11.01 Favored Pre-proline 0 C--N 1.324 -0.519 0 O-C-N 124.522 1.139 . . . . 0.0 109.234 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.96 -29.06 8.7 Favored 'Trans proline' 0 C--N 1.359 1.105 0 O-C-N 124.539 1.81 . . . . 0.0 110.999 179.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . 0.517 ' O ' ' CD1' ' A' ' 170' ' ' TRP . 3.0 mm-40 -105.26 166.02 10.7 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.446 1.091 . . . . 0.0 110.296 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 13.3 mt-10 -96.38 -27.82 14.75 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.463 1.102 . . . . 0.0 110.309 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 11.4 tt0 -82.35 -58.68 2.83 Favored 'General case' 0 C--N 1.324 -0.536 0 O-C-N 124.533 1.146 . . . . 0.0 110.284 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 169' ' ' TRP . . . . . 0.58 ' CZ3' ' HD3' ' A' ' 183' ' ' PRO . 9.9 m0 -109.7 163.26 13.66 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.501 1.126 . . . . 0.0 107.968 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 170' ' ' TRP . . . . . 0.587 ' CZ3' ' CG1' ' A' ' 184' ' ' VAL . 30.9 m0 -139.57 157.11 46.36 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.525 1.141 . . . . 0.0 107.951 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 4.6 t30 -88.55 107.6 18.98 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.472 1.107 . . . . 0.0 109.291 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . 0.635 ' HA ' ' O ' ' A' ' 160' ' ' ARG . . . -121.78 178.45 4.85 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.454 1.096 . . . . 0.0 109.312 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . 0.471 ' CG ' ' HG3' ' A' ' 179' ' ' ARG . 17.9 mt-10 -116.49 115.95 26.74 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.548 1.155 . . . . 0.0 110.201 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -64.51 -164.91 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.498 1.124 . . . . 0.0 109.239 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -88.36 60.0 5.48 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.439 1.087 . . . . 0.0 110.016 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 174.16 22.58 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.455 1.097 . . . . 0.0 110.362 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 67.75 15.52 66.77 Favored Glycine 0 CA--C 1.531 1.035 0 O-C-N 124.464 1.102 . . . . 0.0 111.023 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 8.0 mttt -70.9 101.77 2.23 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.505 0.768 . . . . 0.0 109.325 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 179' ' ' ARG . . . . . 0.471 ' HG3' ' CG ' ' A' ' 173' ' ' GLU . 11.3 mtt85 -87.68 105.76 17.58 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.494 1.121 . . . . 0.0 110.255 -179.914 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -151.87 169.45 31.26 Favored Glycine 0 CA--C 1.53 0.983 0 O-C-N 124.507 1.129 . . . . 0.0 111.033 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 181' ' ' MET . . . . . 0.414 ' HA ' ' O ' ' A' ' 170' ' ' TRP . 4.9 mmm -87.68 116.89 26.13 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.52 0.776 . . . . 0.0 111.064 179.904 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . 0.489 ' CG2' ' CB ' ' A' ' 151' ' ' LEU . 1.0 OUTLIER -112.91 161.85 24.62 Favored Pre-proline 0 C--N 1.325 -0.484 0 O-C-N 124.504 1.127 . . . . 0.0 109.252 -179.967 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 183' ' ' PRO . . . . . 0.737 ' HG2' ' HB2' ' A' ' 186' ' ' TYR . 18.2 Cg_endo -75.0 134.05 17.35 Favored 'Trans proline' 0 C--N 1.36 1.151 0 O-C-N 124.502 1.79 . . . . 0.0 110.979 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . 0.834 ' N ' ' CD ' ' A' ' 185' ' ' PRO . 38.7 t -79.96 -31.1 0.64 Allowed Pre-proline 0 C--N 1.325 -0.467 0 O-C-N 124.429 1.081 . . . . 0.0 109.275 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 185' ' ' PRO . . . . . 0.834 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.5 Cg_endo -74.99 -25.26 12.06 Favored 'Trans proline' 0 C--N 1.36 1.135 0 O-C-N 124.504 1.792 . . . . 0.0 111.059 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 186' ' ' TYR . . . . . 0.737 ' HB2' ' HG2' ' A' ' 183' ' ' PRO . 3.5 m-85 -93.82 22.84 5.23 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.522 1.139 . . . . 0.0 110.988 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 187' ' ' VAL . . . . . 0.473 ' CG2' HG23 ' A' ' 137' ' ' VAL . 26.2 m -146.53 169.52 5.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 O-C-N 124.475 1.109 . . . . 0.0 109.369 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . 0.544 ' O ' ' CG2' ' A' ' 137' ' ' VAL . 0.0 OUTLIER -126.82 160.47 30.81 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.543 1.152 . . . . 0.0 110.255 -179.976 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 24.6 mmmt -85.04 127.19 34.11 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.573 1.171 . . . . 0.0 109.259 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 190' ' ' TYR . . . . . 0.498 ' O ' ' O ' ' A' ' 191' ' ' GLY . 0.1 OUTLIER -109.47 142.94 39.77 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.516 1.135 . . . . 0.0 111.012 179.945 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . 0.498 ' O ' ' O ' ' A' ' 190' ' ' TYR . . . . . . . . 0 CA--C 1.531 1.037 0 O-C-N 124.483 1.114 . . . . 0.0 110.929 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.453 -0.317 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 108.1 -74.05 0.21 Allowed Glycine 0 CA--C 1.531 1.052 0 O-C-N 124.509 1.131 . . . . 0.0 110.98 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -91.21 -166.98 1.69 Allowed 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.556 0.797 . . . . 0.0 109.31 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . 0.51 ' O ' ' HG2' ' A' ' 160' ' ' ARG . 0.7 OUTLIER -118.11 61.13 0.77 Allowed 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.554 1.159 . . . . 0.0 110.282 179.955 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -112.03 128.71 56.26 Favored 'General case' 0 C--N 1.324 -0.522 0 O-C-N 124.531 1.145 . . . . 0.0 111.037 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.478 ' CG2' ' O ' ' A' ' 188' ' ' GLU . 0.4 OUTLIER -119.35 174.98 4.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 O-C-N 124.471 1.107 . . . . 0.0 109.332 179.988 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . 0.549 ' O ' ' HA ' ' A' ' 187' ' ' VAL . 14.0 ttm180 -144.69 146.73 32.36 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.535 1.147 . . . . 0.0 110.289 -179.958 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . 0.438 ' N ' ' HG3' ' A' ' 138' ' ' ARG . . . -107.72 109.83 21.52 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.456 1.098 . . . . 0.0 109.306 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.482 ' CD1' ' HG2' ' A' ' 188' ' ' GLU . 1.0 OUTLIER -88.86 -7.15 56.66 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.52 1.138 . . . . 0.0 109.361 179.977 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 18.6 m-85 -120.67 158.24 27.86 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.576 1.173 . . . . 0.0 110.966 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . 0.487 ' HB3' ' HG2' ' A' ' 154' ' ' LYS . 2.0 p-10 -108.27 147.07 31.96 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.492 1.12 . . . . 0.0 109.339 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' PHE . . . . . 0.624 ' HB3' ' CE1' ' A' ' 153' ' ' PHE . 31.6 t80 -179.22 69.53 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.546 1.154 . . . . 0.0 110.986 179.958 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . 0.445 ' CG ' ' HB3' ' A' ' 152' ' ' PRO . 14.2 t-20 -38.64 145.08 0.09 Allowed 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.488 1.118 . . . . 0.0 109.266 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -58.63 99.87 0.14 Allowed Glycine 0 CA--C 1.529 0.964 0 O-C-N 124.49 1.119 . . . . 0.0 111.025 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 13.3 t-20 -83.93 -47.28 11.19 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.444 0.732 . . . . 0.0 109.331 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -70.13 168.96 14.51 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.574 1.171 . . . . 0.0 109.325 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -92.65 47.99 1.34 Allowed 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.51 1.131 . . . . 0.0 110.326 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -178.39 55.68 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.512 1.133 . . . . 0.0 110.276 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 29.7 p30 -163.14 165.29 24.73 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.501 1.125 . . . . 0.0 109.315 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.474 ' HG ' ' CG2' ' A' ' 182' ' ' ILE . 2.1 pp -113.05 140.0 23.66 Favored Pre-proline 0 C--N 1.325 -0.465 0 O-C-N 124.509 1.131 . . . . 0.0 109.3 -179.993 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . 0.445 ' HB3' ' CG ' ' A' ' 144' ' ' ASN . 18.3 Cg_endo -74.97 134.68 18.16 Favored 'Trans proline' 0 C--N 1.36 1.161 0 O-C-N 124.518 1.799 . . . . 0.0 111.022 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . 0.624 ' CE1' ' HB3' ' A' ' 143' ' ' PHE . 13.4 p90 -145.49 169.61 18.02 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.53 1.143 . . . . 0.0 111.064 179.912 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . 0.487 ' HG2' ' HB3' ' A' ' 142' ' ' ASP . 1.0 OUTLIER -127.98 -158.86 0.9 Allowed 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.434 1.084 . . . . 0.0 109.255 -179.937 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.43 108.31 20.98 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.466 1.104 . . . . 0.0 109.29 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 114.51 17.9 6.85 Favored Glycine 0 CA--C 1.53 0.974 0 O-C-N 124.433 1.083 . . . . 0.0 111.041 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . 0.446 ' C ' ' CD1' ' A' ' 158' ' ' ILE . 8.9 t70 -87.5 168.68 12.87 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.488 0.758 . . . . 0.0 109.366 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . 0.485 ' N ' HD13 ' A' ' 158' ' ' ILE . 2.3 mp -128.56 143.98 39.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 O-C-N 124.559 1.162 . . . . 0.0 109.31 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.465 HD21 ' N ' ' A' ' 174' ' ' ASP . 0.3 OUTLIER -149.27 128.47 12.84 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.467 1.104 . . . . 0.0 109.29 -179.913 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . 0.526 ' O ' ' HA ' ' A' ' 172' ' ' ALA . 0.0 OUTLIER -84.57 138.32 32.81 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.515 1.134 . . . . 0.0 110.26 -179.994 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . 0.463 ' HB ' ' HB2' ' A' ' 135' ' ' GLU . 43.9 mm -84.77 112.65 22.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 O-C-N 124.482 1.114 . . . . 0.0 109.306 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.45 -56.0 2.4 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.424 1.077 . . . . 0.0 110.309 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -134.88 167.01 21.69 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.464 1.103 . . . . 0.0 109.282 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . 0.584 ' HB3' ' CD1' ' A' ' 170' ' ' TRP . 23.3 mtmt -144.44 83.13 10.06 Favored Pre-proline 0 C--N 1.325 -0.492 0 O-C-N 124.531 1.144 . . . . 0.0 109.296 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.03 -27.48 9.93 Favored 'Trans proline' 0 C--N 1.36 1.152 0 O-C-N 124.523 1.802 . . . . 0.0 110.99 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . 0.492 ' O ' ' CD1' ' A' ' 170' ' ' TRP . 2.7 mt-10 -121.03 172.75 7.72 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.501 1.126 . . . . 0.0 110.284 -179.941 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -95.56 -29.8 14.16 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.516 1.135 . . . . 0.0 110.319 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . 0.403 ' O ' ' CG2' ' A' ' 184' ' ' VAL . 6.8 tt0 -79.11 -60.19 2.47 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.473 1.108 . . . . 0.0 110.287 -179.954 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 169' ' ' TRP . . . . . 0.42 ' O ' ' CD1' ' A' ' 170' ' ' TRP . 11.2 m0 -104.96 157.74 17.01 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 170' ' ' TRP . . . . . 0.64 ' CZ3' HG12 ' A' ' 184' ' ' VAL . 39.9 m0 -136.13 155.61 49.92 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.467 1.104 . . . . 0.0 108.055 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 171' ' ' ASN . . . . . 0.405 ' HA ' ' O ' ' A' ' 180' ' ' GLY . 42.1 t-20 -88.37 99.2 12.08 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.525 1.141 . . . . 0.0 109.266 -179.947 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . 0.526 ' HA ' ' O ' ' A' ' 160' ' ' ARG . . . -109.41 174.77 5.72 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.514 1.134 . . . . 0.0 109.342 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . 0.403 ' OE2' ' HD3' ' A' ' 179' ' ' ARG . 8.0 mt-10 -119.39 117.19 27.84 Favored 'General case' 0 C--N 1.326 -0.437 0 O-C-N 124.475 1.109 . . . . 0.0 110.315 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . 0.465 ' N ' HD21 ' A' ' 159' ' ' LEU . 3.7 m-20 -67.2 -176.39 0.55 Allowed 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.471 1.107 . . . . 0.0 109.273 -179.952 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 73.4 p -79.24 60.17 3.0 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.528 1.142 . . . . 0.0 110.002 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -176.54 7.56 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.428 0 O-C-N 124.485 1.116 . . . . 0.0 110.292 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 75.66 18.23 79.81 Favored Glycine 0 CA--C 1.529 0.959 0 O-C-N 124.495 1.122 . . . . 0.0 110.985 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 14.1 mtmm -83.92 106.25 15.44 Favored 'General case' 0 C--N 1.326 -0.435 0 O-C-N 124.41 0.712 . . . . 0.0 109.277 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 179' ' ' ARG . . . . . 0.403 ' HD3' ' OE2' ' A' ' 173' ' ' GLU . 4.1 ttp180 -88.51 118.04 27.88 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.444 1.09 . . . . 0.0 110.265 -179.936 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . 0.405 ' O ' ' HA ' ' A' ' 171' ' ' ASN . . . -151.57 166.86 30.83 Favored Glycine 0 CA--C 1.53 1.002 0 O-C-N 124.501 1.126 . . . . 0.0 110.979 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 181' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -87.61 114.43 24.22 Favored 'General case' 0 C--N 1.324 -0.528 0 O-C-N 124.497 0.763 . . . . 0.0 110.939 -179.957 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . 0.474 ' CG2' ' HG ' ' A' ' 151' ' ' LEU . 2.1 pt -116.02 163.44 21.35 Favored Pre-proline 0 C--N 1.325 -0.487 0 O-C-N 124.492 1.12 . . . . 0.0 109.256 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 183' ' ' PRO . . . . . 0.774 ' HG2' ' HB2' ' A' ' 186' ' ' TYR . 18.0 Cg_endo -75.02 135.63 19.3 Favored 'Trans proline' 0 C--N 1.361 1.199 0 O-C-N 124.52 1.8 . . . . 0.0 110.946 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . 0.82 ' N ' ' CD ' ' A' ' 185' ' ' PRO . 50.6 t -80.17 -31.98 0.68 Allowed Pre-proline 0 C--N 1.325 -0.469 0 O-C-N 124.486 1.117 . . . . 0.0 109.299 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 185' ' ' PRO . . . . . 0.82 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.3 Cg_endo -75.0 -23.09 14.13 Favored 'Trans proline' 0 C--N 1.361 1.214 0 O-C-N 124.541 1.811 . . . . 0.0 110.985 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 186' ' ' TYR . . . . . 0.774 ' HB2' ' HG2' ' A' ' 183' ' ' PRO . 3.8 m-85 -93.66 16.02 14.86 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.503 1.127 . . . . 0.0 111.037 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 187' ' ' VAL . . . . . 0.549 ' HA ' ' O ' ' A' ' 138' ' ' ARG . 6.0 m -145.49 165.58 10.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 O-C-N 124.449 1.093 . . . . 0.0 109.305 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . 0.485 ' N ' ' O ' ' A' ' 138' ' ' ARG . 0.0 OUTLIER -130.16 166.05 21.05 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.47 1.106 . . . . 0.0 110.371 -179.971 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.65 121.85 32.92 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.462 1.101 . . . . 0.0 109.369 179.911 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -42.18 -50.94 4.8 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.543 1.152 . . . . 0.0 110.991 -179.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.962 0 O-C-N 124.456 1.097 . . . . 0.0 111.009 -179.987 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' CYS . . . . . . . . . . . . . 18.0 p . . . . . 0 N--CA 1.453 -0.319 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -163.32 -126.5 0.82 Allowed Glycine 0 CA--C 1.529 0.909 0 O-C-N 124.503 1.127 . . . . 0.0 110.989 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -70.16 -134.51 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.431 0.724 . . . . 0.0 109.273 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -114.57 61.3 0.67 Allowed 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.491 1.119 . . . . 0.0 110.301 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -128.08 116.68 20.35 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 124.518 1.136 . . . . 0.0 110.967 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.477 HG13 ' CD1' ' A' ' 161' ' ' ILE . 32.4 m -107.77 165.02 4.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 O-C-N 124.542 1.151 . . . . 0.0 109.36 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . 0.461 ' HD3' ' O ' ' A' ' 157' ' ' ASP . 2.7 tpp85 -125.12 132.18 53.15 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.445 1.091 . . . . 0.0 110.306 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . 0.578 ' O ' ' N ' ' A' ' 156' ' ' GLY . . . -98.22 112.94 24.74 Favored 'General case' 0 C--N 1.326 -0.444 0 O-C-N 124.474 1.109 . . . . 0.0 109.307 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.484 ' CD1' ' HG2' ' A' ' 188' ' ' GLU . 0.1 OUTLIER -92.71 -12.02 32.5 Favored 'General case' 0 C--N 1.326 -0.437 0 O-C-N 124.448 1.092 . . . . 0.0 109.302 -179.953 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -121.73 156.69 32.56 Favored 'General case' 0 C--N 1.326 -0.416 0 O-C-N 124.507 1.129 . . . . 0.0 110.966 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . 0.464 ' OD1' ' N ' ' A' ' 155' ' ' LYS . 0.0 OUTLIER -102.68 138.41 39.61 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.439 1.087 . . . . 0.0 109.316 -179.954 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' PHE . . . . . 0.628 ' HB3' ' CZ ' ' A' ' 153' ' ' PHE . 5.8 t80 -150.16 7.94 0.62 Allowed 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.456 1.098 . . . . 0.0 111.012 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . 0.46 ' C ' ' O ' ' A' ' 143' ' ' PHE . 0.8 OUTLIER 36.06 -153.47 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.499 1.125 . . . . 0.0 109.304 -179.995 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . 0.476 ' N ' ' HB3' ' A' ' 152' ' ' PRO . . . -175.21 -145.85 5.56 Favored Glycine 0 CA--C 1.53 1.016 0 O-C-N 124.576 1.172 . . . . 0.0 110.946 -179.955 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' ASN . . . . . 0.428 ' O ' ' CG ' ' A' ' 147' ' ' ASP . 26.6 t-20 175.52 57.84 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.453 0.737 . . . . 0.0 109.379 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . 0.482 ' O ' ' N ' ' A' ' 150' ' ' ASP . 2.3 p-10 46.17 -114.46 0.49 Allowed 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.524 1.14 . . . . 0.0 109.325 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . 0.447 ' C ' ' O ' ' A' ' 147' ' ' ASP . 2.0 pt-20 35.52 46.51 0.29 Allowed 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.495 1.122 . . . . 0.0 110.259 179.939 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 8.3 tt0 67.04 47.13 1.42 Allowed 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.486 1.117 . . . . 0.0 110.278 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . 0.482 ' N ' ' O ' ' A' ' 147' ' ' ASP . 0.0 OUTLIER -155.52 159.21 39.56 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.465 1.103 . . . . 0.0 109.308 179.997 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.499 HD13 ' CB ' ' A' ' 174' ' ' ASP . 1.2 pt? -128.75 127.78 23.49 Favored Pre-proline 0 C--N 1.325 -0.466 0 O-C-N 124.484 1.115 . . . . 0.0 109.329 179.95 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . 0.476 ' HB3' ' N ' ' A' ' 145' ' ' GLY . 18.4 Cg_endo -74.98 148.69 35.71 Favored 'Trans proline' 0 C--N 1.359 1.128 0 O-C-N 124.444 1.76 . . . . 0.0 111.021 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . 0.628 ' CZ ' ' HB3' ' A' ' 143' ' ' PHE . 52.2 p90 -150.66 169.35 21.81 Favored 'General case' 0 C--N 1.326 -0.437 0 O-C-N 124.456 1.098 . . . . 0.0 110.967 -179.935 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . 0.421 ' HA ' ' HA ' ' A' ' 142' ' ' ASP . 2.9 tttm -128.92 -161.75 1.14 Allowed 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.528 1.143 . . . . 0.0 109.273 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.464 ' N ' ' OD1' ' A' ' 142' ' ' ASP . 0.0 OUTLIER -91.64 101.12 13.74 Favored 'General case' 0 C--N 1.324 -0.522 0 O-C-N 124.507 1.129 . . . . 0.0 109.302 -179.987 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . 0.578 ' N ' ' O ' ' A' ' 139' ' ' ALA . . . 114.47 27.64 3.27 Favored Glycine 0 CA--C 1.53 0.981 0 O-C-N 124.491 1.12 . . . . 0.0 111.023 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . 0.461 ' O ' ' HD3' ' A' ' 138' ' ' ARG . 2.5 t70 -105.08 163.47 12.53 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.555 0.797 . . . . 0.0 109.299 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . 0.432 HG12 ' HD3' ' A' ' 138' ' ' ARG . 4.4 mt -119.59 149.08 22.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 O-C-N 124.47 1.107 . . . . 0.0 109.297 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.425 ' CD1' ' N ' ' A' ' 159' ' ' LEU . 0.0 OUTLIER -147.5 137.45 22.93 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 124.515 1.135 . . . . 0.0 109.279 -179.969 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . 0.602 ' O ' ' CB ' ' A' ' 172' ' ' ALA . 7.3 ttt180 -88.25 136.29 33.05 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.522 1.139 . . . . 0.0 110.325 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . 0.477 ' CD1' HG13 ' A' ' 137' ' ' VAL . 0.9 OUTLIER -83.68 110.3 18.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 O-C-N 124.44 1.087 . . . . 0.0 109.324 -179.948 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . 0.43 ' HB3' ' ND2' ' A' ' 171' ' ' ASN . 2.5 tpt85 -88.33 -59.6 2.19 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.483 1.114 . . . . 0.0 110.353 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . 0.43 ' O ' ' HB3' ' A' ' 170' ' ' TRP . 20.3 t0 -149.19 149.68 31.4 Favored 'General case' 0 C--N 1.324 -0.526 0 O-C-N 124.515 1.134 . . . . 0.0 109.34 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . 0.542 ' HB2' ' CE2' ' A' ' 170' ' ' TRP . 0.4 OUTLIER -132.76 76.51 70.9 Favored Pre-proline 0 C--N 1.325 -0.496 0 O-C-N 124.474 1.109 . . . . 0.0 109.324 -179.987 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -75.14 -44.89 0.3 Allowed 'Trans proline' 0 C--N 1.361 1.207 0 O-C-N 124.426 1.75 . . . . 0.0 110.959 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 -78.97 175.5 10.51 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.457 1.098 . . . . 0.0 110.303 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 32.6 mm-40 -114.03 54.12 0.76 Allowed 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.464 1.102 . . . . 0.0 110.322 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . 0.421 ' O ' ' CG2' ' A' ' 184' ' ' VAL . 0.0 OUTLIER -178.5 -57.63 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.432 0 O-C-N 124.464 1.103 . . . . 0.0 110.261 -179.971 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 169' ' ' TRP . . . . . 0.565 ' CZ3' ' HA ' ' A' ' 182' ' ' ILE . 14.0 m95 -109.8 142.13 41.49 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 107.961 -1.125 . . . . 0.0 107.961 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 170' ' ' TRP . . . . . 0.607 ' CZ3' HG11 ' A' ' 184' ' ' VAL . 22.8 m0 -133.91 161.39 34.91 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.518 1.136 . . . . 0.0 108.011 179.964 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 171' ' ' ASN . . . . . 0.468 ' HA ' ' HA ' ' A' ' 181' ' ' MET . 5.3 p-10 -94.08 111.26 22.96 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.556 1.16 . . . . 0.0 109.296 179.986 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . 0.602 ' CB ' ' O ' ' A' ' 160' ' ' ARG . . . -117.34 -176.79 3.08 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.499 1.125 . . . . 0.0 109.308 179.991 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . 0.435 ' OE2' ' CD ' ' A' ' 179' ' ' ARG . 40.2 mt-10 -128.09 124.27 36.59 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.439 1.087 . . . . 0.0 110.338 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . 0.499 ' CB ' HD13 ' A' ' 151' ' ' LEU . 0.9 OUTLIER -75.99 -172.65 2.06 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.407 1.067 . . . . 0.0 109.278 -179.954 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 1.4 m -82.35 61.59 5.62 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.55 1.156 . . . . 0.0 110.028 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -177.16 9.95 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.451 1.094 . . . . 0.0 110.312 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 74.07 17.25 79.45 Favored Glycine 0 CA--C 1.531 1.034 0 O-C-N 124.51 1.132 . . . . 0.0 111.029 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 178' ' ' LYS . . . . . 0.4 ' O ' ' HA ' ' A' ' 173' ' ' GLU . 0.8 OUTLIER -82.8 101.38 10.9 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.544 0.79 . . . . 0.0 109.262 -179.97 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 179' ' ' ARG . . . . . 0.499 ' HA ' ' O ' ' A' ' 172' ' ' ALA . 0.0 OUTLIER -91.42 115.42 28.02 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.528 1.142 . . . . 0.0 110.275 -179.968 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . 0.456 ' CA ' HD22 ' A' ' 151' ' ' LEU . . . -150.96 169.0 30.7 Favored Glycine 0 CA--C 1.53 1.005 0 O-C-N 124.457 1.098 . . . . 0.0 110.998 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 181' ' ' MET . . . . . 0.495 ' HG3' ' HB3' ' A' ' 169' ' ' TRP . 1.4 ttm -87.75 111.95 21.88 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.44 0.729 . . . . 0.0 110.99 -179.978 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . 0.565 ' HA ' ' CZ3' ' A' ' 169' ' ' TRP . 1.5 pp -115.27 166.88 10.94 Favored Pre-proline 0 C--N 1.325 -0.472 0 O-C-N 124.538 1.149 . . . . 0.0 109.263 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 183' ' ' PRO . . . . . 0.607 ' HG2' ' CB ' ' A' ' 186' ' ' TYR . 18.3 Cg_endo -75.02 135.11 18.61 Favored 'Trans proline' 0 C--N 1.36 1.145 0 O-C-N 124.471 1.774 . . . . 0.0 110.973 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . 0.811 ' N ' ' CD ' ' A' ' 185' ' ' PRO . 86.9 t -79.98 -32.3 0.71 Allowed Pre-proline 0 C--N 1.325 -0.467 0 O-C-N 124.482 1.114 . . . . 0.0 109.293 179.986 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 185' ' ' PRO . . . . . 0.811 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.3 Cg_endo -74.99 -11.38 21.49 Favored 'Trans proline' 0 C--N 1.359 1.124 0 O-C-N 124.48 1.779 . . . . 0.0 110.999 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 186' ' ' TYR . . . . . 0.607 ' CB ' ' HG2' ' A' ' 183' ' ' PRO . 6.8 m-85 -93.97 -1.98 53.82 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.501 1.126 . . . . 0.0 111.022 -179.979 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 187' ' ' VAL . . . . . 0.425 ' HA ' ' O ' ' A' ' 138' ' ' ARG . 14.4 m -133.22 174.03 13.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 O-C-N 124.477 1.111 . . . . 0.0 109.307 179.963 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . 0.484 ' HG2' ' CD1' ' A' ' 140' ' ' LEU . 0.0 OUTLIER -135.53 172.51 12.9 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.457 1.098 . . . . 0.0 110.307 179.991 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.8 126.07 34.8 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.454 1.096 . . . . 0.0 109.288 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 72.2 t80 -43.54 -72.2 0.06 Allowed 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.47 1.106 . . . . 0.0 110.953 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.979 0 O-C-N 124.552 1.157 . . . . 0.0 111.019 179.984 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' CYS . . . . . . . . . . . . . 4.9 t . . . . . 0 N--CA 1.452 -0.325 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 118.7 48.23 0.38 Allowed Glycine 0 CA--C 1.529 0.956 0 O-C-N 124.521 1.138 . . . . 0.0 111.063 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . 0.429 ' O ' ' CB ' ' A' ' 135' ' ' GLU . . . 177.87 -104.64 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.492 0.76 . . . . 0.0 109.292 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . 0.442 ' HB2' ' O ' ' A' ' 161' ' ' ILE . 1.2 pt-20 165.79 63.46 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.434 0 O-C-N 124.429 1.08 . . . . 0.0 110.32 -179.942 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 7.3 m-85 -124.19 117.06 23.75 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.489 1.118 . . . . 0.0 110.957 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.516 ' CG2' ' O ' ' A' ' 188' ' ' GLU . 0.4 OUTLIER -119.41 132.54 68.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 O-C-N 124.544 1.153 . . . . 0.0 109.309 179.973 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . 0.499 ' CZ ' ' OH ' ' A' ' 190' ' ' TYR . 12.7 ttm180 -95.2 148.37 22.47 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.525 1.14 . . . . 0.0 110.373 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . 0.51 ' O ' ' N ' ' A' ' 156' ' ' GLY . . . -105.91 110.66 23.01 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.512 1.132 . . . . 0.0 109.268 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.511 ' O ' ' CD ' ' A' ' 155' ' ' LYS . 0.3 OUTLIER -93.89 -7.9 41.82 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.456 1.098 . . . . 0.0 109.274 179.965 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . 0.456 ' C ' ' O ' ' A' ' 154' ' ' LYS . 14.7 m-85 -104.61 158.73 16.3 Favored 'General case' 0 C--N 1.324 -0.524 0 O-C-N 124.525 1.141 . . . . 0.0 110.976 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . 0.57 ' CA ' ' O ' ' A' ' 154' ' ' LYS . 0.0 OUTLIER -122.0 115.96 23.45 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.449 1.093 . . . . 0.0 109.276 -179.942 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' PHE . . . . . 0.498 ' O ' ' CG ' ' A' ' 143' ' ' PHE . 50.4 t80 -154.07 9.66 0.38 Allowed 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.46 1.1 . . . . 0.0 110.977 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . 0.503 ' OD1' ' N ' ' A' ' 145' ' ' GLY . 18.4 p30 35.13 -154.79 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.512 1.132 . . . . 0.0 109.321 -179.95 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . 0.503 ' N ' ' OD1' ' A' ' 144' ' ' ASN . . . -135.05 142.76 14.25 Favored Glycine 0 CA--C 1.53 1.016 0 O-C-N 124.464 1.102 . . . . 0.0 110.988 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 20.0 p30 178.93 58.09 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.6 0.823 . . . . 0.0 109.272 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -139.9 -59.3 0.55 Allowed 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.471 1.107 . . . . 0.0 109.388 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -170.42 58.77 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.552 1.158 . . . . 0.0 110.326 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 70.05 51.9 0.4 Allowed 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.521 1.138 . . . . 0.0 110.335 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -92.7 136.5 33.17 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.555 1.159 . . . . 0.0 109.301 -179.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.543 ' CD2' HD23 ' A' ' 159' ' ' LEU . 1.0 OUTLIER -50.9 106.74 0.69 Allowed Pre-proline 0 C--N 1.325 -0.485 0 O-C-N 124.583 1.177 . . . . 0.0 109.358 179.987 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . 0.408 ' HD2' ' OD2' ' A' ' 174' ' ' ASP . 18.3 Cg_endo -74.98 131.93 14.87 Favored 'Trans proline' 0 C--N 1.36 1.179 0 O-C-N 124.509 1.794 . . . . 0.0 110.996 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . 0.565 ' CD1' ' N ' ' A' ' 153' ' ' PHE . 0.0 OUTLIER -145.22 166.29 25.89 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.5 1.125 . . . . 0.0 110.971 -179.975 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . 0.57 ' O ' ' CA ' ' A' ' 142' ' ' ASP . 0.0 OUTLIER -127.0 -75.37 0.58 Allowed 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.5 1.125 . . . . 0.0 109.258 179.97 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.511 ' CD ' ' O ' ' A' ' 140' ' ' LEU . 0.0 OUTLIER -165.26 109.64 0.88 Allowed 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.54 1.15 . . . . 0.0 109.278 -179.97 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . 0.51 ' N ' ' O ' ' A' ' 139' ' ' ALA . . . 93.45 29.88 9.7 Favored Glycine 0 CA--C 1.531 1.042 0 O-C-N 124.593 1.183 . . . . 0.0 110.98 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . 0.492 ' OD1' ' N ' ' A' ' 158' ' ' ILE . 0.4 OUTLIER -88.66 158.65 18.16 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.482 0.754 . . . . 0.0 109.285 179.995 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . 0.529 ' N ' ' CD1' ' A' ' 158' ' ' ILE . 1.5 mp -116.38 136.34 53.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 O-C-N 124.492 1.12 . . . . 0.0 109.278 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.543 HD23 ' CD2' ' A' ' 151' ' ' LEU . 0.6 OUTLIER -138.09 126.22 22.9 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.51 1.131 . . . . 0.0 109.3 -179.971 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . 0.478 ' O ' ' HA ' ' A' ' 172' ' ' ALA . 0.0 OUTLIER -86.84 126.28 34.54 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.535 1.147 . . . . 0.0 110.299 -179.98 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . 0.457 HG23 ' CE ' ' A' ' 164' ' ' LYS . 12.4 mm -81.77 122.56 36.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 O-C-N 124.502 1.127 . . . . 0.0 109.336 179.998 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . 0.463 ' HG3' ' N ' ' A' ' 163' ' ' ASP . 0.0 OUTLIER -122.53 -29.55 4.06 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.526 1.141 . . . . 0.0 110.276 179.989 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . 0.463 ' N ' ' HG3' ' A' ' 162' ' ' ARG . 0.8 OUTLIER -135.99 146.0 46.73 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.477 1.111 . . . . 0.0 109.312 -179.949 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . 0.62 ' CE ' ' CE3' ' A' ' 170' ' ' TRP . 15.9 mtpt -146.84 62.64 7.7 Favored Pre-proline 0 C--N 1.324 -0.506 0 O-C-N 124.459 1.099 . . . . 0.0 109.342 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . 0.442 ' HD3' ' N ' ' A' ' 164' ' ' LYS . 18.1 Cg_endo -75.04 -73.54 0.01 OUTLIER 'Trans proline' 0 C--N 1.361 1.218 0 O-C-N 124.474 1.776 . . . . 0.0 110.976 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -50.69 160.06 0.47 Allowed 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.523 1.139 . . . . 0.0 110.293 -179.967 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -100.91 35.21 2.25 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.477 1.11 . . . . 0.0 110.271 -179.938 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -157.75 -51.35 0.07 Allowed 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.417 1.073 . . . . 0.0 110.353 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 169' ' ' TRP . . . . . . . . . . . . . 13.0 m95 -103.79 140.53 37.5 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.607 1.192 . . . . 0.0 108.039 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 170' ' ' TRP . . . . . 0.62 ' CE3' ' CE ' ' A' ' 164' ' ' LYS . 50.5 m0 -121.0 147.35 45.61 Favored 'General case' 0 C--N 1.324 -0.53 0 O-C-N 124.511 1.132 . . . . 0.0 107.975 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 16.4 t30 -87.47 98.06 11.18 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.473 1.108 . . . . 0.0 109.233 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . 0.478 ' HA ' ' O ' ' A' ' 160' ' ' ARG . . . -107.77 173.54 6.28 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.43 1.081 . . . . 0.0 109.334 179.909 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . 0.511 ' CG ' ' HG2' ' A' ' 179' ' ' ARG . 23.9 mt-10 -118.95 120.24 36.7 Favored 'General case' 0 C--N 1.326 -0.439 0 O-C-N 124.479 1.112 . . . . 0.0 110.268 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . 0.408 ' OD2' ' HD2' ' A' ' 152' ' ' PRO . 0.4 OUTLIER -73.92 -169.55 0.76 Allowed 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.489 1.118 . . . . 0.0 109.307 179.944 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 27.6 t -83.69 63.98 7.73 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.496 1.122 . . . . 0.0 110.038 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -176.33 7.23 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.511 1.132 . . . . 0.0 110.341 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 70.68 22.46 78.04 Favored Glycine 0 CA--C 1.53 0.984 0 O-C-N 124.492 1.12 . . . . 0.0 111.005 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 4.6 ptpp? -94.4 115.45 27.66 Favored 'General case' 0 C--N 1.324 -0.53 0 O-C-N 124.454 0.738 . . . . 0.0 109.29 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 179' ' ' ARG . . . . . 0.511 ' HG2' ' CG ' ' A' ' 173' ' ' GLU . 1.3 mtt180 -92.87 123.63 36.27 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.579 1.175 . . . . 0.0 110.331 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -151.04 160.49 28.66 Favored Glycine 0 CA--C 1.53 1.001 0 O-C-N 124.48 1.112 . . . . 0.0 110.996 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 181' ' ' MET . . . . . 0.421 ' HA ' ' O ' ' A' ' 170' ' ' TRP . 4.7 mmm -88.6 107.13 18.75 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.472 0.748 . . . . 0.0 110.997 -179.966 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . 0.553 ' CG2' ' CE2' ' A' ' 153' ' ' PHE . 1.0 OUTLIER -112.32 170.12 5.62 Favored Pre-proline 0 C--N 1.325 -0.474 0 O-C-N 124.41 1.069 . . . . 0.0 109.338 179.969 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 183' ' ' PRO . . . . . 0.598 ' HG2' ' CB ' ' A' ' 186' ' ' TYR . 18.5 Cg_endo -74.98 132.82 15.88 Favored 'Trans proline' 0 C--N 1.36 1.132 0 O-C-N 124.425 1.75 . . . . 0.0 111.022 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . 0.819 ' N ' ' CD ' ' A' ' 185' ' ' PRO . 84.5 t -76.62 -31.68 0.96 Allowed Pre-proline 0 C--N 1.326 -0.456 0 O-C-N 124.577 1.173 . . . . 0.0 109.282 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 185' ' ' PRO . . . . . 0.819 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.4 Cg_endo -74.9 -8.72 20.44 Favored 'Trans proline' 0 C--N 1.36 1.153 0 O-C-N 124.454 1.765 . . . . 0.0 111.057 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 186' ' ' TYR . . . . . 0.598 ' CB ' ' HG2' ' A' ' 183' ' ' PRO . 3.4 m-85 -99.7 6.68 45.53 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.459 1.1 . . . . 0.0 110.941 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 187' ' ' VAL . . . . . 0.452 ' HB ' ' O ' ' A' ' 138' ' ' ARG . 34.5 m -136.92 174.5 11.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 O-C-N 124.506 1.129 . . . . 0.0 109.252 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . 0.516 ' O ' ' CG2' ' A' ' 137' ' ' VAL . 0.0 OUTLIER -131.58 163.69 27.5 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.558 1.161 . . . . 0.0 110.302 179.986 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.53 124.14 35.47 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.461 1.101 . . . . 0.0 109.288 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 190' ' ' TYR . . . . . 0.499 ' OH ' ' CZ ' ' A' ' 138' ' ' ARG . 0.1 OUTLIER -98.94 77.96 2.24 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.448 1.093 . . . . 0.0 111.049 179.967 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . 0.4 ' O ' ' O ' ' A' ' 190' ' ' TYR . . . . . . . . 0 CA--C 1.531 1.039 0 O-C-N 124.52 1.138 . . . . 0.0 110.992 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' CYS . . . . . 0.494 ' O ' ' C ' ' A' ' 133' ' ' GLY . 76.5 m . . . . . 0 N--CA 1.452 -0.33 0 N-CA-C 108.358 -0.978 . . . . 0.0 108.358 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . 0.494 ' C ' ' O ' ' A' ' 132' ' ' CYS . . . -29.13 -82.92 0.01 OUTLIER Glycine 0 CA--C 1.531 1.048 0 O-C-N 124.492 1.12 . . . . 0.0 111.019 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . 0.489 ' O ' ' CG ' ' A' ' 135' ' ' GLU . . . -80.92 -105.37 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.54 0.788 . . . . 0.0 109.294 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . 0.489 ' CG ' ' O ' ' A' ' 134' ' ' ALA . 5.5 mp0 -166.82 75.96 0.17 Allowed 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.482 1.114 . . . . 0.0 110.268 179.966 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . 0.584 ' CD1' ' HG2' ' A' ' 160' ' ' ARG . 86.2 m-85 -128.33 140.11 52.04 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.549 1.155 . . . . 0.0 110.956 -179.965 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.533 ' CG2' HD11 ' A' ' 161' ' ' ILE . 29.1 m -138.1 149.64 24.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 124.514 1.134 . . . . 0.0 109.335 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . 0.434 ' HB3' ' CD ' ' A' ' 188' ' ' GLU . 1.2 ttm180 -107.54 130.02 54.91 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.495 1.122 . . . . 0.0 110.275 -179.948 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . 0.659 ' O ' ' N ' ' A' ' 156' ' ' GLY . . . -89.25 103.37 16.0 Favored 'General case' 0 C--N 1.326 -0.443 0 O-C-N 124.461 1.1 . . . . 0.0 109.281 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -86.85 -2.8 58.86 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.521 1.138 . . . . 0.0 109.345 179.933 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 46.7 m-85 -128.92 157.63 41.06 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.5 1.125 . . . . 0.0 111.009 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . 0.424 ' HB2' ' HA ' ' A' ' 154' ' ' LYS . 1.5 t70 -112.28 156.89 21.66 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.388 1.055 . . . . 0.0 109.266 -179.928 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' PHE . . . . . 0.619 ' HB3' ' CZ ' ' A' ' 153' ' ' PHE . 11.7 t80 -178.99 41.89 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.434 1.084 . . . . 0.0 110.955 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 71.9 m-80 -49.23 161.68 0.16 Allowed 'General case' 0 C--N 1.323 -0.549 0 O-C-N 124.529 1.143 . . . . 0.0 109.254 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . 0.404 ' O ' ' OD1' ' A' ' 146' ' ' ASN . . . -145.8 -125.18 1.71 Allowed Glycine 0 CA--C 1.53 0.991 0 O-C-N 124.525 1.141 . . . . 0.0 110.999 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' ASN . . . . . 0.404 ' OD1' ' O ' ' A' ' 145' ' ' GLY . 0.7 OUTLIER 162.74 77.44 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.506 0.769 . . . . 0.0 109.324 -179.99 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -171.4 164.69 7.04 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.481 1.113 . . . . 0.0 109.312 -179.945 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -92.77 55.62 2.46 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.558 1.161 . . . . 0.0 110.315 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 9.8 tt0 -149.44 -45.27 0.14 Allowed 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.499 1.124 . . . . 0.0 110.291 179.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 29.2 t0 -105.43 169.92 8.18 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.514 1.134 . . . . 0.0 109.31 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.545 ' HB3' ' CG2' ' A' ' 182' ' ' ILE . 0.2 OUTLIER -119.41 126.18 27.14 Favored Pre-proline 0 C--N 1.326 -0.452 0 O-C-N 124.479 1.112 . . . . 0.0 109.247 -179.96 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -74.94 135.25 18.94 Favored 'Trans proline' 0 C--N 1.36 1.136 0 O-C-N 124.513 1.796 . . . . 0.0 110.991 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . 0.619 ' CZ ' ' HB3' ' A' ' 143' ' ' PHE . 8.4 p90 -154.51 170.54 21.19 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.472 1.108 . . . . 0.0 111.003 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . 0.424 ' HA ' ' HB2' ' A' ' 142' ' ' ASP . 6.8 tttt -128.49 -164.9 1.43 Allowed 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.441 1.088 . . . . 0.0 109.272 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 35.4 tttt -92.94 106.47 18.43 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.483 1.114 . . . . 0.0 109.293 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . 0.659 ' N ' ' O ' ' A' ' 139' ' ' ALA . . . 109.86 29.01 3.97 Favored Glycine 0 CA--C 1.531 1.034 0 O-C-N 124.496 1.123 . . . . 0.0 111.004 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -97.39 167.05 11.24 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.482 0.754 . . . . 0.0 109.352 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . 0.421 ' C ' ' HG ' ' A' ' 159' ' ' LEU . 18.0 mm -121.46 136.78 57.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 O-C-N 124.52 1.137 . . . . 0.0 109.306 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.421 ' HG ' ' C ' ' A' ' 158' ' ' ILE . 0.8 OUTLIER -141.48 136.63 31.44 Favored 'General case' 0 C--N 1.326 -0.427 0 O-C-N 124.495 1.122 . . . . 0.0 109.325 -179.97 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . 0.584 ' HG2' ' CD1' ' A' ' 136' ' ' TYR . 0.0 OUTLIER -97.33 134.98 39.88 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.528 1.143 . . . . 0.0 110.347 179.96 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . 0.533 HD11 ' CG2' ' A' ' 137' ' ' VAL . 1.7 mp -87.19 125.22 41.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 O-C-N 124.501 1.126 . . . . 0.0 109.346 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . 0.482 ' CG ' ' N ' ' A' ' 163' ' ' ASP . 0.8 OUTLIER -118.63 -41.03 2.83 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 124.5 1.125 . . . . 0.0 110.291 -179.953 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . 0.482 ' N ' ' CG ' ' A' ' 162' ' ' ARG . 13.7 m-20 -148.78 176.99 9.91 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.492 1.12 . . . . 0.0 109.34 -179.987 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . 0.591 ' HB3' ' CD1' ' A' ' 170' ' ' TRP . 6.9 mtmm -144.88 65.45 12.24 Favored Pre-proline 0 C--N 1.325 -0.478 0 O-C-N 124.564 1.165 . . . . 0.0 109.283 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . 0.514 ' O ' ' CB ' ' A' ' 166' ' ' GLU . 18.5 Cg_endo -74.92 73.29 4.32 Favored 'Trans proline' 0 C--N 1.361 1.212 0 O-C-N 124.507 1.793 . . . . 0.0 110.997 179.966 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . 0.514 ' CB ' ' O ' ' A' ' 165' ' ' PRO . 2.5 mt-10 159.93 179.35 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.528 1.142 . . . . 0.0 110.325 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -118.16 46.11 1.85 Allowed 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.513 1.133 . . . . 0.0 110.318 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -178.83 -54.35 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.484 1.115 . . . . 0.0 110.322 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 169' ' ' TRP . . . . . . . . . . . . . 10.2 m95 -95.52 144.35 26.07 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.539 1.149 . . . . 0.0 107.991 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 170' ' ' TRP . . . . . 0.591 ' CD1' ' HB3' ' A' ' 164' ' ' LYS . 53.2 m0 -118.71 148.38 42.83 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 -179.963 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 171' ' ' ASN . . . . . 0.459 ' HB2' ' CD ' ' A' ' 165' ' ' PRO . 5.4 t-20 -87.58 107.73 18.73 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.555 1.16 . . . . 0.0 109.366 179.903 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . 0.528 ' CA ' ' O ' ' A' ' 160' ' ' ARG . . . -119.28 174.88 6.09 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.511 1.132 . . . . 0.0 109.31 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . 0.515 ' HG3' ' CG ' ' A' ' 179' ' ' ARG . 3.8 mt-10 -118.17 119.92 36.16 Favored 'General case' 0 C--N 1.326 -0.427 0 O-C-N 124.543 1.152 . . . . 0.0 110.262 -179.947 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . 0.533 ' HB3' ' CD2' ' A' ' 151' ' ' LEU . 0.8 OUTLIER -76.19 -173.7 2.5 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.411 1.069 . . . . 0.0 109.319 -179.943 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 40.6 t -75.82 63.89 1.73 Allowed 'General case' 0 C--N 1.324 -0.539 0 O-C-N 124.591 1.182 . . . . 0.0 110.079 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . 0.42 ' H ' ' H ' ' A' ' 177' ' ' GLY . 0.9 OUTLIER -177.56 1.53 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.55 1.156 . . . . 0.0 110.276 -179.921 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . 0.42 ' H ' ' H ' ' A' ' 176' ' ' GLU . . . 74.94 15.47 80.98 Favored Glycine 0 CA--C 1.53 0.998 0 O-C-N 124.522 1.139 . . . . 0.0 111.019 -179.954 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 178' ' ' LYS . . . . . 0.4 ' HB3' ' OD1' ' A' ' 174' ' ' ASP . 0.0 OUTLIER -84.91 117.59 24.01 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.506 0.768 . . . . 0.0 109.38 179.986 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 179' ' ' ARG . . . . . 0.515 ' CG ' ' HG3' ' A' ' 173' ' ' GLU . 3.3 mtt85 -90.18 123.34 33.92 Favored 'General case' 0 C--N 1.326 -0.441 0 O-C-N 124.498 1.124 . . . . 0.0 110.294 -179.949 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . 0.472 ' HA3' ' CD1' ' A' ' 151' ' ' LEU . . . -152.21 164.57 30.56 Favored Glycine 0 CA--C 1.53 1.011 0 O-C-N 124.471 1.107 . . . . 0.0 111.017 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 181' ' ' MET . . . . . 0.401 ' HA ' ' O ' ' A' ' 170' ' ' TRP . 21.7 mtp -86.37 101.77 13.41 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.528 0.781 . . . . 0.0 110.95 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . 0.545 ' CG2' ' HB3' ' A' ' 151' ' ' LEU . 23.3 pt -99.2 158.12 32.82 Favored Pre-proline 0 C--N 1.326 -0.452 0 O-C-N 124.492 1.12 . . . . 0.0 109.301 179.922 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 183' ' ' PRO . . . . . 0.753 ' HG2' ' HB2' ' A' ' 186' ' ' TYR . 18.4 Cg_endo -74.96 134.13 17.5 Favored 'Trans proline' 0 C--N 1.36 1.159 0 O-C-N 124.404 1.739 . . . . 0.0 110.947 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . 0.807 ' N ' ' CD ' ' A' ' 185' ' ' PRO . 73.9 t -77.43 -33.36 1.04 Allowed Pre-proline 0 C--N 1.325 -0.46 0 O-C-N 124.578 1.174 . . . . 0.0 109.271 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 185' ' ' PRO . . . . . 0.807 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.3 Cg_endo -74.96 -14.7 21.15 Favored 'Trans proline' 0 C--N 1.361 1.191 0 O-C-N 124.5 1.789 . . . . 0.0 111.026 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 186' ' ' TYR . . . . . 0.753 ' HB2' ' HG2' ' A' ' 183' ' ' PRO . 3.3 m-85 -96.59 0.31 49.78 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.508 1.13 . . . . 0.0 111.057 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 4.1 m -135.4 164.49 32.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 O-C-N 124.463 1.102 . . . . 0.0 109.271 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . 0.434 ' CD ' ' HB3' ' A' ' 138' ' ' ARG . 0.0 OUTLIER -122.46 166.92 13.99 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.52 1.137 . . . . 0.0 110.293 179.963 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -87.69 135.59 33.31 Favored 'General case' 0 C--N 1.326 -0.422 0 O-C-N 124.492 1.12 . . . . 0.0 109.288 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -129.39 91.61 3.21 Favored 'General case' 0 C--N 1.326 -0.423 0 O-C-N 124.447 1.092 . . . . 0.0 110.948 -179.957 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.075 0 O-C-N 124.586 1.179 . . . . 0.0 110.952 179.931 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 135' ' ' GLU . . . . . 0.463 ' HB3' ' O ' ' A' ' 161' ' ' ILE . 0.3 OUTLIER . . . . . 0 N--CA 1.453 -0.275 0 N-CA-C 110.283 -0.265 . . . . 0.0 110.283 . . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 136' ' ' TYR . . . . . 0.812 ' CD1' ' CG ' ' A' ' 190' ' ' TYR . 1.9 t80 -112.49 128.77 56.43 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.482 1.113 . . . . 0.0 110.965 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.742 HG13 ' O ' ' A' ' 188' ' ' GLU . 10.5 t -139.61 141.48 34.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 O-C-N 124.534 1.146 . . . . 0.0 109.306 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 138' ' ' ARG . . . . . 0.417 ' NE ' ' HA2' ' A' ' 156' ' ' GLY . 0.5 OUTLIER -112.18 139.18 47.93 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.44 1.087 . . . . 0.0 110.287 -179.987 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 0.464 ' CB ' HG12 ' A' ' 187' ' ' VAL . . . -95.17 114.5 26.3 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.468 1.105 . . . . 0.0 109.318 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.453 ' O ' ' CB ' ' A' ' 155' ' ' LYS . 0.5 OUTLIER -87.26 -22.83 24.95 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.498 1.124 . . . . 0.0 109.277 -179.984 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 20.2 m-85 -101.67 167.58 10.02 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.474 1.109 . . . . 0.0 110.995 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 1.9 p30 . . . . . 0 C--N 1.325 -0.484 0 O-C-N 124.504 1.127 . . . . 0.0 109.309 -179.992 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 153' ' ' PHE . . . . . 0.515 ' CE2' HG13 ' A' ' 182' ' ' ILE . 12.8 p90 . . . . . 0 N--CA 1.453 -0.296 0 CA-C-O 120.468 0.175 . . . . 0.0 110.999 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 8.6 tttt -126.56 -167.22 1.69 Allowed 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.556 1.16 . . . . 0.0 109.284 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.453 ' CB ' ' O ' ' A' ' 140' ' ' LEU . 2.9 ptmt -91.29 106.84 18.79 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.532 1.145 . . . . 0.0 109.257 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 156' ' ' GLY . . . . . 0.417 ' HA2' ' NE ' ' A' ' 138' ' ' ARG . . . 105.14 27.2 5.98 Favored Glycine 0 CA--C 1.531 1.033 0 O-C-N 124.505 1.128 . . . . 0.0 111.03 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 157' ' ' ASP . . . . . 0.503 ' C ' HD13 ' A' ' 158' ' ' ILE . 32.2 t70 -92.34 161.46 14.66 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.502 0.766 . . . . 0.0 109.32 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 158' ' ' ILE . . . . . 0.67 HG23 ' CZ ' ' A' ' 136' ' ' TYR . 6.5 mm -111.76 128.1 68.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 O-C-N 124.474 1.109 . . . . 0.0 109.312 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.839 HD22 HD12 ' A' ' 182' ' ' ILE . 1.7 mp -142.19 127.55 18.8 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.48 1.112 . . . . 0.0 109.292 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 160' ' ' ARG . . . . . 0.41 ' HG2' ' O ' ' A' ' 135' ' ' GLU . 4.4 mtt180 -86.53 143.56 27.65 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.497 1.123 . . . . 0.0 110.333 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.463 ' O ' ' HB3' ' A' ' 135' ' ' GLU . 0.9 OUTLIER -86.81 116.15 28.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 O-C-N 124.542 1.151 . . . . 0.0 109.275 -179.969 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 162' ' ' ARG . . . . . 0.401 ' NH1' ' OE2' ' A' ' 173' ' ' GLU . 3.1 tpt180 -97.7 -69.27 0.76 Allowed 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.49 1.119 . . . . 0.0 110.285 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -134.42 173.43 11.64 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.422 1.076 . . . . 0.0 109.316 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 164' ' ' LYS . . . . . 0.535 ' HG2' ' CD2' ' A' ' 170' ' ' TRP . 0.0 OUTLIER -135.1 87.32 29.3 Favored Pre-proline 0 C--N 1.325 -0.47 0 O-C-N 124.515 1.135 . . . . 0.0 109.316 -179.958 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -74.97 -25.21 12.13 Favored 'Trans proline' 0 C--N 1.361 1.192 0 O-C-N 124.486 1.782 . . . . 0.0 111.001 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 6.7 mt-10 -125.22 167.36 14.97 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.551 1.157 . . . . 0.0 110.302 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -87.62 -18.82 28.78 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.497 1.123 . . . . 0.0 110.274 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 12.0 mt-30 -103.28 -53.44 2.81 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.491 1.119 . . . . 0.0 110.31 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 169' ' ' TRP . . . . . . . . . . . . . 7.0 m95 -100.7 133.58 44.94 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.504 1.127 . . . . 0.0 107.999 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 170' ' ' TRP . . . . . 0.682 ' CE2' HG21 ' A' ' 184' ' ' VAL . 54.7 m0 -116.63 155.09 29.38 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.553 1.158 . . . . 0.0 107.983 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 171' ' ' ASN . . . . . 0.485 ' HA ' ' O ' ' A' ' 180' ' ' GLY . 19.5 t30 -86.5 97.48 10.52 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.495 1.122 . . . . 0.0 109.31 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -109.91 166.59 10.81 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.556 1.16 . . . . 0.0 109.308 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 173' ' ' GLU . . . . . 0.401 ' OE2' ' NH1' ' A' ' 162' ' ' ARG . 23.1 mt-10 -116.18 112.92 22.35 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.463 1.102 . . . . 0.0 110.273 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 174' ' ' ASP . . . . . 0.484 ' OD1' ' N ' ' A' ' 174' ' ' ASP . 0.0 OUTLIER -68.63 -177.38 0.95 Allowed 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.427 1.08 . . . . 0.0 109.335 179.955 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 73.0 p -77.32 57.71 1.53 Allowed 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.506 1.129 . . . . 0.0 110.03 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 176' ' ' GLU . . . . . 0.409 ' O ' ' HD2' ' A' ' 178' ' ' LYS . 2.7 mt-10 -175.35 22.68 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.519 1.137 . . . . 0.0 110.284 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 55.57 29.18 53.34 Favored Glycine 0 CA--C 1.53 1.004 0 O-C-N 124.522 1.139 . . . . 0.0 110.991 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 178' ' ' LYS . . . . . 0.422 ' O ' ' OD1' ' A' ' 174' ' ' ASP . 0.0 OUTLIER -96.7 110.99 23.32 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.429 0.723 . . . . 0.0 109.308 179.982 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 3.4 ttp180 -91.1 120.5 32.1 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.523 1.139 . . . . 0.0 110.237 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 180' ' ' GLY . . . . . 0.485 ' O ' ' HA ' ' A' ' 171' ' ' ASN . . . -149.84 172.54 29.75 Favored Glycine 0 CA--C 1.53 0.998 0 O-C-N 124.483 1.114 . . . . 0.0 111.001 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 181' ' ' MET . . . . . 0.459 ' HA ' ' O ' ' A' ' 170' ' ' TRP . 20.7 mtp -86.94 92.55 9.06 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.497 0.763 . . . . 0.0 110.998 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 182' ' ' ILE . . . . . 0.839 HD12 HD22 ' A' ' 159' ' ' LEU . 6.6 tt -89.87 144.88 32.24 Favored Pre-proline 0 C--N 1.326 -0.455 0 O-C-N 124.495 1.122 . . . . 0.0 109.32 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 183' ' ' PRO . . . . . 0.674 ' HG2' ' HB2' ' A' ' 186' ' ' TYR . 18.4 Cg_endo -74.97 132.13 15.1 Favored 'Trans proline' 0 C--N 1.36 1.148 0 O-C-N 124.479 1.778 . . . . 0.0 111.028 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 184' ' ' VAL . . . . . 0.821 ' N ' ' CD ' ' A' ' 185' ' ' PRO . 28.1 t -74.48 -30.68 1.1 Allowed Pre-proline 0 C--N 1.325 -0.489 0 O-C-N 124.522 1.139 . . . . 0.0 109.303 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 185' ' ' PRO . . . . . 0.821 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.3 Cg_endo -74.92 -10.86 21.54 Favored 'Trans proline' 0 C--N 1.36 1.153 0 O-C-N 124.559 1.82 . . . . 0.0 111.025 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 186' ' ' TYR . . . . . 0.674 ' HB2' ' HG2' ' A' ' 183' ' ' PRO . 3.7 m-30 -101.61 -19.47 15.44 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.513 1.133 . . . . 0.0 111.018 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 187' ' ' VAL . . . . . 0.706 ' CG2' HG11 ' A' ' 137' ' ' VAL . 13.8 m -115.5 175.9 2.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 O-C-N 124.457 1.098 . . . . 0.0 109.311 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 188' ' ' GLU . . . . . 0.742 ' O ' HG13 ' A' ' 137' ' ' VAL . 0.0 OUTLIER -135.97 168.08 20.02 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 124.481 1.113 . . . . 0.0 110.311 -179.988 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 189' ' ' LYS . . . . . 0.519 ' HD2' HG22 ' A' ' 137' ' ' VAL . 5.8 mmmt -94.69 141.09 29.02 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.536 1.148 . . . . 0.0 109.31 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 190' ' ' TYR . . . . . 0.812 ' CG ' ' CD1' ' A' ' 136' ' ' TYR . 0.2 OUTLIER . . . . . 0 C--N 1.325 -0.47 0 O-C-N 124.459 1.1 . . . . 0.0 111.059 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 135' ' ' GLU . . . . . 0.481 ' O ' ' HA ' ' A' ' 160' ' ' ARG . 0.7 OUTLIER . . . . . 0 N--CA 1.454 -0.266 0 N-CA-C 110.311 -0.255 . . . . 0.0 110.311 . . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 136' ' ' TYR . . . . . 0.443 ' CD1' ' C ' ' A' ' 135' ' ' GLU . 1.9 m-85 -121.17 132.77 55.04 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.562 1.164 . . . . 0.0 110.975 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.601 ' CG2' HD11 ' A' ' 161' ' ' ILE . 22.4 m -129.6 162.31 37.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 O-C-N 124.58 1.175 . . . . 0.0 109.294 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 138' ' ' ARG . . . . . 0.448 ' O ' ' HA ' ' A' ' 187' ' ' VAL . 0.0 OUTLIER -119.25 125.04 48.19 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.505 1.128 . . . . 0.0 110.341 179.999 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 0.661 ' CB ' HG12 ' A' ' 187' ' ' VAL . . . -89.1 107.09 18.85 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.497 1.123 . . . . 0.0 109.284 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.57 HD11 ' HG2' ' A' ' 188' ' ' GLU . 0.1 OUTLIER -88.68 -29.86 19.57 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.571 1.169 . . . . 0.0 109.349 -179.998 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 141' ' ' PHE . . . . . 0.494 ' C ' ' O ' ' A' ' 154' ' ' LYS . 47.2 m-85 -91.2 153.55 19.93 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.523 1.14 . . . . 0.0 110.989 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 142' ' ' ASP . . . . . 0.43 ' HB2' ' HA ' ' A' ' 154' ' ' LYS . 4.2 t70 . . . . . 0 C--N 1.325 -0.467 0 O-C-N 124.475 1.11 . . . . 0.0 109.361 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 153' ' ' PHE . . . . . 0.414 ' O ' ' OD1' ' A' ' 142' ' ' ASP . 10.7 p90 . . . . . 0 N--CA 1.453 -0.285 0 CA-C-O 120.501 0.191 . . . . 0.0 111.004 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 154' ' ' LYS . . . . . 0.494 ' O ' ' C ' ' A' ' 141' ' ' PHE . 0.1 OUTLIER -121.27 -90.77 0.57 Allowed 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.492 1.12 . . . . 0.0 109.363 179.954 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.41 ' CG ' ' O ' ' A' ' 140' ' ' LEU . 10.3 ttpp -157.45 118.28 3.55 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.534 1.146 . . . . 0.0 109.28 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 156' ' ' GLY . . . . . 0.614 ' N ' ' O ' ' A' ' 139' ' ' ALA . . . 98.42 16.36 32.23 Favored Glycine 0 CA--C 1.531 1.033 0 O-C-N 124.544 1.153 . . . . 0.0 111.0 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 157' ' ' ASP . . . . . 0.537 ' HB3' ' HB3' ' A' ' 139' ' ' ALA . 14.4 t70 -81.31 156.67 25.4 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.519 0.776 . . . . 0.0 109.3 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 5.1 mm -110.68 138.62 37.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 O-C-N 124.485 1.116 . . . . 0.0 109.347 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 1.046 HD22 HD13 ' A' ' 182' ' ' ILE . 1.5 mp -141.19 136.3 31.65 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.506 1.129 . . . . 0.0 109.272 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 160' ' ' ARG . . . . . 0.593 ' O ' ' HA ' ' A' ' 172' ' ' ALA . 0.0 OUTLIER -99.46 129.52 45.65 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.476 1.11 . . . . 0.0 110.313 179.981 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.601 HD11 ' CG2' ' A' ' 137' ' ' VAL . 1.7 mp -83.76 122.08 37.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 O-C-N 124.516 1.135 . . . . 0.0 109.286 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -122.65 -42.44 2.32 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.505 1.128 . . . . 0.0 110.261 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -135.06 170.81 15.34 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.491 1.119 . . . . 0.0 109.295 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 164' ' ' LYS . . . . . 0.565 ' HB2' ' CD1' ' A' ' 170' ' ' TRP . 0.6 OUTLIER -164.74 84.98 1.13 Allowed Pre-proline 0 C--N 1.325 -0.458 0 O-C-N 124.505 1.128 . . . . 0.0 109.3 179.928 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.08 -27.52 9.82 Favored 'Trans proline' 0 C--N 1.36 1.17 0 O-C-N 124.51 1.795 . . . . 0.0 110.983 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -118.54 168.94 10.21 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.539 1.15 . . . . 0.0 110.299 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -93.27 -19.67 21.17 Favored 'General case' 0 C--N 1.326 -0.441 0 O-C-N 124.522 1.139 . . . . 0.0 110.333 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -85.58 -57.12 3.19 Favored 'General case' 0 C--N 1.326 -0.422 0 O-C-N 124.506 1.129 . . . . 0.0 110.336 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 169' ' ' TRP . . . . . . . . . . . . . 10.6 m95 -107.18 150.62 26.41 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.549 1.156 . . . . 0.0 108.04 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 170' ' ' TRP . . . . . 0.769 ' CD2' HG21 ' A' ' 184' ' ' VAL . 37.5 m0 -127.51 151.6 48.66 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.549 1.155 . . . . 0.0 108.0 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 171' ' ' ASN . . . . . 0.414 ' HA ' ' O ' ' A' ' 180' ' ' GLY . 1.9 t-20 -87.37 99.14 11.78 Favored 'General case' 0 C--N 1.324 -0.532 0 O-C-N 124.468 1.105 . . . . 0.0 109.283 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 172' ' ' ALA . . . . . 0.593 ' HA ' ' O ' ' A' ' 160' ' ' ARG . . . -119.05 -178.43 3.56 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.476 1.11 . . . . 0.0 109.303 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 173' ' ' GLU . . . . . 0.436 ' CG ' ' HG3' ' A' ' 179' ' ' ARG . 34.0 mt-10 -119.73 121.15 38.55 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.47 1.106 . . . . 0.0 110.27 -179.898 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -72.44 -164.22 0.14 Allowed 'General case' 0 C--N 1.323 -0.547 0 O-C-N 124.594 1.184 . . . . 0.0 109.259 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 52.6 p -87.53 56.94 4.15 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.465 1.103 . . . . 0.0 109.999 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -177.22 28.45 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.532 1.145 . . . . 0.0 110.189 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 53.23 24.69 23.06 Favored Glycine 0 CA--C 1.531 1.078 0 O-C-N 124.562 1.164 . . . . 0.0 111.003 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 3.1 mtpm? -90.93 108.89 20.15 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.503 0.767 . . . . 0.0 109.355 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 179' ' ' ARG . . . . . 0.436 ' HG3' ' CG ' ' A' ' 173' ' ' GLU . 0.0 OUTLIER -90.7 114.97 27.42 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.499 1.125 . . . . 0.0 110.34 179.955 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 180' ' ' GLY . . . . . 0.414 ' O ' ' HA ' ' A' ' 171' ' ' ASN . . . -150.79 174.31 30.13 Favored Glycine 0 CA--C 1.53 1.013 0 O-C-N 124.486 1.116 . . . . 0.0 111.01 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 181' ' ' MET . . . . . 0.419 ' HA ' ' O ' ' A' ' 170' ' ' TRP . 33.5 mtp -88.04 106.19 17.98 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.537 0.786 . . . . 0.0 110.99 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 182' ' ' ILE . . . . . 1.046 HD13 HD22 ' A' ' 159' ' ' LEU . 6.8 pt -106.65 159.38 30.06 Favored Pre-proline 0 C--N 1.325 -0.496 0 O-C-N 124.505 1.128 . . . . 0.0 109.36 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 183' ' ' PRO . . . . . 0.565 ' HG2' ' CB ' ' A' ' 186' ' ' TYR . 18.1 Cg_endo -75.02 127.5 10.72 Favored 'Trans proline' 0 C--N 1.36 1.174 0 O-C-N 124.418 1.746 . . . . 0.0 111.013 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 184' ' ' VAL . . . . . 0.769 HG21 ' CD2' ' A' ' 170' ' ' TRP . 21.8 t -76.17 -34.92 1.51 Allowed Pre-proline 0 C--N 1.325 -0.49 0 O-C-N 124.514 1.134 . . . . 0.0 109.334 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 185' ' ' PRO . . . . . 0.758 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.4 Cg_endo -74.95 -9.73 20.98 Favored 'Trans proline' 0 C--N 1.36 1.162 0 O-C-N 124.51 1.795 . . . . 0.0 110.988 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 186' ' ' TYR . . . . . 0.565 ' CB ' ' HG2' ' A' ' 183' ' ' PRO . 3.2 m-85 -95.95 -5.92 40.23 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.464 1.103 . . . . 0.0 110.962 -179.897 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 187' ' ' VAL . . . . . 0.661 HG12 ' CB ' ' A' ' 139' ' ' ALA . 7.6 m -129.33 175.47 10.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 O-C-N 124.391 1.057 . . . . 0.0 109.282 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 188' ' ' GLU . . . . . 0.57 ' HG2' HD11 ' A' ' 140' ' ' LEU . 0.0 OUTLIER -131.63 173.26 11.31 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.534 1.147 . . . . 0.0 110.297 179.971 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.05 119.43 28.41 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.502 1.126 . . . . 0.0 109.273 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 1.6 t80 . . . . . 0 C--N 1.324 -0.507 0 O-C-N 124.448 1.092 . . . . 0.0 110.92 -179.991 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 135' ' ' GLU . . . . . 0.641 ' HG2' HG22 ' A' ' 161' ' ' ILE . 0.8 OUTLIER . . . . . 0 N--CA 1.452 -0.344 0 N-CA-C 110.351 -0.24 . . . . 0.0 110.351 . . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -124.46 114.5 19.54 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.496 1.123 . . . . 0.0 111.038 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.443 HG22 ' HB ' ' A' ' 187' ' ' VAL . 0.4 OUTLIER -113.06 132.22 62.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 O-C-N 124.419 1.074 . . . . 0.0 109.282 -179.993 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 138' ' ' ARG . . . . . 0.501 ' HG3' ' N ' ' A' ' 139' ' ' ALA . 2.7 ttm180 -101.09 142.85 31.95 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.462 1.101 . . . . 0.0 110.259 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 0.515 ' O ' ' N ' ' A' ' 156' ' ' GLY . . . -105.85 109.08 20.91 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.564 1.165 . . . . 0.0 109.345 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.511 ' O ' ' CG ' ' A' ' 155' ' ' LYS . 0.3 OUTLIER -87.36 -22.42 25.08 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.496 1.123 . . . . 0.0 109.272 -179.944 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 141' ' ' PHE . . . . . 0.408 ' CD1' ' N ' ' A' ' 141' ' ' PHE . 0.6 OUTLIER -108.99 146.9 33.13 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.487 1.117 . . . . 0.0 111.013 179.972 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 142' ' ' ASP . . . . . 0.426 ' CB ' ' HA ' ' A' ' 154' ' ' LYS . 5.7 t70 . . . . . 0 C--N 1.325 -0.489 0 O-C-N 124.537 1.148 . . . . 0.0 109.296 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 153' ' ' PHE . . . . . 0.596 ' CZ ' ' CD ' ' A' ' 183' ' ' PRO . 0.4 OUTLIER . . . . . 0 N--CA 1.453 -0.307 0 CA-C-O 120.542 0.211 . . . . 0.0 111.018 . . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 154' ' ' LYS . . . . . 0.426 ' HA ' ' CB ' ' A' ' 142' ' ' ASP . 0.1 OUTLIER -127.13 -164.91 1.4 Allowed 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.458 1.099 . . . . 0.0 109.315 -179.995 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.511 ' CG ' ' O ' ' A' ' 140' ' ' LEU . 1.5 tttp -97.08 99.16 10.68 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.475 1.109 . . . . 0.0 109.317 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 156' ' ' GLY . . . . . 0.515 ' N ' ' O ' ' A' ' 139' ' ' ALA . . . 116.08 29.54 2.34 Favored Glycine 0 CA--C 1.53 1.008 0 O-C-N 124.534 1.146 . . . . 0.0 111.01 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 157' ' ' ASP . . . . . 0.932 ' C ' HD12 ' A' ' 158' ' ' ILE . 12.4 t70 -102.9 166.81 10.25 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.607 0.828 . . . . 0.0 109.305 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 158' ' ' ILE . . . . . 0.932 HD12 ' C ' ' A' ' 157' ' ' ASP . 1.9 mp -123.56 146.28 29.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 O-C-N 124.476 1.11 . . . . 0.0 109.344 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.775 HD21 ' OD2' ' A' ' 174' ' ' ASP . 0.8 OUTLIER -144.11 128.85 18.27 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.513 1.133 . . . . 0.0 109.314 -179.98 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 160' ' ' ARG . . . . . 0.558 ' O ' ' HA ' ' A' ' 172' ' ' ALA . 2.0 tmt_? -87.72 127.77 35.3 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.458 1.099 . . . . 0.0 110.292 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.641 HG22 ' HG2' ' A' ' 135' ' ' GLU . 1.7 mp -84.96 130.85 35.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.455 1.097 . . . . 0.0 109.288 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 162' ' ' ARG . . . . . 0.467 ' HD3' ' CZ ' ' A' ' 179' ' ' ARG . 33.7 ttt85 -127.3 -46.44 1.49 Allowed 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.46 1.1 . . . . 0.0 110.314 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 163' ' ' ASP . . . . . 0.48 ' CB ' ' HB3' ' A' ' 171' ' ' ASN . 0.2 OUTLIER -123.7 161.4 25.19 Favored 'General case' 0 C--N 1.326 -0.433 0 O-C-N 124.508 1.13 . . . . 0.0 109.281 179.991 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 164' ' ' LYS . . . . . 0.513 ' CG ' ' O ' ' A' ' 164' ' ' LYS . 0.1 OUTLIER -165.23 64.14 1.0 Allowed Pre-proline 0 C--N 1.327 -0.391 0 O-C-N 124.463 1.102 . . . . 0.0 109.261 179.98 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 165' ' ' PRO . . . . . 0.425 ' HD3' ' N ' ' A' ' 164' ' ' LYS . 18.1 Cg_endo -75.03 -49.18 0.15 Allowed 'Trans proline' 0 C--N 1.359 1.089 0 O-C-N 124.547 1.814 . . . . 0.0 110.977 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 166' ' ' GLU . . . . . 0.588 ' HG3' ' HE1' ' A' ' 181' ' ' MET . 5.4 mt-10 -66.14 167.57 9.86 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.499 1.124 . . . . 0.0 110.244 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 5.3 mp0 -110.87 40.91 1.91 Allowed 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.448 1.093 . . . . 0.0 110.309 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 5.4 mt-30 -159.44 -57.82 0.06 Allowed 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.553 1.158 . . . . 0.0 110.263 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 169' ' ' TRP . . . . . . . . . . . . . 10.4 m95 -102.04 144.45 30.62 Favored 'General case' 0 C--N 1.324 -0.523 0 O-C-N 124.567 1.167 . . . . 0.0 107.972 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 170' ' ' TRP . . . . . 0.75 ' CE2' HG21 ' A' ' 184' ' ' VAL . 50.8 m0 -116.28 146.88 42.06 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 171' ' ' ASN . . . . . 0.499 ' OD1' ' CD ' ' A' ' 179' ' ' ARG . 18.7 t-20 -87.72 99.88 12.42 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.505 1.128 . . . . 0.0 109.288 180.0 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 172' ' ' ALA . . . . . 0.558 ' HA ' ' O ' ' A' ' 160' ' ' ARG . . . -119.87 168.77 10.77 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.484 1.115 . . . . 0.0 109.267 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 173' ' ' GLU . . . . . 0.485 ' HG3' ' CB ' ' A' ' 179' ' ' ARG . 1.8 mt-10 -113.92 124.12 51.41 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.53 1.144 . . . . 0.0 110.292 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 174' ' ' ASP . . . . . 0.775 ' OD2' HD21 ' A' ' 159' ' ' LEU . 0.2 OUTLIER -73.99 -168.5 0.62 Allowed 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.47 1.106 . . . . 0.0 109.309 179.97 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 10.5 t -81.17 58.31 3.48 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 124.404 1.065 . . . . 0.0 110.024 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -175.11 16.85 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.449 1.093 . . . . 0.0 110.317 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 177' ' ' GLY . . . . . 0.405 ' C ' ' HG2' ' A' ' 173' ' ' GLU . . . 64.12 17.36 61.2 Favored Glycine 0 CA--C 1.529 0.951 0 O-C-N 124.562 1.164 . . . . 0.0 111.005 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 178' ' ' LYS . . . . . 0.408 ' O ' ' HA ' ' A' ' 173' ' ' GLU . 0.8 OUTLIER -85.95 102.09 13.45 Favored 'General case' 0 C--N 1.326 -0.441 0 O-C-N 124.472 0.748 . . . . 0.0 109.307 179.985 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 179' ' ' ARG . . . . . 0.499 ' CD ' ' OD1' ' A' ' 171' ' ' ASN . 20.1 ttm-85 -88.15 120.35 29.42 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.464 1.102 . . . . 0.0 110.328 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 180' ' ' GLY . . . . . 0.416 ' O ' ' HA ' ' A' ' 171' ' ' ASN . . . -152.36 172.45 31.56 Favored Glycine 0 CA--C 1.53 1.013 0 O-C-N 124.554 1.159 . . . . 0.0 110.953 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 181' ' ' MET . . . . . 0.588 ' HE1' ' HG3' ' A' ' 166' ' ' GLU . 35.7 mtp -86.96 99.82 12.15 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.46 0.741 . . . . 0.0 111.009 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 182' ' ' ILE . . . . . 0.583 HD13 HD13 ' A' ' 159' ' ' LEU . 5.7 pt -99.38 160.6 27.1 Favored Pre-proline 0 C--N 1.325 -0.46 0 O-C-N 124.454 1.096 . . . . 0.0 109.381 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 183' ' ' PRO . . . . . 0.739 ' HG2' ' HB2' ' A' ' 186' ' ' TYR . 18.5 Cg_endo -75.05 135.16 18.61 Favored 'Trans proline' 0 C--N 1.359 1.1 0 O-C-N 124.462 1.77 . . . . 0.0 111.019 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 184' ' ' VAL . . . . . 0.851 ' N ' ' CD ' ' A' ' 185' ' ' PRO . 42.9 t -80.07 -30.16 0.59 Allowed Pre-proline 0 C--N 1.325 -0.493 0 O-C-N 124.522 1.139 . . . . 0.0 109.321 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 185' ' ' PRO . . . . . 0.851 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.4 Cg_endo -75.02 -21.42 15.83 Favored 'Trans proline' 0 C--N 1.36 1.155 0 O-C-N 124.532 1.806 . . . . 0.0 110.963 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 186' ' ' TYR . . . . . 0.739 ' HB2' ' HG2' ' A' ' 183' ' ' PRO . 4.1 m-85 -94.42 15.52 17.51 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.52 1.138 . . . . 0.0 111.001 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 187' ' ' VAL . . . . . 0.474 ' HA ' ' O ' ' A' ' 138' ' ' ARG . 27.4 m -143.37 171.83 8.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 O-C-N 124.453 1.096 . . . . 0.0 109.294 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 188' ' ' GLU . . . . . 0.475 ' N ' ' O ' ' A' ' 138' ' ' ARG . 0.0 OUTLIER -131.75 169.65 15.92 Favored 'General case' 0 C--N 1.326 -0.442 0 O-C-N 124.462 1.102 . . . . 0.0 110.257 179.999 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -88.15 127.9 35.43 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.427 1.079 . . . . 0.0 109.304 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.325 -0.498 0 O-C-N 124.481 1.113 . . . . 0.0 111.053 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 135' ' ' GLU . . . . . 0.41 ' CB ' ' HB ' ' A' ' 161' ' ' ILE . 0.4 OUTLIER . . . . . 0 N--CA 1.452 -0.334 0 N-CA-C 110.286 -0.264 . . . . 0.0 110.286 . . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 8.6 m-85 -130.95 99.97 5.09 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.522 1.139 . . . . 0.0 110.94 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.855 HG22 ' HB ' ' A' ' 187' ' ' VAL . 11.8 p -102.22 130.66 51.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 O-C-N 124.55 1.156 . . . . 0.0 109.289 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 138' ' ' ARG . . . . . 0.495 ' O ' ' N ' ' A' ' 188' ' ' GLU . 13.7 ttm180 -97.59 151.55 19.95 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.502 1.126 . . . . 0.0 110.339 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 0.858 ' HB3' ' OD2' ' A' ' 157' ' ' ASP . . . -120.63 106.34 11.65 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.467 1.104 . . . . 0.0 109.259 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.608 HD11 ' HG2' ' A' ' 188' ' ' GLU . 0.0 OUTLIER -91.14 -22.97 20.41 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.561 1.163 . . . . 0.0 109.331 179.944 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 141' ' ' PHE . . . . . 0.512 ' CD2' ' HA ' ' A' ' 186' ' ' TYR . 97.1 m-85 -85.66 161.38 19.27 Favored 'General case' 0 C--N 1.326 -0.418 0 O-C-N 124.44 1.088 . . . . 0.0 110.98 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 142' ' ' ASP . . . . . 0.498 ' CA ' ' O ' ' A' ' 154' ' ' LYS . 0.5 OUTLIER . . . . . 0 C--N 1.324 -0.507 0 O-C-N 124.508 1.13 . . . . 0.0 109.272 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 1.2 p90 . . . . . 0 N--CA 1.454 -0.253 0 CA-C-O 120.502 0.191 . . . . 0.0 110.955 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 154' ' ' LYS . . . . . 0.498 ' O ' ' CA ' ' A' ' 142' ' ' ASP . 32.2 tttt -121.6 -82.26 0.65 Allowed 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.498 1.124 . . . . 0.0 109.348 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.477 ' CG ' ' O ' ' A' ' 140' ' ' LEU . 0.0 OUTLIER -175.25 108.63 0.1 Allowed 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.499 1.124 . . . . 0.0 109.326 179.973 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 156' ' ' GLY . . . . . 0.434 ' N ' ' O ' ' A' ' 139' ' ' ALA . . . 104.83 16.1 18.27 Favored Glycine 0 CA--C 1.529 0.964 0 O-C-N 124.493 1.12 . . . . 0.0 111.05 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 157' ' ' ASP . . . . . 0.858 ' OD2' ' HB3' ' A' ' 139' ' ' ALA . 2.3 p-10 -88.2 144.51 26.42 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.494 0.761 . . . . 0.0 109.327 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 158' ' ' ILE . . . . . 0.668 HD12 ' N ' ' A' ' 158' ' ' ILE . 1.1 mp -95.93 150.02 4.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 O-C-N 124.438 1.086 . . . . 0.0 109.314 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.796 HD13 HG21 ' A' ' 182' ' ' ILE . 5.3 mt -145.65 133.77 21.55 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.542 1.151 . . . . 0.0 109.28 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 160' ' ' ARG . . . . . 0.517 ' O ' ' HB1' ' A' ' 172' ' ' ALA . 2.0 ttt180 -90.28 129.48 36.51 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.51 1.131 . . . . 0.0 110.322 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.459 HD12 ' HE3' ' A' ' 170' ' ' TRP . 24.1 mm -85.23 124.2 39.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 O-C-N 124.517 1.136 . . . . 0.0 109.253 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -119.39 -62.96 1.44 Allowed 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.507 1.129 . . . . 0.0 110.336 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -111.31 157.03 20.65 Favored 'General case' 0 C--N 1.324 -0.522 0 O-C-N 124.498 1.124 . . . . 0.0 109.333 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 164' ' ' LYS . . . . . 0.536 ' HG3' ' CE2' ' A' ' 170' ' ' TRP . 0.0 OUTLIER -157.81 63.08 2.67 Favored Pre-proline 0 C--N 1.324 -0.506 0 O-C-N 124.469 1.105 . . . . 0.0 109.306 -179.989 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 165' ' ' PRO . . . . . 0.441 ' HD3' ' N ' ' A' ' 164' ' ' LYS . 18.2 Cg_endo -75.05 -58.89 0.04 OUTLIER 'Trans proline' 0 C--N 1.36 1.148 0 O-C-N 124.445 1.761 . . . . 0.0 111.005 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -62.01 167.26 3.98 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.509 1.131 . . . . 0.0 110.248 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 6.5 mt-10 -106.99 45.77 0.97 Allowed 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.501 1.126 . . . . 0.0 110.349 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -167.03 -59.53 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.535 1.147 . . . . 0.0 110.346 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 169' ' ' TRP . . . . . . . . . . . . . 25.4 m95 -102.69 135.2 44.76 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.553 1.158 . . . . 0.0 107.966 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 170' ' ' TRP . . . . . 1.009 ' CE2' HG21 ' A' ' 184' ' ' VAL . 27.8 m0 -117.31 151.65 36.54 Favored 'General case' 0 C--N 1.324 -0.533 0 O-C-N 124.551 1.157 . . . . 0.0 108.048 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 171' ' ' ASN . . . . . 0.418 ' HA ' ' O ' ' A' ' 180' ' ' GLY . 2.8 t-20 -86.23 102.98 14.42 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.432 1.083 . . . . 0.0 109.268 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 172' ' ' ALA . . . . . 1.125 ' HB3' HD13 ' A' ' 182' ' ' ILE . . . -113.1 179.89 3.83 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.488 1.117 . . . . 0.0 109.309 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 173' ' ' GLU . . . . . 0.473 ' CG ' ' HG3' ' A' ' 179' ' ' ARG . 28.0 mt-10 -125.34 125.91 44.23 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.5 1.125 . . . . 0.0 110.271 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 174' ' ' ASP . . . . . 0.604 ' HA ' HD23 ' A' ' 159' ' ' LEU . 2.9 t70 -74.6 -163.92 0.24 Allowed 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.477 1.111 . . . . 0.0 109.307 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -89.32 47.04 1.43 Allowed 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.582 1.177 . . . . 0.0 110.019 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -169.68 24.51 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.546 1.154 . . . . 0.0 110.287 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 62.57 20.51 61.57 Favored Glycine 0 CA--C 1.53 0.976 0 O-C-N 124.441 1.088 . . . . 0.0 111.004 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 4.8 tptt -81.21 104.26 11.56 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.524 0.779 . . . . 0.0 109.285 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 179' ' ' ARG . . . . . 0.476 ' HA ' ' O ' ' A' ' 172' ' ' ALA . 0.0 OUTLIER -89.26 116.92 27.84 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.427 1.079 . . . . 0.0 110.373 179.946 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 180' ' ' GLY . . . . . 0.549 ' O ' HD12 ' A' ' 182' ' ' ILE . . . -151.46 173.39 30.83 Favored Glycine 0 CA--C 1.53 0.979 0 O-C-N 124.452 1.095 . . . . 0.0 111.007 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 181' ' ' MET . . . . . 0.43 ' HA ' ' O ' ' A' ' 170' ' ' TRP . 12.9 mmm -86.14 103.6 14.94 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.461 0.742 . . . . 0.0 110.986 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 182' ' ' ILE . . . . . 1.125 HD13 ' HB3' ' A' ' 172' ' ' ALA . 4.1 mp -94.5 145.27 29.37 Favored Pre-proline 0 C--N 1.324 -0.509 0 O-C-N 124.563 1.164 . . . . 0.0 109.289 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 183' ' ' PRO . . . . . 0.836 ' HD2' HG23 ' A' ' 182' ' ' ILE . 18.3 Cg_endo -75.01 133.63 16.81 Favored 'Trans proline' 0 C--N 1.36 1.164 0 O-C-N 124.448 1.762 . . . . 0.0 110.977 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 184' ' ' VAL . . . . . 1.009 HG21 ' CE2' ' A' ' 170' ' ' TRP . 25.2 t -78.62 -31.14 0.73 Allowed Pre-proline 0 C--N 1.325 -0.469 0 O-C-N 124.509 1.131 . . . . 0.0 109.309 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 185' ' ' PRO . . . . . 0.814 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.1 Cg_endo -75.09 -25.96 11.23 Favored 'Trans proline' 0 C--N 1.359 1.123 0 O-C-N 124.474 1.776 . . . . 0.0 110.932 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 186' ' ' TYR . . . . . 0.774 ' HB2' ' HG2' ' A' ' 183' ' ' PRO . 4.1 m-85 -95.91 15.54 20.18 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.475 1.109 . . . . 0.0 110.994 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 187' ' ' VAL . . . . . 0.855 ' HB ' HG22 ' A' ' 137' ' ' VAL . 24.4 m -139.59 173.96 10.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 O-C-N 124.451 1.094 . . . . 0.0 109.278 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 188' ' ' GLU . . . . . 0.608 ' HG2' HD11 ' A' ' 140' ' ' LEU . 0.0 OUTLIER -135.18 172.31 13.2 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.448 1.093 . . . . 0.0 110.353 179.966 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 189' ' ' LYS . . . . . 0.45 ' HD2' ' N ' ' A' ' 189' ' ' LYS . 0.0 OUTLIER -95.63 114.19 25.91 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.545 1.153 . . . . 0.0 109.267 -179.96 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 15.6 t80 . . . . . 0 C--N 1.325 -0.482 0 O-C-N 124.507 1.129 . . . . 0.0 110.962 -179.991 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 135' ' ' GLU . . . . . 0.512 ' HG2' HG22 ' A' ' 161' ' ' ILE . 0.2 OUTLIER . . . . . 0 N--CA 1.452 -0.366 0 N-CA-C 110.32 -0.252 . . . . 0.0 110.32 . . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 136' ' ' TYR . . . . . 0.434 ' O ' ' HB3' ' A' ' 190' ' ' TYR . 0.4 OUTLIER -135.64 141.74 45.09 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.473 1.108 . . . . 0.0 111.003 179.993 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.556 HG21 HD11 ' A' ' 182' ' ' ILE . 34.3 m -133.66 157.51 42.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 O-C-N 124.476 1.11 . . . . 0.0 109.322 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 138' ' ' ARG . . . . . 0.785 ' HD3' HD13 ' A' ' 158' ' ' ILE . 4.2 tpp85 -127.3 127.07 43.73 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.436 1.085 . . . . 0.0 110.241 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 0.698 ' O ' ' N ' ' A' ' 156' ' ' GLY . . . -88.41 106.93 18.58 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.432 1.083 . . . . 0.0 109.323 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.413 HD11 ' HB3' ' A' ' 188' ' ' GLU . 0.4 OUTLIER -87.29 -5.14 59.03 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.538 1.149 . . . . 0.0 109.336 -179.994 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 141' ' ' PHE . . . . . 0.492 ' CD1' ' HA ' ' A' ' 186' ' ' TYR . 6.2 m-85 -123.32 151.92 41.97 Favored 'General case' 0 C--N 1.326 -0.443 0 O-C-N 124.486 1.116 . . . . 0.0 111.028 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 3.5 t70 . . . . . 0 C--N 1.326 -0.454 0 O-C-N 124.506 1.129 . . . . 0.0 109.345 179.96 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 6.5 p90 . . . . . 0 N--CA 1.453 -0.296 0 CA-C-O 120.469 0.176 . . . . 0.0 111.049 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.56 -164.42 1.38 Allowed 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.472 1.107 . . . . 0.0 109.305 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -96.4 96.29 8.63 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.534 1.147 . . . . 0.0 109.288 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 156' ' ' GLY . . . . . 0.698 ' N ' ' O ' ' A' ' 139' ' ' ALA . . . 122.63 29.81 1.24 Allowed Glycine 0 CA--C 1.53 0.981 0 O-C-N 124.487 1.117 . . . . 0.0 111.002 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 157' ' ' ASP . . . . . 0.489 ' HB3' ' HB3' ' A' ' 139' ' ' ALA . 12.1 t70 -97.9 159.43 14.94 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.449 0.734 . . . . 0.0 109.298 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 158' ' ' ILE . . . . . 0.785 HD13 ' HD3' ' A' ' 138' ' ' ARG . 6.5 mm -115.04 147.37 18.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 O-C-N 124.533 1.146 . . . . 0.0 109.359 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 1.116 HD13 HD13 ' A' ' 182' ' ' ILE . 1.1 mt -149.21 138.79 21.73 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.531 1.144 . . . . 0.0 109.371 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 160' ' ' ARG . . . . . 0.609 ' O ' ' HA ' ' A' ' 172' ' ' ALA . 0.0 OUTLIER -95.71 134.22 38.89 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.543 1.152 . . . . 0.0 110.349 -179.983 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.512 HG22 ' HG2' ' A' ' 135' ' ' GLU . 15.4 mm -84.43 118.41 31.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 O-C-N 124.424 1.077 . . . . 0.0 109.264 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -112.36 -51.57 2.83 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.469 1.106 . . . . 0.0 110.285 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -138.86 168.39 19.93 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.495 1.122 . . . . 0.0 109.325 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 164' ' ' LYS . . . . . 0.581 ' HB3' ' CD1' ' A' ' 170' ' ' TRP . 27.4 mtmt -148.93 85.97 5.85 Favored Pre-proline 0 C--N 1.324 -0.513 0 O-C-N 124.499 1.124 . . . . 0.0 109.341 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.03 -30.57 6.98 Favored 'Trans proline' 0 C--N 1.36 1.138 0 O-C-N 124.498 1.788 . . . . 0.0 111.012 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -128.92 153.99 46.97 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.554 1.159 . . . . 0.0 110.272 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -77.75 -23.62 49.24 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.497 1.123 . . . . 0.0 110.265 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -75.9 -57.06 4.1 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.487 1.117 . . . . 0.0 110.329 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 169' ' ' TRP . . . . . . . . . . . . . 14.0 m95 -111.33 156.22 21.88 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.547 1.154 . . . . 0.0 107.995 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 170' ' ' TRP . . . . . 0.581 ' CD1' ' HB3' ' A' ' 164' ' ' LYS . 23.6 m0 -131.46 148.53 52.65 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.477 1.111 . . . . 0.0 108.017 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 171' ' ' ASN . . . . . 0.529 ' OD1' ' HG2' ' A' ' 179' ' ' ARG . 6.2 t-20 -87.26 98.98 11.63 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.503 1.127 . . . . 0.0 109.306 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 172' ' ' ALA . . . . . 0.609 ' HA ' ' O ' ' A' ' 160' ' ' ARG . . . -118.86 175.59 5.68 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.456 1.097 . . . . 0.0 109.327 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 173' ' ' GLU . . . . . 0.66 ' C ' HD23 ' A' ' 159' ' ' LEU . 1.5 tt0 -118.02 118.26 31.44 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.441 1.088 . . . . 0.0 110.324 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 174' ' ' ASP . . . . . 0.577 ' N ' HD23 ' A' ' 159' ' ' LEU . 0.9 OUTLIER -66.43 -174.73 0.3 Allowed 'General case' 0 C--N 1.326 -0.434 0 O-C-N 124.461 1.101 . . . . 0.0 109.308 -179.947 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -78.72 53.16 1.3 Allowed 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.461 1.1 . . . . 0.0 110.018 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -172.21 11.25 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.446 1.091 . . . . 0.0 110.323 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 177' ' ' GLY . . . . . 0.49 ' C ' ' HG2' ' A' ' 173' ' ' GLU . . . 73.27 18.02 79.09 Favored Glycine 0 CA--C 1.53 0.978 0 O-C-N 124.509 1.131 . . . . 0.0 111.008 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -79.66 103.85 9.86 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.54 0.788 . . . . 0.0 109.349 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 179' ' ' ARG . . . . . 0.558 ' HG3' ' HG3' ' A' ' 173' ' ' GLU . 0.0 OUTLIER -87.65 113.21 23.12 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.434 1.084 . . . . 0.0 110.296 179.985 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 180' ' ' GLY . . . . . 0.403 ' O ' ' HA ' ' A' ' 171' ' ' ASN . . . -152.2 172.89 31.43 Favored Glycine 0 CA--C 1.53 0.977 0 O-C-N 124.428 1.08 . . . . 0.0 111.026 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 181' ' ' MET . . . . . 0.422 ' HA ' ' O ' ' A' ' 170' ' ' TRP . 3.0 mmm -87.7 97.49 10.92 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.492 0.76 . . . . 0.0 111.017 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 182' ' ' ILE . . . . . 1.116 HD13 HD13 ' A' ' 159' ' ' LEU . 3.4 pt -90.78 157.69 43.37 Favored Pre-proline 0 C--N 1.325 -0.498 0 O-C-N 124.498 1.124 . . . . 0.0 109.323 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 183' ' ' PRO . . . . . 0.741 ' HG2' ' HB2' ' A' ' 186' ' ' TYR . 18.3 Cg_endo -75.06 136.86 20.84 Favored 'Trans proline' 0 C--N 1.36 1.164 0 O-C-N 124.557 1.819 . . . . 0.0 111.012 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 184' ' ' VAL . . . . . 0.838 ' N ' ' CD ' ' A' ' 185' ' ' PRO . 92.2 t -82.08 -31.07 0.54 Allowed Pre-proline 0 C--N 1.325 -0.474 0 O-C-N 124.527 1.142 . . . . 0.0 109.37 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 185' ' ' PRO . . . . . 0.838 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.4 Cg_endo -74.99 -27.71 9.81 Favored 'Trans proline' 0 C--N 1.36 1.184 0 O-C-N 124.458 1.767 . . . . 0.0 111.012 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 186' ' ' TYR . . . . . 0.741 ' HB2' ' HG2' ' A' ' 183' ' ' PRO . 5.1 m-85 -91.37 15.17 12.7 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.493 1.12 . . . . 0.0 110.997 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 187' ' ' VAL . . . . . 0.699 HG11 HD12 ' A' ' 182' ' ' ILE . 34.5 m -143.22 167.32 13.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 O-C-N 124.504 1.127 . . . . 0.0 109.261 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 188' ' ' GLU . . . . . 0.483 ' CG ' ' HB3' ' A' ' 138' ' ' ARG . 0.0 OUTLIER -126.3 168.03 14.68 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 124.487 1.117 . . . . 0.0 110.329 179.943 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 12.3 mmmm -89.25 129.88 35.74 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.511 1.132 . . . . 0.0 109.274 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 190' ' ' TYR . . . . . 0.434 ' HB3' ' O ' ' A' ' 136' ' ' TYR . 0.8 OUTLIER . . . . . 0 C--N 1.324 -0.512 0 O-C-N 124.48 1.112 . . . . 0.0 110.963 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 135' ' ' GLU . . . . . 0.522 ' O ' ' HG2' ' A' ' 160' ' ' ARG . 0.1 OUTLIER . . . . . 0 N--CA 1.454 -0.262 0 N-CA-C 110.266 -0.272 . . . . 0.0 110.266 . . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 136' ' ' TYR . . . . . 0.44 ' CE1' ' HG3' ' A' ' 160' ' ' ARG . 0.7 OUTLIER -129.19 132.4 47.28 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.432 1.083 . . . . 0.0 110.963 179.963 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.42 ' HA ' ' O ' ' A' ' 188' ' ' GLU . 3.4 m -128.15 164.51 29.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 O-C-N 124.449 1.093 . . . . 0.0 109.297 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 138' ' ' ARG . . . . . 0.455 ' O ' ' HA ' ' A' ' 187' ' ' VAL . 0.5 OUTLIER -123.57 126.32 46.45 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.482 1.114 . . . . 0.0 110.308 179.975 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 0.472 ' O ' ' N ' ' A' ' 156' ' ' GLY . . . -89.8 103.9 16.51 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.559 1.162 . . . . 0.0 109.258 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.774 HD11 ' HG2' ' A' ' 188' ' ' GLU . 0.2 OUTLIER -87.94 12.62 12.79 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.498 1.123 . . . . 0.0 109.231 -179.99 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 141' ' ' PHE . . . . . 0.471 ' O ' ' O ' ' A' ' 154' ' ' LYS . 23.7 m-85 -146.69 154.99 42.08 Favored 'General case' 0 C--N 1.324 -0.532 0 O-C-N 124.577 1.173 . . . . 0.0 111.041 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 142' ' ' ASP . . . . . 0.487 ' CB ' ' HA ' ' A' ' 154' ' ' LYS . 7.2 p-10 . . . . . 0 C--N 1.325 -0.457 0 O-C-N 124.51 1.131 . . . . 0.0 109.237 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 153' ' ' PHE . . . . . 0.457 ' CD1' ' C ' ' A' ' 153' ' ' PHE . 7.3 p90 . . . . . 0 N--CA 1.453 -0.308 0 CA-C-O 120.482 0.182 . . . . 0.0 110.981 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 154' ' ' LYS . . . . . 0.487 ' HA ' ' CB ' ' A' ' 142' ' ' ASP . 3.8 tttt -135.61 -156.1 0.69 Allowed 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.562 1.164 . . . . 0.0 109.232 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 4.4 ptpp? -99.84 106.74 18.63 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.494 1.121 . . . . 0.0 109.334 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 156' ' ' GLY . . . . . 0.472 ' N ' ' O ' ' A' ' 139' ' ' ALA . . . 108.88 27.65 4.8 Favored Glycine 0 CA--C 1.53 1.018 0 O-C-N 124.499 1.125 . . . . 0.0 110.953 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 157' ' ' ASP . . . . . 0.406 ' OD2' ' HG ' ' A' ' 159' ' ' LEU . 13.4 t70 -101.04 162.05 13.16 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.46 0.741 . . . . 0.0 109.306 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 19.6 mm -114.0 142.34 26.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 O-C-N 124.621 1.201 . . . . 0.0 109.327 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.818 HD13 HD13 ' A' ' 182' ' ' ILE . 2.2 mt -142.41 135.19 28.28 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.486 1.116 . . . . 0.0 109.328 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 160' ' ' ARG . . . . . 0.571 ' O ' ' HB1' ' A' ' 172' ' ' ALA . 8.2 ttm-85 -97.59 134.72 40.43 Favored 'General case' 0 C--N 1.324 -0.531 0 O-C-N 124.493 1.121 . . . . 0.0 110.303 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.413 ' CB ' ' HB2' ' A' ' 135' ' ' GLU . 1.2 mp -82.65 119.39 32.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 O-C-N 124.537 1.148 . . . . 0.0 109.23 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 162' ' ' ARG . . . . . 0.426 ' NH1' ' HB3' ' A' ' 162' ' ' ARG . 2.8 mmm180 -110.49 -59.19 1.98 Allowed 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.49 1.119 . . . . 0.0 110.332 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -129.23 163.84 24.75 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.456 1.097 . . . . 0.0 109.288 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 164' ' ' LYS . . . . . 0.426 ' HG3' ' NE1' ' A' ' 170' ' ' TRP . 0.3 OUTLIER -139.91 76.19 28.79 Favored Pre-proline 0 C--N 1.325 -0.489 0 O-C-N 124.537 1.148 . . . . 0.0 109.329 -179.951 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.97 -30.73 6.91 Favored 'Trans proline' 0 C--N 1.36 1.165 0 O-C-N 124.469 1.773 . . . . 0.0 111.038 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -113.4 169.68 8.78 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.519 1.137 . . . . 0.0 110.303 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -96.85 -27.92 14.47 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 124.47 1.106 . . . . 0.0 110.33 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -84.51 -55.94 3.88 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.47 1.107 . . . . 0.0 110.308 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 169' ' ' TRP . . . . . 0.436 ' CD1' ' N ' ' A' ' 169' ' ' TRP . 2.7 m95 -111.17 145.68 38.22 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.496 1.122 . . . . 0.0 107.99 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 170' ' ' TRP . . . . . 0.767 ' CD2' HG21 ' A' ' 184' ' ' VAL . 50.3 m0 -122.09 156.78 32.87 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.509 1.131 . . . . 0.0 108.0 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 171' ' ' ASN . . . . . 0.418 ' HA ' ' O ' ' A' ' 180' ' ' GLY . 33.0 t-20 -86.92 98.63 11.34 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.522 1.139 . . . . 0.0 109.351 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 172' ' ' ALA . . . . . 0.571 ' HB1' ' O ' ' A' ' 160' ' ' ARG . . . -113.87 176.19 5.14 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.483 1.114 . . . . 0.0 109.28 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 173' ' ' GLU . . . . . 0.492 ' CG ' ' HG3' ' A' ' 179' ' ' ARG . 9.6 mt-10 -112.75 127.71 56.22 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 124.354 1.033 . . . . 0.0 110.237 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 174' ' ' ASP . . . . . 0.658 ' HA ' HD23 ' A' ' 159' ' ' LEU . 6.2 p30 -83.78 -170.73 3.22 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.483 1.114 . . . . 0.0 109.327 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 1.1 t -79.53 68.06 5.46 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.493 1.121 . . . . 0.0 109.999 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 176.86 -4.39 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.473 1.108 . . . . 0.0 110.28 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 81.61 21.27 62.22 Favored Glycine 0 CA--C 1.53 1.012 0 O-C-N 124.542 1.151 . . . . 0.0 110.98 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 12.9 mtpt -92.04 118.67 31.02 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.483 0.754 . . . . 0.0 109.306 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 179' ' ' ARG . . . . . 0.492 ' HG3' ' CG ' ' A' ' 173' ' ' GLU . 61.0 mtt180 -89.92 121.92 32.47 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.443 1.089 . . . . 0.0 110.237 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 180' ' ' GLY . . . . . 0.418 ' O ' ' HA ' ' A' ' 171' ' ' ASN . . . -150.77 166.93 30.4 Favored Glycine 0 CA--C 1.53 0.994 0 O-C-N 124.456 1.097 . . . . 0.0 111.0 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 181' ' ' MET . . . . . 0.451 ' HA ' ' O ' ' A' ' 170' ' ' TRP . 11.0 mtp -87.16 104.23 16.16 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.488 0.758 . . . . 0.0 110.921 -179.935 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 182' ' ' ILE . . . . . 0.818 HD13 HD13 ' A' ' 159' ' ' LEU . 1.4 pp -106.9 159.99 27.95 Favored Pre-proline 0 C--N 1.324 -0.527 0 O-C-N 124.587 1.18 . . . . 0.0 109.292 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 183' ' ' PRO . . . . . 0.628 ' HG2' ' HB2' ' A' ' 186' ' ' TYR . 18.5 Cg_endo -74.89 131.1 14.04 Favored 'Trans proline' 0 C--N 1.36 1.18 0 O-C-N 124.55 1.816 . . . . 0.0 111.066 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 184' ' ' VAL . . . . . 0.767 HG21 ' CD2' ' A' ' 170' ' ' TRP . 93.4 t -77.87 -33.99 1.06 Allowed Pre-proline 0 C--N 1.324 -0.506 0 O-C-N 124.54 1.15 . . . . 0.0 109.351 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 185' ' ' PRO . . . . . 0.764 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.3 Cg_endo -75.02 -11.44 21.45 Favored 'Trans proline' 0 C--N 1.361 1.199 0 O-C-N 124.41 1.742 . . . . 0.0 111.028 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 186' ' ' TYR . . . . . 0.628 ' HB2' ' HG2' ' A' ' 183' ' ' PRO . 6.7 m-85 -97.01 5.98 49.44 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.586 1.179 . . . . 0.0 110.996 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 187' ' ' VAL . . . . . 0.455 ' HA ' ' O ' ' A' ' 138' ' ' ARG . 8.4 m -137.74 173.32 13.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 O-C-N 124.507 1.13 . . . . 0.0 109.245 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 188' ' ' GLU . . . . . 0.774 ' HG2' HD11 ' A' ' 140' ' ' LEU . 0.0 OUTLIER -129.61 174.64 9.49 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.468 1.105 . . . . 0.0 110.253 -179.972 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 12.2 mmmm -86.98 117.19 25.54 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.472 1.108 . . . . 0.0 109.296 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 5.1 t80 . . . . . 0 C--N 1.325 -0.492 0 O-C-N 124.483 1.114 . . . . 0.0 111.014 179.962 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 135' ' ' GLU . . . . . 0.53 ' HB2' ' O ' ' A' ' 161' ' ' ILE . 1.6 pm0 . . . . . 0 N--CA 1.453 -0.301 0 N-CA-C 110.278 -0.268 . . . . 0.0 110.278 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 136' ' ' TYR . . . . . 0.797 ' CE1' ' CD2' ' A' ' 190' ' ' TYR . 1.4 t80 -122.29 131.13 53.76 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.476 1.11 . . . . 0.0 110.952 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.614 HG11 HG21 ' A' ' 187' ' ' VAL . 3.8 t -132.55 162.16 40.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 O-C-N 124.497 1.123 . . . . 0.0 109.326 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 138' ' ' ARG . . . . . 0.476 ' N ' ' CG1' ' A' ' 137' ' ' VAL . 2.2 tpp85 -136.14 135.28 39.12 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.494 1.121 . . . . 0.0 110.31 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 0.538 ' O ' ' N ' ' A' ' 156' ' ' GLY . . . -98.57 109.51 22.25 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.506 1.129 . . . . 0.0 109.332 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.817 HD21 ' OE2' ' A' ' 188' ' ' GLU . 1.2 mt -88.71 -4.22 58.59 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.435 1.084 . . . . 0.0 109.263 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -133.28 154.46 50.67 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.536 1.147 . . . . 0.0 110.951 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 142' ' ' ASP . . . . . 0.432 ' CB ' ' HA ' ' A' ' 154' ' ' LYS . 7.6 t70 . . . . . 0 C--N 1.326 -0.427 0 O-C-N 124.484 1.115 . . . . 0.0 109.293 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 153' ' ' PHE . . . . . 0.466 ' CE2' ' CG ' ' A' ' 183' ' ' PRO . 18.9 p90 . . . . . 0 N--CA 1.453 -0.318 0 CA-C-O 120.472 0.177 . . . . 0.0 111.031 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 154' ' ' LYS . . . . . 0.432 ' HA ' ' CB ' ' A' ' 142' ' ' ASP . 0.1 OUTLIER -125.9 -164.04 1.27 Allowed 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.504 1.127 . . . . 0.0 109.282 -179.993 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -99.7 103.28 14.94 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.48 1.112 . . . . 0.0 109.267 -179.932 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 156' ' ' GLY . . . . . 0.538 ' N ' ' O ' ' A' ' 139' ' ' ALA . . . 114.76 23.42 4.68 Favored Glycine 0 CA--C 1.529 0.964 0 O-C-N 124.434 1.084 . . . . 0.0 111.013 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 157' ' ' ASP . . . . . 0.481 ' C ' HD12 ' A' ' 158' ' ' ILE . 19.8 t70 -101.69 170.0 8.46 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.454 0.738 . . . . 0.0 109.295 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 158' ' ' ILE . . . . . 0.618 ' CG2' ' CE1' ' A' ' 136' ' ' TYR . 3.6 mp -120.62 146.17 25.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 O-C-N 124.413 1.071 . . . . 0.0 109.257 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.954 HD23 ' HA ' ' A' ' 174' ' ' ASP . 0.9 OUTLIER -140.13 125.54 18.97 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.435 1.084 . . . . 0.0 109.313 179.973 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 160' ' ' ARG . . . . . 0.673 ' O ' ' HB1' ' A' ' 172' ' ' ALA . 1.1 ttp85 -88.04 130.89 34.85 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.554 1.159 . . . . 0.0 110.291 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.53 ' O ' ' HB2' ' A' ' 135' ' ' GLU . 8.7 mm -83.3 125.88 40.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 O-C-N 124.518 1.136 . . . . 0.0 109.283 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.32 -58.85 1.89 Allowed 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.495 1.122 . . . . 0.0 110.34 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 163' ' ' ASP . . . . . 0.421 ' CB ' ' HB3' ' A' ' 171' ' ' ASN . 0.1 OUTLIER -115.37 154.65 28.81 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.5 1.125 . . . . 0.0 109.313 179.948 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 164' ' ' LYS . . . . . 0.543 ' HG3' ' CD1' ' A' ' 170' ' ' TRP . 28.9 tttm -146.47 66.64 11.15 Favored Pre-proline 0 C--N 1.325 -0.476 0 O-C-N 124.552 1.157 . . . . 0.0 109.241 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -74.99 -33.08 4.86 Favored 'Trans proline' 0 C--N 1.36 1.133 0 O-C-N 124.522 1.801 . . . . 0.0 111.019 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -104.48 171.02 7.56 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.498 1.124 . . . . 0.0 110.289 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 21.5 mt-10 -101.4 -30.08 11.66 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.504 1.128 . . . . 0.0 110.31 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -74.47 -61.11 1.98 Allowed 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.559 1.162 . . . . 0.0 110.292 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 169' ' ' TRP . . . . . 0.562 ' CZ2' ' HB3' ' A' ' 183' ' ' PRO . 13.3 m95 -114.35 160.54 18.99 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.481 1.113 . . . . 0.0 108.001 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 170' ' ' TRP . . . . . 0.574 ' CE3' HG22 ' A' ' 184' ' ' VAL . 10.6 m0 -134.19 156.95 47.44 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.53 1.144 . . . . 0.0 108.011 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 171' ' ' ASN . . . . . 0.486 ' HA ' ' O ' ' A' ' 180' ' ' GLY . 40.5 t30 -87.42 102.48 14.58 Favored 'General case' 0 C--N 1.324 -0.522 0 O-C-N 124.523 1.14 . . . . 0.0 109.291 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 172' ' ' ALA . . . . . 0.673 ' HB1' ' O ' ' A' ' 160' ' ' ARG . . . -118.35 -178.19 3.46 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.521 1.138 . . . . 0.0 109.367 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 173' ' ' GLU . . . . . 0.421 ' HA ' ' O ' ' A' ' 178' ' ' LYS . 31.9 mt-10 -114.76 118.52 33.82 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.527 1.142 . . . . 0.0 110.227 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 174' ' ' ASP . . . . . 0.954 ' HA ' HD23 ' A' ' 159' ' ' LEU . 0.2 OUTLIER -73.43 -171.53 1.0 Allowed 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.522 1.139 . . . . 0.0 109.285 -179.998 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 29.1 t -80.07 56.56 2.43 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.546 1.154 . . . . 0.0 110.0 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -173.82 27.05 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.402 1.064 . . . . 0.0 110.392 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 50.47 22.53 5.46 Favored Glycine 0 CA--C 1.53 0.999 0 O-C-N 124.51 1.131 . . . . 0.0 110.992 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 178' ' ' LYS . . . . . 0.421 ' O ' ' HA ' ' A' ' 173' ' ' GLU . 2.7 ptpt -92.86 122.28 35.08 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.515 0.773 . . . . 0.0 109.352 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 40.6 mtt85 -91.16 115.4 27.99 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.467 1.104 . . . . 0.0 110.312 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 180' ' ' GLY . . . . . 0.486 ' O ' ' HA ' ' A' ' 171' ' ' ASN . . . -150.38 179.51 27.05 Favored Glycine 0 CA--C 1.531 1.05 0 O-C-N 124.595 1.185 . . . . 0.0 110.998 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 181' ' ' MET . . . . . 0.41 ' HA ' ' O ' ' A' ' 170' ' ' TRP . 0.4 OUTLIER -85.33 107.35 17.29 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.576 0.81 . . . . 0.0 110.971 -179.989 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 182' ' ' ILE . . . . . 0.839 HG21 HD13 ' A' ' 159' ' ' LEU . 0.9 OUTLIER -98.0 144.14 27.49 Favored Pre-proline 0 C--N 1.325 -0.496 0 O-C-N 124.541 1.151 . . . . 0.0 109.262 -179.982 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 183' ' ' PRO . . . . . 0.724 ' HG2' ' HB2' ' A' ' 186' ' ' TYR . 18.5 Cg_endo -75.01 136.48 20.44 Favored 'Trans proline' 0 C--N 1.36 1.18 0 O-C-N 124.476 1.777 . . . . 0.0 111.021 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 184' ' ' VAL . . . . . 0.815 ' N ' ' CD ' ' A' ' 185' ' ' PRO . 44.3 t -82.03 -32.59 0.6 Allowed Pre-proline 0 C--N 1.326 -0.447 0 O-C-N 124.478 1.111 . . . . 0.0 109.305 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 185' ' ' PRO . . . . . 0.815 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.5 Cg_endo -75.0 -31.46 6.19 Favored 'Trans proline' 0 C--N 1.36 1.163 0 O-C-N 124.48 1.779 . . . . 0.0 111.024 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 186' ' ' TYR . . . . . 0.724 ' HB2' ' HG2' ' A' ' 183' ' ' PRO . 3.8 m-85 -90.8 19.39 5.55 Favored 'General case' 0 C--N 1.326 -0.428 0 O-C-N 124.483 1.114 . . . . 0.0 111.005 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 187' ' ' VAL . . . . . 0.658 HG22 ' O ' ' A' ' 183' ' ' PRO . 11.3 m -149.64 179.49 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 O-C-N 124.44 1.088 . . . . 0.0 109.371 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 188' ' ' GLU . . . . . 0.817 ' OE2' HD21 ' A' ' 140' ' ' LEU . 0.0 OUTLIER -139.54 166.33 24.86 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.496 1.122 . . . . 0.0 110.37 -179.994 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.64 129.74 39.81 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.478 1.111 . . . . 0.0 109.325 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 190' ' ' TYR . . . . . 0.797 ' CD2' ' CE1' ' A' ' 136' ' ' TYR . 0.2 OUTLIER . . . . . 0 C--N 1.326 -0.456 0 O-C-N 124.495 1.122 . . . . 0.0 111.045 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 135' ' ' GLU . . . . . 0.422 ' O ' ' HA ' ' A' ' 160' ' ' ARG . 1.9 pt-20 . . . . . 0 N--CA 1.453 -0.319 0 N-CA-C 110.292 -0.262 . . . . 0.0 110.292 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -111.35 135.17 52.29 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.546 1.154 . . . . 0.0 110.987 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.745 HG12 ' O ' ' A' ' 159' ' ' LEU . 0.5 OUTLIER -126.01 157.03 36.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 O-C-N 124.498 1.124 . . . . 0.0 109.254 -179.933 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 138' ' ' ARG . . . . . 0.531 ' O ' ' HA ' ' A' ' 187' ' ' VAL . 1.4 ttm180 -126.22 139.48 53.31 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.513 1.133 . . . . 0.0 110.263 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 0.629 ' HB3' ' HB3' ' A' ' 157' ' ' ASP . . . -103.61 106.23 16.68 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 124.523 1.14 . . . . 0.0 109.306 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.444 ' O ' ' CG ' ' A' ' 155' ' ' LYS . 0.2 OUTLIER -87.32 -1.39 57.88 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.513 1.133 . . . . 0.0 109.327 179.965 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 141' ' ' PHE . . . . . 0.402 ' O ' ' O ' ' A' ' 154' ' ' LYS . 35.1 m-85 -128.14 159.63 34.54 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.488 1.118 . . . . 0.0 110.96 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 142' ' ' ASP . . . . . 0.468 ' CB ' ' HA ' ' A' ' 154' ' ' LYS . 45.2 p-10 . . . . . 0 C--N 1.324 -0.509 0 O-C-N 124.531 1.145 . . . . 0.0 109.278 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 15.3 p90 . . . . . 0 N--CA 1.452 -0.33 0 CA-C-O 120.447 0.165 . . . . 0.0 111.035 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 154' ' ' LYS . . . . . 0.468 ' HA ' ' CB ' ' A' ' 142' ' ' ASP . 0.0 OUTLIER -130.54 -162.2 1.19 Allowed 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.537 1.148 . . . . 0.0 109.294 179.98 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.444 ' CG ' ' O ' ' A' ' 140' ' ' LEU . 2.9 tmtt? -94.47 107.51 19.48 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.495 1.122 . . . . 0.0 109.335 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 156' ' ' GLY . . . . . 0.453 ' HA2' ' CZ ' ' A' ' 138' ' ' ARG . . . 112.29 23.15 5.58 Favored Glycine 0 CA--C 1.529 0.949 0 O-C-N 124.529 1.143 . . . . 0.0 111.049 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 157' ' ' ASP . . . . . 0.633 ' C ' HD12 ' A' ' 158' ' ' ILE . 21.6 t70 -93.76 170.2 9.74 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.434 0.726 . . . . 0.0 109.296 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 158' ' ' ILE . . . . . 0.633 HD12 ' C ' ' A' ' 157' ' ' ASP . 3.0 mp -132.63 147.85 31.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 O-C-N 124.514 1.134 . . . . 0.0 109.234 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.745 ' O ' HG12 ' A' ' 137' ' ' VAL . 12.0 mt -147.67 131.82 17.36 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.483 1.114 . . . . 0.0 109.335 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 160' ' ' ARG . . . . . 0.604 ' O ' ' HA ' ' A' ' 172' ' ' ALA . 0.5 OUTLIER -86.85 139.38 30.72 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.457 1.098 . . . . 0.0 110.31 -179.975 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.464 ' CD1' ' HB ' ' A' ' 137' ' ' VAL . 1.4 mp -84.02 116.44 27.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 O-C-N 124.48 1.112 . . . . 0.0 109.287 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.92 -58.28 2.0 Allowed 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.499 1.124 . . . . 0.0 110.222 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 163' ' ' ASP . . . . . 0.442 ' OD1' ' N ' ' A' ' 164' ' ' LYS . 0.6 OUTLIER -136.47 161.37 36.02 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.484 1.115 . . . . 0.0 109.307 -179.918 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 164' ' ' LYS . . . . . 0.442 ' N ' ' OD1' ' A' ' 163' ' ' ASP . 0.0 OUTLIER -143.1 84.62 10.29 Favored Pre-proline 0 C--N 1.325 -0.48 0 O-C-N 124.489 1.118 . . . . 0.0 109.298 179.925 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -75.04 -39.04 1.31 Allowed 'Trans proline' 0 C--N 1.36 1.174 0 O-C-N 124.385 1.729 . . . . 0.0 111.029 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 166' ' ' GLU . . . . . 0.463 ' O ' ' NE1' ' A' ' 170' ' ' TRP . 3.9 mm-40 -111.36 178.24 4.4 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.532 1.145 . . . . 0.0 110.345 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.82 -22.02 14.45 Favored 'General case' 0 C--N 1.323 -0.546 0 O-C-N 124.51 1.131 . . . . 0.0 110.31 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 168' ' ' GLN . . . . . 0.444 ' HB3' ' CD1' ' A' ' 169' ' ' TRP . 0.0 OUTLIER -83.89 -57.89 3.02 Favored 'General case' 0 C--N 1.324 -0.523 0 O-C-N 124.527 1.142 . . . . 0.0 110.273 -179.996 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 169' ' ' TRP . . . . . 0.444 ' CD1' ' HB3' ' A' ' 168' ' ' GLN . 11.7 m95 -108.03 149.98 27.73 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.51 1.131 . . . . 0.0 107.994 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 170' ' ' TRP . . . . . 0.656 ' CZ3' HG11 ' A' ' 184' ' ' VAL . 26.6 m0 -131.3 151.59 51.36 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.486 1.116 . . . . 0.0 108.015 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 171' ' ' ASN . . . . . 0.469 ' HB2' ' HE3' ' A' ' 181' ' ' MET . 1.0 OUTLIER -87.64 98.89 11.67 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.548 1.155 . . . . 0.0 109.229 -179.913 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 172' ' ' ALA . . . . . 0.604 ' HA ' ' O ' ' A' ' 160' ' ' ARG . . . -112.46 166.17 11.56 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.434 1.084 . . . . 0.0 109.286 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 173' ' ' GLU . . . . . 0.442 ' HA ' ' O ' ' A' ' 178' ' ' LYS . 18.9 mt-10 -116.13 120.87 40.43 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.523 1.139 . . . . 0.0 110.256 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 174' ' ' ASP . . . . . 0.725 ' HA ' HD23 ' A' ' 159' ' ' LEU . 1.1 p30 -74.77 -173.4 1.84 Allowed 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.521 1.138 . . . . 0.0 109.321 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 22.6 t -79.83 63.24 4.32 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.507 1.129 . . . . 0.0 110.048 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -174.25 9.78 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.553 1.158 . . . . 0.0 110.309 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 68.69 19.49 73.2 Favored Glycine 0 CA--C 1.531 1.08 0 O-C-N 124.57 1.169 . . . . 0.0 110.986 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 178' ' ' LYS . . . . . 0.442 ' O ' ' HA ' ' A' ' 173' ' ' GLU . 0.1 OUTLIER -94.29 112.32 24.11 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 124.583 0.813 . . . . 0.0 109.228 -179.945 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 179' ' ' ARG . . . . . 0.471 ' HA ' ' O ' ' A' ' 172' ' ' ALA . 0.1 OUTLIER -96.69 124.6 40.73 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.548 1.155 . . . . 0.0 110.324 179.915 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -149.9 164.87 29.65 Favored Glycine 0 CA--C 1.531 1.092 0 O-C-N 124.531 1.144 . . . . 0.0 110.947 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 181' ' ' MET . . . . . 0.469 ' HE3' ' HB2' ' A' ' 171' ' ' ASN . 0.3 OUTLIER -88.98 100.98 13.63 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.57 0.806 . . . . 0.0 111.005 179.992 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 182' ' ' ILE . . . . . 0.481 HG12 ' N ' ' A' ' 183' ' ' PRO . 0.2 OUTLIER -108.52 174.09 2.64 Favored Pre-proline 0 C--N 1.325 -0.488 0 O-C-N 124.436 1.085 . . . . 0.0 109.311 -179.999 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 183' ' ' PRO . . . . . 0.601 ' HB2' ' CD1' ' A' ' 186' ' ' TYR . 18.5 Cg_endo -74.95 129.21 12.17 Favored 'Trans proline' 0 C--N 1.36 1.132 0 O-C-N 124.535 1.808 . . . . 0.0 111.014 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 184' ' ' VAL . . . . . 0.816 ' N ' ' CD ' ' A' ' 185' ' ' PRO . 38.7 t -78.91 -32.94 0.83 Allowed Pre-proline 0 C--N 1.325 -0.459 0 O-C-N 124.473 1.108 . . . . 0.0 109.358 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 185' ' ' PRO . . . . . 0.816 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.6 Cg_endo -75.02 -13.84 21.25 Favored 'Trans proline' 0 C--N 1.361 1.189 0 O-C-N 124.45 1.763 . . . . 0.0 111.033 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 186' ' ' TYR . . . . . 0.601 ' CD1' ' HB2' ' A' ' 183' ' ' PRO . 7.9 m-85 -93.93 10.59 32.74 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.514 1.134 . . . . 0.0 110.985 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 187' ' ' VAL . . . . . 0.531 ' HA ' ' O ' ' A' ' 138' ' ' ARG . 20.3 m -143.12 165.01 15.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 O-C-N 124.503 1.127 . . . . 0.0 109.311 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 188' ' ' GLU . . . . . 0.519 ' O ' ' CG2' ' A' ' 137' ' ' VAL . 0.0 OUTLIER -120.42 159.61 24.76 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.512 1.132 . . . . 0.0 110.303 -179.995 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -86.59 134.17 33.66 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.519 1.137 . . . . 0.0 109.292 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.325 -0.475 0 O-C-N 124.53 1.144 . . . . 0.0 111.028 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 135' ' ' GLU . . . . . 0.526 ' O ' ' HG2' ' A' ' 160' ' ' ARG . 0.4 OUTLIER . . . . . 0 N--CA 1.453 -0.293 0 N-CA-C 110.285 -0.265 . . . . 0.0 110.285 . . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 39.2 m-85 -128.82 126.91 40.85 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.459 1.099 . . . . 0.0 110.984 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.796 HG22 ' O ' ' A' ' 159' ' ' LEU . 28.5 m -121.06 170.03 11.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 O-C-N 124.535 1.147 . . . . 0.0 109.334 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 138' ' ' ARG . . . . . 0.494 ' O ' ' HA ' ' A' ' 187' ' ' VAL . 5.1 ttm180 -133.91 127.64 32.91 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.498 1.124 . . . . 0.0 110.306 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 0.597 ' O ' ' N ' ' A' ' 156' ' ' GLY . . . -93.5 115.58 28.1 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.582 1.176 . . . . 0.0 109.27 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.989 HD21 ' OE2' ' A' ' 188' ' ' GLU . 0.2 OUTLIER -95.22 -19.58 19.92 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.545 1.153 . . . . 0.0 109.338 179.908 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 141' ' ' PHE . . . . . 0.444 ' O ' ' O ' ' A' ' 154' ' ' LYS . 5.8 m-85 -114.45 147.52 39.16 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.45 1.094 . . . . 0.0 110.96 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 142' ' ' ASP . . . . . 0.461 ' HB3' ' HA ' ' A' ' 154' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--N 1.325 -0.49 0 O-C-N 124.476 1.11 . . . . 0.0 109.275 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 153' ' ' PHE . . . . . 0.496 ' CE2' ' HD2' ' A' ' 183' ' ' PRO . 20.9 p90 . . . . . 0 N--CA 1.454 -0.248 0 CA-C-O 120.581 0.229 . . . . 0.0 110.947 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 154' ' ' LYS . . . . . 0.461 ' HA ' ' HB3' ' A' ' 142' ' ' ASP . 3.4 tttt -130.0 -120.92 0.22 Allowed 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.46 1.1 . . . . 0.0 109.317 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.52 ' CB ' ' O ' ' A' ' 140' ' ' LEU . 0.3 OUTLIER -126.65 118.22 24.34 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.559 1.162 . . . . 0.0 109.315 179.976 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 156' ' ' GLY . . . . . 0.597 ' N ' ' O ' ' A' ' 139' ' ' ALA . . . 98.16 19.61 23.18 Favored Glycine 0 CA--C 1.53 1.004 0 O-C-N 124.513 1.133 . . . . 0.0 111.012 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -91.45 157.04 17.28 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.54 0.788 . . . . 0.0 109.291 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 12.8 mm -113.19 141.04 30.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 O-C-N 124.486 1.116 . . . . 0.0 109.298 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.796 ' O ' HG22 ' A' ' 137' ' ' VAL . 7.2 mt -145.3 124.95 13.26 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.503 1.127 . . . . 0.0 109.316 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 160' ' ' ARG . . . . . 0.572 ' O ' ' HA ' ' A' ' 172' ' ' ALA . 0.0 OUTLIER -87.68 135.21 33.46 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.42 1.075 . . . . 0.0 110.342 179.99 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.466 HD13 HG13 ' A' ' 137' ' ' VAL . 1.4 mp -83.0 119.37 32.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 O-C-N 124.428 1.08 . . . . 0.0 109.286 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.56 -46.35 2.58 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.573 1.17 . . . . 0.0 110.309 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 163' ' ' ASP . . . . . 0.458 ' CB ' ' HB3' ' A' ' 171' ' ' ASN . 0.1 OUTLIER -134.94 179.59 6.22 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.564 1.165 . . . . 0.0 109.264 179.998 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 164' ' ' LYS . . . . . 0.599 ' HB2' ' CD1' ' A' ' 170' ' ' TRP . 0.0 OUTLIER -170.82 91.97 0.46 Allowed Pre-proline 0 C--N 1.326 -0.432 0 O-C-N 124.462 1.101 . . . . 0.0 109.311 -179.994 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.03 -26.35 10.95 Favored 'Trans proline' 0 C--N 1.362 1.239 0 O-C-N 124.513 1.796 . . . . 0.0 111.023 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -126.26 166.27 17.42 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.508 1.13 . . . . 0.0 110.24 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -86.54 -26.09 24.72 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.501 1.126 . . . . 0.0 110.299 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 4.4 mt-30 -78.02 -56.58 4.37 Favored 'General case' 0 C--N 1.324 -0.524 0 O-C-N 124.568 1.167 . . . . 0.0 110.316 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 169' ' ' TRP . . . . . . . . . . . . . 9.2 m95 -104.87 145.83 29.85 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 170' ' ' TRP . . . . . 0.8 ' CD2' HG21 ' A' ' 184' ' ' VAL . 30.8 m0 -122.44 151.43 41.28 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.564 1.165 . . . . 0.0 108.034 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 171' ' ' ASN . . . . . 0.458 ' HB3' ' CB ' ' A' ' 163' ' ' ASP . 2.7 t30 -86.44 96.19 9.95 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.544 1.153 . . . . 0.0 109.289 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 172' ' ' ALA . . . . . 0.572 ' HA ' ' O ' ' A' ' 160' ' ' ARG . . . -107.26 166.65 10.48 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.496 1.123 . . . . 0.0 109.259 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 173' ' ' GLU . . . . . 0.475 ' HA ' ' O ' ' A' ' 178' ' ' LYS . 34.3 mt-10 -126.03 126.25 43.95 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.503 1.127 . . . . 0.0 110.31 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 174' ' ' ASP . . . . . 0.492 ' HB2' ' CG ' ' A' ' 178' ' ' LYS . 1.1 m-20 -79.48 -174.57 4.3 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.521 1.138 . . . . 0.0 109.277 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 38.4 t -77.74 56.27 1.48 Allowed 'General case' 0 C--N 1.324 -0.528 0 O-C-N 124.584 1.178 . . . . 0.0 109.964 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 176' ' ' GLU . . . . . 0.458 ' CB ' ' HD2' ' A' ' 178' ' ' LYS . 0.0 OUTLIER -167.68 16.68 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.466 1.104 . . . . 0.0 110.298 179.925 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 62.57 15.13 52.73 Favored Glycine 0 CA--C 1.53 0.983 0 O-C-N 124.503 1.127 . . . . 0.0 110.992 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 178' ' ' LYS . . . . . 0.492 ' CG ' ' HB2' ' A' ' 174' ' ' ASP . 1.5 ptmm? -86.04 108.15 18.12 Favored 'General case' 0 C--N 1.326 -0.429 0 O-C-N 124.469 0.747 . . . . 0.0 109.334 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 179' ' ' ARG . . . . . 0.46 ' HA ' ' O ' ' A' ' 172' ' ' ALA . 0.0 OUTLIER -96.11 127.82 42.47 Favored 'General case' 0 C--N 1.324 -0.523 0 O-C-N 124.51 1.131 . . . . 0.0 110.284 -179.961 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -152.27 165.84 30.94 Favored Glycine 0 CA--C 1.53 0.993 0 O-C-N 124.511 1.132 . . . . 0.0 111.021 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 181' ' ' MET . . . . . 0.456 ' HA ' ' O ' ' A' ' 170' ' ' TRP . 25.4 mtp -88.41 105.32 17.52 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.488 0.758 . . . . 0.0 110.98 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 182' ' ' ILE . . . . . 0.767 HD13 ' O ' ' A' ' 182' ' ' ILE . 0.0 OUTLIER -110.15 164.11 15.6 Favored Pre-proline 0 C--N 1.324 -0.536 0 O-C-N 124.514 1.134 . . . . 0.0 109.359 179.956 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 183' ' ' PRO . . . . . 0.638 ' HG2' ' HB2' ' A' ' 186' ' ' TYR . 18.3 Cg_endo -74.99 128.85 11.82 Favored 'Trans proline' 0 C--N 1.36 1.169 0 O-C-N 124.51 1.795 . . . . 0.0 111.048 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 184' ' ' VAL . . . . . 0.812 ' N ' ' CD ' ' A' ' 185' ' ' PRO . 59.8 t -76.87 -32.96 1.06 Allowed Pre-proline 0 C--N 1.324 -0.506 0 O-C-N 124.576 1.173 . . . . 0.0 109.266 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 185' ' ' PRO . . . . . 0.812 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.5 Cg_endo -74.99 -14.57 21.13 Favored 'Trans proline' 0 C--N 1.36 1.15 0 O-C-N 124.485 1.782 . . . . 0.0 111.048 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 186' ' ' TYR . . . . . 0.638 ' HB2' ' HG2' ' A' ' 183' ' ' PRO . 6.3 m-85 -96.26 5.01 51.93 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.522 1.139 . . . . 0.0 111.001 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 187' ' ' VAL . . . . . 0.494 ' HA ' ' O ' ' A' ' 138' ' ' ARG . 12.6 m -135.81 165.02 30.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 O-C-N 124.499 1.124 . . . . 0.0 109.248 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 188' ' ' GLU . . . . . 0.989 ' OE2' HD21 ' A' ' 140' ' ' LEU . 0.3 OUTLIER -115.03 153.22 31.07 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.475 1.11 . . . . 0.0 110.277 -179.984 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 189' ' ' LYS . . . . . 0.446 ' NZ ' HG13 ' A' ' 184' ' ' VAL . 0.0 OUTLIER -88.54 137.01 32.7 Favored 'General case' 0 C--N 1.326 -0.436 0 O-C-N 124.505 1.128 . . . . 0.0 109.334 179.99 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 . . . . . 0 C--N 1.326 -0.456 0 O-C-N 124.57 1.169 . . . . 0.0 110.987 179.99 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 135' ' ' GLU . . . . . 0.523 ' CB ' ' O ' ' A' ' 161' ' ' ILE . 25.3 mp0 . . . . . 0 N--CA 1.453 -0.279 0 N-CA-C 110.379 -0.23 . . . . 0.0 110.379 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 76.0 m-85 -126.66 125.07 41.27 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.512 1.133 . . . . 0.0 111.021 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.528 HG13 HD13 ' A' ' 161' ' ' ILE . 7.5 m -131.84 141.26 46.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 O-C-N 124.533 1.145 . . . . 0.0 109.336 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 138' ' ' ARG . . . . . 0.547 ' HD2' ' CE1' ' A' ' 190' ' ' TYR . 0.8 OUTLIER -115.58 137.5 52.0 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.57 1.169 . . . . 0.0 110.261 -179.956 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 0.683 ' HB3' ' OD1' ' A' ' 157' ' ' ASP . . . -92.56 115.6 28.25 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.501 1.126 . . . . 0.0 109.273 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.852 HD21 ' OE2' ' A' ' 188' ' ' GLU . 0.2 OUTLIER -87.44 -8.41 56.53 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.495 1.122 . . . . 0.0 109.331 179.993 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 141' ' ' PHE . . . . . 0.57 ' CE1' ' HB2' ' A' ' 140' ' ' LEU . 0.4 OUTLIER -128.04 144.31 51.1 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.494 1.121 . . . . 0.0 111.004 179.991 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 142' ' ' ASP . . . . . 0.421 ' CB ' ' HA ' ' A' ' 154' ' ' LYS . 0.9 OUTLIER . . . . . 0 C--N 1.325 -0.494 0 O-C-N 124.55 1.156 . . . . 0.0 109.242 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 153' ' ' PHE . . . . . 0.573 ' CE1' ' CG ' ' A' ' 183' ' ' PRO . 24.4 p90 . . . . . 0 N--CA 1.452 -0.363 0 CA-C-O 120.491 0.186 . . . . 0.0 111.046 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 154' ' ' LYS . . . . . 0.421 ' HA ' ' CB ' ' A' ' 142' ' ' ASP . 0.6 OUTLIER -119.76 -155.56 0.62 Allowed 'General case' 0 C--N 1.326 -0.438 0 O-C-N 124.479 1.112 . . . . 0.0 109.296 -179.992 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 1.1 tttp -111.96 98.78 7.6 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.473 1.108 . . . . 0.0 109.314 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 156' ' ' GLY . . . . . 0.645 ' N ' ' O ' ' A' ' 139' ' ' ALA . . . 115.55 25.75 3.62 Favored Glycine 0 CA--C 1.529 0.967 0 O-C-N 124.525 1.141 . . . . 0.0 111.038 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 157' ' ' ASP . . . . . 0.863 ' C ' HD12 ' A' ' 158' ' ' ILE . 3.4 p-10 -99.13 166.85 11.05 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.438 0.728 . . . . 0.0 109.28 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 158' ' ' ILE . . . . . 0.863 HD12 ' C ' ' A' ' 157' ' ' ASP . 2.1 mp -122.5 150.88 26.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 O-C-N 124.422 1.076 . . . . 0.0 109.268 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.902 HD21 ' CG ' ' A' ' 174' ' ' ASP . 0.4 OUTLIER -151.94 134.84 15.65 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.482 1.114 . . . . 0.0 109.336 179.988 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 160' ' ' ARG . . . . . 0.48 ' O ' ' HB1' ' A' ' 172' ' ' ALA . 0.1 OUTLIER -93.53 127.56 39.25 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.431 1.082 . . . . 0.0 110.314 -179.981 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.528 HD13 HG13 ' A' ' 137' ' ' VAL . 1.6 mp -85.67 121.49 37.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 O-C-N 124.48 1.112 . . . . 0.0 109.362 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 162' ' ' ARG . . . . . 0.429 ' CD ' ' HB2' ' A' ' 163' ' ' ASP . 0.2 OUTLIER -119.99 -32.21 4.26 Favored 'General case' 0 C--N 1.326 -0.431 0 O-C-N 124.425 1.078 . . . . 0.0 110.289 -179.976 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 163' ' ' ASP . . . . . 0.448 ' CB ' ' HB3' ' A' ' 171' ' ' ASN . 0.4 OUTLIER -139.8 171.34 14.36 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.554 1.159 . . . . 0.0 109.299 179.985 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 164' ' ' LYS . . . . . 0.573 ' HB2' ' CD1' ' A' ' 170' ' ' TRP . 0.5 OUTLIER -156.8 82.62 3.26 Favored Pre-proline 0 C--N 1.325 -0.476 0 O-C-N 124.496 1.123 . . . . 0.0 109.312 -179.939 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -74.9 -25.71 11.83 Favored 'Trans proline' 0 C--N 1.359 1.129 0 O-C-N 124.438 1.757 . . . . 0.0 111.075 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 9.6 mt-10 -111.64 169.01 9.11 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.464 1.102 . . . . 0.0 110.317 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -90.98 -32.04 16.1 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.544 1.153 . . . . 0.0 110.296 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 168' ' ' GLN . . . . . 0.437 ' HB3' ' CD1' ' A' ' 169' ' ' TRP . 6.6 mt-30 -87.3 -53.45 4.83 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.552 1.158 . . . . 0.0 110.31 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 169' ' ' TRP . . . . . 0.473 ' CD1' ' N ' ' A' ' 169' ' ' TRP . 1.6 m95 -104.8 148.18 26.91 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.546 1.154 . . . . 0.0 107.972 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 170' ' ' TRP . . . . . 0.585 ' CE2' HG21 ' A' ' 184' ' ' VAL . 36.9 m0 -125.38 159.67 31.26 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.558 1.161 . . . . 0.0 108.05 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 171' ' ' ASN . . . . . 0.448 ' HB3' ' CB ' ' A' ' 163' ' ' ASP . 23.6 t-20 -86.14 109.5 18.92 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.511 1.132 . . . . 0.0 109.289 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 172' ' ' ALA . . . . . 0.48 ' HB1' ' O ' ' A' ' 160' ' ' ARG . . . -122.82 176.92 5.71 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.457 1.098 . . . . 0.0 109.323 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 173' ' ' GLU . . . . . 0.5 ' CG ' ' HG2' ' A' ' 179' ' ' ARG . 7.1 mt-10 -116.36 119.74 36.64 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.453 1.096 . . . . 0.0 110.357 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 174' ' ' ASP . . . . . 0.902 ' CG ' HD21 ' A' ' 159' ' ' LEU . 1.7 m-20 -74.66 -175.93 2.62 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.508 1.13 . . . . 0.0 109.361 179.954 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 98.2 p -76.74 58.93 1.49 Allowed 'General case' 0 C--N 1.324 -0.531 0 O-C-N 124.506 1.129 . . . . 0.0 109.99 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 176' ' ' GLU . . . . . 0.409 ' H ' ' H ' ' A' ' 177' ' ' GLY . 0.4 OUTLIER -170.93 -2.22 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.52 0 O-C-N 124.515 1.134 . . . . 0.0 110.333 -179.986 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 177' ' ' GLY . . . . . 0.409 ' H ' ' H ' ' A' ' 176' ' ' GLU . . . 79.16 19.58 71.9 Favored Glycine 0 CA--C 1.53 1.012 0 O-C-N 124.524 1.14 . . . . 0.0 111.037 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 178' ' ' LYS . . . . . 0.497 ' CG ' ' HB2' ' A' ' 174' ' ' ASP . 2.1 ptpp? -91.88 121.26 33.31 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.499 0.764 . . . . 0.0 109.331 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 179' ' ' ARG . . . . . 0.5 ' HG2' ' CG ' ' A' ' 173' ' ' GLU . 21.1 mtt85 -89.81 122.44 32.88 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.475 1.109 . . . . 0.0 110.275 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 180' ' ' GLY . . . . . 0.427 ' O ' ' HA ' ' A' ' 171' ' ' ASN . . . -152.02 167.04 31.11 Favored Glycine 0 CA--C 1.531 1.037 0 O-C-N 124.486 1.117 . . . . 0.0 110.972 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 181' ' ' MET . . . . . 0.473 ' HA ' ' O ' ' A' ' 170' ' ' TRP . 33.8 mtp -87.97 103.5 15.75 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.471 0.748 . . . . 0.0 110.988 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 182' ' ' ILE . . . . . 0.807 HG21 HD22 ' A' ' 159' ' ' LEU . 8.2 pt -98.7 157.12 34.79 Favored Pre-proline 0 C--N 1.324 -0.528 0 O-C-N 124.526 1.141 . . . . 0.0 109.281 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 183' ' ' PRO . . . . . 0.717 ' HG2' ' HB2' ' A' ' 186' ' ' TYR . 18.4 Cg_endo -75.0 135.27 18.85 Favored 'Trans proline' 0 C--N 1.36 1.148 0 O-C-N 124.495 1.787 . . . . 0.0 111.029 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 184' ' ' VAL . . . . . 0.816 ' N ' ' CD ' ' A' ' 185' ' ' PRO . 62.8 t -81.74 -32.45 0.61 Allowed Pre-proline 0 C--N 1.324 -0.501 0 O-C-N 124.547 1.155 . . . . 0.0 109.359 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 185' ' ' PRO . . . . . 0.816 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.5 Cg_endo -74.98 -25.35 11.97 Favored 'Trans proline' 0 C--N 1.36 1.159 0 O-C-N 124.508 1.794 . . . . 0.0 111.011 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 186' ' ' TYR . . . . . 0.717 ' HB2' ' HG2' ' A' ' 183' ' ' PRO . 3.8 m-85 -93.48 14.43 18.69 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.504 1.127 . . . . 0.0 111.068 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 187' ' ' VAL . . . . . 0.694 HG22 ' O ' ' A' ' 183' ' ' PRO . 21.4 m -138.22 163.69 28.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 O-C-N 124.525 1.14 . . . . 0.0 109.272 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 188' ' ' GLU . . . . . 0.852 ' OE2' HD21 ' A' ' 140' ' ' LEU . 0.0 OUTLIER -126.07 167.62 15.1 Favored 'General case' 0 C--N 1.326 -0.416 0 O-C-N 124.431 1.082 . . . . 0.0 110.335 179.958 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -87.5 125.39 34.28 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.508 1.13 . . . . 0.0 109.251 -179.9 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 190' ' ' TYR . . . . . 0.547 ' CE1' ' HD2' ' A' ' 138' ' ' ARG . 0.1 OUTLIER . . . . . 0 C--N 1.325 -0.472 0 O-C-N 124.444 1.09 . . . . 0.0 111.034 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 135' ' ' GLU . . . . . 0.442 ' HB2' ' HB ' ' A' ' 161' ' ' ILE . 0.2 OUTLIER . . . . . 0 N--CA 1.452 -0.328 0 N-CA-C 110.294 -0.262 . . . . 0.0 110.294 . . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 136' ' ' TYR . . . . . 0.582 ' C ' ' CD1' ' A' ' 136' ' ' TYR . 0.4 OUTLIER -121.97 143.0 49.73 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.493 1.121 . . . . 0.0 110.978 179.998 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.834 HG22 ' O ' ' A' ' 159' ' ' LEU . 35.1 m -145.03 137.45 21.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 O-C-N 124.431 1.082 . . . . 0.0 109.243 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 138' ' ' ARG . . . . . 0.447 ' HB3' ' HG3' ' A' ' 188' ' ' GLU . 0.6 OUTLIER -105.07 133.98 48.93 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.466 1.104 . . . . 0.0 110.285 -179.993 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 0.578 ' HB2' HD11 ' A' ' 159' ' ' LEU . . . -95.97 112.57 24.27 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.56 1.163 . . . . 0.0 109.305 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.955 HD21 ' OE2' ' A' ' 188' ' ' GLU . 0.2 OUTLIER -98.5 -9.48 24.97 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.561 1.163 . . . . 0.0 109.325 -179.971 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 141' ' ' PHE . . . . . 0.495 ' C ' ' O ' ' A' ' 154' ' ' LYS . 14.3 m-85 -109.22 152.02 25.74 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.448 1.093 . . . . 0.0 111.062 179.906 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 142' ' ' ASP . . . . . 0.502 ' CA ' ' O ' ' A' ' 154' ' ' LYS . 3.3 t70 . . . . . 0 C--N 1.325 -0.495 0 O-C-N 124.551 1.157 . . . . 0.0 109.353 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 11.7 p90 . . . . . 0 N--CA 1.454 -0.263 0 CA-C-O 120.576 0.227 . . . . 0.0 110.922 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 154' ' ' LYS . . . . . 0.502 ' O ' ' CA ' ' A' ' 142' ' ' ASP . 0.0 OUTLIER -127.02 -80.73 0.6 Allowed 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.484 1.115 . . . . 0.0 109.303 -179.979 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -165.77 115.51 1.01 Allowed 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.538 1.149 . . . . 0.0 109.34 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 156' ' ' GLY . . . . . 0.499 ' N ' ' O ' ' A' ' 139' ' ' ALA . . . 100.38 20.83 14.27 Favored Glycine 0 CA--C 1.53 1.017 0 O-C-N 124.437 1.086 . . . . 0.0 111.049 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 157' ' ' ASP . . . . . 0.422 ' HB3' ' HB3' ' A' ' 139' ' ' ALA . 23.1 t70 -84.59 155.23 22.14 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.488 0.757 . . . . 0.0 109.32 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 158' ' ' ILE . . . . . 0.48 HG23 ' CE2' ' A' ' 136' ' ' TYR . 13.1 mm -105.1 133.78 48.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 O-C-N 124.417 1.073 . . . . 0.0 109.342 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.834 ' O ' HG22 ' A' ' 137' ' ' VAL . 0.4 OUTLIER -142.96 124.93 15.19 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.538 1.149 . . . . 0.0 109.286 -179.976 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 160' ' ' ARG . . . . . 0.672 ' O ' ' HA ' ' A' ' 172' ' ' ALA . 0.0 OUTLIER -94.65 141.01 29.11 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.529 1.143 . . . . 0.0 110.271 179.992 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.442 ' HB ' ' HB2' ' A' ' 135' ' ' GLU . 19.9 mm -84.28 114.71 25.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 O-C-N 124.533 1.145 . . . . 0.0 109.313 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.47 -52.59 2.75 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.491 1.119 . . . . 0.0 110.293 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 11.8 t0 -136.34 174.7 10.33 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.451 1.094 . . . . 0.0 109.284 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 164' ' ' LYS . . . . . 0.564 ' HB2' ' CD1' ' A' ' 170' ' ' TRP . 0.0 OUTLIER -167.1 89.16 0.75 Allowed Pre-proline 0 C--N 1.325 -0.499 0 O-C-N 124.472 1.108 . . . . 0.0 109.299 -179.99 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.04 -34.2 3.97 Favored 'Trans proline' 0 C--N 1.36 1.166 0 O-C-N 124.532 1.806 . . . . 0.0 110.952 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -107.8 170.13 8.18 Favored 'General case' 0 C--N 1.324 -0.532 0 O-C-N 124.542 1.151 . . . . 0.0 110.28 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 18.7 pt-20 -95.36 -15.56 22.98 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.471 1.107 . . . . 0.0 110.355 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 168' ' ' GLN . . . . . 0.445 ' HG2' ' CD1' ' A' ' 169' ' ' TRP . 20.5 tt0 -92.41 -56.29 3.09 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.502 1.126 . . . . 0.0 110.333 179.952 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 169' ' ' TRP . . . . . 0.445 ' CD1' ' HG2' ' A' ' 168' ' ' GLN . 32.4 m95 -105.61 140.34 38.83 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.449 1.093 . . . . 0.0 108.064 179.934 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 170' ' ' TRP . . . . . 0.712 ' CD2' HG21 ' A' ' 184' ' ' VAL . 53.1 m0 -120.02 152.78 36.99 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.523 1.139 . . . . 0.0 107.98 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 171' ' ' ASN . . . . . 0.448 ' HA ' ' O ' ' A' ' 180' ' ' GLY . 0.6 OUTLIER -88.04 97.34 10.91 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.493 1.121 . . . . 0.0 109.268 179.976 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 172' ' ' ALA . . . . . 0.672 ' HA ' ' O ' ' A' ' 160' ' ' ARG . . . -107.47 173.17 6.44 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.51 1.131 . . . . 0.0 109.342 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 173' ' ' GLU . . . . . 0.442 ' O ' ' HA ' ' A' ' 159' ' ' LEU . 18.1 mt-10 -118.94 120.08 36.21 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.517 1.136 . . . . 0.0 110.329 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -74.34 -169.92 0.89 Allowed 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.468 1.105 . . . . 0.0 109.297 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 72.6 p -81.3 59.79 4.11 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.441 1.088 . . . . 0.0 110.004 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 177.61 25.48 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.484 1.115 . . . . 0.0 110.266 -179.974 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 57.79 19.2 35.2 Favored Glycine 0 CA--C 1.531 1.043 0 O-C-N 124.534 1.146 . . . . 0.0 110.997 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 6.6 mtmt -81.28 104.06 11.49 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.504 0.767 . . . . 0.0 109.293 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 179' ' ' ARG . . . . . 0.45 ' HA ' ' O ' ' A' ' 172' ' ' ALA . 4.7 ttp180 -90.46 118.75 30.18 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.528 1.143 . . . . 0.0 110.288 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 180' ' ' GLY . . . . . 0.448 ' O ' ' HA ' ' A' ' 171' ' ' ASN . . . -152.25 168.86 31.47 Favored Glycine 0 CA--C 1.531 1.032 0 O-C-N 124.612 1.195 . . . . 0.0 111.04 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 181' ' ' MET . . . . . 0.461 ' HA ' ' O ' ' A' ' 170' ' ' TRP . 1.5 mmm -85.98 106.76 17.38 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.546 0.792 . . . . 0.0 110.961 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 182' ' ' ILE . . . . . 0.481 HD13 HD22 ' A' ' 159' ' ' LEU . 1.4 pp -110.41 162.12 21.81 Favored Pre-proline 0 C--N 1.326 -0.446 0 O-C-N 124.515 1.134 . . . . 0.0 109.278 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 183' ' ' PRO . . . . . 0.705 ' HG2' ' HB2' ' A' ' 186' ' ' TYR . 18.6 Cg_endo -74.99 132.56 15.58 Favored 'Trans proline' 0 C--N 1.36 1.162 0 O-C-N 124.508 1.794 . . . . 0.0 111.05 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 184' ' ' VAL . . . . . 0.807 ' N ' ' CD ' ' A' ' 185' ' ' PRO . 62.1 t -78.94 -32.45 0.79 Allowed Pre-proline 0 C--N 1.324 -0.527 0 O-C-N 124.568 1.168 . . . . 0.0 109.332 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 185' ' ' PRO . . . . . 0.807 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.4 Cg_endo -74.96 -17.44 19.65 Favored 'Trans proline' 0 C--N 1.36 1.156 0 O-C-N 124.438 1.757 . . . . 0.0 111.006 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 186' ' ' TYR . . . . . 0.705 ' HB2' ' HG2' ' A' ' 183' ' ' PRO . 3.5 m-30 -97.25 17.7 16.72 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.496 1.123 . . . . 0.0 110.972 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 187' ' ' VAL . . . . . 0.43 HG12 ' CB ' ' A' ' 139' ' ' ALA . 16.7 m -145.44 173.61 3.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 O-C-N 124.515 1.134 . . . . 0.0 109.359 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 188' ' ' GLU . . . . . 0.955 ' OE2' HD21 ' A' ' 140' ' ' LEU . 0.1 OUTLIER -127.95 159.6 34.47 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.504 1.127 . . . . 0.0 110.245 -179.962 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 7.4 mmmm -88.18 135.84 33.25 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.433 1.083 . . . . 0.0 109.306 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 8.9 t80 . . . . . 0 C--N 1.326 -0.452 0 O-C-N 124.456 1.098 . . . . 0.0 111.02 179.987 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 135' ' ' GLU . . . . . 0.459 ' CD ' HG22 ' A' ' 161' ' ' ILE . 1.5 mt-10 . . . . . 0 N--CA 1.453 -0.301 0 N-CA-C 110.248 -0.279 . . . . 0.0 110.248 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 136' ' ' TYR . . . . . 0.513 ' CE1' ' HB2' ' A' ' 160' ' ' ARG . 26.0 m-85 -86.86 106.55 17.82 Favored 'General case' 0 C--N 1.324 -0.527 0 O-C-N 124.491 1.119 . . . . 0.0 110.946 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.604 ' HA ' ' O ' ' A' ' 188' ' ' GLU . 19.8 m -117.19 138.39 48.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 O-C-N 124.502 1.126 . . . . 0.0 109.301 179.943 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 138' ' ' ARG . . . . . 0.43 ' HG2' ' CG ' ' A' ' 188' ' ' GLU . 0.0 OUTLIER -108.27 147.01 32.03 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.532 1.145 . . . . 0.0 110.275 -179.956 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 0.663 ' O ' ' N ' ' A' ' 156' ' ' GLY . . . -93.88 119.89 33.41 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.506 1.128 . . . . 0.0 109.336 179.955 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.52 HD11 ' HG2' ' A' ' 188' ' ' GLU . 1.1 mt -88.51 -3.46 58.81 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.472 1.108 . . . . 0.0 109.281 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 13.8 m-85 -139.96 154.34 47.16 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.433 1.083 . . . . 0.0 110.984 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 142' ' ' ASP . . . . . 0.495 ' CB ' ' HA ' ' A' ' 154' ' ' LYS . 10.8 p-10 . . . . . 0 C--N 1.325 -0.485 0 O-C-N 124.495 1.122 . . . . 0.0 109.285 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 153' ' ' PHE . . . . . 0.596 ' CZ ' ' CG ' ' A' ' 183' ' ' PRO . 30.0 p90 . . . . . 0 N--CA 1.453 -0.298 0 CA-C-O 120.504 0.193 . . . . 0.0 111.072 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 154' ' ' LYS . . . . . 0.495 ' HA ' ' CB ' ' A' ' 142' ' ' ASP . 0.1 OUTLIER -126.1 -166.64 1.59 Allowed 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.453 1.096 . . . . 0.0 109.331 -179.985 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 6.4 ptpt -95.65 105.63 17.64 Favored 'General case' 0 C--N 1.324 -0.531 0 O-C-N 124.545 1.153 . . . . 0.0 109.329 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 156' ' ' GLY . . . . . 0.663 ' N ' ' O ' ' A' ' 139' ' ' ALA . . . 106.75 27.72 5.34 Favored Glycine 0 CA--C 1.53 0.999 0 O-C-N 124.434 1.084 . . . . 0.0 110.993 -180.0 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 157' ' ' ASP . . . . . 0.405 ' O ' ' HA ' ' A' ' 138' ' ' ARG . 16.6 t70 -97.45 165.9 11.78 Favored 'General case' 0 C--N 1.324 -0.522 0 O-C-N 124.482 0.754 . . . . 0.0 109.27 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -123.96 138.83 52.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 O-C-N 124.507 1.13 . . . . 0.0 109.268 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.989 HD22 HD13 ' A' ' 182' ' ' ILE . 0.7 OUTLIER -147.13 130.28 16.46 Favored 'General case' 0 C--N 1.324 -0.54 0 O-C-N 124.579 1.174 . . . . 0.0 109.326 179.971 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 160' ' ' ARG . . . . . 0.513 ' HB2' ' CE1' ' A' ' 136' ' ' TYR . 0.0 OUTLIER -93.91 132.63 38.16 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.476 1.11 . . . . 0.0 110.308 179.982 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.583 ' CD1' HG22 ' A' ' 137' ' ' VAL . 1.6 mp -89.09 132.59 33.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 O-C-N 124.519 1.137 . . . . 0.0 109.327 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -127.01 -36.59 2.16 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.522 1.139 . . . . 0.0 110.263 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -132.68 169.66 16.34 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.455 1.097 . . . . 0.0 109.242 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 164' ' ' LYS . . . . . 0.588 ' HB2' ' CD1' ' A' ' 170' ' ' TRP . 0.0 OUTLIER -163.36 84.48 1.38 Allowed Pre-proline 0 C--N 1.326 -0.454 0 O-C-N 124.423 1.077 . . . . 0.0 109.334 -179.988 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.94 -25.54 11.9 Favored 'Trans proline' 0 C--N 1.361 1.194 0 O-C-N 124.56 1.821 . . . . 0.0 111.022 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -113.6 174.77 5.76 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.487 1.117 . . . . 0.0 110.292 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -99.71 -19.66 16.65 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.546 1.154 . . . . 0.0 110.317 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 3.6 mt-30 -88.18 -66.69 0.89 Allowed 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.41 1.069 . . . . 0.0 110.326 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 169' ' ' TRP . . . . . . . . . . . . . 6.5 m95 -95.49 153.17 17.83 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.537 1.148 . . . . 0.0 108.025 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 170' ' ' TRP . . . . . 0.699 ' CD2' HG21 ' A' ' 184' ' ' VAL . 43.2 m0 -126.03 153.93 43.7 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 -179.925 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 171' ' ' ASN . . . . . 0.417 ' HA ' ' O ' ' A' ' 180' ' ' GLY . 0.6 OUTLIER -86.97 104.23 16.08 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.459 1.099 . . . . 0.0 109.325 179.952 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 172' ' ' ALA . . . . . 0.462 ' HA ' ' O ' ' A' ' 160' ' ' ARG . . . -123.0 170.74 9.84 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.514 1.134 . . . . 0.0 109.319 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 173' ' ' GLU . . . . . 0.404 ' HA ' ' O ' ' A' ' 178' ' ' LYS . 3.9 mt-10 -115.93 126.48 53.95 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.505 1.128 . . . . 0.0 110.319 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 174' ' ' ASP . . . . . 0.513 ' HB3' HD21 ' A' ' 159' ' ' LEU . 0.9 OUTLIER -78.34 -174.18 3.62 Favored 'General case' 0 C--N 1.324 -0.543 0 O-C-N 124.491 1.12 . . . . 0.0 109.298 179.986 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 80.7 p -76.19 64.48 2.01 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.514 1.134 . . . . 0.0 109.932 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -177.27 0.22 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.453 1.096 . . . . 0.0 110.345 -179.974 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 79.12 12.59 83.87 Favored Glycine 0 CA--C 1.53 1.006 0 O-C-N 124.575 1.172 . . . . 0.0 110.931 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 178' ' ' LYS . . . . . 0.404 ' O ' ' HA ' ' A' ' 173' ' ' GLU . 0.0 OUTLIER -83.91 109.4 17.57 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.554 0.797 . . . . 0.0 109.272 -179.977 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 179' ' ' ARG . . . . . 0.435 ' HA ' ' O ' ' A' ' 172' ' ' ALA . 2.1 ttp85 -87.99 123.19 32.45 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.495 1.122 . . . . 0.0 110.242 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 180' ' ' GLY . . . . . 0.417 ' O ' ' HA ' ' A' ' 171' ' ' ASN . . . -151.25 172.03 30.83 Favored Glycine 0 CA--C 1.53 1.022 0 O-C-N 124.486 1.116 . . . . 0.0 110.96 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 181' ' ' MET . . . . . 0.458 ' HA ' ' O ' ' A' ' 170' ' ' TRP . 0.9 OUTLIER -87.73 93.77 9.54 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.507 0.769 . . . . 0.0 111.001 -179.987 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 182' ' ' ILE . . . . . 0.989 HD13 HD22 ' A' ' 159' ' ' LEU . 0.0 OUTLIER -91.79 158.17 40.45 Favored Pre-proline 0 C--N 1.325 -0.497 0 O-C-N 124.459 1.099 . . . . 0.0 109.316 179.969 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 183' ' ' PRO . . . . . 0.688 ' HG2' ' HB2' ' A' ' 186' ' ' TYR . 18.2 Cg_endo -74.97 131.44 14.33 Favored 'Trans proline' 0 C--N 1.361 1.206 0 O-C-N 124.438 1.757 . . . . 0.0 111.026 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 184' ' ' VAL . . . . . 0.813 ' N ' ' CD ' ' A' ' 185' ' ' PRO . 85.9 t -79.96 -31.91 0.69 Allowed Pre-proline 0 C--N 1.325 -0.46 0 O-C-N 124.435 1.084 . . . . 0.0 109.265 180.0 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 185' ' ' PRO . . . . . 0.813 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.3 Cg_endo -74.99 -25.2 12.12 Favored 'Trans proline' 0 C--N 1.359 1.103 0 O-C-N 124.526 1.803 . . . . 0.0 111.002 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 186' ' ' TYR . . . . . 0.688 ' HB2' ' HG2' ' A' ' 183' ' ' PRO . 7.9 m-85 -92.83 16.64 12.01 Favored 'General case' 0 C--N 1.326 -0.431 0 O-C-N 124.498 1.124 . . . . 0.0 111.038 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 187' ' ' VAL . . . . . 0.557 HG22 ' O ' ' A' ' 183' ' ' PRO . 27.4 m -141.78 170.57 12.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 O-C-N 124.535 1.147 . . . . 0.0 109.317 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 188' ' ' GLU . . . . . 0.604 ' O ' ' HA ' ' A' ' 137' ' ' VAL . 0.0 OUTLIER -131.76 155.91 46.89 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.53 1.144 . . . . 0.0 110.295 -179.997 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 189' ' ' LYS . . . . . 0.477 ' HA ' HG12 ' A' ' 137' ' ' VAL . 0.0 OUTLIER -88.62 132.36 34.59 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.513 1.133 . . . . 0.0 109.21 -179.956 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 190' ' ' TYR . . . . . 0.565 ' CE1' ' OE2' ' A' ' 188' ' ' GLU . 0.1 OUTLIER . . . . . 0 C--N 1.325 -0.474 0 O-C-N 124.502 1.126 . . . . 0.0 110.977 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 135' ' ' GLU . . . . . 0.801 ' HG2' HG22 ' A' ' 161' ' ' ILE . 2.4 mp0 . . . . . 0 N--CA 1.453 -0.284 0 N-CA-C 110.303 -0.258 . . . . 0.0 110.303 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 31.7 m-85 -126.11 131.93 51.98 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.434 1.084 . . . . 0.0 111.078 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.632 ' CG2' HG23 ' A' ' 187' ' ' VAL . 0.7 OUTLIER -132.68 127.82 56.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 O-C-N 124.516 1.135 . . . . 0.0 109.329 -179.931 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 138' ' ' ARG . . . . . 0.468 ' O ' ' HA ' ' A' ' 187' ' ' VAL . 0.0 OUTLIER -96.03 134.15 39.41 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.501 1.126 . . . . 0.0 110.371 -179.988 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 0.625 ' CB ' HG12 ' A' ' 187' ' ' VAL . . . -96.35 109.47 21.98 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.52 1.138 . . . . 0.0 109.279 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.624 HD11 ' HG2' ' A' ' 188' ' ' GLU . 0.2 OUTLIER -89.91 -31.79 17.13 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.483 1.115 . . . . 0.0 109.284 179.996 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 141' ' ' PHE . . . . . 0.505 ' O ' ' CD1' ' A' ' 153' ' ' PHE . 71.2 m-85 -88.53 152.62 21.74 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.529 1.143 . . . . 0.0 111.007 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 142' ' ' ASP . . . . . 0.507 ' HA ' ' O ' ' A' ' 154' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--N 1.325 -0.497 0 O-C-N 124.497 1.123 . . . . 0.0 109.36 179.942 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 153' ' ' PHE . . . . . 0.505 ' CD1' ' O ' ' A' ' 141' ' ' PHE . 28.9 p90 . . . . . 0 N--CA 1.452 -0.327 0 CA-C-O 120.401 0.143 . . . . 0.0 111.055 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 154' ' ' LYS . . . . . 0.507 ' O ' ' HA ' ' A' ' 142' ' ' ASP . 5.6 ttmt -127.25 -99.51 0.37 Allowed 'General case' 0 C--N 1.324 -0.53 0 O-C-N 124.554 1.159 . . . . 0.0 109.301 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 17.2 ttpp -156.09 118.82 4.16 Favored 'General case' 0 C--N 1.326 -0.443 0 O-C-N 124.445 1.09 . . . . 0.0 109.353 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 156' ' ' GLY . . . . . 0.494 ' N ' ' O ' ' A' ' 139' ' ' ALA . . . 97.46 15.06 39.04 Favored Glycine 0 CA--C 1.53 1.023 0 O-C-N 124.572 1.17 . . . . 0.0 110.948 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 157' ' ' ASP . . . . . 0.5 ' C ' HD12 ' A' ' 158' ' ' ILE . 8.9 t0 -83.83 163.28 20.22 Favored 'General case' 0 C--N 1.324 -0.523 0 O-C-N 124.479 0.752 . . . . 0.0 109.254 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 158' ' ' ILE . . . . . 0.501 HD12 ' N ' ' A' ' 158' ' ' ILE . 3.5 mp -119.01 148.74 21.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 O-C-N 124.473 1.108 . . . . 0.0 109.29 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.725 HD21 ' OD1' ' A' ' 174' ' ' ASP . 0.7 OUTLIER -147.43 130.88 16.69 Favored 'General case' 0 C--N 1.326 -0.443 0 O-C-N 124.468 1.105 . . . . 0.0 109.303 -179.953 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 160' ' ' ARG . . . . . 0.684 ' O ' ' HA ' ' A' ' 172' ' ' ALA . 3.7 tpp180 -87.45 127.37 35.23 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.523 1.14 . . . . 0.0 110.273 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.801 HG22 ' HG2' ' A' ' 135' ' ' GLU . 1.5 mp -82.37 119.23 31.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 O-C-N 124.434 1.084 . . . . 0.0 109.305 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 162' ' ' ARG . . . . . 0.484 ' NH1' ' OD2' ' A' ' 163' ' ' ASP . 1.0 OUTLIER -115.25 -48.89 2.79 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.467 1.105 . . . . 0.0 110.345 179.952 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 163' ' ' ASP . . . . . 0.484 ' OD2' ' NH1' ' A' ' 162' ' ' ARG . 67.4 m-20 -141.54 171.34 14.2 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.485 1.116 . . . . 0.0 109.291 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 164' ' ' LYS . . . . . 0.591 ' HB3' ' CD1' ' A' ' 170' ' ' TRP . 14.5 mtmm -138.71 58.46 13.84 Favored Pre-proline 0 C--N 1.325 -0.486 0 O-C-N 124.521 1.138 . . . . 0.0 109.309 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 165' ' ' PRO . . . . . 0.541 ' HD3' ' N ' ' A' ' 164' ' ' LYS . 18.5 Cg_endo -74.99 76.41 3.4 Favored 'Trans proline' 0 C--N 1.36 1.163 0 O-C-N 124.455 1.766 . . . . 0.0 111.02 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 166' ' ' GLU . . . . . 0.47 ' CB ' ' O ' ' A' ' 165' ' ' PRO . 1.5 mt-10 162.77 177.24 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.547 1.155 . . . . 0.0 110.296 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -117.08 42.68 2.47 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.433 1.083 . . . . 0.0 110.277 -179.923 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER 178.29 -51.53 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.493 1.121 . . . . 0.0 110.306 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 169' ' ' TRP . . . . . . . . . . . . . 7.2 m95 -95.29 144.05 26.18 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 170' ' ' TRP . . . . . 0.789 ' CD2' HG21 ' A' ' 184' ' ' VAL . 48.6 m0 -120.45 149.82 41.78 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.474 1.109 . . . . 0.0 108.02 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 171' ' ' ASN . . . . . 0.417 ' HA ' ' O ' ' A' ' 180' ' ' GLY . 1.2 t-20 -86.6 98.99 11.4 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.428 1.08 . . . . 0.0 109.322 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 172' ' ' ALA . . . . . 0.684 ' HA ' ' O ' ' A' ' 160' ' ' ARG . . . -116.04 171.41 7.81 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.474 1.109 . . . . 0.0 109.239 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 173' ' ' GLU . . . . . 0.484 ' HG3' ' CG ' ' A' ' 179' ' ' ARG . 5.2 mt-10 -115.89 117.4 30.08 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.493 1.12 . . . . 0.0 110.326 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 174' ' ' ASP . . . . . 0.725 ' OD1' HD21 ' A' ' 159' ' ' LEU . 0.1 OUTLIER -68.28 -164.28 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.559 1.162 . . . . 0.0 109.355 179.969 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 88.1 p -85.09 60.03 5.99 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.444 1.09 . . . . 0.0 109.905 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -178.95 18.62 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.418 1.074 . . . . 0.0 110.286 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 63.54 14.96 56.52 Favored Glycine 0 CA--C 1.531 1.038 0 O-C-N 124.605 1.19 . . . . 0.0 110.999 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 178' ' ' LYS . . . . . 0.412 ' O ' ' HA ' ' A' ' 173' ' ' GLU . 1.5 mttt -80.51 105.59 11.87 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.495 0.762 . . . . 0.0 109.255 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 179' ' ' ARG . . . . . 0.484 ' CG ' ' HG3' ' A' ' 173' ' ' GLU . 0.0 OUTLIER -89.58 118.29 29.1 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.488 1.118 . . . . 0.0 110.243 -179.997 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 180' ' ' GLY . . . . . 0.417 ' O ' ' HA ' ' A' ' 171' ' ' ASN . . . -151.55 171.09 31.09 Favored Glycine 0 CA--C 1.53 1.026 0 O-C-N 124.54 1.15 . . . . 0.0 111.004 179.938 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 181' ' ' MET . . . . . 0.451 ' CE ' ' HD2' ' A' ' 165' ' ' PRO . 0.4 OUTLIER -88.81 103.73 16.26 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.524 0.779 . . . . 0.0 110.926 -179.926 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 182' ' ' ILE . . . . . 0.445 HG21 HD22 ' A' ' 159' ' ' LEU . 0.0 OUTLIER -107.36 165.72 12.31 Favored Pre-proline 0 C--N 1.325 -0.495 0 O-C-N 124.49 1.119 . . . . 0.0 109.298 -179.998 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 183' ' ' PRO . . . . . 0.6 ' HG2' ' HB2' ' A' ' 186' ' ' TYR . 18.3 Cg_endo -75.02 131.38 14.2 Favored 'Trans proline' 0 C--N 1.359 1.088 0 O-C-N 124.534 1.807 . . . . 0.0 110.984 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 184' ' ' VAL . . . . . 0.803 ' N ' ' CD ' ' A' ' 185' ' ' PRO . 90.5 t -79.92 -33.64 0.8 Allowed Pre-proline 0 C--N 1.326 -0.447 0 O-C-N 124.529 1.143 . . . . 0.0 109.28 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 185' ' ' PRO . . . . . 0.803 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.3 Cg_endo -74.93 -13.87 21.46 Favored 'Trans proline' 0 C--N 1.361 1.194 0 O-C-N 124.517 1.798 . . . . 0.0 111.054 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 186' ' ' TYR . . . . . 0.6 ' HB2' ' HG2' ' A' ' 183' ' ' PRO . 8.8 m-85 -95.96 4.98 52.26 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.458 1.098 . . . . 0.0 110.983 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 187' ' ' VAL . . . . . 0.632 HG23 ' CG2' ' A' ' 137' ' ' VAL . 25.0 m -136.18 170.25 19.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 O-C-N 124.424 1.078 . . . . 0.0 109.319 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 188' ' ' GLU . . . . . 0.624 ' HG2' HD11 ' A' ' 140' ' ' LEU . 0.0 OUTLIER -121.82 155.27 35.69 Favored 'General case' 0 C--N 1.326 -0.432 0 O-C-N 124.426 1.079 . . . . 0.0 110.26 -179.994 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.44 126.75 35.07 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.527 1.142 . . . . 0.0 109.259 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.324 -0.521 0 O-C-N 124.455 1.097 . . . . 0.0 111.017 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 135' ' ' GLU . . . . . 0.46 ' O ' ' HA ' ' A' ' 160' ' ' ARG . 0.4 OUTLIER . . . . . 0 N--CA 1.453 -0.301 0 N-CA-C 110.33 -0.248 . . . . 0.0 110.33 . . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 136' ' ' TYR . . . . . 0.471 ' CE2' HG21 ' A' ' 158' ' ' ILE . 0.1 OUTLIER -127.72 113.8 16.48 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.416 1.072 . . . . 0.0 111.012 -179.973 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.511 HG13 HD13 ' A' ' 161' ' ' ILE . 16.0 m -108.17 137.18 40.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 O-C-N 124.539 1.149 . . . . 0.0 109.275 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 138' ' ' ARG . . . . . 0.427 ' O ' ' HA ' ' A' ' 187' ' ' VAL . 6.4 ttm180 -101.89 128.83 48.1 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.529 1.143 . . . . 0.0 110.3 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 0.867 ' HB3' ' HB3' ' A' ' 157' ' ' ASP . . . -88.52 103.69 16.12 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 124.557 1.16 . . . . 0.0 109.267 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.715 HD11 ' HB3' ' A' ' 188' ' ' GLU . 0.2 OUTLIER -90.41 -29.06 18.23 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.464 1.102 . . . . 0.0 109.26 179.984 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 141' ' ' PHE . . . . . 0.498 ' C ' ' O ' ' A' ' 154' ' ' LYS . 27.0 m-85 -92.16 151.22 20.49 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.498 1.124 . . . . 0.0 110.951 -179.907 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.325 -0.499 0 O-C-N 124.508 1.13 . . . . 0.0 109.322 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 153' ' ' PHE . . . . . 0.681 ' HD2' HD11 ' A' ' 182' ' ' ILE . 20.5 p90 . . . . . 0 N--CA 1.454 -0.255 0 CA-C-O 120.537 0.208 . . . . 0.0 110.95 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 154' ' ' LYS . . . . . 0.498 ' O ' ' C ' ' A' ' 141' ' ' PHE . 1.2 ttmm -127.32 -83.73 0.61 Allowed 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.471 1.107 . . . . 0.0 109.364 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -161.46 113.52 1.81 Allowed 'General case' 0 C--N 1.326 -0.431 0 O-C-N 124.378 1.048 . . . . 0.0 109.312 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 156' ' ' GLY . . . . . 0.568 ' N ' ' O ' ' A' ' 139' ' ' ALA . . . 108.38 16.08 12.79 Favored Glycine 0 CA--C 1.53 1.022 0 O-C-N 124.435 1.084 . . . . 0.0 111.041 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 157' ' ' ASP . . . . . 0.867 ' HB3' ' HB3' ' A' ' 139' ' ' ALA . 24.6 t70 -81.27 158.06 24.93 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.55 0.794 . . . . 0.0 109.336 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 158' ' ' ILE . . . . . 0.471 HG21 ' CE2' ' A' ' 136' ' ' TYR . 7.5 mm -119.35 133.21 66.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 O-C-N 124.468 1.105 . . . . 0.0 109.328 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.815 HD22 HD13 ' A' ' 182' ' ' ILE . 0.1 OUTLIER -138.07 128.71 26.61 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.48 1.113 . . . . 0.0 109.316 -179.953 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 160' ' ' ARG . . . . . 0.59 ' O ' ' HA ' ' A' ' 172' ' ' ALA . 1.5 ttp180 -90.1 131.18 36.1 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.426 1.079 . . . . 0.0 110.271 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.511 HD13 HG13 ' A' ' 137' ' ' VAL . 1.3 mp -82.82 120.7 34.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 O-C-N 124.482 1.114 . . . . 0.0 109.353 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 3.5 mtp180 -114.41 -56.91 2.34 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.494 1.122 . . . . 0.0 110.245 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -123.83 161.41 25.34 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.478 1.111 . . . . 0.0 109.295 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 164' ' ' LYS . . . . . 0.628 ' CD ' ' CE2' ' A' ' 170' ' ' TRP . 2.6 ttpt -144.95 76.0 13.92 Favored Pre-proline 0 C--N 1.326 -0.451 0 O-C-N 124.506 1.128 . . . . 0.0 109.33 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.96 -33.07 4.91 Favored 'Trans proline' 0 C--N 1.36 1.145 0 O-C-N 124.527 1.804 . . . . 0.0 111.0 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 166' ' ' GLU . . . . . 0.406 ' O ' ' CD1' ' A' ' 170' ' ' TRP . 2.9 mt-10 -114.18 163.8 14.73 Favored 'General case' 0 C--N 1.324 -0.536 0 O-C-N 124.569 1.168 . . . . 0.0 110.282 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -88.64 -23.35 23.07 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.446 1.092 . . . . 0.0 110.283 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 168' ' ' GLN . . . . . 0.527 ' O ' HG23 ' A' ' 184' ' ' VAL . 3.9 mt-30 -87.03 -69.92 0.65 Allowed 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.499 1.125 . . . . 0.0 110.331 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 169' ' ' TRP . . . . . . . . . . . . . 5.8 m95 -94.1 141.35 28.64 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 170' ' ' TRP . . . . . 0.692 ' CE2' HG21 ' A' ' 184' ' ' VAL . 50.8 m0 -120.15 153.24 36.49 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.517 1.135 . . . . 0.0 107.957 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 171' ' ' ASN . . . . . 0.411 ' HA ' ' O ' ' A' ' 180' ' ' GLY . 1.3 t-20 -86.67 92.63 8.99 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.503 1.127 . . . . 0.0 109.334 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 172' ' ' ALA . . . . . 0.59 ' HA ' ' O ' ' A' ' 160' ' ' ARG . . . -109.21 176.66 5.01 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.507 1.129 . . . . 0.0 109.317 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 173' ' ' GLU . . . . . 0.406 ' HA ' ' O ' ' A' ' 178' ' ' LYS . 30.2 mt-10 -123.06 123.4 40.77 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.496 1.122 . . . . 0.0 110.331 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -73.79 -171.46 1.07 Allowed 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.475 1.109 . . . . 0.0 109.369 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -83.21 64.48 7.74 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.458 1.099 . . . . 0.0 110.063 179.958 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -176.22 8.25 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.559 1.162 . . . . 0.0 110.279 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 69.03 29.26 72.41 Favored Glycine 0 CA--C 1.53 0.985 0 O-C-N 124.453 1.095 . . . . 0.0 111.03 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 178' ' ' LYS . . . . . 0.406 ' O ' ' HA ' ' A' ' 173' ' ' GLU . 8.4 mtpt -103.86 115.27 30.15 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.518 0.775 . . . . 0.0 109.346 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 179' ' ' ARG . . . . . 0.476 ' HA ' ' O ' ' A' ' 172' ' ' ALA . 8.9 ttp180 -88.95 128.03 35.68 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.5 1.125 . . . . 0.0 110.316 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 180' ' ' GLY . . . . . 0.411 ' O ' ' HA ' ' A' ' 171' ' ' ASN . . . -151.71 170.34 31.18 Favored Glycine 0 CA--C 1.53 1.025 0 O-C-N 124.527 1.142 . . . . 0.0 110.991 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 181' ' ' MET . . . . . 0.439 ' HA ' ' O ' ' A' ' 170' ' ' TRP . 0.2 OUTLIER -92.13 99.47 12.27 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.49 0.759 . . . . 0.0 111.039 179.987 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 182' ' ' ILE . . . . . 0.815 HD13 HD22 ' A' ' 159' ' ' LEU . 0.6 OUTLIER -103.78 151.64 38.85 Favored Pre-proline 0 C--N 1.324 -0.504 0 O-C-N 124.482 1.114 . . . . 0.0 109.311 -179.976 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 183' ' ' PRO . . . . . 0.658 ' HD2' ' CG1' ' A' ' 182' ' ' ILE . 18.4 Cg_endo -74.99 134.19 17.53 Favored 'Trans proline' 0 C--N 1.359 1.109 0 O-C-N 124.441 1.759 . . . . 0.0 110.979 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 184' ' ' VAL . . . . . 0.858 ' N ' ' CD ' ' A' ' 185' ' ' PRO . 21.6 t -75.8 -29.14 0.79 Allowed Pre-proline 0 C--N 1.326 -0.441 0 O-C-N 124.398 1.061 . . . . 0.0 109.286 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 185' ' ' PRO . . . . . 0.858 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.5 Cg_endo -74.87 -13.68 21.65 Favored 'Trans proline' 0 C--N 1.36 1.146 0 O-C-N 124.477 1.777 . . . . 0.0 111.037 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 186' ' ' TYR . . . . . 0.635 ' HB2' ' HG2' ' A' ' 183' ' ' PRO . 8.2 m-85 -98.54 4.56 48.21 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.476 1.11 . . . . 0.0 111.009 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 187' ' ' VAL . . . . . 0.47 HG11 ' CD1' ' A' ' 159' ' ' LEU . 19.2 m -137.05 171.09 16.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 O-C-N 124.547 1.154 . . . . 0.0 109.312 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 188' ' ' GLU . . . . . 0.715 ' HB3' HD11 ' A' ' 140' ' ' LEU . 1.5 pp20? -125.89 176.76 6.74 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.458 1.099 . . . . 0.0 110.259 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -93.44 112.39 24.28 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.522 1.139 . . . . 0.0 109.335 179.958 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 190' ' ' TYR . . . . . 0.45 ' C ' ' CD1' ' A' ' 190' ' ' TYR . 0.8 OUTLIER . . . . . 0 C--N 1.325 -0.491 0 O-C-N 124.53 1.144 . . . . 0.0 111.027 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 135' ' ' GLU . . . . . 0.456 ' HB2' ' O ' ' A' ' 161' ' ' ILE . 5.1 pt-20 . . . . . 0 N--CA 1.453 -0.293 0 N-CA-C 110.262 -0.273 . . . . 0.0 110.262 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -123.81 118.9 28.19 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.487 1.117 . . . . 0.0 110.99 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.645 ' HB ' HD13 ' A' ' 161' ' ' ILE . 0.9 OUTLIER -121.83 123.04 68.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 O-C-N 124.543 1.152 . . . . 0.0 109.275 -179.969 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 138' ' ' ARG . . . . . 0.537 ' O ' ' HA ' ' A' ' 187' ' ' VAL . 12.1 ttm180 -87.45 150.29 23.87 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.489 1.118 . . . . 0.0 110.299 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 0.521 ' HB2' HG12 ' A' ' 187' ' ' VAL . . . -113.75 108.48 17.16 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.499 1.125 . . . . 0.0 109.317 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.807 HD21 ' OE2' ' A' ' 188' ' ' GLU . 0.0 OUTLIER -93.5 -7.56 43.98 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.607 1.192 . . . . 0.0 109.262 -179.991 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 59.9 m-85 -113.78 164.11 14.16 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.554 1.159 . . . . 0.0 110.955 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 142' ' ' ASP . . . . . 0.462 ' N ' ' OD1' ' A' ' 142' ' ' ASP . 0.0 OUTLIER . . . . . 0 C--N 1.325 -0.462 0 O-C-N 124.493 1.121 . . . . 0.0 109.299 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 21.8 p90 . . . . . 0 N--CA 1.453 -0.324 0 CA-C-O 120.466 0.175 . . . . 0.0 111.028 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 154' ' ' LYS . . . . . 0.417 ' HA ' ' HA ' ' A' ' 142' ' ' ASP . 1.6 tttm -132.09 -169.36 2.2 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.549 1.155 . . . . 0.0 109.319 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.498 ' CB ' ' O ' ' A' ' 140' ' ' LEU . 9.6 ptpt -89.31 111.17 21.94 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.517 1.136 . . . . 0.0 109.301 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 117.3 8.24 11.58 Favored Glycine 0 CA--C 1.529 0.96 0 O-C-N 124.486 1.116 . . . . 0.0 111.05 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 157' ' ' ASP . . . . . 0.432 ' CG ' ' N ' ' A' ' 158' ' ' ILE . 14.5 t0 -91.12 172.63 8.42 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.512 0.772 . . . . 0.0 109.277 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 158' ' ' ILE . . . . . 0.433 ' C ' ' HG ' ' A' ' 159' ' ' LEU . 3.2 mt -140.27 142.55 31.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 O-C-N 124.547 1.154 . . . . 0.0 109.332 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.588 ' CD1' HG11 ' A' ' 187' ' ' VAL . 0.1 OUTLIER -136.93 141.23 42.67 Favored 'General case' 0 C--N 1.324 -0.533 0 O-C-N 124.555 1.159 . . . . 0.0 109.328 179.997 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 160' ' ' ARG . . . . . 0.481 ' O ' ' HA ' ' A' ' 172' ' ' ALA . 15.2 ttm105 -87.86 134.91 33.6 Favored 'General case' 0 C--N 1.326 -0.437 0 O-C-N 124.581 1.176 . . . . 0.0 110.333 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.645 HD13 ' HB ' ' A' ' 137' ' ' VAL . 1.0 OUTLIER -83.53 109.81 17.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 O-C-N 124.536 1.148 . . . . 0.0 109.321 179.969 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 162' ' ' ARG . . . . . 0.452 ' HG3' ' CG ' ' A' ' 179' ' ' ARG . 20.8 mmm180 -90.68 -59.34 2.2 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.546 1.154 . . . . 0.0 110.303 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 163' ' ' ASP . . . . . 0.515 ' N ' ' OD1' ' A' ' 171' ' ' ASN . 0.7 OUTLIER -151.34 144.53 24.69 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.481 1.113 . . . . 0.0 109.32 179.963 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 164' ' ' LYS . . . . . 0.598 ' CB ' ' CG ' ' A' ' 170' ' ' TRP . 0.6 OUTLIER -128.02 78.38 75.36 Favored Pre-proline 0 C--N 1.325 -0.475 0 O-C-N 124.494 1.121 . . . . 0.0 109.307 -179.942 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.03 -48.08 0.18 Allowed 'Trans proline' 0 C--N 1.359 1.116 0 O-C-N 124.51 1.795 . . . . 0.0 110.914 -179.925 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 13.7 mp0 -69.68 176.23 3.7 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.402 1.064 . . . . 0.0 110.322 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -115.24 51.44 0.92 Allowed 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.547 1.154 . . . . 0.0 110.29 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 168' ' ' GLN . . . . . 0.476 ' HB3' ' CD1' ' A' ' 169' ' ' TRP . 3.3 mt-30 -179.25 -55.58 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.582 1.176 . . . . 0.0 110.278 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 169' ' ' TRP . . . . . 0.476 ' CD1' ' HB3' ' A' ' 168' ' ' GLN . 12.2 m95 -108.91 133.05 53.44 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.491 1.12 . . . . 0.0 107.995 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 170' ' ' TRP . . . . . 0.743 ' CE2' HG21 ' A' ' 184' ' ' VAL . 26.6 m0 -120.8 154.66 35.43 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 171' ' ' ASN . . . . . 0.515 ' OD1' ' N ' ' A' ' 163' ' ' ASP . 6.0 p30 -87.16 108.9 19.11 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.46 1.1 . . . . 0.0 109.265 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 172' ' ' ALA . . . . . 0.513 ' O ' ' HA ' ' A' ' 179' ' ' ARG . . . -117.35 174.63 6.02 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.511 1.132 . . . . 0.0 109.331 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -116.34 116.69 28.19 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.406 1.066 . . . . 0.0 110.278 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 174' ' ' ASP . . . . . 0.582 ' OD1' HD23 ' A' ' 159' ' ' LEU . 0.4 OUTLIER -74.43 -176.88 2.86 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.56 1.163 . . . . 0.0 109.316 -179.993 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 37.6 t -76.01 61.91 1.58 Allowed 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.53 1.144 . . . . 0.0 109.969 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -173.79 8.11 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.415 1.072 . . . . 0.0 110.319 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 67.88 20.91 72.94 Favored Glycine 0 CA--C 1.53 1.014 0 O-C-N 124.58 1.175 . . . . 0.0 110.998 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.06 115.63 27.68 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.481 0.754 . . . . 0.0 109.329 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 179' ' ' ARG . . . . . 0.513 ' HA ' ' O ' ' A' ' 172' ' ' ALA . 0.1 OUTLIER -90.13 122.53 33.17 Favored 'General case' 0 C--N 1.326 -0.442 0 O-C-N 124.459 1.099 . . . . 0.0 110.286 -179.958 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 180' ' ' GLY . . . . . 0.495 ' O ' ' HA ' ' A' ' 171' ' ' ASN . . . -151.34 165.9 30.5 Favored Glycine 0 CA--C 1.53 0.971 0 O-C-N 124.487 1.117 . . . . 0.0 111.001 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 181' ' ' MET . . . . . 0.437 ' HA ' ' O ' ' A' ' 170' ' ' TRP . 0.4 OUTLIER -84.5 103.7 13.86 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.503 0.766 . . . . 0.0 111.035 179.943 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 182' ' ' ILE . . . . . 0.452 ' HB ' ' HD2' ' A' ' 183' ' ' PRO . 2.2 pp -106.93 161.11 23.94 Favored Pre-proline 0 C--N 1.325 -0.493 0 O-C-N 124.498 1.124 . . . . 0.0 109.267 -179.952 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 183' ' ' PRO . . . . . 0.642 ' HG2' ' HB2' ' A' ' 186' ' ' TYR . 18.4 Cg_endo -74.98 135.37 19.02 Favored 'Trans proline' 0 C--N 1.361 1.214 0 O-C-N 124.505 1.792 . . . . 0.0 110.989 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 184' ' ' VAL . . . . . 0.843 ' N ' ' CD ' ' A' ' 185' ' ' PRO . 58.0 t -80.1 -30.28 0.6 Allowed Pre-proline 0 C--N 1.326 -0.427 0 O-C-N 124.467 1.105 . . . . 0.0 109.28 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 185' ' ' PRO . . . . . 0.843 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.2 Cg_endo -75.05 -15.53 20.58 Favored 'Trans proline' 0 C--N 1.36 1.154 0 O-C-N 124.482 1.78 . . . . 0.0 110.973 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 186' ' ' TYR . . . . . 0.642 ' HB2' ' HG2' ' A' ' 183' ' ' PRO . 4.5 m-85 -94.95 5.91 50.58 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.492 1.12 . . . . 0.0 111.056 179.923 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 187' ' ' VAL . . . . . 0.588 HG11 ' CD1' ' A' ' 159' ' ' LEU . 35.4 m -136.94 164.48 30.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 O-C-N 124.475 1.11 . . . . 0.0 109.314 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 188' ' ' GLU . . . . . 0.807 ' OE2' HD21 ' A' ' 140' ' ' LEU . 0.0 OUTLIER -120.49 165.75 14.54 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.487 1.117 . . . . 0.0 110.262 -180.0 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 189' ' ' LYS . . . . . 0.453 ' CD ' ' H ' ' A' ' 189' ' ' LYS . 0.0 OUTLIER -89.33 126.54 35.57 Favored 'General case' 0 C--N 1.326 -0.439 0 O-C-N 124.455 1.097 . . . . 0.0 109.366 179.969 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 190' ' ' TYR . . . . . 0.436 ' CD1' ' OE1' ' A' ' 188' ' ' GLU . 0.1 OUTLIER . . . . . 0 C--N 1.326 -0.449 0 O-C-N 124.528 1.143 . . . . 0.0 110.98 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.453 -0.299 0 N-CA-C 110.321 -0.252 . . . . 0.0 110.321 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 136' ' ' TYR . . . . . 0.529 ' CE2' ' HD2' ' A' ' 160' ' ' ARG . 36.6 m-85 -126.62 130.88 51.33 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.547 1.154 . . . . 0.0 110.982 -179.969 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.716 HG12 ' O ' ' A' ' 159' ' ' LEU . 2.9 p -125.75 155.83 35.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 O-C-N 124.491 1.119 . . . . 0.0 109.273 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 138' ' ' ARG . . . . . 0.455 ' HB3' ' HG3' ' A' ' 188' ' ' GLU . 0.0 OUTLIER -126.08 133.03 51.8 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.501 1.125 . . . . 0.0 110.338 179.98 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 0.519 ' HB3' ' HB3' ' A' ' 157' ' ' ASP . . . -97.06 110.64 23.14 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.514 1.134 . . . . 0.0 109.316 -179.965 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.672 HD11 ' HG2' ' A' ' 188' ' ' GLU . 0.2 OUTLIER -95.33 -22.39 17.78 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.555 1.159 . . . . 0.0 109.344 179.948 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 141' ' ' PHE . . . . . 0.476 ' C ' ' O ' ' A' ' 154' ' ' LYS . 12.1 m-85 -94.62 150.31 20.36 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.474 1.109 . . . . 0.0 111.031 179.939 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 142' ' ' ASP . . . . . 0.431 ' CA ' ' O ' ' A' ' 154' ' ' LYS . 0.1 OUTLIER . . . . . 0 C--N 1.324 -0.502 0 O-C-N 124.538 1.149 . . . . 0.0 109.322 -179.969 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 14.9 p90 . . . . . 0 N--CA 1.454 -0.273 0 CA-C-O 120.558 0.218 . . . . 0.0 111.006 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 154' ' ' LYS . . . . . 0.476 ' O ' ' C ' ' A' ' 141' ' ' PHE . 0.0 OUTLIER -125.86 -84.99 0.63 Allowed 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.488 1.118 . . . . 0.0 109.233 -179.984 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -165.58 113.14 0.96 Allowed 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.501 1.126 . . . . 0.0 109.252 -179.949 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 156' ' ' GLY . . . . . 0.402 ' N ' ' O ' ' A' ' 139' ' ' ALA . . . 108.84 14.07 16.47 Favored Glycine 0 CA--C 1.53 1.003 0 O-C-N 124.391 1.057 . . . . 0.0 111.016 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 157' ' ' ASP . . . . . 0.519 ' HB3' ' HB3' ' A' ' 139' ' ' ALA . 6.9 t0 -82.72 158.26 22.96 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.532 0.783 . . . . 0.0 109.27 -179.974 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 158' ' ' ILE . . . . . 0.53 HD12 ' N ' ' A' ' 158' ' ' ILE . 3.9 mp -119.79 141.19 41.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 O-C-N 124.571 1.169 . . . . 0.0 109.266 -179.945 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.816 ' CD2' HG21 ' A' ' 182' ' ' ILE . 2.9 mp -142.04 126.79 18.07 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.42 1.075 . . . . 0.0 109.345 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 160' ' ' ARG . . . . . 0.685 ' O ' ' HA ' ' A' ' 172' ' ' ALA . 0.0 OUTLIER -88.26 132.87 34.21 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.545 1.153 . . . . 0.0 110.328 179.997 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 14.3 mm -82.15 117.14 27.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 O-C-N 124.42 1.075 . . . . 0.0 109.312 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 162' ' ' ARG . . . . . 0.47 ' HG3' ' N ' ' A' ' 163' ' ' ASP . 0.8 OUTLIER -118.22 -32.58 4.65 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.537 1.148 . . . . 0.0 110.368 179.943 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 163' ' ' ASP . . . . . 0.47 ' N ' ' HG3' ' A' ' 162' ' ' ARG . 0.9 OUTLIER -146.35 155.25 42.48 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.486 1.116 . . . . 0.0 109.338 179.949 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 164' ' ' LYS . . . . . 0.575 ' HB3' ' CD1' ' A' ' 170' ' ' TRP . 1.4 mtmp? -148.25 71.93 11.01 Favored Pre-proline 0 C--N 1.324 -0.519 0 O-C-N 124.522 1.139 . . . . 0.0 109.234 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.96 -29.06 8.7 Favored 'Trans proline' 0 C--N 1.359 1.105 0 O-C-N 124.539 1.81 . . . . 0.0 110.999 179.922 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 166' ' ' GLU . . . . . 0.517 ' O ' ' CD1' ' A' ' 170' ' ' TRP . 3.0 mm-40 -105.26 166.02 10.7 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.446 1.091 . . . . 0.0 110.296 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 13.3 mt-10 -96.38 -27.82 14.75 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.463 1.102 . . . . 0.0 110.309 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 168' ' ' GLN . . . . . 0.452 ' O ' HG23 ' A' ' 184' ' ' VAL . 11.4 tt0 -82.35 -58.68 2.83 Favored 'General case' 0 C--N 1.324 -0.536 0 O-C-N 124.533 1.146 . . . . 0.0 110.284 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 169' ' ' TRP . . . . . 0.581 ' CZ3' ' HD3' ' A' ' 183' ' ' PRO . 9.9 m0 -109.7 163.26 13.66 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.501 1.126 . . . . 0.0 107.968 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 170' ' ' TRP . . . . . 0.698 ' CH2' HG11 ' A' ' 184' ' ' VAL . 30.9 m0 -139.57 157.11 46.36 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.525 1.141 . . . . 0.0 107.951 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 4.6 t30 -88.55 107.6 18.98 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.472 1.107 . . . . 0.0 109.291 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 172' ' ' ALA . . . . . 0.685 ' HA ' ' O ' ' A' ' 160' ' ' ARG . . . -121.78 178.45 4.85 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.454 1.096 . . . . 0.0 109.312 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 173' ' ' GLU . . . . . 0.47 ' CG ' ' HG3' ' A' ' 179' ' ' ARG . 17.9 mt-10 -116.49 115.95 26.74 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.548 1.155 . . . . 0.0 110.201 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -64.51 -164.91 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.498 1.124 . . . . 0.0 109.239 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -88.36 60.0 5.48 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.439 1.087 . . . . 0.0 110.016 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 176' ' ' GLU . . . . . 0.4 ' H ' ' H ' ' A' ' 177' ' ' GLY . 4.2 mt-10 174.16 22.58 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.455 1.097 . . . . 0.0 110.362 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 177' ' ' GLY . . . . . 0.4 ' H ' ' H ' ' A' ' 176' ' ' GLU . . . 67.75 15.52 66.77 Favored Glycine 0 CA--C 1.531 1.035 0 O-C-N 124.464 1.102 . . . . 0.0 111.023 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 8.0 mttt -70.9 101.77 2.23 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.505 0.768 . . . . 0.0 109.325 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 179' ' ' ARG . . . . . 0.47 ' HG3' ' CG ' ' A' ' 173' ' ' GLU . 11.3 mtt85 -87.68 105.76 17.58 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.494 1.121 . . . . 0.0 110.255 -179.914 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -151.87 169.45 31.26 Favored Glycine 0 CA--C 1.53 0.983 0 O-C-N 124.507 1.129 . . . . 0.0 111.033 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 181' ' ' MET . . . . . 0.44 ' HA ' ' O ' ' A' ' 170' ' ' TRP . 4.9 mmm -87.68 116.89 26.13 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.52 0.776 . . . . 0.0 111.064 179.904 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 182' ' ' ILE . . . . . 0.816 HG21 ' CD2' ' A' ' 159' ' ' LEU . 1.0 OUTLIER -112.91 161.85 24.62 Favored Pre-proline 0 C--N 1.325 -0.484 0 O-C-N 124.504 1.127 . . . . 0.0 109.252 -179.967 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 183' ' ' PRO . . . . . 0.738 ' HG2' ' HB2' ' A' ' 186' ' ' TYR . 18.2 Cg_endo -75.0 134.05 17.35 Favored 'Trans proline' 0 C--N 1.36 1.151 0 O-C-N 124.502 1.79 . . . . 0.0 110.979 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 184' ' ' VAL . . . . . 0.834 ' N ' ' CD ' ' A' ' 185' ' ' PRO . 38.7 t -79.96 -31.1 0.64 Allowed Pre-proline 0 C--N 1.325 -0.467 0 O-C-N 124.429 1.081 . . . . 0.0 109.275 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 185' ' ' PRO . . . . . 0.834 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.5 Cg_endo -74.99 -25.26 12.06 Favored 'Trans proline' 0 C--N 1.36 1.135 0 O-C-N 124.504 1.792 . . . . 0.0 111.059 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 186' ' ' TYR . . . . . 0.738 ' HB2' ' HG2' ' A' ' 183' ' ' PRO . 3.5 m-85 -93.82 22.84 5.23 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.522 1.139 . . . . 0.0 110.988 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 187' ' ' VAL . . . . . 0.64 ' HB ' HG22 ' A' ' 137' ' ' VAL . 26.2 m -146.53 169.52 5.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 O-C-N 124.475 1.109 . . . . 0.0 109.369 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 188' ' ' GLU . . . . . 0.672 ' HG2' HD11 ' A' ' 140' ' ' LEU . 0.0 OUTLIER -126.82 160.47 30.81 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.543 1.152 . . . . 0.0 110.255 -179.976 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 24.6 mmmt -85.04 127.19 34.11 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.573 1.171 . . . . 0.0 109.259 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.326 -0.451 0 O-C-N 124.516 1.135 . . . . 0.0 111.012 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 135' ' ' GLU . . . . . 0.512 ' O ' ' HG2' ' A' ' 160' ' ' ARG . 0.7 OUTLIER . . . . . 0 N--CA 1.453 -0.3 0 N-CA-C 110.282 -0.266 . . . . 0.0 110.282 . . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -112.03 128.71 56.26 Favored 'General case' 0 C--N 1.324 -0.522 0 O-C-N 124.531 1.145 . . . . 0.0 111.037 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.774 HG22 ' O ' ' A' ' 188' ' ' GLU . 0.4 OUTLIER -119.35 174.98 4.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 O-C-N 124.471 1.107 . . . . 0.0 109.332 179.988 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 138' ' ' ARG . . . . . 0.673 HH21 HD11 ' A' ' 158' ' ' ILE . 14.0 ttm180 -144.69 146.73 32.36 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.535 1.147 . . . . 0.0 110.289 -179.958 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 0.597 ' HB3' ' HB3' ' A' ' 157' ' ' ASP . . . -107.72 109.83 21.52 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.456 1.098 . . . . 0.0 109.306 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.64 HD11 ' HG2' ' A' ' 188' ' ' GLU . 1.0 OUTLIER -88.86 -7.15 56.66 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.52 1.138 . . . . 0.0 109.361 179.977 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 18.6 m-85 -120.67 158.24 27.86 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.576 1.173 . . . . 0.0 110.966 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 142' ' ' ASP . . . . . 0.487 ' HB3' ' HG2' ' A' ' 154' ' ' LYS . 2.0 p-10 . . . . . 0 C--N 1.326 -0.453 0 O-C-N 124.492 1.12 . . . . 0.0 109.339 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 13.4 p90 . . . . . 0 N--CA 1.453 -0.281 0 CA-C-O 120.529 0.204 . . . . 0.0 111.064 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 154' ' ' LYS . . . . . 0.487 ' HG2' ' HB3' ' A' ' 142' ' ' ASP . 1.0 OUTLIER -127.98 -158.86 0.9 Allowed 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.434 1.084 . . . . 0.0 109.255 -179.937 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.43 108.31 20.98 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.466 1.104 . . . . 0.0 109.29 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 114.51 17.9 6.85 Favored Glycine 0 CA--C 1.53 0.974 0 O-C-N 124.433 1.083 . . . . 0.0 111.041 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 157' ' ' ASP . . . . . 0.968 ' C ' HD12 ' A' ' 158' ' ' ILE . 8.9 t70 -87.5 168.68 12.87 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.488 0.758 . . . . 0.0 109.366 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 158' ' ' ILE . . . . . 0.968 HD12 ' C ' ' A' ' 157' ' ' ASP . 2.3 mp -128.56 143.98 39.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 O-C-N 124.559 1.162 . . . . 0.0 109.31 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.911 HD13 HD13 ' A' ' 182' ' ' ILE . 0.3 OUTLIER -149.27 128.47 12.84 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.467 1.104 . . . . 0.0 109.29 -179.913 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 160' ' ' ARG . . . . . 0.573 ' O ' ' HA ' ' A' ' 172' ' ' ALA . 0.0 OUTLIER -84.57 138.32 32.81 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.515 1.134 . . . . 0.0 110.26 -179.994 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.461 ' HB ' ' HB2' ' A' ' 135' ' ' GLU . 43.9 mm -84.77 112.65 22.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 O-C-N 124.482 1.114 . . . . 0.0 109.306 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.45 -56.0 2.4 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.424 1.077 . . . . 0.0 110.309 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -134.88 167.01 21.69 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.464 1.103 . . . . 0.0 109.282 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 164' ' ' LYS . . . . . 0.585 ' HB3' ' CD1' ' A' ' 170' ' ' TRP . 23.3 mtmt -144.44 83.13 10.06 Favored Pre-proline 0 C--N 1.325 -0.492 0 O-C-N 124.531 1.144 . . . . 0.0 109.296 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.03 -27.48 9.93 Favored 'Trans proline' 0 C--N 1.36 1.152 0 O-C-N 124.523 1.802 . . . . 0.0 110.99 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 166' ' ' GLU . . . . . 0.492 ' O ' ' CD1' ' A' ' 170' ' ' TRP . 2.7 mt-10 -121.03 172.75 7.72 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.501 1.126 . . . . 0.0 110.284 -179.941 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -95.56 -29.8 14.16 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.516 1.135 . . . . 0.0 110.319 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 168' ' ' GLN . . . . . 0.654 ' O ' HG23 ' A' ' 184' ' ' VAL . 6.8 tt0 -79.11 -60.19 2.47 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.473 1.108 . . . . 0.0 110.287 -179.954 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 169' ' ' TRP . . . . . 0.42 ' O ' ' CD1' ' A' ' 170' ' ' TRP . 11.2 m0 -104.96 157.74 17.01 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 170' ' ' TRP . . . . . 0.585 ' CD1' ' HB3' ' A' ' 164' ' ' LYS . 39.9 m0 -136.13 155.61 49.92 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.467 1.104 . . . . 0.0 108.055 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 171' ' ' ASN . . . . . 0.426 ' HA ' ' O ' ' A' ' 180' ' ' GLY . 42.1 t-20 -88.37 99.2 12.08 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.525 1.141 . . . . 0.0 109.266 -179.947 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 172' ' ' ALA . . . . . 0.573 ' HA ' ' O ' ' A' ' 160' ' ' ARG . . . -109.41 174.77 5.72 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.514 1.134 . . . . 0.0 109.342 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 173' ' ' GLU . . . . . 0.472 ' C ' HD23 ' A' ' 159' ' ' LEU . 8.0 mt-10 -119.39 117.19 27.84 Favored 'General case' 0 C--N 1.326 -0.437 0 O-C-N 124.475 1.109 . . . . 0.0 110.315 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 174' ' ' ASP . . . . . 0.523 ' OD1' HD21 ' A' ' 159' ' ' LEU . 3.7 m-20 -67.2 -176.39 0.55 Allowed 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.471 1.107 . . . . 0.0 109.273 -179.952 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 73.4 p -79.24 60.17 3.0 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.528 1.142 . . . . 0.0 110.002 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 176' ' ' GLU . . . . . 0.414 ' H ' ' H ' ' A' ' 177' ' ' GLY . 0.2 OUTLIER -176.54 7.56 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.428 0 O-C-N 124.485 1.116 . . . . 0.0 110.292 -179.996 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 177' ' ' GLY . . . . . 0.414 ' H ' ' H ' ' A' ' 176' ' ' GLU . . . 75.66 18.23 79.81 Favored Glycine 0 CA--C 1.529 0.959 0 O-C-N 124.495 1.122 . . . . 0.0 110.985 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 14.1 mtmm -83.92 106.25 15.44 Favored 'General case' 0 C--N 1.326 -0.435 0 O-C-N 124.41 0.712 . . . . 0.0 109.277 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 179' ' ' ARG . . . . . 0.403 ' HD3' ' OE2' ' A' ' 173' ' ' GLU . 4.1 ttp180 -88.51 118.04 27.88 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.444 1.09 . . . . 0.0 110.265 -179.936 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 180' ' ' GLY . . . . . 0.426 ' O ' ' HA ' ' A' ' 171' ' ' ASN . . . -151.57 166.86 30.83 Favored Glycine 0 CA--C 1.53 1.002 0 O-C-N 124.501 1.126 . . . . 0.0 110.979 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 181' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -87.61 114.43 24.22 Favored 'General case' 0 C--N 1.324 -0.528 0 O-C-N 124.497 0.763 . . . . 0.0 110.939 -179.957 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 182' ' ' ILE . . . . . 0.911 HD13 HD13 ' A' ' 159' ' ' LEU . 2.1 pt -116.02 163.44 21.35 Favored Pre-proline 0 C--N 1.325 -0.487 0 O-C-N 124.492 1.12 . . . . 0.0 109.256 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 183' ' ' PRO . . . . . 0.775 ' HG2' ' HB2' ' A' ' 186' ' ' TYR . 18.0 Cg_endo -75.02 135.63 19.3 Favored 'Trans proline' 0 C--N 1.361 1.199 0 O-C-N 124.52 1.8 . . . . 0.0 110.946 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 184' ' ' VAL . . . . . 0.82 ' N ' ' CD ' ' A' ' 185' ' ' PRO . 50.6 t -80.17 -31.98 0.68 Allowed Pre-proline 0 C--N 1.325 -0.469 0 O-C-N 124.486 1.117 . . . . 0.0 109.299 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 185' ' ' PRO . . . . . 0.82 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.3 Cg_endo -75.0 -23.09 14.13 Favored 'Trans proline' 0 C--N 1.361 1.214 0 O-C-N 124.541 1.811 . . . . 0.0 110.985 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 186' ' ' TYR . . . . . 0.775 ' HB2' ' HG2' ' A' ' 183' ' ' PRO . 3.8 m-85 -93.66 16.02 14.86 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.503 1.127 . . . . 0.0 111.037 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 187' ' ' VAL . . . . . 0.601 ' HA ' ' O ' ' A' ' 138' ' ' ARG . 6.0 m -145.49 165.58 10.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 O-C-N 124.449 1.093 . . . . 0.0 109.305 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 188' ' ' GLU . . . . . 0.774 ' O ' HG22 ' A' ' 137' ' ' VAL . 0.0 OUTLIER -130.16 166.05 21.05 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.47 1.106 . . . . 0.0 110.371 -179.971 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.65 121.85 32.92 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.462 1.101 . . . . 0.0 109.369 179.911 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 2.6 t80 . . . . . 0 C--N 1.325 -0.487 0 O-C-N 124.543 1.152 . . . . 0.0 110.991 -179.913 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 135' ' ' GLU . . . . . 0.437 ' O ' ' HA ' ' A' ' 160' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.453 -0.287 0 N-CA-C 110.301 -0.259 . . . . 0.0 110.301 . . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -128.08 116.68 20.35 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 124.518 1.136 . . . . 0.0 110.967 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.593 HG13 HD13 ' A' ' 161' ' ' ILE . 32.4 m -107.77 165.02 4.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 O-C-N 124.542 1.151 . . . . 0.0 109.36 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 138' ' ' ARG . . . . . 0.473 ' O ' ' HA ' ' A' ' 187' ' ' VAL . 2.7 tpp85 -125.12 132.18 53.15 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.445 1.091 . . . . 0.0 110.306 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 0.578 ' O ' ' N ' ' A' ' 156' ' ' GLY . . . -98.22 112.94 24.74 Favored 'General case' 0 C--N 1.326 -0.444 0 O-C-N 124.474 1.109 . . . . 0.0 109.307 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.881 HD21 ' OE2' ' A' ' 188' ' ' GLU . 0.1 OUTLIER -92.71 -12.02 32.5 Favored 'General case' 0 C--N 1.326 -0.437 0 O-C-N 124.448 1.092 . . . . 0.0 109.302 -179.953 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -121.73 156.69 32.56 Favored 'General case' 0 C--N 1.326 -0.416 0 O-C-N 124.507 1.129 . . . . 0.0 110.966 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 142' ' ' ASP . . . . . 0.464 ' OD1' ' N ' ' A' ' 155' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--N 1.326 -0.454 0 O-C-N 124.439 1.087 . . . . 0.0 109.316 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 52.2 p90 . . . . . 0 N--CA 1.453 -0.306 0 CA-C-O 120.475 0.179 . . . . 0.0 110.967 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 154' ' ' LYS . . . . . 0.435 ' HA ' ' HB3' ' A' ' 142' ' ' ASP . 2.9 tttm -128.92 -161.75 1.14 Allowed 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.528 1.143 . . . . 0.0 109.273 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.464 ' N ' ' OD1' ' A' ' 142' ' ' ASP . 0.0 OUTLIER -91.64 101.12 13.74 Favored 'General case' 0 C--N 1.324 -0.522 0 O-C-N 124.507 1.129 . . . . 0.0 109.302 -179.987 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 156' ' ' GLY . . . . . 0.578 ' N ' ' O ' ' A' ' 139' ' ' ALA . . . 114.47 27.64 3.27 Favored Glycine 0 CA--C 1.53 0.981 0 O-C-N 124.491 1.12 . . . . 0.0 111.023 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 157' ' ' ASP . . . . . 0.46 ' O ' ' HD3' ' A' ' 138' ' ' ARG . 2.5 t70 -105.08 163.47 12.53 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.555 0.797 . . . . 0.0 109.299 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 158' ' ' ILE . . . . . 0.433 HG12 ' HD3' ' A' ' 138' ' ' ARG . 4.4 mt -119.59 149.08 22.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 O-C-N 124.47 1.107 . . . . 0.0 109.297 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.643 HD12 ' N ' ' A' ' 159' ' ' LEU . 0.0 OUTLIER -147.5 137.45 22.93 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 124.515 1.135 . . . . 0.0 109.279 -179.969 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 160' ' ' ARG . . . . . 0.702 ' O ' ' HB1' ' A' ' 172' ' ' ALA . 7.3 ttt180 -88.25 136.29 33.05 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.522 1.139 . . . . 0.0 110.325 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.593 HD13 HG13 ' A' ' 137' ' ' VAL . 0.9 OUTLIER -83.68 110.3 18.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 O-C-N 124.44 1.087 . . . . 0.0 109.324 -179.948 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 162' ' ' ARG . . . . . 0.43 ' HB3' ' ND2' ' A' ' 171' ' ' ASN . 2.5 tpt85 -88.33 -59.6 2.19 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.483 1.114 . . . . 0.0 110.353 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 163' ' ' ASP . . . . . 0.429 ' O ' ' HB3' ' A' ' 170' ' ' TRP . 20.3 t0 -149.19 149.68 31.4 Favored 'General case' 0 C--N 1.324 -0.526 0 O-C-N 124.515 1.134 . . . . 0.0 109.34 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 164' ' ' LYS . . . . . 0.542 ' HB2' ' CE2' ' A' ' 170' ' ' TRP . 0.4 OUTLIER -132.76 76.51 70.9 Favored Pre-proline 0 C--N 1.325 -0.496 0 O-C-N 124.474 1.109 . . . . 0.0 109.324 -179.987 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -75.14 -44.89 0.3 Allowed 'Trans proline' 0 C--N 1.361 1.207 0 O-C-N 124.426 1.75 . . . . 0.0 110.959 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 -78.97 175.5 10.51 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.457 1.098 . . . . 0.0 110.303 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 32.6 mm-40 -114.03 54.12 0.76 Allowed 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.464 1.102 . . . . 0.0 110.322 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 168' ' ' GLN . . . . . 0.524 ' O ' HG23 ' A' ' 184' ' ' VAL . 0.0 OUTLIER -178.5 -57.63 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.432 0 O-C-N 124.464 1.103 . . . . 0.0 110.261 -179.971 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 169' ' ' TRP . . . . . 0.563 ' CH2' ' HD3' ' A' ' 183' ' ' PRO . 14.0 m95 -109.8 142.13 41.49 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 107.961 -1.125 . . . . 0.0 107.961 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 170' ' ' TRP . . . . . 0.671 ' CD2' HG21 ' A' ' 184' ' ' VAL . 22.8 m0 -133.91 161.39 34.91 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.518 1.136 . . . . 0.0 108.011 179.964 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 171' ' ' ASN . . . . . 0.43 ' ND2' ' HB3' ' A' ' 162' ' ' ARG . 5.3 p-10 -94.08 111.26 22.96 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.556 1.16 . . . . 0.0 109.296 179.986 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 172' ' ' ALA . . . . . 0.702 ' HB1' ' O ' ' A' ' 160' ' ' ARG . . . -117.34 -176.79 3.08 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.499 1.125 . . . . 0.0 109.308 179.991 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 173' ' ' GLU . . . . . 0.435 ' OE2' ' CD ' ' A' ' 179' ' ' ARG . 40.2 mt-10 -128.09 124.27 36.59 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.439 1.087 . . . . 0.0 110.338 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -75.99 -172.65 2.06 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.407 1.067 . . . . 0.0 109.278 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 1.4 m -82.35 61.59 5.62 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.55 1.156 . . . . 0.0 110.028 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -177.16 9.95 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.451 1.094 . . . . 0.0 110.312 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 74.07 17.25 79.45 Favored Glycine 0 CA--C 1.531 1.034 0 O-C-N 124.51 1.132 . . . . 0.0 111.029 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 178' ' ' LYS . . . . . 0.415 ' O ' ' HA ' ' A' ' 173' ' ' GLU . 0.8 OUTLIER -82.8 101.38 10.9 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.544 0.79 . . . . 0.0 109.262 -179.97 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 179' ' ' ARG . . . . . 0.531 ' HA ' ' O ' ' A' ' 172' ' ' ALA . 0.0 OUTLIER -91.42 115.42 28.02 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.528 1.142 . . . . 0.0 110.275 -179.968 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 180' ' ' GLY . . . . . 0.427 ' O ' ' HA ' ' A' ' 171' ' ' ASN . . . -150.96 169.0 30.7 Favored Glycine 0 CA--C 1.53 1.005 0 O-C-N 124.457 1.098 . . . . 0.0 110.998 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 181' ' ' MET . . . . . 0.496 ' HG3' ' HB3' ' A' ' 169' ' ' TRP . 1.4 ttm -87.75 111.95 21.88 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.44 0.729 . . . . 0.0 110.99 -179.978 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 182' ' ' ILE . . . . . 0.557 ' HA ' ' CZ3' ' A' ' 169' ' ' TRP . 1.5 pp -115.27 166.88 10.94 Favored Pre-proline 0 C--N 1.325 -0.472 0 O-C-N 124.538 1.149 . . . . 0.0 109.263 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 183' ' ' PRO . . . . . 0.607 ' HG2' ' CB ' ' A' ' 186' ' ' TYR . 18.3 Cg_endo -75.02 135.11 18.61 Favored 'Trans proline' 0 C--N 1.36 1.145 0 O-C-N 124.471 1.774 . . . . 0.0 110.973 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 184' ' ' VAL . . . . . 0.811 ' N ' ' CD ' ' A' ' 185' ' ' PRO . 86.9 t -79.98 -32.3 0.71 Allowed Pre-proline 0 C--N 1.325 -0.467 0 O-C-N 124.482 1.114 . . . . 0.0 109.293 179.986 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 185' ' ' PRO . . . . . 0.811 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.3 Cg_endo -74.99 -11.38 21.49 Favored 'Trans proline' 0 C--N 1.359 1.124 0 O-C-N 124.48 1.779 . . . . 0.0 110.999 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 186' ' ' TYR . . . . . 0.607 ' CB ' ' HG2' ' A' ' 183' ' ' PRO . 6.8 m-85 -93.97 -1.98 53.82 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.501 1.126 . . . . 0.0 111.022 -179.979 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 187' ' ' VAL . . . . . 0.473 ' HA ' ' O ' ' A' ' 138' ' ' ARG . 14.4 m -133.22 174.03 13.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 O-C-N 124.477 1.111 . . . . 0.0 109.307 179.963 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 188' ' ' GLU . . . . . 0.881 ' OE2' HD21 ' A' ' 140' ' ' LEU . 0.0 OUTLIER -135.53 172.51 12.9 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.457 1.098 . . . . 0.0 110.307 179.991 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.8 126.07 34.8 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.454 1.096 . . . . 0.0 109.288 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 72.2 t80 . . . . . 0 C--N 1.325 -0.484 0 O-C-N 124.47 1.106 . . . . 0.0 110.953 -179.977 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 135' ' ' GLU . . . . . 0.442 ' HB2' ' O ' ' A' ' 161' ' ' ILE . 1.2 pt-20 . . . . . 0 N--CA 1.452 -0.354 0 N-CA-C 110.32 -0.252 . . . . 0.0 110.32 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 7.3 m-85 -124.19 117.06 23.75 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.489 1.118 . . . . 0.0 110.957 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.516 ' CG2' ' O ' ' A' ' 188' ' ' GLU . 0.4 OUTLIER -119.41 132.54 68.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 O-C-N 124.544 1.153 . . . . 0.0 109.309 179.973 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 138' ' ' ARG . . . . . 0.617 HH21 HD11 ' A' ' 158' ' ' ILE . 12.7 ttm180 -95.2 148.37 22.47 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.525 1.14 . . . . 0.0 110.373 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 0.671 ' HB3' ' HB3' ' A' ' 157' ' ' ASP . . . -105.91 110.66 23.01 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.512 1.132 . . . . 0.0 109.268 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.572 HD11 ' HG2' ' A' ' 188' ' ' GLU . 0.3 OUTLIER -93.89 -7.9 41.82 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.456 1.098 . . . . 0.0 109.274 179.965 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 141' ' ' PHE . . . . . 0.456 ' C ' ' O ' ' A' ' 154' ' ' LYS . 14.7 m-85 -104.61 158.73 16.3 Favored 'General case' 0 C--N 1.324 -0.524 0 O-C-N 124.525 1.141 . . . . 0.0 110.976 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 142' ' ' ASP . . . . . 0.57 ' CA ' ' O ' ' A' ' 154' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--N 1.325 -0.461 0 O-C-N 124.449 1.093 . . . . 0.0 109.276 -179.942 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 153' ' ' PHE . . . . . 0.565 ' CD1' ' N ' ' A' ' 153' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.454 -0.251 0 CA-C-O 120.496 0.188 . . . . 0.0 110.971 . . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 154' ' ' LYS . . . . . 0.57 ' O ' ' CA ' ' A' ' 142' ' ' ASP . 0.0 OUTLIER -127.0 -75.37 0.58 Allowed 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.5 1.125 . . . . 0.0 109.258 179.97 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.511 ' CD ' ' O ' ' A' ' 140' ' ' LEU . 0.0 OUTLIER -165.26 109.64 0.88 Allowed 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.54 1.15 . . . . 0.0 109.278 -179.97 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 156' ' ' GLY . . . . . 0.51 ' N ' ' O ' ' A' ' 139' ' ' ALA . . . 93.45 29.88 9.7 Favored Glycine 0 CA--C 1.531 1.042 0 O-C-N 124.593 1.183 . . . . 0.0 110.98 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 157' ' ' ASP . . . . . 0.887 ' C ' HD12 ' A' ' 158' ' ' ILE . 0.4 OUTLIER -88.66 158.65 18.16 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.482 0.754 . . . . 0.0 109.285 179.995 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 158' ' ' ILE . . . . . 0.887 HD12 ' C ' ' A' ' 157' ' ' ASP . 1.5 mp -116.38 136.34 53.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 O-C-N 124.492 1.12 . . . . 0.0 109.278 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.756 HD23 ' HA ' ' A' ' 174' ' ' ASP . 0.6 OUTLIER -138.09 126.22 22.9 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.51 1.131 . . . . 0.0 109.3 -179.971 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 160' ' ' ARG . . . . . 0.525 ' O ' ' HA ' ' A' ' 172' ' ' ALA . 0.0 OUTLIER -86.84 126.28 34.54 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.535 1.147 . . . . 0.0 110.299 -179.98 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.659 HG21 ' CE ' ' A' ' 164' ' ' LYS . 12.4 mm -81.77 122.56 36.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 O-C-N 124.502 1.127 . . . . 0.0 109.336 179.998 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 162' ' ' ARG . . . . . 0.463 ' HG3' ' N ' ' A' ' 163' ' ' ASP . 0.0 OUTLIER -122.53 -29.55 4.06 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.526 1.141 . . . . 0.0 110.276 179.989 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 163' ' ' ASP . . . . . 0.463 ' N ' ' HG3' ' A' ' 162' ' ' ARG . 0.8 OUTLIER -135.99 146.0 46.73 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.477 1.111 . . . . 0.0 109.312 -179.949 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 164' ' ' LYS . . . . . 0.659 ' CE ' HG21 ' A' ' 161' ' ' ILE . 15.9 mtpt -146.84 62.64 7.7 Favored Pre-proline 0 C--N 1.324 -0.506 0 O-C-N 124.459 1.099 . . . . 0.0 109.342 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 165' ' ' PRO . . . . . 0.443 ' HD3' ' N ' ' A' ' 164' ' ' LYS . 18.1 Cg_endo -75.04 -73.54 0.01 OUTLIER 'Trans proline' 0 C--N 1.361 1.218 0 O-C-N 124.474 1.776 . . . . 0.0 110.976 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -50.69 160.06 0.47 Allowed 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.523 1.139 . . . . 0.0 110.293 -179.967 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -100.91 35.21 2.25 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.477 1.11 . . . . 0.0 110.271 -179.938 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -157.75 -51.35 0.07 Allowed 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.417 1.073 . . . . 0.0 110.353 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 169' ' ' TRP . . . . . . . . . . . . . 13.0 m95 -103.79 140.53 37.5 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.607 1.192 . . . . 0.0 108.039 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 170' ' ' TRP . . . . . 0.62 ' CE3' ' CE ' ' A' ' 164' ' ' LYS . 50.5 m0 -121.0 147.35 45.61 Favored 'General case' 0 C--N 1.324 -0.53 0 O-C-N 124.511 1.132 . . . . 0.0 107.975 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 16.4 t30 -87.47 98.06 11.18 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.473 1.108 . . . . 0.0 109.233 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 172' ' ' ALA . . . . . 0.566 ' HB3' HD11 ' A' ' 182' ' ' ILE . . . -107.77 173.54 6.28 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.43 1.081 . . . . 0.0 109.334 179.909 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 173' ' ' GLU . . . . . 0.51 ' CG ' ' HG2' ' A' ' 179' ' ' ARG . 23.9 mt-10 -118.95 120.24 36.7 Favored 'General case' 0 C--N 1.326 -0.439 0 O-C-N 124.479 1.112 . . . . 0.0 110.268 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 174' ' ' ASP . . . . . 0.756 ' HA ' HD23 ' A' ' 159' ' ' LEU . 0.4 OUTLIER -73.92 -169.55 0.76 Allowed 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.489 1.118 . . . . 0.0 109.307 179.944 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 27.6 t -83.69 63.98 7.73 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.496 1.122 . . . . 0.0 110.038 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 176' ' ' GLU . . . . . 0.457 ' H ' ' H ' ' A' ' 177' ' ' GLY . 1.3 mt-10 -176.33 7.23 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.511 1.132 . . . . 0.0 110.341 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 177' ' ' GLY . . . . . 0.457 ' H ' ' H ' ' A' ' 176' ' ' GLU . . . 70.68 22.46 78.04 Favored Glycine 0 CA--C 1.53 0.984 0 O-C-N 124.492 1.12 . . . . 0.0 111.005 -179.969 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 178' ' ' LYS . . . . . 0.411 ' O ' ' HA ' ' A' ' 173' ' ' GLU . 4.6 ptpp? -94.4 115.45 27.66 Favored 'General case' 0 C--N 1.324 -0.53 0 O-C-N 124.454 0.738 . . . . 0.0 109.29 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 179' ' ' ARG . . . . . 0.51 ' HG2' ' CG ' ' A' ' 173' ' ' GLU . 1.3 mtt180 -92.87 123.63 36.27 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.579 1.175 . . . . 0.0 110.331 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -151.04 160.49 28.66 Favored Glycine 0 CA--C 1.53 1.001 0 O-C-N 124.48 1.112 . . . . 0.0 110.996 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 181' ' ' MET . . . . . 0.431 ' HA ' ' O ' ' A' ' 170' ' ' TRP . 4.7 mmm -88.6 107.13 18.75 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.472 0.748 . . . . 0.0 110.997 -179.966 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 182' ' ' ILE . . . . . 0.566 HD11 ' HB3' ' A' ' 172' ' ' ALA . 1.0 OUTLIER -112.32 170.12 5.62 Favored Pre-proline 0 C--N 1.325 -0.474 0 O-C-N 124.41 1.069 . . . . 0.0 109.338 179.969 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 183' ' ' PRO . . . . . 0.599 ' HG2' ' CB ' ' A' ' 186' ' ' TYR . 18.5 Cg_endo -74.98 132.82 15.88 Favored 'Trans proline' 0 C--N 1.36 1.132 0 O-C-N 124.425 1.75 . . . . 0.0 111.022 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 184' ' ' VAL . . . . . 0.819 ' N ' ' CD ' ' A' ' 185' ' ' PRO . 84.5 t -76.62 -31.68 0.96 Allowed Pre-proline 0 C--N 1.326 -0.456 0 O-C-N 124.577 1.173 . . . . 0.0 109.282 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 185' ' ' PRO . . . . . 0.819 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.4 Cg_endo -74.9 -8.72 20.44 Favored 'Trans proline' 0 C--N 1.36 1.153 0 O-C-N 124.454 1.765 . . . . 0.0 111.057 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 186' ' ' TYR . . . . . 0.599 ' CB ' ' HG2' ' A' ' 183' ' ' PRO . 3.4 m-85 -99.7 6.68 45.53 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.459 1.1 . . . . 0.0 110.941 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 187' ' ' VAL . . . . . 0.504 ' HA ' ' O ' ' A' ' 138' ' ' ARG . 34.5 m -136.92 174.5 11.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 O-C-N 124.506 1.129 . . . . 0.0 109.252 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 188' ' ' GLU . . . . . 0.572 ' HG2' HD11 ' A' ' 140' ' ' LEU . 0.0 OUTLIER -131.58 163.69 27.5 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.558 1.161 . . . . 0.0 110.302 179.986 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.53 124.14 35.47 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.461 1.101 . . . . 0.0 109.288 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 190' ' ' TYR . . . . . 0.499 ' OH ' ' CZ ' ' A' ' 138' ' ' ARG . 0.1 OUTLIER . . . . . 0 C--N 1.325 -0.493 0 O-C-N 124.448 1.093 . . . . 0.0 111.049 179.967 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 135' ' ' GLU . . . . . 0.436 ' HB3' ' O ' ' A' ' 161' ' ' ILE . 5.5 mp0 . . . . . 0 N--CA 1.453 -0.315 0 N-CA-C 110.268 -0.271 . . . . 0.0 110.268 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 136' ' ' TYR . . . . . 0.584 ' CD1' ' HG2' ' A' ' 160' ' ' ARG . 86.2 m-85 -128.33 140.11 52.04 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.549 1.155 . . . . 0.0 110.956 -179.965 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.531 ' CG2' HD11 ' A' ' 161' ' ' ILE . 29.1 m -138.1 149.64 24.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 124.514 1.134 . . . . 0.0 109.335 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 138' ' ' ARG . . . . . 0.433 ' HB3' ' CD ' ' A' ' 188' ' ' GLU . 1.2 ttm180 -107.54 130.02 54.91 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.495 1.122 . . . . 0.0 110.275 -179.948 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 0.659 ' O ' ' N ' ' A' ' 156' ' ' GLY . . . -89.25 103.37 16.0 Favored 'General case' 0 C--N 1.326 -0.443 0 O-C-N 124.461 1.1 . . . . 0.0 109.281 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.468 HD11 ' HB3' ' A' ' 188' ' ' GLU . 0.2 OUTLIER -86.85 -2.8 58.86 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.521 1.138 . . . . 0.0 109.345 179.933 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 46.7 m-85 -128.92 157.63 41.06 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.5 1.125 . . . . 0.0 111.009 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 142' ' ' ASP . . . . . 0.465 ' HB2' ' HA ' ' A' ' 154' ' ' LYS . 1.5 t70 . . . . . 0 C--N 1.325 -0.458 0 O-C-N 124.388 1.055 . . . . 0.0 109.266 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 8.4 p90 . . . . . 0 N--CA 1.454 -0.272 0 CA-C-O 120.51 0.195 . . . . 0.0 111.003 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 154' ' ' LYS . . . . . 0.465 ' HA ' ' HB2' ' A' ' 142' ' ' ASP . 6.8 tttt -128.49 -164.9 1.43 Allowed 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.441 1.088 . . . . 0.0 109.272 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 35.4 tttt -92.94 106.47 18.43 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.483 1.114 . . . . 0.0 109.293 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 156' ' ' GLY . . . . . 0.659 ' N ' ' O ' ' A' ' 139' ' ' ALA . . . 109.86 29.01 3.97 Favored Glycine 0 CA--C 1.531 1.034 0 O-C-N 124.496 1.123 . . . . 0.0 111.004 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 157' ' ' ASP . . . . . 0.494 ' HB3' ' HB3' ' A' ' 139' ' ' ALA . 22.8 t70 -97.39 167.05 11.24 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.482 0.754 . . . . 0.0 109.352 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 158' ' ' ILE . . . . . 0.43 HD13 ' O ' ' A' ' 157' ' ' ASP . 18.0 mm -121.46 136.78 57.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 O-C-N 124.52 1.137 . . . . 0.0 109.306 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.6 HD22 HD13 ' A' ' 182' ' ' ILE . 0.8 OUTLIER -141.48 136.63 31.44 Favored 'General case' 0 C--N 1.326 -0.427 0 O-C-N 124.495 1.122 . . . . 0.0 109.325 -179.97 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 160' ' ' ARG . . . . . 0.584 ' HG2' ' CD1' ' A' ' 136' ' ' TYR . 0.0 OUTLIER -97.33 134.98 39.88 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.528 1.143 . . . . 0.0 110.347 179.96 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.531 HD11 ' CG2' ' A' ' 137' ' ' VAL . 1.7 mp -87.19 125.22 41.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 O-C-N 124.501 1.126 . . . . 0.0 109.346 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 162' ' ' ARG . . . . . 0.482 ' CG ' ' N ' ' A' ' 163' ' ' ASP . 0.8 OUTLIER -118.63 -41.03 2.83 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 124.5 1.125 . . . . 0.0 110.291 -179.953 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 163' ' ' ASP . . . . . 0.482 ' N ' ' CG ' ' A' ' 162' ' ' ARG . 13.7 m-20 -148.78 176.99 9.91 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.492 1.12 . . . . 0.0 109.34 -179.987 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 164' ' ' LYS . . . . . 0.592 ' HB3' ' CD1' ' A' ' 170' ' ' TRP . 6.9 mtmm -144.88 65.45 12.24 Favored Pre-proline 0 C--N 1.325 -0.478 0 O-C-N 124.564 1.165 . . . . 0.0 109.283 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 165' ' ' PRO . . . . . 0.514 ' O ' ' CB ' ' A' ' 166' ' ' GLU . 18.5 Cg_endo -74.92 73.29 4.32 Favored 'Trans proline' 0 C--N 1.361 1.212 0 O-C-N 124.507 1.793 . . . . 0.0 110.997 179.966 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 166' ' ' GLU . . . . . 0.535 ' OE1' ' HE2' ' A' ' 181' ' ' MET . 2.5 mt-10 159.93 179.35 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.528 1.142 . . . . 0.0 110.325 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -118.16 46.11 1.85 Allowed 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.513 1.133 . . . . 0.0 110.318 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -178.83 -54.35 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.484 1.115 . . . . 0.0 110.322 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 169' ' ' TRP . . . . . . . . . . . . . 10.2 m95 -95.52 144.35 26.07 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.539 1.149 . . . . 0.0 107.991 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 170' ' ' TRP . . . . . 0.592 ' CD1' ' HB3' ' A' ' 164' ' ' LYS . 53.2 m0 -118.71 148.38 42.83 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 -179.963 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 171' ' ' ASN . . . . . 0.458 ' HB2' ' CD ' ' A' ' 165' ' ' PRO . 5.4 t-20 -87.58 107.73 18.73 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.555 1.16 . . . . 0.0 109.366 179.903 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 172' ' ' ALA . . . . . 0.576 ' HA ' ' O ' ' A' ' 160' ' ' ARG . . . -119.28 174.88 6.09 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.511 1.132 . . . . 0.0 109.31 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 173' ' ' GLU . . . . . 0.514 ' HG3' ' CG ' ' A' ' 179' ' ' ARG . 3.8 mt-10 -118.17 119.92 36.16 Favored 'General case' 0 C--N 1.326 -0.427 0 O-C-N 124.543 1.152 . . . . 0.0 110.262 -179.947 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 174' ' ' ASP . . . . . 0.4 ' OD1' ' HB3' ' A' ' 178' ' ' LYS . 0.8 OUTLIER -76.19 -173.7 2.5 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.411 1.069 . . . . 0.0 109.319 -179.943 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 40.6 t -75.82 63.89 1.73 Allowed 'General case' 0 C--N 1.324 -0.539 0 O-C-N 124.591 1.182 . . . . 0.0 110.079 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 176' ' ' GLU . . . . . 0.442 ' H ' ' H ' ' A' ' 177' ' ' GLY . 0.9 OUTLIER -177.56 1.53 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.55 1.156 . . . . 0.0 110.276 -179.921 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 177' ' ' GLY . . . . . 0.442 ' H ' ' H ' ' A' ' 176' ' ' GLU . . . 74.94 15.47 80.98 Favored Glycine 0 CA--C 1.53 0.998 0 O-C-N 124.522 1.139 . . . . 0.0 111.019 -179.954 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 178' ' ' LYS . . . . . 0.407 ' O ' ' HA ' ' A' ' 173' ' ' GLU . 0.0 OUTLIER -84.91 117.59 24.01 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.506 0.768 . . . . 0.0 109.38 179.986 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 179' ' ' ARG . . . . . 0.514 ' CG ' ' HG3' ' A' ' 173' ' ' GLU . 3.3 mtt85 -90.18 123.34 33.92 Favored 'General case' 0 C--N 1.326 -0.441 0 O-C-N 124.498 1.124 . . . . 0.0 110.294 -179.949 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 180' ' ' GLY . . . . . 0.443 ' O ' ' HA ' ' A' ' 171' ' ' ASN . . . -152.21 164.57 30.56 Favored Glycine 0 CA--C 1.53 1.011 0 O-C-N 124.471 1.107 . . . . 0.0 111.017 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 181' ' ' MET . . . . . 0.535 ' HE2' ' OE1' ' A' ' 166' ' ' GLU . 21.7 mtp -86.37 101.77 13.41 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.528 0.781 . . . . 0.0 110.95 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 182' ' ' ILE . . . . . 0.6 HD13 HD22 ' A' ' 159' ' ' LEU . 23.3 pt -99.2 158.12 32.82 Favored Pre-proline 0 C--N 1.326 -0.452 0 O-C-N 124.492 1.12 . . . . 0.0 109.301 179.922 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 183' ' ' PRO . . . . . 0.754 ' HG2' ' HB2' ' A' ' 186' ' ' TYR . 18.4 Cg_endo -74.96 134.13 17.5 Favored 'Trans proline' 0 C--N 1.36 1.159 0 O-C-N 124.404 1.739 . . . . 0.0 110.947 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 184' ' ' VAL . . . . . 0.807 ' N ' ' CD ' ' A' ' 185' ' ' PRO . 73.9 t -77.43 -33.36 1.04 Allowed Pre-proline 0 C--N 1.325 -0.46 0 O-C-N 124.578 1.174 . . . . 0.0 109.271 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 185' ' ' PRO . . . . . 0.807 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.3 Cg_endo -74.96 -14.7 21.15 Favored 'Trans proline' 0 C--N 1.361 1.191 0 O-C-N 124.5 1.789 . . . . 0.0 111.026 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 186' ' ' TYR . . . . . 0.754 ' HB2' ' HG2' ' A' ' 183' ' ' PRO . 3.3 m-85 -96.59 0.31 49.78 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.508 1.13 . . . . 0.0 111.057 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 4.1 m -135.4 164.49 32.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 O-C-N 124.463 1.102 . . . . 0.0 109.271 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 188' ' ' GLU . . . . . 0.474 ' O ' ' HA ' ' A' ' 137' ' ' VAL . 0.0 OUTLIER -122.46 166.92 13.99 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.52 1.137 . . . . 0.0 110.293 179.963 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -87.69 135.59 33.31 Favored 'General case' 0 C--N 1.326 -0.422 0 O-C-N 124.492 1.12 . . . . 0.0 109.288 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.326 -0.423 0 O-C-N 124.447 1.092 . . . . 0.0 110.948 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' CYS . . . . . . . . . . . . . 3.9 m . . . . . 0 N--CA 1.452 -0.329 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 143.58 -35.34 1.64 Allowed Glycine 0 CA--C 1.53 1.026 0 O-C-N 124.463 1.102 . . . . 0.0 111.009 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -74.76 59.63 0.88 Allowed 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.504 0.767 . . . . 0.0 109.293 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.463 ' HB3' ' O ' ' A' ' 161' ' ' ILE . 0.3 OUTLIER 39.05 69.02 0.3 Allowed 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.529 1.143 . . . . 0.0 110.283 -179.981 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 136' ' ' TYR . . . . . 0.812 ' CD1' ' CG ' ' A' ' 190' ' ' TYR . 1.9 t80 -112.49 128.77 56.43 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.482 1.113 . . . . 0.0 110.965 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.742 HG13 ' O ' ' A' ' 188' ' ' GLU . 10.5 t -139.61 141.48 34.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 O-C-N 124.534 1.146 . . . . 0.0 109.306 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 138' ' ' ARG . . . . . 0.417 ' NE ' ' HA2' ' A' ' 156' ' ' GLY . 0.5 OUTLIER -112.18 139.18 47.93 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.44 1.087 . . . . 0.0 110.287 -179.987 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.464 ' CB ' HG12 ' A' ' 187' ' ' VAL . . . -95.17 114.5 26.3 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.468 1.105 . . . . 0.0 109.318 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.453 ' O ' ' CB ' ' A' ' 155' ' ' LYS . 0.5 OUTLIER -87.26 -22.83 24.95 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.498 1.124 . . . . 0.0 109.277 -179.984 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 20.2 m-85 -101.67 167.58 10.02 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.474 1.109 . . . . 0.0 110.995 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' ASP . . . . . 0.405 ' O ' ' HB2' ' A' ' 143' ' ' PHE . 1.9 p30 -120.26 147.55 44.82 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.504 1.127 . . . . 0.0 109.309 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 143' ' ' PHE . . . . . 0.558 ' HB3' ' CZ ' ' A' ' 153' ' ' PHE . 85.5 t80 179.0 59.82 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.494 1.121 . . . . 0.0 110.992 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 144' ' ' ASN . . . . . 0.454 ' O ' ' O ' ' A' ' 145' ' ' GLY . 20.1 t-20 -55.22 -15.85 2.73 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.474 1.109 . . . . 0.0 109.293 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 145' ' ' GLY . . . . . 0.454 ' O ' ' O ' ' A' ' 144' ' ' ASN . . . -51.82 -168.89 0.01 OUTLIER Glycine 0 CA--C 1.53 1.001 0 O-C-N 124.466 1.104 . . . . 0.0 111.001 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 2.6 p30 -167.53 66.28 0.08 Allowed 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.478 0.752 . . . . 0.0 109.31 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 24.3 m-20 -41.22 -57.22 2.16 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.501 1.126 . . . . 0.0 109.277 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -130.7 58.82 1.68 Allowed 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.517 1.136 . . . . 0.0 110.285 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER 66.24 36.2 5.58 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.543 1.152 . . . . 0.0 110.3 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 150' ' ' ASP . . . . . 0.631 ' OD2' ' CZ3' ' A' ' 169' ' ' TRP . 0.1 OUTLIER -68.67 179.85 1.61 Allowed 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.507 1.129 . . . . 0.0 109.251 -179.994 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.96 HD21 ' OD1' ' A' ' 174' ' ' ASP . 14.7 tp -103.36 130.3 23.84 Favored Pre-proline 0 C--N 1.325 -0.465 0 O-C-N 124.533 1.146 . . . . 0.0 109.285 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 152' ' ' PRO . . . . . 0.428 ' HA ' ' HA ' ' A' ' 144' ' ' ASN . 18.3 Cg_endo -75.01 152.59 40.89 Favored 'Trans proline' 0 C--N 1.359 1.131 0 O-C-N 124.531 1.806 . . . . 0.0 110.972 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 153' ' ' PHE . . . . . 0.584 ' CE2' ' O ' ' A' ' 151' ' ' LEU . 12.8 p90 -179.48 168.98 1.43 Allowed 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.521 1.138 . . . . 0.0 110.999 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 8.6 tttt -126.56 -167.22 1.69 Allowed 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.556 1.16 . . . . 0.0 109.284 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.453 ' CB ' ' O ' ' A' ' 140' ' ' LEU . 2.9 ptmt -91.29 106.84 18.79 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.532 1.145 . . . . 0.0 109.257 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 156' ' ' GLY . . . . . 0.417 ' HA2' ' NE ' ' A' ' 138' ' ' ARG . . . 105.14 27.2 5.98 Favored Glycine 0 CA--C 1.531 1.033 0 O-C-N 124.505 1.128 . . . . 0.0 111.03 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 157' ' ' ASP . . . . . 0.503 ' C ' HD13 ' A' ' 158' ' ' ILE . 32.2 t70 -92.34 161.46 14.66 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.502 0.766 . . . . 0.0 109.32 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 158' ' ' ILE . . . . . 0.67 HG23 ' CZ ' ' A' ' 136' ' ' TYR . 6.5 mm -111.76 128.1 68.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 O-C-N 124.474 1.109 . . . . 0.0 109.312 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.839 HD22 HD12 ' A' ' 182' ' ' ILE . 1.7 mp -142.19 127.55 18.8 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.48 1.112 . . . . 0.0 109.292 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 160' ' ' ARG . . . . . 0.41 ' HG2' ' O ' ' A' ' 135' ' ' GLU . 4.4 mtt180 -86.53 143.56 27.65 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.497 1.123 . . . . 0.0 110.333 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.463 ' O ' ' HB3' ' A' ' 135' ' ' GLU . 0.9 OUTLIER -86.81 116.15 28.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 O-C-N 124.542 1.151 . . . . 0.0 109.275 -179.969 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 162' ' ' ARG . . . . . 0.401 ' NH1' ' OE2' ' A' ' 173' ' ' GLU . 3.1 tpt180 -97.7 -69.27 0.76 Allowed 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.49 1.119 . . . . 0.0 110.285 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -134.42 173.43 11.64 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.422 1.076 . . . . 0.0 109.316 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 164' ' ' LYS . . . . . 0.535 ' HG2' ' CD2' ' A' ' 170' ' ' TRP . 0.0 OUTLIER -135.1 87.32 29.3 Favored Pre-proline 0 C--N 1.325 -0.47 0 O-C-N 124.515 1.135 . . . . 0.0 109.316 -179.958 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -74.97 -25.21 12.13 Favored 'Trans proline' 0 C--N 1.361 1.192 0 O-C-N 124.486 1.782 . . . . 0.0 111.001 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 6.7 mt-10 -125.22 167.36 14.97 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.551 1.157 . . . . 0.0 110.302 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -87.62 -18.82 28.78 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.497 1.123 . . . . 0.0 110.274 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 12.0 mt-30 -103.28 -53.44 2.81 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.491 1.119 . . . . 0.0 110.31 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 169' ' ' TRP . . . . . 0.631 ' CZ3' ' OD2' ' A' ' 150' ' ' ASP . 7.0 m95 -100.7 133.58 44.94 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.504 1.127 . . . . 0.0 107.999 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 170' ' ' TRP . . . . . 0.682 ' CE2' HG21 ' A' ' 184' ' ' VAL . 54.7 m0 -116.63 155.09 29.38 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.553 1.158 . . . . 0.0 107.983 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 171' ' ' ASN . . . . . 0.485 ' HA ' ' O ' ' A' ' 180' ' ' GLY . 19.5 t30 -86.5 97.48 10.52 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.495 1.122 . . . . 0.0 109.31 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -109.91 166.59 10.81 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.556 1.16 . . . . 0.0 109.308 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 173' ' ' GLU . . . . . 0.401 ' OE2' ' NH1' ' A' ' 162' ' ' ARG . 23.1 mt-10 -116.18 112.92 22.35 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.463 1.102 . . . . 0.0 110.273 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 174' ' ' ASP . . . . . 0.96 ' OD1' HD21 ' A' ' 151' ' ' LEU . 0.0 OUTLIER -68.63 -177.38 0.95 Allowed 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.427 1.08 . . . . 0.0 109.335 179.955 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 73.0 p -77.32 57.71 1.53 Allowed 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.506 1.129 . . . . 0.0 110.03 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 176' ' ' GLU . . . . . 0.409 ' O ' ' HD2' ' A' ' 178' ' ' LYS . 2.7 mt-10 -175.35 22.68 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.519 1.137 . . . . 0.0 110.284 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 55.57 29.18 53.34 Favored Glycine 0 CA--C 1.53 1.004 0 O-C-N 124.522 1.139 . . . . 0.0 110.991 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 178' ' ' LYS . . . . . 0.422 ' O ' ' OD1' ' A' ' 174' ' ' ASP . 0.0 OUTLIER -96.7 110.99 23.32 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.429 0.723 . . . . 0.0 109.308 179.982 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 3.4 ttp180 -91.1 120.5 32.1 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.523 1.139 . . . . 0.0 110.237 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 180' ' ' GLY . . . . . 0.913 ' HA3' HD13 ' A' ' 151' ' ' LEU . . . -149.84 172.54 29.75 Favored Glycine 0 CA--C 1.53 0.998 0 O-C-N 124.483 1.114 . . . . 0.0 111.001 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 181' ' ' MET . . . . . 0.459 ' HA ' ' O ' ' A' ' 170' ' ' TRP . 20.7 mtp -86.94 92.55 9.06 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.497 0.763 . . . . 0.0 110.998 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 182' ' ' ILE . . . . . 0.839 HD12 HD22 ' A' ' 159' ' ' LEU . 6.6 tt -89.87 144.88 32.24 Favored Pre-proline 0 C--N 1.326 -0.455 0 O-C-N 124.495 1.122 . . . . 0.0 109.32 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 183' ' ' PRO . . . . . 0.674 ' HG2' ' HB2' ' A' ' 186' ' ' TYR . 18.4 Cg_endo -74.97 132.13 15.1 Favored 'Trans proline' 0 C--N 1.36 1.148 0 O-C-N 124.479 1.778 . . . . 0.0 111.028 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 184' ' ' VAL . . . . . 0.821 ' N ' ' CD ' ' A' ' 185' ' ' PRO . 28.1 t -74.48 -30.68 1.1 Allowed Pre-proline 0 C--N 1.325 -0.489 0 O-C-N 124.522 1.139 . . . . 0.0 109.303 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 185' ' ' PRO . . . . . 0.821 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.3 Cg_endo -74.92 -10.86 21.54 Favored 'Trans proline' 0 C--N 1.36 1.153 0 O-C-N 124.559 1.82 . . . . 0.0 111.025 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 186' ' ' TYR . . . . . 0.674 ' HB2' ' HG2' ' A' ' 183' ' ' PRO . 3.7 m-30 -101.61 -19.47 15.44 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.513 1.133 . . . . 0.0 111.018 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 187' ' ' VAL . . . . . 0.706 ' CG2' HG11 ' A' ' 137' ' ' VAL . 13.8 m -115.5 175.9 2.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 O-C-N 124.457 1.098 . . . . 0.0 109.311 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 188' ' ' GLU . . . . . 0.742 ' O ' HG13 ' A' ' 137' ' ' VAL . 0.0 OUTLIER -135.97 168.08 20.02 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 124.481 1.113 . . . . 0.0 110.311 -179.988 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 189' ' ' LYS . . . . . 0.519 ' HD2' HG22 ' A' ' 137' ' ' VAL . 5.8 mmmt -94.69 141.09 29.02 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.536 1.148 . . . . 0.0 109.31 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 190' ' ' TYR . . . . . 0.812 ' CG ' ' CD1' ' A' ' 136' ' ' TYR . 0.2 OUTLIER -93.18 172.86 8.03 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.459 1.1 . . . . 0.0 111.059 179.972 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.981 0 O-C-N 124.528 1.143 . . . . 0.0 110.999 -179.993 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 132' ' ' CYS . . . . . 0.437 ' O ' ' O ' ' A' ' 191' ' ' GLY . 90.0 m . . . . . 0 N--CA 1.452 -0.345 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' GLY . . . . . 0.44 ' O ' ' HB3' ' A' ' 134' ' ' ALA . . . -61.45 -161.16 0.14 Allowed Glycine 0 CA--C 1.53 0.986 0 O-C-N 124.419 1.075 . . . . 0.0 111.002 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 134' ' ' ALA . . . . . 0.818 ' HB1' ' CZ ' ' A' ' 136' ' ' TYR . . . 68.4 -159.64 0.2 Allowed 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.437 0.728 . . . . 0.0 109.325 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.481 ' O ' ' HA ' ' A' ' 160' ' ' ARG . 0.7 OUTLIER -148.58 67.83 1.07 Allowed 'General case' 0 C--N 1.326 -0.442 0 O-C-N 124.446 1.091 . . . . 0.0 110.311 -179.98 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 136' ' ' TYR . . . . . 0.818 ' CZ ' ' HB1' ' A' ' 134' ' ' ALA . 1.9 m-85 -121.17 132.77 55.04 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.562 1.164 . . . . 0.0 110.975 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.601 ' CG2' HD11 ' A' ' 161' ' ' ILE . 22.4 m -129.6 162.31 37.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 O-C-N 124.58 1.175 . . . . 0.0 109.294 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 138' ' ' ARG . . . . . 0.448 ' O ' ' HA ' ' A' ' 187' ' ' VAL . 0.0 OUTLIER -119.25 125.04 48.19 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.505 1.128 . . . . 0.0 110.341 179.999 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.661 ' CB ' HG12 ' A' ' 187' ' ' VAL . . . -89.1 107.09 18.85 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.497 1.123 . . . . 0.0 109.284 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.57 HD11 ' HG2' ' A' ' 188' ' ' GLU . 0.1 OUTLIER -88.68 -29.86 19.57 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.571 1.169 . . . . 0.0 109.349 -179.998 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 141' ' ' PHE . . . . . 0.494 ' C ' ' O ' ' A' ' 154' ' ' LYS . 47.2 m-85 -91.2 153.55 19.93 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.523 1.14 . . . . 0.0 110.989 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 142' ' ' ASP . . . . . 0.43 ' HB2' ' HA ' ' A' ' 154' ' ' LYS . 4.2 t70 -106.86 153.64 22.21 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.475 1.11 . . . . 0.0 109.361 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 143' ' ' PHE . . . . . 0.587 ' HB3' ' CZ ' ' A' ' 153' ' ' PHE . 19.6 t80 -179.36 34.73 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.5 1.125 . . . . 0.0 110.967 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 144' ' ' ASN . . . . . 0.478 ' HA ' ' HA ' ' A' ' 152' ' ' PRO . 0.9 OUTLIER -45.18 137.85 4.25 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.472 1.108 . . . . 0.0 109.229 -179.931 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 145' ' ' GLY . . . . . 0.41 ' O ' ' ND2' ' A' ' 144' ' ' ASN . . . -103.59 -116.96 4.27 Favored Glycine 0 CA--C 1.53 0.981 0 O-C-N 124.597 1.186 . . . . 0.0 110.984 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 7.5 p-10 -177.74 -50.19 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.443 0 O-C-N 124.461 0.742 . . . . 0.0 109.346 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -42.1 154.82 0.05 OUTLIER 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.511 1.132 . . . . 0.0 109.285 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 9.5 tt0 -90.94 46.21 1.31 Allowed 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.485 1.116 . . . . 0.0 110.31 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -144.2 -46.52 0.26 Allowed 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.455 1.097 . . . . 0.0 110.288 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 2.6 p-10 -70.52 168.22 16.73 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.472 1.107 . . . . 0.0 109.307 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.74 HD23 HD23 ' A' ' 159' ' ' LEU . 1.3 mp -113.72 107.59 52.59 Favored Pre-proline 0 C--N 1.325 -0.458 0 O-C-N 124.514 1.134 . . . . 0.0 109.321 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 152' ' ' PRO . . . . . 0.478 ' HA ' ' HA ' ' A' ' 144' ' ' ASN . 18.5 Cg_endo -74.95 136.04 19.96 Favored 'Trans proline' 0 C--N 1.36 1.171 0 O-C-N 124.429 1.752 . . . . 0.0 111.015 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 153' ' ' PHE . . . . . 0.587 ' CZ ' ' HB3' ' A' ' 143' ' ' PHE . 10.7 p90 -148.29 166.94 26.48 Favored 'General case' 0 C--N 1.326 -0.427 0 O-C-N 124.5 1.125 . . . . 0.0 111.004 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 154' ' ' LYS . . . . . 0.494 ' O ' ' C ' ' A' ' 141' ' ' PHE . 0.1 OUTLIER -121.27 -90.77 0.57 Allowed 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.492 1.12 . . . . 0.0 109.363 179.954 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.41 ' CG ' ' O ' ' A' ' 140' ' ' LEU . 10.3 ttpp -157.45 118.28 3.55 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.534 1.146 . . . . 0.0 109.28 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 156' ' ' GLY . . . . . 0.614 ' N ' ' O ' ' A' ' 139' ' ' ALA . . . 98.42 16.36 32.23 Favored Glycine 0 CA--C 1.531 1.033 0 O-C-N 124.544 1.153 . . . . 0.0 111.0 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 157' ' ' ASP . . . . . 0.537 ' HB3' ' HB3' ' A' ' 139' ' ' ALA . 14.4 t70 -81.31 156.67 25.4 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.519 0.776 . . . . 0.0 109.3 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 5.1 mm -110.68 138.62 37.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 O-C-N 124.485 1.116 . . . . 0.0 109.347 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 1.046 HD22 HD13 ' A' ' 182' ' ' ILE . 1.5 mp -141.19 136.3 31.65 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.506 1.129 . . . . 0.0 109.272 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 160' ' ' ARG . . . . . 0.593 ' O ' ' HA ' ' A' ' 172' ' ' ALA . 0.0 OUTLIER -99.46 129.52 45.65 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.476 1.11 . . . . 0.0 110.313 179.981 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.601 HD11 ' CG2' ' A' ' 137' ' ' VAL . 1.7 mp -83.76 122.08 37.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 O-C-N 124.516 1.135 . . . . 0.0 109.286 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -122.65 -42.44 2.32 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.505 1.128 . . . . 0.0 110.261 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -135.06 170.81 15.34 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.491 1.119 . . . . 0.0 109.295 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 164' ' ' LYS . . . . . 0.565 ' HB2' ' CD1' ' A' ' 170' ' ' TRP . 0.6 OUTLIER -164.74 84.98 1.13 Allowed Pre-proline 0 C--N 1.325 -0.458 0 O-C-N 124.505 1.128 . . . . 0.0 109.3 179.928 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.08 -27.52 9.82 Favored 'Trans proline' 0 C--N 1.36 1.17 0 O-C-N 124.51 1.795 . . . . 0.0 110.983 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -118.54 168.94 10.21 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.539 1.15 . . . . 0.0 110.299 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -93.27 -19.67 21.17 Favored 'General case' 0 C--N 1.326 -0.441 0 O-C-N 124.522 1.139 . . . . 0.0 110.333 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -85.58 -57.12 3.19 Favored 'General case' 0 C--N 1.326 -0.422 0 O-C-N 124.506 1.129 . . . . 0.0 110.336 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 169' ' ' TRP . . . . . . . . . . . . . 10.6 m95 -107.18 150.62 26.41 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.549 1.156 . . . . 0.0 108.04 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 170' ' ' TRP . . . . . 0.769 ' CD2' HG21 ' A' ' 184' ' ' VAL . 37.5 m0 -127.51 151.6 48.66 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.549 1.155 . . . . 0.0 108.0 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 171' ' ' ASN . . . . . 0.414 ' HA ' ' O ' ' A' ' 180' ' ' GLY . 1.9 t-20 -87.37 99.14 11.78 Favored 'General case' 0 C--N 1.324 -0.532 0 O-C-N 124.468 1.105 . . . . 0.0 109.283 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 172' ' ' ALA . . . . . 0.593 ' HA ' ' O ' ' A' ' 160' ' ' ARG . . . -119.05 -178.43 3.56 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.476 1.11 . . . . 0.0 109.303 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 173' ' ' GLU . . . . . 0.436 ' CG ' ' HG3' ' A' ' 179' ' ' ARG . 34.0 mt-10 -119.73 121.15 38.55 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.47 1.106 . . . . 0.0 110.27 -179.898 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 174' ' ' ASP . . . . . 0.597 ' H ' HD21 ' A' ' 151' ' ' LEU . 0.2 OUTLIER -72.44 -164.22 0.14 Allowed 'General case' 0 C--N 1.323 -0.547 0 O-C-N 124.594 1.184 . . . . 0.0 109.259 -179.998 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 52.6 p -87.53 56.94 4.15 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.465 1.103 . . . . 0.0 109.999 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -177.22 28.45 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.532 1.145 . . . . 0.0 110.189 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 53.23 24.69 23.06 Favored Glycine 0 CA--C 1.531 1.078 0 O-C-N 124.562 1.164 . . . . 0.0 111.003 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 178' ' ' LYS . . . . . 0.46 ' O ' HD11 ' A' ' 151' ' ' LEU . 3.1 mtpm? -90.93 108.89 20.15 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.503 0.767 . . . . 0.0 109.355 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 179' ' ' ARG . . . . . 0.436 ' HG3' ' CG ' ' A' ' 173' ' ' GLU . 0.0 OUTLIER -90.7 114.97 27.42 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.499 1.125 . . . . 0.0 110.34 179.955 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 180' ' ' GLY . . . . . 0.489 ' HA3' HD13 ' A' ' 151' ' ' LEU . . . -150.79 174.31 30.13 Favored Glycine 0 CA--C 1.53 1.013 0 O-C-N 124.486 1.116 . . . . 0.0 111.01 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 181' ' ' MET . . . . . 0.419 ' HA ' ' O ' ' A' ' 170' ' ' TRP . 33.5 mtp -88.04 106.19 17.98 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.537 0.786 . . . . 0.0 110.99 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 182' ' ' ILE . . . . . 1.046 HD13 HD22 ' A' ' 159' ' ' LEU . 6.8 pt -106.65 159.38 30.06 Favored Pre-proline 0 C--N 1.325 -0.496 0 O-C-N 124.505 1.128 . . . . 0.0 109.36 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 183' ' ' PRO . . . . . 0.565 ' HG2' ' CB ' ' A' ' 186' ' ' TYR . 18.1 Cg_endo -75.02 127.5 10.72 Favored 'Trans proline' 0 C--N 1.36 1.174 0 O-C-N 124.418 1.746 . . . . 0.0 111.013 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 184' ' ' VAL . . . . . 0.769 HG21 ' CD2' ' A' ' 170' ' ' TRP . 21.8 t -76.17 -34.92 1.51 Allowed Pre-proline 0 C--N 1.325 -0.49 0 O-C-N 124.514 1.134 . . . . 0.0 109.334 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 185' ' ' PRO . . . . . 0.758 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.4 Cg_endo -74.95 -9.73 20.98 Favored 'Trans proline' 0 C--N 1.36 1.162 0 O-C-N 124.51 1.795 . . . . 0.0 110.988 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 186' ' ' TYR . . . . . 0.565 ' CB ' ' HG2' ' A' ' 183' ' ' PRO . 3.2 m-85 -95.95 -5.92 40.23 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.464 1.103 . . . . 0.0 110.962 -179.897 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 187' ' ' VAL . . . . . 0.661 HG12 ' CB ' ' A' ' 139' ' ' ALA . 7.6 m -129.33 175.47 10.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 O-C-N 124.391 1.057 . . . . 0.0 109.282 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 188' ' ' GLU . . . . . 0.57 ' HG2' HD11 ' A' ' 140' ' ' LEU . 0.0 OUTLIER -131.63 173.26 11.31 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.534 1.147 . . . . 0.0 110.297 179.971 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.05 119.43 28.41 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.502 1.126 . . . . 0.0 109.273 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -78.05 -45.01 24.77 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.448 1.092 . . . . 0.0 110.92 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 191' ' ' GLY . . . . . 0.437 ' O ' ' O ' ' A' ' 132' ' ' CYS . . . . . . . . 0 CA--C 1.531 1.032 0 O-C-N 124.496 1.123 . . . . 0.0 111.014 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' CYS . . . . . . . . . . . . . 1.9 m . . . . . 0 N--CA 1.452 -0.363 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 133' ' ' GLY . . . . . 0.497 ' O ' ' CE1' ' A' ' 136' ' ' TYR . . . -121.3 31.3 5.13 Favored Glycine 0 CA--C 1.529 0.965 0 O-C-N 124.47 1.106 . . . . 0.0 111.038 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 134' ' ' ALA . . . . . 0.428 ' O ' ' O ' ' A' ' 133' ' ' GLY . . . 56.54 109.61 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.432 0 O-C-N 124.454 0.737 . . . . 0.0 109.26 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.641 ' HG2' HG22 ' A' ' 161' ' ' ILE . 0.8 OUTLIER 57.02 69.12 0.77 Allowed 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.546 1.154 . . . . 0.0 110.351 -179.988 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 136' ' ' TYR . . . . . 0.497 ' CE1' ' O ' ' A' ' 133' ' ' GLY . 2.0 m-85 -124.46 114.5 19.54 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.496 1.123 . . . . 0.0 111.038 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.443 HG22 ' HB ' ' A' ' 187' ' ' VAL . 0.4 OUTLIER -113.06 132.22 62.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 O-C-N 124.419 1.074 . . . . 0.0 109.282 -179.993 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 138' ' ' ARG . . . . . 0.501 ' HG3' ' N ' ' A' ' 139' ' ' ALA . 2.7 ttm180 -101.09 142.85 31.95 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.462 1.101 . . . . 0.0 110.259 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.515 ' O ' ' N ' ' A' ' 156' ' ' GLY . . . -105.85 109.08 20.91 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.564 1.165 . . . . 0.0 109.345 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.511 ' O ' ' CG ' ' A' ' 155' ' ' LYS . 0.3 OUTLIER -87.36 -22.42 25.08 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.496 1.123 . . . . 0.0 109.272 -179.944 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 141' ' ' PHE . . . . . 0.408 ' CD1' ' N ' ' A' ' 141' ' ' PHE . 0.6 OUTLIER -108.99 146.9 33.13 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.487 1.117 . . . . 0.0 111.013 179.972 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 142' ' ' ASP . . . . . 0.426 ' CB ' ' HA ' ' A' ' 154' ' ' LYS . 5.7 t70 -101.1 156.25 17.52 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.537 1.148 . . . . 0.0 109.296 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 143' ' ' PHE . . . . . 0.592 ' CE2' ' O ' ' A' ' 144' ' ' ASN . 0.0 OUTLIER -149.03 -42.35 0.15 Allowed 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.434 1.083 . . . . 0.0 111.042 179.97 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 144' ' ' ASN . . . . . 0.592 ' O ' ' CE2' ' A' ' 143' ' ' PHE . 4.4 t-20 58.61 169.39 0.06 Allowed 'General case' 0 C--N 1.326 -0.437 0 O-C-N 124.476 1.11 . . . . 0.0 109.309 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 145' ' ' GLY . . . . . 0.464 ' N ' ' HB3' ' A' ' 152' ' ' PRO . . . -177.24 -176.83 45.66 Favored Glycine 0 CA--C 1.531 1.043 0 O-C-N 124.502 1.126 . . . . 0.0 111.037 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 6.5 m120 -157.42 57.33 0.5 Allowed 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.568 0.805 . . . . 0.0 109.276 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -121.23 161.73 21.42 Favored 'General case' 0 C--N 1.326 -0.443 0 O-C-N 124.446 1.091 . . . . 0.0 109.26 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 17.3 tt0 -101.67 58.01 0.84 Allowed 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.511 1.132 . . . . 0.0 110.282 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -179.51 -43.74 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.523 0 O-C-N 124.505 1.128 . . . . 0.0 110.247 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -74.26 170.73 14.97 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.498 1.124 . . . . 0.0 109.398 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.499 HD11 ' HB2' ' A' ' 174' ' ' ASP . 57.4 tp -132.72 110.99 13.45 Favored Pre-proline 0 C--N 1.326 -0.451 0 O-C-N 124.464 1.102 . . . . 0.0 109.307 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 152' ' ' PRO . . . . . 0.464 ' HB3' ' N ' ' A' ' 145' ' ' GLY . 18.4 Cg_endo -74.96 174.4 12.84 Favored 'Trans proline' 0 C--N 1.36 1.158 0 O-C-N 124.431 1.753 . . . . 0.0 110.997 180.0 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 153' ' ' PHE . . . . . 0.596 ' CZ ' ' CD ' ' A' ' 183' ' ' PRO . 0.4 OUTLIER -169.25 173.83 6.47 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.54 1.15 . . . . 0.0 111.018 179.979 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 154' ' ' LYS . . . . . 0.426 ' HA ' ' CB ' ' A' ' 142' ' ' ASP . 0.1 OUTLIER -127.13 -164.91 1.4 Allowed 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.458 1.099 . . . . 0.0 109.315 -179.995 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.511 ' CG ' ' O ' ' A' ' 140' ' ' LEU . 1.5 tttp -97.08 99.16 10.68 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.475 1.109 . . . . 0.0 109.317 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 156' ' ' GLY . . . . . 0.515 ' N ' ' O ' ' A' ' 139' ' ' ALA . . . 116.08 29.54 2.34 Favored Glycine 0 CA--C 1.53 1.008 0 O-C-N 124.534 1.146 . . . . 0.0 111.01 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 157' ' ' ASP . . . . . 0.932 ' C ' HD12 ' A' ' 158' ' ' ILE . 12.4 t70 -102.9 166.81 10.25 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.607 0.828 . . . . 0.0 109.305 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 158' ' ' ILE . . . . . 0.932 HD12 ' C ' ' A' ' 157' ' ' ASP . 1.9 mp -123.56 146.28 29.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 O-C-N 124.476 1.11 . . . . 0.0 109.344 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.775 HD21 ' OD2' ' A' ' 174' ' ' ASP . 0.8 OUTLIER -144.11 128.85 18.27 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.513 1.133 . . . . 0.0 109.314 -179.98 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 160' ' ' ARG . . . . . 0.558 ' O ' ' HA ' ' A' ' 172' ' ' ALA . 2.0 tmt_? -87.72 127.77 35.3 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.458 1.099 . . . . 0.0 110.292 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.641 HG22 ' HG2' ' A' ' 135' ' ' GLU . 1.7 mp -84.96 130.85 35.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.455 1.097 . . . . 0.0 109.288 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 162' ' ' ARG . . . . . 0.467 ' HD3' ' CZ ' ' A' ' 179' ' ' ARG . 33.7 ttt85 -127.3 -46.44 1.49 Allowed 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.46 1.1 . . . . 0.0 110.314 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 163' ' ' ASP . . . . . 0.48 ' CB ' ' HB3' ' A' ' 171' ' ' ASN . 0.2 OUTLIER -123.7 161.4 25.19 Favored 'General case' 0 C--N 1.326 -0.433 0 O-C-N 124.508 1.13 . . . . 0.0 109.281 179.991 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 164' ' ' LYS . . . . . 0.513 ' CG ' ' O ' ' A' ' 164' ' ' LYS . 0.1 OUTLIER -165.23 64.14 1.0 Allowed Pre-proline 0 C--N 1.327 -0.391 0 O-C-N 124.463 1.102 . . . . 0.0 109.261 179.98 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 165' ' ' PRO . . . . . 0.425 ' HD3' ' N ' ' A' ' 164' ' ' LYS . 18.1 Cg_endo -75.03 -49.18 0.15 Allowed 'Trans proline' 0 C--N 1.359 1.089 0 O-C-N 124.547 1.814 . . . . 0.0 110.977 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 166' ' ' GLU . . . . . 0.588 ' HG3' ' HE1' ' A' ' 181' ' ' MET . 5.4 mt-10 -66.14 167.57 9.86 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.499 1.124 . . . . 0.0 110.244 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 5.3 mp0 -110.87 40.91 1.91 Allowed 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.448 1.093 . . . . 0.0 110.309 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 5.4 mt-30 -159.44 -57.82 0.06 Allowed 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.553 1.158 . . . . 0.0 110.263 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 169' ' ' TRP . . . . . . . . . . . . . 10.4 m95 -102.04 144.45 30.62 Favored 'General case' 0 C--N 1.324 -0.523 0 O-C-N 124.567 1.167 . . . . 0.0 107.972 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 170' ' ' TRP . . . . . 0.75 ' CE2' HG21 ' A' ' 184' ' ' VAL . 50.8 m0 -116.28 146.88 42.06 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 171' ' ' ASN . . . . . 0.499 ' OD1' ' CD ' ' A' ' 179' ' ' ARG . 18.7 t-20 -87.72 99.88 12.42 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.505 1.128 . . . . 0.0 109.288 180.0 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 172' ' ' ALA . . . . . 0.558 ' HA ' ' O ' ' A' ' 160' ' ' ARG . . . -119.87 168.77 10.77 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.484 1.115 . . . . 0.0 109.267 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 173' ' ' GLU . . . . . 0.485 ' HG3' ' CB ' ' A' ' 179' ' ' ARG . 1.8 mt-10 -113.92 124.12 51.41 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.53 1.144 . . . . 0.0 110.292 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 174' ' ' ASP . . . . . 0.775 ' OD2' HD21 ' A' ' 159' ' ' LEU . 0.2 OUTLIER -73.99 -168.5 0.62 Allowed 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.47 1.106 . . . . 0.0 109.309 179.97 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 10.5 t -81.17 58.31 3.48 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 124.404 1.065 . . . . 0.0 110.024 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -175.11 16.85 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.449 1.093 . . . . 0.0 110.317 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 177' ' ' GLY . . . . . 0.405 ' C ' ' HG2' ' A' ' 173' ' ' GLU . . . 64.12 17.36 61.2 Favored Glycine 0 CA--C 1.529 0.951 0 O-C-N 124.562 1.164 . . . . 0.0 111.005 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 178' ' ' LYS . . . . . 0.408 ' O ' ' HA ' ' A' ' 173' ' ' GLU . 0.8 OUTLIER -85.95 102.09 13.45 Favored 'General case' 0 C--N 1.326 -0.441 0 O-C-N 124.472 0.748 . . . . 0.0 109.307 179.985 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 179' ' ' ARG . . . . . 0.499 ' CD ' ' OD1' ' A' ' 171' ' ' ASN . 20.1 ttm-85 -88.15 120.35 29.42 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.464 1.102 . . . . 0.0 110.328 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 180' ' ' GLY . . . . . 0.416 ' O ' ' HA ' ' A' ' 171' ' ' ASN . . . -152.36 172.45 31.56 Favored Glycine 0 CA--C 1.53 1.013 0 O-C-N 124.554 1.159 . . . . 0.0 110.953 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 181' ' ' MET . . . . . 0.588 ' HE1' ' HG3' ' A' ' 166' ' ' GLU . 35.7 mtp -86.96 99.82 12.15 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.46 0.741 . . . . 0.0 111.009 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 182' ' ' ILE . . . . . 0.583 HD13 HD13 ' A' ' 159' ' ' LEU . 5.7 pt -99.38 160.6 27.1 Favored Pre-proline 0 C--N 1.325 -0.46 0 O-C-N 124.454 1.096 . . . . 0.0 109.381 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 183' ' ' PRO . . . . . 0.739 ' HG2' ' HB2' ' A' ' 186' ' ' TYR . 18.5 Cg_endo -75.05 135.16 18.61 Favored 'Trans proline' 0 C--N 1.359 1.1 0 O-C-N 124.462 1.77 . . . . 0.0 111.019 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 184' ' ' VAL . . . . . 0.851 ' N ' ' CD ' ' A' ' 185' ' ' PRO . 42.9 t -80.07 -30.16 0.59 Allowed Pre-proline 0 C--N 1.325 -0.493 0 O-C-N 124.522 1.139 . . . . 0.0 109.321 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 185' ' ' PRO . . . . . 0.851 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.4 Cg_endo -75.02 -21.42 15.83 Favored 'Trans proline' 0 C--N 1.36 1.155 0 O-C-N 124.532 1.806 . . . . 0.0 110.963 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 186' ' ' TYR . . . . . 0.739 ' HB2' ' HG2' ' A' ' 183' ' ' PRO . 4.1 m-85 -94.42 15.52 17.51 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.52 1.138 . . . . 0.0 111.001 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 187' ' ' VAL . . . . . 0.474 ' HA ' ' O ' ' A' ' 138' ' ' ARG . 27.4 m -143.37 171.83 8.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 O-C-N 124.453 1.096 . . . . 0.0 109.294 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 188' ' ' GLU . . . . . 0.475 ' N ' ' O ' ' A' ' 138' ' ' ARG . 0.0 OUTLIER -131.75 169.65 15.92 Favored 'General case' 0 C--N 1.326 -0.442 0 O-C-N 124.462 1.102 . . . . 0.0 110.257 179.999 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -88.15 127.9 35.43 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.427 1.079 . . . . 0.0 109.304 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -99.75 -58.5 1.91 Allowed 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.481 1.113 . . . . 0.0 111.053 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.041 0 O-C-N 124.54 1.15 . . . . 0.0 110.971 179.976 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 132' ' ' CYS . . . . . . . . . . . . . 4.5 t . . . . . 0 N--CA 1.453 -0.32 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 164.87 -107.97 0.31 Allowed Glycine 0 CA--C 1.532 1.146 0 O-C-N 124.435 1.085 . . . . 0.0 110.978 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -168.59 77.96 0.13 Allowed 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.607 0.827 . . . . 0.0 109.256 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.41 ' CB ' ' HB ' ' A' ' 161' ' ' ILE . 0.4 OUTLIER 46.66 75.54 0.12 Allowed 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.416 1.073 . . . . 0.0 110.286 179.949 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 8.6 m-85 -130.95 99.97 5.09 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.522 1.139 . . . . 0.0 110.94 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.855 HG22 ' HB ' ' A' ' 187' ' ' VAL . 11.8 p -102.22 130.66 51.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 O-C-N 124.55 1.156 . . . . 0.0 109.289 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 138' ' ' ARG . . . . . 0.495 ' O ' ' N ' ' A' ' 188' ' ' GLU . 13.7 ttm180 -97.59 151.55 19.95 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.502 1.126 . . . . 0.0 110.339 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.858 ' HB3' ' OD2' ' A' ' 157' ' ' ASP . . . -120.63 106.34 11.65 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.467 1.104 . . . . 0.0 109.259 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.608 HD11 ' HG2' ' A' ' 188' ' ' GLU . 0.0 OUTLIER -91.14 -22.97 20.41 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.561 1.163 . . . . 0.0 109.331 179.944 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 141' ' ' PHE . . . . . 0.512 ' CD2' ' HA ' ' A' ' 186' ' ' TYR . 97.1 m-85 -85.66 161.38 19.27 Favored 'General case' 0 C--N 1.326 -0.418 0 O-C-N 124.44 1.088 . . . . 0.0 110.98 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 142' ' ' ASP . . . . . 0.498 ' CA ' ' O ' ' A' ' 154' ' ' LYS . 0.5 OUTLIER -115.17 142.8 46.17 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.508 1.13 . . . . 0.0 109.272 -179.984 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 143' ' ' PHE . . . . . 0.633 ' HB3' ' CE1' ' A' ' 153' ' ' PHE . 33.9 t80 -170.09 29.22 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.532 1.145 . . . . 0.0 110.961 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 144' ' ' ASN . . . . . 0.552 ' HA ' ' CB ' ' A' ' 152' ' ' PRO . 1.5 t-20 -47.25 169.73 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.512 1.133 . . . . 0.0 109.315 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 164.21 -98.12 0.15 Allowed Glycine 0 CA--C 1.53 0.998 0 O-C-N 124.419 1.074 . . . . 0.0 111.012 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 146' ' ' ASN . . . . . 0.433 ' O ' ' CG ' ' A' ' 147' ' ' ASP . 1.6 p30 -176.87 -53.68 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.495 0.762 . . . . 0.0 109.326 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 147' ' ' ASP . . . . . 0.47 ' CG ' ' CB ' ' A' ' 150' ' ' ASP . 2.6 p30 46.04 -171.77 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.49 1.119 . . . . 0.0 109.3 -179.962 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -124.45 -33.94 2.96 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.47 1.106 . . . . 0.0 110.295 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -131.06 31.47 4.43 Favored 'General case' 0 C--N 1.323 -0.545 0 O-C-N 124.485 1.116 . . . . 0.0 110.345 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 150' ' ' ASP . . . . . 0.47 ' CB ' ' CG ' ' A' ' 147' ' ' ASP . 0.1 OUTLIER -127.95 176.28 7.72 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.521 1.138 . . . . 0.0 109.301 179.98 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.966 HD21 ' HB2' ' A' ' 174' ' ' ASP . 2.5 tp -129.27 113.59 18.35 Favored Pre-proline 0 C--N 1.326 -0.435 0 O-C-N 124.467 1.104 . . . . 0.0 109.324 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 152' ' ' PRO . . . . . 0.552 ' CB ' ' HA ' ' A' ' 144' ' ' ASN . 18.0 Cg_endo -75.03 126.74 10.15 Favored 'Trans proline' 0 C--N 1.36 1.135 0 O-C-N 124.43 1.753 . . . . 0.0 110.945 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 153' ' ' PHE . . . . . 0.633 ' CE1' ' HB3' ' A' ' 143' ' ' PHE . 1.2 p90 -129.57 -179.49 5.2 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.547 1.155 . . . . 0.0 110.955 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 154' ' ' LYS . . . . . 0.498 ' O ' ' CA ' ' A' ' 142' ' ' ASP . 32.2 tttt -121.6 -82.26 0.65 Allowed 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.498 1.124 . . . . 0.0 109.348 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.477 ' CG ' ' O ' ' A' ' 140' ' ' LEU . 0.0 OUTLIER -175.25 108.63 0.1 Allowed 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.499 1.124 . . . . 0.0 109.326 179.973 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 156' ' ' GLY . . . . . 0.434 ' N ' ' O ' ' A' ' 139' ' ' ALA . . . 104.83 16.1 18.27 Favored Glycine 0 CA--C 1.529 0.964 0 O-C-N 124.493 1.12 . . . . 0.0 111.05 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 157' ' ' ASP . . . . . 0.858 ' OD2' ' HB3' ' A' ' 139' ' ' ALA . 2.3 p-10 -88.2 144.51 26.42 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.494 0.761 . . . . 0.0 109.327 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 158' ' ' ILE . . . . . 0.668 HD12 ' N ' ' A' ' 158' ' ' ILE . 1.1 mp -95.93 150.02 4.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 O-C-N 124.438 1.086 . . . . 0.0 109.314 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.801 ' CD2' HD23 ' A' ' 151' ' ' LEU . 5.3 mt -145.65 133.77 21.55 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.542 1.151 . . . . 0.0 109.28 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 160' ' ' ARG . . . . . 0.517 ' O ' ' HB1' ' A' ' 172' ' ' ALA . 2.0 ttt180 -90.28 129.48 36.51 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.51 1.131 . . . . 0.0 110.322 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.459 HD12 ' HE3' ' A' ' 170' ' ' TRP . 24.1 mm -85.23 124.2 39.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 O-C-N 124.517 1.136 . . . . 0.0 109.253 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -119.39 -62.96 1.44 Allowed 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.507 1.129 . . . . 0.0 110.336 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -111.31 157.03 20.65 Favored 'General case' 0 C--N 1.324 -0.522 0 O-C-N 124.498 1.124 . . . . 0.0 109.333 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 164' ' ' LYS . . . . . 0.536 ' HG3' ' CE2' ' A' ' 170' ' ' TRP . 0.0 OUTLIER -157.81 63.08 2.67 Favored Pre-proline 0 C--N 1.324 -0.506 0 O-C-N 124.469 1.105 . . . . 0.0 109.306 -179.989 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 165' ' ' PRO . . . . . 0.441 ' HD3' ' N ' ' A' ' 164' ' ' LYS . 18.2 Cg_endo -75.05 -58.89 0.04 OUTLIER 'Trans proline' 0 C--N 1.36 1.148 0 O-C-N 124.445 1.761 . . . . 0.0 111.005 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -62.01 167.26 3.98 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.509 1.131 . . . . 0.0 110.248 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 6.5 mt-10 -106.99 45.77 0.97 Allowed 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.501 1.126 . . . . 0.0 110.349 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -167.03 -59.53 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.535 1.147 . . . . 0.0 110.346 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 169' ' ' TRP . . . . . . . . . . . . . 25.4 m95 -102.69 135.2 44.76 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.553 1.158 . . . . 0.0 107.966 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 170' ' ' TRP . . . . . 1.009 ' CE2' HG21 ' A' ' 184' ' ' VAL . 27.8 m0 -117.31 151.65 36.54 Favored 'General case' 0 C--N 1.324 -0.533 0 O-C-N 124.551 1.157 . . . . 0.0 108.048 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 171' ' ' ASN . . . . . 0.418 ' HA ' ' O ' ' A' ' 180' ' ' GLY . 2.8 t-20 -86.23 102.98 14.42 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.432 1.083 . . . . 0.0 109.268 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 172' ' ' ALA . . . . . 1.125 ' HB3' HD13 ' A' ' 182' ' ' ILE . . . -113.1 179.89 3.83 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.488 1.117 . . . . 0.0 109.309 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 173' ' ' GLU . . . . . 0.473 ' CG ' ' HG3' ' A' ' 179' ' ' ARG . 28.0 mt-10 -125.34 125.91 44.23 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.5 1.125 . . . . 0.0 110.271 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 174' ' ' ASP . . . . . 0.966 ' HB2' HD21 ' A' ' 151' ' ' LEU . 2.9 t70 -74.6 -163.92 0.24 Allowed 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.477 1.111 . . . . 0.0 109.307 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -89.32 47.04 1.43 Allowed 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.582 1.177 . . . . 0.0 110.019 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -169.68 24.51 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.546 1.154 . . . . 0.0 110.287 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 62.57 20.51 61.57 Favored Glycine 0 CA--C 1.53 0.976 0 O-C-N 124.441 1.088 . . . . 0.0 111.004 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 178' ' ' LYS . . . . . 0.646 ' HG2' HD11 ' A' ' 151' ' ' LEU . 4.8 tptt -81.21 104.26 11.56 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.524 0.779 . . . . 0.0 109.285 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 179' ' ' ARG . . . . . 0.476 ' HA ' ' O ' ' A' ' 172' ' ' ALA . 0.0 OUTLIER -89.26 116.92 27.84 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.427 1.079 . . . . 0.0 110.373 179.946 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 180' ' ' GLY . . . . . 0.549 ' O ' HD12 ' A' ' 182' ' ' ILE . . . -151.46 173.39 30.83 Favored Glycine 0 CA--C 1.53 0.979 0 O-C-N 124.452 1.095 . . . . 0.0 111.007 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 181' ' ' MET . . . . . 0.43 ' HA ' ' O ' ' A' ' 170' ' ' TRP . 12.9 mmm -86.14 103.6 14.94 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.461 0.742 . . . . 0.0 110.986 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 182' ' ' ILE . . . . . 1.125 HD13 ' HB3' ' A' ' 172' ' ' ALA . 4.1 mp -94.5 145.27 29.37 Favored Pre-proline 0 C--N 1.324 -0.509 0 O-C-N 124.563 1.164 . . . . 0.0 109.289 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 183' ' ' PRO . . . . . 0.836 ' HD2' HG23 ' A' ' 182' ' ' ILE . 18.3 Cg_endo -75.01 133.63 16.81 Favored 'Trans proline' 0 C--N 1.36 1.164 0 O-C-N 124.448 1.762 . . . . 0.0 110.977 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 184' ' ' VAL . . . . . 1.009 HG21 ' CE2' ' A' ' 170' ' ' TRP . 25.2 t -78.62 -31.14 0.73 Allowed Pre-proline 0 C--N 1.325 -0.469 0 O-C-N 124.509 1.131 . . . . 0.0 109.309 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 185' ' ' PRO . . . . . 0.814 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.1 Cg_endo -75.09 -25.96 11.23 Favored 'Trans proline' 0 C--N 1.359 1.123 0 O-C-N 124.474 1.776 . . . . 0.0 110.932 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 186' ' ' TYR . . . . . 0.774 ' HB2' ' HG2' ' A' ' 183' ' ' PRO . 4.1 m-85 -95.91 15.54 20.18 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.475 1.109 . . . . 0.0 110.994 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 187' ' ' VAL . . . . . 0.855 ' HB ' HG22 ' A' ' 137' ' ' VAL . 24.4 m -139.59 173.96 10.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 O-C-N 124.451 1.094 . . . . 0.0 109.278 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 188' ' ' GLU . . . . . 0.608 ' HG2' HD11 ' A' ' 140' ' ' LEU . 0.0 OUTLIER -135.18 172.31 13.2 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.448 1.093 . . . . 0.0 110.353 179.966 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 189' ' ' LYS . . . . . 0.45 ' HD2' ' N ' ' A' ' 189' ' ' LYS . 0.0 OUTLIER -95.63 114.19 25.91 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.545 1.153 . . . . 0.0 109.267 -179.96 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 15.6 t80 -60.06 -45.18 93.75 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.507 1.129 . . . . 0.0 110.962 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.977 0 O-C-N 124.461 1.1 . . . . 0.0 111.023 179.99 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 132' ' ' CYS . . . . . 0.436 ' O ' ' O ' ' A' ' 133' ' ' GLY . 3.0 t . . . . . 0 N--CA 1.453 -0.311 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' GLY . . . . . 0.436 ' O ' ' O ' ' A' ' 132' ' ' CYS . . . -55.39 -114.23 0.01 OUTLIER Glycine 0 CA--C 1.53 1.003 0 O-C-N 124.515 1.134 . . . . 0.0 110.996 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -163.64 124.03 2.21 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.448 0.734 . . . . 0.0 109.259 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.512 ' HG2' HG22 ' A' ' 161' ' ' ILE . 0.2 OUTLIER 39.14 74.88 0.08 Allowed 'General case' 0 C--N 1.326 -0.443 0 O-C-N 124.477 1.111 . . . . 0.0 110.32 179.988 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 136' ' ' TYR . . . . . 0.434 ' O ' ' HB3' ' A' ' 190' ' ' TYR . 0.4 OUTLIER -135.64 141.74 45.09 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.473 1.108 . . . . 0.0 111.003 179.993 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.556 HG21 HD11 ' A' ' 182' ' ' ILE . 34.3 m -133.66 157.51 42.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 O-C-N 124.476 1.11 . . . . 0.0 109.322 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 138' ' ' ARG . . . . . 0.785 ' HD3' HD13 ' A' ' 158' ' ' ILE . 4.2 tpp85 -127.3 127.07 43.73 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.436 1.085 . . . . 0.0 110.241 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.698 ' O ' ' N ' ' A' ' 156' ' ' GLY . . . -88.41 106.93 18.58 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.432 1.083 . . . . 0.0 109.323 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.413 HD11 ' HB3' ' A' ' 188' ' ' GLU . 0.4 OUTLIER -87.29 -5.14 59.03 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.538 1.149 . . . . 0.0 109.336 -179.994 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 141' ' ' PHE . . . . . 0.492 ' CD1' ' HA ' ' A' ' 186' ' ' TYR . 6.2 m-85 -123.32 151.92 41.97 Favored 'General case' 0 C--N 1.326 -0.443 0 O-C-N 124.486 1.116 . . . . 0.0 111.028 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -102.7 157.06 17.21 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.506 1.129 . . . . 0.0 109.345 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' PHE . . . . . 0.647 ' HB3' ' CZ ' ' A' ' 153' ' ' PHE . 28.1 t80 -179.14 36.09 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.523 1.139 . . . . 0.0 110.983 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 144' ' ' ASN . . . . . 0.544 ' HA ' ' CB ' ' A' ' 152' ' ' PRO . 17.2 p-10 -40.99 107.36 0.07 Allowed 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.436 1.085 . . . . 0.0 109.281 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 145' ' ' GLY . . . . . 0.435 ' N ' ' HB3' ' A' ' 152' ' ' PRO . . . -92.99 -125.02 3.75 Favored Glycine 0 CA--C 1.53 0.974 0 O-C-N 124.538 1.149 . . . . 0.0 111.031 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 6.5 m120 -174.39 -51.56 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.509 0.77 . . . . 0.0 109.313 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -40.54 154.4 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.503 1.127 . . . . 0.0 109.282 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.03 -20.71 48.29 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.451 1.094 . . . . 0.0 110.267 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 13.1 tt0 -63.88 -39.7 94.81 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.475 1.11 . . . . 0.0 110.255 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 150' ' ' ASP . . . . . 0.42 ' OD1' ' CZ3' ' A' ' 169' ' ' TRP . 0.2 OUTLIER -122.26 153.18 39.23 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.519 1.137 . . . . 0.0 109.315 179.996 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.902 HD13 ' OD2' ' A' ' 174' ' ' ASP . 3.4 pp -108.06 142.77 25.99 Favored Pre-proline 0 C--N 1.326 -0.45 0 O-C-N 124.468 1.105 . . . . 0.0 109.295 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 152' ' ' PRO . . . . . 0.544 ' CB ' ' HA ' ' A' ' 144' ' ' ASN . 18.3 Cg_endo -75.05 134.04 17.25 Favored 'Trans proline' 0 C--N 1.359 1.121 0 O-C-N 124.604 1.844 . . . . 0.0 110.985 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 153' ' ' PHE . . . . . 0.647 ' CZ ' ' HB3' ' A' ' 143' ' ' PHE . 6.5 p90 -141.31 175.58 9.54 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.487 1.117 . . . . 0.0 111.049 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.56 -164.42 1.38 Allowed 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.472 1.107 . . . . 0.0 109.305 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -96.4 96.29 8.63 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.534 1.147 . . . . 0.0 109.288 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 156' ' ' GLY . . . . . 0.698 ' N ' ' O ' ' A' ' 139' ' ' ALA . . . 122.63 29.81 1.24 Allowed Glycine 0 CA--C 1.53 0.981 0 O-C-N 124.487 1.117 . . . . 0.0 111.002 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 157' ' ' ASP . . . . . 0.489 ' HB3' ' HB3' ' A' ' 139' ' ' ALA . 12.1 t70 -97.9 159.43 14.94 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.449 0.734 . . . . 0.0 109.298 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 158' ' ' ILE . . . . . 0.785 HD13 ' HD3' ' A' ' 138' ' ' ARG . 6.5 mm -115.04 147.37 18.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 O-C-N 124.533 1.146 . . . . 0.0 109.359 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 1.116 HD13 HD13 ' A' ' 182' ' ' ILE . 1.1 mt -149.21 138.79 21.73 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.531 1.144 . . . . 0.0 109.371 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 160' ' ' ARG . . . . . 0.609 ' O ' ' HA ' ' A' ' 172' ' ' ALA . 0.0 OUTLIER -95.71 134.22 38.89 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.543 1.152 . . . . 0.0 110.349 -179.983 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.512 HG22 ' HG2' ' A' ' 135' ' ' GLU . 15.4 mm -84.43 118.41 31.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 O-C-N 124.424 1.077 . . . . 0.0 109.264 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -112.36 -51.57 2.83 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.469 1.106 . . . . 0.0 110.285 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -138.86 168.39 19.93 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.495 1.122 . . . . 0.0 109.325 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 164' ' ' LYS . . . . . 0.581 ' HB3' ' CD1' ' A' ' 170' ' ' TRP . 27.4 mtmt -148.93 85.97 5.85 Favored Pre-proline 0 C--N 1.324 -0.513 0 O-C-N 124.499 1.124 . . . . 0.0 109.341 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.03 -30.57 6.98 Favored 'Trans proline' 0 C--N 1.36 1.138 0 O-C-N 124.498 1.788 . . . . 0.0 111.012 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -128.92 153.99 46.97 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.554 1.159 . . . . 0.0 110.272 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -77.75 -23.62 49.24 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.497 1.123 . . . . 0.0 110.265 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -75.9 -57.06 4.1 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.487 1.117 . . . . 0.0 110.329 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 169' ' ' TRP . . . . . 0.42 ' CZ3' ' OD1' ' A' ' 150' ' ' ASP . 14.0 m95 -111.33 156.22 21.88 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.547 1.154 . . . . 0.0 107.995 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 170' ' ' TRP . . . . . 0.581 ' CD1' ' HB3' ' A' ' 164' ' ' LYS . 23.6 m0 -131.46 148.53 52.65 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.477 1.111 . . . . 0.0 108.017 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 171' ' ' ASN . . . . . 0.529 ' OD1' ' HG2' ' A' ' 179' ' ' ARG . 6.2 t-20 -87.26 98.98 11.63 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.503 1.127 . . . . 0.0 109.306 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 172' ' ' ALA . . . . . 0.609 ' HA ' ' O ' ' A' ' 160' ' ' ARG . . . -118.86 175.59 5.68 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.456 1.097 . . . . 0.0 109.327 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 173' ' ' GLU . . . . . 0.66 ' C ' HD23 ' A' ' 159' ' ' LEU . 1.5 tt0 -118.02 118.26 31.44 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.441 1.088 . . . . 0.0 110.324 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 174' ' ' ASP . . . . . 0.902 ' OD2' HD13 ' A' ' 151' ' ' LEU . 0.9 OUTLIER -66.43 -174.73 0.3 Allowed 'General case' 0 C--N 1.326 -0.434 0 O-C-N 124.461 1.101 . . . . 0.0 109.308 -179.947 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -78.72 53.16 1.3 Allowed 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.461 1.1 . . . . 0.0 110.018 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -172.21 11.25 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.446 1.091 . . . . 0.0 110.323 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 177' ' ' GLY . . . . . 0.49 ' C ' ' HG2' ' A' ' 173' ' ' GLU . . . 73.27 18.02 79.09 Favored Glycine 0 CA--C 1.53 0.978 0 O-C-N 124.509 1.131 . . . . 0.0 111.008 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -79.66 103.85 9.86 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.54 0.788 . . . . 0.0 109.349 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 179' ' ' ARG . . . . . 0.558 ' HG3' ' HG3' ' A' ' 173' ' ' GLU . 0.0 OUTLIER -87.65 113.21 23.12 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.434 1.084 . . . . 0.0 110.296 179.985 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 180' ' ' GLY . . . . . 0.403 ' O ' ' HA ' ' A' ' 171' ' ' ASN . . . -152.2 172.89 31.43 Favored Glycine 0 CA--C 1.53 0.977 0 O-C-N 124.428 1.08 . . . . 0.0 111.026 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 181' ' ' MET . . . . . 0.422 ' HA ' ' O ' ' A' ' 170' ' ' TRP . 3.0 mmm -87.7 97.49 10.92 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.492 0.76 . . . . 0.0 111.017 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 182' ' ' ILE . . . . . 1.116 HD13 HD13 ' A' ' 159' ' ' LEU . 3.4 pt -90.78 157.69 43.37 Favored Pre-proline 0 C--N 1.325 -0.498 0 O-C-N 124.498 1.124 . . . . 0.0 109.323 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 183' ' ' PRO . . . . . 0.741 ' HG2' ' HB2' ' A' ' 186' ' ' TYR . 18.3 Cg_endo -75.06 136.86 20.84 Favored 'Trans proline' 0 C--N 1.36 1.164 0 O-C-N 124.557 1.819 . . . . 0.0 111.012 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 184' ' ' VAL . . . . . 0.838 ' N ' ' CD ' ' A' ' 185' ' ' PRO . 92.2 t -82.08 -31.07 0.54 Allowed Pre-proline 0 C--N 1.325 -0.474 0 O-C-N 124.527 1.142 . . . . 0.0 109.37 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 185' ' ' PRO . . . . . 0.838 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.4 Cg_endo -74.99 -27.71 9.81 Favored 'Trans proline' 0 C--N 1.36 1.184 0 O-C-N 124.458 1.767 . . . . 0.0 111.012 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 186' ' ' TYR . . . . . 0.741 ' HB2' ' HG2' ' A' ' 183' ' ' PRO . 5.1 m-85 -91.37 15.17 12.7 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.493 1.12 . . . . 0.0 110.997 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 187' ' ' VAL . . . . . 0.699 HG11 HD12 ' A' ' 182' ' ' ILE . 34.5 m -143.22 167.32 13.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 O-C-N 124.504 1.127 . . . . 0.0 109.261 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 188' ' ' GLU . . . . . 0.483 ' CG ' ' HB3' ' A' ' 138' ' ' ARG . 0.0 OUTLIER -126.3 168.03 14.68 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 124.487 1.117 . . . . 0.0 110.329 179.943 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 12.3 mmmm -89.25 129.88 35.74 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.511 1.132 . . . . 0.0 109.274 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 190' ' ' TYR . . . . . 0.498 ' CG ' ' N ' ' A' ' 191' ' ' GLY . 0.8 OUTLIER -61.57 -149.89 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.48 1.112 . . . . 0.0 110.963 179.991 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 191' ' ' GLY . . . . . 0.498 ' N ' ' CG ' ' A' ' 190' ' ' TYR . . . . . . . . 0 CA--C 1.53 1.02 0 O-C-N 124.567 1.167 . . . . 0.0 110.988 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' CYS . . . . . . . . . . . . . 1.1 m . . . . . 0 N--CA 1.453 -0.316 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 133' ' ' GLY . . . . . 0.419 ' O ' ' HB2' ' A' ' 134' ' ' ALA . . . -77.25 56.99 3.67 Favored Glycine 0 CA--C 1.529 0.96 0 O-C-N 124.497 1.123 . . . . 0.0 111.022 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 134' ' ' ALA . . . . . 0.419 ' HB2' ' O ' ' A' ' 133' ' ' GLY . . . 179.39 -159.17 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.434 0 O-C-N 124.436 0.727 . . . . 0.0 109.248 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.522 ' O ' ' HG2' ' A' ' 160' ' ' ARG . 0.1 OUTLIER -131.17 64.78 1.57 Allowed 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.485 1.116 . . . . 0.0 110.266 179.969 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 136' ' ' TYR . . . . . 0.44 ' CE1' ' HG3' ' A' ' 160' ' ' ARG . 0.7 OUTLIER -129.19 132.4 47.28 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.432 1.083 . . . . 0.0 110.963 179.963 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.42 ' HA ' ' O ' ' A' ' 188' ' ' GLU . 3.4 m -128.15 164.51 29.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 O-C-N 124.449 1.093 . . . . 0.0 109.297 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 138' ' ' ARG . . . . . 0.455 ' O ' ' HA ' ' A' ' 187' ' ' VAL . 0.5 OUTLIER -123.57 126.32 46.45 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.482 1.114 . . . . 0.0 110.308 179.975 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.472 ' O ' ' N ' ' A' ' 156' ' ' GLY . . . -89.8 103.9 16.51 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.559 1.162 . . . . 0.0 109.258 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.774 HD11 ' HG2' ' A' ' 188' ' ' GLU . 0.2 OUTLIER -87.94 12.62 12.79 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.498 1.123 . . . . 0.0 109.231 -179.99 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 141' ' ' PHE . . . . . 0.471 ' O ' ' O ' ' A' ' 154' ' ' LYS . 23.7 m-85 -146.69 154.99 42.08 Favored 'General case' 0 C--N 1.324 -0.532 0 O-C-N 124.577 1.173 . . . . 0.0 111.041 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 142' ' ' ASP . . . . . 0.487 ' CB ' ' HA ' ' A' ' 154' ' ' LYS . 7.2 p-10 -103.19 139.74 38.27 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.51 1.131 . . . . 0.0 109.237 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 143' ' ' PHE . . . . . 0.648 ' O ' ' CE2' ' A' ' 153' ' ' PHE . 0.2 OUTLIER 166.55 81.87 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.444 0 O-C-N 124.507 1.129 . . . . 0.0 111.044 -179.992 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 144' ' ' ASN . . . . . 0.469 ' HA ' ' HA ' ' A' ' 152' ' ' PRO . 51.9 t-20 -39.58 154.58 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.539 1.149 . . . . 0.0 109.314 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 145' ' ' GLY . . . . . 0.446 ' N ' ' OD1' ' A' ' 144' ' ' ASN . . . -74.8 -156.77 5.33 Favored Glycine 0 CA--C 1.53 1.001 0 O-C-N 124.563 1.164 . . . . 0.0 110.988 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 146' ' ' ASN . . . . . 0.401 ' OD1' ' C ' ' A' ' 145' ' ' GLY . 6.7 p-10 166.39 76.56 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.493 0.761 . . . . 0.0 109.271 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -159.72 -81.4 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.423 1.077 . . . . 0.0 109.265 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.646 ' O ' ' CB ' ' A' ' 149' ' ' GLU . 9.8 mm-40 -113.95 74.24 0.86 Allowed 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.555 1.159 . . . . 0.0 110.277 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 149' ' ' GLU . . . . . 0.646 ' CB ' ' O ' ' A' ' 148' ' ' GLU . 5.8 tt0 98.42 -29.26 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.442 0 O-C-N 124.535 1.147 . . . . 0.0 110.311 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 150' ' ' ASP . . . . . 0.446 ' O ' ' O ' ' A' ' 149' ' ' GLU . 0.3 OUTLIER 60.68 136.43 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.509 1.131 . . . . 0.0 109.228 179.975 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.551 ' HB3' ' CG2' ' A' ' 182' ' ' ILE . 2.4 tp -118.32 111.83 38.08 Favored Pre-proline 0 C--N 1.326 -0.429 0 O-C-N 124.445 1.091 . . . . 0.0 109.288 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 152' ' ' PRO . . . . . 0.469 ' HA ' ' HA ' ' A' ' 144' ' ' ASN . 18.4 Cg_endo -75.01 117.47 4.92 Favored 'Trans proline' 0 C--N 1.359 1.127 0 O-C-N 124.535 1.808 . . . . 0.0 110.988 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 153' ' ' PHE . . . . . 0.648 ' CE2' ' O ' ' A' ' 143' ' ' PHE . 7.3 p90 -130.95 174.87 9.56 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.445 1.091 . . . . 0.0 110.981 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 154' ' ' LYS . . . . . 0.487 ' HA ' ' CB ' ' A' ' 142' ' ' ASP . 3.8 tttt -135.61 -156.1 0.69 Allowed 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.562 1.164 . . . . 0.0 109.232 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 4.4 ptpp? -99.84 106.74 18.63 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.494 1.121 . . . . 0.0 109.334 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 156' ' ' GLY . . . . . 0.472 ' N ' ' O ' ' A' ' 139' ' ' ALA . . . 108.88 27.65 4.8 Favored Glycine 0 CA--C 1.53 1.018 0 O-C-N 124.499 1.125 . . . . 0.0 110.953 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 157' ' ' ASP . . . . . 0.406 ' OD2' ' HG ' ' A' ' 159' ' ' LEU . 13.4 t70 -101.04 162.05 13.16 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.46 0.741 . . . . 0.0 109.306 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 19.6 mm -114.0 142.34 26.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 O-C-N 124.621 1.201 . . . . 0.0 109.327 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.818 HD13 HD13 ' A' ' 182' ' ' ILE . 2.2 mt -142.41 135.19 28.28 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.486 1.116 . . . . 0.0 109.328 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 160' ' ' ARG . . . . . 0.571 ' O ' ' HB1' ' A' ' 172' ' ' ALA . 8.2 ttm-85 -97.59 134.72 40.43 Favored 'General case' 0 C--N 1.324 -0.531 0 O-C-N 124.493 1.121 . . . . 0.0 110.303 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.413 ' CB ' ' HB2' ' A' ' 135' ' ' GLU . 1.2 mp -82.65 119.39 32.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 O-C-N 124.537 1.148 . . . . 0.0 109.23 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 162' ' ' ARG . . . . . 0.426 ' NH1' ' HB3' ' A' ' 162' ' ' ARG . 2.8 mmm180 -110.49 -59.19 1.98 Allowed 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.49 1.119 . . . . 0.0 110.332 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -129.23 163.84 24.75 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.456 1.097 . . . . 0.0 109.288 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 164' ' ' LYS . . . . . 0.426 ' HG3' ' NE1' ' A' ' 170' ' ' TRP . 0.3 OUTLIER -139.91 76.19 28.79 Favored Pre-proline 0 C--N 1.325 -0.489 0 O-C-N 124.537 1.148 . . . . 0.0 109.329 -179.951 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.97 -30.73 6.91 Favored 'Trans proline' 0 C--N 1.36 1.165 0 O-C-N 124.469 1.773 . . . . 0.0 111.038 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -113.4 169.68 8.78 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.519 1.137 . . . . 0.0 110.303 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -96.85 -27.92 14.47 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 124.47 1.106 . . . . 0.0 110.33 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -84.51 -55.94 3.88 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.47 1.107 . . . . 0.0 110.308 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 169' ' ' TRP . . . . . 0.436 ' CD1' ' N ' ' A' ' 169' ' ' TRP . 2.7 m95 -111.17 145.68 38.22 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.496 1.122 . . . . 0.0 107.99 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 170' ' ' TRP . . . . . 0.767 ' CD2' HG21 ' A' ' 184' ' ' VAL . 50.3 m0 -122.09 156.78 32.87 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.509 1.131 . . . . 0.0 108.0 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 171' ' ' ASN . . . . . 0.418 ' HA ' ' O ' ' A' ' 180' ' ' GLY . 33.0 t-20 -86.92 98.63 11.34 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.522 1.139 . . . . 0.0 109.351 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 172' ' ' ALA . . . . . 0.571 ' HB1' ' O ' ' A' ' 160' ' ' ARG . . . -113.87 176.19 5.14 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.483 1.114 . . . . 0.0 109.28 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 173' ' ' GLU . . . . . 0.492 ' CG ' ' HG3' ' A' ' 179' ' ' ARG . 9.6 mt-10 -112.75 127.71 56.22 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 124.354 1.033 . . . . 0.0 110.237 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 174' ' ' ASP . . . . . 0.658 ' HA ' HD23 ' A' ' 159' ' ' LEU . 6.2 p30 -83.78 -170.73 3.22 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.483 1.114 . . . . 0.0 109.327 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 1.1 t -79.53 68.06 5.46 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.493 1.121 . . . . 0.0 109.999 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 176.86 -4.39 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.473 1.108 . . . . 0.0 110.28 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 81.61 21.27 62.22 Favored Glycine 0 CA--C 1.53 1.012 0 O-C-N 124.542 1.151 . . . . 0.0 110.98 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 178' ' ' LYS . . . . . 0.403 ' O ' HD11 ' A' ' 151' ' ' LEU . 12.9 mtpt -92.04 118.67 31.02 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.483 0.754 . . . . 0.0 109.306 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 179' ' ' ARG . . . . . 0.492 ' HG3' ' CG ' ' A' ' 173' ' ' GLU . 61.0 mtt180 -89.92 121.92 32.47 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.443 1.089 . . . . 0.0 110.237 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 180' ' ' GLY . . . . . 0.436 ' HA3' HD13 ' A' ' 151' ' ' LEU . . . -150.77 166.93 30.4 Favored Glycine 0 CA--C 1.53 0.994 0 O-C-N 124.456 1.097 . . . . 0.0 111.0 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 181' ' ' MET . . . . . 0.451 ' HA ' ' O ' ' A' ' 170' ' ' TRP . 11.0 mtp -87.16 104.23 16.16 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.488 0.758 . . . . 0.0 110.921 -179.935 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 182' ' ' ILE . . . . . 0.818 HD13 HD13 ' A' ' 159' ' ' LEU . 1.4 pp -106.9 159.99 27.95 Favored Pre-proline 0 C--N 1.324 -0.527 0 O-C-N 124.587 1.18 . . . . 0.0 109.292 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 183' ' ' PRO . . . . . 0.628 ' HG2' ' HB2' ' A' ' 186' ' ' TYR . 18.5 Cg_endo -74.89 131.1 14.04 Favored 'Trans proline' 0 C--N 1.36 1.18 0 O-C-N 124.55 1.816 . . . . 0.0 111.066 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 184' ' ' VAL . . . . . 0.767 HG21 ' CD2' ' A' ' 170' ' ' TRP . 93.4 t -77.87 -33.99 1.06 Allowed Pre-proline 0 C--N 1.324 -0.506 0 O-C-N 124.54 1.15 . . . . 0.0 109.351 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 185' ' ' PRO . . . . . 0.764 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.3 Cg_endo -75.02 -11.44 21.45 Favored 'Trans proline' 0 C--N 1.361 1.199 0 O-C-N 124.41 1.742 . . . . 0.0 111.028 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 186' ' ' TYR . . . . . 0.628 ' HB2' ' HG2' ' A' ' 183' ' ' PRO . 6.7 m-85 -97.01 5.98 49.44 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.586 1.179 . . . . 0.0 110.996 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 187' ' ' VAL . . . . . 0.455 ' HA ' ' O ' ' A' ' 138' ' ' ARG . 8.4 m -137.74 173.32 13.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 O-C-N 124.507 1.13 . . . . 0.0 109.245 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 188' ' ' GLU . . . . . 0.774 ' HG2' HD11 ' A' ' 140' ' ' LEU . 0.0 OUTLIER -129.61 174.64 9.49 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.468 1.105 . . . . 0.0 110.253 -179.972 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 12.2 mmmm -86.98 117.19 25.54 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.472 1.108 . . . . 0.0 109.296 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 5.1 t80 -55.47 -41.8 73.46 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.483 1.114 . . . . 0.0 111.014 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.953 0 O-C-N 124.443 1.089 . . . . 0.0 111.007 179.967 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 132' ' ' CYS . . . . . 0.415 ' O ' ' SG ' ' A' ' 132' ' ' CYS . 32.1 p . . . . . 0 N--CA 1.453 -0.323 0 N-CA-C 108.334 -0.988 . . . . 0.0 108.334 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -173.07 -100.38 0.13 Allowed Glycine 0 CA--C 1.531 1.032 0 O-C-N 124.439 1.087 . . . . 0.0 110.988 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' ALA . . . . . 0.478 ' O ' ' C ' ' A' ' 135' ' ' GLU . . . -158.38 85.79 0.86 Allowed 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.523 0.778 . . . . 0.0 109.323 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.53 ' HB2' ' O ' ' A' ' 161' ' ' ILE . 1.6 pm0 30.87 68.68 0.1 Allowed 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.485 1.116 . . . . 0.0 110.278 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 136' ' ' TYR . . . . . 0.797 ' CE1' ' CD2' ' A' ' 190' ' ' TYR . 1.4 t80 -122.29 131.13 53.76 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.476 1.11 . . . . 0.0 110.952 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.614 HG11 HG21 ' A' ' 187' ' ' VAL . 3.8 t -132.55 162.16 40.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 O-C-N 124.497 1.123 . . . . 0.0 109.326 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 138' ' ' ARG . . . . . 0.476 ' N ' ' CG1' ' A' ' 137' ' ' VAL . 2.2 tpp85 -136.14 135.28 39.12 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.494 1.121 . . . . 0.0 110.31 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.538 ' O ' ' N ' ' A' ' 156' ' ' GLY . . . -98.57 109.51 22.25 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.506 1.129 . . . . 0.0 109.332 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.817 HD21 ' OE2' ' A' ' 188' ' ' GLU . 1.2 mt -88.71 -4.22 58.59 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.435 1.084 . . . . 0.0 109.263 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -133.28 154.46 50.67 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.536 1.147 . . . . 0.0 110.951 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' ASP . . . . . 0.432 ' CB ' ' HA ' ' A' ' 154' ' ' LYS . 7.6 t70 -100.27 152.88 19.78 Favored 'General case' 0 C--N 1.326 -0.427 0 O-C-N 124.484 1.115 . . . . 0.0 109.293 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 143' ' ' PHE . . . . . 0.604 ' HB3' ' CZ ' ' A' ' 153' ' ' PHE . 1.7 t80 177.46 59.84 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.422 0 O-C-N 124.479 1.112 . . . . 0.0 110.986 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 144' ' ' ASN . . . . . 0.534 ' HA ' ' HA ' ' A' ' 152' ' ' PRO . 0.4 OUTLIER -41.87 144.4 0.43 Allowed 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.51 1.131 . . . . 0.0 109.293 -179.999 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -89.15 -179.89 45.43 Favored Glycine 0 CA--C 1.53 0.984 0 O-C-N 124.534 1.146 . . . . 0.0 111.033 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 146' ' ' ASN . . . . . 0.417 ' O ' ' O ' ' A' ' 147' ' ' ASP . 12.1 t-20 175.3 -35.74 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.515 0.774 . . . . 0.0 109.322 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 147' ' ' ASP . . . . . 0.417 ' O ' ' O ' ' A' ' 146' ' ' ASN . 68.9 m-20 -41.52 -91.78 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.549 1.156 . . . . 0.0 109.33 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 175.72 39.35 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.481 1.113 . . . . 0.0 110.305 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 170.48 46.31 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.452 1.095 . . . . 0.0 110.319 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 150' ' ' ASP . . . . . 0.607 ' OD2' ' CH2' ' A' ' 169' ' ' TRP . 0.3 OUTLIER -155.47 133.06 11.14 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.547 1.154 . . . . 0.0 109.283 179.992 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.905 HD23 HD11 ' A' ' 182' ' ' ILE . 5.4 tp -89.72 138.11 28.21 Favored Pre-proline 0 C--N 1.324 -0.507 0 O-C-N 124.475 1.109 . . . . 0.0 109.312 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 152' ' ' PRO . . . . . 0.534 ' HA ' ' HA ' ' A' ' 144' ' ' ASN . 18.3 Cg_endo -75.03 137.36 21.54 Favored 'Trans proline' 0 C--N 1.361 1.19 0 O-C-N 124.466 1.772 . . . . 0.0 110.989 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 153' ' ' PHE . . . . . 0.604 ' CZ ' ' HB3' ' A' ' 143' ' ' PHE . 18.9 p90 -154.65 170.35 21.73 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.445 1.091 . . . . 0.0 111.031 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 154' ' ' LYS . . . . . 0.432 ' HA ' ' CB ' ' A' ' 142' ' ' ASP . 0.1 OUTLIER -125.9 -164.04 1.27 Allowed 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.504 1.127 . . . . 0.0 109.282 -179.993 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -99.7 103.28 14.94 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.48 1.112 . . . . 0.0 109.267 -179.932 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 156' ' ' GLY . . . . . 0.538 ' N ' ' O ' ' A' ' 139' ' ' ALA . . . 114.76 23.42 4.68 Favored Glycine 0 CA--C 1.529 0.964 0 O-C-N 124.434 1.084 . . . . 0.0 111.013 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 157' ' ' ASP . . . . . 0.481 ' C ' HD12 ' A' ' 158' ' ' ILE . 19.8 t70 -101.69 170.0 8.46 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.454 0.738 . . . . 0.0 109.295 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 158' ' ' ILE . . . . . 0.618 ' CG2' ' CE1' ' A' ' 136' ' ' TYR . 3.6 mp -120.62 146.17 25.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 O-C-N 124.413 1.071 . . . . 0.0 109.257 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.954 HD23 ' HA ' ' A' ' 174' ' ' ASP . 0.9 OUTLIER -140.13 125.54 18.97 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.435 1.084 . . . . 0.0 109.313 179.973 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 160' ' ' ARG . . . . . 0.673 ' O ' ' HB1' ' A' ' 172' ' ' ALA . 1.1 ttp85 -88.04 130.89 34.85 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.554 1.159 . . . . 0.0 110.291 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.53 ' O ' ' HB2' ' A' ' 135' ' ' GLU . 8.7 mm -83.3 125.88 40.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 O-C-N 124.518 1.136 . . . . 0.0 109.283 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.32 -58.85 1.89 Allowed 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.495 1.122 . . . . 0.0 110.34 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 163' ' ' ASP . . . . . 0.421 ' CB ' ' HB3' ' A' ' 171' ' ' ASN . 0.1 OUTLIER -115.37 154.65 28.81 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.5 1.125 . . . . 0.0 109.313 179.948 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 164' ' ' LYS . . . . . 0.543 ' HG3' ' CD1' ' A' ' 170' ' ' TRP . 28.9 tttm -146.47 66.64 11.15 Favored Pre-proline 0 C--N 1.325 -0.476 0 O-C-N 124.552 1.157 . . . . 0.0 109.241 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -74.99 -33.08 4.86 Favored 'Trans proline' 0 C--N 1.36 1.133 0 O-C-N 124.522 1.801 . . . . 0.0 111.019 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -104.48 171.02 7.56 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.498 1.124 . . . . 0.0 110.289 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 21.5 mt-10 -101.4 -30.08 11.66 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.504 1.128 . . . . 0.0 110.31 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -74.47 -61.11 1.98 Allowed 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.559 1.162 . . . . 0.0 110.292 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 169' ' ' TRP . . . . . 0.607 ' CH2' ' OD2' ' A' ' 150' ' ' ASP . 13.3 m95 -114.35 160.54 18.99 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.481 1.113 . . . . 0.0 108.001 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 170' ' ' TRP . . . . . 0.574 ' CE3' HG22 ' A' ' 184' ' ' VAL . 10.6 m0 -134.19 156.95 47.44 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.53 1.144 . . . . 0.0 108.011 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 171' ' ' ASN . . . . . 0.486 ' HA ' ' O ' ' A' ' 180' ' ' GLY . 40.5 t30 -87.42 102.48 14.58 Favored 'General case' 0 C--N 1.324 -0.522 0 O-C-N 124.523 1.14 . . . . 0.0 109.291 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 172' ' ' ALA . . . . . 0.673 ' HB1' ' O ' ' A' ' 160' ' ' ARG . . . -118.35 -178.19 3.46 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.521 1.138 . . . . 0.0 109.367 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 173' ' ' GLU . . . . . 0.421 ' HA ' ' O ' ' A' ' 178' ' ' LYS . 31.9 mt-10 -114.76 118.52 33.82 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.527 1.142 . . . . 0.0 110.227 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 174' ' ' ASP . . . . . 0.954 ' HA ' HD23 ' A' ' 159' ' ' LEU . 0.2 OUTLIER -73.43 -171.53 1.0 Allowed 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.522 1.139 . . . . 0.0 109.285 -179.998 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 29.1 t -80.07 56.56 2.43 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.546 1.154 . . . . 0.0 110.0 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -173.82 27.05 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.402 1.064 . . . . 0.0 110.392 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 50.47 22.53 5.46 Favored Glycine 0 CA--C 1.53 0.999 0 O-C-N 124.51 1.131 . . . . 0.0 110.992 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 178' ' ' LYS . . . . . 0.628 ' O ' HD21 ' A' ' 151' ' ' LEU . 2.7 ptpt -92.86 122.28 35.08 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.515 0.773 . . . . 0.0 109.352 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 40.6 mtt85 -91.16 115.4 27.99 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.467 1.104 . . . . 0.0 110.312 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 180' ' ' GLY . . . . . 0.748 ' HA3' HD13 ' A' ' 151' ' ' LEU . . . -150.38 179.51 27.05 Favored Glycine 0 CA--C 1.531 1.05 0 O-C-N 124.595 1.185 . . . . 0.0 110.998 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 181' ' ' MET . . . . . 0.41 ' HA ' ' O ' ' A' ' 170' ' ' TRP . 0.4 OUTLIER -85.33 107.35 17.29 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.576 0.81 . . . . 0.0 110.971 -179.989 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 182' ' ' ILE . . . . . 0.905 HD11 HD23 ' A' ' 151' ' ' LEU . 0.9 OUTLIER -98.0 144.14 27.49 Favored Pre-proline 0 C--N 1.325 -0.496 0 O-C-N 124.541 1.151 . . . . 0.0 109.262 -179.982 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 183' ' ' PRO . . . . . 0.724 ' HG2' ' HB2' ' A' ' 186' ' ' TYR . 18.5 Cg_endo -75.01 136.48 20.44 Favored 'Trans proline' 0 C--N 1.36 1.18 0 O-C-N 124.476 1.777 . . . . 0.0 111.021 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 184' ' ' VAL . . . . . 0.815 ' N ' ' CD ' ' A' ' 185' ' ' PRO . 44.3 t -82.03 -32.59 0.6 Allowed Pre-proline 0 C--N 1.326 -0.447 0 O-C-N 124.478 1.111 . . . . 0.0 109.305 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 185' ' ' PRO . . . . . 0.815 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.5 Cg_endo -75.0 -31.46 6.19 Favored 'Trans proline' 0 C--N 1.36 1.163 0 O-C-N 124.48 1.779 . . . . 0.0 111.024 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 186' ' ' TYR . . . . . 0.724 ' HB2' ' HG2' ' A' ' 183' ' ' PRO . 3.8 m-85 -90.8 19.39 5.55 Favored 'General case' 0 C--N 1.326 -0.428 0 O-C-N 124.483 1.114 . . . . 0.0 111.005 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 187' ' ' VAL . . . . . 0.658 HG22 ' O ' ' A' ' 183' ' ' PRO . 11.3 m -149.64 179.49 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 O-C-N 124.44 1.088 . . . . 0.0 109.371 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 188' ' ' GLU . . . . . 0.817 ' OE2' HD21 ' A' ' 140' ' ' LEU . 0.0 OUTLIER -139.54 166.33 24.86 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.496 1.122 . . . . 0.0 110.37 -179.994 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.64 129.74 39.81 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.478 1.111 . . . . 0.0 109.325 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 190' ' ' TYR . . . . . 0.797 ' CD2' ' CE1' ' A' ' 136' ' ' TYR . 0.2 OUTLIER -85.02 -47.61 10.05 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.495 1.122 . . . . 0.0 111.045 179.976 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.94 0 O-C-N 124.503 1.127 . . . . 0.0 111.038 179.954 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 132' ' ' CYS . . . . . 0.403 ' O ' ' C ' ' A' ' 133' ' ' GLY . 1.6 m . . . . . 0 N--CA 1.453 -0.32 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' GLY . . . . . 0.412 ' O ' ' HB2' ' A' ' 134' ' ' ALA . . . -36.52 -81.97 0.02 OUTLIER Glycine 0 CA--C 1.531 1.032 0 O-C-N 124.491 1.12 . . . . 0.0 110.977 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 134' ' ' ALA . . . . . 0.412 ' HB2' ' O ' ' A' ' 133' ' ' GLY . . . 179.96 -98.89 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.489 0.758 . . . . 0.0 109.256 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.422 ' O ' ' HA ' ' A' ' 160' ' ' ARG . 1.9 pt-20 -105.91 59.01 0.66 Allowed 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.575 1.172 . . . . 0.0 110.292 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -111.35 135.17 52.29 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.546 1.154 . . . . 0.0 110.987 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.745 HG12 ' O ' ' A' ' 159' ' ' LEU . 0.5 OUTLIER -126.01 157.03 36.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 O-C-N 124.498 1.124 . . . . 0.0 109.254 -179.933 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 138' ' ' ARG . . . . . 0.531 ' O ' ' HA ' ' A' ' 187' ' ' VAL . 1.4 ttm180 -126.22 139.48 53.31 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.513 1.133 . . . . 0.0 110.263 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.629 ' HB3' ' HB3' ' A' ' 157' ' ' ASP . . . -103.61 106.23 16.68 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 124.523 1.14 . . . . 0.0 109.306 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.444 ' O ' ' CG ' ' A' ' 155' ' ' LYS . 0.2 OUTLIER -87.32 -1.39 57.88 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.513 1.133 . . . . 0.0 109.327 179.965 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 141' ' ' PHE . . . . . 0.402 ' O ' ' O ' ' A' ' 154' ' ' LYS . 35.1 m-85 -128.14 159.63 34.54 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.488 1.118 . . . . 0.0 110.96 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 142' ' ' ASP . . . . . 0.468 ' CB ' ' HA ' ' A' ' 154' ' ' LYS . 45.2 p-10 -112.66 145.45 40.4 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.531 1.145 . . . . 0.0 109.278 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 143' ' ' PHE . . . . . 0.573 ' HB3' ' CZ ' ' A' ' 153' ' ' PHE . 36.3 t80 -179.88 69.29 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.549 1.156 . . . . 0.0 111.033 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 144' ' ' ASN . . . . . 0.533 ' HA ' ' HA ' ' A' ' 152' ' ' PRO . 23.0 p-10 -39.93 145.91 0.13 Allowed 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.525 1.141 . . . . 0.0 109.332 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 145' ' ' GLY . . . . . 0.429 ' C ' ' N ' ' A' ' 147' ' ' ASP . . . -96.7 -97.49 1.88 Allowed Glycine 0 CA--C 1.53 0.99 0 O-C-N 124.442 1.089 . . . . 0.0 111.005 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 146' ' ' ASN . . . . . 0.569 ' ND2' ' O ' ' A' ' 146' ' ' ASN . 0.6 OUTLIER 45.42 25.94 0.26 Allowed 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.502 0.766 . . . . 0.0 109.276 179.972 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 147' ' ' ASP . . . . . 0.429 ' N ' ' C ' ' A' ' 145' ' ' GLY . 49.4 m-20 -119.13 -63.83 1.35 Allowed 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.543 1.152 . . . . 0.0 109.274 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.438 ' C ' ' N ' ' A' ' 150' ' ' ASP . 0.9 OUTLIER -115.72 69.47 0.73 Allowed 'General case' 0 C--N 1.326 -0.426 0 O-C-N 124.434 1.084 . . . . 0.0 110.258 -179.929 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 149' ' ' GLU . . . . . 0.534 ' CG ' ' O ' ' A' ' 149' ' ' GLU . 1.0 OUTLIER 42.34 25.04 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.534 1.146 . . . . 0.0 110.33 179.998 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 150' ' ' ASP . . . . . 0.438 ' N ' ' C ' ' A' ' 148' ' ' GLU . 70.5 m-20 -90.32 166.49 13.28 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.542 1.151 . . . . 0.0 109.303 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.603 HD11 ' OD2' ' A' ' 174' ' ' ASP . 3.9 tp -105.23 132.84 20.52 Favored Pre-proline 0 C--N 1.325 -0.484 0 O-C-N 124.519 1.137 . . . . 0.0 109.287 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 152' ' ' PRO . . . . . 0.533 ' HA ' ' HA ' ' A' ' 144' ' ' ASN . 18.3 Cg_endo -75.0 143.63 29.28 Favored 'Trans proline' 0 C--N 1.36 1.146 0 O-C-N 124.59 1.837 . . . . 0.0 110.969 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 153' ' ' PHE . . . . . 0.573 ' CZ ' ' HB3' ' A' ' 143' ' ' PHE . 15.3 p90 -151.01 172.62 15.44 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.447 1.092 . . . . 0.0 111.035 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 154' ' ' LYS . . . . . 0.468 ' HA ' ' CB ' ' A' ' 142' ' ' ASP . 0.0 OUTLIER -130.54 -162.2 1.19 Allowed 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.537 1.148 . . . . 0.0 109.294 179.98 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.444 ' CG ' ' O ' ' A' ' 140' ' ' LEU . 2.9 tmtt? -94.47 107.51 19.48 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.495 1.122 . . . . 0.0 109.335 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 156' ' ' GLY . . . . . 0.453 ' HA2' ' CZ ' ' A' ' 138' ' ' ARG . . . 112.29 23.15 5.58 Favored Glycine 0 CA--C 1.529 0.949 0 O-C-N 124.529 1.143 . . . . 0.0 111.049 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 157' ' ' ASP . . . . . 0.633 ' C ' HD12 ' A' ' 158' ' ' ILE . 21.6 t70 -93.76 170.2 9.74 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.434 0.726 . . . . 0.0 109.296 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 158' ' ' ILE . . . . . 0.633 HD12 ' C ' ' A' ' 157' ' ' ASP . 3.0 mp -132.63 147.85 31.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 O-C-N 124.514 1.134 . . . . 0.0 109.234 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.745 ' O ' HG12 ' A' ' 137' ' ' VAL . 12.0 mt -147.67 131.82 17.36 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.483 1.114 . . . . 0.0 109.335 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 160' ' ' ARG . . . . . 0.604 ' O ' ' HA ' ' A' ' 172' ' ' ALA . 0.5 OUTLIER -86.85 139.38 30.72 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.457 1.098 . . . . 0.0 110.31 -179.975 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.464 ' CD1' ' HB ' ' A' ' 137' ' ' VAL . 1.4 mp -84.02 116.44 27.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 O-C-N 124.48 1.112 . . . . 0.0 109.287 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.92 -58.28 2.0 Allowed 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.499 1.124 . . . . 0.0 110.222 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 163' ' ' ASP . . . . . 0.442 ' OD1' ' N ' ' A' ' 164' ' ' LYS . 0.6 OUTLIER -136.47 161.37 36.02 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.484 1.115 . . . . 0.0 109.307 -179.918 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 164' ' ' LYS . . . . . 0.442 ' N ' ' OD1' ' A' ' 163' ' ' ASP . 0.0 OUTLIER -143.1 84.62 10.29 Favored Pre-proline 0 C--N 1.325 -0.48 0 O-C-N 124.489 1.118 . . . . 0.0 109.298 179.925 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -75.04 -39.04 1.31 Allowed 'Trans proline' 0 C--N 1.36 1.174 0 O-C-N 124.385 1.729 . . . . 0.0 111.029 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 166' ' ' GLU . . . . . 0.463 ' O ' ' NE1' ' A' ' 170' ' ' TRP . 3.9 mm-40 -111.36 178.24 4.4 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.532 1.145 . . . . 0.0 110.345 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.82 -22.02 14.45 Favored 'General case' 0 C--N 1.323 -0.546 0 O-C-N 124.51 1.131 . . . . 0.0 110.31 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 168' ' ' GLN . . . . . 0.444 ' HB3' ' CD1' ' A' ' 169' ' ' TRP . 0.0 OUTLIER -83.89 -57.89 3.02 Favored 'General case' 0 C--N 1.324 -0.523 0 O-C-N 124.527 1.142 . . . . 0.0 110.273 -179.996 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 169' ' ' TRP . . . . . 0.444 ' CD1' ' HB3' ' A' ' 168' ' ' GLN . 11.7 m95 -108.03 149.98 27.73 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.51 1.131 . . . . 0.0 107.994 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 170' ' ' TRP . . . . . 0.656 ' CZ3' HG11 ' A' ' 184' ' ' VAL . 26.6 m0 -131.3 151.59 51.36 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.486 1.116 . . . . 0.0 108.015 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 171' ' ' ASN . . . . . 0.469 ' HB2' ' HE3' ' A' ' 181' ' ' MET . 1.0 OUTLIER -87.64 98.89 11.67 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.548 1.155 . . . . 0.0 109.229 -179.913 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 172' ' ' ALA . . . . . 0.604 ' HA ' ' O ' ' A' ' 160' ' ' ARG . . . -112.46 166.17 11.56 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.434 1.084 . . . . 0.0 109.286 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 173' ' ' GLU . . . . . 0.442 ' HA ' ' O ' ' A' ' 178' ' ' LYS . 18.9 mt-10 -116.13 120.87 40.43 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.523 1.139 . . . . 0.0 110.256 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 174' ' ' ASP . . . . . 0.725 ' HA ' HD23 ' A' ' 159' ' ' LEU . 1.1 p30 -74.77 -173.4 1.84 Allowed 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.521 1.138 . . . . 0.0 109.321 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 22.6 t -79.83 63.24 4.32 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.507 1.129 . . . . 0.0 110.048 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -174.25 9.78 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.553 1.158 . . . . 0.0 110.309 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 68.69 19.49 73.2 Favored Glycine 0 CA--C 1.531 1.08 0 O-C-N 124.57 1.169 . . . . 0.0 110.986 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 178' ' ' LYS . . . . . 0.442 ' O ' ' HA ' ' A' ' 173' ' ' GLU . 0.1 OUTLIER -94.29 112.32 24.11 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 124.583 0.813 . . . . 0.0 109.228 -179.945 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 179' ' ' ARG . . . . . 0.471 ' HA ' ' O ' ' A' ' 172' ' ' ALA . 0.1 OUTLIER -96.69 124.6 40.73 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.548 1.155 . . . . 0.0 110.324 179.915 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -149.9 164.87 29.65 Favored Glycine 0 CA--C 1.531 1.092 0 O-C-N 124.531 1.144 . . . . 0.0 110.947 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 181' ' ' MET . . . . . 0.469 ' HE3' ' HB2' ' A' ' 171' ' ' ASN . 0.3 OUTLIER -88.98 100.98 13.63 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.57 0.806 . . . . 0.0 111.005 179.992 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 182' ' ' ILE . . . . . 0.505 HG22 ' HB3' ' A' ' 151' ' ' LEU . 0.2 OUTLIER -108.52 174.09 2.64 Favored Pre-proline 0 C--N 1.325 -0.488 0 O-C-N 124.436 1.085 . . . . 0.0 109.311 -179.999 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 183' ' ' PRO . . . . . 0.601 ' HB2' ' CD1' ' A' ' 186' ' ' TYR . 18.5 Cg_endo -74.95 129.21 12.17 Favored 'Trans proline' 0 C--N 1.36 1.132 0 O-C-N 124.535 1.808 . . . . 0.0 111.014 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 184' ' ' VAL . . . . . 0.816 ' N ' ' CD ' ' A' ' 185' ' ' PRO . 38.7 t -78.91 -32.94 0.83 Allowed Pre-proline 0 C--N 1.325 -0.459 0 O-C-N 124.473 1.108 . . . . 0.0 109.358 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 185' ' ' PRO . . . . . 0.816 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.6 Cg_endo -75.02 -13.84 21.25 Favored 'Trans proline' 0 C--N 1.361 1.189 0 O-C-N 124.45 1.763 . . . . 0.0 111.033 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 186' ' ' TYR . . . . . 0.601 ' CD1' ' HB2' ' A' ' 183' ' ' PRO . 7.9 m-85 -93.93 10.59 32.74 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.514 1.134 . . . . 0.0 110.985 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 187' ' ' VAL . . . . . 0.531 ' HA ' ' O ' ' A' ' 138' ' ' ARG . 20.3 m -143.12 165.01 15.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 O-C-N 124.503 1.127 . . . . 0.0 109.311 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 188' ' ' GLU . . . . . 0.519 ' O ' ' CG2' ' A' ' 137' ' ' VAL . 0.0 OUTLIER -120.42 159.61 24.76 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.512 1.132 . . . . 0.0 110.303 -179.995 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -86.59 134.17 33.66 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.519 1.137 . . . . 0.0 109.292 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -111.53 86.41 2.33 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.53 1.144 . . . . 0.0 111.028 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 1.0 0 O-C-N 124.501 1.126 . . . . 0.0 110.993 -179.989 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 132' ' ' CYS . . . . . 0.475 ' N ' ' O ' ' A' ' 190' ' ' TYR . 26.9 p . . . . . 0 N--CA 1.453 -0.319 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 96.9 -49.57 1.56 Allowed Glycine 0 CA--C 1.529 0.963 0 O-C-N 124.505 1.128 . . . . 0.0 110.988 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -61.32 -150.52 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.454 0.737 . . . . 0.0 109.243 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.526 ' O ' ' HG2' ' A' ' 160' ' ' ARG . 0.4 OUTLIER -142.63 73.16 1.39 Allowed 'General case' 0 C--N 1.326 -0.427 0 O-C-N 124.424 1.078 . . . . 0.0 110.285 -179.979 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 39.2 m-85 -128.82 126.91 40.85 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.459 1.099 . . . . 0.0 110.984 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.796 HG22 ' O ' ' A' ' 159' ' ' LEU . 28.5 m -121.06 170.03 11.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 O-C-N 124.535 1.147 . . . . 0.0 109.334 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 138' ' ' ARG . . . . . 0.494 ' O ' ' HA ' ' A' ' 187' ' ' VAL . 5.1 ttm180 -133.91 127.64 32.91 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.498 1.124 . . . . 0.0 110.306 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.597 ' O ' ' N ' ' A' ' 156' ' ' GLY . . . -93.5 115.58 28.1 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.582 1.176 . . . . 0.0 109.27 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.989 HD21 ' OE2' ' A' ' 188' ' ' GLU . 0.2 OUTLIER -95.22 -19.58 19.92 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.545 1.153 . . . . 0.0 109.338 179.908 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 141' ' ' PHE . . . . . 0.444 ' O ' ' O ' ' A' ' 154' ' ' LYS . 5.8 m-85 -114.45 147.52 39.16 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.45 1.094 . . . . 0.0 110.96 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 142' ' ' ASP . . . . . 0.461 ' HB3' ' HA ' ' A' ' 154' ' ' LYS . 0.0 OUTLIER -89.5 138.84 31.11 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.476 1.11 . . . . 0.0 109.275 179.991 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 143' ' ' PHE . . . . . 0.69 ' O ' ' CZ ' ' A' ' 153' ' ' PHE . 0.1 OUTLIER 172.17 82.04 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.575 1.172 . . . . 0.0 110.962 179.966 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 144' ' ' ASN . . . . . 0.469 ' HA ' ' HA ' ' A' ' 152' ' ' PRO . 33.3 p-10 -43.54 163.9 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.518 1.136 . . . . 0.0 109.317 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 145' ' ' GLY . . . . . 0.454 ' N ' ' OD1' ' A' ' 150' ' ' ASP . . . -77.47 -156.79 8.27 Favored Glycine 0 CA--C 1.53 0.996 0 O-C-N 124.521 1.138 . . . . 0.0 111.067 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 22.2 t-20 177.24 72.08 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.547 0.792 . . . . 0.0 109.285 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' ASP . . . . . 0.429 ' N ' ' OD1' ' A' ' 147' ' ' ASP . 0.0 OUTLIER -163.14 -162.07 0.73 Allowed 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.453 1.096 . . . . 0.0 109.295 179.992 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.444 ' O ' ' CB ' ' A' ' 149' ' ' GLU . 0.6 OUTLIER -70.73 52.1 0.14 Allowed 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.436 1.085 . . . . 0.0 110.278 179.994 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 149' ' ' GLU . . . . . 0.458 ' O ' ' O ' ' A' ' 150' ' ' ASP . 0.2 OUTLIER 164.41 -58.59 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.462 1.101 . . . . 0.0 110.291 -179.958 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 150' ' ' ASP . . . . . 0.458 ' O ' ' O ' ' A' ' 149' ' ' GLU . 1.4 t0 60.22 134.15 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.587 1.179 . . . . 0.0 109.261 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.86 HD11 ' OD2' ' A' ' 174' ' ' ASP . 1.0 OUTLIER -119.79 103.82 45.38 Favored Pre-proline 0 C--N 1.325 -0.467 0 O-C-N 124.481 1.113 . . . . 0.0 109.339 179.985 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 152' ' ' PRO . . . . . 0.469 ' HA ' ' HA ' ' A' ' 144' ' ' ASN . 18.0 Cg_endo -75.04 117.95 5.08 Favored 'Trans proline' 0 C--N 1.36 1.146 0 O-C-N 124.559 1.82 . . . . 0.0 111.041 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 153' ' ' PHE . . . . . 0.69 ' CZ ' ' O ' ' A' ' 143' ' ' PHE . 20.9 p90 -137.91 169.87 17.03 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.561 1.163 . . . . 0.0 110.947 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 154' ' ' LYS . . . . . 0.461 ' HA ' ' HB3' ' A' ' 142' ' ' ASP . 3.4 tttt -130.0 -120.92 0.22 Allowed 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.46 1.1 . . . . 0.0 109.317 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.52 ' CB ' ' O ' ' A' ' 140' ' ' LEU . 0.3 OUTLIER -126.65 118.22 24.34 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.559 1.162 . . . . 0.0 109.315 179.976 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 156' ' ' GLY . . . . . 0.597 ' N ' ' O ' ' A' ' 139' ' ' ALA . . . 98.16 19.61 23.18 Favored Glycine 0 CA--C 1.53 1.004 0 O-C-N 124.513 1.133 . . . . 0.0 111.012 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -91.45 157.04 17.28 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.54 0.788 . . . . 0.0 109.291 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 12.8 mm -113.19 141.04 30.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 O-C-N 124.486 1.116 . . . . 0.0 109.298 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.796 ' O ' HG22 ' A' ' 137' ' ' VAL . 7.2 mt -145.3 124.95 13.26 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.503 1.127 . . . . 0.0 109.316 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 160' ' ' ARG . . . . . 0.572 ' O ' ' HA ' ' A' ' 172' ' ' ALA . 0.0 OUTLIER -87.68 135.21 33.46 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.42 1.075 . . . . 0.0 110.342 179.99 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.466 HD13 HG13 ' A' ' 137' ' ' VAL . 1.4 mp -83.0 119.37 32.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 O-C-N 124.428 1.08 . . . . 0.0 109.286 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.56 -46.35 2.58 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.573 1.17 . . . . 0.0 110.309 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 163' ' ' ASP . . . . . 0.458 ' CB ' ' HB3' ' A' ' 171' ' ' ASN . 0.1 OUTLIER -134.94 179.59 6.22 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.564 1.165 . . . . 0.0 109.264 179.998 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 164' ' ' LYS . . . . . 0.599 ' HB2' ' CD1' ' A' ' 170' ' ' TRP . 0.0 OUTLIER -170.82 91.97 0.46 Allowed Pre-proline 0 C--N 1.326 -0.432 0 O-C-N 124.462 1.101 . . . . 0.0 109.311 -179.994 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.03 -26.35 10.95 Favored 'Trans proline' 0 C--N 1.362 1.239 0 O-C-N 124.513 1.796 . . . . 0.0 111.023 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -126.26 166.27 17.42 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.508 1.13 . . . . 0.0 110.24 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -86.54 -26.09 24.72 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.501 1.126 . . . . 0.0 110.299 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 4.4 mt-30 -78.02 -56.58 4.37 Favored 'General case' 0 C--N 1.324 -0.524 0 O-C-N 124.568 1.167 . . . . 0.0 110.316 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 169' ' ' TRP . . . . . . . . . . . . . 9.2 m95 -104.87 145.83 29.85 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 170' ' ' TRP . . . . . 0.8 ' CD2' HG21 ' A' ' 184' ' ' VAL . 30.8 m0 -122.44 151.43 41.28 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.564 1.165 . . . . 0.0 108.034 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 171' ' ' ASN . . . . . 0.458 ' HB3' ' CB ' ' A' ' 163' ' ' ASP . 2.7 t30 -86.44 96.19 9.95 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.544 1.153 . . . . 0.0 109.289 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 172' ' ' ALA . . . . . 0.572 ' HA ' ' O ' ' A' ' 160' ' ' ARG . . . -107.26 166.65 10.48 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.496 1.123 . . . . 0.0 109.259 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 173' ' ' GLU . . . . . 0.475 ' HA ' ' O ' ' A' ' 178' ' ' LYS . 34.3 mt-10 -126.03 126.25 43.95 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.503 1.127 . . . . 0.0 110.31 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 174' ' ' ASP . . . . . 0.86 ' OD2' HD11 ' A' ' 151' ' ' LEU . 1.1 m-20 -79.48 -174.57 4.3 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.521 1.138 . . . . 0.0 109.277 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 38.4 t -77.74 56.27 1.48 Allowed 'General case' 0 C--N 1.324 -0.528 0 O-C-N 124.584 1.178 . . . . 0.0 109.964 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 176' ' ' GLU . . . . . 0.458 ' CB ' ' HD2' ' A' ' 178' ' ' LYS . 0.0 OUTLIER -167.68 16.68 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.466 1.104 . . . . 0.0 110.298 179.925 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 62.57 15.13 52.73 Favored Glycine 0 CA--C 1.53 0.983 0 O-C-N 124.503 1.127 . . . . 0.0 110.992 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 178' ' ' LYS . . . . . 0.492 ' CG ' ' HB2' ' A' ' 174' ' ' ASP . 1.5 ptmm? -86.04 108.15 18.12 Favored 'General case' 0 C--N 1.326 -0.429 0 O-C-N 124.469 0.747 . . . . 0.0 109.334 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 179' ' ' ARG . . . . . 0.46 ' HA ' ' O ' ' A' ' 172' ' ' ALA . 0.0 OUTLIER -96.11 127.82 42.47 Favored 'General case' 0 C--N 1.324 -0.523 0 O-C-N 124.51 1.131 . . . . 0.0 110.284 -179.961 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -152.27 165.84 30.94 Favored Glycine 0 CA--C 1.53 0.993 0 O-C-N 124.511 1.132 . . . . 0.0 111.021 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 181' ' ' MET . . . . . 0.456 ' HA ' ' O ' ' A' ' 170' ' ' TRP . 25.4 mtp -88.41 105.32 17.52 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.488 0.758 . . . . 0.0 110.98 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 182' ' ' ILE . . . . . 0.847 HG22 ' HB3' ' A' ' 151' ' ' LEU . 0.0 OUTLIER -110.15 164.11 15.6 Favored Pre-proline 0 C--N 1.324 -0.536 0 O-C-N 124.514 1.134 . . . . 0.0 109.359 179.956 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 183' ' ' PRO . . . . . 0.638 ' HG2' ' HB2' ' A' ' 186' ' ' TYR . 18.3 Cg_endo -74.99 128.85 11.82 Favored 'Trans proline' 0 C--N 1.36 1.169 0 O-C-N 124.51 1.795 . . . . 0.0 111.048 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 184' ' ' VAL . . . . . 0.812 ' N ' ' CD ' ' A' ' 185' ' ' PRO . 59.8 t -76.87 -32.96 1.06 Allowed Pre-proline 0 C--N 1.324 -0.506 0 O-C-N 124.576 1.173 . . . . 0.0 109.266 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 185' ' ' PRO . . . . . 0.812 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.5 Cg_endo -74.99 -14.57 21.13 Favored 'Trans proline' 0 C--N 1.36 1.15 0 O-C-N 124.485 1.782 . . . . 0.0 111.048 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 186' ' ' TYR . . . . . 0.638 ' HB2' ' HG2' ' A' ' 183' ' ' PRO . 6.3 m-85 -96.26 5.01 51.93 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.522 1.139 . . . . 0.0 111.001 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 187' ' ' VAL . . . . . 0.494 ' HA ' ' O ' ' A' ' 138' ' ' ARG . 12.6 m -135.81 165.02 30.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 O-C-N 124.499 1.124 . . . . 0.0 109.248 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 188' ' ' GLU . . . . . 0.989 ' OE2' HD21 ' A' ' 140' ' ' LEU . 0.3 OUTLIER -115.03 153.22 31.07 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.475 1.11 . . . . 0.0 110.277 -179.984 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 189' ' ' LYS . . . . . 0.446 ' NZ ' HG13 ' A' ' 184' ' ' VAL . 0.0 OUTLIER -88.54 137.01 32.7 Favored 'General case' 0 C--N 1.326 -0.436 0 O-C-N 124.505 1.128 . . . . 0.0 109.334 179.99 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 190' ' ' TYR . . . . . 0.565 ' O ' ' C ' ' A' ' 191' ' ' GLY . 3.4 m-85 -136.81 -86.22 0.32 Allowed 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.57 1.169 . . . . 0.0 110.987 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 191' ' ' GLY . . . . . 0.565 ' C ' ' O ' ' A' ' 190' ' ' TYR . . . . . . . . 0 CA--C 1.53 1.01 0 O-C-N 124.627 1.204 . . . . 0.0 111.077 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' CYS . . . . . 0.466 ' O ' ' O ' ' A' ' 191' ' ' GLY . 15.5 p . . . . . 0 N--CA 1.452 -0.339 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' GLY . . . . . 0.503 ' O ' ' HB3' ' A' ' 134' ' ' ALA . . . -65.9 -149.45 0.09 OUTLIER Glycine 0 CA--C 1.53 0.994 0 O-C-N 124.541 1.151 . . . . 0.0 110.994 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 134' ' ' ALA . . . . . 0.503 ' HB3' ' O ' ' A' ' 133' ' ' GLY . . . 71.97 -157.13 0.1 Allowed 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.454 0.738 . . . . 0.0 109.317 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.523 ' CB ' ' O ' ' A' ' 161' ' ' ILE . 25.3 mp0 -148.6 76.41 1.35 Allowed 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.481 1.113 . . . . 0.0 110.379 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 76.0 m-85 -126.66 125.07 41.27 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.512 1.133 . . . . 0.0 111.021 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.528 HG13 HD13 ' A' ' 161' ' ' ILE . 7.5 m -131.84 141.26 46.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 O-C-N 124.533 1.145 . . . . 0.0 109.336 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 138' ' ' ARG . . . . . 0.547 ' HD2' ' CE1' ' A' ' 190' ' ' TYR . 0.8 OUTLIER -115.58 137.5 52.0 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.57 1.169 . . . . 0.0 110.261 -179.956 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.683 ' HB3' ' OD1' ' A' ' 157' ' ' ASP . . . -92.56 115.6 28.25 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.501 1.126 . . . . 0.0 109.273 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.852 HD21 ' OE2' ' A' ' 188' ' ' GLU . 0.2 OUTLIER -87.44 -8.41 56.53 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.495 1.122 . . . . 0.0 109.331 179.993 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 141' ' ' PHE . . . . . 0.57 ' CE1' ' HB2' ' A' ' 140' ' ' LEU . 0.4 OUTLIER -128.04 144.31 51.1 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.494 1.121 . . . . 0.0 111.004 179.991 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 142' ' ' ASP . . . . . 0.421 ' CB ' ' HA ' ' A' ' 154' ' ' LYS . 0.9 OUTLIER -93.3 157.39 16.27 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.55 1.156 . . . . 0.0 109.242 -179.984 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 143' ' ' PHE . . . . . 0.574 ' HB3' ' CZ ' ' A' ' 153' ' ' PHE . 0.0 OUTLIER -149.43 -40.03 0.15 Allowed 'General case' 0 C--N 1.326 -0.42 0 O-C-N 124.479 1.112 . . . . 0.0 111.008 -179.987 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 144' ' ' ASN . . . . . 0.479 ' O ' ' CE1' ' A' ' 143' ' ' PHE . 10.1 m120 55.42 175.0 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.435 0 O-C-N 124.418 1.074 . . . . 0.0 109.295 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 145' ' ' GLY . . . . . 0.44 ' N ' ' HB3' ' A' ' 152' ' ' PRO . . . 162.32 -170.09 37.83 Favored Glycine 0 CA--C 1.53 0.979 0 O-C-N 124.426 1.079 . . . . 0.0 111.035 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 12.2 p-10 171.17 74.02 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.47 0.747 . . . . 0.0 109.3 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -97.3 -84.67 0.37 Allowed 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.445 1.091 . . . . 0.0 109.32 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 177.51 36.73 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.49 1.119 . . . . 0.0 110.308 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 170.07 -39.04 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.476 1.11 . . . . 0.0 110.334 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -52.18 167.37 0.13 Allowed 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.478 1.112 . . . . 0.0 109.314 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.958 HD23 HG23 ' A' ' 182' ' ' ILE . 12.5 tp -130.55 107.34 15.77 Favored Pre-proline 0 C--N 1.324 -0.51 0 O-C-N 124.496 1.122 . . . . 0.0 109.265 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 152' ' ' PRO . . . . . 0.44 ' HB3' ' N ' ' A' ' 145' ' ' GLY . 18.3 Cg_endo -75.0 172.02 17.18 Favored 'Trans proline' 0 C--N 1.36 1.166 0 O-C-N 124.552 1.817 . . . . 0.0 111.012 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 153' ' ' PHE . . . . . 0.574 ' CZ ' ' HB3' ' A' ' 143' ' ' PHE . 24.4 p90 -169.5 176.7 4.92 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.516 1.135 . . . . 0.0 111.046 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 154' ' ' LYS . . . . . 0.421 ' HA ' ' CB ' ' A' ' 142' ' ' ASP . 0.6 OUTLIER -119.76 -155.56 0.62 Allowed 'General case' 0 C--N 1.326 -0.438 0 O-C-N 124.479 1.112 . . . . 0.0 109.296 -179.992 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 1.1 tttp -111.96 98.78 7.6 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.473 1.108 . . . . 0.0 109.314 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 156' ' ' GLY . . . . . 0.645 ' N ' ' O ' ' A' ' 139' ' ' ALA . . . 115.55 25.75 3.62 Favored Glycine 0 CA--C 1.529 0.967 0 O-C-N 124.525 1.141 . . . . 0.0 111.038 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 157' ' ' ASP . . . . . 0.863 ' C ' HD12 ' A' ' 158' ' ' ILE . 3.4 p-10 -99.13 166.85 11.05 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.438 0.728 . . . . 0.0 109.28 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 158' ' ' ILE . . . . . 0.863 HD12 ' C ' ' A' ' 157' ' ' ASP . 2.1 mp -122.5 150.88 26.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 O-C-N 124.422 1.076 . . . . 0.0 109.268 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.902 HD21 ' CG ' ' A' ' 174' ' ' ASP . 0.4 OUTLIER -151.94 134.84 15.65 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.482 1.114 . . . . 0.0 109.336 179.988 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 160' ' ' ARG . . . . . 0.48 ' O ' ' HB1' ' A' ' 172' ' ' ALA . 0.1 OUTLIER -93.53 127.56 39.25 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.431 1.082 . . . . 0.0 110.314 -179.981 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.528 HD13 HG13 ' A' ' 137' ' ' VAL . 1.6 mp -85.67 121.49 37.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 O-C-N 124.48 1.112 . . . . 0.0 109.362 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 162' ' ' ARG . . . . . 0.429 ' CD ' ' HB2' ' A' ' 163' ' ' ASP . 0.2 OUTLIER -119.99 -32.21 4.26 Favored 'General case' 0 C--N 1.326 -0.431 0 O-C-N 124.425 1.078 . . . . 0.0 110.289 -179.976 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 163' ' ' ASP . . . . . 0.448 ' CB ' ' HB3' ' A' ' 171' ' ' ASN . 0.4 OUTLIER -139.8 171.34 14.36 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.554 1.159 . . . . 0.0 109.299 179.985 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 164' ' ' LYS . . . . . 0.573 ' HB2' ' CD1' ' A' ' 170' ' ' TRP . 0.5 OUTLIER -156.8 82.62 3.26 Favored Pre-proline 0 C--N 1.325 -0.476 0 O-C-N 124.496 1.123 . . . . 0.0 109.312 -179.939 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -74.9 -25.71 11.83 Favored 'Trans proline' 0 C--N 1.359 1.129 0 O-C-N 124.438 1.757 . . . . 0.0 111.075 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 9.6 mt-10 -111.64 169.01 9.11 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.464 1.102 . . . . 0.0 110.317 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -90.98 -32.04 16.1 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.544 1.153 . . . . 0.0 110.296 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 168' ' ' GLN . . . . . 0.437 ' HB3' ' CD1' ' A' ' 169' ' ' TRP . 6.6 mt-30 -87.3 -53.45 4.83 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.552 1.158 . . . . 0.0 110.31 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 169' ' ' TRP . . . . . 0.473 ' CD1' ' N ' ' A' ' 169' ' ' TRP . 1.6 m95 -104.8 148.18 26.91 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.546 1.154 . . . . 0.0 107.972 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 170' ' ' TRP . . . . . 0.585 ' CE2' HG21 ' A' ' 184' ' ' VAL . 36.9 m0 -125.38 159.67 31.26 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.558 1.161 . . . . 0.0 108.05 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 171' ' ' ASN . . . . . 0.448 ' HB3' ' CB ' ' A' ' 163' ' ' ASP . 23.6 t-20 -86.14 109.5 18.92 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.511 1.132 . . . . 0.0 109.289 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 172' ' ' ALA . . . . . 0.48 ' HB1' ' O ' ' A' ' 160' ' ' ARG . . . -122.82 176.92 5.71 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.457 1.098 . . . . 0.0 109.323 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 173' ' ' GLU . . . . . 0.5 ' CG ' ' HG2' ' A' ' 179' ' ' ARG . 7.1 mt-10 -116.36 119.74 36.64 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.453 1.096 . . . . 0.0 110.357 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 174' ' ' ASP . . . . . 0.902 ' CG ' HD21 ' A' ' 159' ' ' LEU . 1.7 m-20 -74.66 -175.93 2.62 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.508 1.13 . . . . 0.0 109.361 179.954 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 98.2 p -76.74 58.93 1.49 Allowed 'General case' 0 C--N 1.324 -0.531 0 O-C-N 124.506 1.129 . . . . 0.0 109.99 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 176' ' ' GLU . . . . . 0.409 ' H ' ' H ' ' A' ' 177' ' ' GLY . 0.4 OUTLIER -170.93 -2.22 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.52 0 O-C-N 124.515 1.134 . . . . 0.0 110.333 -179.986 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 177' ' ' GLY . . . . . 0.409 ' H ' ' H ' ' A' ' 176' ' ' GLU . . . 79.16 19.58 71.9 Favored Glycine 0 CA--C 1.53 1.012 0 O-C-N 124.524 1.14 . . . . 0.0 111.037 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 178' ' ' LYS . . . . . 0.497 ' CG ' ' HB2' ' A' ' 174' ' ' ASP . 2.1 ptpp? -91.88 121.26 33.31 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.499 0.764 . . . . 0.0 109.331 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 179' ' ' ARG . . . . . 0.5 ' HG2' ' CG ' ' A' ' 173' ' ' GLU . 21.1 mtt85 -89.81 122.44 32.88 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.475 1.109 . . . . 0.0 110.275 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 180' ' ' GLY . . . . . 0.649 ' CA ' HD22 ' A' ' 151' ' ' LEU . . . -152.02 167.04 31.11 Favored Glycine 0 CA--C 1.531 1.037 0 O-C-N 124.486 1.117 . . . . 0.0 110.972 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 181' ' ' MET . . . . . 0.473 ' HA ' ' O ' ' A' ' 170' ' ' TRP . 33.8 mtp -87.97 103.5 15.75 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.471 0.748 . . . . 0.0 110.988 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 182' ' ' ILE . . . . . 0.958 HG23 HD23 ' A' ' 151' ' ' LEU . 8.2 pt -98.7 157.12 34.79 Favored Pre-proline 0 C--N 1.324 -0.528 0 O-C-N 124.526 1.141 . . . . 0.0 109.281 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 183' ' ' PRO . . . . . 0.717 ' HG2' ' HB2' ' A' ' 186' ' ' TYR . 18.4 Cg_endo -75.0 135.27 18.85 Favored 'Trans proline' 0 C--N 1.36 1.148 0 O-C-N 124.495 1.787 . . . . 0.0 111.029 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 184' ' ' VAL . . . . . 0.816 ' N ' ' CD ' ' A' ' 185' ' ' PRO . 62.8 t -81.74 -32.45 0.61 Allowed Pre-proline 0 C--N 1.324 -0.501 0 O-C-N 124.547 1.155 . . . . 0.0 109.359 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 185' ' ' PRO . . . . . 0.816 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.5 Cg_endo -74.98 -25.35 11.97 Favored 'Trans proline' 0 C--N 1.36 1.159 0 O-C-N 124.508 1.794 . . . . 0.0 111.011 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 186' ' ' TYR . . . . . 0.717 ' HB2' ' HG2' ' A' ' 183' ' ' PRO . 3.8 m-85 -93.48 14.43 18.69 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.504 1.127 . . . . 0.0 111.068 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 187' ' ' VAL . . . . . 0.694 HG22 ' O ' ' A' ' 183' ' ' PRO . 21.4 m -138.22 163.69 28.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 O-C-N 124.525 1.14 . . . . 0.0 109.272 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 188' ' ' GLU . . . . . 0.852 ' OE2' HD21 ' A' ' 140' ' ' LEU . 0.0 OUTLIER -126.07 167.62 15.1 Favored 'General case' 0 C--N 1.326 -0.416 0 O-C-N 124.431 1.082 . . . . 0.0 110.335 179.958 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -87.5 125.39 34.28 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.508 1.13 . . . . 0.0 109.251 -179.9 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 190' ' ' TYR . . . . . 0.547 ' CE1' ' HD2' ' A' ' 138' ' ' ARG . 0.1 OUTLIER -109.32 81.61 1.47 Allowed 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.444 1.09 . . . . 0.0 111.034 179.948 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 191' ' ' GLY . . . . . 0.466 ' O ' ' O ' ' A' ' 132' ' ' CYS . . . . . . . . 0 CA--C 1.531 1.048 0 O-C-N 124.443 1.089 . . . . 0.0 110.93 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' CYS . . . . . . . . . . . . . 5.8 t . . . . . 0 N--CA 1.452 -0.342 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -127.4 149.88 17.98 Favored Glycine 0 CA--C 1.53 1.022 0 O-C-N 124.474 1.109 . . . . 0.0 110.976 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . 48.73 -157.2 0.07 Allowed 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.449 0.735 . . . . 0.0 109.297 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.442 ' HB2' ' HB ' ' A' ' 161' ' ' ILE . 0.2 OUTLIER -120.16 60.65 0.87 Allowed 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.492 1.12 . . . . 0.0 110.294 179.981 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 136' ' ' TYR . . . . . 0.582 ' C ' ' CD1' ' A' ' 136' ' ' TYR . 0.4 OUTLIER -121.97 143.0 49.73 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.493 1.121 . . . . 0.0 110.978 179.998 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.834 HG22 ' O ' ' A' ' 159' ' ' LEU . 35.1 m -145.03 137.45 21.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 O-C-N 124.431 1.082 . . . . 0.0 109.243 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 138' ' ' ARG . . . . . 0.447 ' HB3' ' HG3' ' A' ' 188' ' ' GLU . 0.6 OUTLIER -105.07 133.98 48.93 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.466 1.104 . . . . 0.0 110.285 -179.993 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.578 ' HB2' HD11 ' A' ' 159' ' ' LEU . . . -95.97 112.57 24.27 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.56 1.163 . . . . 0.0 109.305 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.955 HD21 ' OE2' ' A' ' 188' ' ' GLU . 0.2 OUTLIER -98.5 -9.48 24.97 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.561 1.163 . . . . 0.0 109.325 -179.971 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 141' ' ' PHE . . . . . 0.495 ' C ' ' O ' ' A' ' 154' ' ' LYS . 14.3 m-85 -109.22 152.02 25.74 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.448 1.093 . . . . 0.0 111.062 179.906 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 142' ' ' ASP . . . . . 0.502 ' CA ' ' O ' ' A' ' 154' ' ' LYS . 3.3 t70 -106.9 149.53 27.36 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.551 1.157 . . . . 0.0 109.353 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 143' ' ' PHE . . . . . 0.579 ' HB3' ' CZ ' ' A' ' 153' ' ' PHE . 8.0 t80 -174.28 25.4 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.419 1.074 . . . . 0.0 110.965 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 144' ' ' ASN . . . . . 0.542 ' C ' ' HA ' ' A' ' 152' ' ' PRO . 16.9 p30 36.67 -157.5 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.563 1.165 . . . . 0.0 109.279 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 145' ' ' GLY . . . . . 0.473 ' N ' ' OD1' ' A' ' 144' ' ' ASN . . . 164.2 112.77 0.28 Allowed Glycine 0 CA--C 1.53 0.987 0 O-C-N 124.564 1.165 . . . . 0.0 110.988 -179.956 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 -159.97 52.4 0.33 Allowed 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.459 0.74 . . . . 0.0 109.316 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 60.5 m-20 -162.49 149.16 13.14 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.503 1.127 . . . . 0.0 109.336 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 42.41 35.49 0.64 Allowed 'General case' 0 C--N 1.326 -0.447 0 O-C-N 124.43 1.081 . . . . 0.0 110.344 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 60.7 47.97 7.62 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.54 1.15 . . . . 0.0 110.268 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -84.54 146.97 27.28 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.446 1.091 . . . . 0.0 109.32 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.716 HD23 ' OD1' ' A' ' 174' ' ' ASP . 1.1 mp -92.16 112.7 56.33 Favored Pre-proline 0 C--N 1.325 -0.487 0 O-C-N 124.499 1.124 . . . . 0.0 109.328 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 152' ' ' PRO . . . . . 0.542 ' HA ' ' C ' ' A' ' 144' ' ' ASN . 18.4 Cg_endo -74.98 138.88 23.65 Favored 'Trans proline' 0 C--N 1.359 1.104 0 O-C-N 124.505 1.792 . . . . 0.0 110.977 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 153' ' ' PHE . . . . . 0.579 ' CZ ' ' HB3' ' A' ' 143' ' ' PHE . 11.7 p90 -151.82 170.2 20.37 Favored 'General case' 0 C--N 1.326 -0.437 0 O-C-N 124.441 1.088 . . . . 0.0 110.922 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 154' ' ' LYS . . . . . 0.502 ' O ' ' CA ' ' A' ' 142' ' ' ASP . 0.0 OUTLIER -127.02 -80.73 0.6 Allowed 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.484 1.115 . . . . 0.0 109.303 -179.979 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -165.77 115.51 1.01 Allowed 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.538 1.149 . . . . 0.0 109.34 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 156' ' ' GLY . . . . . 0.499 ' N ' ' O ' ' A' ' 139' ' ' ALA . . . 100.38 20.83 14.27 Favored Glycine 0 CA--C 1.53 1.017 0 O-C-N 124.437 1.086 . . . . 0.0 111.049 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 157' ' ' ASP . . . . . 0.422 ' HB3' ' HB3' ' A' ' 139' ' ' ALA . 23.1 t70 -84.59 155.23 22.14 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.488 0.757 . . . . 0.0 109.32 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 158' ' ' ILE . . . . . 0.48 HG23 ' CE2' ' A' ' 136' ' ' TYR . 13.1 mm -105.1 133.78 48.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 O-C-N 124.417 1.073 . . . . 0.0 109.342 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.834 ' O ' HG22 ' A' ' 137' ' ' VAL . 0.4 OUTLIER -142.96 124.93 15.19 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.538 1.149 . . . . 0.0 109.286 -179.976 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 160' ' ' ARG . . . . . 0.672 ' O ' ' HA ' ' A' ' 172' ' ' ALA . 0.0 OUTLIER -94.65 141.01 29.11 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.529 1.143 . . . . 0.0 110.271 179.992 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.442 ' HB ' ' HB2' ' A' ' 135' ' ' GLU . 19.9 mm -84.28 114.71 25.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 O-C-N 124.533 1.145 . . . . 0.0 109.313 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.47 -52.59 2.75 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.491 1.119 . . . . 0.0 110.293 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 11.8 t0 -136.34 174.7 10.33 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.451 1.094 . . . . 0.0 109.284 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 164' ' ' LYS . . . . . 0.564 ' HB2' ' CD1' ' A' ' 170' ' ' TRP . 0.0 OUTLIER -167.1 89.16 0.75 Allowed Pre-proline 0 C--N 1.325 -0.499 0 O-C-N 124.472 1.108 . . . . 0.0 109.299 -179.99 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.04 -34.2 3.97 Favored 'Trans proline' 0 C--N 1.36 1.166 0 O-C-N 124.532 1.806 . . . . 0.0 110.952 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -107.8 170.13 8.18 Favored 'General case' 0 C--N 1.324 -0.532 0 O-C-N 124.542 1.151 . . . . 0.0 110.28 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 18.7 pt-20 -95.36 -15.56 22.98 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.471 1.107 . . . . 0.0 110.355 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 168' ' ' GLN . . . . . 0.445 ' HG2' ' CD1' ' A' ' 169' ' ' TRP . 20.5 tt0 -92.41 -56.29 3.09 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.502 1.126 . . . . 0.0 110.333 179.952 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 169' ' ' TRP . . . . . 0.445 ' CD1' ' HG2' ' A' ' 168' ' ' GLN . 32.4 m95 -105.61 140.34 38.83 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.449 1.093 . . . . 0.0 108.064 179.934 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 170' ' ' TRP . . . . . 0.712 ' CD2' HG21 ' A' ' 184' ' ' VAL . 53.1 m0 -120.02 152.78 36.99 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.523 1.139 . . . . 0.0 107.98 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 171' ' ' ASN . . . . . 0.448 ' HA ' ' O ' ' A' ' 180' ' ' GLY . 0.6 OUTLIER -88.04 97.34 10.91 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.493 1.121 . . . . 0.0 109.268 179.976 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 172' ' ' ALA . . . . . 0.672 ' HA ' ' O ' ' A' ' 160' ' ' ARG . . . -107.47 173.17 6.44 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.51 1.131 . . . . 0.0 109.342 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 173' ' ' GLU . . . . . 0.442 ' O ' ' HA ' ' A' ' 159' ' ' LEU . 18.1 mt-10 -118.94 120.08 36.21 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.517 1.136 . . . . 0.0 110.329 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 174' ' ' ASP . . . . . 0.716 ' OD1' HD23 ' A' ' 151' ' ' LEU . 0.1 OUTLIER -74.34 -169.92 0.89 Allowed 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.468 1.105 . . . . 0.0 109.297 -179.952 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 72.6 p -81.3 59.79 4.11 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.441 1.088 . . . . 0.0 110.004 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 177.61 25.48 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.484 1.115 . . . . 0.0 110.266 -179.974 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 57.79 19.2 35.2 Favored Glycine 0 CA--C 1.531 1.043 0 O-C-N 124.534 1.146 . . . . 0.0 110.997 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 178' ' ' LYS . . . . . 0.52 ' O ' HD21 ' A' ' 151' ' ' LEU . 6.6 mtmt -81.28 104.06 11.49 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.504 0.767 . . . . 0.0 109.293 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 179' ' ' ARG . . . . . 0.45 ' HA ' ' O ' ' A' ' 172' ' ' ALA . 4.7 ttp180 -90.46 118.75 30.18 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.528 1.143 . . . . 0.0 110.288 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 180' ' ' GLY . . . . . 0.621 ' HA3' HD13 ' A' ' 151' ' ' LEU . . . -152.25 168.86 31.47 Favored Glycine 0 CA--C 1.531 1.032 0 O-C-N 124.612 1.195 . . . . 0.0 111.04 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 181' ' ' MET . . . . . 0.461 ' HA ' ' O ' ' A' ' 170' ' ' TRP . 1.5 mmm -85.98 106.76 17.38 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.546 0.792 . . . . 0.0 110.961 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 182' ' ' ILE . . . . . 0.505 ' CG2' ' HB2' ' A' ' 151' ' ' LEU . 1.4 pp -110.41 162.12 21.81 Favored Pre-proline 0 C--N 1.326 -0.446 0 O-C-N 124.515 1.134 . . . . 0.0 109.278 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 183' ' ' PRO . . . . . 0.705 ' HG2' ' HB2' ' A' ' 186' ' ' TYR . 18.6 Cg_endo -74.99 132.56 15.58 Favored 'Trans proline' 0 C--N 1.36 1.162 0 O-C-N 124.508 1.794 . . . . 0.0 111.05 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 184' ' ' VAL . . . . . 0.807 ' N ' ' CD ' ' A' ' 185' ' ' PRO . 62.1 t -78.94 -32.45 0.79 Allowed Pre-proline 0 C--N 1.324 -0.527 0 O-C-N 124.568 1.168 . . . . 0.0 109.332 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 185' ' ' PRO . . . . . 0.807 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.4 Cg_endo -74.96 -17.44 19.65 Favored 'Trans proline' 0 C--N 1.36 1.156 0 O-C-N 124.438 1.757 . . . . 0.0 111.006 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 186' ' ' TYR . . . . . 0.705 ' HB2' ' HG2' ' A' ' 183' ' ' PRO . 3.5 m-30 -97.25 17.7 16.72 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.496 1.123 . . . . 0.0 110.972 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 187' ' ' VAL . . . . . 0.43 HG12 ' CB ' ' A' ' 139' ' ' ALA . 16.7 m -145.44 173.61 3.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 O-C-N 124.515 1.134 . . . . 0.0 109.359 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 188' ' ' GLU . . . . . 0.955 ' OE2' HD21 ' A' ' 140' ' ' LEU . 0.1 OUTLIER -127.95 159.6 34.47 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.504 1.127 . . . . 0.0 110.245 -179.962 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 7.4 mmmm -88.18 135.84 33.25 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.433 1.083 . . . . 0.0 109.306 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 8.9 t80 -38.54 -62.8 0.56 Allowed 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.456 1.098 . . . . 0.0 111.02 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.977 0 O-C-N 124.531 1.144 . . . . 0.0 110.962 179.981 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 132' ' ' CYS . . . . . . . . . . . . . 52.4 m . . . . . 0 N--CA 1.452 -0.364 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -147.04 -90.31 0.09 OUTLIER Glycine 0 CA--C 1.53 1.01 0 O-C-N 124.485 1.116 . . . . 0.0 111.022 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 134' ' ' ALA . . . . . 0.42 ' C ' ' HG2' ' A' ' 135' ' ' GLU . . . -156.14 -78.13 0.09 Allowed 'General case' 0 C--N 1.326 -0.443 0 O-C-N 124.558 0.799 . . . . 0.0 109.299 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.459 ' CD ' HG22 ' A' ' 161' ' ' ILE . 1.5 mt-10 -145.16 44.03 1.32 Allowed 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.49 1.119 . . . . 0.0 110.248 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 136' ' ' TYR . . . . . 0.513 ' CE1' ' HB2' ' A' ' 160' ' ' ARG . 26.0 m-85 -86.86 106.55 17.82 Favored 'General case' 0 C--N 1.324 -0.527 0 O-C-N 124.491 1.119 . . . . 0.0 110.946 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.604 ' HA ' ' O ' ' A' ' 188' ' ' GLU . 19.8 m -117.19 138.39 48.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 O-C-N 124.502 1.126 . . . . 0.0 109.301 179.943 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 138' ' ' ARG . . . . . 0.43 ' HG2' ' CG ' ' A' ' 188' ' ' GLU . 0.0 OUTLIER -108.27 147.01 32.03 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.532 1.145 . . . . 0.0 110.275 -179.956 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.663 ' O ' ' N ' ' A' ' 156' ' ' GLY . . . -93.88 119.89 33.41 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.506 1.128 . . . . 0.0 109.336 179.955 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.52 HD11 ' HG2' ' A' ' 188' ' ' GLU . 1.1 mt -88.51 -3.46 58.81 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.472 1.108 . . . . 0.0 109.281 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 13.8 m-85 -139.96 154.34 47.16 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.433 1.083 . . . . 0.0 110.984 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 142' ' ' ASP . . . . . 0.495 ' CB ' ' HA ' ' A' ' 154' ' ' LYS . 10.8 p-10 -97.36 147.48 24.14 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.495 1.122 . . . . 0.0 109.285 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 143' ' ' PHE . . . . . 0.569 ' HB3' ' CZ ' ' A' ' 153' ' ' PHE . 1.7 t80 177.85 67.82 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.516 1.135 . . . . 0.0 111.001 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 144' ' ' ASN . . . . . 0.532 ' HA ' ' HA ' ' A' ' 152' ' ' PRO . 76.6 m-20 -38.71 154.69 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.484 1.115 . . . . 0.0 109.295 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -47.19 -98.05 0.01 OUTLIER Glycine 0 CA--C 1.53 1.018 0 O-C-N 124.488 1.118 . . . . 0.0 111.045 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 9.3 p-10 -170.67 -51.1 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.474 0.749 . . . . 0.0 109.283 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -122.83 -59.59 1.59 Allowed 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.471 1.107 . . . . 0.0 109.325 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 179.29 -36.02 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.535 1.147 . . . . 0.0 110.245 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -50.91 -34.25 27.67 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.549 1.156 . . . . 0.0 110.385 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -87.23 168.69 12.99 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.479 1.112 . . . . 0.0 109.312 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.937 ' HB3' HD12 ' A' ' 182' ' ' ILE . 8.4 tp -105.12 112.37 65.12 Favored Pre-proline 0 C--N 1.325 -0.468 0 O-C-N 124.425 1.078 . . . . 0.0 109.324 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 152' ' ' PRO . . . . . 0.532 ' HA ' ' HA ' ' A' ' 144' ' ' ASN . 18.4 Cg_endo -74.96 148.82 36.01 Favored 'Trans proline' 0 C--N 1.36 1.149 0 O-C-N 124.506 1.792 . . . . 0.0 110.996 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 153' ' ' PHE . . . . . 0.596 ' CZ ' ' CG ' ' A' ' 183' ' ' PRO . 30.0 p90 -150.45 172.36 15.57 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.512 1.132 . . . . 0.0 111.072 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 154' ' ' LYS . . . . . 0.495 ' HA ' ' CB ' ' A' ' 142' ' ' ASP . 0.1 OUTLIER -126.1 -166.64 1.59 Allowed 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.453 1.096 . . . . 0.0 109.331 -179.985 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 6.4 ptpt -95.65 105.63 17.64 Favored 'General case' 0 C--N 1.324 -0.531 0 O-C-N 124.545 1.153 . . . . 0.0 109.329 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 156' ' ' GLY . . . . . 0.663 ' N ' ' O ' ' A' ' 139' ' ' ALA . . . 106.75 27.72 5.34 Favored Glycine 0 CA--C 1.53 0.999 0 O-C-N 124.434 1.084 . . . . 0.0 110.993 -180.0 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 157' ' ' ASP . . . . . 0.405 ' O ' ' HA ' ' A' ' 138' ' ' ARG . 16.6 t70 -97.45 165.9 11.78 Favored 'General case' 0 C--N 1.324 -0.522 0 O-C-N 124.482 0.754 . . . . 0.0 109.27 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -123.96 138.83 52.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 O-C-N 124.507 1.13 . . . . 0.0 109.268 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.989 HD22 HD13 ' A' ' 182' ' ' ILE . 0.7 OUTLIER -147.13 130.28 16.46 Favored 'General case' 0 C--N 1.324 -0.54 0 O-C-N 124.579 1.174 . . . . 0.0 109.326 179.971 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 160' ' ' ARG . . . . . 0.513 ' HB2' ' CE1' ' A' ' 136' ' ' TYR . 0.0 OUTLIER -93.91 132.63 38.16 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.476 1.11 . . . . 0.0 110.308 179.982 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.583 ' CD1' HG22 ' A' ' 137' ' ' VAL . 1.6 mp -89.09 132.59 33.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 O-C-N 124.519 1.137 . . . . 0.0 109.327 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -127.01 -36.59 2.16 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.522 1.139 . . . . 0.0 110.263 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -132.68 169.66 16.34 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.455 1.097 . . . . 0.0 109.242 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 164' ' ' LYS . . . . . 0.588 ' HB2' ' CD1' ' A' ' 170' ' ' TRP . 0.0 OUTLIER -163.36 84.48 1.38 Allowed Pre-proline 0 C--N 1.326 -0.454 0 O-C-N 124.423 1.077 . . . . 0.0 109.334 -179.988 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.94 -25.54 11.9 Favored 'Trans proline' 0 C--N 1.361 1.194 0 O-C-N 124.56 1.821 . . . . 0.0 111.022 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -113.6 174.77 5.76 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.487 1.117 . . . . 0.0 110.292 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -99.71 -19.66 16.65 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.546 1.154 . . . . 0.0 110.317 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 3.6 mt-30 -88.18 -66.69 0.89 Allowed 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.41 1.069 . . . . 0.0 110.326 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 169' ' ' TRP . . . . . . . . . . . . . 6.5 m95 -95.49 153.17 17.83 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.537 1.148 . . . . 0.0 108.025 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 170' ' ' TRP . . . . . 0.699 ' CD2' HG21 ' A' ' 184' ' ' VAL . 43.2 m0 -126.03 153.93 43.7 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 -179.925 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 171' ' ' ASN . . . . . 0.417 ' HA ' ' O ' ' A' ' 180' ' ' GLY . 0.6 OUTLIER -86.97 104.23 16.08 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.459 1.099 . . . . 0.0 109.325 179.952 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 172' ' ' ALA . . . . . 0.462 ' HA ' ' O ' ' A' ' 160' ' ' ARG . . . -123.0 170.74 9.84 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.514 1.134 . . . . 0.0 109.319 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 173' ' ' GLU . . . . . 0.404 ' HA ' ' O ' ' A' ' 178' ' ' LYS . 3.9 mt-10 -115.93 126.48 53.95 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.505 1.128 . . . . 0.0 110.319 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 174' ' ' ASP . . . . . 0.513 ' HB3' HD21 ' A' ' 159' ' ' LEU . 0.9 OUTLIER -78.34 -174.18 3.62 Favored 'General case' 0 C--N 1.324 -0.543 0 O-C-N 124.491 1.12 . . . . 0.0 109.298 179.986 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 80.7 p -76.19 64.48 2.01 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.514 1.134 . . . . 0.0 109.932 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -177.27 0.22 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.453 1.096 . . . . 0.0 110.345 -179.974 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 79.12 12.59 83.87 Favored Glycine 0 CA--C 1.53 1.006 0 O-C-N 124.575 1.172 . . . . 0.0 110.931 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 178' ' ' LYS . . . . . 0.404 ' O ' ' HA ' ' A' ' 173' ' ' GLU . 0.0 OUTLIER -83.91 109.4 17.57 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.554 0.797 . . . . 0.0 109.272 -179.977 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 179' ' ' ARG . . . . . 0.435 ' HA ' ' O ' ' A' ' 172' ' ' ALA . 2.1 ttp85 -87.99 123.19 32.45 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.495 1.122 . . . . 0.0 110.242 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 180' ' ' GLY . . . . . 0.643 ' N ' HD22 ' A' ' 151' ' ' LEU . . . -151.25 172.03 30.83 Favored Glycine 0 CA--C 1.53 1.022 0 O-C-N 124.486 1.116 . . . . 0.0 110.96 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 181' ' ' MET . . . . . 0.458 ' HA ' ' O ' ' A' ' 170' ' ' TRP . 0.9 OUTLIER -87.73 93.77 9.54 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.507 0.769 . . . . 0.0 111.001 -179.987 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 182' ' ' ILE . . . . . 0.989 HD13 HD22 ' A' ' 159' ' ' LEU . 0.0 OUTLIER -91.79 158.17 40.45 Favored Pre-proline 0 C--N 1.325 -0.497 0 O-C-N 124.459 1.099 . . . . 0.0 109.316 179.969 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 183' ' ' PRO . . . . . 0.688 ' HG2' ' HB2' ' A' ' 186' ' ' TYR . 18.2 Cg_endo -74.97 131.44 14.33 Favored 'Trans proline' 0 C--N 1.361 1.206 0 O-C-N 124.438 1.757 . . . . 0.0 111.026 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 184' ' ' VAL . . . . . 0.813 ' N ' ' CD ' ' A' ' 185' ' ' PRO . 85.9 t -79.96 -31.91 0.69 Allowed Pre-proline 0 C--N 1.325 -0.46 0 O-C-N 124.435 1.084 . . . . 0.0 109.265 180.0 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 185' ' ' PRO . . . . . 0.813 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.3 Cg_endo -74.99 -25.2 12.12 Favored 'Trans proline' 0 C--N 1.359 1.103 0 O-C-N 124.526 1.803 . . . . 0.0 111.002 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 186' ' ' TYR . . . . . 0.688 ' HB2' ' HG2' ' A' ' 183' ' ' PRO . 7.9 m-85 -92.83 16.64 12.01 Favored 'General case' 0 C--N 1.326 -0.431 0 O-C-N 124.498 1.124 . . . . 0.0 111.038 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 187' ' ' VAL . . . . . 0.557 HG22 ' O ' ' A' ' 183' ' ' PRO . 27.4 m -141.78 170.57 12.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 O-C-N 124.535 1.147 . . . . 0.0 109.317 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 188' ' ' GLU . . . . . 0.604 ' O ' ' HA ' ' A' ' 137' ' ' VAL . 0.0 OUTLIER -131.76 155.91 46.89 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.53 1.144 . . . . 0.0 110.295 -179.997 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 189' ' ' LYS . . . . . 0.477 ' HA ' HG12 ' A' ' 137' ' ' VAL . 0.0 OUTLIER -88.62 132.36 34.59 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.513 1.133 . . . . 0.0 109.21 -179.956 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 190' ' ' TYR . . . . . 0.565 ' CE1' ' OE2' ' A' ' 188' ' ' GLU . 0.1 OUTLIER -109.15 -61.46 1.62 Allowed 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.502 1.126 . . . . 0.0 110.977 179.964 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.919 0 O-C-N 124.533 1.146 . . . . 0.0 110.998 -179.962 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 132' ' ' CYS . . . . . . . . . . . . . 1.7 t . . . . . 0 N--CA 1.453 -0.322 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 150.68 -118.53 0.93 Allowed Glycine 0 CA--C 1.529 0.928 0 O-C-N 124.418 1.073 . . . . 0.0 110.996 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -168.97 -64.06 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.492 0.76 . . . . 0.0 109.275 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.801 ' HG2' HG22 ' A' ' 161' ' ' ILE . 2.4 mp0 -153.69 76.31 1.07 Allowed 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.455 1.097 . . . . 0.0 110.303 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 31.7 m-85 -126.11 131.93 51.98 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.434 1.084 . . . . 0.0 111.078 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.632 ' CG2' HG23 ' A' ' 187' ' ' VAL . 0.7 OUTLIER -132.68 127.82 56.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 O-C-N 124.516 1.135 . . . . 0.0 109.329 -179.931 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 138' ' ' ARG . . . . . 0.468 ' O ' ' HA ' ' A' ' 187' ' ' VAL . 0.0 OUTLIER -96.03 134.15 39.41 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.501 1.126 . . . . 0.0 110.371 -179.988 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.625 ' CB ' HG12 ' A' ' 187' ' ' VAL . . . -96.35 109.47 21.98 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.52 1.138 . . . . 0.0 109.279 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.624 HD11 ' HG2' ' A' ' 188' ' ' GLU . 0.2 OUTLIER -89.91 -31.79 17.13 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.483 1.115 . . . . 0.0 109.284 179.996 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 141' ' ' PHE . . . . . 0.505 ' O ' ' CD1' ' A' ' 153' ' ' PHE . 71.2 m-85 -88.53 152.62 21.74 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.529 1.143 . . . . 0.0 111.007 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 142' ' ' ASP . . . . . 0.507 ' HA ' ' O ' ' A' ' 154' ' ' LYS . 0.0 OUTLIER -105.86 141.44 37.27 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.497 1.123 . . . . 0.0 109.36 179.942 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 143' ' ' PHE . . . . . 0.644 ' HB3' ' CZ ' ' A' ' 153' ' ' PHE . 5.5 t80 179.73 57.31 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.502 1.126 . . . . 0.0 111.01 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 144' ' ' ASN . . . . . 0.491 ' HA ' ' CA ' ' A' ' 152' ' ' PRO . 15.9 p-10 -36.96 -49.03 0.8 Allowed 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.5 1.125 . . . . 0.0 109.294 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 91.03 -110.4 3.82 Favored Glycine 0 CA--C 1.53 1.023 0 O-C-N 124.515 1.135 . . . . 0.0 110.977 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 9.1 t30 177.08 51.5 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.498 0.764 . . . . 0.0 109.331 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 147' ' ' ASP . . . . . 0.416 ' O ' ' CB ' ' A' ' 148' ' ' GLU . 5.1 p-10 45.12 -161.07 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.469 1.106 . . . . 0.0 109.332 -179.92 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.416 ' CB ' ' O ' ' A' ' 147' ' ' ASP . 0.0 OUTLIER 79.68 50.98 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.527 1.142 . . . . 0.0 110.315 -179.998 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 76.75 40.79 0.19 Allowed 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.495 1.122 . . . . 0.0 110.334 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 34.0 m-20 -154.96 115.17 3.82 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.442 1.089 . . . . 0.0 109.243 -179.885 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.902 HD13 ' HA3' ' A' ' 180' ' ' GLY . 1.3 mp -78.39 119.81 78.71 Favored Pre-proline 0 C--N 1.323 -0.553 0 O-C-N 124.595 1.184 . . . . 0.0 109.264 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 152' ' ' PRO . . . . . 0.491 ' CA ' ' HA ' ' A' ' 144' ' ' ASN . 18.0 Cg_endo -75.07 133.8 16.91 Favored 'Trans proline' 0 C--N 1.359 1.131 0 O-C-N 124.533 1.807 . . . . 0.0 110.986 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 153' ' ' PHE . . . . . 0.644 ' CZ ' ' HB3' ' A' ' 143' ' ' PHE . 28.9 p90 -134.86 179.12 6.5 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.426 1.079 . . . . 0.0 111.055 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 154' ' ' LYS . . . . . 0.507 ' O ' ' HA ' ' A' ' 142' ' ' ASP . 5.6 ttmt -127.25 -99.51 0.37 Allowed 'General case' 0 C--N 1.324 -0.53 0 O-C-N 124.554 1.159 . . . . 0.0 109.301 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 17.2 ttpp -156.09 118.82 4.16 Favored 'General case' 0 C--N 1.326 -0.443 0 O-C-N 124.445 1.09 . . . . 0.0 109.353 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 156' ' ' GLY . . . . . 0.494 ' N ' ' O ' ' A' ' 139' ' ' ALA . . . 97.46 15.06 39.04 Favored Glycine 0 CA--C 1.53 1.023 0 O-C-N 124.572 1.17 . . . . 0.0 110.948 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 157' ' ' ASP . . . . . 0.5 ' C ' HD12 ' A' ' 158' ' ' ILE . 8.9 t0 -83.83 163.28 20.22 Favored 'General case' 0 C--N 1.324 -0.523 0 O-C-N 124.479 0.752 . . . . 0.0 109.254 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 158' ' ' ILE . . . . . 0.501 HD12 ' N ' ' A' ' 158' ' ' ILE . 3.5 mp -119.01 148.74 21.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 O-C-N 124.473 1.108 . . . . 0.0 109.29 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.725 HD21 ' OD1' ' A' ' 174' ' ' ASP . 0.7 OUTLIER -147.43 130.88 16.69 Favored 'General case' 0 C--N 1.326 -0.443 0 O-C-N 124.468 1.105 . . . . 0.0 109.303 -179.953 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 160' ' ' ARG . . . . . 0.684 ' O ' ' HA ' ' A' ' 172' ' ' ALA . 3.7 tpp180 -87.45 127.37 35.23 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.523 1.14 . . . . 0.0 110.273 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.801 HG22 ' HG2' ' A' ' 135' ' ' GLU . 1.5 mp -82.37 119.23 31.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 O-C-N 124.434 1.084 . . . . 0.0 109.305 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 162' ' ' ARG . . . . . 0.484 ' NH1' ' OD2' ' A' ' 163' ' ' ASP . 1.0 OUTLIER -115.25 -48.89 2.79 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.467 1.105 . . . . 0.0 110.345 179.952 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 163' ' ' ASP . . . . . 0.484 ' OD2' ' NH1' ' A' ' 162' ' ' ARG . 67.4 m-20 -141.54 171.34 14.2 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.485 1.116 . . . . 0.0 109.291 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 164' ' ' LYS . . . . . 0.591 ' HB3' ' CD1' ' A' ' 170' ' ' TRP . 14.5 mtmm -138.71 58.46 13.84 Favored Pre-proline 0 C--N 1.325 -0.486 0 O-C-N 124.521 1.138 . . . . 0.0 109.309 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 165' ' ' PRO . . . . . 0.541 ' HD3' ' N ' ' A' ' 164' ' ' LYS . 18.5 Cg_endo -74.99 76.41 3.4 Favored 'Trans proline' 0 C--N 1.36 1.163 0 O-C-N 124.455 1.766 . . . . 0.0 111.02 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 166' ' ' GLU . . . . . 0.47 ' CB ' ' O ' ' A' ' 165' ' ' PRO . 1.5 mt-10 162.77 177.24 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.547 1.155 . . . . 0.0 110.296 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -117.08 42.68 2.47 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.433 1.083 . . . . 0.0 110.277 -179.923 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER 178.29 -51.53 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.493 1.121 . . . . 0.0 110.306 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 169' ' ' TRP . . . . . . . . . . . . . 7.2 m95 -95.29 144.05 26.18 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 170' ' ' TRP . . . . . 0.789 ' CD2' HG21 ' A' ' 184' ' ' VAL . 48.6 m0 -120.45 149.82 41.78 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.474 1.109 . . . . 0.0 108.02 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 171' ' ' ASN . . . . . 0.417 ' HA ' ' O ' ' A' ' 180' ' ' GLY . 1.2 t-20 -86.6 98.99 11.4 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.428 1.08 . . . . 0.0 109.322 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 172' ' ' ALA . . . . . 0.684 ' HA ' ' O ' ' A' ' 160' ' ' ARG . . . -116.04 171.41 7.81 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.474 1.109 . . . . 0.0 109.239 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 173' ' ' GLU . . . . . 0.484 ' HG3' ' CG ' ' A' ' 179' ' ' ARG . 5.2 mt-10 -115.89 117.4 30.08 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.493 1.12 . . . . 0.0 110.326 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 174' ' ' ASP . . . . . 0.725 ' OD1' HD21 ' A' ' 159' ' ' LEU . 0.1 OUTLIER -68.28 -164.28 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.559 1.162 . . . . 0.0 109.355 179.969 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 88.1 p -85.09 60.03 5.99 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.444 1.09 . . . . 0.0 109.905 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -178.95 18.62 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.418 1.074 . . . . 0.0 110.286 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 63.54 14.96 56.52 Favored Glycine 0 CA--C 1.531 1.038 0 O-C-N 124.605 1.19 . . . . 0.0 110.999 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 178' ' ' LYS . . . . . 0.588 ' O ' HD21 ' A' ' 151' ' ' LEU . 1.5 mttt -80.51 105.59 11.87 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.495 0.762 . . . . 0.0 109.255 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 179' ' ' ARG . . . . . 0.484 ' CG ' ' HG3' ' A' ' 173' ' ' GLU . 0.0 OUTLIER -89.58 118.29 29.1 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.488 1.118 . . . . 0.0 110.243 -179.997 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 180' ' ' GLY . . . . . 0.902 ' HA3' HD13 ' A' ' 151' ' ' LEU . . . -151.55 171.09 31.09 Favored Glycine 0 CA--C 1.53 1.026 0 O-C-N 124.54 1.15 . . . . 0.0 111.004 179.938 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 181' ' ' MET . . . . . 0.451 ' CE ' ' HD2' ' A' ' 165' ' ' PRO . 0.4 OUTLIER -88.81 103.73 16.26 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.524 0.779 . . . . 0.0 110.926 -179.926 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 182' ' ' ILE . . . . . 0.598 HG22 ' HB2' ' A' ' 151' ' ' LEU . 0.0 OUTLIER -107.36 165.72 12.31 Favored Pre-proline 0 C--N 1.325 -0.495 0 O-C-N 124.49 1.119 . . . . 0.0 109.298 -179.998 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 183' ' ' PRO . . . . . 0.6 ' HG2' ' HB2' ' A' ' 186' ' ' TYR . 18.3 Cg_endo -75.02 131.38 14.2 Favored 'Trans proline' 0 C--N 1.359 1.088 0 O-C-N 124.534 1.807 . . . . 0.0 110.984 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 184' ' ' VAL . . . . . 0.803 ' N ' ' CD ' ' A' ' 185' ' ' PRO . 90.5 t -79.92 -33.64 0.8 Allowed Pre-proline 0 C--N 1.326 -0.447 0 O-C-N 124.529 1.143 . . . . 0.0 109.28 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 185' ' ' PRO . . . . . 0.803 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.3 Cg_endo -74.93 -13.87 21.46 Favored 'Trans proline' 0 C--N 1.361 1.194 0 O-C-N 124.517 1.798 . . . . 0.0 111.054 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 186' ' ' TYR . . . . . 0.6 ' HB2' ' HG2' ' A' ' 183' ' ' PRO . 8.8 m-85 -95.96 4.98 52.26 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.458 1.098 . . . . 0.0 110.983 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 187' ' ' VAL . . . . . 0.632 HG23 ' CG2' ' A' ' 137' ' ' VAL . 25.0 m -136.18 170.25 19.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 O-C-N 124.424 1.078 . . . . 0.0 109.319 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 188' ' ' GLU . . . . . 0.624 ' HG2' HD11 ' A' ' 140' ' ' LEU . 0.0 OUTLIER -121.82 155.27 35.69 Favored 'General case' 0 C--N 1.326 -0.432 0 O-C-N 124.426 1.079 . . . . 0.0 110.26 -179.994 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.44 126.75 35.07 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.527 1.142 . . . . 0.0 109.259 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -120.66 106.94 12.21 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.455 1.097 . . . . 0.0 111.017 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 1.005 0 O-C-N 124.551 1.157 . . . . 0.0 111.015 179.962 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 132' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.453 -0.315 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 178.96 110.38 0.28 Allowed Glycine 0 CA--C 1.53 1.001 0 O-C-N 124.493 1.121 . . . . 0.0 110.98 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -175.78 -156.98 0.05 Allowed 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.513 0.772 . . . . 0.0 109.309 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.46 ' O ' ' HA ' ' A' ' 160' ' ' ARG . 0.4 OUTLIER -119.1 63.06 0.79 Allowed 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.455 1.097 . . . . 0.0 110.33 179.978 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 136' ' ' TYR . . . . . 0.471 ' CE2' HG21 ' A' ' 158' ' ' ILE . 0.1 OUTLIER -127.72 113.8 16.48 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.416 1.072 . . . . 0.0 111.012 -179.973 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.511 HG13 HD13 ' A' ' 161' ' ' ILE . 16.0 m -108.17 137.18 40.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 O-C-N 124.539 1.149 . . . . 0.0 109.275 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 138' ' ' ARG . . . . . 0.427 ' O ' ' HA ' ' A' ' 187' ' ' VAL . 6.4 ttm180 -101.89 128.83 48.1 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.529 1.143 . . . . 0.0 110.3 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.867 ' HB3' ' HB3' ' A' ' 157' ' ' ASP . . . -88.52 103.69 16.12 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 124.557 1.16 . . . . 0.0 109.267 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.715 HD11 ' HB3' ' A' ' 188' ' ' GLU . 0.2 OUTLIER -90.41 -29.06 18.23 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.464 1.102 . . . . 0.0 109.26 179.984 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 141' ' ' PHE . . . . . 0.498 ' C ' ' O ' ' A' ' 154' ' ' LYS . 27.0 m-85 -92.16 151.22 20.49 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.498 1.124 . . . . 0.0 110.951 -179.907 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -98.37 143.19 29.1 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.508 1.13 . . . . 0.0 109.322 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 143' ' ' PHE . . . . . 0.629 ' HB3' ' CE1' ' A' ' 153' ' ' PHE . 0.3 OUTLIER -132.32 -33.92 1.26 Allowed 'General case' 0 C--N 1.324 -0.523 0 O-C-N 124.442 1.089 . . . . 0.0 111.002 -179.978 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 144' ' ' ASN . . . . . 0.401 ' O ' ' O ' ' A' ' 143' ' ' PHE . 40.0 t-20 62.15 134.83 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.452 1.095 . . . . 0.0 109.313 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 145' ' ' GLY . . . . . 0.438 ' N ' ' HB3' ' A' ' 152' ' ' PRO . . . -157.74 -179.54 32.71 Favored Glycine 0 CA--C 1.53 1.009 0 O-C-N 124.486 1.116 . . . . 0.0 110.97 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 146' ' ' ASN . . . . . 0.436 ' CB ' ' O ' ' A' ' 145' ' ' GLY . 3.9 m-20 161.37 66.31 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.439 0.729 . . . . 0.0 109.354 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -119.22 -85.76 0.65 Allowed 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.469 1.106 . . . . 0.0 109.275 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 168.36 46.36 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.537 1.148 . . . . 0.0 110.256 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 179.45 -46.21 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.511 1.132 . . . . 0.0 110.321 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -67.05 164.31 18.1 Favored 'General case' 0 C--N 1.326 -0.415 0 O-C-N 124.444 1.09 . . . . 0.0 109.316 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 1.038 ' CB ' HD12 ' A' ' 182' ' ' ILE . 0.6 OUTLIER -114.2 103.92 54.93 Favored Pre-proline 0 C--N 1.326 -0.434 0 O-C-N 124.557 1.161 . . . . 0.0 109.288 179.996 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 152' ' ' PRO . . . . . 0.438 ' HB3' ' N ' ' A' ' 145' ' ' GLY . 18.3 Cg_endo -74.93 132.72 15.85 Favored 'Trans proline' 0 C--N 1.36 1.163 0 O-C-N 124.497 1.788 . . . . 0.0 110.986 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 153' ' ' PHE . . . . . 0.681 ' HD2' HD11 ' A' ' 182' ' ' ILE . 20.5 p90 -149.04 174.92 11.79 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.551 1.157 . . . . 0.0 110.95 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 154' ' ' LYS . . . . . 0.498 ' O ' ' C ' ' A' ' 141' ' ' PHE . 1.2 ttmm -127.32 -83.73 0.61 Allowed 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.471 1.107 . . . . 0.0 109.364 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -161.46 113.52 1.81 Allowed 'General case' 0 C--N 1.326 -0.431 0 O-C-N 124.378 1.048 . . . . 0.0 109.312 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 156' ' ' GLY . . . . . 0.568 ' N ' ' O ' ' A' ' 139' ' ' ALA . . . 108.38 16.08 12.79 Favored Glycine 0 CA--C 1.53 1.022 0 O-C-N 124.435 1.084 . . . . 0.0 111.041 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 157' ' ' ASP . . . . . 0.867 ' HB3' ' HB3' ' A' ' 139' ' ' ALA . 24.6 t70 -81.27 158.06 24.93 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.55 0.794 . . . . 0.0 109.336 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 158' ' ' ILE . . . . . 0.471 HG21 ' CE2' ' A' ' 136' ' ' TYR . 7.5 mm -119.35 133.21 66.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 O-C-N 124.468 1.105 . . . . 0.0 109.328 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.815 HD22 HD13 ' A' ' 182' ' ' ILE . 0.1 OUTLIER -138.07 128.71 26.61 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.48 1.113 . . . . 0.0 109.316 -179.953 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 160' ' ' ARG . . . . . 0.59 ' O ' ' HA ' ' A' ' 172' ' ' ALA . 1.5 ttp180 -90.1 131.18 36.1 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.426 1.079 . . . . 0.0 110.271 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.511 HD13 HG13 ' A' ' 137' ' ' VAL . 1.3 mp -82.82 120.7 34.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 O-C-N 124.482 1.114 . . . . 0.0 109.353 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 3.5 mtp180 -114.41 -56.91 2.34 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.494 1.122 . . . . 0.0 110.245 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -123.83 161.41 25.34 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.478 1.111 . . . . 0.0 109.295 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 164' ' ' LYS . . . . . 0.628 ' CD ' ' CE2' ' A' ' 170' ' ' TRP . 2.6 ttpt -144.95 76.0 13.92 Favored Pre-proline 0 C--N 1.326 -0.451 0 O-C-N 124.506 1.128 . . . . 0.0 109.33 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.96 -33.07 4.91 Favored 'Trans proline' 0 C--N 1.36 1.145 0 O-C-N 124.527 1.804 . . . . 0.0 111.0 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 166' ' ' GLU . . . . . 0.406 ' O ' ' CD1' ' A' ' 170' ' ' TRP . 2.9 mt-10 -114.18 163.8 14.73 Favored 'General case' 0 C--N 1.324 -0.536 0 O-C-N 124.569 1.168 . . . . 0.0 110.282 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -88.64 -23.35 23.07 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.446 1.092 . . . . 0.0 110.283 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 168' ' ' GLN . . . . . 0.527 ' O ' HG23 ' A' ' 184' ' ' VAL . 3.9 mt-30 -87.03 -69.92 0.65 Allowed 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.499 1.125 . . . . 0.0 110.331 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 169' ' ' TRP . . . . . . . . . . . . . 5.8 m95 -94.1 141.35 28.64 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 170' ' ' TRP . . . . . 0.692 ' CE2' HG21 ' A' ' 184' ' ' VAL . 50.8 m0 -120.15 153.24 36.49 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.517 1.135 . . . . 0.0 107.957 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 171' ' ' ASN . . . . . 0.411 ' HA ' ' O ' ' A' ' 180' ' ' GLY . 1.3 t-20 -86.67 92.63 8.99 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.503 1.127 . . . . 0.0 109.334 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 172' ' ' ALA . . . . . 0.59 ' HA ' ' O ' ' A' ' 160' ' ' ARG . . . -109.21 176.66 5.01 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.507 1.129 . . . . 0.0 109.317 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 173' ' ' GLU . . . . . 0.406 ' HA ' ' O ' ' A' ' 178' ' ' LYS . 30.2 mt-10 -123.06 123.4 40.77 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.496 1.122 . . . . 0.0 110.331 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 174' ' ' ASP . . . . . 0.513 ' OD2' ' CD2' ' A' ' 151' ' ' LEU . 1.4 p30 -73.79 -171.46 1.07 Allowed 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.475 1.109 . . . . 0.0 109.369 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -83.21 64.48 7.74 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.458 1.099 . . . . 0.0 110.063 179.958 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -176.22 8.25 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.559 1.162 . . . . 0.0 110.279 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 69.03 29.26 72.41 Favored Glycine 0 CA--C 1.53 0.985 0 O-C-N 124.453 1.095 . . . . 0.0 111.03 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 178' ' ' LYS . . . . . 0.406 ' O ' ' HA ' ' A' ' 173' ' ' GLU . 8.4 mtpt -103.86 115.27 30.15 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.518 0.775 . . . . 0.0 109.346 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 179' ' ' ARG . . . . . 0.476 ' HA ' ' O ' ' A' ' 172' ' ' ALA . 8.9 ttp180 -88.95 128.03 35.68 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.5 1.125 . . . . 0.0 110.316 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 180' ' ' GLY . . . . . 0.568 ' CA ' HD11 ' A' ' 151' ' ' LEU . . . -151.71 170.34 31.18 Favored Glycine 0 CA--C 1.53 1.025 0 O-C-N 124.527 1.142 . . . . 0.0 110.991 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 181' ' ' MET . . . . . 0.439 ' HA ' ' O ' ' A' ' 170' ' ' TRP . 0.2 OUTLIER -92.13 99.47 12.27 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.49 0.759 . . . . 0.0 111.039 179.987 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 182' ' ' ILE . . . . . 1.038 HD12 ' CB ' ' A' ' 151' ' ' LEU . 0.6 OUTLIER -103.78 151.64 38.85 Favored Pre-proline 0 C--N 1.324 -0.504 0 O-C-N 124.482 1.114 . . . . 0.0 109.311 -179.976 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 183' ' ' PRO . . . . . 0.658 ' HD2' ' CG1' ' A' ' 182' ' ' ILE . 18.4 Cg_endo -74.99 134.19 17.53 Favored 'Trans proline' 0 C--N 1.359 1.109 0 O-C-N 124.441 1.759 . . . . 0.0 110.979 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 184' ' ' VAL . . . . . 0.858 ' N ' ' CD ' ' A' ' 185' ' ' PRO . 21.6 t -75.8 -29.14 0.79 Allowed Pre-proline 0 C--N 1.326 -0.441 0 O-C-N 124.398 1.061 . . . . 0.0 109.286 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 185' ' ' PRO . . . . . 0.858 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.5 Cg_endo -74.87 -13.68 21.65 Favored 'Trans proline' 0 C--N 1.36 1.146 0 O-C-N 124.477 1.777 . . . . 0.0 111.037 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 186' ' ' TYR . . . . . 0.635 ' HB2' ' HG2' ' A' ' 183' ' ' PRO . 8.2 m-85 -98.54 4.56 48.21 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.476 1.11 . . . . 0.0 111.009 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 187' ' ' VAL . . . . . 0.47 HG11 ' CD1' ' A' ' 159' ' ' LEU . 19.2 m -137.05 171.09 16.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 O-C-N 124.547 1.154 . . . . 0.0 109.312 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 188' ' ' GLU . . . . . 0.715 ' HB3' HD11 ' A' ' 140' ' ' LEU . 1.5 pp20? -125.89 176.76 6.74 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.458 1.099 . . . . 0.0 110.259 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -93.44 112.39 24.28 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.522 1.139 . . . . 0.0 109.335 179.958 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 190' ' ' TYR . . . . . 0.45 ' C ' ' CD1' ' A' ' 190' ' ' TYR . 0.8 OUTLIER -48.22 -77.96 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.53 1.144 . . . . 0.0 111.027 -179.99 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.993 0 O-C-N 124.472 1.108 . . . . 0.0 110.997 -179.963 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 132' ' ' CYS . . . . . 0.453 ' O ' ' O ' ' A' ' 191' ' ' GLY . 7.6 m . . . . . 0 N--CA 1.452 -0.364 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -138.32 71.87 0.45 Allowed Glycine 0 CA--C 1.53 0.993 0 O-C-N 124.466 1.104 . . . . 0.0 110.964 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 134' ' ' ALA . . . . . 0.453 ' C ' ' HG2' ' A' ' 135' ' ' GLU . . . -115.93 -74.72 0.6 Allowed 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.415 0.715 . . . . 0.0 109.33 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.456 ' HB2' ' O ' ' A' ' 161' ' ' ILE . 5.1 pt-20 169.76 61.37 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.502 1.126 . . . . 0.0 110.262 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 136' ' ' TYR . . . . . 0.433 ' CE2' ' HB3' ' A' ' 134' ' ' ALA . 95.6 m-85 -123.81 118.9 28.19 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.487 1.117 . . . . 0.0 110.99 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.645 ' HB ' HD13 ' A' ' 161' ' ' ILE . 0.9 OUTLIER -121.83 123.04 68.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 O-C-N 124.543 1.152 . . . . 0.0 109.275 -179.969 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 138' ' ' ARG . . . . . 0.537 ' O ' ' HA ' ' A' ' 187' ' ' VAL . 12.1 ttm180 -87.45 150.29 23.87 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.489 1.118 . . . . 0.0 110.299 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.521 ' HB2' HG12 ' A' ' 187' ' ' VAL . . . -113.75 108.48 17.16 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.499 1.125 . . . . 0.0 109.317 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.807 HD21 ' OE2' ' A' ' 188' ' ' GLU . 0.0 OUTLIER -93.5 -7.56 43.98 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.607 1.192 . . . . 0.0 109.262 -179.991 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 59.9 m-85 -113.78 164.11 14.16 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.554 1.159 . . . . 0.0 110.955 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 142' ' ' ASP . . . . . 0.462 ' N ' ' OD1' ' A' ' 142' ' ' ASP . 0.0 OUTLIER -115.01 148.46 38.8 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.493 1.121 . . . . 0.0 109.299 179.942 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 143' ' ' PHE . . . . . 0.596 ' HB3' ' CZ ' ' A' ' 153' ' ' PHE . 16.1 t80 -167.86 30.32 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.51 1.131 . . . . 0.0 111.024 -179.955 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 144' ' ' ASN . . . . . 0.442 ' HA ' ' HA ' ' A' ' 152' ' ' PRO . 14.8 p-10 -58.07 119.64 7.16 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.391 1.057 . . . . 0.0 109.351 180.0 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 145' ' ' GLY . . . . . 0.515 ' O ' ' ND2' ' A' ' 146' ' ' ASN . . . 101.18 99.0 2.35 Favored Glycine 0 CA--C 1.53 0.994 0 O-C-N 124.473 1.108 . . . . 0.0 111.038 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 146' ' ' ASN . . . . . 0.591 ' ND2' ' CE2' ' A' ' 143' ' ' PHE . 4.5 m120 -146.16 -49.18 0.21 Allowed 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.479 0.752 . . . . 0.0 109.267 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 28.0 m-20 -165.09 164.72 20.32 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.588 1.18 . . . . 0.0 109.325 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -65.85 -20.12 66.13 Favored 'General case' 0 C--N 1.323 -0.557 0 O-C-N 124.571 1.169 . . . . 0.0 110.312 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -96.36 -32.19 12.49 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.462 1.101 . . . . 0.0 110.263 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 150' ' ' ASP . . . . . 0.466 ' CB ' ' HB2' ' A' ' 146' ' ' ASN . 0.2 OUTLIER -61.3 167.46 3.19 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.527 1.142 . . . . 0.0 109.272 179.952 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.984 HD23 ' OD1' ' A' ' 174' ' ' ASP . 1.2 tp -120.44 119.21 30.61 Favored Pre-proline 0 C--N 1.325 -0.474 0 O-C-N 124.535 1.147 . . . . 0.0 109.361 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 152' ' ' PRO . . . . . 0.442 ' HA ' ' HA ' ' A' ' 144' ' ' ASN . 18.2 Cg_endo -74.98 137.36 21.66 Favored 'Trans proline' 0 C--N 1.359 1.131 0 O-C-N 124.509 1.794 . . . . 0.0 110.959 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 153' ' ' PHE . . . . . 0.596 ' CZ ' ' HB3' ' A' ' 143' ' ' PHE . 21.8 p90 -150.41 173.75 13.68 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.49 1.119 . . . . 0.0 111.028 179.899 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 154' ' ' LYS . . . . . 0.417 ' HA ' ' HA ' ' A' ' 142' ' ' ASP . 1.6 tttm -132.09 -169.36 2.2 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.549 1.155 . . . . 0.0 109.319 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.498 ' CB ' ' O ' ' A' ' 140' ' ' LEU . 9.6 ptpt -89.31 111.17 21.94 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.517 1.136 . . . . 0.0 109.301 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 117.3 8.24 11.58 Favored Glycine 0 CA--C 1.529 0.96 0 O-C-N 124.486 1.116 . . . . 0.0 111.05 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 157' ' ' ASP . . . . . 0.432 ' CG ' ' N ' ' A' ' 158' ' ' ILE . 14.5 t0 -91.12 172.63 8.42 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.512 0.772 . . . . 0.0 109.277 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 158' ' ' ILE . . . . . 0.433 ' C ' ' HG ' ' A' ' 159' ' ' LEU . 3.2 mt -140.27 142.55 31.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 O-C-N 124.547 1.154 . . . . 0.0 109.332 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.588 ' CD1' HG11 ' A' ' 187' ' ' VAL . 0.1 OUTLIER -136.93 141.23 42.67 Favored 'General case' 0 C--N 1.324 -0.533 0 O-C-N 124.555 1.159 . . . . 0.0 109.328 179.997 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 160' ' ' ARG . . . . . 0.481 ' O ' ' HA ' ' A' ' 172' ' ' ALA . 15.2 ttm105 -87.86 134.91 33.6 Favored 'General case' 0 C--N 1.326 -0.437 0 O-C-N 124.581 1.176 . . . . 0.0 110.333 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.645 HD13 ' HB ' ' A' ' 137' ' ' VAL . 1.0 OUTLIER -83.53 109.81 17.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 O-C-N 124.536 1.148 . . . . 0.0 109.321 179.969 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 162' ' ' ARG . . . . . 0.452 ' HG3' ' CG ' ' A' ' 179' ' ' ARG . 20.8 mmm180 -90.68 -59.34 2.2 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.546 1.154 . . . . 0.0 110.303 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 163' ' ' ASP . . . . . 0.515 ' N ' ' OD1' ' A' ' 171' ' ' ASN . 0.7 OUTLIER -151.34 144.53 24.69 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.481 1.113 . . . . 0.0 109.32 179.963 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 164' ' ' LYS . . . . . 0.598 ' CB ' ' CG ' ' A' ' 170' ' ' TRP . 0.6 OUTLIER -128.02 78.38 75.36 Favored Pre-proline 0 C--N 1.325 -0.475 0 O-C-N 124.494 1.121 . . . . 0.0 109.307 -179.942 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.03 -48.08 0.18 Allowed 'Trans proline' 0 C--N 1.359 1.116 0 O-C-N 124.51 1.795 . . . . 0.0 110.914 -179.925 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 13.7 mp0 -69.68 176.23 3.7 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.402 1.064 . . . . 0.0 110.322 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -115.24 51.44 0.92 Allowed 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.547 1.154 . . . . 0.0 110.29 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 168' ' ' GLN . . . . . 0.476 ' HB3' ' CD1' ' A' ' 169' ' ' TRP . 3.3 mt-30 -179.25 -55.58 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.582 1.176 . . . . 0.0 110.278 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 169' ' ' TRP . . . . . 0.476 ' CD1' ' HB3' ' A' ' 168' ' ' GLN . 12.2 m95 -108.91 133.05 53.44 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.491 1.12 . . . . 0.0 107.995 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 170' ' ' TRP . . . . . 0.743 ' CE2' HG21 ' A' ' 184' ' ' VAL . 26.6 m0 -120.8 154.66 35.43 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 171' ' ' ASN . . . . . 0.515 ' OD1' ' N ' ' A' ' 163' ' ' ASP . 6.0 p30 -87.16 108.9 19.11 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.46 1.1 . . . . 0.0 109.265 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 172' ' ' ALA . . . . . 0.513 ' O ' ' HA ' ' A' ' 179' ' ' ARG . . . -117.35 174.63 6.02 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.511 1.132 . . . . 0.0 109.331 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -116.34 116.69 28.19 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.406 1.066 . . . . 0.0 110.278 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 174' ' ' ASP . . . . . 0.984 ' OD1' HD23 ' A' ' 151' ' ' LEU . 0.4 OUTLIER -74.43 -176.88 2.86 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.56 1.163 . . . . 0.0 109.316 -179.993 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 37.6 t -76.01 61.91 1.58 Allowed 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.53 1.144 . . . . 0.0 109.969 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -173.79 8.11 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.415 1.072 . . . . 0.0 110.319 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 67.88 20.91 72.94 Favored Glycine 0 CA--C 1.53 1.014 0 O-C-N 124.58 1.175 . . . . 0.0 110.998 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 178' ' ' LYS . . . . . 0.64 ' O ' HD21 ' A' ' 151' ' ' LEU . 0.0 OUTLIER -95.06 115.63 27.68 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.481 0.754 . . . . 0.0 109.329 -179.986 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 179' ' ' ARG . . . . . 0.513 ' HA ' ' O ' ' A' ' 172' ' ' ALA . 0.1 OUTLIER -90.13 122.53 33.17 Favored 'General case' 0 C--N 1.326 -0.442 0 O-C-N 124.459 1.099 . . . . 0.0 110.286 -179.958 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 180' ' ' GLY . . . . . 0.524 ' HA3' HD13 ' A' ' 151' ' ' LEU . . . -151.34 165.9 30.5 Favored Glycine 0 CA--C 1.53 0.971 0 O-C-N 124.487 1.117 . . . . 0.0 111.001 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 181' ' ' MET . . . . . 0.437 ' HA ' ' O ' ' A' ' 170' ' ' TRP . 0.4 OUTLIER -84.5 103.7 13.86 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.503 0.766 . . . . 0.0 111.035 179.943 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 182' ' ' ILE . . . . . 0.452 ' HB ' ' HD2' ' A' ' 183' ' ' PRO . 2.2 pp -106.93 161.11 23.94 Favored Pre-proline 0 C--N 1.325 -0.493 0 O-C-N 124.498 1.124 . . . . 0.0 109.267 -179.952 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 183' ' ' PRO . . . . . 0.642 ' HG2' ' HB2' ' A' ' 186' ' ' TYR . 18.4 Cg_endo -74.98 135.37 19.02 Favored 'Trans proline' 0 C--N 1.361 1.214 0 O-C-N 124.505 1.792 . . . . 0.0 110.989 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 184' ' ' VAL . . . . . 0.843 ' N ' ' CD ' ' A' ' 185' ' ' PRO . 58.0 t -80.1 -30.28 0.6 Allowed Pre-proline 0 C--N 1.326 -0.427 0 O-C-N 124.467 1.105 . . . . 0.0 109.28 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 185' ' ' PRO . . . . . 0.843 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.2 Cg_endo -75.05 -15.53 20.58 Favored 'Trans proline' 0 C--N 1.36 1.154 0 O-C-N 124.482 1.78 . . . . 0.0 110.973 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 186' ' ' TYR . . . . . 0.642 ' HB2' ' HG2' ' A' ' 183' ' ' PRO . 4.5 m-85 -94.95 5.91 50.58 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.492 1.12 . . . . 0.0 111.056 179.923 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 187' ' ' VAL . . . . . 0.588 HG11 ' CD1' ' A' ' 159' ' ' LEU . 35.4 m -136.94 164.48 30.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 O-C-N 124.475 1.11 . . . . 0.0 109.314 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 188' ' ' GLU . . . . . 0.807 ' OE2' HD21 ' A' ' 140' ' ' LEU . 0.0 OUTLIER -120.49 165.75 14.54 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.487 1.117 . . . . 0.0 110.262 -180.0 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 189' ' ' LYS . . . . . 0.453 ' CD ' ' H ' ' A' ' 189' ' ' LYS . 0.0 OUTLIER -89.33 126.54 35.57 Favored 'General case' 0 C--N 1.326 -0.439 0 O-C-N 124.455 1.097 . . . . 0.0 109.366 179.969 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 190' ' ' TYR . . . . . 0.436 ' CD1' ' OE1' ' A' ' 188' ' ' GLU . 0.1 OUTLIER -120.38 179.49 4.29 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.528 1.143 . . . . 0.0 110.98 -179.968 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 191' ' ' GLY . . . . . 0.453 ' O ' ' O ' ' A' ' 132' ' ' CYS . . . . . . . . 0 CA--C 1.531 1.038 0 O-C-N 124.494 1.121 . . . . 0.0 110.994 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 132' ' ' CYS . . . . . 0.418 ' O ' ' C ' ' A' ' 133' ' ' GLY . 28.5 p . . . . . 0 N--CA 1.452 -0.338 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 133' ' ' GLY . . . . . 0.418 ' C ' ' O ' ' A' ' 132' ' ' CYS . . . 35.2 86.05 0.01 OUTLIER Glycine 0 CA--C 1.53 0.983 0 O-C-N 124.471 1.107 . . . . 0.0 111.019 -179.941 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -175.17 -149.8 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.468 0.746 . . . . 0.0 109.354 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -137.43 70.56 1.4 Allowed 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.454 1.097 . . . . 0.0 110.321 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 136' ' ' TYR . . . . . 0.529 ' CE2' ' HD2' ' A' ' 160' ' ' ARG . 36.6 m-85 -126.62 130.88 51.33 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.547 1.154 . . . . 0.0 110.982 -179.969 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.716 HG12 ' O ' ' A' ' 159' ' ' LEU . 2.9 p -125.75 155.83 35.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 O-C-N 124.491 1.119 . . . . 0.0 109.273 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 138' ' ' ARG . . . . . 0.455 ' HB3' ' HG3' ' A' ' 188' ' ' GLU . 0.0 OUTLIER -126.08 133.03 51.8 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.501 1.125 . . . . 0.0 110.338 179.98 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.519 ' HB3' ' HB3' ' A' ' 157' ' ' ASP . . . -97.06 110.64 23.14 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.514 1.134 . . . . 0.0 109.316 -179.965 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.672 HD11 ' HG2' ' A' ' 188' ' ' GLU . 0.2 OUTLIER -95.33 -22.39 17.78 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.555 1.159 . . . . 0.0 109.344 179.948 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 141' ' ' PHE . . . . . 0.476 ' C ' ' O ' ' A' ' 154' ' ' LYS . 12.1 m-85 -94.62 150.31 20.36 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.474 1.109 . . . . 0.0 111.031 179.939 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 142' ' ' ASP . . . . . 0.431 ' CA ' ' O ' ' A' ' 154' ' ' LYS . 0.1 OUTLIER -103.48 145.8 29.47 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.538 1.149 . . . . 0.0 109.322 -179.969 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 143' ' ' PHE . . . . . 0.619 ' HB3' ' CE1' ' A' ' 153' ' ' PHE . 54.9 t80 -151.85 -43.94 0.11 Allowed 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.51 1.131 . . . . 0.0 111.008 -179.949 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 144' ' ' ASN . . . . . 0.423 ' O ' ' O ' ' A' ' 143' ' ' PHE . 8.3 t-20 51.4 100.44 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.411 0 O-C-N 124.435 1.085 . . . . 0.0 109.352 -179.93 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -174.01 108.07 0.26 Allowed Glycine 0 CA--C 1.529 0.926 0 O-C-N 124.479 1.112 . . . . 0.0 111.024 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 146' ' ' ASN . . . . . 0.499 ' O ' ' N ' ' A' ' 148' ' ' GLU . 2.8 p-10 -104.52 -50.81 3.22 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.459 0.741 . . . . 0.0 109.343 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 66.64 -66.26 0.18 Allowed 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.575 1.172 . . . . 0.0 109.309 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.499 ' N ' ' O ' ' A' ' 146' ' ' ASN . 0.1 OUTLIER 169.91 40.51 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.454 1.097 . . . . 0.0 110.277 179.994 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 172.71 -33.29 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.561 1.163 . . . . 0.0 110.289 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -74.49 171.75 13.22 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.484 1.115 . . . . 0.0 109.328 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.614 HD21 ' HB2' ' A' ' 174' ' ' ASP . 1.4 tp -125.66 119.04 24.39 Favored Pre-proline 0 C--N 1.325 -0.493 0 O-C-N 124.577 1.173 . . . . 0.0 109.347 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -74.97 142.96 28.6 Favored 'Trans proline' 0 C--N 1.361 1.208 0 O-C-N 124.434 1.755 . . . . 0.0 111.004 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 153' ' ' PHE . . . . . 0.619 ' CE1' ' HB3' ' A' ' 143' ' ' PHE . 14.9 p90 -151.64 173.12 15.05 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.42 1.075 . . . . 0.0 111.006 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 154' ' ' LYS . . . . . 0.476 ' O ' ' C ' ' A' ' 141' ' ' PHE . 0.0 OUTLIER -125.86 -84.99 0.63 Allowed 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.488 1.118 . . . . 0.0 109.233 -179.984 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -165.58 113.14 0.96 Allowed 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.501 1.126 . . . . 0.0 109.252 -179.949 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 156' ' ' GLY . . . . . 0.402 ' N ' ' O ' ' A' ' 139' ' ' ALA . . . 108.84 14.07 16.47 Favored Glycine 0 CA--C 1.53 1.003 0 O-C-N 124.391 1.057 . . . . 0.0 111.016 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 157' ' ' ASP . . . . . 0.519 ' HB3' ' HB3' ' A' ' 139' ' ' ALA . 6.9 t0 -82.72 158.26 22.96 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.532 0.783 . . . . 0.0 109.27 -179.974 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 158' ' ' ILE . . . . . 0.53 HD12 ' N ' ' A' ' 158' ' ' ILE . 3.9 mp -119.79 141.19 41.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 O-C-N 124.571 1.169 . . . . 0.0 109.266 -179.945 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.816 ' CD2' HG21 ' A' ' 182' ' ' ILE . 2.9 mp -142.04 126.79 18.07 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.42 1.075 . . . . 0.0 109.345 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 160' ' ' ARG . . . . . 0.685 ' O ' ' HA ' ' A' ' 172' ' ' ALA . 0.0 OUTLIER -88.26 132.87 34.21 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.545 1.153 . . . . 0.0 110.328 179.997 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 14.3 mm -82.15 117.14 27.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 O-C-N 124.42 1.075 . . . . 0.0 109.312 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 162' ' ' ARG . . . . . 0.47 ' HG3' ' N ' ' A' ' 163' ' ' ASP . 0.8 OUTLIER -118.22 -32.58 4.65 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.537 1.148 . . . . 0.0 110.368 179.943 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 163' ' ' ASP . . . . . 0.47 ' N ' ' HG3' ' A' ' 162' ' ' ARG . 0.9 OUTLIER -146.35 155.25 42.48 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.486 1.116 . . . . 0.0 109.338 179.949 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 164' ' ' LYS . . . . . 0.575 ' HB3' ' CD1' ' A' ' 170' ' ' TRP . 1.4 mtmp? -148.25 71.93 11.01 Favored Pre-proline 0 C--N 1.324 -0.519 0 O-C-N 124.522 1.139 . . . . 0.0 109.234 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.96 -29.06 8.7 Favored 'Trans proline' 0 C--N 1.359 1.105 0 O-C-N 124.539 1.81 . . . . 0.0 110.999 179.922 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 166' ' ' GLU . . . . . 0.517 ' O ' ' CD1' ' A' ' 170' ' ' TRP . 3.0 mm-40 -105.26 166.02 10.7 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.446 1.091 . . . . 0.0 110.296 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 13.3 mt-10 -96.38 -27.82 14.75 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.463 1.102 . . . . 0.0 110.309 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 168' ' ' GLN . . . . . 0.452 ' O ' HG23 ' A' ' 184' ' ' VAL . 11.4 tt0 -82.35 -58.68 2.83 Favored 'General case' 0 C--N 1.324 -0.536 0 O-C-N 124.533 1.146 . . . . 0.0 110.284 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 169' ' ' TRP . . . . . 0.581 ' CZ3' ' HD3' ' A' ' 183' ' ' PRO . 9.9 m0 -109.7 163.26 13.66 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.501 1.126 . . . . 0.0 107.968 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 170' ' ' TRP . . . . . 0.698 ' CH2' HG11 ' A' ' 184' ' ' VAL . 30.9 m0 -139.57 157.11 46.36 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.525 1.141 . . . . 0.0 107.951 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 4.6 t30 -88.55 107.6 18.98 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.472 1.107 . . . . 0.0 109.291 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 172' ' ' ALA . . . . . 0.685 ' HA ' ' O ' ' A' ' 160' ' ' ARG . . . -121.78 178.45 4.85 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.454 1.096 . . . . 0.0 109.312 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 173' ' ' GLU . . . . . 0.47 ' CG ' ' HG3' ' A' ' 179' ' ' ARG . 17.9 mt-10 -116.49 115.95 26.74 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.548 1.155 . . . . 0.0 110.201 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 174' ' ' ASP . . . . . 0.614 ' HB2' HD21 ' A' ' 151' ' ' LEU . 0.4 OUTLIER -64.51 -164.91 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.498 1.124 . . . . 0.0 109.239 179.994 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -88.36 60.0 5.48 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.439 1.087 . . . . 0.0 110.016 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 176' ' ' GLU . . . . . 0.4 ' H ' ' H ' ' A' ' 177' ' ' GLY . 4.2 mt-10 174.16 22.58 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.455 1.097 . . . . 0.0 110.362 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 177' ' ' GLY . . . . . 0.4 ' H ' ' H ' ' A' ' 176' ' ' GLU . . . 67.75 15.52 66.77 Favored Glycine 0 CA--C 1.531 1.035 0 O-C-N 124.464 1.102 . . . . 0.0 111.023 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 178' ' ' LYS . . . . . 0.421 ' HB3' HD11 ' A' ' 151' ' ' LEU . 8.0 mttt -70.9 101.77 2.23 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.505 0.768 . . . . 0.0 109.325 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 179' ' ' ARG . . . . . 0.47 ' HG3' ' CG ' ' A' ' 173' ' ' GLU . 11.3 mtt85 -87.68 105.76 17.58 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.494 1.121 . . . . 0.0 110.255 -179.914 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 180' ' ' GLY . . . . . 0.412 ' HA3' HD13 ' A' ' 151' ' ' LEU . . . -151.87 169.45 31.26 Favored Glycine 0 CA--C 1.53 0.983 0 O-C-N 124.507 1.129 . . . . 0.0 111.033 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 181' ' ' MET . . . . . 0.44 ' HA ' ' O ' ' A' ' 170' ' ' TRP . 4.9 mmm -87.68 116.89 26.13 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.52 0.776 . . . . 0.0 111.064 179.904 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 182' ' ' ILE . . . . . 0.816 HG21 ' CD2' ' A' ' 159' ' ' LEU . 1.0 OUTLIER -112.91 161.85 24.62 Favored Pre-proline 0 C--N 1.325 -0.484 0 O-C-N 124.504 1.127 . . . . 0.0 109.252 -179.967 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 183' ' ' PRO . . . . . 0.738 ' HG2' ' HB2' ' A' ' 186' ' ' TYR . 18.2 Cg_endo -75.0 134.05 17.35 Favored 'Trans proline' 0 C--N 1.36 1.151 0 O-C-N 124.502 1.79 . . . . 0.0 110.979 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 184' ' ' VAL . . . . . 0.834 ' N ' ' CD ' ' A' ' 185' ' ' PRO . 38.7 t -79.96 -31.1 0.64 Allowed Pre-proline 0 C--N 1.325 -0.467 0 O-C-N 124.429 1.081 . . . . 0.0 109.275 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 185' ' ' PRO . . . . . 0.834 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.5 Cg_endo -74.99 -25.26 12.06 Favored 'Trans proline' 0 C--N 1.36 1.135 0 O-C-N 124.504 1.792 . . . . 0.0 111.059 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 186' ' ' TYR . . . . . 0.738 ' HB2' ' HG2' ' A' ' 183' ' ' PRO . 3.5 m-85 -93.82 22.84 5.23 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.522 1.139 . . . . 0.0 110.988 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 187' ' ' VAL . . . . . 0.64 ' HB ' HG22 ' A' ' 137' ' ' VAL . 26.2 m -146.53 169.52 5.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 O-C-N 124.475 1.109 . . . . 0.0 109.369 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 188' ' ' GLU . . . . . 0.672 ' HG2' HD11 ' A' ' 140' ' ' LEU . 0.0 OUTLIER -126.82 160.47 30.81 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.543 1.152 . . . . 0.0 110.255 -179.976 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 24.6 mmmt -85.04 127.19 34.11 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.573 1.171 . . . . 0.0 109.259 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 190' ' ' TYR . . . . . 0.498 ' O ' ' O ' ' A' ' 191' ' ' GLY . 0.1 OUTLIER -109.47 142.94 39.77 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.516 1.135 . . . . 0.0 111.012 179.945 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 191' ' ' GLY . . . . . 0.498 ' O ' ' O ' ' A' ' 190' ' ' TYR . . . . . . . . 0 CA--C 1.531 1.037 0 O-C-N 124.483 1.114 . . . . 0.0 110.929 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 132' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.453 -0.317 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 108.1 -74.05 0.21 Allowed Glycine 0 CA--C 1.531 1.052 0 O-C-N 124.509 1.131 . . . . 0.0 110.98 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -91.21 -166.98 1.69 Allowed 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.556 0.797 . . . . 0.0 109.31 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.512 ' O ' ' HG2' ' A' ' 160' ' ' ARG . 0.7 OUTLIER -118.11 61.13 0.77 Allowed 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.554 1.159 . . . . 0.0 110.282 179.955 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -112.03 128.71 56.26 Favored 'General case' 0 C--N 1.324 -0.522 0 O-C-N 124.531 1.145 . . . . 0.0 111.037 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.774 HG22 ' O ' ' A' ' 188' ' ' GLU . 0.4 OUTLIER -119.35 174.98 4.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 O-C-N 124.471 1.107 . . . . 0.0 109.332 179.988 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 138' ' ' ARG . . . . . 0.673 HH21 HD11 ' A' ' 158' ' ' ILE . 14.0 ttm180 -144.69 146.73 32.36 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.535 1.147 . . . . 0.0 110.289 -179.958 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.597 ' HB3' ' HB3' ' A' ' 157' ' ' ASP . . . -107.72 109.83 21.52 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.456 1.098 . . . . 0.0 109.306 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.64 HD11 ' HG2' ' A' ' 188' ' ' GLU . 1.0 OUTLIER -88.86 -7.15 56.66 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.52 1.138 . . . . 0.0 109.361 179.977 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 18.6 m-85 -120.67 158.24 27.86 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.576 1.173 . . . . 0.0 110.966 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 142' ' ' ASP . . . . . 0.487 ' HB3' ' HG2' ' A' ' 154' ' ' LYS . 2.0 p-10 -108.27 147.07 31.96 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.492 1.12 . . . . 0.0 109.339 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 143' ' ' PHE . . . . . 0.624 ' HB3' ' CE1' ' A' ' 153' ' ' PHE . 31.6 t80 -179.22 69.53 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.546 1.154 . . . . 0.0 110.986 179.958 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 144' ' ' ASN . . . . . 0.445 ' CG ' ' HB3' ' A' ' 152' ' ' PRO . 14.2 t-20 -38.64 145.08 0.09 Allowed 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.488 1.118 . . . . 0.0 109.266 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -58.63 99.87 0.14 Allowed Glycine 0 CA--C 1.529 0.964 0 O-C-N 124.49 1.119 . . . . 0.0 111.025 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 13.3 t-20 -83.93 -47.28 11.19 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.444 0.732 . . . . 0.0 109.331 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -70.13 168.96 14.51 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.574 1.171 . . . . 0.0 109.325 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -92.65 47.99 1.34 Allowed 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.51 1.131 . . . . 0.0 110.326 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -178.39 55.68 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.512 1.133 . . . . 0.0 110.276 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 29.7 p30 -163.14 165.29 24.73 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.501 1.125 . . . . 0.0 109.315 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.942 HD13 ' OD2' ' A' ' 174' ' ' ASP . 2.1 pp -113.05 140.0 23.66 Favored Pre-proline 0 C--N 1.325 -0.465 0 O-C-N 124.509 1.131 . . . . 0.0 109.3 -179.993 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 152' ' ' PRO . . . . . 0.445 ' HB3' ' CG ' ' A' ' 144' ' ' ASN . 18.3 Cg_endo -74.97 134.68 18.16 Favored 'Trans proline' 0 C--N 1.36 1.161 0 O-C-N 124.518 1.799 . . . . 0.0 111.022 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 153' ' ' PHE . . . . . 0.624 ' CE1' ' HB3' ' A' ' 143' ' ' PHE . 13.4 p90 -145.49 169.61 18.02 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.53 1.143 . . . . 0.0 111.064 179.912 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 154' ' ' LYS . . . . . 0.487 ' HG2' ' HB3' ' A' ' 142' ' ' ASP . 1.0 OUTLIER -127.98 -158.86 0.9 Allowed 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.434 1.084 . . . . 0.0 109.255 -179.937 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.43 108.31 20.98 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.466 1.104 . . . . 0.0 109.29 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 114.51 17.9 6.85 Favored Glycine 0 CA--C 1.53 0.974 0 O-C-N 124.433 1.083 . . . . 0.0 111.041 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 157' ' ' ASP . . . . . 0.968 ' C ' HD12 ' A' ' 158' ' ' ILE . 8.9 t70 -87.5 168.68 12.87 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.488 0.758 . . . . 0.0 109.366 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 158' ' ' ILE . . . . . 0.968 HD12 ' C ' ' A' ' 157' ' ' ASP . 2.3 mp -128.56 143.98 39.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 O-C-N 124.559 1.162 . . . . 0.0 109.31 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.911 HD13 HD13 ' A' ' 182' ' ' ILE . 0.3 OUTLIER -149.27 128.47 12.84 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.467 1.104 . . . . 0.0 109.29 -179.913 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 160' ' ' ARG . . . . . 0.573 ' O ' ' HA ' ' A' ' 172' ' ' ALA . 0.0 OUTLIER -84.57 138.32 32.81 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.515 1.134 . . . . 0.0 110.26 -179.994 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.461 ' HB ' ' HB2' ' A' ' 135' ' ' GLU . 43.9 mm -84.77 112.65 22.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 O-C-N 124.482 1.114 . . . . 0.0 109.306 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.45 -56.0 2.4 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.424 1.077 . . . . 0.0 110.309 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -134.88 167.01 21.69 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.464 1.103 . . . . 0.0 109.282 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 164' ' ' LYS . . . . . 0.585 ' HB3' ' CD1' ' A' ' 170' ' ' TRP . 23.3 mtmt -144.44 83.13 10.06 Favored Pre-proline 0 C--N 1.325 -0.492 0 O-C-N 124.531 1.144 . . . . 0.0 109.296 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.03 -27.48 9.93 Favored 'Trans proline' 0 C--N 1.36 1.152 0 O-C-N 124.523 1.802 . . . . 0.0 110.99 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 166' ' ' GLU . . . . . 0.492 ' O ' ' CD1' ' A' ' 170' ' ' TRP . 2.7 mt-10 -121.03 172.75 7.72 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.501 1.126 . . . . 0.0 110.284 -179.941 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -95.56 -29.8 14.16 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.516 1.135 . . . . 0.0 110.319 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 168' ' ' GLN . . . . . 0.654 ' O ' HG23 ' A' ' 184' ' ' VAL . 6.8 tt0 -79.11 -60.19 2.47 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.473 1.108 . . . . 0.0 110.287 -179.954 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 169' ' ' TRP . . . . . 0.42 ' O ' ' CD1' ' A' ' 170' ' ' TRP . 11.2 m0 -104.96 157.74 17.01 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 170' ' ' TRP . . . . . 0.585 ' CD1' ' HB3' ' A' ' 164' ' ' LYS . 39.9 m0 -136.13 155.61 49.92 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.467 1.104 . . . . 0.0 108.055 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 171' ' ' ASN . . . . . 0.426 ' HA ' ' O ' ' A' ' 180' ' ' GLY . 42.1 t-20 -88.37 99.2 12.08 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.525 1.141 . . . . 0.0 109.266 -179.947 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 172' ' ' ALA . . . . . 0.573 ' HA ' ' O ' ' A' ' 160' ' ' ARG . . . -109.41 174.77 5.72 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.514 1.134 . . . . 0.0 109.342 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 173' ' ' GLU . . . . . 0.472 ' C ' HD23 ' A' ' 159' ' ' LEU . 8.0 mt-10 -119.39 117.19 27.84 Favored 'General case' 0 C--N 1.326 -0.437 0 O-C-N 124.475 1.109 . . . . 0.0 110.315 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 174' ' ' ASP . . . . . 0.942 ' OD2' HD13 ' A' ' 151' ' ' LEU . 3.7 m-20 -67.2 -176.39 0.55 Allowed 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.471 1.107 . . . . 0.0 109.273 -179.952 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 73.4 p -79.24 60.17 3.0 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.528 1.142 . . . . 0.0 110.002 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 176' ' ' GLU . . . . . 0.414 ' H ' ' H ' ' A' ' 177' ' ' GLY . 0.2 OUTLIER -176.54 7.56 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.428 0 O-C-N 124.485 1.116 . . . . 0.0 110.292 -179.996 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 177' ' ' GLY . . . . . 0.414 ' H ' ' H ' ' A' ' 176' ' ' GLU . . . 75.66 18.23 79.81 Favored Glycine 0 CA--C 1.529 0.959 0 O-C-N 124.495 1.122 . . . . 0.0 110.985 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 14.1 mtmm -83.92 106.25 15.44 Favored 'General case' 0 C--N 1.326 -0.435 0 O-C-N 124.41 0.712 . . . . 0.0 109.277 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 179' ' ' ARG . . . . . 0.403 ' HD3' ' OE2' ' A' ' 173' ' ' GLU . 4.1 ttp180 -88.51 118.04 27.88 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.444 1.09 . . . . 0.0 110.265 -179.936 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 180' ' ' GLY . . . . . 0.467 ' HA3' HD23 ' A' ' 151' ' ' LEU . . . -151.57 166.86 30.83 Favored Glycine 0 CA--C 1.53 1.002 0 O-C-N 124.501 1.126 . . . . 0.0 110.979 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 181' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -87.61 114.43 24.22 Favored 'General case' 0 C--N 1.324 -0.528 0 O-C-N 124.497 0.763 . . . . 0.0 110.939 -179.957 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 182' ' ' ILE . . . . . 0.911 HD13 HD13 ' A' ' 159' ' ' LEU . 2.1 pt -116.02 163.44 21.35 Favored Pre-proline 0 C--N 1.325 -0.487 0 O-C-N 124.492 1.12 . . . . 0.0 109.256 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 183' ' ' PRO . . . . . 0.775 ' HG2' ' HB2' ' A' ' 186' ' ' TYR . 18.0 Cg_endo -75.02 135.63 19.3 Favored 'Trans proline' 0 C--N 1.361 1.199 0 O-C-N 124.52 1.8 . . . . 0.0 110.946 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 184' ' ' VAL . . . . . 0.82 ' N ' ' CD ' ' A' ' 185' ' ' PRO . 50.6 t -80.17 -31.98 0.68 Allowed Pre-proline 0 C--N 1.325 -0.469 0 O-C-N 124.486 1.117 . . . . 0.0 109.299 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 185' ' ' PRO . . . . . 0.82 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.3 Cg_endo -75.0 -23.09 14.13 Favored 'Trans proline' 0 C--N 1.361 1.214 0 O-C-N 124.541 1.811 . . . . 0.0 110.985 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 186' ' ' TYR . . . . . 0.775 ' HB2' ' HG2' ' A' ' 183' ' ' PRO . 3.8 m-85 -93.66 16.02 14.86 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.503 1.127 . . . . 0.0 111.037 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 187' ' ' VAL . . . . . 0.601 ' HA ' ' O ' ' A' ' 138' ' ' ARG . 6.0 m -145.49 165.58 10.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 O-C-N 124.449 1.093 . . . . 0.0 109.305 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 188' ' ' GLU . . . . . 0.774 ' O ' HG22 ' A' ' 137' ' ' VAL . 0.0 OUTLIER -130.16 166.05 21.05 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.47 1.106 . . . . 0.0 110.371 -179.971 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.65 121.85 32.92 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.462 1.101 . . . . 0.0 109.369 179.911 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -42.18 -50.94 4.8 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.543 1.152 . . . . 0.0 110.991 -179.913 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.962 0 O-C-N 124.456 1.097 . . . . 0.0 111.009 -179.987 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 132' ' ' CYS . . . . . . . . . . . . . 18.0 p . . . . . 0 N--CA 1.453 -0.319 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -163.32 -126.5 0.82 Allowed Glycine 0 CA--C 1.529 0.909 0 O-C-N 124.503 1.127 . . . . 0.0 110.989 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -70.16 -134.51 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.431 0.724 . . . . 0.0 109.273 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.437 ' O ' ' HA ' ' A' ' 160' ' ' ARG . 0.0 OUTLIER -114.57 61.3 0.67 Allowed 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.491 1.119 . . . . 0.0 110.301 -179.988 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -128.08 116.68 20.35 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 124.518 1.136 . . . . 0.0 110.967 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.593 HG13 HD13 ' A' ' 161' ' ' ILE . 32.4 m -107.77 165.02 4.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 O-C-N 124.542 1.151 . . . . 0.0 109.36 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 138' ' ' ARG . . . . . 0.473 ' O ' ' HA ' ' A' ' 187' ' ' VAL . 2.7 tpp85 -125.12 132.18 53.15 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.445 1.091 . . . . 0.0 110.306 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.578 ' O ' ' N ' ' A' ' 156' ' ' GLY . . . -98.22 112.94 24.74 Favored 'General case' 0 C--N 1.326 -0.444 0 O-C-N 124.474 1.109 . . . . 0.0 109.307 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.881 HD21 ' OE2' ' A' ' 188' ' ' GLU . 0.1 OUTLIER -92.71 -12.02 32.5 Favored 'General case' 0 C--N 1.326 -0.437 0 O-C-N 124.448 1.092 . . . . 0.0 109.302 -179.953 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -121.73 156.69 32.56 Favored 'General case' 0 C--N 1.326 -0.416 0 O-C-N 124.507 1.129 . . . . 0.0 110.966 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 142' ' ' ASP . . . . . 0.464 ' OD1' ' N ' ' A' ' 155' ' ' LYS . 0.0 OUTLIER -102.68 138.41 39.61 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.439 1.087 . . . . 0.0 109.316 -179.954 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 143' ' ' PHE . . . . . 0.629 ' HB3' ' CZ ' ' A' ' 153' ' ' PHE . 5.8 t80 -150.16 7.94 0.62 Allowed 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.456 1.098 . . . . 0.0 111.012 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 144' ' ' ASN . . . . . 0.46 ' C ' ' O ' ' A' ' 143' ' ' PHE . 0.8 OUTLIER 36.06 -153.47 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.499 1.125 . . . . 0.0 109.304 -179.995 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 145' ' ' GLY . . . . . 0.477 ' N ' ' HB3' ' A' ' 152' ' ' PRO . . . -175.21 -145.85 5.56 Favored Glycine 0 CA--C 1.53 1.016 0 O-C-N 124.576 1.172 . . . . 0.0 110.946 -179.955 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 146' ' ' ASN . . . . . 0.428 ' O ' ' CG ' ' A' ' 147' ' ' ASP . 26.6 t-20 175.52 57.84 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.453 0.737 . . . . 0.0 109.379 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 147' ' ' ASP . . . . . 0.482 ' O ' ' N ' ' A' ' 150' ' ' ASP . 2.3 p-10 46.17 -114.46 0.49 Allowed 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.524 1.14 . . . . 0.0 109.325 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.447 ' C ' ' O ' ' A' ' 147' ' ' ASP . 2.0 pt-20 35.52 46.51 0.29 Allowed 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.495 1.122 . . . . 0.0 110.259 179.939 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 8.3 tt0 67.04 47.13 1.42 Allowed 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.486 1.117 . . . . 0.0 110.278 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 150' ' ' ASP . . . . . 0.482 ' N ' ' O ' ' A' ' 147' ' ' ASP . 0.0 OUTLIER -155.52 159.21 39.56 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.465 1.103 . . . . 0.0 109.308 179.997 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.945 HD12 ' CG ' ' A' ' 174' ' ' ASP . 1.2 pt? -128.75 127.78 23.49 Favored Pre-proline 0 C--N 1.325 -0.466 0 O-C-N 124.484 1.115 . . . . 0.0 109.329 179.95 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 152' ' ' PRO . . . . . 0.477 ' HB3' ' N ' ' A' ' 145' ' ' GLY . 18.4 Cg_endo -74.98 148.69 35.71 Favored 'Trans proline' 0 C--N 1.359 1.128 0 O-C-N 124.444 1.76 . . . . 0.0 111.021 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 153' ' ' PHE . . . . . 0.629 ' CZ ' ' HB3' ' A' ' 143' ' ' PHE . 52.2 p90 -150.66 169.35 21.81 Favored 'General case' 0 C--N 1.326 -0.437 0 O-C-N 124.456 1.098 . . . . 0.0 110.967 -179.935 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 154' ' ' LYS . . . . . 0.435 ' HA ' ' HB3' ' A' ' 142' ' ' ASP . 2.9 tttm -128.92 -161.75 1.14 Allowed 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.528 1.143 . . . . 0.0 109.273 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.464 ' N ' ' OD1' ' A' ' 142' ' ' ASP . 0.0 OUTLIER -91.64 101.12 13.74 Favored 'General case' 0 C--N 1.324 -0.522 0 O-C-N 124.507 1.129 . . . . 0.0 109.302 -179.987 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 156' ' ' GLY . . . . . 0.578 ' N ' ' O ' ' A' ' 139' ' ' ALA . . . 114.47 27.64 3.27 Favored Glycine 0 CA--C 1.53 0.981 0 O-C-N 124.491 1.12 . . . . 0.0 111.023 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 157' ' ' ASP . . . . . 0.46 ' O ' ' HD3' ' A' ' 138' ' ' ARG . 2.5 t70 -105.08 163.47 12.53 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.555 0.797 . . . . 0.0 109.299 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 158' ' ' ILE . . . . . 0.433 HG12 ' HD3' ' A' ' 138' ' ' ARG . 4.4 mt -119.59 149.08 22.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 O-C-N 124.47 1.107 . . . . 0.0 109.297 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.643 HD12 ' N ' ' A' ' 159' ' ' LEU . 0.0 OUTLIER -147.5 137.45 22.93 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 124.515 1.135 . . . . 0.0 109.279 -179.969 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 160' ' ' ARG . . . . . 0.702 ' O ' ' HB1' ' A' ' 172' ' ' ALA . 7.3 ttt180 -88.25 136.29 33.05 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.522 1.139 . . . . 0.0 110.325 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.593 HD13 HG13 ' A' ' 137' ' ' VAL . 0.9 OUTLIER -83.68 110.3 18.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 O-C-N 124.44 1.087 . . . . 0.0 109.324 -179.948 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 162' ' ' ARG . . . . . 0.43 ' HB3' ' ND2' ' A' ' 171' ' ' ASN . 2.5 tpt85 -88.33 -59.6 2.19 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.483 1.114 . . . . 0.0 110.353 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 163' ' ' ASP . . . . . 0.429 ' O ' ' HB3' ' A' ' 170' ' ' TRP . 20.3 t0 -149.19 149.68 31.4 Favored 'General case' 0 C--N 1.324 -0.526 0 O-C-N 124.515 1.134 . . . . 0.0 109.34 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 164' ' ' LYS . . . . . 0.542 ' HB2' ' CE2' ' A' ' 170' ' ' TRP . 0.4 OUTLIER -132.76 76.51 70.9 Favored Pre-proline 0 C--N 1.325 -0.496 0 O-C-N 124.474 1.109 . . . . 0.0 109.324 -179.987 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -75.14 -44.89 0.3 Allowed 'Trans proline' 0 C--N 1.361 1.207 0 O-C-N 124.426 1.75 . . . . 0.0 110.959 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 -78.97 175.5 10.51 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.457 1.098 . . . . 0.0 110.303 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 32.6 mm-40 -114.03 54.12 0.76 Allowed 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.464 1.102 . . . . 0.0 110.322 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 168' ' ' GLN . . . . . 0.524 ' O ' HG23 ' A' ' 184' ' ' VAL . 0.0 OUTLIER -178.5 -57.63 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.432 0 O-C-N 124.464 1.103 . . . . 0.0 110.261 -179.971 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 169' ' ' TRP . . . . . 0.563 ' CH2' ' HD3' ' A' ' 183' ' ' PRO . 14.0 m95 -109.8 142.13 41.49 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 107.961 -1.125 . . . . 0.0 107.961 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 170' ' ' TRP . . . . . 0.671 ' CD2' HG21 ' A' ' 184' ' ' VAL . 22.8 m0 -133.91 161.39 34.91 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.518 1.136 . . . . 0.0 108.011 179.964 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 171' ' ' ASN . . . . . 0.43 ' ND2' ' HB3' ' A' ' 162' ' ' ARG . 5.3 p-10 -94.08 111.26 22.96 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.556 1.16 . . . . 0.0 109.296 179.986 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 172' ' ' ALA . . . . . 0.702 ' HB1' ' O ' ' A' ' 160' ' ' ARG . . . -117.34 -176.79 3.08 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.499 1.125 . . . . 0.0 109.308 179.991 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 173' ' ' GLU . . . . . 0.435 ' OE2' ' CD ' ' A' ' 179' ' ' ARG . 40.2 mt-10 -128.09 124.27 36.59 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.439 1.087 . . . . 0.0 110.338 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 174' ' ' ASP . . . . . 0.945 ' CG ' HD12 ' A' ' 151' ' ' LEU . 0.9 OUTLIER -75.99 -172.65 2.06 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.407 1.067 . . . . 0.0 109.278 -179.954 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 1.4 m -82.35 61.59 5.62 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.55 1.156 . . . . 0.0 110.028 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -177.16 9.95 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.451 1.094 . . . . 0.0 110.312 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 74.07 17.25 79.45 Favored Glycine 0 CA--C 1.531 1.034 0 O-C-N 124.51 1.132 . . . . 0.0 111.029 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 178' ' ' LYS . . . . . 0.415 ' O ' ' HA ' ' A' ' 173' ' ' GLU . 0.8 OUTLIER -82.8 101.38 10.9 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.544 0.79 . . . . 0.0 109.262 -179.97 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 179' ' ' ARG . . . . . 0.531 ' HA ' ' O ' ' A' ' 172' ' ' ALA . 0.0 OUTLIER -91.42 115.42 28.02 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.528 1.142 . . . . 0.0 110.275 -179.968 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 180' ' ' GLY . . . . . 0.552 ' H ' HD22 ' A' ' 151' ' ' LEU . . . -150.96 169.0 30.7 Favored Glycine 0 CA--C 1.53 1.005 0 O-C-N 124.457 1.098 . . . . 0.0 110.998 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 181' ' ' MET . . . . . 0.496 ' HG3' ' HB3' ' A' ' 169' ' ' TRP . 1.4 ttm -87.75 111.95 21.88 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.44 0.729 . . . . 0.0 110.99 -179.978 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 182' ' ' ILE . . . . . 0.557 ' HA ' ' CZ3' ' A' ' 169' ' ' TRP . 1.5 pp -115.27 166.88 10.94 Favored Pre-proline 0 C--N 1.325 -0.472 0 O-C-N 124.538 1.149 . . . . 0.0 109.263 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 183' ' ' PRO . . . . . 0.607 ' HG2' ' CB ' ' A' ' 186' ' ' TYR . 18.3 Cg_endo -75.02 135.11 18.61 Favored 'Trans proline' 0 C--N 1.36 1.145 0 O-C-N 124.471 1.774 . . . . 0.0 110.973 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 184' ' ' VAL . . . . . 0.811 ' N ' ' CD ' ' A' ' 185' ' ' PRO . 86.9 t -79.98 -32.3 0.71 Allowed Pre-proline 0 C--N 1.325 -0.467 0 O-C-N 124.482 1.114 . . . . 0.0 109.293 179.986 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 185' ' ' PRO . . . . . 0.811 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.3 Cg_endo -74.99 -11.38 21.49 Favored 'Trans proline' 0 C--N 1.359 1.124 0 O-C-N 124.48 1.779 . . . . 0.0 110.999 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 186' ' ' TYR . . . . . 0.607 ' CB ' ' HG2' ' A' ' 183' ' ' PRO . 6.8 m-85 -93.97 -1.98 53.82 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.501 1.126 . . . . 0.0 111.022 -179.979 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 187' ' ' VAL . . . . . 0.473 ' HA ' ' O ' ' A' ' 138' ' ' ARG . 14.4 m -133.22 174.03 13.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 O-C-N 124.477 1.111 . . . . 0.0 109.307 179.963 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 188' ' ' GLU . . . . . 0.881 ' OE2' HD21 ' A' ' 140' ' ' LEU . 0.0 OUTLIER -135.53 172.51 12.9 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.457 1.098 . . . . 0.0 110.307 179.991 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.8 126.07 34.8 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.454 1.096 . . . . 0.0 109.288 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 72.2 t80 -43.54 -72.2 0.06 Allowed 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.47 1.106 . . . . 0.0 110.953 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.979 0 O-C-N 124.552 1.157 . . . . 0.0 111.019 179.984 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 132' ' ' CYS . . . . . . . . . . . . . 4.9 t . . . . . 0 N--CA 1.452 -0.325 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 133' ' ' GLY . . . . . 0.454 ' O ' ' HB2' ' A' ' 134' ' ' ALA . . . 118.7 48.23 0.38 Allowed Glycine 0 CA--C 1.529 0.956 0 O-C-N 124.521 1.138 . . . . 0.0 111.063 -179.943 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 134' ' ' ALA . . . . . 0.454 ' HB2' ' O ' ' A' ' 133' ' ' GLY . . . 177.87 -104.64 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.492 0.76 . . . . 0.0 109.292 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.442 ' HB2' ' O ' ' A' ' 161' ' ' ILE . 1.2 pt-20 165.79 63.46 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.434 0 O-C-N 124.429 1.08 . . . . 0.0 110.32 -179.942 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 7.3 m-85 -124.19 117.06 23.75 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.489 1.118 . . . . 0.0 110.957 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.516 ' CG2' ' O ' ' A' ' 188' ' ' GLU . 0.4 OUTLIER -119.41 132.54 68.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 O-C-N 124.544 1.153 . . . . 0.0 109.309 179.973 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 138' ' ' ARG . . . . . 0.617 HH21 HD11 ' A' ' 158' ' ' ILE . 12.7 ttm180 -95.2 148.37 22.47 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.525 1.14 . . . . 0.0 110.373 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.671 ' HB3' ' HB3' ' A' ' 157' ' ' ASP . . . -105.91 110.66 23.01 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.512 1.132 . . . . 0.0 109.268 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.572 HD11 ' HG2' ' A' ' 188' ' ' GLU . 0.3 OUTLIER -93.89 -7.9 41.82 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.456 1.098 . . . . 0.0 109.274 179.965 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 141' ' ' PHE . . . . . 0.456 ' C ' ' O ' ' A' ' 154' ' ' LYS . 14.7 m-85 -104.61 158.73 16.3 Favored 'General case' 0 C--N 1.324 -0.524 0 O-C-N 124.525 1.141 . . . . 0.0 110.976 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 142' ' ' ASP . . . . . 0.57 ' CA ' ' O ' ' A' ' 154' ' ' LYS . 0.0 OUTLIER -122.0 115.96 23.45 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.449 1.093 . . . . 0.0 109.276 -179.942 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 143' ' ' PHE . . . . . 0.498 ' CG ' ' O ' ' A' ' 143' ' ' PHE . 50.4 t80 -154.07 9.66 0.38 Allowed 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.46 1.1 . . . . 0.0 110.977 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 144' ' ' ASN . . . . . 0.503 ' OD1' ' N ' ' A' ' 145' ' ' GLY . 18.4 p30 35.13 -154.79 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.512 1.132 . . . . 0.0 109.321 -179.95 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 145' ' ' GLY . . . . . 0.503 ' N ' ' OD1' ' A' ' 144' ' ' ASN . . . -135.05 142.76 14.25 Favored Glycine 0 CA--C 1.53 1.016 0 O-C-N 124.464 1.102 . . . . 0.0 110.988 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 20.0 p30 178.93 58.09 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.6 0.823 . . . . 0.0 109.272 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -139.9 -59.3 0.55 Allowed 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.471 1.107 . . . . 0.0 109.388 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -170.42 58.77 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.552 1.158 . . . . 0.0 110.326 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 70.05 51.9 0.4 Allowed 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.521 1.138 . . . . 0.0 110.335 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -92.7 136.5 33.17 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.555 1.159 . . . . 0.0 109.301 -179.951 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 1.061 HD23 HD22 ' A' ' 159' ' ' LEU . 1.0 OUTLIER -50.9 106.74 0.69 Allowed Pre-proline 0 C--N 1.325 -0.485 0 O-C-N 124.583 1.177 . . . . 0.0 109.358 179.987 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 152' ' ' PRO . . . . . 0.409 ' HD2' ' OD2' ' A' ' 174' ' ' ASP . 18.3 Cg_endo -74.98 131.93 14.87 Favored 'Trans proline' 0 C--N 1.36 1.179 0 O-C-N 124.509 1.794 . . . . 0.0 110.996 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 153' ' ' PHE . . . . . 0.565 ' CD1' ' N ' ' A' ' 153' ' ' PHE . 0.0 OUTLIER -145.22 166.29 25.89 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.5 1.125 . . . . 0.0 110.971 -179.975 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 154' ' ' LYS . . . . . 0.57 ' O ' ' CA ' ' A' ' 142' ' ' ASP . 0.0 OUTLIER -127.0 -75.37 0.58 Allowed 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.5 1.125 . . . . 0.0 109.258 179.97 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.511 ' CD ' ' O ' ' A' ' 140' ' ' LEU . 0.0 OUTLIER -165.26 109.64 0.88 Allowed 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.54 1.15 . . . . 0.0 109.278 -179.97 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 156' ' ' GLY . . . . . 0.51 ' N ' ' O ' ' A' ' 139' ' ' ALA . . . 93.45 29.88 9.7 Favored Glycine 0 CA--C 1.531 1.042 0 O-C-N 124.593 1.183 . . . . 0.0 110.98 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 157' ' ' ASP . . . . . 0.887 ' C ' HD12 ' A' ' 158' ' ' ILE . 0.4 OUTLIER -88.66 158.65 18.16 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.482 0.754 . . . . 0.0 109.285 179.995 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 158' ' ' ILE . . . . . 0.887 HD12 ' C ' ' A' ' 157' ' ' ASP . 1.5 mp -116.38 136.34 53.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 O-C-N 124.492 1.12 . . . . 0.0 109.278 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 1.061 HD22 HD23 ' A' ' 151' ' ' LEU . 0.6 OUTLIER -138.09 126.22 22.9 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.51 1.131 . . . . 0.0 109.3 -179.971 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 160' ' ' ARG . . . . . 0.525 ' O ' ' HA ' ' A' ' 172' ' ' ALA . 0.0 OUTLIER -86.84 126.28 34.54 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.535 1.147 . . . . 0.0 110.299 -179.98 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.659 HG21 ' CE ' ' A' ' 164' ' ' LYS . 12.4 mm -81.77 122.56 36.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 O-C-N 124.502 1.127 . . . . 0.0 109.336 179.998 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 162' ' ' ARG . . . . . 0.463 ' HG3' ' N ' ' A' ' 163' ' ' ASP . 0.0 OUTLIER -122.53 -29.55 4.06 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.526 1.141 . . . . 0.0 110.276 179.989 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 163' ' ' ASP . . . . . 0.463 ' N ' ' HG3' ' A' ' 162' ' ' ARG . 0.8 OUTLIER -135.99 146.0 46.73 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.477 1.111 . . . . 0.0 109.312 -179.949 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 164' ' ' LYS . . . . . 0.659 ' CE ' HG21 ' A' ' 161' ' ' ILE . 15.9 mtpt -146.84 62.64 7.7 Favored Pre-proline 0 C--N 1.324 -0.506 0 O-C-N 124.459 1.099 . . . . 0.0 109.342 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 165' ' ' PRO . . . . . 0.443 ' HD3' ' N ' ' A' ' 164' ' ' LYS . 18.1 Cg_endo -75.04 -73.54 0.01 OUTLIER 'Trans proline' 0 C--N 1.361 1.218 0 O-C-N 124.474 1.776 . . . . 0.0 110.976 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -50.69 160.06 0.47 Allowed 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.523 1.139 . . . . 0.0 110.293 -179.967 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -100.91 35.21 2.25 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.477 1.11 . . . . 0.0 110.271 -179.938 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -157.75 -51.35 0.07 Allowed 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.417 1.073 . . . . 0.0 110.353 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 169' ' ' TRP . . . . . . . . . . . . . 13.0 m95 -103.79 140.53 37.5 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.607 1.192 . . . . 0.0 108.039 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 170' ' ' TRP . . . . . 0.62 ' CE3' ' CE ' ' A' ' 164' ' ' LYS . 50.5 m0 -121.0 147.35 45.61 Favored 'General case' 0 C--N 1.324 -0.53 0 O-C-N 124.511 1.132 . . . . 0.0 107.975 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 16.4 t30 -87.47 98.06 11.18 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.473 1.108 . . . . 0.0 109.233 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 172' ' ' ALA . . . . . 0.566 ' HB3' HD11 ' A' ' 182' ' ' ILE . . . -107.77 173.54 6.28 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.43 1.081 . . . . 0.0 109.334 179.909 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 173' ' ' GLU . . . . . 0.51 ' CG ' ' HG2' ' A' ' 179' ' ' ARG . 23.9 mt-10 -118.95 120.24 36.7 Favored 'General case' 0 C--N 1.326 -0.439 0 O-C-N 124.479 1.112 . . . . 0.0 110.268 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 174' ' ' ASP . . . . . 0.756 ' HA ' HD23 ' A' ' 159' ' ' LEU . 0.4 OUTLIER -73.92 -169.55 0.76 Allowed 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.489 1.118 . . . . 0.0 109.307 179.944 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 27.6 t -83.69 63.98 7.73 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.496 1.122 . . . . 0.0 110.038 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 176' ' ' GLU . . . . . 0.457 ' H ' ' H ' ' A' ' 177' ' ' GLY . 1.3 mt-10 -176.33 7.23 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.511 1.132 . . . . 0.0 110.341 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 177' ' ' GLY . . . . . 0.457 ' H ' ' H ' ' A' ' 176' ' ' GLU . . . 70.68 22.46 78.04 Favored Glycine 0 CA--C 1.53 0.984 0 O-C-N 124.492 1.12 . . . . 0.0 111.005 -179.969 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 178' ' ' LYS . . . . . 0.772 ' O ' HD11 ' A' ' 151' ' ' LEU . 4.6 ptpp? -94.4 115.45 27.66 Favored 'General case' 0 C--N 1.324 -0.53 0 O-C-N 124.454 0.738 . . . . 0.0 109.29 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 179' ' ' ARG . . . . . 0.51 ' HG2' ' CG ' ' A' ' 173' ' ' GLU . 1.3 mtt180 -92.87 123.63 36.27 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.579 1.175 . . . . 0.0 110.331 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -151.04 160.49 28.66 Favored Glycine 0 CA--C 1.53 1.001 0 O-C-N 124.48 1.112 . . . . 0.0 110.996 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 181' ' ' MET . . . . . 0.431 ' HA ' ' O ' ' A' ' 170' ' ' TRP . 4.7 mmm -88.6 107.13 18.75 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.472 0.748 . . . . 0.0 110.997 -179.966 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 182' ' ' ILE . . . . . 0.566 HD11 ' HB3' ' A' ' 172' ' ' ALA . 1.0 OUTLIER -112.32 170.12 5.62 Favored Pre-proline 0 C--N 1.325 -0.474 0 O-C-N 124.41 1.069 . . . . 0.0 109.338 179.969 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 183' ' ' PRO . . . . . 0.599 ' HG2' ' CB ' ' A' ' 186' ' ' TYR . 18.5 Cg_endo -74.98 132.82 15.88 Favored 'Trans proline' 0 C--N 1.36 1.132 0 O-C-N 124.425 1.75 . . . . 0.0 111.022 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 184' ' ' VAL . . . . . 0.819 ' N ' ' CD ' ' A' ' 185' ' ' PRO . 84.5 t -76.62 -31.68 0.96 Allowed Pre-proline 0 C--N 1.326 -0.456 0 O-C-N 124.577 1.173 . . . . 0.0 109.282 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 185' ' ' PRO . . . . . 0.819 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.4 Cg_endo -74.9 -8.72 20.44 Favored 'Trans proline' 0 C--N 1.36 1.153 0 O-C-N 124.454 1.765 . . . . 0.0 111.057 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 186' ' ' TYR . . . . . 0.599 ' CB ' ' HG2' ' A' ' 183' ' ' PRO . 3.4 m-85 -99.7 6.68 45.53 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.459 1.1 . . . . 0.0 110.941 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 187' ' ' VAL . . . . . 0.504 ' HA ' ' O ' ' A' ' 138' ' ' ARG . 34.5 m -136.92 174.5 11.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 O-C-N 124.506 1.129 . . . . 0.0 109.252 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 188' ' ' GLU . . . . . 0.572 ' HG2' HD11 ' A' ' 140' ' ' LEU . 0.0 OUTLIER -131.58 163.69 27.5 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.558 1.161 . . . . 0.0 110.302 179.986 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.53 124.14 35.47 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.461 1.101 . . . . 0.0 109.288 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 190' ' ' TYR . . . . . 0.499 ' OH ' ' CZ ' ' A' ' 138' ' ' ARG . 0.1 OUTLIER -98.94 77.96 2.24 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.448 1.093 . . . . 0.0 111.049 179.967 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 191' ' ' GLY . . . . . 0.4 ' O ' ' O ' ' A' ' 190' ' ' TYR . . . . . . . . 0 CA--C 1.531 1.039 0 O-C-N 124.52 1.138 . . . . 0.0 110.992 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 132' ' ' CYS . . . . . 0.494 ' O ' ' C ' ' A' ' 133' ' ' GLY . 76.5 m . . . . . 0 N--CA 1.452 -0.33 0 N-CA-C 108.358 -0.978 . . . . 0.0 108.358 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 133' ' ' GLY . . . . . 0.494 ' C ' ' O ' ' A' ' 132' ' ' CYS . . . -29.13 -82.92 0.01 OUTLIER Glycine 0 CA--C 1.531 1.048 0 O-C-N 124.492 1.12 . . . . 0.0 111.019 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 134' ' ' ALA . . . . . 0.489 ' O ' ' CG ' ' A' ' 135' ' ' GLU . . . -80.92 -105.37 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.54 0.788 . . . . 0.0 109.294 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.489 ' CG ' ' O ' ' A' ' 134' ' ' ALA . 5.5 mp0 -166.82 75.96 0.17 Allowed 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.482 1.114 . . . . 0.0 110.268 179.966 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 136' ' ' TYR . . . . . 0.584 ' CD1' ' HG2' ' A' ' 160' ' ' ARG . 86.2 m-85 -128.33 140.11 52.04 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.549 1.155 . . . . 0.0 110.956 -179.965 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.531 ' CG2' HD11 ' A' ' 161' ' ' ILE . 29.1 m -138.1 149.64 24.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 124.514 1.134 . . . . 0.0 109.335 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 138' ' ' ARG . . . . . 0.433 ' HB3' ' CD ' ' A' ' 188' ' ' GLU . 1.2 ttm180 -107.54 130.02 54.91 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.495 1.122 . . . . 0.0 110.275 -179.948 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.659 ' O ' ' N ' ' A' ' 156' ' ' GLY . . . -89.25 103.37 16.0 Favored 'General case' 0 C--N 1.326 -0.443 0 O-C-N 124.461 1.1 . . . . 0.0 109.281 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.468 HD11 ' HB3' ' A' ' 188' ' ' GLU . 0.2 OUTLIER -86.85 -2.8 58.86 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.521 1.138 . . . . 0.0 109.345 179.933 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 46.7 m-85 -128.92 157.63 41.06 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.5 1.125 . . . . 0.0 111.009 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 142' ' ' ASP . . . . . 0.465 ' HB2' ' HA ' ' A' ' 154' ' ' LYS . 1.5 t70 -112.28 156.89 21.66 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.388 1.055 . . . . 0.0 109.266 -179.928 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 143' ' ' PHE . . . . . 0.619 ' HB3' ' CZ ' ' A' ' 153' ' ' PHE . 11.7 t80 -178.99 41.89 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.434 1.084 . . . . 0.0 110.955 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 144' ' ' ASN . . . . . 0.489 ' HA ' ' HA ' ' A' ' 152' ' ' PRO . 71.9 m-80 -49.23 161.68 0.16 Allowed 'General case' 0 C--N 1.323 -0.549 0 O-C-N 124.529 1.143 . . . . 0.0 109.254 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 145' ' ' GLY . . . . . 0.545 ' O ' ' ND2' ' A' ' 146' ' ' ASN . . . -145.8 -125.18 1.71 Allowed Glycine 0 CA--C 1.53 0.991 0 O-C-N 124.525 1.141 . . . . 0.0 110.999 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 146' ' ' ASN . . . . . 0.545 ' ND2' ' O ' ' A' ' 145' ' ' GLY . 0.5 OUTLIER 162.74 77.44 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.506 0.769 . . . . 0.0 109.324 -179.99 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -171.4 164.69 7.04 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.481 1.113 . . . . 0.0 109.312 -179.945 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -92.77 55.62 2.46 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.558 1.161 . . . . 0.0 110.315 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 9.8 tt0 -149.44 -45.27 0.14 Allowed 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.499 1.124 . . . . 0.0 110.291 179.935 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 29.2 t0 -105.43 169.92 8.18 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.514 1.134 . . . . 0.0 109.31 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.933 HD21 ' OD2' ' A' ' 174' ' ' ASP . 0.2 OUTLIER -119.41 126.18 27.14 Favored Pre-proline 0 C--N 1.326 -0.452 0 O-C-N 124.479 1.112 . . . . 0.0 109.247 -179.96 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 152' ' ' PRO . . . . . 0.489 ' HA ' ' HA ' ' A' ' 144' ' ' ASN . 18.5 Cg_endo -74.94 135.25 18.94 Favored 'Trans proline' 0 C--N 1.36 1.136 0 O-C-N 124.513 1.796 . . . . 0.0 110.991 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 153' ' ' PHE . . . . . 0.619 ' CZ ' ' HB3' ' A' ' 143' ' ' PHE . 8.4 p90 -154.51 170.54 21.19 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.472 1.108 . . . . 0.0 111.003 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 154' ' ' LYS . . . . . 0.465 ' HA ' ' HB2' ' A' ' 142' ' ' ASP . 6.8 tttt -128.49 -164.9 1.43 Allowed 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.441 1.088 . . . . 0.0 109.272 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 35.4 tttt -92.94 106.47 18.43 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.483 1.114 . . . . 0.0 109.293 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 156' ' ' GLY . . . . . 0.659 ' N ' ' O ' ' A' ' 139' ' ' ALA . . . 109.86 29.01 3.97 Favored Glycine 0 CA--C 1.531 1.034 0 O-C-N 124.496 1.123 . . . . 0.0 111.004 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 157' ' ' ASP . . . . . 0.494 ' HB3' ' HB3' ' A' ' 139' ' ' ALA . 22.8 t70 -97.39 167.05 11.24 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.482 0.754 . . . . 0.0 109.352 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 158' ' ' ILE . . . . . 0.43 HD13 ' O ' ' A' ' 157' ' ' ASP . 18.0 mm -121.46 136.78 57.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 O-C-N 124.52 1.137 . . . . 0.0 109.306 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.6 HD22 HD13 ' A' ' 182' ' ' ILE . 0.8 OUTLIER -141.48 136.63 31.44 Favored 'General case' 0 C--N 1.326 -0.427 0 O-C-N 124.495 1.122 . . . . 0.0 109.325 -179.97 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 160' ' ' ARG . . . . . 0.584 ' HG2' ' CD1' ' A' ' 136' ' ' TYR . 0.0 OUTLIER -97.33 134.98 39.88 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.528 1.143 . . . . 0.0 110.347 179.96 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.531 HD11 ' CG2' ' A' ' 137' ' ' VAL . 1.7 mp -87.19 125.22 41.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 O-C-N 124.501 1.126 . . . . 0.0 109.346 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 162' ' ' ARG . . . . . 0.482 ' CG ' ' N ' ' A' ' 163' ' ' ASP . 0.8 OUTLIER -118.63 -41.03 2.83 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 124.5 1.125 . . . . 0.0 110.291 -179.953 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 163' ' ' ASP . . . . . 0.482 ' N ' ' CG ' ' A' ' 162' ' ' ARG . 13.7 m-20 -148.78 176.99 9.91 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.492 1.12 . . . . 0.0 109.34 -179.987 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 164' ' ' LYS . . . . . 0.592 ' HB3' ' CD1' ' A' ' 170' ' ' TRP . 6.9 mtmm -144.88 65.45 12.24 Favored Pre-proline 0 C--N 1.325 -0.478 0 O-C-N 124.564 1.165 . . . . 0.0 109.283 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 165' ' ' PRO . . . . . 0.514 ' O ' ' CB ' ' A' ' 166' ' ' GLU . 18.5 Cg_endo -74.92 73.29 4.32 Favored 'Trans proline' 0 C--N 1.361 1.212 0 O-C-N 124.507 1.793 . . . . 0.0 110.997 179.966 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 166' ' ' GLU . . . . . 0.535 ' OE1' ' HE2' ' A' ' 181' ' ' MET . 2.5 mt-10 159.93 179.35 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.528 1.142 . . . . 0.0 110.325 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -118.16 46.11 1.85 Allowed 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.513 1.133 . . . . 0.0 110.318 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -178.83 -54.35 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.484 1.115 . . . . 0.0 110.322 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 169' ' ' TRP . . . . . . . . . . . . . 10.2 m95 -95.52 144.35 26.07 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.539 1.149 . . . . 0.0 107.991 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 170' ' ' TRP . . . . . 0.592 ' CD1' ' HB3' ' A' ' 164' ' ' LYS . 53.2 m0 -118.71 148.38 42.83 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 -179.963 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 171' ' ' ASN . . . . . 0.458 ' HB2' ' CD ' ' A' ' 165' ' ' PRO . 5.4 t-20 -87.58 107.73 18.73 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.555 1.16 . . . . 0.0 109.366 179.903 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 172' ' ' ALA . . . . . 0.576 ' HA ' ' O ' ' A' ' 160' ' ' ARG . . . -119.28 174.88 6.09 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.511 1.132 . . . . 0.0 109.31 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 173' ' ' GLU . . . . . 0.514 ' HG3' ' CG ' ' A' ' 179' ' ' ARG . 3.8 mt-10 -118.17 119.92 36.16 Favored 'General case' 0 C--N 1.326 -0.427 0 O-C-N 124.543 1.152 . . . . 0.0 110.262 -179.947 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 174' ' ' ASP . . . . . 0.933 ' OD2' HD21 ' A' ' 151' ' ' LEU . 0.8 OUTLIER -76.19 -173.7 2.5 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.411 1.069 . . . . 0.0 109.319 -179.943 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 40.6 t -75.82 63.89 1.73 Allowed 'General case' 0 C--N 1.324 -0.539 0 O-C-N 124.591 1.182 . . . . 0.0 110.079 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 176' ' ' GLU . . . . . 0.442 ' H ' ' H ' ' A' ' 177' ' ' GLY . 0.9 OUTLIER -177.56 1.53 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.55 1.156 . . . . 0.0 110.276 -179.921 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 177' ' ' GLY . . . . . 0.442 ' H ' ' H ' ' A' ' 176' ' ' GLU . . . 74.94 15.47 80.98 Favored Glycine 0 CA--C 1.53 0.998 0 O-C-N 124.522 1.139 . . . . 0.0 111.019 -179.954 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 178' ' ' LYS . . . . . 0.407 ' O ' ' HA ' ' A' ' 173' ' ' GLU . 0.0 OUTLIER -84.91 117.59 24.01 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.506 0.768 . . . . 0.0 109.38 179.986 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 179' ' ' ARG . . . . . 0.514 ' CG ' ' HG3' ' A' ' 173' ' ' GLU . 3.3 mtt85 -90.18 123.34 33.92 Favored 'General case' 0 C--N 1.326 -0.441 0 O-C-N 124.498 1.124 . . . . 0.0 110.294 -179.949 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 180' ' ' GLY . . . . . 0.549 ' HA3' HD12 ' A' ' 151' ' ' LEU . . . -152.21 164.57 30.56 Favored Glycine 0 CA--C 1.53 1.011 0 O-C-N 124.471 1.107 . . . . 0.0 111.017 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 181' ' ' MET . . . . . 0.535 ' HE2' ' OE1' ' A' ' 166' ' ' GLU . 21.7 mtp -86.37 101.77 13.41 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.528 0.781 . . . . 0.0 110.95 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 182' ' ' ILE . . . . . 0.6 HD13 HD22 ' A' ' 159' ' ' LEU . 23.3 pt -99.2 158.12 32.82 Favored Pre-proline 0 C--N 1.326 -0.452 0 O-C-N 124.492 1.12 . . . . 0.0 109.301 179.922 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 183' ' ' PRO . . . . . 0.754 ' HG2' ' HB2' ' A' ' 186' ' ' TYR . 18.4 Cg_endo -74.96 134.13 17.5 Favored 'Trans proline' 0 C--N 1.36 1.159 0 O-C-N 124.404 1.739 . . . . 0.0 110.947 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 184' ' ' VAL . . . . . 0.807 ' N ' ' CD ' ' A' ' 185' ' ' PRO . 73.9 t -77.43 -33.36 1.04 Allowed Pre-proline 0 C--N 1.325 -0.46 0 O-C-N 124.578 1.174 . . . . 0.0 109.271 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 185' ' ' PRO . . . . . 0.807 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.3 Cg_endo -74.96 -14.7 21.15 Favored 'Trans proline' 0 C--N 1.361 1.191 0 O-C-N 124.5 1.789 . . . . 0.0 111.026 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 186' ' ' TYR . . . . . 0.754 ' HB2' ' HG2' ' A' ' 183' ' ' PRO . 3.3 m-85 -96.59 0.31 49.78 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.508 1.13 . . . . 0.0 111.057 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 4.1 m -135.4 164.49 32.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 O-C-N 124.463 1.102 . . . . 0.0 109.271 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 188' ' ' GLU . . . . . 0.474 ' O ' ' HA ' ' A' ' 137' ' ' VAL . 0.0 OUTLIER -122.46 166.92 13.99 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.52 1.137 . . . . 0.0 110.293 179.963 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -87.69 135.59 33.31 Favored 'General case' 0 C--N 1.326 -0.422 0 O-C-N 124.492 1.12 . . . . 0.0 109.288 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -129.39 91.61 3.21 Favored 'General case' 0 C--N 1.326 -0.423 0 O-C-N 124.447 1.092 . . . . 0.0 110.948 -179.957 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.075 0 O-C-N 124.586 1.179 . . . . 0.0 110.952 179.931 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . 0.463 ' HB3' ' O ' ' A' ' 161' ' ' ILE . 0.3 OUTLIER . . . . . 0 N--CA 1.453 -0.275 0 N-CA-C 110.283 -0.265 . . . . 0.0 110.283 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . 0.812 ' CD1' ' CG ' ' A' ' 190' ' ' TYR . 1.9 t80 -112.49 128.77 56.43 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.482 1.113 . . . . 0.0 110.965 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.742 HG13 ' O ' ' A' ' 188' ' ' GLU . 10.5 t -139.61 141.48 34.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 O-C-N 124.534 1.146 . . . . 0.0 109.306 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . 0.417 ' NE ' ' HA2' ' A' ' 156' ' ' GLY . 0.5 OUTLIER -112.18 139.18 47.93 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.44 1.087 . . . . 0.0 110.287 -179.987 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.464 ' CB ' HG12 ' A' ' 187' ' ' VAL . . . -95.17 114.5 26.3 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.468 1.105 . . . . 0.0 109.318 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.453 ' O ' ' CB ' ' A' ' 155' ' ' LYS . 0.5 OUTLIER -87.26 -22.83 24.95 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.498 1.124 . . . . 0.0 109.277 -179.984 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 20.2 m-85 -101.67 167.58 10.02 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.474 1.109 . . . . 0.0 110.995 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 1.9 p30 . . . . . 0 C--N 1.325 -0.484 0 O-C-N 124.504 1.127 . . . . 0.0 109.309 -179.992 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . 0.515 ' CE2' HG13 ' A' ' 182' ' ' ILE . 12.8 p90 . . . . . 0 N--CA 1.453 -0.296 0 CA-C-O 120.468 0.175 . . . . 0.0 110.999 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 8.6 tttt -126.56 -167.22 1.69 Allowed 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.556 1.16 . . . . 0.0 109.284 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.453 ' CB ' ' O ' ' A' ' 140' ' ' LEU . 2.9 ptmt -91.29 106.84 18.79 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.532 1.145 . . . . 0.0 109.257 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . 0.417 ' HA2' ' NE ' ' A' ' 138' ' ' ARG . . . 105.14 27.2 5.98 Favored Glycine 0 CA--C 1.531 1.033 0 O-C-N 124.505 1.128 . . . . 0.0 111.03 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . 0.503 ' C ' HD13 ' A' ' 158' ' ' ILE . 32.2 t70 -92.34 161.46 14.66 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.502 0.766 . . . . 0.0 109.32 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . 0.67 HG23 ' CZ ' ' A' ' 136' ' ' TYR . 6.5 mm -111.76 128.1 68.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 O-C-N 124.474 1.109 . . . . 0.0 109.312 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.839 HD22 HD12 ' A' ' 182' ' ' ILE . 1.7 mp -142.19 127.55 18.8 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.48 1.112 . . . . 0.0 109.292 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . 0.41 ' HG2' ' O ' ' A' ' 135' ' ' GLU . 4.4 mtt180 -86.53 143.56 27.65 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.497 1.123 . . . . 0.0 110.333 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.463 ' O ' ' HB3' ' A' ' 135' ' ' GLU . 0.9 OUTLIER -86.81 116.15 28.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 O-C-N 124.542 1.151 . . . . 0.0 109.275 -179.969 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . 0.401 ' NH1' ' OE2' ' A' ' 173' ' ' GLU . 3.1 tpt180 -97.7 -69.27 0.76 Allowed 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.49 1.119 . . . . 0.0 110.285 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -134.42 173.43 11.64 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.422 1.076 . . . . 0.0 109.316 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . 0.535 ' HG2' ' CD2' ' A' ' 170' ' ' TRP . 0.0 OUTLIER -135.1 87.32 29.3 Favored Pre-proline 0 C--N 1.325 -0.47 0 O-C-N 124.515 1.135 . . . . 0.0 109.316 -179.958 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -74.97 -25.21 12.13 Favored 'Trans proline' 0 C--N 1.361 1.192 0 O-C-N 124.486 1.782 . . . . 0.0 111.001 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 6.7 mt-10 -125.22 167.36 14.97 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.551 1.157 . . . . 0.0 110.302 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -87.62 -18.82 28.78 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.497 1.123 . . . . 0.0 110.274 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 12.0 mt-30 -103.28 -53.44 2.81 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.491 1.119 . . . . 0.0 110.31 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 169' ' ' TRP . . . . . . . . . . . . . 7.0 m95 -100.7 133.58 44.94 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.504 1.127 . . . . 0.0 107.999 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 170' ' ' TRP . . . . . 0.682 ' CE2' HG21 ' A' ' 184' ' ' VAL . 54.7 m0 -116.63 155.09 29.38 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.553 1.158 . . . . 0.0 107.983 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 171' ' ' ASN . . . . . 0.485 ' HA ' ' O ' ' A' ' 180' ' ' GLY . 19.5 t30 -86.5 97.48 10.52 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.495 1.122 . . . . 0.0 109.31 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -109.91 166.59 10.81 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.556 1.16 . . . . 0.0 109.308 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . 0.401 ' OE2' ' NH1' ' A' ' 162' ' ' ARG . 23.1 mt-10 -116.18 112.92 22.35 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.463 1.102 . . . . 0.0 110.273 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . 0.484 ' OD1' ' N ' ' A' ' 174' ' ' ASP . 0.0 OUTLIER -68.63 -177.38 0.95 Allowed 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.427 1.08 . . . . 0.0 109.335 179.955 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 73.0 p -77.32 57.71 1.53 Allowed 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.506 1.129 . . . . 0.0 110.03 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . 0.409 ' O ' ' HD2' ' A' ' 178' ' ' LYS . 2.7 mt-10 -175.35 22.68 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.519 1.137 . . . . 0.0 110.284 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 55.57 29.18 53.34 Favored Glycine 0 CA--C 1.53 1.004 0 O-C-N 124.522 1.139 . . . . 0.0 110.991 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 178' ' ' LYS . . . . . 0.422 ' O ' ' OD1' ' A' ' 174' ' ' ASP . 0.0 OUTLIER -96.7 110.99 23.32 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.429 0.723 . . . . 0.0 109.308 179.982 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 3.4 ttp180 -91.1 120.5 32.1 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.523 1.139 . . . . 0.0 110.237 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . 0.485 ' O ' ' HA ' ' A' ' 171' ' ' ASN . . . -149.84 172.54 29.75 Favored Glycine 0 CA--C 1.53 0.998 0 O-C-N 124.483 1.114 . . . . 0.0 111.001 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 181' ' ' MET . . . . . 0.459 ' HA ' ' O ' ' A' ' 170' ' ' TRP . 20.7 mtp -86.94 92.55 9.06 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.497 0.763 . . . . 0.0 110.998 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . 0.839 HD12 HD22 ' A' ' 159' ' ' LEU . 6.6 tt -89.87 144.88 32.24 Favored Pre-proline 0 C--N 1.326 -0.455 0 O-C-N 124.495 1.122 . . . . 0.0 109.32 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 183' ' ' PRO . . . . . 0.674 ' HG2' ' HB2' ' A' ' 186' ' ' TYR . 18.4 Cg_endo -74.97 132.13 15.1 Favored 'Trans proline' 0 C--N 1.36 1.148 0 O-C-N 124.479 1.778 . . . . 0.0 111.028 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . 0.821 ' N ' ' CD ' ' A' ' 185' ' ' PRO . 28.1 t -74.48 -30.68 1.1 Allowed Pre-proline 0 C--N 1.325 -0.489 0 O-C-N 124.522 1.139 . . . . 0.0 109.303 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 185' ' ' PRO . . . . . 0.821 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.3 Cg_endo -74.92 -10.86 21.54 Favored 'Trans proline' 0 C--N 1.36 1.153 0 O-C-N 124.559 1.82 . . . . 0.0 111.025 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 186' ' ' TYR . . . . . 0.674 ' HB2' ' HG2' ' A' ' 183' ' ' PRO . 3.7 m-30 -101.61 -19.47 15.44 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.513 1.133 . . . . 0.0 111.018 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 187' ' ' VAL . . . . . 0.706 ' CG2' HG11 ' A' ' 137' ' ' VAL . 13.8 m -115.5 175.9 2.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 O-C-N 124.457 1.098 . . . . 0.0 109.311 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 188' ' ' GLU . . . . . 0.742 ' O ' HG13 ' A' ' 137' ' ' VAL . 0.0 OUTLIER -135.97 168.08 20.02 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 124.481 1.113 . . . . 0.0 110.311 -179.988 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . 0.519 ' HD2' HG22 ' A' ' 137' ' ' VAL . 5.8 mmmt -94.69 141.09 29.02 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.536 1.148 . . . . 0.0 109.31 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 190' ' ' TYR . . . . . 0.812 ' CG ' ' CD1' ' A' ' 136' ' ' TYR . 0.2 OUTLIER . . . . . 0 C--N 1.325 -0.47 0 O-C-N 124.459 1.1 . . . . 0.0 111.059 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . 0.481 ' O ' ' HA ' ' A' ' 160' ' ' ARG . 0.7 OUTLIER . . . . . 0 N--CA 1.454 -0.266 0 N-CA-C 110.311 -0.255 . . . . 0.0 110.311 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . 0.443 ' CD1' ' C ' ' A' ' 135' ' ' GLU . 1.9 m-85 -121.17 132.77 55.04 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.562 1.164 . . . . 0.0 110.975 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.601 ' CG2' HD11 ' A' ' 161' ' ' ILE . 22.4 m -129.6 162.31 37.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 O-C-N 124.58 1.175 . . . . 0.0 109.294 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . 0.448 ' O ' ' HA ' ' A' ' 187' ' ' VAL . 0.0 OUTLIER -119.25 125.04 48.19 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.505 1.128 . . . . 0.0 110.341 179.999 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.661 ' CB ' HG12 ' A' ' 187' ' ' VAL . . . -89.1 107.09 18.85 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.497 1.123 . . . . 0.0 109.284 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.57 HD11 ' HG2' ' A' ' 188' ' ' GLU . 0.1 OUTLIER -88.68 -29.86 19.57 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.571 1.169 . . . . 0.0 109.349 -179.998 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . 0.494 ' C ' ' O ' ' A' ' 154' ' ' LYS . 47.2 m-85 -91.2 153.55 19.93 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.523 1.14 . . . . 0.0 110.989 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . 0.43 ' HB2' ' HA ' ' A' ' 154' ' ' LYS . 4.2 t70 . . . . . 0 C--N 1.325 -0.467 0 O-C-N 124.475 1.11 . . . . 0.0 109.361 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . 0.414 ' O ' ' OD1' ' A' ' 142' ' ' ASP . 10.7 p90 . . . . . 0 N--CA 1.453 -0.285 0 CA-C-O 120.501 0.191 . . . . 0.0 111.004 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . 0.494 ' O ' ' C ' ' A' ' 141' ' ' PHE . 0.1 OUTLIER -121.27 -90.77 0.57 Allowed 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.492 1.12 . . . . 0.0 109.363 179.954 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.41 ' CG ' ' O ' ' A' ' 140' ' ' LEU . 10.3 ttpp -157.45 118.28 3.55 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.534 1.146 . . . . 0.0 109.28 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . 0.614 ' N ' ' O ' ' A' ' 139' ' ' ALA . . . 98.42 16.36 32.23 Favored Glycine 0 CA--C 1.531 1.033 0 O-C-N 124.544 1.153 . . . . 0.0 111.0 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . 0.537 ' HB3' ' HB3' ' A' ' 139' ' ' ALA . 14.4 t70 -81.31 156.67 25.4 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.519 0.776 . . . . 0.0 109.3 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 5.1 mm -110.68 138.62 37.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 O-C-N 124.485 1.116 . . . . 0.0 109.347 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 1.046 HD22 HD13 ' A' ' 182' ' ' ILE . 1.5 mp -141.19 136.3 31.65 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.506 1.129 . . . . 0.0 109.272 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . 0.593 ' O ' ' HA ' ' A' ' 172' ' ' ALA . 0.0 OUTLIER -99.46 129.52 45.65 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.476 1.11 . . . . 0.0 110.313 179.981 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.601 HD11 ' CG2' ' A' ' 137' ' ' VAL . 1.7 mp -83.76 122.08 37.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 O-C-N 124.516 1.135 . . . . 0.0 109.286 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -122.65 -42.44 2.32 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.505 1.128 . . . . 0.0 110.261 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -135.06 170.81 15.34 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.491 1.119 . . . . 0.0 109.295 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . 0.565 ' HB2' ' CD1' ' A' ' 170' ' ' TRP . 0.6 OUTLIER -164.74 84.98 1.13 Allowed Pre-proline 0 C--N 1.325 -0.458 0 O-C-N 124.505 1.128 . . . . 0.0 109.3 179.928 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.08 -27.52 9.82 Favored 'Trans proline' 0 C--N 1.36 1.17 0 O-C-N 124.51 1.795 . . . . 0.0 110.983 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -118.54 168.94 10.21 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.539 1.15 . . . . 0.0 110.299 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -93.27 -19.67 21.17 Favored 'General case' 0 C--N 1.326 -0.441 0 O-C-N 124.522 1.139 . . . . 0.0 110.333 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -85.58 -57.12 3.19 Favored 'General case' 0 C--N 1.326 -0.422 0 O-C-N 124.506 1.129 . . . . 0.0 110.336 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 169' ' ' TRP . . . . . . . . . . . . . 10.6 m95 -107.18 150.62 26.41 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.549 1.156 . . . . 0.0 108.04 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 170' ' ' TRP . . . . . 0.769 ' CD2' HG21 ' A' ' 184' ' ' VAL . 37.5 m0 -127.51 151.6 48.66 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.549 1.155 . . . . 0.0 108.0 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 171' ' ' ASN . . . . . 0.414 ' HA ' ' O ' ' A' ' 180' ' ' GLY . 0.2 OUTLIER -87.37 99.14 11.78 Favored 'General case' 0 C--N 1.324 -0.532 0 O-C-N 124.468 1.105 . . . . 0.0 109.283 179.994 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . 0.593 ' HA ' ' O ' ' A' ' 160' ' ' ARG . . . -119.05 -178.43 3.56 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.476 1.11 . . . . 0.0 109.303 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . 0.436 ' CG ' ' HG3' ' A' ' 179' ' ' ARG . 34.0 mt-10 -119.73 121.15 38.55 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.47 1.106 . . . . 0.0 110.27 -179.898 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -72.44 -164.22 0.14 Allowed 'General case' 0 C--N 1.323 -0.547 0 O-C-N 124.594 1.184 . . . . 0.0 109.259 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 52.6 p -87.53 56.94 4.15 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.465 1.103 . . . . 0.0 109.999 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -177.22 28.45 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.532 1.145 . . . . 0.0 110.189 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 53.23 24.69 23.06 Favored Glycine 0 CA--C 1.531 1.078 0 O-C-N 124.562 1.164 . . . . 0.0 111.003 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 3.1 mtpm? -90.93 108.89 20.15 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.503 0.767 . . . . 0.0 109.355 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 179' ' ' ARG . . . . . 0.436 ' HG3' ' CG ' ' A' ' 173' ' ' GLU . 0.0 OUTLIER -90.7 114.97 27.42 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.499 1.125 . . . . 0.0 110.34 179.955 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . 0.414 ' O ' ' HA ' ' A' ' 171' ' ' ASN . . . -150.79 174.31 30.13 Favored Glycine 0 CA--C 1.53 1.013 0 O-C-N 124.486 1.116 . . . . 0.0 111.01 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 181' ' ' MET . . . . . 0.419 ' HA ' ' O ' ' A' ' 170' ' ' TRP . 33.5 mtp -88.04 106.19 17.98 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.537 0.786 . . . . 0.0 110.99 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . 1.046 HD13 HD22 ' A' ' 159' ' ' LEU . 6.8 pt -106.65 159.38 30.06 Favored Pre-proline 0 C--N 1.325 -0.496 0 O-C-N 124.505 1.128 . . . . 0.0 109.36 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 183' ' ' PRO . . . . . 0.565 ' HG2' ' CB ' ' A' ' 186' ' ' TYR . 18.1 Cg_endo -75.02 127.5 10.72 Favored 'Trans proline' 0 C--N 1.36 1.174 0 O-C-N 124.418 1.746 . . . . 0.0 111.013 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . 0.769 HG21 ' CD2' ' A' ' 170' ' ' TRP . 21.8 t -76.17 -34.92 1.51 Allowed Pre-proline 0 C--N 1.325 -0.49 0 O-C-N 124.514 1.134 . . . . 0.0 109.334 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 185' ' ' PRO . . . . . 0.758 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.4 Cg_endo -74.95 -9.73 20.98 Favored 'Trans proline' 0 C--N 1.36 1.162 0 O-C-N 124.51 1.795 . . . . 0.0 110.988 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 186' ' ' TYR . . . . . 0.565 ' CB ' ' HG2' ' A' ' 183' ' ' PRO . 3.2 m-85 -95.95 -5.92 40.23 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.464 1.103 . . . . 0.0 110.962 -179.897 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 187' ' ' VAL . . . . . 0.661 HG12 ' CB ' ' A' ' 139' ' ' ALA . 7.6 m -129.33 175.47 10.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 O-C-N 124.391 1.057 . . . . 0.0 109.282 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 188' ' ' GLU . . . . . 0.57 ' HG2' HD11 ' A' ' 140' ' ' LEU . 0.0 OUTLIER -131.63 173.26 11.31 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.534 1.147 . . . . 0.0 110.297 179.971 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.05 119.43 28.41 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.502 1.126 . . . . 0.0 109.273 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 1.6 t80 . . . . . 0 C--N 1.324 -0.507 0 O-C-N 124.448 1.092 . . . . 0.0 110.92 -179.991 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . 0.641 ' HG2' HG22 ' A' ' 161' ' ' ILE . 0.8 OUTLIER . . . . . 0 N--CA 1.452 -0.344 0 N-CA-C 110.351 -0.24 . . . . 0.0 110.351 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -124.46 114.5 19.54 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.496 1.123 . . . . 0.0 111.038 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.443 HG22 ' HB ' ' A' ' 187' ' ' VAL . 0.4 OUTLIER -113.06 132.22 62.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 O-C-N 124.419 1.074 . . . . 0.0 109.282 -179.993 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . 0.501 ' HG3' ' N ' ' A' ' 139' ' ' ALA . 2.7 ttm180 -101.09 142.85 31.95 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.462 1.101 . . . . 0.0 110.259 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.515 ' O ' ' N ' ' A' ' 156' ' ' GLY . . . -105.85 109.08 20.91 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.564 1.165 . . . . 0.0 109.345 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.511 ' O ' ' CG ' ' A' ' 155' ' ' LYS . 0.3 OUTLIER -87.36 -22.42 25.08 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.496 1.123 . . . . 0.0 109.272 -179.944 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . 0.408 ' CD1' ' N ' ' A' ' 141' ' ' PHE . 0.6 OUTLIER -108.99 146.9 33.13 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.487 1.117 . . . . 0.0 111.013 179.972 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . 0.426 ' CB ' ' HA ' ' A' ' 154' ' ' LYS . 5.7 t70 . . . . . 0 C--N 1.325 -0.489 0 O-C-N 124.537 1.148 . . . . 0.0 109.296 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . 0.596 ' CZ ' ' CD ' ' A' ' 183' ' ' PRO . 0.4 OUTLIER . . . . . 0 N--CA 1.453 -0.307 0 CA-C-O 120.542 0.211 . . . . 0.0 111.018 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . 0.426 ' HA ' ' CB ' ' A' ' 142' ' ' ASP . 0.1 OUTLIER -127.13 -164.91 1.4 Allowed 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.458 1.099 . . . . 0.0 109.315 -179.995 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.511 ' CG ' ' O ' ' A' ' 140' ' ' LEU . 1.5 tttp -97.08 99.16 10.68 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.475 1.109 . . . . 0.0 109.317 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . 0.515 ' N ' ' O ' ' A' ' 139' ' ' ALA . . . 116.08 29.54 2.34 Favored Glycine 0 CA--C 1.53 1.008 0 O-C-N 124.534 1.146 . . . . 0.0 111.01 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . 0.932 ' C ' HD12 ' A' ' 158' ' ' ILE . 12.4 t70 -102.9 166.81 10.25 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.607 0.828 . . . . 0.0 109.305 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . 0.932 HD12 ' C ' ' A' ' 157' ' ' ASP . 1.9 mp -123.56 146.28 29.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 O-C-N 124.476 1.11 . . . . 0.0 109.344 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.775 HD21 ' OD2' ' A' ' 174' ' ' ASP . 0.8 OUTLIER -144.11 128.85 18.27 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.513 1.133 . . . . 0.0 109.314 -179.98 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . 0.558 ' O ' ' HA ' ' A' ' 172' ' ' ALA . 2.0 tmt_? -87.72 127.77 35.3 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.458 1.099 . . . . 0.0 110.292 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.641 HG22 ' HG2' ' A' ' 135' ' ' GLU . 1.7 mp -84.96 130.85 35.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.455 1.097 . . . . 0.0 109.288 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . 0.467 ' HD3' ' CZ ' ' A' ' 179' ' ' ARG . 33.7 ttt85 -127.3 -46.44 1.49 Allowed 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.46 1.1 . . . . 0.0 110.314 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . 0.48 ' CB ' ' HB3' ' A' ' 171' ' ' ASN . 0.2 OUTLIER -123.7 161.4 25.19 Favored 'General case' 0 C--N 1.326 -0.433 0 O-C-N 124.508 1.13 . . . . 0.0 109.281 179.991 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . 0.513 ' O ' ' CG ' ' A' ' 164' ' ' LYS . 0.1 OUTLIER -165.23 64.14 1.0 Allowed Pre-proline 0 C--N 1.327 -0.391 0 O-C-N 124.463 1.102 . . . . 0.0 109.261 179.98 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' PRO . . . . . 0.425 ' HD3' ' N ' ' A' ' 164' ' ' LYS . 18.1 Cg_endo -75.03 -49.18 0.15 Allowed 'Trans proline' 0 C--N 1.359 1.089 0 O-C-N 124.547 1.814 . . . . 0.0 110.977 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . 0.588 ' HG3' ' HE1' ' A' ' 181' ' ' MET . 5.4 mt-10 -66.14 167.57 9.86 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.499 1.124 . . . . 0.0 110.244 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 5.3 mp0 -110.87 40.91 1.91 Allowed 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.448 1.093 . . . . 0.0 110.309 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 5.4 mt-30 -159.44 -57.82 0.06 Allowed 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.553 1.158 . . . . 0.0 110.263 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 169' ' ' TRP . . . . . . . . . . . . . 10.4 m95 -102.04 144.45 30.62 Favored 'General case' 0 C--N 1.324 -0.523 0 O-C-N 124.567 1.167 . . . . 0.0 107.972 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 170' ' ' TRP . . . . . 0.75 ' CE2' HG21 ' A' ' 184' ' ' VAL . 50.8 m0 -116.28 146.88 42.06 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 171' ' ' ASN . . . . . 0.499 ' OD1' ' CD ' ' A' ' 179' ' ' ARG . 18.7 t-20 -87.72 99.88 12.42 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.505 1.128 . . . . 0.0 109.288 180.0 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . 0.558 ' HA ' ' O ' ' A' ' 160' ' ' ARG . . . -119.87 168.77 10.77 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.484 1.115 . . . . 0.0 109.267 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . 0.485 ' HG3' ' CB ' ' A' ' 179' ' ' ARG . 1.8 mt-10 -113.92 124.12 51.41 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.53 1.144 . . . . 0.0 110.292 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . 0.775 ' OD2' HD21 ' A' ' 159' ' ' LEU . 0.2 OUTLIER -73.99 -168.5 0.62 Allowed 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.47 1.106 . . . . 0.0 109.309 179.97 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 10.5 t -81.17 58.31 3.48 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 124.404 1.065 . . . . 0.0 110.024 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -175.11 16.85 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.449 1.093 . . . . 0.0 110.317 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 177' ' ' GLY . . . . . 0.405 ' C ' ' HG2' ' A' ' 173' ' ' GLU . . . 64.12 17.36 61.2 Favored Glycine 0 CA--C 1.529 0.951 0 O-C-N 124.562 1.164 . . . . 0.0 111.005 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 178' ' ' LYS . . . . . 0.408 ' O ' ' HA ' ' A' ' 173' ' ' GLU . 0.8 OUTLIER -85.95 102.09 13.45 Favored 'General case' 0 C--N 1.326 -0.441 0 O-C-N 124.472 0.748 . . . . 0.0 109.307 179.985 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 179' ' ' ARG . . . . . 0.499 ' CD ' ' OD1' ' A' ' 171' ' ' ASN . 20.1 ttm-85 -88.15 120.35 29.42 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.464 1.102 . . . . 0.0 110.328 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . 0.416 ' O ' ' HA ' ' A' ' 171' ' ' ASN . . . -152.36 172.45 31.56 Favored Glycine 0 CA--C 1.53 1.013 0 O-C-N 124.554 1.159 . . . . 0.0 110.953 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 181' ' ' MET . . . . . 0.588 ' HE1' ' HG3' ' A' ' 166' ' ' GLU . 35.7 mtp -86.96 99.82 12.15 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.46 0.741 . . . . 0.0 111.009 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . 0.583 HD13 HD13 ' A' ' 159' ' ' LEU . 5.7 pt -99.38 160.6 27.1 Favored Pre-proline 0 C--N 1.325 -0.46 0 O-C-N 124.454 1.096 . . . . 0.0 109.381 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 183' ' ' PRO . . . . . 0.739 ' HG2' ' HB2' ' A' ' 186' ' ' TYR . 18.5 Cg_endo -75.05 135.16 18.61 Favored 'Trans proline' 0 C--N 1.359 1.1 0 O-C-N 124.462 1.77 . . . . 0.0 111.019 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . 0.851 ' N ' ' CD ' ' A' ' 185' ' ' PRO . 42.9 t -80.07 -30.16 0.59 Allowed Pre-proline 0 C--N 1.325 -0.493 0 O-C-N 124.522 1.139 . . . . 0.0 109.321 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 185' ' ' PRO . . . . . 0.851 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.4 Cg_endo -75.02 -21.42 15.83 Favored 'Trans proline' 0 C--N 1.36 1.155 0 O-C-N 124.532 1.806 . . . . 0.0 110.963 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 186' ' ' TYR . . . . . 0.739 ' HB2' ' HG2' ' A' ' 183' ' ' PRO . 4.1 m-85 -94.42 15.52 17.51 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.52 1.138 . . . . 0.0 111.001 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 187' ' ' VAL . . . . . 0.474 ' HA ' ' O ' ' A' ' 138' ' ' ARG . 27.4 m -143.37 171.83 8.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 O-C-N 124.453 1.096 . . . . 0.0 109.294 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 188' ' ' GLU . . . . . 0.475 ' N ' ' O ' ' A' ' 138' ' ' ARG . 0.0 OUTLIER -131.75 169.65 15.92 Favored 'General case' 0 C--N 1.326 -0.442 0 O-C-N 124.462 1.102 . . . . 0.0 110.257 179.999 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -88.15 127.9 35.43 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.427 1.079 . . . . 0.0 109.304 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.325 -0.498 0 O-C-N 124.481 1.113 . . . . 0.0 111.053 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . 0.41 ' CB ' ' HB ' ' A' ' 161' ' ' ILE . 0.4 OUTLIER . . . . . 0 N--CA 1.452 -0.334 0 N-CA-C 110.286 -0.264 . . . . 0.0 110.286 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 8.6 m-85 -130.95 99.97 5.09 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.522 1.139 . . . . 0.0 110.94 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.855 HG22 ' HB ' ' A' ' 187' ' ' VAL . 11.8 p -102.22 130.66 51.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 O-C-N 124.55 1.156 . . . . 0.0 109.289 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . 0.495 ' O ' ' N ' ' A' ' 188' ' ' GLU . 13.7 ttm180 -97.59 151.55 19.95 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.502 1.126 . . . . 0.0 110.339 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.858 ' HB3' ' OD2' ' A' ' 157' ' ' ASP . . . -120.63 106.34 11.65 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.467 1.104 . . . . 0.0 109.259 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.608 HD11 ' HG2' ' A' ' 188' ' ' GLU . 0.0 OUTLIER -91.14 -22.97 20.41 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.561 1.163 . . . . 0.0 109.331 179.944 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . 0.512 ' CD2' ' HA ' ' A' ' 186' ' ' TYR . 97.1 m-85 -85.66 161.38 19.27 Favored 'General case' 0 C--N 1.326 -0.418 0 O-C-N 124.44 1.088 . . . . 0.0 110.98 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . 0.498 ' CA ' ' O ' ' A' ' 154' ' ' LYS . 0.5 OUTLIER . . . . . 0 C--N 1.324 -0.507 0 O-C-N 124.508 1.13 . . . . 0.0 109.272 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 1.2 p90 . . . . . 0 N--CA 1.454 -0.253 0 CA-C-O 120.502 0.191 . . . . 0.0 110.955 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . 0.498 ' O ' ' CA ' ' A' ' 142' ' ' ASP . 32.2 tttt -121.6 -82.26 0.65 Allowed 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.498 1.124 . . . . 0.0 109.348 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.477 ' CG ' ' O ' ' A' ' 140' ' ' LEU . 0.0 OUTLIER -175.25 108.63 0.1 Allowed 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.499 1.124 . . . . 0.0 109.326 179.973 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . 0.434 ' N ' ' O ' ' A' ' 139' ' ' ALA . . . 104.83 16.1 18.27 Favored Glycine 0 CA--C 1.529 0.964 0 O-C-N 124.493 1.12 . . . . 0.0 111.05 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . 0.858 ' OD2' ' HB3' ' A' ' 139' ' ' ALA . 2.3 p-10 -88.2 144.51 26.42 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.494 0.761 . . . . 0.0 109.327 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . 0.668 ' N ' HD12 ' A' ' 158' ' ' ILE . 1.1 mp -95.93 150.02 4.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 O-C-N 124.438 1.086 . . . . 0.0 109.314 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.796 HD13 HG21 ' A' ' 182' ' ' ILE . 5.3 mt -145.65 133.77 21.55 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.542 1.151 . . . . 0.0 109.28 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . 0.517 ' O ' ' HB1' ' A' ' 172' ' ' ALA . 2.0 ttt180 -90.28 129.48 36.51 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.51 1.131 . . . . 0.0 110.322 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.459 HD12 ' HE3' ' A' ' 170' ' ' TRP . 24.1 mm -85.23 124.2 39.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 O-C-N 124.517 1.136 . . . . 0.0 109.253 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -119.39 -62.96 1.44 Allowed 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.507 1.129 . . . . 0.0 110.336 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -111.31 157.03 20.65 Favored 'General case' 0 C--N 1.324 -0.522 0 O-C-N 124.498 1.124 . . . . 0.0 109.333 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . 0.536 ' HG3' ' CE2' ' A' ' 170' ' ' TRP . 0.0 OUTLIER -157.81 63.08 2.67 Favored Pre-proline 0 C--N 1.324 -0.506 0 O-C-N 124.469 1.105 . . . . 0.0 109.306 -179.989 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' PRO . . . . . 0.441 ' HD3' ' N ' ' A' ' 164' ' ' LYS . 18.2 Cg_endo -75.05 -58.89 0.04 OUTLIER 'Trans proline' 0 C--N 1.36 1.148 0 O-C-N 124.445 1.761 . . . . 0.0 111.005 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -62.01 167.26 3.98 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.509 1.131 . . . . 0.0 110.248 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 6.5 mt-10 -106.99 45.77 0.97 Allowed 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.501 1.126 . . . . 0.0 110.349 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -167.03 -59.53 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.535 1.147 . . . . 0.0 110.346 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 169' ' ' TRP . . . . . . . . . . . . . 25.4 m95 -102.69 135.2 44.76 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.553 1.158 . . . . 0.0 107.966 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 170' ' ' TRP . . . . . 1.009 ' CE2' HG21 ' A' ' 184' ' ' VAL . 27.8 m0 -117.31 151.65 36.54 Favored 'General case' 0 C--N 1.324 -0.533 0 O-C-N 124.551 1.157 . . . . 0.0 108.048 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 171' ' ' ASN . . . . . 0.418 ' HA ' ' O ' ' A' ' 180' ' ' GLY . 2.8 t-20 -86.23 102.98 14.42 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.432 1.083 . . . . 0.0 109.268 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . 1.125 ' HB3' HD13 ' A' ' 182' ' ' ILE . . . -113.1 179.89 3.83 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.488 1.117 . . . . 0.0 109.309 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . 0.473 ' CG ' ' HG3' ' A' ' 179' ' ' ARG . 28.0 mt-10 -125.34 125.91 44.23 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.5 1.125 . . . . 0.0 110.271 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . 0.604 ' HA ' HD23 ' A' ' 159' ' ' LEU . 2.9 t70 -74.6 -163.92 0.24 Allowed 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.477 1.111 . . . . 0.0 109.307 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -89.32 47.04 1.43 Allowed 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.582 1.177 . . . . 0.0 110.019 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -169.68 24.51 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.546 1.154 . . . . 0.0 110.287 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 62.57 20.51 61.57 Favored Glycine 0 CA--C 1.53 0.976 0 O-C-N 124.441 1.088 . . . . 0.0 111.004 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 4.8 tptt -81.21 104.26 11.56 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.524 0.779 . . . . 0.0 109.285 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 179' ' ' ARG . . . . . 0.476 ' HA ' ' O ' ' A' ' 172' ' ' ALA . 0.0 OUTLIER -89.26 116.92 27.84 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.427 1.079 . . . . 0.0 110.373 179.946 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . 0.549 ' O ' HD12 ' A' ' 182' ' ' ILE . . . -151.46 173.39 30.83 Favored Glycine 0 CA--C 1.53 0.979 0 O-C-N 124.452 1.095 . . . . 0.0 111.007 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 181' ' ' MET . . . . . 0.43 ' HA ' ' O ' ' A' ' 170' ' ' TRP . 12.9 mmm -86.14 103.6 14.94 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.461 0.742 . . . . 0.0 110.986 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . 1.125 HD13 ' HB3' ' A' ' 172' ' ' ALA . 4.1 mp -94.5 145.27 29.37 Favored Pre-proline 0 C--N 1.324 -0.509 0 O-C-N 124.563 1.164 . . . . 0.0 109.289 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 183' ' ' PRO . . . . . 0.836 ' HD2' HG23 ' A' ' 182' ' ' ILE . 18.3 Cg_endo -75.01 133.63 16.81 Favored 'Trans proline' 0 C--N 1.36 1.164 0 O-C-N 124.448 1.762 . . . . 0.0 110.977 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . 1.009 HG21 ' CE2' ' A' ' 170' ' ' TRP . 25.2 t -78.62 -31.14 0.73 Allowed Pre-proline 0 C--N 1.325 -0.469 0 O-C-N 124.509 1.131 . . . . 0.0 109.309 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 185' ' ' PRO . . . . . 0.814 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.1 Cg_endo -75.09 -25.96 11.23 Favored 'Trans proline' 0 C--N 1.359 1.123 0 O-C-N 124.474 1.776 . . . . 0.0 110.932 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 186' ' ' TYR . . . . . 0.774 ' HB2' ' HG2' ' A' ' 183' ' ' PRO . 4.1 m-85 -95.91 15.54 20.18 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.475 1.109 . . . . 0.0 110.994 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 187' ' ' VAL . . . . . 0.855 ' HB ' HG22 ' A' ' 137' ' ' VAL . 24.4 m -139.59 173.96 10.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 O-C-N 124.451 1.094 . . . . 0.0 109.278 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 188' ' ' GLU . . . . . 0.608 ' HG2' HD11 ' A' ' 140' ' ' LEU . 0.0 OUTLIER -135.18 172.31 13.2 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.448 1.093 . . . . 0.0 110.353 179.966 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . 0.45 ' HD2' ' N ' ' A' ' 189' ' ' LYS . 0.0 OUTLIER -95.63 114.19 25.91 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.545 1.153 . . . . 0.0 109.267 -179.96 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 15.6 t80 . . . . . 0 C--N 1.325 -0.482 0 O-C-N 124.507 1.129 . . . . 0.0 110.962 -179.991 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . 0.512 ' HG2' HG22 ' A' ' 161' ' ' ILE . 0.2 OUTLIER . . . . . 0 N--CA 1.452 -0.366 0 N-CA-C 110.32 -0.252 . . . . 0.0 110.32 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . 0.434 ' O ' ' HB3' ' A' ' 190' ' ' TYR . 0.4 OUTLIER -135.64 141.74 45.09 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.473 1.108 . . . . 0.0 111.003 179.993 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.556 HG21 HD11 ' A' ' 182' ' ' ILE . 34.3 m -133.66 157.51 42.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 O-C-N 124.476 1.11 . . . . 0.0 109.322 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . 0.785 ' HD3' HD13 ' A' ' 158' ' ' ILE . 4.2 tpp85 -127.3 127.07 43.73 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.436 1.085 . . . . 0.0 110.241 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.698 ' O ' ' N ' ' A' ' 156' ' ' GLY . . . -88.41 106.93 18.58 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.432 1.083 . . . . 0.0 109.323 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.413 HD11 ' HB3' ' A' ' 188' ' ' GLU . 0.4 OUTLIER -87.29 -5.14 59.03 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.538 1.149 . . . . 0.0 109.336 -179.994 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . 0.492 ' CD1' ' HA ' ' A' ' 186' ' ' TYR . 6.2 m-85 -123.32 151.92 41.97 Favored 'General case' 0 C--N 1.326 -0.443 0 O-C-N 124.486 1.116 . . . . 0.0 111.028 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 3.5 t70 . . . . . 0 C--N 1.326 -0.454 0 O-C-N 124.506 1.129 . . . . 0.0 109.345 179.96 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 6.5 p90 . . . . . 0 N--CA 1.453 -0.296 0 CA-C-O 120.469 0.176 . . . . 0.0 111.049 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.56 -164.42 1.38 Allowed 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.472 1.107 . . . . 0.0 109.305 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -96.4 96.29 8.63 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.534 1.147 . . . . 0.0 109.288 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . 0.698 ' N ' ' O ' ' A' ' 139' ' ' ALA . . . 122.63 29.81 1.24 Allowed Glycine 0 CA--C 1.53 0.981 0 O-C-N 124.487 1.117 . . . . 0.0 111.002 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . 0.489 ' HB3' ' HB3' ' A' ' 139' ' ' ALA . 12.1 t70 -97.9 159.43 14.94 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.449 0.734 . . . . 0.0 109.298 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . 0.785 HD13 ' HD3' ' A' ' 138' ' ' ARG . 6.5 mm -115.04 147.37 18.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 O-C-N 124.533 1.146 . . . . 0.0 109.359 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 1.116 HD13 HD13 ' A' ' 182' ' ' ILE . 1.1 mt -149.21 138.79 21.73 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.531 1.144 . . . . 0.0 109.371 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . 0.609 ' O ' ' HA ' ' A' ' 172' ' ' ALA . 0.0 OUTLIER -95.71 134.22 38.89 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.543 1.152 . . . . 0.0 110.349 -179.983 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.512 HG22 ' HG2' ' A' ' 135' ' ' GLU . 15.4 mm -84.43 118.41 31.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 O-C-N 124.424 1.077 . . . . 0.0 109.264 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -112.36 -51.57 2.83 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.469 1.106 . . . . 0.0 110.285 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -138.86 168.39 19.93 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.495 1.122 . . . . 0.0 109.325 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . 0.581 ' HB3' ' CD1' ' A' ' 170' ' ' TRP . 27.4 mtmt -148.93 85.97 5.85 Favored Pre-proline 0 C--N 1.324 -0.513 0 O-C-N 124.499 1.124 . . . . 0.0 109.341 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.03 -30.57 6.98 Favored 'Trans proline' 0 C--N 1.36 1.138 0 O-C-N 124.498 1.788 . . . . 0.0 111.012 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -128.92 153.99 46.97 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.554 1.159 . . . . 0.0 110.272 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -77.75 -23.62 49.24 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.497 1.123 . . . . 0.0 110.265 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -75.9 -57.06 4.1 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.487 1.117 . . . . 0.0 110.329 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 169' ' ' TRP . . . . . . . . . . . . . 14.0 m95 -111.33 156.22 21.88 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.547 1.154 . . . . 0.0 107.995 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 170' ' ' TRP . . . . . 0.581 ' CD1' ' HB3' ' A' ' 164' ' ' LYS . 23.6 m0 -131.46 148.53 52.65 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.477 1.111 . . . . 0.0 108.017 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 171' ' ' ASN . . . . . 0.529 ' OD1' ' HG2' ' A' ' 179' ' ' ARG . 6.2 t-20 -87.26 98.98 11.63 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.503 1.127 . . . . 0.0 109.306 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . 0.609 ' HA ' ' O ' ' A' ' 160' ' ' ARG . . . -118.86 175.59 5.68 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.456 1.097 . . . . 0.0 109.327 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . 0.66 ' C ' HD23 ' A' ' 159' ' ' LEU . 1.5 tt0 -118.02 118.26 31.44 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.441 1.088 . . . . 0.0 110.324 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . 0.577 ' N ' HD23 ' A' ' 159' ' ' LEU . 0.9 OUTLIER -66.43 -174.73 0.3 Allowed 'General case' 0 C--N 1.326 -0.434 0 O-C-N 124.461 1.101 . . . . 0.0 109.308 -179.947 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -78.72 53.16 1.3 Allowed 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.461 1.1 . . . . 0.0 110.018 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -172.21 11.25 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.446 1.091 . . . . 0.0 110.323 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 177' ' ' GLY . . . . . 0.49 ' C ' ' HG2' ' A' ' 173' ' ' GLU . . . 73.27 18.02 79.09 Favored Glycine 0 CA--C 1.53 0.978 0 O-C-N 124.509 1.131 . . . . 0.0 111.008 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -79.66 103.85 9.86 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.54 0.788 . . . . 0.0 109.349 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 179' ' ' ARG . . . . . 0.558 ' HG3' ' HG3' ' A' ' 173' ' ' GLU . 0.0 OUTLIER -87.65 113.21 23.12 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.434 1.084 . . . . 0.0 110.296 179.985 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . 0.403 ' O ' ' HA ' ' A' ' 171' ' ' ASN . . . -152.2 172.89 31.43 Favored Glycine 0 CA--C 1.53 0.977 0 O-C-N 124.428 1.08 . . . . 0.0 111.026 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 181' ' ' MET . . . . . 0.422 ' HA ' ' O ' ' A' ' 170' ' ' TRP . 3.0 mmm -87.7 97.49 10.92 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.492 0.76 . . . . 0.0 111.017 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . 1.116 HD13 HD13 ' A' ' 159' ' ' LEU . 3.4 pt -90.78 157.69 43.37 Favored Pre-proline 0 C--N 1.325 -0.498 0 O-C-N 124.498 1.124 . . . . 0.0 109.323 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 183' ' ' PRO . . . . . 0.741 ' HG2' ' HB2' ' A' ' 186' ' ' TYR . 18.3 Cg_endo -75.06 136.86 20.84 Favored 'Trans proline' 0 C--N 1.36 1.164 0 O-C-N 124.557 1.819 . . . . 0.0 111.012 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . 0.838 ' N ' ' CD ' ' A' ' 185' ' ' PRO . 92.2 t -82.08 -31.07 0.54 Allowed Pre-proline 0 C--N 1.325 -0.474 0 O-C-N 124.527 1.142 . . . . 0.0 109.37 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 185' ' ' PRO . . . . . 0.838 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.4 Cg_endo -74.99 -27.71 9.81 Favored 'Trans proline' 0 C--N 1.36 1.184 0 O-C-N 124.458 1.767 . . . . 0.0 111.012 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 186' ' ' TYR . . . . . 0.741 ' HB2' ' HG2' ' A' ' 183' ' ' PRO . 5.1 m-85 -91.37 15.17 12.7 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.493 1.12 . . . . 0.0 110.997 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 187' ' ' VAL . . . . . 0.699 HG11 HD12 ' A' ' 182' ' ' ILE . 34.5 m -143.22 167.32 13.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 O-C-N 124.504 1.127 . . . . 0.0 109.261 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 188' ' ' GLU . . . . . 0.483 ' CG ' ' HB3' ' A' ' 138' ' ' ARG . 0.0 OUTLIER -126.3 168.03 14.68 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 124.487 1.117 . . . . 0.0 110.329 179.943 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 12.3 mmmm -89.25 129.88 35.74 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.511 1.132 . . . . 0.0 109.274 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 190' ' ' TYR . . . . . 0.434 ' HB3' ' O ' ' A' ' 136' ' ' TYR . 0.8 OUTLIER . . . . . 0 C--N 1.324 -0.512 0 O-C-N 124.48 1.112 . . . . 0.0 110.963 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . 0.522 ' O ' ' HG2' ' A' ' 160' ' ' ARG . 0.1 OUTLIER . . . . . 0 N--CA 1.454 -0.262 0 N-CA-C 110.266 -0.272 . . . . 0.0 110.266 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . 0.44 ' CE1' ' HG3' ' A' ' 160' ' ' ARG . 0.7 OUTLIER -129.19 132.4 47.28 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.432 1.083 . . . . 0.0 110.963 179.963 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.42 ' HA ' ' O ' ' A' ' 188' ' ' GLU . 3.4 m -128.15 164.51 29.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 O-C-N 124.449 1.093 . . . . 0.0 109.297 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . 0.455 ' O ' ' HA ' ' A' ' 187' ' ' VAL . 0.5 OUTLIER -123.57 126.32 46.45 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.482 1.114 . . . . 0.0 110.308 179.975 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.472 ' O ' ' N ' ' A' ' 156' ' ' GLY . . . -89.8 103.9 16.51 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.559 1.162 . . . . 0.0 109.258 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.774 HD11 ' HG2' ' A' ' 188' ' ' GLU . 0.2 OUTLIER -87.94 12.62 12.79 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.498 1.123 . . . . 0.0 109.231 -179.99 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . 0.471 ' O ' ' O ' ' A' ' 154' ' ' LYS . 23.7 m-85 -146.69 154.99 42.08 Favored 'General case' 0 C--N 1.324 -0.532 0 O-C-N 124.577 1.173 . . . . 0.0 111.041 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . 0.487 ' CB ' ' HA ' ' A' ' 154' ' ' LYS . 7.2 p-10 . . . . . 0 C--N 1.325 -0.457 0 O-C-N 124.51 1.131 . . . . 0.0 109.237 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . 0.457 ' C ' ' CD1' ' A' ' 153' ' ' PHE . 7.3 p90 . . . . . 0 N--CA 1.453 -0.308 0 CA-C-O 120.482 0.182 . . . . 0.0 110.981 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . 0.487 ' HA ' ' CB ' ' A' ' 142' ' ' ASP . 3.8 tttt -135.61 -156.1 0.69 Allowed 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.562 1.164 . . . . 0.0 109.232 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 4.4 ptpp? -99.84 106.74 18.63 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.494 1.121 . . . . 0.0 109.334 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . 0.472 ' N ' ' O ' ' A' ' 139' ' ' ALA . . . 108.88 27.65 4.8 Favored Glycine 0 CA--C 1.53 1.018 0 O-C-N 124.499 1.125 . . . . 0.0 110.953 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . 0.406 ' OD2' ' HG ' ' A' ' 159' ' ' LEU . 13.4 t70 -101.04 162.05 13.16 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.46 0.741 . . . . 0.0 109.306 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 19.6 mm -114.0 142.34 26.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 O-C-N 124.621 1.201 . . . . 0.0 109.327 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.818 HD13 HD13 ' A' ' 182' ' ' ILE . 2.2 mt -142.41 135.19 28.28 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.486 1.116 . . . . 0.0 109.328 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . 0.571 ' O ' ' HB1' ' A' ' 172' ' ' ALA . 8.2 ttm-85 -97.59 134.72 40.43 Favored 'General case' 0 C--N 1.324 -0.531 0 O-C-N 124.493 1.121 . . . . 0.0 110.303 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.413 ' CB ' ' HB2' ' A' ' 135' ' ' GLU . 1.2 mp -82.65 119.39 32.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 O-C-N 124.537 1.148 . . . . 0.0 109.23 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . 0.426 ' HB3' ' NH1' ' A' ' 162' ' ' ARG . 2.8 mmm180 -110.49 -59.19 1.98 Allowed 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.49 1.119 . . . . 0.0 110.332 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -129.23 163.84 24.75 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.456 1.097 . . . . 0.0 109.288 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . 0.426 ' HG3' ' NE1' ' A' ' 170' ' ' TRP . 0.3 OUTLIER -139.91 76.19 28.79 Favored Pre-proline 0 C--N 1.325 -0.489 0 O-C-N 124.537 1.148 . . . . 0.0 109.329 -179.951 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.97 -30.73 6.91 Favored 'Trans proline' 0 C--N 1.36 1.165 0 O-C-N 124.469 1.773 . . . . 0.0 111.038 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -113.4 169.68 8.78 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.519 1.137 . . . . 0.0 110.303 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -96.85 -27.92 14.47 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 124.47 1.106 . . . . 0.0 110.33 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -84.51 -55.94 3.88 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.47 1.107 . . . . 0.0 110.308 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 169' ' ' TRP . . . . . 0.436 ' CD1' ' N ' ' A' ' 169' ' ' TRP . 2.7 m95 -111.17 145.68 38.22 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.496 1.122 . . . . 0.0 107.99 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 170' ' ' TRP . . . . . 0.767 ' CD2' HG21 ' A' ' 184' ' ' VAL . 50.3 m0 -122.09 156.78 32.87 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.509 1.131 . . . . 0.0 108.0 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 171' ' ' ASN . . . . . 0.418 ' HA ' ' O ' ' A' ' 180' ' ' GLY . 33.0 t-20 -86.92 98.63 11.34 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.522 1.139 . . . . 0.0 109.351 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . 0.571 ' HB1' ' O ' ' A' ' 160' ' ' ARG . . . -113.87 176.19 5.14 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.483 1.114 . . . . 0.0 109.28 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . 0.492 ' CG ' ' HG3' ' A' ' 179' ' ' ARG . 9.6 mt-10 -112.75 127.71 56.22 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 124.354 1.033 . . . . 0.0 110.237 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . 0.658 ' HA ' HD23 ' A' ' 159' ' ' LEU . 6.2 p30 -83.78 -170.73 3.22 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.483 1.114 . . . . 0.0 109.327 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 1.1 t -79.53 68.06 5.46 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.493 1.121 . . . . 0.0 109.999 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 176.86 -4.39 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.473 1.108 . . . . 0.0 110.28 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 81.61 21.27 62.22 Favored Glycine 0 CA--C 1.53 1.012 0 O-C-N 124.542 1.151 . . . . 0.0 110.98 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 12.9 mtpt -92.04 118.67 31.02 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.483 0.754 . . . . 0.0 109.306 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 179' ' ' ARG . . . . . 0.492 ' HG3' ' CG ' ' A' ' 173' ' ' GLU . 61.0 mtt180 -89.92 121.92 32.47 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.443 1.089 . . . . 0.0 110.237 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . 0.418 ' O ' ' HA ' ' A' ' 171' ' ' ASN . . . -150.77 166.93 30.4 Favored Glycine 0 CA--C 1.53 0.994 0 O-C-N 124.456 1.097 . . . . 0.0 111.0 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 181' ' ' MET . . . . . 0.451 ' HA ' ' O ' ' A' ' 170' ' ' TRP . 11.0 mtp -87.16 104.23 16.16 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.488 0.758 . . . . 0.0 110.921 -179.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . 0.818 HD13 HD13 ' A' ' 159' ' ' LEU . 1.4 pp -106.9 159.99 27.95 Favored Pre-proline 0 C--N 1.324 -0.527 0 O-C-N 124.587 1.18 . . . . 0.0 109.292 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 183' ' ' PRO . . . . . 0.628 ' HG2' ' HB2' ' A' ' 186' ' ' TYR . 18.5 Cg_endo -74.89 131.1 14.04 Favored 'Trans proline' 0 C--N 1.36 1.18 0 O-C-N 124.55 1.816 . . . . 0.0 111.066 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . 0.767 HG21 ' CD2' ' A' ' 170' ' ' TRP . 93.4 t -77.87 -33.99 1.06 Allowed Pre-proline 0 C--N 1.324 -0.506 0 O-C-N 124.54 1.15 . . . . 0.0 109.351 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 185' ' ' PRO . . . . . 0.764 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.3 Cg_endo -75.02 -11.44 21.45 Favored 'Trans proline' 0 C--N 1.361 1.199 0 O-C-N 124.41 1.742 . . . . 0.0 111.028 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 186' ' ' TYR . . . . . 0.628 ' HB2' ' HG2' ' A' ' 183' ' ' PRO . 6.7 m-85 -97.01 5.98 49.44 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.586 1.179 . . . . 0.0 110.996 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 187' ' ' VAL . . . . . 0.455 ' HA ' ' O ' ' A' ' 138' ' ' ARG . 8.4 m -137.74 173.32 13.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 O-C-N 124.507 1.13 . . . . 0.0 109.245 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 188' ' ' GLU . . . . . 0.774 ' HG2' HD11 ' A' ' 140' ' ' LEU . 0.0 OUTLIER -129.61 174.64 9.49 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.468 1.105 . . . . 0.0 110.253 -179.972 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 12.2 mmmm -86.98 117.19 25.54 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.472 1.108 . . . . 0.0 109.296 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 5.1 t80 . . . . . 0 C--N 1.325 -0.492 0 O-C-N 124.483 1.114 . . . . 0.0 111.014 179.962 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . 0.53 ' HB2' ' O ' ' A' ' 161' ' ' ILE . 1.6 pm0 . . . . . 0 N--CA 1.453 -0.301 0 N-CA-C 110.278 -0.268 . . . . 0.0 110.278 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . 0.797 ' CE1' ' CD2' ' A' ' 190' ' ' TYR . 1.4 t80 -122.29 131.13 53.76 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.476 1.11 . . . . 0.0 110.952 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.614 HG11 HG21 ' A' ' 187' ' ' VAL . 3.8 t -132.55 162.16 40.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 O-C-N 124.497 1.123 . . . . 0.0 109.326 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . 0.476 ' N ' ' CG1' ' A' ' 137' ' ' VAL . 2.2 tpp85 -136.14 135.28 39.12 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.494 1.121 . . . . 0.0 110.31 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.538 ' O ' ' N ' ' A' ' 156' ' ' GLY . . . -98.57 109.51 22.25 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.506 1.129 . . . . 0.0 109.332 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.817 HD21 ' OE2' ' A' ' 188' ' ' GLU . 1.2 mt -88.71 -4.22 58.59 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.435 1.084 . . . . 0.0 109.263 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -133.28 154.46 50.67 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.536 1.147 . . . . 0.0 110.951 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . 0.432 ' CB ' ' HA ' ' A' ' 154' ' ' LYS . 7.6 t70 . . . . . 0 C--N 1.326 -0.427 0 O-C-N 124.484 1.115 . . . . 0.0 109.293 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . 0.466 ' CE2' ' CG ' ' A' ' 183' ' ' PRO . 18.9 p90 . . . . . 0 N--CA 1.453 -0.318 0 CA-C-O 120.472 0.177 . . . . 0.0 111.031 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . 0.432 ' HA ' ' CB ' ' A' ' 142' ' ' ASP . 0.1 OUTLIER -125.9 -164.04 1.27 Allowed 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.504 1.127 . . . . 0.0 109.282 -179.993 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -99.7 103.28 14.94 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.48 1.112 . . . . 0.0 109.267 -179.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . 0.538 ' N ' ' O ' ' A' ' 139' ' ' ALA . . . 114.76 23.42 4.68 Favored Glycine 0 CA--C 1.529 0.964 0 O-C-N 124.434 1.084 . . . . 0.0 111.013 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . 0.481 ' C ' HD12 ' A' ' 158' ' ' ILE . 19.8 t70 -101.69 170.0 8.46 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.454 0.738 . . . . 0.0 109.295 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . 0.618 ' CG2' ' CE1' ' A' ' 136' ' ' TYR . 3.6 mp -120.62 146.17 25.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 O-C-N 124.413 1.071 . . . . 0.0 109.257 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.954 HD23 ' HA ' ' A' ' 174' ' ' ASP . 0.9 OUTLIER -140.13 125.54 18.97 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.435 1.084 . . . . 0.0 109.313 179.973 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . 0.673 ' O ' ' HB1' ' A' ' 172' ' ' ALA . 1.1 ttp85 -88.04 130.89 34.85 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.554 1.159 . . . . 0.0 110.291 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.53 ' O ' ' HB2' ' A' ' 135' ' ' GLU . 8.7 mm -83.3 125.88 40.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 O-C-N 124.518 1.136 . . . . 0.0 109.283 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.32 -58.85 1.89 Allowed 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.495 1.122 . . . . 0.0 110.34 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . 0.421 ' CB ' ' HB3' ' A' ' 171' ' ' ASN . 0.1 OUTLIER -115.37 154.65 28.81 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.5 1.125 . . . . 0.0 109.313 179.948 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . 0.543 ' HG3' ' CD1' ' A' ' 170' ' ' TRP . 28.9 tttm -146.47 66.64 11.15 Favored Pre-proline 0 C--N 1.325 -0.476 0 O-C-N 124.552 1.157 . . . . 0.0 109.241 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -74.99 -33.08 4.86 Favored 'Trans proline' 0 C--N 1.36 1.133 0 O-C-N 124.522 1.801 . . . . 0.0 111.019 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -104.48 171.02 7.56 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.498 1.124 . . . . 0.0 110.289 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 21.5 mt-10 -101.4 -30.08 11.66 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.504 1.128 . . . . 0.0 110.31 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 28.3 tt0 -74.47 -61.11 1.98 Allowed 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.559 1.162 . . . . 0.0 110.292 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 169' ' ' TRP . . . . . 0.562 ' CZ2' ' HB3' ' A' ' 183' ' ' PRO . 13.3 m95 -114.35 160.54 18.99 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.481 1.113 . . . . 0.0 108.001 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 170' ' ' TRP . . . . . 0.574 ' CE3' HG22 ' A' ' 184' ' ' VAL . 10.6 m0 -134.19 156.95 47.44 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.53 1.144 . . . . 0.0 108.011 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 171' ' ' ASN . . . . . 0.486 ' HA ' ' O ' ' A' ' 180' ' ' GLY . 40.5 t30 -87.42 102.48 14.58 Favored 'General case' 0 C--N 1.324 -0.522 0 O-C-N 124.523 1.14 . . . . 0.0 109.291 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . 0.673 ' HB1' ' O ' ' A' ' 160' ' ' ARG . . . -118.35 -178.19 3.46 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.521 1.138 . . . . 0.0 109.367 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . 0.421 ' HA ' ' O ' ' A' ' 178' ' ' LYS . 31.9 mt-10 -114.76 118.52 33.82 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.527 1.142 . . . . 0.0 110.227 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . 0.954 ' HA ' HD23 ' A' ' 159' ' ' LEU . 0.2 OUTLIER -73.43 -171.53 1.0 Allowed 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.522 1.139 . . . . 0.0 109.285 -179.998 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 29.1 t -80.07 56.56 2.43 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.546 1.154 . . . . 0.0 110.0 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -173.82 27.05 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.402 1.064 . . . . 0.0 110.392 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 50.47 22.53 5.46 Favored Glycine 0 CA--C 1.53 0.999 0 O-C-N 124.51 1.131 . . . . 0.0 110.992 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 178' ' ' LYS . . . . . 0.421 ' O ' ' HA ' ' A' ' 173' ' ' GLU . 2.7 ptpt -92.86 122.28 35.08 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.515 0.773 . . . . 0.0 109.352 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 40.6 mtt85 -91.16 115.4 27.99 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.467 1.104 . . . . 0.0 110.312 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . 0.486 ' O ' ' HA ' ' A' ' 171' ' ' ASN . . . -150.38 179.51 27.05 Favored Glycine 0 CA--C 1.531 1.05 0 O-C-N 124.595 1.185 . . . . 0.0 110.998 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 181' ' ' MET . . . . . 0.41 ' HA ' ' O ' ' A' ' 170' ' ' TRP . 0.4 OUTLIER -85.33 107.35 17.29 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.576 0.81 . . . . 0.0 110.971 -179.989 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . 0.839 HG21 HD13 ' A' ' 159' ' ' LEU . 0.9 OUTLIER -98.0 144.14 27.49 Favored Pre-proline 0 C--N 1.325 -0.496 0 O-C-N 124.541 1.151 . . . . 0.0 109.262 -179.982 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 183' ' ' PRO . . . . . 0.724 ' HG2' ' HB2' ' A' ' 186' ' ' TYR . 18.5 Cg_endo -75.01 136.48 20.44 Favored 'Trans proline' 0 C--N 1.36 1.18 0 O-C-N 124.476 1.777 . . . . 0.0 111.021 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . 0.815 ' N ' ' CD ' ' A' ' 185' ' ' PRO . 44.3 t -82.03 -32.59 0.6 Allowed Pre-proline 0 C--N 1.326 -0.447 0 O-C-N 124.478 1.111 . . . . 0.0 109.305 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 185' ' ' PRO . . . . . 0.815 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.5 Cg_endo -75.0 -31.46 6.19 Favored 'Trans proline' 0 C--N 1.36 1.163 0 O-C-N 124.48 1.779 . . . . 0.0 111.024 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 186' ' ' TYR . . . . . 0.724 ' HB2' ' HG2' ' A' ' 183' ' ' PRO . 3.8 m-85 -90.8 19.39 5.55 Favored 'General case' 0 C--N 1.326 -0.428 0 O-C-N 124.483 1.114 . . . . 0.0 111.005 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 187' ' ' VAL . . . . . 0.658 HG22 ' O ' ' A' ' 183' ' ' PRO . 11.3 m -149.64 179.49 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 O-C-N 124.44 1.088 . . . . 0.0 109.371 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 188' ' ' GLU . . . . . 0.817 ' OE2' HD21 ' A' ' 140' ' ' LEU . 0.0 OUTLIER -139.54 166.33 24.86 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.496 1.122 . . . . 0.0 110.37 -179.994 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.64 129.74 39.81 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.478 1.111 . . . . 0.0 109.325 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 190' ' ' TYR . . . . . 0.797 ' CD2' ' CE1' ' A' ' 136' ' ' TYR . 0.2 OUTLIER . . . . . 0 C--N 1.326 -0.456 0 O-C-N 124.495 1.122 . . . . 0.0 111.045 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . 0.422 ' O ' ' HA ' ' A' ' 160' ' ' ARG . 1.9 pt-20 . . . . . 0 N--CA 1.453 -0.319 0 N-CA-C 110.292 -0.262 . . . . 0.0 110.292 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -111.35 135.17 52.29 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.546 1.154 . . . . 0.0 110.987 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.745 HG12 ' O ' ' A' ' 159' ' ' LEU . 0.5 OUTLIER -126.01 157.03 36.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 O-C-N 124.498 1.124 . . . . 0.0 109.254 -179.933 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . 0.531 ' O ' ' HA ' ' A' ' 187' ' ' VAL . 1.4 ttm180 -126.22 139.48 53.31 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.513 1.133 . . . . 0.0 110.263 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.629 ' HB3' ' HB3' ' A' ' 157' ' ' ASP . . . -103.61 106.23 16.68 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 124.523 1.14 . . . . 0.0 109.306 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.444 ' O ' ' CG ' ' A' ' 155' ' ' LYS . 0.2 OUTLIER -87.32 -1.39 57.88 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.513 1.133 . . . . 0.0 109.327 179.965 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . 0.402 ' O ' ' O ' ' A' ' 154' ' ' LYS . 35.1 m-85 -128.14 159.63 34.54 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.488 1.118 . . . . 0.0 110.96 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . 0.468 ' CB ' ' HA ' ' A' ' 154' ' ' LYS . 45.2 p-10 . . . . . 0 C--N 1.324 -0.509 0 O-C-N 124.531 1.145 . . . . 0.0 109.278 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 15.3 p90 . . . . . 0 N--CA 1.452 -0.33 0 CA-C-O 120.447 0.165 . . . . 0.0 111.035 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . 0.468 ' HA ' ' CB ' ' A' ' 142' ' ' ASP . 0.0 OUTLIER -130.54 -162.2 1.19 Allowed 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.537 1.148 . . . . 0.0 109.294 179.98 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.444 ' CG ' ' O ' ' A' ' 140' ' ' LEU . 2.9 tmtt? -94.47 107.51 19.48 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.495 1.122 . . . . 0.0 109.335 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . 0.453 ' HA2' ' CZ ' ' A' ' 138' ' ' ARG . . . 112.29 23.15 5.58 Favored Glycine 0 CA--C 1.529 0.949 0 O-C-N 124.529 1.143 . . . . 0.0 111.049 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . 0.633 ' C ' HD12 ' A' ' 158' ' ' ILE . 21.6 t70 -93.76 170.2 9.74 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.434 0.726 . . . . 0.0 109.296 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . 0.633 HD12 ' C ' ' A' ' 157' ' ' ASP . 3.0 mp -132.63 147.85 31.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 O-C-N 124.514 1.134 . . . . 0.0 109.234 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.745 ' O ' HG12 ' A' ' 137' ' ' VAL . 12.0 mt -147.67 131.82 17.36 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.483 1.114 . . . . 0.0 109.335 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . 0.604 ' O ' ' HA ' ' A' ' 172' ' ' ALA . 0.5 OUTLIER -86.85 139.38 30.72 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.457 1.098 . . . . 0.0 110.31 -179.975 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.464 ' CD1' ' HB ' ' A' ' 137' ' ' VAL . 1.4 mp -84.02 116.44 27.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 O-C-N 124.48 1.112 . . . . 0.0 109.287 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.92 -58.28 2.0 Allowed 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.499 1.124 . . . . 0.0 110.222 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . 0.442 ' OD1' ' N ' ' A' ' 164' ' ' LYS . 0.6 OUTLIER -136.47 161.37 36.02 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.484 1.115 . . . . 0.0 109.307 -179.918 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . 0.442 ' N ' ' OD1' ' A' ' 163' ' ' ASP . 0.0 OUTLIER -143.1 84.62 10.29 Favored Pre-proline 0 C--N 1.325 -0.48 0 O-C-N 124.489 1.118 . . . . 0.0 109.298 179.925 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -75.04 -39.04 1.31 Allowed 'Trans proline' 0 C--N 1.36 1.174 0 O-C-N 124.385 1.729 . . . . 0.0 111.029 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . 0.463 ' O ' ' NE1' ' A' ' 170' ' ' TRP . 3.9 mm-40 -111.36 178.24 4.4 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.532 1.145 . . . . 0.0 110.345 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.82 -22.02 14.45 Favored 'General case' 0 C--N 1.323 -0.546 0 O-C-N 124.51 1.131 . . . . 0.0 110.31 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 168' ' ' GLN . . . . . 0.444 ' HB3' ' CD1' ' A' ' 169' ' ' TRP . 0.0 OUTLIER -83.89 -57.89 3.02 Favored 'General case' 0 C--N 1.324 -0.523 0 O-C-N 124.527 1.142 . . . . 0.0 110.273 -179.996 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 169' ' ' TRP . . . . . 0.444 ' CD1' ' HB3' ' A' ' 168' ' ' GLN . 11.7 m95 -108.03 149.98 27.73 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.51 1.131 . . . . 0.0 107.994 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 170' ' ' TRP . . . . . 0.656 ' CZ3' HG11 ' A' ' 184' ' ' VAL . 26.6 m0 -131.3 151.59 51.36 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.486 1.116 . . . . 0.0 108.015 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 171' ' ' ASN . . . . . 0.469 ' HB2' ' HE3' ' A' ' 181' ' ' MET . 1.0 OUTLIER -87.64 98.89 11.67 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.548 1.155 . . . . 0.0 109.229 -179.913 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . 0.604 ' HA ' ' O ' ' A' ' 160' ' ' ARG . . . -112.46 166.17 11.56 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.434 1.084 . . . . 0.0 109.286 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . 0.442 ' HA ' ' O ' ' A' ' 178' ' ' LYS . 18.9 mt-10 -116.13 120.87 40.43 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.523 1.139 . . . . 0.0 110.256 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . 0.725 ' HA ' HD23 ' A' ' 159' ' ' LEU . 1.1 p30 -74.77 -173.4 1.84 Allowed 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.521 1.138 . . . . 0.0 109.321 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 22.6 t -79.83 63.24 4.32 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.507 1.129 . . . . 0.0 110.048 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -174.25 9.78 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.553 1.158 . . . . 0.0 110.309 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 68.69 19.49 73.2 Favored Glycine 0 CA--C 1.531 1.08 0 O-C-N 124.57 1.169 . . . . 0.0 110.986 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 178' ' ' LYS . . . . . 0.442 ' O ' ' HA ' ' A' ' 173' ' ' GLU . 0.1 OUTLIER -94.29 112.32 24.11 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 124.583 0.813 . . . . 0.0 109.228 -179.945 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 179' ' ' ARG . . . . . 0.471 ' HA ' ' O ' ' A' ' 172' ' ' ALA . 0.1 OUTLIER -96.69 124.6 40.73 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.548 1.155 . . . . 0.0 110.324 179.915 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -149.9 164.87 29.65 Favored Glycine 0 CA--C 1.531 1.092 0 O-C-N 124.531 1.144 . . . . 0.0 110.947 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 181' ' ' MET . . . . . 0.469 ' HE3' ' HB2' ' A' ' 171' ' ' ASN . 0.3 OUTLIER -88.98 100.98 13.63 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.57 0.806 . . . . 0.0 111.005 179.992 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . 0.481 HG12 ' N ' ' A' ' 183' ' ' PRO . 0.2 OUTLIER -108.52 174.09 2.64 Favored Pre-proline 0 C--N 1.325 -0.488 0 O-C-N 124.436 1.085 . . . . 0.0 109.311 -179.999 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 183' ' ' PRO . . . . . 0.601 ' HB2' ' CD1' ' A' ' 186' ' ' TYR . 18.5 Cg_endo -74.95 129.21 12.17 Favored 'Trans proline' 0 C--N 1.36 1.132 0 O-C-N 124.535 1.808 . . . . 0.0 111.014 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . 0.816 ' N ' ' CD ' ' A' ' 185' ' ' PRO . 38.7 t -78.91 -32.94 0.83 Allowed Pre-proline 0 C--N 1.325 -0.459 0 O-C-N 124.473 1.108 . . . . 0.0 109.358 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 185' ' ' PRO . . . . . 0.816 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.6 Cg_endo -75.02 -13.84 21.25 Favored 'Trans proline' 0 C--N 1.361 1.189 0 O-C-N 124.45 1.763 . . . . 0.0 111.033 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 186' ' ' TYR . . . . . 0.601 ' CD1' ' HB2' ' A' ' 183' ' ' PRO . 7.9 m-85 -93.93 10.59 32.74 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.514 1.134 . . . . 0.0 110.985 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 187' ' ' VAL . . . . . 0.531 ' HA ' ' O ' ' A' ' 138' ' ' ARG . 20.3 m -143.12 165.01 15.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 O-C-N 124.503 1.127 . . . . 0.0 109.311 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 188' ' ' GLU . . . . . 0.519 ' O ' ' CG2' ' A' ' 137' ' ' VAL . 0.0 OUTLIER -120.42 159.61 24.76 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.512 1.132 . . . . 0.0 110.303 -179.995 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -86.59 134.17 33.66 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.519 1.137 . . . . 0.0 109.292 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.325 -0.475 0 O-C-N 124.53 1.144 . . . . 0.0 111.028 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . 0.526 ' O ' ' HG2' ' A' ' 160' ' ' ARG . 0.4 OUTLIER . . . . . 0 N--CA 1.453 -0.293 0 N-CA-C 110.285 -0.265 . . . . 0.0 110.285 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 39.2 m-85 -128.82 126.91 40.85 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.459 1.099 . . . . 0.0 110.984 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.796 HG22 ' O ' ' A' ' 159' ' ' LEU . 28.5 m -121.06 170.03 11.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 O-C-N 124.535 1.147 . . . . 0.0 109.334 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . 0.494 ' O ' ' HA ' ' A' ' 187' ' ' VAL . 5.1 ttm180 -133.91 127.64 32.91 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.498 1.124 . . . . 0.0 110.306 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.597 ' O ' ' N ' ' A' ' 156' ' ' GLY . . . -93.5 115.58 28.1 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.582 1.176 . . . . 0.0 109.27 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.989 HD21 ' OE2' ' A' ' 188' ' ' GLU . 0.2 OUTLIER -95.22 -19.58 19.92 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.545 1.153 . . . . 0.0 109.338 179.908 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . 0.444 ' O ' ' O ' ' A' ' 154' ' ' LYS . 5.8 m-85 -114.45 147.52 39.16 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.45 1.094 . . . . 0.0 110.96 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . 0.461 ' HB3' ' HA ' ' A' ' 154' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--N 1.325 -0.49 0 O-C-N 124.476 1.11 . . . . 0.0 109.275 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . 0.496 ' CE2' ' HD2' ' A' ' 183' ' ' PRO . 20.9 p90 . . . . . 0 N--CA 1.454 -0.248 0 CA-C-O 120.581 0.229 . . . . 0.0 110.947 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . 0.461 ' HA ' ' HB3' ' A' ' 142' ' ' ASP . 3.4 tttt -130.0 -120.92 0.22 Allowed 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.46 1.1 . . . . 0.0 109.317 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.52 ' CB ' ' O ' ' A' ' 140' ' ' LEU . 0.3 OUTLIER -126.65 118.22 24.34 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.559 1.162 . . . . 0.0 109.315 179.976 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . 0.597 ' N ' ' O ' ' A' ' 139' ' ' ALA . . . 98.16 19.61 23.18 Favored Glycine 0 CA--C 1.53 1.004 0 O-C-N 124.513 1.133 . . . . 0.0 111.012 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -91.45 157.04 17.28 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.54 0.788 . . . . 0.0 109.291 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 12.8 mm -113.19 141.04 30.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 O-C-N 124.486 1.116 . . . . 0.0 109.298 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.796 ' O ' HG22 ' A' ' 137' ' ' VAL . 7.2 mt -145.3 124.95 13.26 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.503 1.127 . . . . 0.0 109.316 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . 0.572 ' O ' ' HA ' ' A' ' 172' ' ' ALA . 0.0 OUTLIER -87.68 135.21 33.46 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.42 1.075 . . . . 0.0 110.342 179.99 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.466 HD13 HG13 ' A' ' 137' ' ' VAL . 1.4 mp -83.0 119.37 32.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 O-C-N 124.428 1.08 . . . . 0.0 109.286 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.56 -46.35 2.58 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.573 1.17 . . . . 0.0 110.309 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . 0.458 ' CB ' ' HB3' ' A' ' 171' ' ' ASN . 0.1 OUTLIER -134.94 179.59 6.22 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.564 1.165 . . . . 0.0 109.264 179.998 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . 0.599 ' HB2' ' CD1' ' A' ' 170' ' ' TRP . 0.0 OUTLIER -170.82 91.97 0.46 Allowed Pre-proline 0 C--N 1.326 -0.432 0 O-C-N 124.462 1.101 . . . . 0.0 109.311 -179.994 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.03 -26.35 10.95 Favored 'Trans proline' 0 C--N 1.362 1.239 0 O-C-N 124.513 1.796 . . . . 0.0 111.023 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -126.26 166.27 17.42 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.508 1.13 . . . . 0.0 110.24 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -86.54 -26.09 24.72 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.501 1.126 . . . . 0.0 110.299 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 4.4 mt-30 -78.02 -56.58 4.37 Favored 'General case' 0 C--N 1.324 -0.524 0 O-C-N 124.568 1.167 . . . . 0.0 110.316 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 169' ' ' TRP . . . . . . . . . . . . . 9.2 m95 -104.87 145.83 29.85 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 170' ' ' TRP . . . . . 0.8 ' CD2' HG21 ' A' ' 184' ' ' VAL . 30.8 m0 -122.44 151.43 41.28 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.564 1.165 . . . . 0.0 108.034 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 171' ' ' ASN . . . . . 0.458 ' HB3' ' CB ' ' A' ' 163' ' ' ASP . 2.7 t30 -86.44 96.19 9.95 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.544 1.153 . . . . 0.0 109.289 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . 0.572 ' HA ' ' O ' ' A' ' 160' ' ' ARG . . . -107.26 166.65 10.48 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.496 1.123 . . . . 0.0 109.259 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . 0.475 ' HA ' ' O ' ' A' ' 178' ' ' LYS . 34.3 mt-10 -126.03 126.25 43.95 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.503 1.127 . . . . 0.0 110.31 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . 0.492 ' HB2' ' CG ' ' A' ' 178' ' ' LYS . 1.1 m-20 -79.48 -174.57 4.3 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.521 1.138 . . . . 0.0 109.277 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 38.4 t -77.74 56.27 1.48 Allowed 'General case' 0 C--N 1.324 -0.528 0 O-C-N 124.584 1.178 . . . . 0.0 109.964 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . 0.458 ' CB ' ' HD2' ' A' ' 178' ' ' LYS . 0.0 OUTLIER -167.68 16.68 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.466 1.104 . . . . 0.0 110.298 179.925 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 62.57 15.13 52.73 Favored Glycine 0 CA--C 1.53 0.983 0 O-C-N 124.503 1.127 . . . . 0.0 110.992 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 178' ' ' LYS . . . . . 0.492 ' CG ' ' HB2' ' A' ' 174' ' ' ASP . 1.5 ptmm? -86.04 108.15 18.12 Favored 'General case' 0 C--N 1.326 -0.429 0 O-C-N 124.469 0.747 . . . . 0.0 109.334 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 179' ' ' ARG . . . . . 0.46 ' HA ' ' O ' ' A' ' 172' ' ' ALA . 0.0 OUTLIER -96.11 127.82 42.47 Favored 'General case' 0 C--N 1.324 -0.523 0 O-C-N 124.51 1.131 . . . . 0.0 110.284 -179.961 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -152.27 165.84 30.94 Favored Glycine 0 CA--C 1.53 0.993 0 O-C-N 124.511 1.132 . . . . 0.0 111.021 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 181' ' ' MET . . . . . 0.456 ' HA ' ' O ' ' A' ' 170' ' ' TRP . 25.4 mtp -88.41 105.32 17.52 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.488 0.758 . . . . 0.0 110.98 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . 0.767 ' O ' HD13 ' A' ' 182' ' ' ILE . 0.0 OUTLIER -110.15 164.11 15.6 Favored Pre-proline 0 C--N 1.324 -0.536 0 O-C-N 124.514 1.134 . . . . 0.0 109.359 179.956 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 183' ' ' PRO . . . . . 0.638 ' HG2' ' HB2' ' A' ' 186' ' ' TYR . 18.3 Cg_endo -74.99 128.85 11.82 Favored 'Trans proline' 0 C--N 1.36 1.169 0 O-C-N 124.51 1.795 . . . . 0.0 111.048 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . 0.812 ' N ' ' CD ' ' A' ' 185' ' ' PRO . 59.8 t -76.87 -32.96 1.06 Allowed Pre-proline 0 C--N 1.324 -0.506 0 O-C-N 124.576 1.173 . . . . 0.0 109.266 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 185' ' ' PRO . . . . . 0.812 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.5 Cg_endo -74.99 -14.57 21.13 Favored 'Trans proline' 0 C--N 1.36 1.15 0 O-C-N 124.485 1.782 . . . . 0.0 111.048 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 186' ' ' TYR . . . . . 0.638 ' HB2' ' HG2' ' A' ' 183' ' ' PRO . 6.3 m-85 -96.26 5.01 51.93 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.522 1.139 . . . . 0.0 111.001 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 187' ' ' VAL . . . . . 0.494 ' HA ' ' O ' ' A' ' 138' ' ' ARG . 12.6 m -135.81 165.02 30.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 O-C-N 124.499 1.124 . . . . 0.0 109.248 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 188' ' ' GLU . . . . . 0.989 ' OE2' HD21 ' A' ' 140' ' ' LEU . 0.3 OUTLIER -115.03 153.22 31.07 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.475 1.11 . . . . 0.0 110.277 -179.984 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . 0.446 ' NZ ' HG13 ' A' ' 184' ' ' VAL . 0.0 OUTLIER -88.54 137.01 32.7 Favored 'General case' 0 C--N 1.326 -0.436 0 O-C-N 124.505 1.128 . . . . 0.0 109.334 179.99 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 . . . . . 0 C--N 1.326 -0.456 0 O-C-N 124.57 1.169 . . . . 0.0 110.987 179.99 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . 0.523 ' CB ' ' O ' ' A' ' 161' ' ' ILE . 25.3 mp0 . . . . . 0 N--CA 1.453 -0.279 0 N-CA-C 110.379 -0.23 . . . . 0.0 110.379 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 76.0 m-85 -126.66 125.07 41.27 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.512 1.133 . . . . 0.0 111.021 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.528 HG13 HD13 ' A' ' 161' ' ' ILE . 7.5 m -131.84 141.26 46.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 O-C-N 124.533 1.145 . . . . 0.0 109.336 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . 0.547 ' HD2' ' CE1' ' A' ' 190' ' ' TYR . 0.8 OUTLIER -115.58 137.5 52.0 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.57 1.169 . . . . 0.0 110.261 -179.956 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.683 ' HB3' ' OD1' ' A' ' 157' ' ' ASP . . . -92.56 115.6 28.25 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.501 1.126 . . . . 0.0 109.273 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.852 HD21 ' OE2' ' A' ' 188' ' ' GLU . 0.2 OUTLIER -87.44 -8.41 56.53 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.495 1.122 . . . . 0.0 109.331 179.993 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . 0.57 ' CE1' ' HB2' ' A' ' 140' ' ' LEU . 0.4 OUTLIER -128.04 144.31 51.1 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.494 1.121 . . . . 0.0 111.004 179.991 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . 0.421 ' CB ' ' HA ' ' A' ' 154' ' ' LYS . 0.9 OUTLIER . . . . . 0 C--N 1.325 -0.494 0 O-C-N 124.55 1.156 . . . . 0.0 109.242 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . 0.573 ' CE1' ' CG ' ' A' ' 183' ' ' PRO . 24.4 p90 . . . . . 0 N--CA 1.452 -0.363 0 CA-C-O 120.491 0.186 . . . . 0.0 111.046 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . 0.421 ' HA ' ' CB ' ' A' ' 142' ' ' ASP . 0.6 OUTLIER -119.76 -155.56 0.62 Allowed 'General case' 0 C--N 1.326 -0.438 0 O-C-N 124.479 1.112 . . . . 0.0 109.296 -179.992 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 1.1 tttp -111.96 98.78 7.6 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.473 1.108 . . . . 0.0 109.314 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . 0.645 ' N ' ' O ' ' A' ' 139' ' ' ALA . . . 115.55 25.75 3.62 Favored Glycine 0 CA--C 1.529 0.967 0 O-C-N 124.525 1.141 . . . . 0.0 111.038 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . 0.863 ' C ' HD12 ' A' ' 158' ' ' ILE . 3.4 p-10 -99.13 166.85 11.05 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.438 0.728 . . . . 0.0 109.28 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . 0.863 HD12 ' C ' ' A' ' 157' ' ' ASP . 2.1 mp -122.5 150.88 26.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 O-C-N 124.422 1.076 . . . . 0.0 109.268 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.902 HD21 ' CG ' ' A' ' 174' ' ' ASP . 0.4 OUTLIER -151.94 134.84 15.65 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.482 1.114 . . . . 0.0 109.336 179.988 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . 0.48 ' O ' ' HB1' ' A' ' 172' ' ' ALA . 0.1 OUTLIER -93.53 127.56 39.25 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.431 1.082 . . . . 0.0 110.314 -179.981 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.528 HD13 HG13 ' A' ' 137' ' ' VAL . 1.6 mp -85.67 121.49 37.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 O-C-N 124.48 1.112 . . . . 0.0 109.362 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . 0.429 ' CD ' ' HB2' ' A' ' 163' ' ' ASP . 0.2 OUTLIER -119.99 -32.21 4.26 Favored 'General case' 0 C--N 1.326 -0.431 0 O-C-N 124.425 1.078 . . . . 0.0 110.289 -179.976 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . 0.448 ' CB ' ' HB3' ' A' ' 171' ' ' ASN . 0.4 OUTLIER -139.8 171.34 14.36 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.554 1.159 . . . . 0.0 109.299 179.985 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . 0.573 ' HB2' ' CD1' ' A' ' 170' ' ' TRP . 0.5 OUTLIER -156.8 82.62 3.26 Favored Pre-proline 0 C--N 1.325 -0.476 0 O-C-N 124.496 1.123 . . . . 0.0 109.312 -179.939 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -74.9 -25.71 11.83 Favored 'Trans proline' 0 C--N 1.359 1.129 0 O-C-N 124.438 1.757 . . . . 0.0 111.075 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 9.6 mt-10 -111.64 169.01 9.11 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.464 1.102 . . . . 0.0 110.317 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -90.98 -32.04 16.1 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.544 1.153 . . . . 0.0 110.296 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 168' ' ' GLN . . . . . 0.437 ' HB3' ' CD1' ' A' ' 169' ' ' TRP . 6.6 mt-30 -87.3 -53.45 4.83 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.552 1.158 . . . . 0.0 110.31 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 169' ' ' TRP . . . . . 0.473 ' N ' ' CD1' ' A' ' 169' ' ' TRP . 1.6 m95 -104.8 148.18 26.91 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.546 1.154 . . . . 0.0 107.972 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 170' ' ' TRP . . . . . 0.585 ' CE2' HG21 ' A' ' 184' ' ' VAL . 36.9 m0 -125.38 159.67 31.26 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.558 1.161 . . . . 0.0 108.05 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 171' ' ' ASN . . . . . 0.448 ' HB3' ' CB ' ' A' ' 163' ' ' ASP . 23.6 t-20 -86.14 109.5 18.92 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.511 1.132 . . . . 0.0 109.289 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . 0.48 ' HB1' ' O ' ' A' ' 160' ' ' ARG . . . -122.82 176.92 5.71 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.457 1.098 . . . . 0.0 109.323 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . 0.5 ' CG ' ' HG2' ' A' ' 179' ' ' ARG . 7.1 mt-10 -116.36 119.74 36.64 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.453 1.096 . . . . 0.0 110.357 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . 0.902 ' CG ' HD21 ' A' ' 159' ' ' LEU . 1.7 m-20 -74.66 -175.93 2.62 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.508 1.13 . . . . 0.0 109.361 179.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 98.2 p -76.74 58.93 1.49 Allowed 'General case' 0 C--N 1.324 -0.531 0 O-C-N 124.506 1.129 . . . . 0.0 109.99 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . 0.409 ' H ' ' H ' ' A' ' 177' ' ' GLY . 0.4 OUTLIER -170.93 -2.22 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.52 0 O-C-N 124.515 1.134 . . . . 0.0 110.333 -179.986 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 177' ' ' GLY . . . . . 0.409 ' H ' ' H ' ' A' ' 176' ' ' GLU . . . 79.16 19.58 71.9 Favored Glycine 0 CA--C 1.53 1.012 0 O-C-N 124.524 1.14 . . . . 0.0 111.037 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 178' ' ' LYS . . . . . 0.497 ' CG ' ' HB2' ' A' ' 174' ' ' ASP . 2.1 ptpp? -91.88 121.26 33.31 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.499 0.764 . . . . 0.0 109.331 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 179' ' ' ARG . . . . . 0.5 ' HG2' ' CG ' ' A' ' 173' ' ' GLU . 21.1 mtt85 -89.81 122.44 32.88 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.475 1.109 . . . . 0.0 110.275 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . 0.427 ' O ' ' HA ' ' A' ' 171' ' ' ASN . . . -152.02 167.04 31.11 Favored Glycine 0 CA--C 1.531 1.037 0 O-C-N 124.486 1.117 . . . . 0.0 110.972 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 181' ' ' MET . . . . . 0.473 ' HA ' ' O ' ' A' ' 170' ' ' TRP . 33.8 mtp -87.97 103.5 15.75 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.471 0.748 . . . . 0.0 110.988 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . 0.807 HG21 HD22 ' A' ' 159' ' ' LEU . 8.2 pt -98.7 157.12 34.79 Favored Pre-proline 0 C--N 1.324 -0.528 0 O-C-N 124.526 1.141 . . . . 0.0 109.281 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 183' ' ' PRO . . . . . 0.717 ' HG2' ' HB2' ' A' ' 186' ' ' TYR . 18.4 Cg_endo -75.0 135.27 18.85 Favored 'Trans proline' 0 C--N 1.36 1.148 0 O-C-N 124.495 1.787 . . . . 0.0 111.029 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . 0.816 ' N ' ' CD ' ' A' ' 185' ' ' PRO . 62.8 t -81.74 -32.45 0.61 Allowed Pre-proline 0 C--N 1.324 -0.501 0 O-C-N 124.547 1.155 . . . . 0.0 109.359 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 185' ' ' PRO . . . . . 0.816 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.5 Cg_endo -74.98 -25.35 11.97 Favored 'Trans proline' 0 C--N 1.36 1.159 0 O-C-N 124.508 1.794 . . . . 0.0 111.011 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 186' ' ' TYR . . . . . 0.717 ' HB2' ' HG2' ' A' ' 183' ' ' PRO . 3.8 m-85 -93.48 14.43 18.69 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.504 1.127 . . . . 0.0 111.068 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 187' ' ' VAL . . . . . 0.694 HG22 ' O ' ' A' ' 183' ' ' PRO . 21.4 m -138.22 163.69 28.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 O-C-N 124.525 1.14 . . . . 0.0 109.272 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 188' ' ' GLU . . . . . 0.852 ' OE2' HD21 ' A' ' 140' ' ' LEU . 0.0 OUTLIER -126.07 167.62 15.1 Favored 'General case' 0 C--N 1.326 -0.416 0 O-C-N 124.431 1.082 . . . . 0.0 110.335 179.958 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -87.5 125.39 34.28 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.508 1.13 . . . . 0.0 109.251 -179.9 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 190' ' ' TYR . . . . . 0.547 ' CE1' ' HD2' ' A' ' 138' ' ' ARG . 0.1 OUTLIER . . . . . 0 C--N 1.325 -0.472 0 O-C-N 124.444 1.09 . . . . 0.0 111.034 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . 0.442 ' HB2' ' HB ' ' A' ' 161' ' ' ILE . 0.2 OUTLIER . . . . . 0 N--CA 1.452 -0.328 0 N-CA-C 110.294 -0.262 . . . . 0.0 110.294 . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . 0.582 ' C ' ' CD1' ' A' ' 136' ' ' TYR . 0.4 OUTLIER -121.97 143.0 49.73 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.493 1.121 . . . . 0.0 110.978 179.998 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.834 HG22 ' O ' ' A' ' 159' ' ' LEU . 35.1 m -145.03 137.45 21.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 O-C-N 124.431 1.082 . . . . 0.0 109.243 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . 0.447 ' HB3' ' HG3' ' A' ' 188' ' ' GLU . 0.6 OUTLIER -105.07 133.98 48.93 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.466 1.104 . . . . 0.0 110.285 -179.993 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.578 ' HB2' HD11 ' A' ' 159' ' ' LEU . . . -95.97 112.57 24.27 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.56 1.163 . . . . 0.0 109.305 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.955 HD21 ' OE2' ' A' ' 188' ' ' GLU . 0.2 OUTLIER -98.5 -9.48 24.97 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.561 1.163 . . . . 0.0 109.325 -179.971 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . 0.495 ' C ' ' O ' ' A' ' 154' ' ' LYS . 14.3 m-85 -109.22 152.02 25.74 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.448 1.093 . . . . 0.0 111.062 179.906 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . 0.502 ' CA ' ' O ' ' A' ' 154' ' ' LYS . 3.3 t70 . . . . . 0 C--N 1.325 -0.495 0 O-C-N 124.551 1.157 . . . . 0.0 109.353 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 11.7 p90 . . . . . 0 N--CA 1.454 -0.263 0 CA-C-O 120.576 0.227 . . . . 0.0 110.922 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . 0.502 ' O ' ' CA ' ' A' ' 142' ' ' ASP . 0.0 OUTLIER -127.02 -80.73 0.6 Allowed 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.484 1.115 . . . . 0.0 109.303 -179.979 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -165.77 115.51 1.01 Allowed 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.538 1.149 . . . . 0.0 109.34 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . 0.499 ' N ' ' O ' ' A' ' 139' ' ' ALA . . . 100.38 20.83 14.27 Favored Glycine 0 CA--C 1.53 1.017 0 O-C-N 124.437 1.086 . . . . 0.0 111.049 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . 0.422 ' HB3' ' HB3' ' A' ' 139' ' ' ALA . 23.1 t70 -84.59 155.23 22.14 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.488 0.757 . . . . 0.0 109.32 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . 0.48 HG23 ' CE2' ' A' ' 136' ' ' TYR . 13.1 mm -105.1 133.78 48.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 O-C-N 124.417 1.073 . . . . 0.0 109.342 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.834 ' O ' HG22 ' A' ' 137' ' ' VAL . 0.4 OUTLIER -142.96 124.93 15.19 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.538 1.149 . . . . 0.0 109.286 -179.976 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . 0.672 ' O ' ' HA ' ' A' ' 172' ' ' ALA . 0.0 OUTLIER -94.65 141.01 29.11 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.529 1.143 . . . . 0.0 110.271 179.992 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.442 ' HB ' ' HB2' ' A' ' 135' ' ' GLU . 19.9 mm -84.28 114.71 25.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 O-C-N 124.533 1.145 . . . . 0.0 109.313 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.47 -52.59 2.75 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.491 1.119 . . . . 0.0 110.293 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 11.8 t0 -136.34 174.7 10.33 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.451 1.094 . . . . 0.0 109.284 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . 0.564 ' HB2' ' CD1' ' A' ' 170' ' ' TRP . 0.0 OUTLIER -167.1 89.16 0.75 Allowed Pre-proline 0 C--N 1.325 -0.499 0 O-C-N 124.472 1.108 . . . . 0.0 109.299 -179.99 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.04 -34.2 3.97 Favored 'Trans proline' 0 C--N 1.36 1.166 0 O-C-N 124.532 1.806 . . . . 0.0 110.952 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -107.8 170.13 8.18 Favored 'General case' 0 C--N 1.324 -0.532 0 O-C-N 124.542 1.151 . . . . 0.0 110.28 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 18.7 pt-20 -95.36 -15.56 22.98 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.471 1.107 . . . . 0.0 110.355 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 168' ' ' GLN . . . . . 0.445 ' HG2' ' CD1' ' A' ' 169' ' ' TRP . 20.5 tt0 -92.41 -56.29 3.09 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.502 1.126 . . . . 0.0 110.333 179.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 169' ' ' TRP . . . . . 0.445 ' CD1' ' HG2' ' A' ' 168' ' ' GLN . 32.4 m95 -105.61 140.34 38.83 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.449 1.093 . . . . 0.0 108.064 179.934 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 170' ' ' TRP . . . . . 0.712 ' CD2' HG21 ' A' ' 184' ' ' VAL . 53.1 m0 -120.02 152.78 36.99 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.523 1.139 . . . . 0.0 107.98 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 171' ' ' ASN . . . . . 0.448 ' HA ' ' O ' ' A' ' 180' ' ' GLY . 0.1 OUTLIER -88.04 97.34 10.91 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.493 1.121 . . . . 0.0 109.268 179.976 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . 0.672 ' HA ' ' O ' ' A' ' 160' ' ' ARG . . . -107.47 173.17 6.44 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.51 1.131 . . . . 0.0 109.342 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . 0.442 ' O ' ' HA ' ' A' ' 159' ' ' LEU . 18.1 mt-10 -118.94 120.08 36.21 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.517 1.136 . . . . 0.0 110.329 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -74.34 -169.92 0.89 Allowed 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.468 1.105 . . . . 0.0 109.297 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 72.6 p -81.3 59.79 4.11 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.441 1.088 . . . . 0.0 110.004 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 177.61 25.48 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.484 1.115 . . . . 0.0 110.266 -179.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 57.79 19.2 35.2 Favored Glycine 0 CA--C 1.531 1.043 0 O-C-N 124.534 1.146 . . . . 0.0 110.997 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 6.6 mtmt -81.28 104.06 11.49 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.504 0.767 . . . . 0.0 109.293 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 179' ' ' ARG . . . . . 0.45 ' HA ' ' O ' ' A' ' 172' ' ' ALA . 4.7 ttp180 -90.46 118.75 30.18 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.528 1.143 . . . . 0.0 110.288 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . 0.448 ' O ' ' HA ' ' A' ' 171' ' ' ASN . . . -152.25 168.86 31.47 Favored Glycine 0 CA--C 1.531 1.032 0 O-C-N 124.612 1.195 . . . . 0.0 111.04 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 181' ' ' MET . . . . . 0.461 ' HA ' ' O ' ' A' ' 170' ' ' TRP . 1.5 mmm -85.98 106.76 17.38 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.546 0.792 . . . . 0.0 110.961 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . 0.481 HD13 HD22 ' A' ' 159' ' ' LEU . 1.4 pp -110.41 162.12 21.81 Favored Pre-proline 0 C--N 1.326 -0.446 0 O-C-N 124.515 1.134 . . . . 0.0 109.278 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 183' ' ' PRO . . . . . 0.705 ' HG2' ' HB2' ' A' ' 186' ' ' TYR . 18.6 Cg_endo -74.99 132.56 15.58 Favored 'Trans proline' 0 C--N 1.36 1.162 0 O-C-N 124.508 1.794 . . . . 0.0 111.05 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . 0.807 ' N ' ' CD ' ' A' ' 185' ' ' PRO . 62.1 t -78.94 -32.45 0.79 Allowed Pre-proline 0 C--N 1.324 -0.527 0 O-C-N 124.568 1.168 . . . . 0.0 109.332 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 185' ' ' PRO . . . . . 0.807 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.4 Cg_endo -74.96 -17.44 19.65 Favored 'Trans proline' 0 C--N 1.36 1.156 0 O-C-N 124.438 1.757 . . . . 0.0 111.006 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 186' ' ' TYR . . . . . 0.705 ' HB2' ' HG2' ' A' ' 183' ' ' PRO . 3.5 m-30 -97.25 17.7 16.72 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.496 1.123 . . . . 0.0 110.972 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 187' ' ' VAL . . . . . 0.43 HG12 ' CB ' ' A' ' 139' ' ' ALA . 16.7 m -145.44 173.61 3.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 O-C-N 124.515 1.134 . . . . 0.0 109.359 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 188' ' ' GLU . . . . . 0.955 ' OE2' HD21 ' A' ' 140' ' ' LEU . 0.1 OUTLIER -127.95 159.6 34.47 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.504 1.127 . . . . 0.0 110.245 -179.962 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 7.4 mmmm -88.18 135.84 33.25 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.433 1.083 . . . . 0.0 109.306 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 8.9 t80 . . . . . 0 C--N 1.326 -0.452 0 O-C-N 124.456 1.098 . . . . 0.0 111.02 179.987 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . 0.459 ' CB ' ' HB ' ' A' ' 161' ' ' ILE . 1.5 mt-10 . . . . . 0 N--CA 1.453 -0.301 0 N-CA-C 110.248 -0.279 . . . . 0.0 110.248 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . 0.513 ' CE1' ' HB2' ' A' ' 160' ' ' ARG . 26.0 m-85 -86.86 106.55 17.82 Favored 'General case' 0 C--N 1.324 -0.527 0 O-C-N 124.491 1.119 . . . . 0.0 110.946 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.604 ' HA ' ' O ' ' A' ' 188' ' ' GLU . 19.8 m -117.19 138.39 48.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 O-C-N 124.502 1.126 . . . . 0.0 109.301 179.943 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . 0.43 ' HG2' ' CG ' ' A' ' 188' ' ' GLU . 0.0 OUTLIER -108.27 147.01 32.03 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.532 1.145 . . . . 0.0 110.275 -179.956 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.663 ' O ' ' N ' ' A' ' 156' ' ' GLY . . . -93.88 119.89 33.41 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.506 1.128 . . . . 0.0 109.336 179.955 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.52 HD11 ' HG2' ' A' ' 188' ' ' GLU . 1.1 mt -88.51 -3.46 58.81 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.472 1.108 . . . . 0.0 109.281 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 13.8 m-85 -139.96 154.34 47.16 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.433 1.083 . . . . 0.0 110.984 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . 0.495 ' CB ' ' HA ' ' A' ' 154' ' ' LYS . 10.8 p-10 . . . . . 0 C--N 1.325 -0.485 0 O-C-N 124.495 1.122 . . . . 0.0 109.285 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . 0.596 ' CZ ' ' CG ' ' A' ' 183' ' ' PRO . 30.0 p90 . . . . . 0 N--CA 1.453 -0.298 0 CA-C-O 120.504 0.193 . . . . 0.0 111.072 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . 0.495 ' HA ' ' CB ' ' A' ' 142' ' ' ASP . 0.1 OUTLIER -126.1 -166.64 1.59 Allowed 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.453 1.096 . . . . 0.0 109.331 -179.985 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 6.4 ptpt -95.65 105.63 17.64 Favored 'General case' 0 C--N 1.324 -0.531 0 O-C-N 124.545 1.153 . . . . 0.0 109.329 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . 0.663 ' N ' ' O ' ' A' ' 139' ' ' ALA . . . 106.75 27.72 5.34 Favored Glycine 0 CA--C 1.53 0.999 0 O-C-N 124.434 1.084 . . . . 0.0 110.993 -180.0 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . 0.405 ' O ' ' HA ' ' A' ' 138' ' ' ARG . 16.6 t70 -97.45 165.9 11.78 Favored 'General case' 0 C--N 1.324 -0.522 0 O-C-N 124.482 0.754 . . . . 0.0 109.27 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -123.96 138.83 52.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 O-C-N 124.507 1.13 . . . . 0.0 109.268 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.989 HD22 HD13 ' A' ' 182' ' ' ILE . 0.7 OUTLIER -147.13 130.28 16.46 Favored 'General case' 0 C--N 1.324 -0.54 0 O-C-N 124.579 1.174 . . . . 0.0 109.326 179.971 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . 0.513 ' HB2' ' CE1' ' A' ' 136' ' ' TYR . 0.0 OUTLIER -93.91 132.63 38.16 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.476 1.11 . . . . 0.0 110.308 179.982 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.583 ' CD1' HG22 ' A' ' 137' ' ' VAL . 1.6 mp -89.09 132.59 33.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 O-C-N 124.519 1.137 . . . . 0.0 109.327 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -127.01 -36.59 2.16 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.522 1.139 . . . . 0.0 110.263 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -132.68 169.66 16.34 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.455 1.097 . . . . 0.0 109.242 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . 0.588 ' HB2' ' CD1' ' A' ' 170' ' ' TRP . 0.0 OUTLIER -163.36 84.48 1.38 Allowed Pre-proline 0 C--N 1.326 -0.454 0 O-C-N 124.423 1.077 . . . . 0.0 109.334 -179.988 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.94 -25.54 11.9 Favored 'Trans proline' 0 C--N 1.361 1.194 0 O-C-N 124.56 1.821 . . . . 0.0 111.022 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -113.6 174.77 5.76 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.487 1.117 . . . . 0.0 110.292 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -99.71 -19.66 16.65 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.546 1.154 . . . . 0.0 110.317 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 3.6 mt-30 -88.18 -66.69 0.89 Allowed 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.41 1.069 . . . . 0.0 110.326 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 169' ' ' TRP . . . . . . . . . . . . . 6.5 m95 -95.49 153.17 17.83 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.537 1.148 . . . . 0.0 108.025 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 170' ' ' TRP . . . . . 0.699 ' CD2' HG21 ' A' ' 184' ' ' VAL . 43.2 m0 -126.03 153.93 43.7 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 -179.925 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 171' ' ' ASN . . . . . 0.417 ' HA ' ' O ' ' A' ' 180' ' ' GLY . 0.6 OUTLIER -86.97 104.23 16.08 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.459 1.099 . . . . 0.0 109.325 179.952 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . 0.462 ' HA ' ' O ' ' A' ' 160' ' ' ARG . . . -123.0 170.74 9.84 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.514 1.134 . . . . 0.0 109.319 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . 0.404 ' HA ' ' O ' ' A' ' 178' ' ' LYS . 3.9 mt-10 -115.93 126.48 53.95 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.505 1.128 . . . . 0.0 110.319 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . 0.513 ' HB3' HD21 ' A' ' 159' ' ' LEU . 0.9 OUTLIER -78.34 -174.18 3.62 Favored 'General case' 0 C--N 1.324 -0.543 0 O-C-N 124.491 1.12 . . . . 0.0 109.298 179.986 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 80.7 p -76.19 64.48 2.01 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.514 1.134 . . . . 0.0 109.932 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -177.27 0.22 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.453 1.096 . . . . 0.0 110.345 -179.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 79.12 12.59 83.87 Favored Glycine 0 CA--C 1.53 1.006 0 O-C-N 124.575 1.172 . . . . 0.0 110.931 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 178' ' ' LYS . . . . . 0.404 ' O ' ' HA ' ' A' ' 173' ' ' GLU . 0.0 OUTLIER -83.91 109.4 17.57 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.554 0.797 . . . . 0.0 109.272 -179.977 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 179' ' ' ARG . . . . . 0.435 ' HA ' ' O ' ' A' ' 172' ' ' ALA . 2.1 ttp85 -87.99 123.19 32.45 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.495 1.122 . . . . 0.0 110.242 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . 0.417 ' O ' ' HA ' ' A' ' 171' ' ' ASN . . . -151.25 172.03 30.83 Favored Glycine 0 CA--C 1.53 1.022 0 O-C-N 124.486 1.116 . . . . 0.0 110.96 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 181' ' ' MET . . . . . 0.458 ' HA ' ' O ' ' A' ' 170' ' ' TRP . 0.9 OUTLIER -87.73 93.77 9.54 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.507 0.769 . . . . 0.0 111.001 -179.987 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . 0.989 HD13 HD22 ' A' ' 159' ' ' LEU . 0.0 OUTLIER -91.79 158.17 40.45 Favored Pre-proline 0 C--N 1.325 -0.497 0 O-C-N 124.459 1.099 . . . . 0.0 109.316 179.969 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 183' ' ' PRO . . . . . 0.688 ' HG2' ' HB2' ' A' ' 186' ' ' TYR . 18.2 Cg_endo -74.97 131.44 14.33 Favored 'Trans proline' 0 C--N 1.361 1.206 0 O-C-N 124.438 1.757 . . . . 0.0 111.026 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . 0.813 ' N ' ' CD ' ' A' ' 185' ' ' PRO . 85.9 t -79.96 -31.91 0.69 Allowed Pre-proline 0 C--N 1.325 -0.46 0 O-C-N 124.435 1.084 . . . . 0.0 109.265 180.0 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 185' ' ' PRO . . . . . 0.813 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.3 Cg_endo -74.99 -25.2 12.12 Favored 'Trans proline' 0 C--N 1.359 1.103 0 O-C-N 124.526 1.803 . . . . 0.0 111.002 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 186' ' ' TYR . . . . . 0.688 ' HB2' ' HG2' ' A' ' 183' ' ' PRO . 7.9 m-85 -92.83 16.64 12.01 Favored 'General case' 0 C--N 1.326 -0.431 0 O-C-N 124.498 1.124 . . . . 0.0 111.038 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 187' ' ' VAL . . . . . 0.557 HG22 ' O ' ' A' ' 183' ' ' PRO . 27.4 m -141.78 170.57 12.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 O-C-N 124.535 1.147 . . . . 0.0 109.317 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 188' ' ' GLU . . . . . 0.604 ' O ' ' HA ' ' A' ' 137' ' ' VAL . 0.0 OUTLIER -131.76 155.91 46.89 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.53 1.144 . . . . 0.0 110.295 -179.997 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . 0.477 ' HA ' HG12 ' A' ' 137' ' ' VAL . 0.0 OUTLIER -88.62 132.36 34.59 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.513 1.133 . . . . 0.0 109.21 -179.956 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 190' ' ' TYR . . . . . 0.565 ' CE1' ' OE2' ' A' ' 188' ' ' GLU . 0.1 OUTLIER . . . . . 0 C--N 1.325 -0.474 0 O-C-N 124.502 1.126 . . . . 0.0 110.977 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . 0.801 ' HG2' HG22 ' A' ' 161' ' ' ILE . 2.4 mp0 . . . . . 0 N--CA 1.453 -0.284 0 N-CA-C 110.303 -0.258 . . . . 0.0 110.303 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 31.7 m-85 -126.11 131.93 51.98 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.434 1.084 . . . . 0.0 111.078 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.632 ' CG2' HG23 ' A' ' 187' ' ' VAL . 0.7 OUTLIER -132.68 127.82 56.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 O-C-N 124.516 1.135 . . . . 0.0 109.329 -179.931 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . 0.468 ' O ' ' HA ' ' A' ' 187' ' ' VAL . 0.0 OUTLIER -96.03 134.15 39.41 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.501 1.126 . . . . 0.0 110.371 -179.988 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.625 ' CB ' HG12 ' A' ' 187' ' ' VAL . . . -96.35 109.47 21.98 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.52 1.138 . . . . 0.0 109.279 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.624 HD11 ' HG2' ' A' ' 188' ' ' GLU . 0.2 OUTLIER -89.91 -31.79 17.13 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.483 1.115 . . . . 0.0 109.284 179.996 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . 0.505 ' O ' ' CD1' ' A' ' 153' ' ' PHE . 71.2 m-85 -88.53 152.62 21.74 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.529 1.143 . . . . 0.0 111.007 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . 0.507 ' HA ' ' O ' ' A' ' 154' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--N 1.325 -0.497 0 O-C-N 124.497 1.123 . . . . 0.0 109.36 179.942 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . 0.505 ' CD1' ' O ' ' A' ' 141' ' ' PHE . 28.9 p90 . . . . . 0 N--CA 1.452 -0.327 0 CA-C-O 120.401 0.143 . . . . 0.0 111.055 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . 0.507 ' O ' ' HA ' ' A' ' 142' ' ' ASP . 5.6 ttmt -127.25 -99.51 0.37 Allowed 'General case' 0 C--N 1.324 -0.53 0 O-C-N 124.554 1.159 . . . . 0.0 109.301 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 17.2 ttpp -156.09 118.82 4.16 Favored 'General case' 0 C--N 1.326 -0.443 0 O-C-N 124.445 1.09 . . . . 0.0 109.353 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . 0.494 ' N ' ' O ' ' A' ' 139' ' ' ALA . . . 97.46 15.06 39.04 Favored Glycine 0 CA--C 1.53 1.023 0 O-C-N 124.572 1.17 . . . . 0.0 110.948 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . 0.5 ' C ' HD12 ' A' ' 158' ' ' ILE . 8.9 t0 -83.83 163.28 20.22 Favored 'General case' 0 C--N 1.324 -0.523 0 O-C-N 124.479 0.752 . . . . 0.0 109.254 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . 0.501 ' N ' HD12 ' A' ' 158' ' ' ILE . 3.5 mp -119.01 148.74 21.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 O-C-N 124.473 1.108 . . . . 0.0 109.29 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.725 HD21 ' OD1' ' A' ' 174' ' ' ASP . 0.7 OUTLIER -147.43 130.88 16.69 Favored 'General case' 0 C--N 1.326 -0.443 0 O-C-N 124.468 1.105 . . . . 0.0 109.303 -179.953 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . 0.684 ' O ' ' HA ' ' A' ' 172' ' ' ALA . 3.7 tpp180 -87.45 127.37 35.23 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.523 1.14 . . . . 0.0 110.273 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.801 HG22 ' HG2' ' A' ' 135' ' ' GLU . 1.5 mp -82.37 119.23 31.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 O-C-N 124.434 1.084 . . . . 0.0 109.305 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . 0.484 ' NH1' ' OD2' ' A' ' 163' ' ' ASP . 1.0 OUTLIER -115.25 -48.89 2.79 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.467 1.105 . . . . 0.0 110.345 179.952 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . 0.484 ' OD2' ' NH1' ' A' ' 162' ' ' ARG . 67.4 m-20 -141.54 171.34 14.2 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.485 1.116 . . . . 0.0 109.291 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . 0.591 ' HB3' ' CD1' ' A' ' 170' ' ' TRP . 14.5 mtmm -138.71 58.46 13.84 Favored Pre-proline 0 C--N 1.325 -0.486 0 O-C-N 124.521 1.138 . . . . 0.0 109.309 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 165' ' ' PRO . . . . . 0.541 ' HD3' ' N ' ' A' ' 164' ' ' LYS . 18.5 Cg_endo -74.99 76.41 3.4 Favored 'Trans proline' 0 C--N 1.36 1.163 0 O-C-N 124.455 1.766 . . . . 0.0 111.02 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . 0.47 ' CB ' ' O ' ' A' ' 165' ' ' PRO . 1.5 mt-10 162.77 177.24 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.547 1.155 . . . . 0.0 110.296 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -117.08 42.68 2.47 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.433 1.083 . . . . 0.0 110.277 -179.923 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER 178.29 -51.53 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.493 1.121 . . . . 0.0 110.306 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 169' ' ' TRP . . . . . . . . . . . . . 7.2 m95 -95.29 144.05 26.18 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 170' ' ' TRP . . . . . 0.789 ' CD2' HG21 ' A' ' 184' ' ' VAL . 48.6 m0 -120.45 149.82 41.78 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.474 1.109 . . . . 0.0 108.02 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 171' ' ' ASN . . . . . 0.417 ' HA ' ' O ' ' A' ' 180' ' ' GLY . 1.2 t-20 -86.6 98.99 11.4 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.428 1.08 . . . . 0.0 109.322 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . 0.684 ' HA ' ' O ' ' A' ' 160' ' ' ARG . . . -116.04 171.41 7.81 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.474 1.109 . . . . 0.0 109.239 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . 0.484 ' HG3' ' CG ' ' A' ' 179' ' ' ARG . 5.2 mt-10 -115.89 117.4 30.08 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.493 1.12 . . . . 0.0 110.326 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . 0.725 ' OD1' HD21 ' A' ' 159' ' ' LEU . 0.1 OUTLIER -68.28 -164.28 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.559 1.162 . . . . 0.0 109.355 179.969 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 88.1 p -85.09 60.03 5.99 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.444 1.09 . . . . 0.0 109.905 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -178.95 18.62 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.418 1.074 . . . . 0.0 110.286 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 63.54 14.96 56.52 Favored Glycine 0 CA--C 1.531 1.038 0 O-C-N 124.605 1.19 . . . . 0.0 110.999 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 178' ' ' LYS . . . . . 0.412 ' O ' ' HA ' ' A' ' 173' ' ' GLU . 1.5 mttt -80.51 105.59 11.87 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.495 0.762 . . . . 0.0 109.255 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 179' ' ' ARG . . . . . 0.484 ' CG ' ' HG3' ' A' ' 173' ' ' GLU . 0.0 OUTLIER -89.58 118.29 29.1 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.488 1.118 . . . . 0.0 110.243 -179.997 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . 0.417 ' O ' ' HA ' ' A' ' 171' ' ' ASN . . . -151.55 171.09 31.09 Favored Glycine 0 CA--C 1.53 1.026 0 O-C-N 124.54 1.15 . . . . 0.0 111.004 179.938 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 181' ' ' MET . . . . . 0.451 ' CE ' ' HD2' ' A' ' 165' ' ' PRO . 0.4 OUTLIER -88.81 103.73 16.26 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.524 0.779 . . . . 0.0 110.926 -179.926 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . 0.445 HG21 HD22 ' A' ' 159' ' ' LEU . 0.0 OUTLIER -107.36 165.72 12.31 Favored Pre-proline 0 C--N 1.325 -0.495 0 O-C-N 124.49 1.119 . . . . 0.0 109.298 -179.998 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 183' ' ' PRO . . . . . 0.6 ' HG2' ' HB2' ' A' ' 186' ' ' TYR . 18.3 Cg_endo -75.02 131.38 14.2 Favored 'Trans proline' 0 C--N 1.359 1.088 0 O-C-N 124.534 1.807 . . . . 0.0 110.984 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . 0.803 ' N ' ' CD ' ' A' ' 185' ' ' PRO . 90.5 t -79.92 -33.64 0.8 Allowed Pre-proline 0 C--N 1.326 -0.447 0 O-C-N 124.529 1.143 . . . . 0.0 109.28 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 185' ' ' PRO . . . . . 0.803 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.3 Cg_endo -74.93 -13.87 21.46 Favored 'Trans proline' 0 C--N 1.361 1.194 0 O-C-N 124.517 1.798 . . . . 0.0 111.054 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 186' ' ' TYR . . . . . 0.6 ' HB2' ' HG2' ' A' ' 183' ' ' PRO . 8.8 m-85 -95.96 4.98 52.26 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.458 1.098 . . . . 0.0 110.983 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 187' ' ' VAL . . . . . 0.632 HG23 ' CG2' ' A' ' 137' ' ' VAL . 25.0 m -136.18 170.25 19.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 O-C-N 124.424 1.078 . . . . 0.0 109.319 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 188' ' ' GLU . . . . . 0.624 ' HG2' HD11 ' A' ' 140' ' ' LEU . 0.0 OUTLIER -121.82 155.27 35.69 Favored 'General case' 0 C--N 1.326 -0.432 0 O-C-N 124.426 1.079 . . . . 0.0 110.26 -179.994 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.44 126.75 35.07 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.527 1.142 . . . . 0.0 109.259 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.324 -0.521 0 O-C-N 124.455 1.097 . . . . 0.0 111.017 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . 0.46 ' O ' ' HA ' ' A' ' 160' ' ' ARG . 0.4 OUTLIER . . . . . 0 N--CA 1.453 -0.301 0 N-CA-C 110.33 -0.248 . . . . 0.0 110.33 . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . 0.471 ' CE2' HG21 ' A' ' 158' ' ' ILE . 0.1 OUTLIER -127.72 113.8 16.48 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.416 1.072 . . . . 0.0 111.012 -179.973 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.511 HG13 HD13 ' A' ' 161' ' ' ILE . 16.0 m -108.17 137.18 40.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 O-C-N 124.539 1.149 . . . . 0.0 109.275 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . 0.427 ' O ' ' HA ' ' A' ' 187' ' ' VAL . 6.4 ttm180 -101.89 128.83 48.1 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.529 1.143 . . . . 0.0 110.3 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.867 ' HB3' ' HB3' ' A' ' 157' ' ' ASP . . . -88.52 103.69 16.12 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 124.557 1.16 . . . . 0.0 109.267 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.715 HD11 ' HB3' ' A' ' 188' ' ' GLU . 0.2 OUTLIER -90.41 -29.06 18.23 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.464 1.102 . . . . 0.0 109.26 179.984 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . 0.498 ' C ' ' O ' ' A' ' 154' ' ' LYS . 27.0 m-85 -92.16 151.22 20.49 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.498 1.124 . . . . 0.0 110.951 -179.907 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.325 -0.499 0 O-C-N 124.508 1.13 . . . . 0.0 109.322 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . 0.681 ' HD2' HD11 ' A' ' 182' ' ' ILE . 20.5 p90 . . . . . 0 N--CA 1.454 -0.255 0 CA-C-O 120.537 0.208 . . . . 0.0 110.95 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . 0.498 ' O ' ' C ' ' A' ' 141' ' ' PHE . 1.2 ttmm -127.32 -83.73 0.61 Allowed 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.471 1.107 . . . . 0.0 109.364 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -161.46 113.52 1.81 Allowed 'General case' 0 C--N 1.326 -0.431 0 O-C-N 124.378 1.048 . . . . 0.0 109.312 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . 0.568 ' N ' ' O ' ' A' ' 139' ' ' ALA . . . 108.38 16.08 12.79 Favored Glycine 0 CA--C 1.53 1.022 0 O-C-N 124.435 1.084 . . . . 0.0 111.041 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . 0.867 ' HB3' ' HB3' ' A' ' 139' ' ' ALA . 24.6 t70 -81.27 158.06 24.93 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.55 0.794 . . . . 0.0 109.336 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . 0.471 HG21 ' CE2' ' A' ' 136' ' ' TYR . 7.5 mm -119.35 133.21 66.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 O-C-N 124.468 1.105 . . . . 0.0 109.328 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.815 HD22 HD13 ' A' ' 182' ' ' ILE . 0.1 OUTLIER -138.07 128.71 26.61 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.48 1.113 . . . . 0.0 109.316 -179.953 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . 0.59 ' O ' ' HA ' ' A' ' 172' ' ' ALA . 1.5 ttp180 -90.1 131.18 36.1 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.426 1.079 . . . . 0.0 110.271 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.511 HD13 HG13 ' A' ' 137' ' ' VAL . 1.3 mp -82.82 120.7 34.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 O-C-N 124.482 1.114 . . . . 0.0 109.353 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 3.5 mtp180 -114.41 -56.91 2.34 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.494 1.122 . . . . 0.0 110.245 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -123.83 161.41 25.34 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.478 1.111 . . . . 0.0 109.295 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . 0.628 ' CD ' ' CE2' ' A' ' 170' ' ' TRP . 2.6 ttpt -144.95 76.0 13.92 Favored Pre-proline 0 C--N 1.326 -0.451 0 O-C-N 124.506 1.128 . . . . 0.0 109.33 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.96 -33.07 4.91 Favored 'Trans proline' 0 C--N 1.36 1.145 0 O-C-N 124.527 1.804 . . . . 0.0 111.0 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . 0.406 ' O ' ' CD1' ' A' ' 170' ' ' TRP . 2.9 mt-10 -114.18 163.8 14.73 Favored 'General case' 0 C--N 1.324 -0.536 0 O-C-N 124.569 1.168 . . . . 0.0 110.282 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -88.64 -23.35 23.07 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.446 1.092 . . . . 0.0 110.283 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 168' ' ' GLN . . . . . 0.527 ' O ' HG23 ' A' ' 184' ' ' VAL . 3.9 mt-30 -87.03 -69.92 0.65 Allowed 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.499 1.125 . . . . 0.0 110.331 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 169' ' ' TRP . . . . . . . . . . . . . 5.8 m95 -94.1 141.35 28.64 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 170' ' ' TRP . . . . . 0.692 ' CE2' HG21 ' A' ' 184' ' ' VAL . 50.8 m0 -120.15 153.24 36.49 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.517 1.135 . . . . 0.0 107.957 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 171' ' ' ASN . . . . . 0.411 ' HA ' ' O ' ' A' ' 180' ' ' GLY . 1.3 t-20 -86.67 92.63 8.99 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.503 1.127 . . . . 0.0 109.334 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . 0.59 ' HA ' ' O ' ' A' ' 160' ' ' ARG . . . -109.21 176.66 5.01 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.507 1.129 . . . . 0.0 109.317 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . 0.406 ' HA ' ' O ' ' A' ' 178' ' ' LYS . 30.2 mt-10 -123.06 123.4 40.77 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.496 1.122 . . . . 0.0 110.331 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -73.79 -171.46 1.07 Allowed 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.475 1.109 . . . . 0.0 109.369 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -83.21 64.48 7.74 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.458 1.099 . . . . 0.0 110.063 179.958 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -176.22 8.25 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.559 1.162 . . . . 0.0 110.279 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 69.03 29.26 72.41 Favored Glycine 0 CA--C 1.53 0.985 0 O-C-N 124.453 1.095 . . . . 0.0 111.03 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 178' ' ' LYS . . . . . 0.406 ' O ' ' HA ' ' A' ' 173' ' ' GLU . 8.4 mtpt -103.86 115.27 30.15 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.518 0.775 . . . . 0.0 109.346 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 179' ' ' ARG . . . . . 0.476 ' HA ' ' O ' ' A' ' 172' ' ' ALA . 8.9 ttp180 -88.95 128.03 35.68 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.5 1.125 . . . . 0.0 110.316 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . 0.411 ' O ' ' HA ' ' A' ' 171' ' ' ASN . . . -151.71 170.34 31.18 Favored Glycine 0 CA--C 1.53 1.025 0 O-C-N 124.527 1.142 . . . . 0.0 110.991 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 181' ' ' MET . . . . . 0.439 ' HA ' ' O ' ' A' ' 170' ' ' TRP . 0.2 OUTLIER -92.13 99.47 12.27 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.49 0.759 . . . . 0.0 111.039 179.987 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . 0.815 HD13 HD22 ' A' ' 159' ' ' LEU . 0.6 OUTLIER -103.78 151.64 38.85 Favored Pre-proline 0 C--N 1.324 -0.504 0 O-C-N 124.482 1.114 . . . . 0.0 109.311 -179.976 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 183' ' ' PRO . . . . . 0.658 ' HD2' ' CG1' ' A' ' 182' ' ' ILE . 18.4 Cg_endo -74.99 134.19 17.53 Favored 'Trans proline' 0 C--N 1.359 1.109 0 O-C-N 124.441 1.759 . . . . 0.0 110.979 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . 0.858 ' N ' ' CD ' ' A' ' 185' ' ' PRO . 21.6 t -75.8 -29.14 0.79 Allowed Pre-proline 0 C--N 1.326 -0.441 0 O-C-N 124.398 1.061 . . . . 0.0 109.286 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 185' ' ' PRO . . . . . 0.858 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.5 Cg_endo -74.87 -13.68 21.65 Favored 'Trans proline' 0 C--N 1.36 1.146 0 O-C-N 124.477 1.777 . . . . 0.0 111.037 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 186' ' ' TYR . . . . . 0.635 ' HB2' ' HG2' ' A' ' 183' ' ' PRO . 8.2 m-85 -98.54 4.56 48.21 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.476 1.11 . . . . 0.0 111.009 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 187' ' ' VAL . . . . . 0.47 HG11 ' CD1' ' A' ' 159' ' ' LEU . 19.2 m -137.05 171.09 16.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 O-C-N 124.547 1.154 . . . . 0.0 109.312 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 188' ' ' GLU . . . . . 0.715 ' HB3' HD11 ' A' ' 140' ' ' LEU . 1.5 pp20? -125.89 176.76 6.74 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.458 1.099 . . . . 0.0 110.259 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -93.44 112.39 24.28 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.522 1.139 . . . . 0.0 109.335 179.958 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 190' ' ' TYR . . . . . 0.45 ' CD1' ' C ' ' A' ' 190' ' ' TYR . 0.8 OUTLIER . . . . . 0 C--N 1.325 -0.491 0 O-C-N 124.53 1.144 . . . . 0.0 111.027 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . 0.456 ' HB2' ' O ' ' A' ' 161' ' ' ILE . 5.1 pt-20 . . . . . 0 N--CA 1.453 -0.293 0 N-CA-C 110.262 -0.273 . . . . 0.0 110.262 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -123.81 118.9 28.19 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.487 1.117 . . . . 0.0 110.99 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.645 ' HB ' HD13 ' A' ' 161' ' ' ILE . 0.9 OUTLIER -121.83 123.04 68.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 O-C-N 124.543 1.152 . . . . 0.0 109.275 -179.969 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . 0.537 ' O ' ' HA ' ' A' ' 187' ' ' VAL . 12.1 ttm180 -87.45 150.29 23.87 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.489 1.118 . . . . 0.0 110.299 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.521 ' HB2' HG12 ' A' ' 187' ' ' VAL . . . -113.75 108.48 17.16 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.499 1.125 . . . . 0.0 109.317 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.807 HD21 ' OE2' ' A' ' 188' ' ' GLU . 0.0 OUTLIER -93.5 -7.56 43.98 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.607 1.192 . . . . 0.0 109.262 -179.991 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 59.9 m-85 -113.78 164.11 14.16 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.554 1.159 . . . . 0.0 110.955 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . 0.462 ' N ' ' OD1' ' A' ' 142' ' ' ASP . 0.0 OUTLIER . . . . . 0 C--N 1.325 -0.462 0 O-C-N 124.493 1.121 . . . . 0.0 109.299 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 21.8 p90 . . . . . 0 N--CA 1.453 -0.324 0 CA-C-O 120.466 0.175 . . . . 0.0 111.028 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . 0.417 ' HA ' ' HA ' ' A' ' 142' ' ' ASP . 1.6 tttm -132.09 -169.36 2.2 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.549 1.155 . . . . 0.0 109.319 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.498 ' CB ' ' O ' ' A' ' 140' ' ' LEU . 9.6 ptpt -89.31 111.17 21.94 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.517 1.136 . . . . 0.0 109.301 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 117.3 8.24 11.58 Favored Glycine 0 CA--C 1.529 0.96 0 O-C-N 124.486 1.116 . . . . 0.0 111.05 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . 0.432 ' CG ' ' N ' ' A' ' 158' ' ' ILE . 14.5 t0 -91.12 172.63 8.42 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.512 0.772 . . . . 0.0 109.277 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . 0.433 ' C ' ' HG ' ' A' ' 159' ' ' LEU . 3.2 mt -140.27 142.55 31.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 O-C-N 124.547 1.154 . . . . 0.0 109.332 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.588 ' CD1' HG11 ' A' ' 187' ' ' VAL . 0.1 OUTLIER -136.93 141.23 42.67 Favored 'General case' 0 C--N 1.324 -0.533 0 O-C-N 124.555 1.159 . . . . 0.0 109.328 179.997 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . 0.481 ' O ' ' HA ' ' A' ' 172' ' ' ALA . 15.2 ttm105 -87.86 134.91 33.6 Favored 'General case' 0 C--N 1.326 -0.437 0 O-C-N 124.581 1.176 . . . . 0.0 110.333 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.645 HD13 ' HB ' ' A' ' 137' ' ' VAL . 1.0 OUTLIER -83.53 109.81 17.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 O-C-N 124.536 1.148 . . . . 0.0 109.321 179.969 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . 0.452 ' HG3' ' CG ' ' A' ' 179' ' ' ARG . 20.8 mmm180 -90.68 -59.34 2.2 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.546 1.154 . . . . 0.0 110.303 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . 0.515 ' N ' ' OD1' ' A' ' 171' ' ' ASN . 0.7 OUTLIER -151.34 144.53 24.69 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.481 1.113 . . . . 0.0 109.32 179.963 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . 0.598 ' CB ' ' CG ' ' A' ' 170' ' ' TRP . 0.6 OUTLIER -128.02 78.38 75.36 Favored Pre-proline 0 C--N 1.325 -0.475 0 O-C-N 124.494 1.121 . . . . 0.0 109.307 -179.942 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.03 -48.08 0.18 Allowed 'Trans proline' 0 C--N 1.359 1.116 0 O-C-N 124.51 1.795 . . . . 0.0 110.914 -179.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 13.7 mp0 -69.68 176.23 3.7 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.402 1.064 . . . . 0.0 110.322 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -115.24 51.44 0.92 Allowed 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.547 1.154 . . . . 0.0 110.29 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 168' ' ' GLN . . . . . 0.476 ' HB3' ' CD1' ' A' ' 169' ' ' TRP . 3.3 mt-30 -179.25 -55.58 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.582 1.176 . . . . 0.0 110.278 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 169' ' ' TRP . . . . . 0.476 ' CD1' ' HB3' ' A' ' 168' ' ' GLN . 12.2 m95 -108.91 133.05 53.44 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.491 1.12 . . . . 0.0 107.995 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 170' ' ' TRP . . . . . 0.743 ' CE2' HG21 ' A' ' 184' ' ' VAL . 26.6 m0 -120.8 154.66 35.43 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 171' ' ' ASN . . . . . 0.515 ' OD1' ' N ' ' A' ' 163' ' ' ASP . 6.0 p30 -87.16 108.9 19.11 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.46 1.1 . . . . 0.0 109.265 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . 0.513 ' O ' ' HA ' ' A' ' 179' ' ' ARG . . . -117.35 174.63 6.02 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.511 1.132 . . . . 0.0 109.331 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -116.34 116.69 28.19 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.406 1.066 . . . . 0.0 110.278 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . 0.582 ' OD1' HD23 ' A' ' 159' ' ' LEU . 0.4 OUTLIER -74.43 -176.88 2.86 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.56 1.163 . . . . 0.0 109.316 -179.993 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 37.6 t -76.01 61.91 1.58 Allowed 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.53 1.144 . . . . 0.0 109.969 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -173.79 8.11 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.415 1.072 . . . . 0.0 110.319 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 67.88 20.91 72.94 Favored Glycine 0 CA--C 1.53 1.014 0 O-C-N 124.58 1.175 . . . . 0.0 110.998 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.06 115.63 27.68 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.481 0.754 . . . . 0.0 109.329 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 179' ' ' ARG . . . . . 0.513 ' HA ' ' O ' ' A' ' 172' ' ' ALA . 0.1 OUTLIER -90.13 122.53 33.17 Favored 'General case' 0 C--N 1.326 -0.442 0 O-C-N 124.459 1.099 . . . . 0.0 110.286 -179.958 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . 0.495 ' O ' ' HA ' ' A' ' 171' ' ' ASN . . . -151.34 165.9 30.5 Favored Glycine 0 CA--C 1.53 0.971 0 O-C-N 124.487 1.117 . . . . 0.0 111.001 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 181' ' ' MET . . . . . 0.437 ' HA ' ' O ' ' A' ' 170' ' ' TRP . 0.4 OUTLIER -84.5 103.7 13.86 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.503 0.766 . . . . 0.0 111.035 179.943 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . 0.452 ' HB ' ' HD2' ' A' ' 183' ' ' PRO . 2.2 pp -106.93 161.11 23.94 Favored Pre-proline 0 C--N 1.325 -0.493 0 O-C-N 124.498 1.124 . . . . 0.0 109.267 -179.952 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 183' ' ' PRO . . . . . 0.642 ' HG2' ' HB2' ' A' ' 186' ' ' TYR . 18.4 Cg_endo -74.98 135.37 19.02 Favored 'Trans proline' 0 C--N 1.361 1.214 0 O-C-N 124.505 1.792 . . . . 0.0 110.989 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . 0.843 ' N ' ' CD ' ' A' ' 185' ' ' PRO . 58.0 t -80.1 -30.28 0.6 Allowed Pre-proline 0 C--N 1.326 -0.427 0 O-C-N 124.467 1.105 . . . . 0.0 109.28 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 185' ' ' PRO . . . . . 0.843 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.2 Cg_endo -75.05 -15.53 20.58 Favored 'Trans proline' 0 C--N 1.36 1.154 0 O-C-N 124.482 1.78 . . . . 0.0 110.973 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 186' ' ' TYR . . . . . 0.642 ' HB2' ' HG2' ' A' ' 183' ' ' PRO . 4.5 m-85 -94.95 5.91 50.58 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.492 1.12 . . . . 0.0 111.056 179.923 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 187' ' ' VAL . . . . . 0.588 HG11 ' CD1' ' A' ' 159' ' ' LEU . 35.4 m -136.94 164.48 30.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 O-C-N 124.475 1.11 . . . . 0.0 109.314 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 188' ' ' GLU . . . . . 0.807 ' OE2' HD21 ' A' ' 140' ' ' LEU . 0.0 OUTLIER -120.49 165.75 14.54 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.487 1.117 . . . . 0.0 110.262 -180.0 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . 0.453 ' CD ' ' H ' ' A' ' 189' ' ' LYS . 0.0 OUTLIER -89.33 126.54 35.57 Favored 'General case' 0 C--N 1.326 -0.439 0 O-C-N 124.455 1.097 . . . . 0.0 109.366 179.969 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 190' ' ' TYR . . . . . 0.436 ' CD1' ' OE1' ' A' ' 188' ' ' GLU . 0.1 OUTLIER . . . . . 0 C--N 1.326 -0.449 0 O-C-N 124.528 1.143 . . . . 0.0 110.98 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.453 -0.299 0 N-CA-C 110.321 -0.252 . . . . 0.0 110.321 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . 0.529 ' CE2' ' HD2' ' A' ' 160' ' ' ARG . 36.6 m-85 -126.62 130.88 51.33 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.547 1.154 . . . . 0.0 110.982 -179.969 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.716 HG12 ' O ' ' A' ' 159' ' ' LEU . 2.9 p -125.75 155.83 35.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 O-C-N 124.491 1.119 . . . . 0.0 109.273 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . 0.455 ' HB3' ' HG3' ' A' ' 188' ' ' GLU . 0.0 OUTLIER -126.08 133.03 51.8 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.501 1.125 . . . . 0.0 110.338 179.98 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.519 ' HB3' ' HB3' ' A' ' 157' ' ' ASP . . . -97.06 110.64 23.14 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.514 1.134 . . . . 0.0 109.316 -179.965 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.672 HD11 ' HG2' ' A' ' 188' ' ' GLU . 0.2 OUTLIER -95.33 -22.39 17.78 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.555 1.159 . . . . 0.0 109.344 179.948 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . 0.476 ' C ' ' O ' ' A' ' 154' ' ' LYS . 12.1 m-85 -94.62 150.31 20.36 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.474 1.109 . . . . 0.0 111.031 179.939 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . 0.431 ' CA ' ' O ' ' A' ' 154' ' ' LYS . 0.1 OUTLIER . . . . . 0 C--N 1.324 -0.502 0 O-C-N 124.538 1.149 . . . . 0.0 109.322 -179.969 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 14.9 p90 . . . . . 0 N--CA 1.454 -0.273 0 CA-C-O 120.558 0.218 . . . . 0.0 111.006 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . 0.476 ' O ' ' C ' ' A' ' 141' ' ' PHE . 0.0 OUTLIER -125.86 -84.99 0.63 Allowed 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.488 1.118 . . . . 0.0 109.233 -179.984 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -165.58 113.14 0.96 Allowed 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.501 1.126 . . . . 0.0 109.252 -179.949 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . 0.402 ' N ' ' O ' ' A' ' 139' ' ' ALA . . . 108.84 14.07 16.47 Favored Glycine 0 CA--C 1.53 1.003 0 O-C-N 124.391 1.057 . . . . 0.0 111.016 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . 0.519 ' HB3' ' HB3' ' A' ' 139' ' ' ALA . 6.9 t0 -82.72 158.26 22.96 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.532 0.783 . . . . 0.0 109.27 -179.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . 0.53 ' N ' HD12 ' A' ' 158' ' ' ILE . 3.9 mp -119.79 141.19 41.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 O-C-N 124.571 1.169 . . . . 0.0 109.266 -179.945 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.816 ' CD2' HG21 ' A' ' 182' ' ' ILE . 2.9 mp -142.04 126.79 18.07 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.42 1.075 . . . . 0.0 109.345 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . 0.685 ' O ' ' HA ' ' A' ' 172' ' ' ALA . 0.0 OUTLIER -88.26 132.87 34.21 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.545 1.153 . . . . 0.0 110.328 179.997 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 14.3 mm -82.15 117.14 27.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 O-C-N 124.42 1.075 . . . . 0.0 109.312 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . 0.47 ' HG3' ' N ' ' A' ' 163' ' ' ASP . 0.8 OUTLIER -118.22 -32.58 4.65 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.537 1.148 . . . . 0.0 110.368 179.943 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . 0.47 ' N ' ' HG3' ' A' ' 162' ' ' ARG . 0.9 OUTLIER -146.35 155.25 42.48 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.486 1.116 . . . . 0.0 109.338 179.949 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . 0.575 ' HB3' ' CD1' ' A' ' 170' ' ' TRP . 1.4 mtmp? -148.25 71.93 11.01 Favored Pre-proline 0 C--N 1.324 -0.519 0 O-C-N 124.522 1.139 . . . . 0.0 109.234 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.96 -29.06 8.7 Favored 'Trans proline' 0 C--N 1.359 1.105 0 O-C-N 124.539 1.81 . . . . 0.0 110.999 179.922 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . 0.517 ' O ' ' CD1' ' A' ' 170' ' ' TRP . 3.0 mm-40 -105.26 166.02 10.7 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.446 1.091 . . . . 0.0 110.296 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 13.3 mt-10 -96.38 -27.82 14.75 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.463 1.102 . . . . 0.0 110.309 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 168' ' ' GLN . . . . . 0.452 ' O ' HG23 ' A' ' 184' ' ' VAL . 11.4 tt0 -82.35 -58.68 2.83 Favored 'General case' 0 C--N 1.324 -0.536 0 O-C-N 124.533 1.146 . . . . 0.0 110.284 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 169' ' ' TRP . . . . . 0.581 ' CZ3' ' HD3' ' A' ' 183' ' ' PRO . 9.9 m0 -109.7 163.26 13.66 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.501 1.126 . . . . 0.0 107.968 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 170' ' ' TRP . . . . . 0.698 ' CH2' HG11 ' A' ' 184' ' ' VAL . 30.9 m0 -139.57 157.11 46.36 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.525 1.141 . . . . 0.0 107.951 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 4.6 t30 -88.55 107.6 18.98 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.472 1.107 . . . . 0.0 109.291 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . 0.685 ' HA ' ' O ' ' A' ' 160' ' ' ARG . . . -121.78 178.45 4.85 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.454 1.096 . . . . 0.0 109.312 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . 0.47 ' CG ' ' HG3' ' A' ' 179' ' ' ARG . 17.9 mt-10 -116.49 115.95 26.74 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.548 1.155 . . . . 0.0 110.201 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -64.51 -164.91 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.498 1.124 . . . . 0.0 109.239 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -88.36 60.0 5.48 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.439 1.087 . . . . 0.0 110.016 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . 0.4 ' H ' ' H ' ' A' ' 177' ' ' GLY . 4.2 mt-10 174.16 22.58 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.455 1.097 . . . . 0.0 110.362 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 177' ' ' GLY . . . . . 0.4 ' H ' ' H ' ' A' ' 176' ' ' GLU . . . 67.75 15.52 66.77 Favored Glycine 0 CA--C 1.531 1.035 0 O-C-N 124.464 1.102 . . . . 0.0 111.023 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 8.0 mttt -70.9 101.77 2.23 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.505 0.768 . . . . 0.0 109.325 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 179' ' ' ARG . . . . . 0.47 ' HG3' ' CG ' ' A' ' 173' ' ' GLU . 11.3 mtt85 -87.68 105.76 17.58 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.494 1.121 . . . . 0.0 110.255 -179.914 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -151.87 169.45 31.26 Favored Glycine 0 CA--C 1.53 0.983 0 O-C-N 124.507 1.129 . . . . 0.0 111.033 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 181' ' ' MET . . . . . 0.44 ' HA ' ' O ' ' A' ' 170' ' ' TRP . 4.9 mmm -87.68 116.89 26.13 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.52 0.776 . . . . 0.0 111.064 179.904 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . 0.816 HG21 ' CD2' ' A' ' 159' ' ' LEU . 1.0 OUTLIER -112.91 161.85 24.62 Favored Pre-proline 0 C--N 1.325 -0.484 0 O-C-N 124.504 1.127 . . . . 0.0 109.252 -179.967 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 183' ' ' PRO . . . . . 0.738 ' HG2' ' HB2' ' A' ' 186' ' ' TYR . 18.2 Cg_endo -75.0 134.05 17.35 Favored 'Trans proline' 0 C--N 1.36 1.151 0 O-C-N 124.502 1.79 . . . . 0.0 110.979 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . 0.834 ' N ' ' CD ' ' A' ' 185' ' ' PRO . 38.7 t -79.96 -31.1 0.64 Allowed Pre-proline 0 C--N 1.325 -0.467 0 O-C-N 124.429 1.081 . . . . 0.0 109.275 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 185' ' ' PRO . . . . . 0.834 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.5 Cg_endo -74.99 -25.26 12.06 Favored 'Trans proline' 0 C--N 1.36 1.135 0 O-C-N 124.504 1.792 . . . . 0.0 111.059 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 186' ' ' TYR . . . . . 0.738 ' HB2' ' HG2' ' A' ' 183' ' ' PRO . 3.5 m-85 -93.82 22.84 5.23 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.522 1.139 . . . . 0.0 110.988 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 187' ' ' VAL . . . . . 0.64 ' HB ' HG22 ' A' ' 137' ' ' VAL . 26.2 m -146.53 169.52 5.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 O-C-N 124.475 1.109 . . . . 0.0 109.369 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 188' ' ' GLU . . . . . 0.672 ' HG2' HD11 ' A' ' 140' ' ' LEU . 0.0 OUTLIER -126.82 160.47 30.81 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.543 1.152 . . . . 0.0 110.255 -179.976 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 24.6 mmmt -85.04 127.19 34.11 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.573 1.171 . . . . 0.0 109.259 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.326 -0.451 0 O-C-N 124.516 1.135 . . . . 0.0 111.012 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . 0.512 ' O ' ' HG2' ' A' ' 160' ' ' ARG . 0.7 OUTLIER . . . . . 0 N--CA 1.453 -0.3 0 N-CA-C 110.282 -0.266 . . . . 0.0 110.282 . . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -112.03 128.71 56.26 Favored 'General case' 0 C--N 1.324 -0.522 0 O-C-N 124.531 1.145 . . . . 0.0 111.037 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.774 HG22 ' O ' ' A' ' 188' ' ' GLU . 0.4 OUTLIER -119.35 174.98 4.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 O-C-N 124.471 1.107 . . . . 0.0 109.332 179.988 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . 0.673 HH21 HD11 ' A' ' 158' ' ' ILE . 14.0 ttm180 -144.69 146.73 32.36 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.535 1.147 . . . . 0.0 110.289 -179.958 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.597 ' HB3' ' HB3' ' A' ' 157' ' ' ASP . . . -107.72 109.83 21.52 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.456 1.098 . . . . 0.0 109.306 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.64 HD11 ' HG2' ' A' ' 188' ' ' GLU . 1.0 OUTLIER -88.86 -7.15 56.66 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.52 1.138 . . . . 0.0 109.361 179.977 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 18.6 m-85 -120.67 158.24 27.86 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.576 1.173 . . . . 0.0 110.966 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . 0.487 ' HB3' ' HG2' ' A' ' 154' ' ' LYS . 2.0 p-10 . . . . . 0 C--N 1.326 -0.453 0 O-C-N 124.492 1.12 . . . . 0.0 109.339 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 13.4 p90 . . . . . 0 N--CA 1.453 -0.281 0 CA-C-O 120.529 0.204 . . . . 0.0 111.064 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . 0.487 ' HG2' ' HB3' ' A' ' 142' ' ' ASP . 1.0 OUTLIER -127.98 -158.86 0.9 Allowed 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.434 1.084 . . . . 0.0 109.255 -179.937 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.43 108.31 20.98 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.466 1.104 . . . . 0.0 109.29 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 114.51 17.9 6.85 Favored Glycine 0 CA--C 1.53 0.974 0 O-C-N 124.433 1.083 . . . . 0.0 111.041 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . 0.968 ' C ' HD12 ' A' ' 158' ' ' ILE . 8.9 t70 -87.5 168.68 12.87 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.488 0.758 . . . . 0.0 109.366 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . 0.968 HD12 ' C ' ' A' ' 157' ' ' ASP . 2.3 mp -128.56 143.98 39.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 O-C-N 124.559 1.162 . . . . 0.0 109.31 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.911 HD13 HD13 ' A' ' 182' ' ' ILE . 0.3 OUTLIER -149.27 128.47 12.84 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.467 1.104 . . . . 0.0 109.29 -179.913 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . 0.573 ' O ' ' HA ' ' A' ' 172' ' ' ALA . 0.0 OUTLIER -84.57 138.32 32.81 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.515 1.134 . . . . 0.0 110.26 -179.994 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.461 ' HB ' ' HB2' ' A' ' 135' ' ' GLU . 43.9 mm -84.77 112.65 22.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 O-C-N 124.482 1.114 . . . . 0.0 109.306 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.45 -56.0 2.4 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.424 1.077 . . . . 0.0 110.309 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -134.88 167.01 21.69 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.464 1.103 . . . . 0.0 109.282 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . 0.585 ' HB3' ' CD1' ' A' ' 170' ' ' TRP . 23.3 mtmt -144.44 83.13 10.06 Favored Pre-proline 0 C--N 1.325 -0.492 0 O-C-N 124.531 1.144 . . . . 0.0 109.296 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.03 -27.48 9.93 Favored 'Trans proline' 0 C--N 1.36 1.152 0 O-C-N 124.523 1.802 . . . . 0.0 110.99 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . 0.492 ' O ' ' CD1' ' A' ' 170' ' ' TRP . 2.7 mt-10 -121.03 172.75 7.72 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.501 1.126 . . . . 0.0 110.284 -179.941 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -95.56 -29.8 14.16 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.516 1.135 . . . . 0.0 110.319 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 168' ' ' GLN . . . . . 0.654 ' O ' HG23 ' A' ' 184' ' ' VAL . 6.8 tt0 -79.11 -60.19 2.47 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.473 1.108 . . . . 0.0 110.287 -179.954 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 169' ' ' TRP . . . . . 0.42 ' O ' ' CD1' ' A' ' 170' ' ' TRP . 11.2 m0 -104.96 157.74 17.01 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 170' ' ' TRP . . . . . 0.585 ' CD1' ' HB3' ' A' ' 164' ' ' LYS . 39.9 m0 -136.13 155.61 49.92 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.467 1.104 . . . . 0.0 108.055 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 171' ' ' ASN . . . . . 0.426 ' HA ' ' O ' ' A' ' 180' ' ' GLY . 42.1 t-20 -88.37 99.2 12.08 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.525 1.141 . . . . 0.0 109.266 -179.947 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . 0.573 ' HA ' ' O ' ' A' ' 160' ' ' ARG . . . -109.41 174.77 5.72 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.514 1.134 . . . . 0.0 109.342 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . 0.472 ' C ' HD23 ' A' ' 159' ' ' LEU . 8.0 mt-10 -119.39 117.19 27.84 Favored 'General case' 0 C--N 1.326 -0.437 0 O-C-N 124.475 1.109 . . . . 0.0 110.315 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . 0.523 ' OD1' HD21 ' A' ' 159' ' ' LEU . 3.7 m-20 -67.2 -176.39 0.55 Allowed 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.471 1.107 . . . . 0.0 109.273 -179.952 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 73.4 p -79.24 60.17 3.0 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.528 1.142 . . . . 0.0 110.002 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . 0.414 ' H ' ' H ' ' A' ' 177' ' ' GLY . 0.2 OUTLIER -176.54 7.56 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.428 0 O-C-N 124.485 1.116 . . . . 0.0 110.292 -179.996 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 177' ' ' GLY . . . . . 0.414 ' H ' ' H ' ' A' ' 176' ' ' GLU . . . 75.66 18.23 79.81 Favored Glycine 0 CA--C 1.529 0.959 0 O-C-N 124.495 1.122 . . . . 0.0 110.985 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 14.1 mtmm -83.92 106.25 15.44 Favored 'General case' 0 C--N 1.326 -0.435 0 O-C-N 124.41 0.712 . . . . 0.0 109.277 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 179' ' ' ARG . . . . . 0.403 ' HD3' ' OE2' ' A' ' 173' ' ' GLU . 4.1 ttp180 -88.51 118.04 27.88 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.444 1.09 . . . . 0.0 110.265 -179.936 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . 0.426 ' O ' ' HA ' ' A' ' 171' ' ' ASN . . . -151.57 166.86 30.83 Favored Glycine 0 CA--C 1.53 1.002 0 O-C-N 124.501 1.126 . . . . 0.0 110.979 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 181' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -87.61 114.43 24.22 Favored 'General case' 0 C--N 1.324 -0.528 0 O-C-N 124.497 0.763 . . . . 0.0 110.939 -179.957 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . 0.911 HD13 HD13 ' A' ' 159' ' ' LEU . 2.1 pt -116.02 163.44 21.35 Favored Pre-proline 0 C--N 1.325 -0.487 0 O-C-N 124.492 1.12 . . . . 0.0 109.256 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 183' ' ' PRO . . . . . 0.775 ' HG2' ' HB2' ' A' ' 186' ' ' TYR . 18.0 Cg_endo -75.02 135.63 19.3 Favored 'Trans proline' 0 C--N 1.361 1.199 0 O-C-N 124.52 1.8 . . . . 0.0 110.946 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . 0.82 ' N ' ' CD ' ' A' ' 185' ' ' PRO . 50.6 t -80.17 -31.98 0.68 Allowed Pre-proline 0 C--N 1.325 -0.469 0 O-C-N 124.486 1.117 . . . . 0.0 109.299 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 185' ' ' PRO . . . . . 0.82 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.3 Cg_endo -75.0 -23.09 14.13 Favored 'Trans proline' 0 C--N 1.361 1.214 0 O-C-N 124.541 1.811 . . . . 0.0 110.985 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 186' ' ' TYR . . . . . 0.775 ' HB2' ' HG2' ' A' ' 183' ' ' PRO . 3.8 m-85 -93.66 16.02 14.86 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.503 1.127 . . . . 0.0 111.037 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 187' ' ' VAL . . . . . 0.601 ' HA ' ' O ' ' A' ' 138' ' ' ARG . 6.0 m -145.49 165.58 10.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 O-C-N 124.449 1.093 . . . . 0.0 109.305 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 188' ' ' GLU . . . . . 0.774 ' O ' HG22 ' A' ' 137' ' ' VAL . 0.0 OUTLIER -130.16 166.05 21.05 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.47 1.106 . . . . 0.0 110.371 -179.971 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.65 121.85 32.92 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.462 1.101 . . . . 0.0 109.369 179.911 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 2.6 t80 . . . . . 0 C--N 1.325 -0.487 0 O-C-N 124.543 1.152 . . . . 0.0 110.991 -179.913 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . 0.437 ' O ' ' HA ' ' A' ' 160' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.453 -0.287 0 N-CA-C 110.301 -0.259 . . . . 0.0 110.301 . . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -128.08 116.68 20.35 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 124.518 1.136 . . . . 0.0 110.967 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.593 HG13 HD13 ' A' ' 161' ' ' ILE . 32.4 m -107.77 165.02 4.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 O-C-N 124.542 1.151 . . . . 0.0 109.36 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . 0.473 ' O ' ' HA ' ' A' ' 187' ' ' VAL . 2.7 tpp85 -125.12 132.18 53.15 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.445 1.091 . . . . 0.0 110.306 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.578 ' O ' ' N ' ' A' ' 156' ' ' GLY . . . -98.22 112.94 24.74 Favored 'General case' 0 C--N 1.326 -0.444 0 O-C-N 124.474 1.109 . . . . 0.0 109.307 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.881 HD21 ' OE2' ' A' ' 188' ' ' GLU . 0.1 OUTLIER -92.71 -12.02 32.5 Favored 'General case' 0 C--N 1.326 -0.437 0 O-C-N 124.448 1.092 . . . . 0.0 109.302 -179.953 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -121.73 156.69 32.56 Favored 'General case' 0 C--N 1.326 -0.416 0 O-C-N 124.507 1.129 . . . . 0.0 110.966 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . 0.464 ' OD1' ' N ' ' A' ' 155' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--N 1.326 -0.454 0 O-C-N 124.439 1.087 . . . . 0.0 109.316 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 52.2 p90 . . . . . 0 N--CA 1.453 -0.306 0 CA-C-O 120.475 0.179 . . . . 0.0 110.967 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . 0.435 ' HA ' ' HB3' ' A' ' 142' ' ' ASP . 2.9 tttm -128.92 -161.75 1.14 Allowed 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.528 1.143 . . . . 0.0 109.273 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.464 ' N ' ' OD1' ' A' ' 142' ' ' ASP . 0.0 OUTLIER -91.64 101.12 13.74 Favored 'General case' 0 C--N 1.324 -0.522 0 O-C-N 124.507 1.129 . . . . 0.0 109.302 -179.987 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . 0.578 ' N ' ' O ' ' A' ' 139' ' ' ALA . . . 114.47 27.64 3.27 Favored Glycine 0 CA--C 1.53 0.981 0 O-C-N 124.491 1.12 . . . . 0.0 111.023 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . 0.46 ' O ' ' HD3' ' A' ' 138' ' ' ARG . 2.5 t70 -105.08 163.47 12.53 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.555 0.797 . . . . 0.0 109.299 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . 0.433 HG12 ' HD3' ' A' ' 138' ' ' ARG . 4.4 mt -119.59 149.08 22.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 O-C-N 124.47 1.107 . . . . 0.0 109.297 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.643 ' N ' HD12 ' A' ' 159' ' ' LEU . 0.0 OUTLIER -147.5 137.45 22.93 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 124.515 1.135 . . . . 0.0 109.279 -179.969 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . 0.702 ' O ' ' HB1' ' A' ' 172' ' ' ALA . 7.3 ttt180 -88.25 136.29 33.05 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.522 1.139 . . . . 0.0 110.325 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.593 HD13 HG13 ' A' ' 137' ' ' VAL . 0.9 OUTLIER -83.68 110.3 18.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 O-C-N 124.44 1.087 . . . . 0.0 109.324 -179.948 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . 0.43 ' HB3' ' ND2' ' A' ' 171' ' ' ASN . 2.5 tpt85 -88.33 -59.6 2.19 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.483 1.114 . . . . 0.0 110.353 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . 0.429 ' O ' ' HB3' ' A' ' 170' ' ' TRP . 20.3 t0 -149.19 149.68 31.4 Favored 'General case' 0 C--N 1.324 -0.526 0 O-C-N 124.515 1.134 . . . . 0.0 109.34 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . 0.542 ' HB2' ' CE2' ' A' ' 170' ' ' TRP . 0.4 OUTLIER -132.76 76.51 70.9 Favored Pre-proline 0 C--N 1.325 -0.496 0 O-C-N 124.474 1.109 . . . . 0.0 109.324 -179.987 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -75.14 -44.89 0.3 Allowed 'Trans proline' 0 C--N 1.361 1.207 0 O-C-N 124.426 1.75 . . . . 0.0 110.959 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 -78.97 175.5 10.51 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.457 1.098 . . . . 0.0 110.303 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 32.6 mm-40 -114.03 54.12 0.76 Allowed 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.464 1.102 . . . . 0.0 110.322 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 168' ' ' GLN . . . . . 0.524 ' O ' HG23 ' A' ' 184' ' ' VAL . 0.0 OUTLIER -178.5 -57.63 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.432 0 O-C-N 124.464 1.103 . . . . 0.0 110.261 -179.971 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 169' ' ' TRP . . . . . 0.563 ' CH2' ' HD3' ' A' ' 183' ' ' PRO . 14.0 m95 -109.8 142.13 41.49 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 107.961 -1.125 . . . . 0.0 107.961 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 170' ' ' TRP . . . . . 0.671 ' CD2' HG21 ' A' ' 184' ' ' VAL . 22.8 m0 -133.91 161.39 34.91 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.518 1.136 . . . . 0.0 108.011 179.964 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 171' ' ' ASN . . . . . 0.43 ' ND2' ' HB3' ' A' ' 162' ' ' ARG . 5.3 p-10 -94.08 111.26 22.96 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.556 1.16 . . . . 0.0 109.296 179.986 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . 0.702 ' HB1' ' O ' ' A' ' 160' ' ' ARG . . . -117.34 -176.79 3.08 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.499 1.125 . . . . 0.0 109.308 179.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . 0.435 ' OE2' ' CD ' ' A' ' 179' ' ' ARG . 40.2 mt-10 -128.09 124.27 36.59 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.439 1.087 . . . . 0.0 110.338 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -75.99 -172.65 2.06 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.407 1.067 . . . . 0.0 109.278 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 1.4 m -82.35 61.59 5.62 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.55 1.156 . . . . 0.0 110.028 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -177.16 9.95 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.451 1.094 . . . . 0.0 110.312 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 74.07 17.25 79.45 Favored Glycine 0 CA--C 1.531 1.034 0 O-C-N 124.51 1.132 . . . . 0.0 111.029 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 178' ' ' LYS . . . . . 0.415 ' O ' ' HA ' ' A' ' 173' ' ' GLU . 0.8 OUTLIER -82.8 101.38 10.9 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.544 0.79 . . . . 0.0 109.262 -179.97 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 179' ' ' ARG . . . . . 0.531 ' HA ' ' O ' ' A' ' 172' ' ' ALA . 0.0 OUTLIER -91.42 115.42 28.02 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.528 1.142 . . . . 0.0 110.275 -179.968 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . 0.427 ' O ' ' HA ' ' A' ' 171' ' ' ASN . . . -150.96 169.0 30.7 Favored Glycine 0 CA--C 1.53 1.005 0 O-C-N 124.457 1.098 . . . . 0.0 110.998 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 181' ' ' MET . . . . . 0.496 ' HG3' ' HB3' ' A' ' 169' ' ' TRP . 1.4 ttm -87.75 111.95 21.88 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.44 0.729 . . . . 0.0 110.99 -179.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . 0.557 ' HA ' ' CZ3' ' A' ' 169' ' ' TRP . 1.5 pp -115.27 166.88 10.94 Favored Pre-proline 0 C--N 1.325 -0.472 0 O-C-N 124.538 1.149 . . . . 0.0 109.263 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 183' ' ' PRO . . . . . 0.607 ' HG2' ' CB ' ' A' ' 186' ' ' TYR . 18.3 Cg_endo -75.02 135.11 18.61 Favored 'Trans proline' 0 C--N 1.36 1.145 0 O-C-N 124.471 1.774 . . . . 0.0 110.973 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . 0.811 ' N ' ' CD ' ' A' ' 185' ' ' PRO . 86.9 t -79.98 -32.3 0.71 Allowed Pre-proline 0 C--N 1.325 -0.467 0 O-C-N 124.482 1.114 . . . . 0.0 109.293 179.986 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 185' ' ' PRO . . . . . 0.811 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.3 Cg_endo -74.99 -11.38 21.49 Favored 'Trans proline' 0 C--N 1.359 1.124 0 O-C-N 124.48 1.779 . . . . 0.0 110.999 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 186' ' ' TYR . . . . . 0.607 ' CB ' ' HG2' ' A' ' 183' ' ' PRO . 6.8 m-85 -93.97 -1.98 53.82 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.501 1.126 . . . . 0.0 111.022 -179.979 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 187' ' ' VAL . . . . . 0.473 ' HA ' ' O ' ' A' ' 138' ' ' ARG . 14.4 m -133.22 174.03 13.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 O-C-N 124.477 1.111 . . . . 0.0 109.307 179.963 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 188' ' ' GLU . . . . . 0.881 ' OE2' HD21 ' A' ' 140' ' ' LEU . 0.0 OUTLIER -135.53 172.51 12.9 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.457 1.098 . . . . 0.0 110.307 179.991 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.8 126.07 34.8 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.454 1.096 . . . . 0.0 109.288 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 72.2 t80 . . . . . 0 C--N 1.325 -0.484 0 O-C-N 124.47 1.106 . . . . 0.0 110.953 -179.977 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . 0.442 ' HB2' ' O ' ' A' ' 161' ' ' ILE . 1.2 pt-20 . . . . . 0 N--CA 1.452 -0.354 0 N-CA-C 110.32 -0.252 . . . . 0.0 110.32 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 7.3 m-85 -124.19 117.06 23.75 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.489 1.118 . . . . 0.0 110.957 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.516 ' CG2' ' O ' ' A' ' 188' ' ' GLU . 0.4 OUTLIER -119.41 132.54 68.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 O-C-N 124.544 1.153 . . . . 0.0 109.309 179.973 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . 0.617 HH21 HD11 ' A' ' 158' ' ' ILE . 12.7 ttm180 -95.2 148.37 22.47 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.525 1.14 . . . . 0.0 110.373 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.671 ' HB3' ' HB3' ' A' ' 157' ' ' ASP . . . -105.91 110.66 23.01 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.512 1.132 . . . . 0.0 109.268 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.572 HD11 ' HG2' ' A' ' 188' ' ' GLU . 0.3 OUTLIER -93.89 -7.9 41.82 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.456 1.098 . . . . 0.0 109.274 179.965 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . 0.456 ' C ' ' O ' ' A' ' 154' ' ' LYS . 14.7 m-85 -104.61 158.73 16.3 Favored 'General case' 0 C--N 1.324 -0.524 0 O-C-N 124.525 1.141 . . . . 0.0 110.976 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . 0.57 ' CA ' ' O ' ' A' ' 154' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--N 1.325 -0.461 0 O-C-N 124.449 1.093 . . . . 0.0 109.276 -179.942 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . 0.565 ' N ' ' CD1' ' A' ' 153' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.454 -0.251 0 CA-C-O 120.496 0.188 . . . . 0.0 110.971 . . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . 0.57 ' O ' ' CA ' ' A' ' 142' ' ' ASP . 0.0 OUTLIER -127.0 -75.37 0.58 Allowed 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.5 1.125 . . . . 0.0 109.258 179.97 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.511 ' CD ' ' O ' ' A' ' 140' ' ' LEU . 0.0 OUTLIER -165.26 109.64 0.88 Allowed 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.54 1.15 . . . . 0.0 109.278 -179.97 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . 0.51 ' N ' ' O ' ' A' ' 139' ' ' ALA . . . 93.45 29.88 9.7 Favored Glycine 0 CA--C 1.531 1.042 0 O-C-N 124.593 1.183 . . . . 0.0 110.98 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . 0.887 ' C ' HD12 ' A' ' 158' ' ' ILE . 0.4 OUTLIER -88.66 158.65 18.16 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.482 0.754 . . . . 0.0 109.285 179.995 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . 0.887 HD12 ' C ' ' A' ' 157' ' ' ASP . 1.5 mp -116.38 136.34 53.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 O-C-N 124.492 1.12 . . . . 0.0 109.278 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.756 HD23 ' HA ' ' A' ' 174' ' ' ASP . 0.6 OUTLIER -138.09 126.22 22.9 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.51 1.131 . . . . 0.0 109.3 -179.971 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . 0.525 ' O ' ' HA ' ' A' ' 172' ' ' ALA . 0.0 OUTLIER -86.84 126.28 34.54 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.535 1.147 . . . . 0.0 110.299 -179.98 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.659 HG21 ' CE ' ' A' ' 164' ' ' LYS . 12.4 mm -81.77 122.56 36.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 O-C-N 124.502 1.127 . . . . 0.0 109.336 179.998 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . 0.463 ' HG3' ' N ' ' A' ' 163' ' ' ASP . 0.0 OUTLIER -122.53 -29.55 4.06 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.526 1.141 . . . . 0.0 110.276 179.989 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . 0.463 ' N ' ' HG3' ' A' ' 162' ' ' ARG . 0.8 OUTLIER -135.99 146.0 46.73 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.477 1.111 . . . . 0.0 109.312 -179.949 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . 0.659 ' CE ' HG21 ' A' ' 161' ' ' ILE . 15.9 mtpt -146.84 62.64 7.7 Favored Pre-proline 0 C--N 1.324 -0.506 0 O-C-N 124.459 1.099 . . . . 0.0 109.342 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 165' ' ' PRO . . . . . 0.443 ' HD3' ' N ' ' A' ' 164' ' ' LYS . 18.1 Cg_endo -75.04 -73.54 0.01 OUTLIER 'Trans proline' 0 C--N 1.361 1.218 0 O-C-N 124.474 1.776 . . . . 0.0 110.976 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -50.69 160.06 0.47 Allowed 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.523 1.139 . . . . 0.0 110.293 -179.967 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -100.91 35.21 2.25 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.477 1.11 . . . . 0.0 110.271 -179.938 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -157.75 -51.35 0.07 Allowed 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.417 1.073 . . . . 0.0 110.353 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 169' ' ' TRP . . . . . . . . . . . . . 13.0 m95 -103.79 140.53 37.5 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.607 1.192 . . . . 0.0 108.039 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 170' ' ' TRP . . . . . 0.62 ' CE3' ' CE ' ' A' ' 164' ' ' LYS . 50.5 m0 -121.0 147.35 45.61 Favored 'General case' 0 C--N 1.324 -0.53 0 O-C-N 124.511 1.132 . . . . 0.0 107.975 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 16.4 t30 -87.47 98.06 11.18 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.473 1.108 . . . . 0.0 109.233 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . 0.566 ' HB3' HD11 ' A' ' 182' ' ' ILE . . . -107.77 173.54 6.28 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.43 1.081 . . . . 0.0 109.334 179.909 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . 0.51 ' CG ' ' HG2' ' A' ' 179' ' ' ARG . 23.9 mt-10 -118.95 120.24 36.7 Favored 'General case' 0 C--N 1.326 -0.439 0 O-C-N 124.479 1.112 . . . . 0.0 110.268 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . 0.756 ' HA ' HD23 ' A' ' 159' ' ' LEU . 0.4 OUTLIER -73.92 -169.55 0.76 Allowed 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.489 1.118 . . . . 0.0 109.307 179.944 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 27.6 t -83.69 63.98 7.73 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.496 1.122 . . . . 0.0 110.038 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . 0.457 ' H ' ' H ' ' A' ' 177' ' ' GLY . 1.3 mt-10 -176.33 7.23 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.511 1.132 . . . . 0.0 110.341 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 177' ' ' GLY . . . . . 0.457 ' H ' ' H ' ' A' ' 176' ' ' GLU . . . 70.68 22.46 78.04 Favored Glycine 0 CA--C 1.53 0.984 0 O-C-N 124.492 1.12 . . . . 0.0 111.005 -179.969 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 178' ' ' LYS . . . . . 0.411 ' O ' ' HA ' ' A' ' 173' ' ' GLU . 4.6 ptpp? -94.4 115.45 27.66 Favored 'General case' 0 C--N 1.324 -0.53 0 O-C-N 124.454 0.738 . . . . 0.0 109.29 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 179' ' ' ARG . . . . . 0.51 ' HG2' ' CG ' ' A' ' 173' ' ' GLU . 1.3 mtt180 -92.87 123.63 36.27 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.579 1.175 . . . . 0.0 110.331 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -151.04 160.49 28.66 Favored Glycine 0 CA--C 1.53 1.001 0 O-C-N 124.48 1.112 . . . . 0.0 110.996 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 181' ' ' MET . . . . . 0.431 ' HA ' ' O ' ' A' ' 170' ' ' TRP . 4.7 mmm -88.6 107.13 18.75 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.472 0.748 . . . . 0.0 110.997 -179.966 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . 0.566 HD11 ' HB3' ' A' ' 172' ' ' ALA . 1.0 OUTLIER -112.32 170.12 5.62 Favored Pre-proline 0 C--N 1.325 -0.474 0 O-C-N 124.41 1.069 . . . . 0.0 109.338 179.969 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 183' ' ' PRO . . . . . 0.599 ' HG2' ' CB ' ' A' ' 186' ' ' TYR . 18.5 Cg_endo -74.98 132.82 15.88 Favored 'Trans proline' 0 C--N 1.36 1.132 0 O-C-N 124.425 1.75 . . . . 0.0 111.022 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . 0.819 ' N ' ' CD ' ' A' ' 185' ' ' PRO . 84.5 t -76.62 -31.68 0.96 Allowed Pre-proline 0 C--N 1.326 -0.456 0 O-C-N 124.577 1.173 . . . . 0.0 109.282 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 185' ' ' PRO . . . . . 0.819 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.4 Cg_endo -74.9 -8.72 20.44 Favored 'Trans proline' 0 C--N 1.36 1.153 0 O-C-N 124.454 1.765 . . . . 0.0 111.057 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 186' ' ' TYR . . . . . 0.599 ' CB ' ' HG2' ' A' ' 183' ' ' PRO . 3.4 m-85 -99.7 6.68 45.53 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.459 1.1 . . . . 0.0 110.941 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 187' ' ' VAL . . . . . 0.504 ' HA ' ' O ' ' A' ' 138' ' ' ARG . 34.5 m -136.92 174.5 11.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 O-C-N 124.506 1.129 . . . . 0.0 109.252 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 188' ' ' GLU . . . . . 0.572 ' HG2' HD11 ' A' ' 140' ' ' LEU . 0.0 OUTLIER -131.58 163.69 27.5 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.558 1.161 . . . . 0.0 110.302 179.986 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.53 124.14 35.47 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.461 1.101 . . . . 0.0 109.288 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 190' ' ' TYR . . . . . 0.499 ' OH ' ' CZ ' ' A' ' 138' ' ' ARG . 0.1 OUTLIER . . . . . 0 C--N 1.325 -0.493 0 O-C-N 124.448 1.093 . . . . 0.0 111.049 179.967 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . 0.436 ' HB3' ' O ' ' A' ' 161' ' ' ILE . 5.5 mp0 . . . . . 0 N--CA 1.453 -0.315 0 N-CA-C 110.268 -0.271 . . . . 0.0 110.268 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . 0.584 ' CD1' ' HG2' ' A' ' 160' ' ' ARG . 86.2 m-85 -128.33 140.11 52.04 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.549 1.155 . . . . 0.0 110.956 -179.965 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.531 ' CG2' HD11 ' A' ' 161' ' ' ILE . 29.1 m -138.1 149.64 24.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 124.514 1.134 . . . . 0.0 109.335 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . 0.433 ' HB3' ' CD ' ' A' ' 188' ' ' GLU . 1.2 ttm180 -107.54 130.02 54.91 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.495 1.122 . . . . 0.0 110.275 -179.948 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.659 ' O ' ' N ' ' A' ' 156' ' ' GLY . . . -89.25 103.37 16.0 Favored 'General case' 0 C--N 1.326 -0.443 0 O-C-N 124.461 1.1 . . . . 0.0 109.281 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.468 HD11 ' HB3' ' A' ' 188' ' ' GLU . 0.2 OUTLIER -86.85 -2.8 58.86 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.521 1.138 . . . . 0.0 109.345 179.933 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 46.7 m-85 -128.92 157.63 41.06 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.5 1.125 . . . . 0.0 111.009 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . 0.465 ' HB2' ' HA ' ' A' ' 154' ' ' LYS . 1.5 t70 . . . . . 0 C--N 1.325 -0.458 0 O-C-N 124.388 1.055 . . . . 0.0 109.266 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 8.4 p90 . . . . . 0 N--CA 1.454 -0.272 0 CA-C-O 120.51 0.195 . . . . 0.0 111.003 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . 0.465 ' HA ' ' HB2' ' A' ' 142' ' ' ASP . 6.8 tttt -128.49 -164.9 1.43 Allowed 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.441 1.088 . . . . 0.0 109.272 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 35.4 tttt -92.94 106.47 18.43 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.483 1.114 . . . . 0.0 109.293 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . 0.659 ' N ' ' O ' ' A' ' 139' ' ' ALA . . . 109.86 29.01 3.97 Favored Glycine 0 CA--C 1.531 1.034 0 O-C-N 124.496 1.123 . . . . 0.0 111.004 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . 0.494 ' HB3' ' HB3' ' A' ' 139' ' ' ALA . 22.8 t70 -97.39 167.05 11.24 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.482 0.754 . . . . 0.0 109.352 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . 0.43 HD13 ' O ' ' A' ' 157' ' ' ASP . 18.0 mm -121.46 136.78 57.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 O-C-N 124.52 1.137 . . . . 0.0 109.306 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.6 HD22 HD13 ' A' ' 182' ' ' ILE . 0.8 OUTLIER -141.48 136.63 31.44 Favored 'General case' 0 C--N 1.326 -0.427 0 O-C-N 124.495 1.122 . . . . 0.0 109.325 -179.97 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . 0.584 ' HG2' ' CD1' ' A' ' 136' ' ' TYR . 0.0 OUTLIER -97.33 134.98 39.88 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.528 1.143 . . . . 0.0 110.347 179.96 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.531 HD11 ' CG2' ' A' ' 137' ' ' VAL . 1.7 mp -87.19 125.22 41.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 O-C-N 124.501 1.126 . . . . 0.0 109.346 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . 0.482 ' CG ' ' N ' ' A' ' 163' ' ' ASP . 0.8 OUTLIER -118.63 -41.03 2.83 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 124.5 1.125 . . . . 0.0 110.291 -179.953 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . 0.482 ' N ' ' CG ' ' A' ' 162' ' ' ARG . 13.7 m-20 -148.78 176.99 9.91 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.492 1.12 . . . . 0.0 109.34 -179.987 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . 0.592 ' HB3' ' CD1' ' A' ' 170' ' ' TRP . 6.9 mtmm -144.88 65.45 12.24 Favored Pre-proline 0 C--N 1.325 -0.478 0 O-C-N 124.564 1.165 . . . . 0.0 109.283 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 165' ' ' PRO . . . . . 0.514 ' O ' ' CB ' ' A' ' 166' ' ' GLU . 18.5 Cg_endo -74.92 73.29 4.32 Favored 'Trans proline' 0 C--N 1.361 1.212 0 O-C-N 124.507 1.793 . . . . 0.0 110.997 179.966 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . 0.535 ' OE1' ' HE2' ' A' ' 181' ' ' MET . 2.5 mt-10 159.93 179.35 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.528 1.142 . . . . 0.0 110.325 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -118.16 46.11 1.85 Allowed 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.513 1.133 . . . . 0.0 110.318 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -178.83 -54.35 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.484 1.115 . . . . 0.0 110.322 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 169' ' ' TRP . . . . . . . . . . . . . 10.2 m95 -95.52 144.35 26.07 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.539 1.149 . . . . 0.0 107.991 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 170' ' ' TRP . . . . . 0.592 ' CD1' ' HB3' ' A' ' 164' ' ' LYS . 53.2 m0 -118.71 148.38 42.83 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 -179.963 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 171' ' ' ASN . . . . . 0.458 ' HB2' ' CD ' ' A' ' 165' ' ' PRO . 5.4 t-20 -87.58 107.73 18.73 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.555 1.16 . . . . 0.0 109.366 179.903 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . 0.576 ' HA ' ' O ' ' A' ' 160' ' ' ARG . . . -119.28 174.88 6.09 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.511 1.132 . . . . 0.0 109.31 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . 0.514 ' HG3' ' CG ' ' A' ' 179' ' ' ARG . 3.8 mt-10 -118.17 119.92 36.16 Favored 'General case' 0 C--N 1.326 -0.427 0 O-C-N 124.543 1.152 . . . . 0.0 110.262 -179.947 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . 0.4 ' OD1' ' HB3' ' A' ' 178' ' ' LYS . 0.8 OUTLIER -76.19 -173.7 2.5 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.411 1.069 . . . . 0.0 109.319 -179.943 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 40.6 t -75.82 63.89 1.73 Allowed 'General case' 0 C--N 1.324 -0.539 0 O-C-N 124.591 1.182 . . . . 0.0 110.079 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . 0.442 ' H ' ' H ' ' A' ' 177' ' ' GLY . 0.9 OUTLIER -177.56 1.53 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.55 1.156 . . . . 0.0 110.276 -179.921 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 177' ' ' GLY . . . . . 0.442 ' H ' ' H ' ' A' ' 176' ' ' GLU . . . 74.94 15.47 80.98 Favored Glycine 0 CA--C 1.53 0.998 0 O-C-N 124.522 1.139 . . . . 0.0 111.019 -179.954 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 178' ' ' LYS . . . . . 0.407 ' O ' ' HA ' ' A' ' 173' ' ' GLU . 0.0 OUTLIER -84.91 117.59 24.01 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.506 0.768 . . . . 0.0 109.38 179.986 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 179' ' ' ARG . . . . . 0.514 ' CG ' ' HG3' ' A' ' 173' ' ' GLU . 3.3 mtt85 -90.18 123.34 33.92 Favored 'General case' 0 C--N 1.326 -0.441 0 O-C-N 124.498 1.124 . . . . 0.0 110.294 -179.949 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . 0.443 ' O ' ' HA ' ' A' ' 171' ' ' ASN . . . -152.21 164.57 30.56 Favored Glycine 0 CA--C 1.53 1.011 0 O-C-N 124.471 1.107 . . . . 0.0 111.017 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 181' ' ' MET . . . . . 0.535 ' HE2' ' OE1' ' A' ' 166' ' ' GLU . 21.7 mtp -86.37 101.77 13.41 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.528 0.781 . . . . 0.0 110.95 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . 0.6 HD13 HD22 ' A' ' 159' ' ' LEU . 23.3 pt -99.2 158.12 32.82 Favored Pre-proline 0 C--N 1.326 -0.452 0 O-C-N 124.492 1.12 . . . . 0.0 109.301 179.922 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 183' ' ' PRO . . . . . 0.754 ' HG2' ' HB2' ' A' ' 186' ' ' TYR . 18.4 Cg_endo -74.96 134.13 17.5 Favored 'Trans proline' 0 C--N 1.36 1.159 0 O-C-N 124.404 1.739 . . . . 0.0 110.947 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . 0.807 ' N ' ' CD ' ' A' ' 185' ' ' PRO . 73.9 t -77.43 -33.36 1.04 Allowed Pre-proline 0 C--N 1.325 -0.46 0 O-C-N 124.578 1.174 . . . . 0.0 109.271 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 185' ' ' PRO . . . . . 0.807 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.3 Cg_endo -74.96 -14.7 21.15 Favored 'Trans proline' 0 C--N 1.361 1.191 0 O-C-N 124.5 1.789 . . . . 0.0 111.026 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 186' ' ' TYR . . . . . 0.754 ' HB2' ' HG2' ' A' ' 183' ' ' PRO . 3.3 m-85 -96.59 0.31 49.78 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.508 1.13 . . . . 0.0 111.057 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 4.1 m -135.4 164.49 32.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 O-C-N 124.463 1.102 . . . . 0.0 109.271 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 188' ' ' GLU . . . . . 0.474 ' O ' ' HA ' ' A' ' 137' ' ' VAL . 0.0 OUTLIER -122.46 166.92 13.99 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.52 1.137 . . . . 0.0 110.293 179.963 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -87.69 135.59 33.31 Favored 'General case' 0 C--N 1.326 -0.422 0 O-C-N 124.492 1.12 . . . . 0.0 109.288 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.326 -0.423 0 O-C-N 124.447 1.092 . . . . 0.0 110.948 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' CYS . . . . . . . . . . . . . 3.9 m . . . . . 0 N--CA 1.452 -0.329 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 143.58 -35.34 1.64 Allowed Glycine 0 CA--C 1.53 1.026 0 O-C-N 124.463 1.102 . . . . 0.0 111.009 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -74.76 59.63 0.88 Allowed 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.504 0.767 . . . . 0.0 109.293 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.463 ' HB3' ' O ' ' A' ' 161' ' ' ILE . 0.3 OUTLIER 39.05 69.02 0.3 Allowed 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.529 1.143 . . . . 0.0 110.283 -179.981 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . 0.812 ' CD1' ' CG ' ' A' ' 190' ' ' TYR . 1.9 t80 -112.49 128.77 56.43 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.482 1.113 . . . . 0.0 110.965 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.742 HG13 ' O ' ' A' ' 188' ' ' GLU . 10.5 t -139.61 141.48 34.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 O-C-N 124.534 1.146 . . . . 0.0 109.306 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . 0.417 ' NE ' ' HA2' ' A' ' 156' ' ' GLY . 0.5 OUTLIER -112.18 139.18 47.93 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.44 1.087 . . . . 0.0 110.287 -179.987 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.464 ' CB ' HG12 ' A' ' 187' ' ' VAL . . . -95.17 114.5 26.3 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.468 1.105 . . . . 0.0 109.318 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.453 ' O ' ' CB ' ' A' ' 155' ' ' LYS . 0.5 OUTLIER -87.26 -22.83 24.95 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.498 1.124 . . . . 0.0 109.277 -179.984 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 20.2 m-85 -101.67 167.58 10.02 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.474 1.109 . . . . 0.0 110.995 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . 0.405 ' O ' ' HB2' ' A' ' 143' ' ' PHE . 1.9 p30 -120.26 147.55 44.82 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.504 1.127 . . . . 0.0 109.309 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' PHE . . . . . 0.558 ' HB3' ' CZ ' ' A' ' 153' ' ' PHE . 85.5 t80 179.0 59.82 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.494 1.121 . . . . 0.0 110.992 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . 0.454 ' O ' ' O ' ' A' ' 145' ' ' GLY . 20.1 t-20 -55.22 -15.85 2.73 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.474 1.109 . . . . 0.0 109.293 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . 0.454 ' O ' ' O ' ' A' ' 144' ' ' ASN . . . -51.82 -168.89 0.01 OUTLIER Glycine 0 CA--C 1.53 1.001 0 O-C-N 124.466 1.104 . . . . 0.0 111.001 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 2.6 p30 -167.53 66.28 0.08 Allowed 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.478 0.752 . . . . 0.0 109.31 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 24.3 m-20 -41.22 -57.22 2.16 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.501 1.126 . . . . 0.0 109.277 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -130.7 58.82 1.68 Allowed 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.517 1.136 . . . . 0.0 110.285 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER 66.24 36.2 5.58 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.543 1.152 . . . . 0.0 110.3 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . 0.631 ' OD2' ' CZ3' ' A' ' 169' ' ' TRP . 0.1 OUTLIER -68.67 179.85 1.61 Allowed 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.507 1.129 . . . . 0.0 109.251 -179.994 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.96 HD21 ' OD1' ' A' ' 174' ' ' ASP . 14.7 tp -103.36 130.3 23.84 Favored Pre-proline 0 C--N 1.325 -0.465 0 O-C-N 124.533 1.146 . . . . 0.0 109.285 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . 0.428 ' HA ' ' HA ' ' A' ' 144' ' ' ASN . 18.3 Cg_endo -75.01 152.59 40.89 Favored 'Trans proline' 0 C--N 1.359 1.131 0 O-C-N 124.531 1.806 . . . . 0.0 110.972 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . 0.584 ' CE2' ' O ' ' A' ' 151' ' ' LEU . 12.8 p90 -179.48 168.98 1.43 Allowed 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.521 1.138 . . . . 0.0 110.999 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 8.6 tttt -126.56 -167.22 1.69 Allowed 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.556 1.16 . . . . 0.0 109.284 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.453 ' CB ' ' O ' ' A' ' 140' ' ' LEU . 2.9 ptmt -91.29 106.84 18.79 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.532 1.145 . . . . 0.0 109.257 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . 0.417 ' HA2' ' NE ' ' A' ' 138' ' ' ARG . . . 105.14 27.2 5.98 Favored Glycine 0 CA--C 1.531 1.033 0 O-C-N 124.505 1.128 . . . . 0.0 111.03 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . 0.503 ' C ' HD13 ' A' ' 158' ' ' ILE . 32.2 t70 -92.34 161.46 14.66 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.502 0.766 . . . . 0.0 109.32 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . 0.67 HG23 ' CZ ' ' A' ' 136' ' ' TYR . 6.5 mm -111.76 128.1 68.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 O-C-N 124.474 1.109 . . . . 0.0 109.312 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.839 HD22 HD12 ' A' ' 182' ' ' ILE . 1.7 mp -142.19 127.55 18.8 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.48 1.112 . . . . 0.0 109.292 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . 0.41 ' HG2' ' O ' ' A' ' 135' ' ' GLU . 4.4 mtt180 -86.53 143.56 27.65 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.497 1.123 . . . . 0.0 110.333 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.463 ' O ' ' HB3' ' A' ' 135' ' ' GLU . 0.9 OUTLIER -86.81 116.15 28.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 O-C-N 124.542 1.151 . . . . 0.0 109.275 -179.969 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . 0.401 ' NH1' ' OE2' ' A' ' 173' ' ' GLU . 3.1 tpt180 -97.7 -69.27 0.76 Allowed 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.49 1.119 . . . . 0.0 110.285 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -134.42 173.43 11.64 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.422 1.076 . . . . 0.0 109.316 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . 0.535 ' HG2' ' CD2' ' A' ' 170' ' ' TRP . 0.0 OUTLIER -135.1 87.32 29.3 Favored Pre-proline 0 C--N 1.325 -0.47 0 O-C-N 124.515 1.135 . . . . 0.0 109.316 -179.958 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -74.97 -25.21 12.13 Favored 'Trans proline' 0 C--N 1.361 1.192 0 O-C-N 124.486 1.782 . . . . 0.0 111.001 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 6.7 mt-10 -125.22 167.36 14.97 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.551 1.157 . . . . 0.0 110.302 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -87.62 -18.82 28.78 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.497 1.123 . . . . 0.0 110.274 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 12.0 mt-30 -103.28 -53.44 2.81 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.491 1.119 . . . . 0.0 110.31 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' TRP . . . . . 0.631 ' CZ3' ' OD2' ' A' ' 150' ' ' ASP . 7.0 m95 -100.7 133.58 44.94 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.504 1.127 . . . . 0.0 107.999 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' TRP . . . . . 0.682 ' CE2' HG21 ' A' ' 184' ' ' VAL . 54.7 m0 -116.63 155.09 29.38 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.553 1.158 . . . . 0.0 107.983 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' ASN . . . . . 0.485 ' HA ' ' O ' ' A' ' 180' ' ' GLY . 19.5 t30 -86.5 97.48 10.52 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.495 1.122 . . . . 0.0 109.31 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -109.91 166.59 10.81 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.556 1.16 . . . . 0.0 109.308 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . 0.401 ' OE2' ' NH1' ' A' ' 162' ' ' ARG . 23.1 mt-10 -116.18 112.92 22.35 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.463 1.102 . . . . 0.0 110.273 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . 0.96 ' OD1' HD21 ' A' ' 151' ' ' LEU . 0.0 OUTLIER -68.63 -177.38 0.95 Allowed 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.427 1.08 . . . . 0.0 109.335 179.955 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 73.0 p -77.32 57.71 1.53 Allowed 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.506 1.129 . . . . 0.0 110.03 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . 0.409 ' O ' ' HD2' ' A' ' 178' ' ' LYS . 2.7 mt-10 -175.35 22.68 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.519 1.137 . . . . 0.0 110.284 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 55.57 29.18 53.34 Favored Glycine 0 CA--C 1.53 1.004 0 O-C-N 124.522 1.139 . . . . 0.0 110.991 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' LYS . . . . . 0.422 ' O ' ' OD1' ' A' ' 174' ' ' ASP . 0.0 OUTLIER -96.7 110.99 23.32 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.429 0.723 . . . . 0.0 109.308 179.982 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 3.4 ttp180 -91.1 120.5 32.1 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.523 1.139 . . . . 0.0 110.237 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . 0.913 ' HA3' HD13 ' A' ' 151' ' ' LEU . . . -149.84 172.54 29.75 Favored Glycine 0 CA--C 1.53 0.998 0 O-C-N 124.483 1.114 . . . . 0.0 111.001 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' MET . . . . . 0.459 ' HA ' ' O ' ' A' ' 170' ' ' TRP . 20.7 mtp -86.94 92.55 9.06 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.497 0.763 . . . . 0.0 110.998 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . 0.839 HD12 HD22 ' A' ' 159' ' ' LEU . 6.6 tt -89.87 144.88 32.24 Favored Pre-proline 0 C--N 1.326 -0.455 0 O-C-N 124.495 1.122 . . . . 0.0 109.32 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' PRO . . . . . 0.674 ' HG2' ' HB2' ' A' ' 186' ' ' TYR . 18.4 Cg_endo -74.97 132.13 15.1 Favored 'Trans proline' 0 C--N 1.36 1.148 0 O-C-N 124.479 1.778 . . . . 0.0 111.028 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . 0.821 ' N ' ' CD ' ' A' ' 185' ' ' PRO . 28.1 t -74.48 -30.68 1.1 Allowed Pre-proline 0 C--N 1.325 -0.489 0 O-C-N 124.522 1.139 . . . . 0.0 109.303 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 185' ' ' PRO . . . . . 0.821 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.3 Cg_endo -74.92 -10.86 21.54 Favored 'Trans proline' 0 C--N 1.36 1.153 0 O-C-N 124.559 1.82 . . . . 0.0 111.025 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 186' ' ' TYR . . . . . 0.674 ' HB2' ' HG2' ' A' ' 183' ' ' PRO . 3.7 m-30 -101.61 -19.47 15.44 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.513 1.133 . . . . 0.0 111.018 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 187' ' ' VAL . . . . . 0.706 ' CG2' HG11 ' A' ' 137' ' ' VAL . 13.8 m -115.5 175.9 2.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 O-C-N 124.457 1.098 . . . . 0.0 109.311 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . 0.742 ' O ' HG13 ' A' ' 137' ' ' VAL . 0.0 OUTLIER -135.97 168.08 20.02 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 124.481 1.113 . . . . 0.0 110.311 -179.988 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . 0.519 ' HD2' HG22 ' A' ' 137' ' ' VAL . 5.8 mmmt -94.69 141.09 29.02 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.536 1.148 . . . . 0.0 109.31 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 190' ' ' TYR . . . . . 0.812 ' CG ' ' CD1' ' A' ' 136' ' ' TYR . 0.2 OUTLIER -93.18 172.86 8.03 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.459 1.1 . . . . 0.0 111.059 179.972 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.981 0 O-C-N 124.528 1.143 . . . . 0.0 110.999 -179.993 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' CYS . . . . . 0.437 ' O ' ' O ' ' A' ' 191' ' ' GLY . 90.0 m . . . . . 0 N--CA 1.452 -0.345 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . 0.44 ' O ' ' HB3' ' A' ' 134' ' ' ALA . . . -61.45 -161.16 0.14 Allowed Glycine 0 CA--C 1.53 0.986 0 O-C-N 124.419 1.075 . . . . 0.0 111.002 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . 0.818 ' HB1' ' CZ ' ' A' ' 136' ' ' TYR . . . 68.4 -159.64 0.2 Allowed 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.437 0.728 . . . . 0.0 109.325 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.481 ' O ' ' HA ' ' A' ' 160' ' ' ARG . 0.7 OUTLIER -148.58 67.83 1.07 Allowed 'General case' 0 C--N 1.326 -0.442 0 O-C-N 124.446 1.091 . . . . 0.0 110.311 -179.98 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . 0.818 ' CZ ' ' HB1' ' A' ' 134' ' ' ALA . 1.9 m-85 -121.17 132.77 55.04 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.562 1.164 . . . . 0.0 110.975 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.601 ' CG2' HD11 ' A' ' 161' ' ' ILE . 22.4 m -129.6 162.31 37.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 O-C-N 124.58 1.175 . . . . 0.0 109.294 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . 0.448 ' O ' ' HA ' ' A' ' 187' ' ' VAL . 0.0 OUTLIER -119.25 125.04 48.19 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.505 1.128 . . . . 0.0 110.341 179.999 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.661 ' CB ' HG12 ' A' ' 187' ' ' VAL . . . -89.1 107.09 18.85 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.497 1.123 . . . . 0.0 109.284 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.57 HD11 ' HG2' ' A' ' 188' ' ' GLU . 0.1 OUTLIER -88.68 -29.86 19.57 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.571 1.169 . . . . 0.0 109.349 -179.998 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . 0.494 ' C ' ' O ' ' A' ' 154' ' ' LYS . 47.2 m-85 -91.2 153.55 19.93 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.523 1.14 . . . . 0.0 110.989 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . 0.43 ' HB2' ' HA ' ' A' ' 154' ' ' LYS . 4.2 t70 -106.86 153.64 22.21 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.475 1.11 . . . . 0.0 109.361 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' PHE . . . . . 0.587 ' HB3' ' CZ ' ' A' ' 153' ' ' PHE . 19.6 t80 -179.36 34.73 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.5 1.125 . . . . 0.0 110.967 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . 0.478 ' HA ' ' HA ' ' A' ' 152' ' ' PRO . 0.9 OUTLIER -45.18 137.85 4.25 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.472 1.108 . . . . 0.0 109.229 -179.931 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . 0.41 ' O ' ' ND2' ' A' ' 144' ' ' ASN . . . -103.59 -116.96 4.27 Favored Glycine 0 CA--C 1.53 0.981 0 O-C-N 124.597 1.186 . . . . 0.0 110.984 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 7.5 p-10 -177.74 -50.19 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.443 0 O-C-N 124.461 0.742 . . . . 0.0 109.346 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -42.1 154.82 0.05 OUTLIER 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.511 1.132 . . . . 0.0 109.285 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 9.5 tt0 -90.94 46.21 1.31 Allowed 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.485 1.116 . . . . 0.0 110.31 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -144.2 -46.52 0.26 Allowed 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.455 1.097 . . . . 0.0 110.288 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 2.6 p-10 -70.52 168.22 16.73 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.472 1.107 . . . . 0.0 109.307 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.74 HD23 HD23 ' A' ' 159' ' ' LEU . 1.3 mp -113.72 107.59 52.59 Favored Pre-proline 0 C--N 1.325 -0.458 0 O-C-N 124.514 1.134 . . . . 0.0 109.321 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . 0.478 ' HA ' ' HA ' ' A' ' 144' ' ' ASN . 18.5 Cg_endo -74.95 136.04 19.96 Favored 'Trans proline' 0 C--N 1.36 1.171 0 O-C-N 124.429 1.752 . . . . 0.0 111.015 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . 0.587 ' CZ ' ' HB3' ' A' ' 143' ' ' PHE . 10.7 p90 -148.29 166.94 26.48 Favored 'General case' 0 C--N 1.326 -0.427 0 O-C-N 124.5 1.125 . . . . 0.0 111.004 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . 0.494 ' O ' ' C ' ' A' ' 141' ' ' PHE . 0.1 OUTLIER -121.27 -90.77 0.57 Allowed 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.492 1.12 . . . . 0.0 109.363 179.954 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.41 ' CG ' ' O ' ' A' ' 140' ' ' LEU . 10.3 ttpp -157.45 118.28 3.55 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.534 1.146 . . . . 0.0 109.28 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . 0.614 ' N ' ' O ' ' A' ' 139' ' ' ALA . . . 98.42 16.36 32.23 Favored Glycine 0 CA--C 1.531 1.033 0 O-C-N 124.544 1.153 . . . . 0.0 111.0 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . 0.537 ' HB3' ' HB3' ' A' ' 139' ' ' ALA . 14.4 t70 -81.31 156.67 25.4 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.519 0.776 . . . . 0.0 109.3 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 5.1 mm -110.68 138.62 37.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 O-C-N 124.485 1.116 . . . . 0.0 109.347 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 1.046 HD22 HD13 ' A' ' 182' ' ' ILE . 1.5 mp -141.19 136.3 31.65 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.506 1.129 . . . . 0.0 109.272 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . 0.593 ' O ' ' HA ' ' A' ' 172' ' ' ALA . 0.0 OUTLIER -99.46 129.52 45.65 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.476 1.11 . . . . 0.0 110.313 179.981 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.601 HD11 ' CG2' ' A' ' 137' ' ' VAL . 1.7 mp -83.76 122.08 37.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 O-C-N 124.516 1.135 . . . . 0.0 109.286 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -122.65 -42.44 2.32 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.505 1.128 . . . . 0.0 110.261 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -135.06 170.81 15.34 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.491 1.119 . . . . 0.0 109.295 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . 0.565 ' HB2' ' CD1' ' A' ' 170' ' ' TRP . 0.6 OUTLIER -164.74 84.98 1.13 Allowed Pre-proline 0 C--N 1.325 -0.458 0 O-C-N 124.505 1.128 . . . . 0.0 109.3 179.928 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.08 -27.52 9.82 Favored 'Trans proline' 0 C--N 1.36 1.17 0 O-C-N 124.51 1.795 . . . . 0.0 110.983 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -118.54 168.94 10.21 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.539 1.15 . . . . 0.0 110.299 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -93.27 -19.67 21.17 Favored 'General case' 0 C--N 1.326 -0.441 0 O-C-N 124.522 1.139 . . . . 0.0 110.333 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -85.58 -57.12 3.19 Favored 'General case' 0 C--N 1.326 -0.422 0 O-C-N 124.506 1.129 . . . . 0.0 110.336 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' TRP . . . . . . . . . . . . . 10.6 m95 -107.18 150.62 26.41 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.549 1.156 . . . . 0.0 108.04 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' TRP . . . . . 0.769 ' CD2' HG21 ' A' ' 184' ' ' VAL . 37.5 m0 -127.51 151.6 48.66 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.549 1.155 . . . . 0.0 108.0 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' ASN . . . . . 0.414 ' HA ' ' O ' ' A' ' 180' ' ' GLY . 0.2 OUTLIER -87.37 99.14 11.78 Favored 'General case' 0 C--N 1.324 -0.532 0 O-C-N 124.468 1.105 . . . . 0.0 109.283 179.994 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . 0.593 ' HA ' ' O ' ' A' ' 160' ' ' ARG . . . -119.05 -178.43 3.56 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.476 1.11 . . . . 0.0 109.303 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . 0.436 ' CG ' ' HG3' ' A' ' 179' ' ' ARG . 34.0 mt-10 -119.73 121.15 38.55 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.47 1.106 . . . . 0.0 110.27 -179.898 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . 0.597 ' H ' HD21 ' A' ' 151' ' ' LEU . 0.2 OUTLIER -72.44 -164.22 0.14 Allowed 'General case' 0 C--N 1.323 -0.547 0 O-C-N 124.594 1.184 . . . . 0.0 109.259 -179.998 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 52.6 p -87.53 56.94 4.15 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.465 1.103 . . . . 0.0 109.999 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -177.22 28.45 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.532 1.145 . . . . 0.0 110.189 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 53.23 24.69 23.06 Favored Glycine 0 CA--C 1.531 1.078 0 O-C-N 124.562 1.164 . . . . 0.0 111.003 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' LYS . . . . . 0.46 ' O ' HD11 ' A' ' 151' ' ' LEU . 3.1 mtpm? -90.93 108.89 20.15 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.503 0.767 . . . . 0.0 109.355 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 179' ' ' ARG . . . . . 0.436 ' HG3' ' CG ' ' A' ' 173' ' ' GLU . 0.0 OUTLIER -90.7 114.97 27.42 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.499 1.125 . . . . 0.0 110.34 179.955 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . 0.489 ' HA3' HD13 ' A' ' 151' ' ' LEU . . . -150.79 174.31 30.13 Favored Glycine 0 CA--C 1.53 1.013 0 O-C-N 124.486 1.116 . . . . 0.0 111.01 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 181' ' ' MET . . . . . 0.419 ' HA ' ' O ' ' A' ' 170' ' ' TRP . 33.5 mtp -88.04 106.19 17.98 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.537 0.786 . . . . 0.0 110.99 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . 1.046 HD13 HD22 ' A' ' 159' ' ' LEU . 6.8 pt -106.65 159.38 30.06 Favored Pre-proline 0 C--N 1.325 -0.496 0 O-C-N 124.505 1.128 . . . . 0.0 109.36 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 183' ' ' PRO . . . . . 0.565 ' HG2' ' CB ' ' A' ' 186' ' ' TYR . 18.1 Cg_endo -75.02 127.5 10.72 Favored 'Trans proline' 0 C--N 1.36 1.174 0 O-C-N 124.418 1.746 . . . . 0.0 111.013 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . 0.769 HG21 ' CD2' ' A' ' 170' ' ' TRP . 21.8 t -76.17 -34.92 1.51 Allowed Pre-proline 0 C--N 1.325 -0.49 0 O-C-N 124.514 1.134 . . . . 0.0 109.334 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 185' ' ' PRO . . . . . 0.758 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.4 Cg_endo -74.95 -9.73 20.98 Favored 'Trans proline' 0 C--N 1.36 1.162 0 O-C-N 124.51 1.795 . . . . 0.0 110.988 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 186' ' ' TYR . . . . . 0.565 ' CB ' ' HG2' ' A' ' 183' ' ' PRO . 3.2 m-85 -95.95 -5.92 40.23 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.464 1.103 . . . . 0.0 110.962 -179.897 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 187' ' ' VAL . . . . . 0.661 HG12 ' CB ' ' A' ' 139' ' ' ALA . 7.6 m -129.33 175.47 10.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 O-C-N 124.391 1.057 . . . . 0.0 109.282 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . 0.57 ' HG2' HD11 ' A' ' 140' ' ' LEU . 0.0 OUTLIER -131.63 173.26 11.31 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.534 1.147 . . . . 0.0 110.297 179.971 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.05 119.43 28.41 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.502 1.126 . . . . 0.0 109.273 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -78.05 -45.01 24.77 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.448 1.092 . . . . 0.0 110.92 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . 0.437 ' O ' ' O ' ' A' ' 132' ' ' CYS . . . . . . . . 0 CA--C 1.531 1.032 0 O-C-N 124.496 1.123 . . . . 0.0 111.014 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' CYS . . . . . . . . . . . . . 1.9 m . . . . . 0 N--CA 1.452 -0.363 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . 0.497 ' O ' ' CE1' ' A' ' 136' ' ' TYR . . . -121.3 31.3 5.13 Favored Glycine 0 CA--C 1.529 0.965 0 O-C-N 124.47 1.106 . . . . 0.0 111.038 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . 0.428 ' O ' ' O ' ' A' ' 133' ' ' GLY . . . 56.54 109.61 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.432 0 O-C-N 124.454 0.737 . . . . 0.0 109.26 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.641 ' HG2' HG22 ' A' ' 161' ' ' ILE . 0.8 OUTLIER 57.02 69.12 0.77 Allowed 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.546 1.154 . . . . 0.0 110.351 -179.988 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . 0.497 ' CE1' ' O ' ' A' ' 133' ' ' GLY . 2.0 m-85 -124.46 114.5 19.54 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.496 1.123 . . . . 0.0 111.038 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.443 HG22 ' HB ' ' A' ' 187' ' ' VAL . 0.4 OUTLIER -113.06 132.22 62.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 O-C-N 124.419 1.074 . . . . 0.0 109.282 -179.993 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . 0.501 ' HG3' ' N ' ' A' ' 139' ' ' ALA . 2.7 ttm180 -101.09 142.85 31.95 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.462 1.101 . . . . 0.0 110.259 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.515 ' O ' ' N ' ' A' ' 156' ' ' GLY . . . -105.85 109.08 20.91 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.564 1.165 . . . . 0.0 109.345 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.511 ' O ' ' CG ' ' A' ' 155' ' ' LYS . 0.3 OUTLIER -87.36 -22.42 25.08 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.496 1.123 . . . . 0.0 109.272 -179.944 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . 0.408 ' CD1' ' N ' ' A' ' 141' ' ' PHE . 0.6 OUTLIER -108.99 146.9 33.13 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.487 1.117 . . . . 0.0 111.013 179.972 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . 0.426 ' CB ' ' HA ' ' A' ' 154' ' ' LYS . 5.7 t70 -101.1 156.25 17.52 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.537 1.148 . . . . 0.0 109.296 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' PHE . . . . . 0.592 ' CE2' ' O ' ' A' ' 144' ' ' ASN . 0.0 OUTLIER -149.03 -42.35 0.15 Allowed 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.434 1.083 . . . . 0.0 111.042 179.97 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . 0.592 ' O ' ' CE2' ' A' ' 143' ' ' PHE . 2.3 t30 58.61 169.39 0.06 Allowed 'General case' 0 C--N 1.326 -0.437 0 O-C-N 124.476 1.11 . . . . 0.0 109.309 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . 0.503 ' H ' ' ND2' ' A' ' 144' ' ' ASN . . . -177.24 -176.83 45.66 Favored Glycine 0 CA--C 1.531 1.043 0 O-C-N 124.502 1.126 . . . . 0.0 111.037 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 6.5 m120 -157.42 57.33 0.5 Allowed 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.568 0.805 . . . . 0.0 109.276 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -121.23 161.73 21.42 Favored 'General case' 0 C--N 1.326 -0.443 0 O-C-N 124.446 1.091 . . . . 0.0 109.26 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 17.3 tt0 -101.67 58.01 0.84 Allowed 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.511 1.132 . . . . 0.0 110.282 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -179.51 -43.74 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.523 0 O-C-N 124.505 1.128 . . . . 0.0 110.247 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -74.26 170.73 14.97 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.498 1.124 . . . . 0.0 109.398 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.499 HD11 ' HB2' ' A' ' 174' ' ' ASP . 57.4 tp -132.72 110.99 13.45 Favored Pre-proline 0 C--N 1.326 -0.451 0 O-C-N 124.464 1.102 . . . . 0.0 109.307 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . 0.464 ' HB3' ' N ' ' A' ' 145' ' ' GLY . 18.4 Cg_endo -74.96 174.4 12.84 Favored 'Trans proline' 0 C--N 1.36 1.158 0 O-C-N 124.431 1.753 . . . . 0.0 110.997 180.0 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . 0.596 ' CZ ' ' CD ' ' A' ' 183' ' ' PRO . 0.4 OUTLIER -169.25 173.83 6.47 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.54 1.15 . . . . 0.0 111.018 179.979 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . 0.426 ' HA ' ' CB ' ' A' ' 142' ' ' ASP . 0.1 OUTLIER -127.13 -164.91 1.4 Allowed 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.458 1.099 . . . . 0.0 109.315 -179.995 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.511 ' CG ' ' O ' ' A' ' 140' ' ' LEU . 1.5 tttp -97.08 99.16 10.68 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.475 1.109 . . . . 0.0 109.317 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . 0.515 ' N ' ' O ' ' A' ' 139' ' ' ALA . . . 116.08 29.54 2.34 Favored Glycine 0 CA--C 1.53 1.008 0 O-C-N 124.534 1.146 . . . . 0.0 111.01 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . 0.932 ' C ' HD12 ' A' ' 158' ' ' ILE . 12.4 t70 -102.9 166.81 10.25 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.607 0.828 . . . . 0.0 109.305 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . 0.932 HD12 ' C ' ' A' ' 157' ' ' ASP . 1.9 mp -123.56 146.28 29.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 O-C-N 124.476 1.11 . . . . 0.0 109.344 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.775 HD21 ' OD2' ' A' ' 174' ' ' ASP . 0.8 OUTLIER -144.11 128.85 18.27 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.513 1.133 . . . . 0.0 109.314 -179.98 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . 0.558 ' O ' ' HA ' ' A' ' 172' ' ' ALA . 2.0 tmt_? -87.72 127.77 35.3 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.458 1.099 . . . . 0.0 110.292 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.641 HG22 ' HG2' ' A' ' 135' ' ' GLU . 1.7 mp -84.96 130.85 35.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.455 1.097 . . . . 0.0 109.288 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . 0.467 ' HD3' ' CZ ' ' A' ' 179' ' ' ARG . 33.7 ttt85 -127.3 -46.44 1.49 Allowed 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.46 1.1 . . . . 0.0 110.314 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . 0.48 ' CB ' ' HB3' ' A' ' 171' ' ' ASN . 0.2 OUTLIER -123.7 161.4 25.19 Favored 'General case' 0 C--N 1.326 -0.433 0 O-C-N 124.508 1.13 . . . . 0.0 109.281 179.991 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . 0.513 ' O ' ' CG ' ' A' ' 164' ' ' LYS . 0.1 OUTLIER -165.23 64.14 1.0 Allowed Pre-proline 0 C--N 1.327 -0.391 0 O-C-N 124.463 1.102 . . . . 0.0 109.261 179.98 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . 0.425 ' HD3' ' N ' ' A' ' 164' ' ' LYS . 18.1 Cg_endo -75.03 -49.18 0.15 Allowed 'Trans proline' 0 C--N 1.359 1.089 0 O-C-N 124.547 1.814 . . . . 0.0 110.977 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . 0.588 ' HG3' ' HE1' ' A' ' 181' ' ' MET . 5.4 mt-10 -66.14 167.57 9.86 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.499 1.124 . . . . 0.0 110.244 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 5.3 mp0 -110.87 40.91 1.91 Allowed 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.448 1.093 . . . . 0.0 110.309 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 5.4 mt-30 -159.44 -57.82 0.06 Allowed 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.553 1.158 . . . . 0.0 110.263 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' TRP . . . . . . . . . . . . . 10.4 m95 -102.04 144.45 30.62 Favored 'General case' 0 C--N 1.324 -0.523 0 O-C-N 124.567 1.167 . . . . 0.0 107.972 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' TRP . . . . . 0.75 ' CE2' HG21 ' A' ' 184' ' ' VAL . 50.8 m0 -116.28 146.88 42.06 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' ASN . . . . . 0.499 ' OD1' ' CD ' ' A' ' 179' ' ' ARG . 18.7 t-20 -87.72 99.88 12.42 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.505 1.128 . . . . 0.0 109.288 180.0 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . 0.558 ' HA ' ' O ' ' A' ' 160' ' ' ARG . . . -119.87 168.77 10.77 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.484 1.115 . . . . 0.0 109.267 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . 0.485 ' HG3' ' CB ' ' A' ' 179' ' ' ARG . 1.8 mt-10 -113.92 124.12 51.41 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.53 1.144 . . . . 0.0 110.292 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . 0.775 ' OD2' HD21 ' A' ' 159' ' ' LEU . 0.2 OUTLIER -73.99 -168.5 0.62 Allowed 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.47 1.106 . . . . 0.0 109.309 179.97 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 10.5 t -81.17 58.31 3.48 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 124.404 1.065 . . . . 0.0 110.024 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -175.11 16.85 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.449 1.093 . . . . 0.0 110.317 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . 0.405 ' C ' ' HG2' ' A' ' 173' ' ' GLU . . . 64.12 17.36 61.2 Favored Glycine 0 CA--C 1.529 0.951 0 O-C-N 124.562 1.164 . . . . 0.0 111.005 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' LYS . . . . . 0.408 ' O ' ' HA ' ' A' ' 173' ' ' GLU . 0.8 OUTLIER -85.95 102.09 13.45 Favored 'General case' 0 C--N 1.326 -0.441 0 O-C-N 124.472 0.748 . . . . 0.0 109.307 179.985 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 179' ' ' ARG . . . . . 0.499 ' CD ' ' OD1' ' A' ' 171' ' ' ASN . 20.1 ttm-85 -88.15 120.35 29.42 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.464 1.102 . . . . 0.0 110.328 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . 0.416 ' O ' ' HA ' ' A' ' 171' ' ' ASN . . . -152.36 172.45 31.56 Favored Glycine 0 CA--C 1.53 1.013 0 O-C-N 124.554 1.159 . . . . 0.0 110.953 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 181' ' ' MET . . . . . 0.588 ' HE1' ' HG3' ' A' ' 166' ' ' GLU . 35.7 mtp -86.96 99.82 12.15 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.46 0.741 . . . . 0.0 111.009 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . 0.583 HD13 HD13 ' A' ' 159' ' ' LEU . 5.7 pt -99.38 160.6 27.1 Favored Pre-proline 0 C--N 1.325 -0.46 0 O-C-N 124.454 1.096 . . . . 0.0 109.381 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 183' ' ' PRO . . . . . 0.739 ' HG2' ' HB2' ' A' ' 186' ' ' TYR . 18.5 Cg_endo -75.05 135.16 18.61 Favored 'Trans proline' 0 C--N 1.359 1.1 0 O-C-N 124.462 1.77 . . . . 0.0 111.019 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . 0.851 ' N ' ' CD ' ' A' ' 185' ' ' PRO . 42.9 t -80.07 -30.16 0.59 Allowed Pre-proline 0 C--N 1.325 -0.493 0 O-C-N 124.522 1.139 . . . . 0.0 109.321 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 185' ' ' PRO . . . . . 0.851 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.4 Cg_endo -75.02 -21.42 15.83 Favored 'Trans proline' 0 C--N 1.36 1.155 0 O-C-N 124.532 1.806 . . . . 0.0 110.963 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 186' ' ' TYR . . . . . 0.739 ' HB2' ' HG2' ' A' ' 183' ' ' PRO . 4.1 m-85 -94.42 15.52 17.51 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.52 1.138 . . . . 0.0 111.001 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 187' ' ' VAL . . . . . 0.474 ' HA ' ' O ' ' A' ' 138' ' ' ARG . 27.4 m -143.37 171.83 8.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 O-C-N 124.453 1.096 . . . . 0.0 109.294 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . 0.475 ' N ' ' O ' ' A' ' 138' ' ' ARG . 0.0 OUTLIER -131.75 169.65 15.92 Favored 'General case' 0 C--N 1.326 -0.442 0 O-C-N 124.462 1.102 . . . . 0.0 110.257 179.999 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -88.15 127.9 35.43 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.427 1.079 . . . . 0.0 109.304 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -99.75 -58.5 1.91 Allowed 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.481 1.113 . . . . 0.0 111.053 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.041 0 O-C-N 124.54 1.15 . . . . 0.0 110.971 179.976 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' CYS . . . . . . . . . . . . . 4.5 t . . . . . 0 N--CA 1.453 -0.32 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 164.87 -107.97 0.31 Allowed Glycine 0 CA--C 1.532 1.146 0 O-C-N 124.435 1.085 . . . . 0.0 110.978 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -168.59 77.96 0.13 Allowed 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.607 0.827 . . . . 0.0 109.256 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.41 ' CB ' ' HB ' ' A' ' 161' ' ' ILE . 0.4 OUTLIER 46.66 75.54 0.12 Allowed 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.416 1.073 . . . . 0.0 110.286 179.949 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 8.6 m-85 -130.95 99.97 5.09 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.522 1.139 . . . . 0.0 110.94 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.855 HG22 ' HB ' ' A' ' 187' ' ' VAL . 11.8 p -102.22 130.66 51.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 O-C-N 124.55 1.156 . . . . 0.0 109.289 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . 0.495 ' O ' ' N ' ' A' ' 188' ' ' GLU . 13.7 ttm180 -97.59 151.55 19.95 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.502 1.126 . . . . 0.0 110.339 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.858 ' HB3' ' OD2' ' A' ' 157' ' ' ASP . . . -120.63 106.34 11.65 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.467 1.104 . . . . 0.0 109.259 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.608 HD11 ' HG2' ' A' ' 188' ' ' GLU . 0.0 OUTLIER -91.14 -22.97 20.41 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.561 1.163 . . . . 0.0 109.331 179.944 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . 0.512 ' CD2' ' HA ' ' A' ' 186' ' ' TYR . 97.1 m-85 -85.66 161.38 19.27 Favored 'General case' 0 C--N 1.326 -0.418 0 O-C-N 124.44 1.088 . . . . 0.0 110.98 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . 0.498 ' CA ' ' O ' ' A' ' 154' ' ' LYS . 0.5 OUTLIER -115.17 142.8 46.17 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.508 1.13 . . . . 0.0 109.272 -179.984 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' PHE . . . . . 0.633 ' HB3' ' CE1' ' A' ' 153' ' ' PHE . 33.9 t80 -170.09 29.22 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.532 1.145 . . . . 0.0 110.961 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . 0.552 ' HA ' ' CB ' ' A' ' 152' ' ' PRO . 2.3 t30 -47.25 169.73 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.512 1.133 . . . . 0.0 109.315 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 164.21 -98.12 0.15 Allowed Glycine 0 CA--C 1.53 0.998 0 O-C-N 124.419 1.074 . . . . 0.0 111.012 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' ASN . . . . . 0.433 ' O ' ' CG ' ' A' ' 147' ' ' ASP . 1.6 p30 -176.87 -53.68 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.495 0.762 . . . . 0.0 109.326 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . 0.47 ' CG ' ' CB ' ' A' ' 150' ' ' ASP . 2.6 p30 46.04 -171.77 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.49 1.119 . . . . 0.0 109.3 -179.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -124.45 -33.94 2.96 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.47 1.106 . . . . 0.0 110.295 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -131.06 31.47 4.43 Favored 'General case' 0 C--N 1.323 -0.545 0 O-C-N 124.485 1.116 . . . . 0.0 110.345 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . 0.47 ' CB ' ' CG ' ' A' ' 147' ' ' ASP . 0.1 OUTLIER -127.95 176.28 7.72 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.521 1.138 . . . . 0.0 109.301 179.98 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.966 HD21 ' HB2' ' A' ' 174' ' ' ASP . 2.5 tp -129.27 113.59 18.35 Favored Pre-proline 0 C--N 1.326 -0.435 0 O-C-N 124.467 1.104 . . . . 0.0 109.324 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . 0.552 ' CB ' ' HA ' ' A' ' 144' ' ' ASN . 18.0 Cg_endo -75.03 126.74 10.15 Favored 'Trans proline' 0 C--N 1.36 1.135 0 O-C-N 124.43 1.753 . . . . 0.0 110.945 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . 0.633 ' CE1' ' HB3' ' A' ' 143' ' ' PHE . 1.2 p90 -129.57 -179.49 5.2 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.547 1.155 . . . . 0.0 110.955 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . 0.498 ' O ' ' CA ' ' A' ' 142' ' ' ASP . 32.2 tttt -121.6 -82.26 0.65 Allowed 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.498 1.124 . . . . 0.0 109.348 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.477 ' CG ' ' O ' ' A' ' 140' ' ' LEU . 0.0 OUTLIER -175.25 108.63 0.1 Allowed 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.499 1.124 . . . . 0.0 109.326 179.973 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . 0.434 ' N ' ' O ' ' A' ' 139' ' ' ALA . . . 104.83 16.1 18.27 Favored Glycine 0 CA--C 1.529 0.964 0 O-C-N 124.493 1.12 . . . . 0.0 111.05 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . 0.858 ' OD2' ' HB3' ' A' ' 139' ' ' ALA . 2.3 p-10 -88.2 144.51 26.42 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.494 0.761 . . . . 0.0 109.327 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . 0.668 ' N ' HD12 ' A' ' 158' ' ' ILE . 1.1 mp -95.93 150.02 4.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 O-C-N 124.438 1.086 . . . . 0.0 109.314 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.801 ' CD2' HD23 ' A' ' 151' ' ' LEU . 5.3 mt -145.65 133.77 21.55 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.542 1.151 . . . . 0.0 109.28 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . 0.517 ' O ' ' HB1' ' A' ' 172' ' ' ALA . 2.0 ttt180 -90.28 129.48 36.51 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.51 1.131 . . . . 0.0 110.322 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.459 HD12 ' HE3' ' A' ' 170' ' ' TRP . 24.1 mm -85.23 124.2 39.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 O-C-N 124.517 1.136 . . . . 0.0 109.253 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -119.39 -62.96 1.44 Allowed 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.507 1.129 . . . . 0.0 110.336 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -111.31 157.03 20.65 Favored 'General case' 0 C--N 1.324 -0.522 0 O-C-N 124.498 1.124 . . . . 0.0 109.333 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . 0.536 ' HG3' ' CE2' ' A' ' 170' ' ' TRP . 0.0 OUTLIER -157.81 63.08 2.67 Favored Pre-proline 0 C--N 1.324 -0.506 0 O-C-N 124.469 1.105 . . . . 0.0 109.306 -179.989 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . 0.441 ' HD3' ' N ' ' A' ' 164' ' ' LYS . 18.2 Cg_endo -75.05 -58.89 0.04 OUTLIER 'Trans proline' 0 C--N 1.36 1.148 0 O-C-N 124.445 1.761 . . . . 0.0 111.005 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -62.01 167.26 3.98 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.509 1.131 . . . . 0.0 110.248 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 6.5 mt-10 -106.99 45.77 0.97 Allowed 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.501 1.126 . . . . 0.0 110.349 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -167.03 -59.53 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.535 1.147 . . . . 0.0 110.346 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' TRP . . . . . . . . . . . . . 25.4 m95 -102.69 135.2 44.76 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.553 1.158 . . . . 0.0 107.966 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' TRP . . . . . 1.009 ' CE2' HG21 ' A' ' 184' ' ' VAL . 27.8 m0 -117.31 151.65 36.54 Favored 'General case' 0 C--N 1.324 -0.533 0 O-C-N 124.551 1.157 . . . . 0.0 108.048 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' ASN . . . . . 0.418 ' HA ' ' O ' ' A' ' 180' ' ' GLY . 2.8 t-20 -86.23 102.98 14.42 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.432 1.083 . . . . 0.0 109.268 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . 1.125 ' HB3' HD13 ' A' ' 182' ' ' ILE . . . -113.1 179.89 3.83 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.488 1.117 . . . . 0.0 109.309 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . 0.473 ' CG ' ' HG3' ' A' ' 179' ' ' ARG . 28.0 mt-10 -125.34 125.91 44.23 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.5 1.125 . . . . 0.0 110.271 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . 0.966 ' HB2' HD21 ' A' ' 151' ' ' LEU . 2.9 t70 -74.6 -163.92 0.24 Allowed 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.477 1.111 . . . . 0.0 109.307 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -89.32 47.04 1.43 Allowed 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.582 1.177 . . . . 0.0 110.019 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -169.68 24.51 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.546 1.154 . . . . 0.0 110.287 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 62.57 20.51 61.57 Favored Glycine 0 CA--C 1.53 0.976 0 O-C-N 124.441 1.088 . . . . 0.0 111.004 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' LYS . . . . . 0.646 ' HG2' HD11 ' A' ' 151' ' ' LEU . 4.8 tptt -81.21 104.26 11.56 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.524 0.779 . . . . 0.0 109.285 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 179' ' ' ARG . . . . . 0.476 ' HA ' ' O ' ' A' ' 172' ' ' ALA . 0.0 OUTLIER -89.26 116.92 27.84 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.427 1.079 . . . . 0.0 110.373 179.946 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . 0.549 ' O ' HD12 ' A' ' 182' ' ' ILE . . . -151.46 173.39 30.83 Favored Glycine 0 CA--C 1.53 0.979 0 O-C-N 124.452 1.095 . . . . 0.0 111.007 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 181' ' ' MET . . . . . 0.43 ' HA ' ' O ' ' A' ' 170' ' ' TRP . 12.9 mmm -86.14 103.6 14.94 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.461 0.742 . . . . 0.0 110.986 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . 1.125 HD13 ' HB3' ' A' ' 172' ' ' ALA . 4.1 mp -94.5 145.27 29.37 Favored Pre-proline 0 C--N 1.324 -0.509 0 O-C-N 124.563 1.164 . . . . 0.0 109.289 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 183' ' ' PRO . . . . . 0.836 ' HD2' HG23 ' A' ' 182' ' ' ILE . 18.3 Cg_endo -75.01 133.63 16.81 Favored 'Trans proline' 0 C--N 1.36 1.164 0 O-C-N 124.448 1.762 . . . . 0.0 110.977 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . 1.009 HG21 ' CE2' ' A' ' 170' ' ' TRP . 25.2 t -78.62 -31.14 0.73 Allowed Pre-proline 0 C--N 1.325 -0.469 0 O-C-N 124.509 1.131 . . . . 0.0 109.309 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 185' ' ' PRO . . . . . 0.814 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.1 Cg_endo -75.09 -25.96 11.23 Favored 'Trans proline' 0 C--N 1.359 1.123 0 O-C-N 124.474 1.776 . . . . 0.0 110.932 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 186' ' ' TYR . . . . . 0.774 ' HB2' ' HG2' ' A' ' 183' ' ' PRO . 4.1 m-85 -95.91 15.54 20.18 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.475 1.109 . . . . 0.0 110.994 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 187' ' ' VAL . . . . . 0.855 ' HB ' HG22 ' A' ' 137' ' ' VAL . 24.4 m -139.59 173.96 10.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 O-C-N 124.451 1.094 . . . . 0.0 109.278 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . 0.608 ' HG2' HD11 ' A' ' 140' ' ' LEU . 0.0 OUTLIER -135.18 172.31 13.2 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.448 1.093 . . . . 0.0 110.353 179.966 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . 0.45 ' HD2' ' N ' ' A' ' 189' ' ' LYS . 0.0 OUTLIER -95.63 114.19 25.91 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.545 1.153 . . . . 0.0 109.267 -179.96 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 15.6 t80 -60.06 -45.18 93.75 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.507 1.129 . . . . 0.0 110.962 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.977 0 O-C-N 124.461 1.1 . . . . 0.0 111.023 179.99 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' CYS . . . . . 0.436 ' O ' ' O ' ' A' ' 133' ' ' GLY . 3.0 t . . . . . 0 N--CA 1.453 -0.311 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . 0.436 ' O ' ' O ' ' A' ' 132' ' ' CYS . . . -55.39 -114.23 0.01 OUTLIER Glycine 0 CA--C 1.53 1.003 0 O-C-N 124.515 1.134 . . . . 0.0 110.996 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -163.64 124.03 2.21 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.448 0.734 . . . . 0.0 109.259 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.512 ' HG2' HG22 ' A' ' 161' ' ' ILE . 0.2 OUTLIER 39.14 74.88 0.08 Allowed 'General case' 0 C--N 1.326 -0.443 0 O-C-N 124.477 1.111 . . . . 0.0 110.32 179.988 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . 0.434 ' O ' ' HB3' ' A' ' 190' ' ' TYR . 0.4 OUTLIER -135.64 141.74 45.09 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.473 1.108 . . . . 0.0 111.003 179.993 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.556 HG21 HD11 ' A' ' 182' ' ' ILE . 34.3 m -133.66 157.51 42.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 O-C-N 124.476 1.11 . . . . 0.0 109.322 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . 0.785 ' HD3' HD13 ' A' ' 158' ' ' ILE . 4.2 tpp85 -127.3 127.07 43.73 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.436 1.085 . . . . 0.0 110.241 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.698 ' O ' ' N ' ' A' ' 156' ' ' GLY . . . -88.41 106.93 18.58 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.432 1.083 . . . . 0.0 109.323 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.413 HD11 ' HB3' ' A' ' 188' ' ' GLU . 0.4 OUTLIER -87.29 -5.14 59.03 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.538 1.149 . . . . 0.0 109.336 -179.994 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . 0.492 ' CD1' ' HA ' ' A' ' 186' ' ' TYR . 6.2 m-85 -123.32 151.92 41.97 Favored 'General case' 0 C--N 1.326 -0.443 0 O-C-N 124.486 1.116 . . . . 0.0 111.028 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -102.7 157.06 17.21 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.506 1.129 . . . . 0.0 109.345 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' PHE . . . . . 0.647 ' HB3' ' CZ ' ' A' ' 153' ' ' PHE . 28.1 t80 -179.14 36.09 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.523 1.139 . . . . 0.0 110.983 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . 0.544 ' HA ' ' CB ' ' A' ' 152' ' ' PRO . 17.2 p-10 -40.99 107.36 0.07 Allowed 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.436 1.085 . . . . 0.0 109.281 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . 0.435 ' N ' ' HB3' ' A' ' 152' ' ' PRO . . . -92.99 -125.02 3.75 Favored Glycine 0 CA--C 1.53 0.974 0 O-C-N 124.538 1.149 . . . . 0.0 111.031 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 6.5 m120 -174.39 -51.56 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.509 0.77 . . . . 0.0 109.313 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -40.54 154.4 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.503 1.127 . . . . 0.0 109.282 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.03 -20.71 48.29 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.451 1.094 . . . . 0.0 110.267 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 13.1 tt0 -63.88 -39.7 94.81 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.475 1.11 . . . . 0.0 110.255 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . 0.42 ' OD1' ' CZ3' ' A' ' 169' ' ' TRP . 0.2 OUTLIER -122.26 153.18 39.23 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.519 1.137 . . . . 0.0 109.315 179.996 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.902 HD13 ' OD2' ' A' ' 174' ' ' ASP . 3.4 pp -108.06 142.77 25.99 Favored Pre-proline 0 C--N 1.326 -0.45 0 O-C-N 124.468 1.105 . . . . 0.0 109.295 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . 0.544 ' CB ' ' HA ' ' A' ' 144' ' ' ASN . 18.3 Cg_endo -75.05 134.04 17.25 Favored 'Trans proline' 0 C--N 1.359 1.121 0 O-C-N 124.604 1.844 . . . . 0.0 110.985 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . 0.647 ' CZ ' ' HB3' ' A' ' 143' ' ' PHE . 6.5 p90 -141.31 175.58 9.54 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.487 1.117 . . . . 0.0 111.049 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.56 -164.42 1.38 Allowed 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.472 1.107 . . . . 0.0 109.305 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -96.4 96.29 8.63 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.534 1.147 . . . . 0.0 109.288 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . 0.698 ' N ' ' O ' ' A' ' 139' ' ' ALA . . . 122.63 29.81 1.24 Allowed Glycine 0 CA--C 1.53 0.981 0 O-C-N 124.487 1.117 . . . . 0.0 111.002 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . 0.489 ' HB3' ' HB3' ' A' ' 139' ' ' ALA . 12.1 t70 -97.9 159.43 14.94 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.449 0.734 . . . . 0.0 109.298 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . 0.785 HD13 ' HD3' ' A' ' 138' ' ' ARG . 6.5 mm -115.04 147.37 18.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 O-C-N 124.533 1.146 . . . . 0.0 109.359 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 1.116 HD13 HD13 ' A' ' 182' ' ' ILE . 1.1 mt -149.21 138.79 21.73 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.531 1.144 . . . . 0.0 109.371 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . 0.609 ' O ' ' HA ' ' A' ' 172' ' ' ALA . 0.0 OUTLIER -95.71 134.22 38.89 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.543 1.152 . . . . 0.0 110.349 -179.983 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.512 HG22 ' HG2' ' A' ' 135' ' ' GLU . 15.4 mm -84.43 118.41 31.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 O-C-N 124.424 1.077 . . . . 0.0 109.264 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -112.36 -51.57 2.83 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.469 1.106 . . . . 0.0 110.285 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -138.86 168.39 19.93 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.495 1.122 . . . . 0.0 109.325 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . 0.581 ' HB3' ' CD1' ' A' ' 170' ' ' TRP . 27.4 mtmt -148.93 85.97 5.85 Favored Pre-proline 0 C--N 1.324 -0.513 0 O-C-N 124.499 1.124 . . . . 0.0 109.341 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.03 -30.57 6.98 Favored 'Trans proline' 0 C--N 1.36 1.138 0 O-C-N 124.498 1.788 . . . . 0.0 111.012 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -128.92 153.99 46.97 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.554 1.159 . . . . 0.0 110.272 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -77.75 -23.62 49.24 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.497 1.123 . . . . 0.0 110.265 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -75.9 -57.06 4.1 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.487 1.117 . . . . 0.0 110.329 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' TRP . . . . . 0.42 ' CZ3' ' OD1' ' A' ' 150' ' ' ASP . 14.0 m95 -111.33 156.22 21.88 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.547 1.154 . . . . 0.0 107.995 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' TRP . . . . . 0.581 ' CD1' ' HB3' ' A' ' 164' ' ' LYS . 23.6 m0 -131.46 148.53 52.65 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.477 1.111 . . . . 0.0 108.017 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' ASN . . . . . 0.529 ' OD1' ' HG2' ' A' ' 179' ' ' ARG . 6.2 t-20 -87.26 98.98 11.63 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.503 1.127 . . . . 0.0 109.306 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . 0.609 ' HA ' ' O ' ' A' ' 160' ' ' ARG . . . -118.86 175.59 5.68 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.456 1.097 . . . . 0.0 109.327 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . 0.66 ' C ' HD23 ' A' ' 159' ' ' LEU . 1.5 tt0 -118.02 118.26 31.44 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.441 1.088 . . . . 0.0 110.324 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . 0.902 ' OD2' HD13 ' A' ' 151' ' ' LEU . 0.9 OUTLIER -66.43 -174.73 0.3 Allowed 'General case' 0 C--N 1.326 -0.434 0 O-C-N 124.461 1.101 . . . . 0.0 109.308 -179.947 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -78.72 53.16 1.3 Allowed 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.461 1.1 . . . . 0.0 110.018 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -172.21 11.25 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.446 1.091 . . . . 0.0 110.323 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . 0.49 ' C ' ' HG2' ' A' ' 173' ' ' GLU . . . 73.27 18.02 79.09 Favored Glycine 0 CA--C 1.53 0.978 0 O-C-N 124.509 1.131 . . . . 0.0 111.008 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -79.66 103.85 9.86 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.54 0.788 . . . . 0.0 109.349 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 179' ' ' ARG . . . . . 0.558 ' HG3' ' HG3' ' A' ' 173' ' ' GLU . 0.0 OUTLIER -87.65 113.21 23.12 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.434 1.084 . . . . 0.0 110.296 179.985 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . 0.403 ' O ' ' HA ' ' A' ' 171' ' ' ASN . . . -152.2 172.89 31.43 Favored Glycine 0 CA--C 1.53 0.977 0 O-C-N 124.428 1.08 . . . . 0.0 111.026 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 181' ' ' MET . . . . . 0.422 ' HA ' ' O ' ' A' ' 170' ' ' TRP . 3.0 mmm -87.7 97.49 10.92 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.492 0.76 . . . . 0.0 111.017 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . 1.116 HD13 HD13 ' A' ' 159' ' ' LEU . 3.4 pt -90.78 157.69 43.37 Favored Pre-proline 0 C--N 1.325 -0.498 0 O-C-N 124.498 1.124 . . . . 0.0 109.323 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 183' ' ' PRO . . . . . 0.741 ' HG2' ' HB2' ' A' ' 186' ' ' TYR . 18.3 Cg_endo -75.06 136.86 20.84 Favored 'Trans proline' 0 C--N 1.36 1.164 0 O-C-N 124.557 1.819 . . . . 0.0 111.012 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . 0.838 ' N ' ' CD ' ' A' ' 185' ' ' PRO . 92.2 t -82.08 -31.07 0.54 Allowed Pre-proline 0 C--N 1.325 -0.474 0 O-C-N 124.527 1.142 . . . . 0.0 109.37 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 185' ' ' PRO . . . . . 0.838 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.4 Cg_endo -74.99 -27.71 9.81 Favored 'Trans proline' 0 C--N 1.36 1.184 0 O-C-N 124.458 1.767 . . . . 0.0 111.012 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 186' ' ' TYR . . . . . 0.741 ' HB2' ' HG2' ' A' ' 183' ' ' PRO . 5.1 m-85 -91.37 15.17 12.7 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.493 1.12 . . . . 0.0 110.997 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 187' ' ' VAL . . . . . 0.699 HG11 HD12 ' A' ' 182' ' ' ILE . 34.5 m -143.22 167.32 13.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 O-C-N 124.504 1.127 . . . . 0.0 109.261 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . 0.483 ' CG ' ' HB3' ' A' ' 138' ' ' ARG . 0.0 OUTLIER -126.3 168.03 14.68 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 124.487 1.117 . . . . 0.0 110.329 179.943 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 12.3 mmmm -89.25 129.88 35.74 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.511 1.132 . . . . 0.0 109.274 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 190' ' ' TYR . . . . . 0.498 ' CG ' ' N ' ' A' ' 191' ' ' GLY . 0.8 OUTLIER -61.57 -149.89 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.48 1.112 . . . . 0.0 110.963 179.991 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . 0.498 ' N ' ' CG ' ' A' ' 190' ' ' TYR . . . . . . . . 0 CA--C 1.53 1.02 0 O-C-N 124.567 1.167 . . . . 0.0 110.988 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' CYS . . . . . . . . . . . . . 1.1 m . . . . . 0 N--CA 1.453 -0.316 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . 0.419 ' O ' ' HB2' ' A' ' 134' ' ' ALA . . . -77.25 56.99 3.67 Favored Glycine 0 CA--C 1.529 0.96 0 O-C-N 124.497 1.123 . . . . 0.0 111.022 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . 0.419 ' HB2' ' O ' ' A' ' 133' ' ' GLY . . . 179.39 -159.17 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.434 0 O-C-N 124.436 0.727 . . . . 0.0 109.248 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.522 ' O ' ' HG2' ' A' ' 160' ' ' ARG . 0.1 OUTLIER -131.17 64.78 1.57 Allowed 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.485 1.116 . . . . 0.0 110.266 179.969 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . 0.44 ' CE1' ' HG3' ' A' ' 160' ' ' ARG . 0.7 OUTLIER -129.19 132.4 47.28 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.432 1.083 . . . . 0.0 110.963 179.963 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.42 ' HA ' ' O ' ' A' ' 188' ' ' GLU . 3.4 m -128.15 164.51 29.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 O-C-N 124.449 1.093 . . . . 0.0 109.297 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . 0.455 ' O ' ' HA ' ' A' ' 187' ' ' VAL . 0.5 OUTLIER -123.57 126.32 46.45 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.482 1.114 . . . . 0.0 110.308 179.975 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.472 ' O ' ' N ' ' A' ' 156' ' ' GLY . . . -89.8 103.9 16.51 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.559 1.162 . . . . 0.0 109.258 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.774 HD11 ' HG2' ' A' ' 188' ' ' GLU . 0.2 OUTLIER -87.94 12.62 12.79 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.498 1.123 . . . . 0.0 109.231 -179.99 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . 0.471 ' O ' ' O ' ' A' ' 154' ' ' LYS . 23.7 m-85 -146.69 154.99 42.08 Favored 'General case' 0 C--N 1.324 -0.532 0 O-C-N 124.577 1.173 . . . . 0.0 111.041 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . 0.487 ' CB ' ' HA ' ' A' ' 154' ' ' LYS . 7.2 p-10 -103.19 139.74 38.27 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.51 1.131 . . . . 0.0 109.237 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' PHE . . . . . 0.648 ' O ' ' CE2' ' A' ' 153' ' ' PHE . 0.2 OUTLIER 166.55 81.87 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.444 0 O-C-N 124.507 1.129 . . . . 0.0 111.044 -179.992 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . 0.469 ' HA ' ' HA ' ' A' ' 152' ' ' PRO . 51.9 t-20 -39.58 154.58 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.539 1.149 . . . . 0.0 109.314 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . 0.446 ' N ' ' OD1' ' A' ' 144' ' ' ASN . . . -74.8 -156.77 5.33 Favored Glycine 0 CA--C 1.53 1.001 0 O-C-N 124.563 1.164 . . . . 0.0 110.988 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' ASN . . . . . 0.401 ' OD1' ' C ' ' A' ' 145' ' ' GLY . 6.7 p-10 166.39 76.56 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.493 0.761 . . . . 0.0 109.271 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -159.72 -81.4 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.423 1.077 . . . . 0.0 109.265 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.646 ' O ' ' CB ' ' A' ' 149' ' ' GLU . 9.8 mm-40 -113.95 74.24 0.86 Allowed 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.555 1.159 . . . . 0.0 110.277 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . 0.646 ' CB ' ' O ' ' A' ' 148' ' ' GLU . 5.8 tt0 98.42 -29.26 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.442 0 O-C-N 124.535 1.147 . . . . 0.0 110.311 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . 0.446 ' O ' ' O ' ' A' ' 149' ' ' GLU . 0.3 OUTLIER 60.68 136.43 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.509 1.131 . . . . 0.0 109.228 179.975 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.551 ' HB3' ' CG2' ' A' ' 182' ' ' ILE . 2.4 tp -118.32 111.83 38.08 Favored Pre-proline 0 C--N 1.326 -0.429 0 O-C-N 124.445 1.091 . . . . 0.0 109.288 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . 0.469 ' HA ' ' HA ' ' A' ' 144' ' ' ASN . 18.4 Cg_endo -75.01 117.47 4.92 Favored 'Trans proline' 0 C--N 1.359 1.127 0 O-C-N 124.535 1.808 . . . . 0.0 110.988 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . 0.648 ' CE2' ' O ' ' A' ' 143' ' ' PHE . 7.3 p90 -130.95 174.87 9.56 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.445 1.091 . . . . 0.0 110.981 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . 0.487 ' HA ' ' CB ' ' A' ' 142' ' ' ASP . 3.8 tttt -135.61 -156.1 0.69 Allowed 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.562 1.164 . . . . 0.0 109.232 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 4.4 ptpp? -99.84 106.74 18.63 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.494 1.121 . . . . 0.0 109.334 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . 0.472 ' N ' ' O ' ' A' ' 139' ' ' ALA . . . 108.88 27.65 4.8 Favored Glycine 0 CA--C 1.53 1.018 0 O-C-N 124.499 1.125 . . . . 0.0 110.953 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . 0.406 ' OD2' ' HG ' ' A' ' 159' ' ' LEU . 13.4 t70 -101.04 162.05 13.16 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.46 0.741 . . . . 0.0 109.306 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 19.6 mm -114.0 142.34 26.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 O-C-N 124.621 1.201 . . . . 0.0 109.327 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.818 HD13 HD13 ' A' ' 182' ' ' ILE . 2.2 mt -142.41 135.19 28.28 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.486 1.116 . . . . 0.0 109.328 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . 0.571 ' O ' ' HB1' ' A' ' 172' ' ' ALA . 8.2 ttm-85 -97.59 134.72 40.43 Favored 'General case' 0 C--N 1.324 -0.531 0 O-C-N 124.493 1.121 . . . . 0.0 110.303 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.413 ' CB ' ' HB2' ' A' ' 135' ' ' GLU . 1.2 mp -82.65 119.39 32.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 O-C-N 124.537 1.148 . . . . 0.0 109.23 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . 0.426 ' HB3' ' NH1' ' A' ' 162' ' ' ARG . 2.8 mmm180 -110.49 -59.19 1.98 Allowed 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.49 1.119 . . . . 0.0 110.332 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -129.23 163.84 24.75 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.456 1.097 . . . . 0.0 109.288 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . 0.426 ' HG3' ' NE1' ' A' ' 170' ' ' TRP . 0.3 OUTLIER -139.91 76.19 28.79 Favored Pre-proline 0 C--N 1.325 -0.489 0 O-C-N 124.537 1.148 . . . . 0.0 109.329 -179.951 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.97 -30.73 6.91 Favored 'Trans proline' 0 C--N 1.36 1.165 0 O-C-N 124.469 1.773 . . . . 0.0 111.038 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -113.4 169.68 8.78 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.519 1.137 . . . . 0.0 110.303 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -96.85 -27.92 14.47 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 124.47 1.106 . . . . 0.0 110.33 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -84.51 -55.94 3.88 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.47 1.107 . . . . 0.0 110.308 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' TRP . . . . . 0.436 ' CD1' ' N ' ' A' ' 169' ' ' TRP . 2.7 m95 -111.17 145.68 38.22 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.496 1.122 . . . . 0.0 107.99 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' TRP . . . . . 0.767 ' CD2' HG21 ' A' ' 184' ' ' VAL . 50.3 m0 -122.09 156.78 32.87 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.509 1.131 . . . . 0.0 108.0 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' ASN . . . . . 0.418 ' HA ' ' O ' ' A' ' 180' ' ' GLY . 33.0 t-20 -86.92 98.63 11.34 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.522 1.139 . . . . 0.0 109.351 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . 0.571 ' HB1' ' O ' ' A' ' 160' ' ' ARG . . . -113.87 176.19 5.14 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.483 1.114 . . . . 0.0 109.28 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . 0.492 ' CG ' ' HG3' ' A' ' 179' ' ' ARG . 9.6 mt-10 -112.75 127.71 56.22 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 124.354 1.033 . . . . 0.0 110.237 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . 0.658 ' HA ' HD23 ' A' ' 159' ' ' LEU . 6.2 p30 -83.78 -170.73 3.22 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.483 1.114 . . . . 0.0 109.327 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 1.1 t -79.53 68.06 5.46 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.493 1.121 . . . . 0.0 109.999 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 176.86 -4.39 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.473 1.108 . . . . 0.0 110.28 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 81.61 21.27 62.22 Favored Glycine 0 CA--C 1.53 1.012 0 O-C-N 124.542 1.151 . . . . 0.0 110.98 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 178' ' ' LYS . . . . . 0.403 ' O ' HD11 ' A' ' 151' ' ' LEU . 12.9 mtpt -92.04 118.67 31.02 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.483 0.754 . . . . 0.0 109.306 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 179' ' ' ARG . . . . . 0.492 ' HG3' ' CG ' ' A' ' 173' ' ' GLU . 61.0 mtt180 -89.92 121.92 32.47 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.443 1.089 . . . . 0.0 110.237 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . 0.436 ' HA3' HD13 ' A' ' 151' ' ' LEU . . . -150.77 166.93 30.4 Favored Glycine 0 CA--C 1.53 0.994 0 O-C-N 124.456 1.097 . . . . 0.0 111.0 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 181' ' ' MET . . . . . 0.451 ' HA ' ' O ' ' A' ' 170' ' ' TRP . 11.0 mtp -87.16 104.23 16.16 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.488 0.758 . . . . 0.0 110.921 -179.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . 0.818 HD13 HD13 ' A' ' 159' ' ' LEU . 1.4 pp -106.9 159.99 27.95 Favored Pre-proline 0 C--N 1.324 -0.527 0 O-C-N 124.587 1.18 . . . . 0.0 109.292 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 183' ' ' PRO . . . . . 0.628 ' HG2' ' HB2' ' A' ' 186' ' ' TYR . 18.5 Cg_endo -74.89 131.1 14.04 Favored 'Trans proline' 0 C--N 1.36 1.18 0 O-C-N 124.55 1.816 . . . . 0.0 111.066 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . 0.767 HG21 ' CD2' ' A' ' 170' ' ' TRP . 93.4 t -77.87 -33.99 1.06 Allowed Pre-proline 0 C--N 1.324 -0.506 0 O-C-N 124.54 1.15 . . . . 0.0 109.351 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 185' ' ' PRO . . . . . 0.764 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.3 Cg_endo -75.02 -11.44 21.45 Favored 'Trans proline' 0 C--N 1.361 1.199 0 O-C-N 124.41 1.742 . . . . 0.0 111.028 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 186' ' ' TYR . . . . . 0.628 ' HB2' ' HG2' ' A' ' 183' ' ' PRO . 6.7 m-85 -97.01 5.98 49.44 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.586 1.179 . . . . 0.0 110.996 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 187' ' ' VAL . . . . . 0.455 ' HA ' ' O ' ' A' ' 138' ' ' ARG . 8.4 m -137.74 173.32 13.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 O-C-N 124.507 1.13 . . . . 0.0 109.245 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . 0.774 ' HG2' HD11 ' A' ' 140' ' ' LEU . 0.0 OUTLIER -129.61 174.64 9.49 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.468 1.105 . . . . 0.0 110.253 -179.972 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 12.2 mmmm -86.98 117.19 25.54 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.472 1.108 . . . . 0.0 109.296 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 5.1 t80 -55.47 -41.8 73.46 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.483 1.114 . . . . 0.0 111.014 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.953 0 O-C-N 124.443 1.089 . . . . 0.0 111.007 179.967 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' CYS . . . . . 0.415 ' O ' ' SG ' ' A' ' 132' ' ' CYS . 32.1 p . . . . . 0 N--CA 1.453 -0.323 0 N-CA-C 108.334 -0.988 . . . . 0.0 108.334 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -173.07 -100.38 0.13 Allowed Glycine 0 CA--C 1.531 1.032 0 O-C-N 124.439 1.087 . . . . 0.0 110.988 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . 0.478 ' O ' ' C ' ' A' ' 135' ' ' GLU . . . -158.38 85.79 0.86 Allowed 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.523 0.778 . . . . 0.0 109.323 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.53 ' HB2' ' O ' ' A' ' 161' ' ' ILE . 1.6 pm0 30.87 68.68 0.1 Allowed 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.485 1.116 . . . . 0.0 110.278 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . 0.797 ' CE1' ' CD2' ' A' ' 190' ' ' TYR . 1.4 t80 -122.29 131.13 53.76 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.476 1.11 . . . . 0.0 110.952 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.614 HG11 HG21 ' A' ' 187' ' ' VAL . 3.8 t -132.55 162.16 40.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 O-C-N 124.497 1.123 . . . . 0.0 109.326 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . 0.476 ' N ' ' CG1' ' A' ' 137' ' ' VAL . 2.2 tpp85 -136.14 135.28 39.12 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.494 1.121 . . . . 0.0 110.31 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.538 ' O ' ' N ' ' A' ' 156' ' ' GLY . . . -98.57 109.51 22.25 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.506 1.129 . . . . 0.0 109.332 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.817 HD21 ' OE2' ' A' ' 188' ' ' GLU . 1.2 mt -88.71 -4.22 58.59 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.435 1.084 . . . . 0.0 109.263 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -133.28 154.46 50.67 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.536 1.147 . . . . 0.0 110.951 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . 0.432 ' CB ' ' HA ' ' A' ' 154' ' ' LYS . 7.6 t70 -100.27 152.88 19.78 Favored 'General case' 0 C--N 1.326 -0.427 0 O-C-N 124.484 1.115 . . . . 0.0 109.293 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' PHE . . . . . 0.604 ' HB3' ' CZ ' ' A' ' 153' ' ' PHE . 1.7 t80 177.46 59.84 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.422 0 O-C-N 124.479 1.112 . . . . 0.0 110.986 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . 0.534 ' HA ' ' HA ' ' A' ' 152' ' ' PRO . 0.4 OUTLIER -41.87 144.4 0.43 Allowed 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.51 1.131 . . . . 0.0 109.293 -179.999 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -89.15 -179.89 45.43 Favored Glycine 0 CA--C 1.53 0.984 0 O-C-N 124.534 1.146 . . . . 0.0 111.033 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' ASN . . . . . 0.417 ' O ' ' O ' ' A' ' 147' ' ' ASP . 3.8 t30 175.3 -35.74 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.515 0.774 . . . . 0.0 109.322 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . 0.417 ' O ' ' O ' ' A' ' 146' ' ' ASN . 68.9 m-20 -41.52 -91.78 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.549 1.156 . . . . 0.0 109.33 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 175.72 39.35 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.481 1.113 . . . . 0.0 110.305 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 170.48 46.31 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.452 1.095 . . . . 0.0 110.319 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . 0.607 ' OD2' ' CH2' ' A' ' 169' ' ' TRP . 0.3 OUTLIER -155.47 133.06 11.14 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.547 1.154 . . . . 0.0 109.283 179.992 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.905 HD23 HD11 ' A' ' 182' ' ' ILE . 5.4 tp -89.72 138.11 28.21 Favored Pre-proline 0 C--N 1.324 -0.507 0 O-C-N 124.475 1.109 . . . . 0.0 109.312 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . 0.534 ' HA ' ' HA ' ' A' ' 144' ' ' ASN . 18.3 Cg_endo -75.03 137.36 21.54 Favored 'Trans proline' 0 C--N 1.361 1.19 0 O-C-N 124.466 1.772 . . . . 0.0 110.989 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . 0.604 ' CZ ' ' HB3' ' A' ' 143' ' ' PHE . 18.9 p90 -154.65 170.35 21.73 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.445 1.091 . . . . 0.0 111.031 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . 0.432 ' HA ' ' CB ' ' A' ' 142' ' ' ASP . 0.1 OUTLIER -125.9 -164.04 1.27 Allowed 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.504 1.127 . . . . 0.0 109.282 -179.993 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -99.7 103.28 14.94 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.48 1.112 . . . . 0.0 109.267 -179.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . 0.538 ' N ' ' O ' ' A' ' 139' ' ' ALA . . . 114.76 23.42 4.68 Favored Glycine 0 CA--C 1.529 0.964 0 O-C-N 124.434 1.084 . . . . 0.0 111.013 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . 0.481 ' C ' HD12 ' A' ' 158' ' ' ILE . 19.8 t70 -101.69 170.0 8.46 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.454 0.738 . . . . 0.0 109.295 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . 0.618 ' CG2' ' CE1' ' A' ' 136' ' ' TYR . 3.6 mp -120.62 146.17 25.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 O-C-N 124.413 1.071 . . . . 0.0 109.257 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.954 HD23 ' HA ' ' A' ' 174' ' ' ASP . 0.9 OUTLIER -140.13 125.54 18.97 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.435 1.084 . . . . 0.0 109.313 179.973 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . 0.673 ' O ' ' HB1' ' A' ' 172' ' ' ALA . 1.1 ttp85 -88.04 130.89 34.85 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.554 1.159 . . . . 0.0 110.291 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.53 ' O ' ' HB2' ' A' ' 135' ' ' GLU . 8.7 mm -83.3 125.88 40.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 O-C-N 124.518 1.136 . . . . 0.0 109.283 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.32 -58.85 1.89 Allowed 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.495 1.122 . . . . 0.0 110.34 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . 0.421 ' CB ' ' HB3' ' A' ' 171' ' ' ASN . 0.1 OUTLIER -115.37 154.65 28.81 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.5 1.125 . . . . 0.0 109.313 179.948 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . 0.543 ' HG3' ' CD1' ' A' ' 170' ' ' TRP . 28.9 tttm -146.47 66.64 11.15 Favored Pre-proline 0 C--N 1.325 -0.476 0 O-C-N 124.552 1.157 . . . . 0.0 109.241 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -74.99 -33.08 4.86 Favored 'Trans proline' 0 C--N 1.36 1.133 0 O-C-N 124.522 1.801 . . . . 0.0 111.019 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -104.48 171.02 7.56 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.498 1.124 . . . . 0.0 110.289 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 21.5 mt-10 -101.4 -30.08 11.66 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.504 1.128 . . . . 0.0 110.31 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 28.3 tt0 -74.47 -61.11 1.98 Allowed 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.559 1.162 . . . . 0.0 110.292 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' TRP . . . . . 0.607 ' CH2' ' OD2' ' A' ' 150' ' ' ASP . 13.3 m95 -114.35 160.54 18.99 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.481 1.113 . . . . 0.0 108.001 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' TRP . . . . . 0.574 ' CE3' HG22 ' A' ' 184' ' ' VAL . 10.6 m0 -134.19 156.95 47.44 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.53 1.144 . . . . 0.0 108.011 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' ASN . . . . . 0.486 ' HA ' ' O ' ' A' ' 180' ' ' GLY . 40.5 t30 -87.42 102.48 14.58 Favored 'General case' 0 C--N 1.324 -0.522 0 O-C-N 124.523 1.14 . . . . 0.0 109.291 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . 0.673 ' HB1' ' O ' ' A' ' 160' ' ' ARG . . . -118.35 -178.19 3.46 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.521 1.138 . . . . 0.0 109.367 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . 0.421 ' HA ' ' O ' ' A' ' 178' ' ' LYS . 31.9 mt-10 -114.76 118.52 33.82 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.527 1.142 . . . . 0.0 110.227 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . 0.954 ' HA ' HD23 ' A' ' 159' ' ' LEU . 0.2 OUTLIER -73.43 -171.53 1.0 Allowed 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.522 1.139 . . . . 0.0 109.285 -179.998 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 29.1 t -80.07 56.56 2.43 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.546 1.154 . . . . 0.0 110.0 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -173.82 27.05 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.402 1.064 . . . . 0.0 110.392 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 50.47 22.53 5.46 Favored Glycine 0 CA--C 1.53 0.999 0 O-C-N 124.51 1.131 . . . . 0.0 110.992 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 178' ' ' LYS . . . . . 0.628 ' O ' HD21 ' A' ' 151' ' ' LEU . 2.7 ptpt -92.86 122.28 35.08 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.515 0.773 . . . . 0.0 109.352 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 40.6 mtt85 -91.16 115.4 27.99 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.467 1.104 . . . . 0.0 110.312 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . 0.748 ' HA3' HD13 ' A' ' 151' ' ' LEU . . . -150.38 179.51 27.05 Favored Glycine 0 CA--C 1.531 1.05 0 O-C-N 124.595 1.185 . . . . 0.0 110.998 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 181' ' ' MET . . . . . 0.41 ' HA ' ' O ' ' A' ' 170' ' ' TRP . 0.4 OUTLIER -85.33 107.35 17.29 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.576 0.81 . . . . 0.0 110.971 -179.989 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . 0.905 HD11 HD23 ' A' ' 151' ' ' LEU . 0.9 OUTLIER -98.0 144.14 27.49 Favored Pre-proline 0 C--N 1.325 -0.496 0 O-C-N 124.541 1.151 . . . . 0.0 109.262 -179.982 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 183' ' ' PRO . . . . . 0.724 ' HG2' ' HB2' ' A' ' 186' ' ' TYR . 18.5 Cg_endo -75.01 136.48 20.44 Favored 'Trans proline' 0 C--N 1.36 1.18 0 O-C-N 124.476 1.777 . . . . 0.0 111.021 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . 0.815 ' N ' ' CD ' ' A' ' 185' ' ' PRO . 44.3 t -82.03 -32.59 0.6 Allowed Pre-proline 0 C--N 1.326 -0.447 0 O-C-N 124.478 1.111 . . . . 0.0 109.305 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 185' ' ' PRO . . . . . 0.815 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.5 Cg_endo -75.0 -31.46 6.19 Favored 'Trans proline' 0 C--N 1.36 1.163 0 O-C-N 124.48 1.779 . . . . 0.0 111.024 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 186' ' ' TYR . . . . . 0.724 ' HB2' ' HG2' ' A' ' 183' ' ' PRO . 3.8 m-85 -90.8 19.39 5.55 Favored 'General case' 0 C--N 1.326 -0.428 0 O-C-N 124.483 1.114 . . . . 0.0 111.005 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 187' ' ' VAL . . . . . 0.658 HG22 ' O ' ' A' ' 183' ' ' PRO . 11.3 m -149.64 179.49 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 O-C-N 124.44 1.088 . . . . 0.0 109.371 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . 0.817 ' OE2' HD21 ' A' ' 140' ' ' LEU . 0.0 OUTLIER -139.54 166.33 24.86 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.496 1.122 . . . . 0.0 110.37 -179.994 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.64 129.74 39.81 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.478 1.111 . . . . 0.0 109.325 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 190' ' ' TYR . . . . . 0.797 ' CD2' ' CE1' ' A' ' 136' ' ' TYR . 0.2 OUTLIER -85.02 -47.61 10.05 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.495 1.122 . . . . 0.0 111.045 179.976 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.94 0 O-C-N 124.503 1.127 . . . . 0.0 111.038 179.954 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' CYS . . . . . 0.403 ' O ' ' C ' ' A' ' 133' ' ' GLY . 1.6 m . . . . . 0 N--CA 1.453 -0.32 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . 0.412 ' O ' ' HB2' ' A' ' 134' ' ' ALA . . . -36.52 -81.97 0.02 OUTLIER Glycine 0 CA--C 1.531 1.032 0 O-C-N 124.491 1.12 . . . . 0.0 110.977 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . 0.412 ' HB2' ' O ' ' A' ' 133' ' ' GLY . . . 179.96 -98.89 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.489 0.758 . . . . 0.0 109.256 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.422 ' O ' ' HA ' ' A' ' 160' ' ' ARG . 1.9 pt-20 -105.91 59.01 0.66 Allowed 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.575 1.172 . . . . 0.0 110.292 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -111.35 135.17 52.29 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.546 1.154 . . . . 0.0 110.987 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.745 HG12 ' O ' ' A' ' 159' ' ' LEU . 0.5 OUTLIER -126.01 157.03 36.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 O-C-N 124.498 1.124 . . . . 0.0 109.254 -179.933 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . 0.531 ' O ' ' HA ' ' A' ' 187' ' ' VAL . 1.4 ttm180 -126.22 139.48 53.31 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.513 1.133 . . . . 0.0 110.263 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.629 ' HB3' ' HB3' ' A' ' 157' ' ' ASP . . . -103.61 106.23 16.68 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 124.523 1.14 . . . . 0.0 109.306 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.444 ' O ' ' CG ' ' A' ' 155' ' ' LYS . 0.2 OUTLIER -87.32 -1.39 57.88 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.513 1.133 . . . . 0.0 109.327 179.965 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . 0.402 ' O ' ' O ' ' A' ' 154' ' ' LYS . 35.1 m-85 -128.14 159.63 34.54 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.488 1.118 . . . . 0.0 110.96 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . 0.468 ' CB ' ' HA ' ' A' ' 154' ' ' LYS . 45.2 p-10 -112.66 145.45 40.4 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.531 1.145 . . . . 0.0 109.278 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' PHE . . . . . 0.573 ' HB3' ' CZ ' ' A' ' 153' ' ' PHE . 36.3 t80 -179.88 69.29 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.549 1.156 . . . . 0.0 111.033 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . 0.533 ' HA ' ' HA ' ' A' ' 152' ' ' PRO . 23.0 p-10 -39.93 145.91 0.13 Allowed 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.525 1.141 . . . . 0.0 109.332 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . 0.429 ' C ' ' N ' ' A' ' 147' ' ' ASP . . . -96.7 -97.49 1.88 Allowed Glycine 0 CA--C 1.53 0.99 0 O-C-N 124.442 1.089 . . . . 0.0 111.005 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' ASN . . . . . 0.428 ' CG ' ' O ' ' A' ' 145' ' ' GLY . 13.6 p30 45.42 25.94 0.26 Allowed 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.502 0.766 . . . . 0.0 109.276 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . 0.429 ' N ' ' C ' ' A' ' 145' ' ' GLY . 49.4 m-20 -119.13 -63.83 1.35 Allowed 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.543 1.152 . . . . 0.0 109.274 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.438 ' C ' ' N ' ' A' ' 150' ' ' ASP . 0.9 OUTLIER -115.72 69.47 0.73 Allowed 'General case' 0 C--N 1.326 -0.426 0 O-C-N 124.434 1.084 . . . . 0.0 110.258 -179.929 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . 0.534 ' O ' ' CG ' ' A' ' 149' ' ' GLU . 1.0 OUTLIER 42.34 25.04 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.534 1.146 . . . . 0.0 110.33 179.998 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . 0.438 ' N ' ' C ' ' A' ' 148' ' ' GLU . 70.5 m-20 -90.32 166.49 13.28 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.542 1.151 . . . . 0.0 109.303 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.603 HD11 ' OD2' ' A' ' 174' ' ' ASP . 3.9 tp -105.23 132.84 20.52 Favored Pre-proline 0 C--N 1.325 -0.484 0 O-C-N 124.519 1.137 . . . . 0.0 109.287 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . 0.533 ' HA ' ' HA ' ' A' ' 144' ' ' ASN . 18.3 Cg_endo -75.0 143.63 29.28 Favored 'Trans proline' 0 C--N 1.36 1.146 0 O-C-N 124.59 1.837 . . . . 0.0 110.969 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . 0.573 ' CZ ' ' HB3' ' A' ' 143' ' ' PHE . 15.3 p90 -151.01 172.62 15.44 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.447 1.092 . . . . 0.0 111.035 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . 0.468 ' HA ' ' CB ' ' A' ' 142' ' ' ASP . 0.0 OUTLIER -130.54 -162.2 1.19 Allowed 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.537 1.148 . . . . 0.0 109.294 179.98 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.444 ' CG ' ' O ' ' A' ' 140' ' ' LEU . 2.9 tmtt? -94.47 107.51 19.48 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.495 1.122 . . . . 0.0 109.335 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . 0.453 ' HA2' ' CZ ' ' A' ' 138' ' ' ARG . . . 112.29 23.15 5.58 Favored Glycine 0 CA--C 1.529 0.949 0 O-C-N 124.529 1.143 . . . . 0.0 111.049 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . 0.633 ' C ' HD12 ' A' ' 158' ' ' ILE . 21.6 t70 -93.76 170.2 9.74 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.434 0.726 . . . . 0.0 109.296 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . 0.633 HD12 ' C ' ' A' ' 157' ' ' ASP . 3.0 mp -132.63 147.85 31.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 O-C-N 124.514 1.134 . . . . 0.0 109.234 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.745 ' O ' HG12 ' A' ' 137' ' ' VAL . 12.0 mt -147.67 131.82 17.36 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.483 1.114 . . . . 0.0 109.335 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . 0.604 ' O ' ' HA ' ' A' ' 172' ' ' ALA . 0.5 OUTLIER -86.85 139.38 30.72 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.457 1.098 . . . . 0.0 110.31 -179.975 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.464 ' CD1' ' HB ' ' A' ' 137' ' ' VAL . 1.4 mp -84.02 116.44 27.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 O-C-N 124.48 1.112 . . . . 0.0 109.287 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.92 -58.28 2.0 Allowed 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.499 1.124 . . . . 0.0 110.222 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . 0.442 ' OD1' ' N ' ' A' ' 164' ' ' LYS . 0.6 OUTLIER -136.47 161.37 36.02 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.484 1.115 . . . . 0.0 109.307 -179.918 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . 0.442 ' N ' ' OD1' ' A' ' 163' ' ' ASP . 0.0 OUTLIER -143.1 84.62 10.29 Favored Pre-proline 0 C--N 1.325 -0.48 0 O-C-N 124.489 1.118 . . . . 0.0 109.298 179.925 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -75.04 -39.04 1.31 Allowed 'Trans proline' 0 C--N 1.36 1.174 0 O-C-N 124.385 1.729 . . . . 0.0 111.029 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . 0.463 ' O ' ' NE1' ' A' ' 170' ' ' TRP . 3.9 mm-40 -111.36 178.24 4.4 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.532 1.145 . . . . 0.0 110.345 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.82 -22.02 14.45 Favored 'General case' 0 C--N 1.323 -0.546 0 O-C-N 124.51 1.131 . . . . 0.0 110.31 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . 0.444 ' HB3' ' CD1' ' A' ' 169' ' ' TRP . 0.0 OUTLIER -83.89 -57.89 3.02 Favored 'General case' 0 C--N 1.324 -0.523 0 O-C-N 124.527 1.142 . . . . 0.0 110.273 -179.996 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' TRP . . . . . 0.444 ' CD1' ' HB3' ' A' ' 168' ' ' GLN . 11.7 m95 -108.03 149.98 27.73 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.51 1.131 . . . . 0.0 107.994 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' TRP . . . . . 0.656 ' CZ3' HG11 ' A' ' 184' ' ' VAL . 26.6 m0 -131.3 151.59 51.36 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.486 1.116 . . . . 0.0 108.015 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' ASN . . . . . 0.469 ' HB2' ' HE3' ' A' ' 181' ' ' MET . 1.0 OUTLIER -87.64 98.89 11.67 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.548 1.155 . . . . 0.0 109.229 -179.913 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . 0.604 ' HA ' ' O ' ' A' ' 160' ' ' ARG . . . -112.46 166.17 11.56 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.434 1.084 . . . . 0.0 109.286 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . 0.442 ' HA ' ' O ' ' A' ' 178' ' ' LYS . 18.9 mt-10 -116.13 120.87 40.43 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.523 1.139 . . . . 0.0 110.256 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . 0.725 ' HA ' HD23 ' A' ' 159' ' ' LEU . 1.1 p30 -74.77 -173.4 1.84 Allowed 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.521 1.138 . . . . 0.0 109.321 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 22.6 t -79.83 63.24 4.32 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.507 1.129 . . . . 0.0 110.048 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -174.25 9.78 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.553 1.158 . . . . 0.0 110.309 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 68.69 19.49 73.2 Favored Glycine 0 CA--C 1.531 1.08 0 O-C-N 124.57 1.169 . . . . 0.0 110.986 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 178' ' ' LYS . . . . . 0.442 ' O ' ' HA ' ' A' ' 173' ' ' GLU . 0.1 OUTLIER -94.29 112.32 24.11 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 124.583 0.813 . . . . 0.0 109.228 -179.945 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 179' ' ' ARG . . . . . 0.471 ' HA ' ' O ' ' A' ' 172' ' ' ALA . 0.1 OUTLIER -96.69 124.6 40.73 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.548 1.155 . . . . 0.0 110.324 179.915 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -149.9 164.87 29.65 Favored Glycine 0 CA--C 1.531 1.092 0 O-C-N 124.531 1.144 . . . . 0.0 110.947 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 181' ' ' MET . . . . . 0.469 ' HE3' ' HB2' ' A' ' 171' ' ' ASN . 0.3 OUTLIER -88.98 100.98 13.63 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.57 0.806 . . . . 0.0 111.005 179.992 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . 0.505 HG22 ' HB3' ' A' ' 151' ' ' LEU . 0.2 OUTLIER -108.52 174.09 2.64 Favored Pre-proline 0 C--N 1.325 -0.488 0 O-C-N 124.436 1.085 . . . . 0.0 109.311 -179.999 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 183' ' ' PRO . . . . . 0.601 ' HB2' ' CD1' ' A' ' 186' ' ' TYR . 18.5 Cg_endo -74.95 129.21 12.17 Favored 'Trans proline' 0 C--N 1.36 1.132 0 O-C-N 124.535 1.808 . . . . 0.0 111.014 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . 0.816 ' N ' ' CD ' ' A' ' 185' ' ' PRO . 38.7 t -78.91 -32.94 0.83 Allowed Pre-proline 0 C--N 1.325 -0.459 0 O-C-N 124.473 1.108 . . . . 0.0 109.358 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 185' ' ' PRO . . . . . 0.816 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.6 Cg_endo -75.02 -13.84 21.25 Favored 'Trans proline' 0 C--N 1.361 1.189 0 O-C-N 124.45 1.763 . . . . 0.0 111.033 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 186' ' ' TYR . . . . . 0.601 ' CD1' ' HB2' ' A' ' 183' ' ' PRO . 7.9 m-85 -93.93 10.59 32.74 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.514 1.134 . . . . 0.0 110.985 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 187' ' ' VAL . . . . . 0.531 ' HA ' ' O ' ' A' ' 138' ' ' ARG . 20.3 m -143.12 165.01 15.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 O-C-N 124.503 1.127 . . . . 0.0 109.311 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . 0.519 ' O ' ' CG2' ' A' ' 137' ' ' VAL . 0.0 OUTLIER -120.42 159.61 24.76 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.512 1.132 . . . . 0.0 110.303 -179.995 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -86.59 134.17 33.66 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.519 1.137 . . . . 0.0 109.292 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -111.53 86.41 2.33 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.53 1.144 . . . . 0.0 111.028 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 1.0 0 O-C-N 124.501 1.126 . . . . 0.0 110.993 -179.989 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' CYS . . . . . 0.475 ' N ' ' O ' ' A' ' 190' ' ' TYR . 26.9 p . . . . . 0 N--CA 1.453 -0.319 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 96.9 -49.57 1.56 Allowed Glycine 0 CA--C 1.529 0.963 0 O-C-N 124.505 1.128 . . . . 0.0 110.988 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -61.32 -150.52 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.454 0.737 . . . . 0.0 109.243 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.526 ' O ' ' HG2' ' A' ' 160' ' ' ARG . 0.4 OUTLIER -142.63 73.16 1.39 Allowed 'General case' 0 C--N 1.326 -0.427 0 O-C-N 124.424 1.078 . . . . 0.0 110.285 -179.979 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 39.2 m-85 -128.82 126.91 40.85 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.459 1.099 . . . . 0.0 110.984 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.796 HG22 ' O ' ' A' ' 159' ' ' LEU . 28.5 m -121.06 170.03 11.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 O-C-N 124.535 1.147 . . . . 0.0 109.334 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . 0.494 ' O ' ' HA ' ' A' ' 187' ' ' VAL . 5.1 ttm180 -133.91 127.64 32.91 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.498 1.124 . . . . 0.0 110.306 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.597 ' O ' ' N ' ' A' ' 156' ' ' GLY . . . -93.5 115.58 28.1 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.582 1.176 . . . . 0.0 109.27 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.989 HD21 ' OE2' ' A' ' 188' ' ' GLU . 0.2 OUTLIER -95.22 -19.58 19.92 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.545 1.153 . . . . 0.0 109.338 179.908 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . 0.444 ' O ' ' O ' ' A' ' 154' ' ' LYS . 5.8 m-85 -114.45 147.52 39.16 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.45 1.094 . . . . 0.0 110.96 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . 0.461 ' HB3' ' HA ' ' A' ' 154' ' ' LYS . 0.0 OUTLIER -89.5 138.84 31.11 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.476 1.11 . . . . 0.0 109.275 179.991 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' PHE . . . . . 0.69 ' O ' ' CZ ' ' A' ' 153' ' ' PHE . 0.1 OUTLIER 172.17 82.04 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.575 1.172 . . . . 0.0 110.962 179.966 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . 0.469 ' HA ' ' HA ' ' A' ' 152' ' ' PRO . 33.3 p-10 -43.54 163.9 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.518 1.136 . . . . 0.0 109.317 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . 0.454 ' N ' ' OD1' ' A' ' 150' ' ' ASP . . . -77.47 -156.79 8.27 Favored Glycine 0 CA--C 1.53 0.996 0 O-C-N 124.521 1.138 . . . . 0.0 111.067 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 22.2 t-20 177.24 72.08 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.547 0.792 . . . . 0.0 109.285 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . 0.429 ' N ' ' OD1' ' A' ' 147' ' ' ASP . 0.0 OUTLIER -163.14 -162.07 0.73 Allowed 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.453 1.096 . . . . 0.0 109.295 179.992 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.444 ' O ' ' CB ' ' A' ' 149' ' ' GLU . 0.6 OUTLIER -70.73 52.1 0.14 Allowed 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.436 1.085 . . . . 0.0 110.278 179.994 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . 0.458 ' O ' ' O ' ' A' ' 150' ' ' ASP . 0.2 OUTLIER 164.41 -58.59 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.462 1.101 . . . . 0.0 110.291 -179.958 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . 0.458 ' O ' ' O ' ' A' ' 149' ' ' GLU . 1.4 t0 60.22 134.15 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.587 1.179 . . . . 0.0 109.261 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.86 HD11 ' OD2' ' A' ' 174' ' ' ASP . 1.0 OUTLIER -119.79 103.82 45.38 Favored Pre-proline 0 C--N 1.325 -0.467 0 O-C-N 124.481 1.113 . . . . 0.0 109.339 179.985 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . 0.469 ' HA ' ' HA ' ' A' ' 144' ' ' ASN . 18.0 Cg_endo -75.04 117.95 5.08 Favored 'Trans proline' 0 C--N 1.36 1.146 0 O-C-N 124.559 1.82 . . . . 0.0 111.041 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . 0.69 ' CZ ' ' O ' ' A' ' 143' ' ' PHE . 20.9 p90 -137.91 169.87 17.03 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.561 1.163 . . . . 0.0 110.947 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . 0.461 ' HA ' ' HB3' ' A' ' 142' ' ' ASP . 3.4 tttt -130.0 -120.92 0.22 Allowed 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.46 1.1 . . . . 0.0 109.317 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.52 ' CB ' ' O ' ' A' ' 140' ' ' LEU . 0.3 OUTLIER -126.65 118.22 24.34 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.559 1.162 . . . . 0.0 109.315 179.976 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . 0.597 ' N ' ' O ' ' A' ' 139' ' ' ALA . . . 98.16 19.61 23.18 Favored Glycine 0 CA--C 1.53 1.004 0 O-C-N 124.513 1.133 . . . . 0.0 111.012 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -91.45 157.04 17.28 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.54 0.788 . . . . 0.0 109.291 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 12.8 mm -113.19 141.04 30.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 O-C-N 124.486 1.116 . . . . 0.0 109.298 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.796 ' O ' HG22 ' A' ' 137' ' ' VAL . 7.2 mt -145.3 124.95 13.26 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.503 1.127 . . . . 0.0 109.316 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . 0.572 ' O ' ' HA ' ' A' ' 172' ' ' ALA . 0.0 OUTLIER -87.68 135.21 33.46 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.42 1.075 . . . . 0.0 110.342 179.99 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.466 HD13 HG13 ' A' ' 137' ' ' VAL . 1.4 mp -83.0 119.37 32.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 O-C-N 124.428 1.08 . . . . 0.0 109.286 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.56 -46.35 2.58 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.573 1.17 . . . . 0.0 110.309 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . 0.458 ' CB ' ' HB3' ' A' ' 171' ' ' ASN . 0.1 OUTLIER -134.94 179.59 6.22 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.564 1.165 . . . . 0.0 109.264 179.998 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . 0.599 ' HB2' ' CD1' ' A' ' 170' ' ' TRP . 0.0 OUTLIER -170.82 91.97 0.46 Allowed Pre-proline 0 C--N 1.326 -0.432 0 O-C-N 124.462 1.101 . . . . 0.0 109.311 -179.994 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.03 -26.35 10.95 Favored 'Trans proline' 0 C--N 1.362 1.239 0 O-C-N 124.513 1.796 . . . . 0.0 111.023 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -126.26 166.27 17.42 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.508 1.13 . . . . 0.0 110.24 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -86.54 -26.09 24.72 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.501 1.126 . . . . 0.0 110.299 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 4.4 mt-30 -78.02 -56.58 4.37 Favored 'General case' 0 C--N 1.324 -0.524 0 O-C-N 124.568 1.167 . . . . 0.0 110.316 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' TRP . . . . . . . . . . . . . 9.2 m95 -104.87 145.83 29.85 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' TRP . . . . . 0.8 ' CD2' HG21 ' A' ' 184' ' ' VAL . 30.8 m0 -122.44 151.43 41.28 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.564 1.165 . . . . 0.0 108.034 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' ASN . . . . . 0.458 ' HB3' ' CB ' ' A' ' 163' ' ' ASP . 2.7 t30 -86.44 96.19 9.95 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.544 1.153 . . . . 0.0 109.289 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . 0.572 ' HA ' ' O ' ' A' ' 160' ' ' ARG . . . -107.26 166.65 10.48 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.496 1.123 . . . . 0.0 109.259 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . 0.475 ' HA ' ' O ' ' A' ' 178' ' ' LYS . 34.3 mt-10 -126.03 126.25 43.95 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.503 1.127 . . . . 0.0 110.31 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . 0.86 ' OD2' HD11 ' A' ' 151' ' ' LEU . 1.1 m-20 -79.48 -174.57 4.3 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.521 1.138 . . . . 0.0 109.277 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 38.4 t -77.74 56.27 1.48 Allowed 'General case' 0 C--N 1.324 -0.528 0 O-C-N 124.584 1.178 . . . . 0.0 109.964 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . 0.458 ' CB ' ' HD2' ' A' ' 178' ' ' LYS . 0.0 OUTLIER -167.68 16.68 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.466 1.104 . . . . 0.0 110.298 179.925 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 62.57 15.13 52.73 Favored Glycine 0 CA--C 1.53 0.983 0 O-C-N 124.503 1.127 . . . . 0.0 110.992 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 178' ' ' LYS . . . . . 0.492 ' CG ' ' HB2' ' A' ' 174' ' ' ASP . 1.5 ptmm? -86.04 108.15 18.12 Favored 'General case' 0 C--N 1.326 -0.429 0 O-C-N 124.469 0.747 . . . . 0.0 109.334 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 179' ' ' ARG . . . . . 0.46 ' HA ' ' O ' ' A' ' 172' ' ' ALA . 0.0 OUTLIER -96.11 127.82 42.47 Favored 'General case' 0 C--N 1.324 -0.523 0 O-C-N 124.51 1.131 . . . . 0.0 110.284 -179.961 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -152.27 165.84 30.94 Favored Glycine 0 CA--C 1.53 0.993 0 O-C-N 124.511 1.132 . . . . 0.0 111.021 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 181' ' ' MET . . . . . 0.456 ' HA ' ' O ' ' A' ' 170' ' ' TRP . 25.4 mtp -88.41 105.32 17.52 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.488 0.758 . . . . 0.0 110.98 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . 0.847 HG22 ' HB3' ' A' ' 151' ' ' LEU . 0.0 OUTLIER -110.15 164.11 15.6 Favored Pre-proline 0 C--N 1.324 -0.536 0 O-C-N 124.514 1.134 . . . . 0.0 109.359 179.956 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 183' ' ' PRO . . . . . 0.638 ' HG2' ' HB2' ' A' ' 186' ' ' TYR . 18.3 Cg_endo -74.99 128.85 11.82 Favored 'Trans proline' 0 C--N 1.36 1.169 0 O-C-N 124.51 1.795 . . . . 0.0 111.048 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . 0.812 ' N ' ' CD ' ' A' ' 185' ' ' PRO . 59.8 t -76.87 -32.96 1.06 Allowed Pre-proline 0 C--N 1.324 -0.506 0 O-C-N 124.576 1.173 . . . . 0.0 109.266 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 185' ' ' PRO . . . . . 0.812 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.5 Cg_endo -74.99 -14.57 21.13 Favored 'Trans proline' 0 C--N 1.36 1.15 0 O-C-N 124.485 1.782 . . . . 0.0 111.048 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 186' ' ' TYR . . . . . 0.638 ' HB2' ' HG2' ' A' ' 183' ' ' PRO . 6.3 m-85 -96.26 5.01 51.93 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.522 1.139 . . . . 0.0 111.001 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 187' ' ' VAL . . . . . 0.494 ' HA ' ' O ' ' A' ' 138' ' ' ARG . 12.6 m -135.81 165.02 30.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 O-C-N 124.499 1.124 . . . . 0.0 109.248 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . 0.989 ' OE2' HD21 ' A' ' 140' ' ' LEU . 0.3 OUTLIER -115.03 153.22 31.07 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.475 1.11 . . . . 0.0 110.277 -179.984 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . 0.446 ' NZ ' HG13 ' A' ' 184' ' ' VAL . 0.0 OUTLIER -88.54 137.01 32.7 Favored 'General case' 0 C--N 1.326 -0.436 0 O-C-N 124.505 1.128 . . . . 0.0 109.334 179.99 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 190' ' ' TYR . . . . . 0.565 ' O ' ' C ' ' A' ' 191' ' ' GLY . 3.4 m-85 -136.81 -86.22 0.32 Allowed 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.57 1.169 . . . . 0.0 110.987 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . 0.565 ' C ' ' O ' ' A' ' 190' ' ' TYR . . . . . . . . 0 CA--C 1.53 1.01 0 O-C-N 124.627 1.204 . . . . 0.0 111.077 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' CYS . . . . . 0.466 ' O ' ' O ' ' A' ' 191' ' ' GLY . 15.5 p . . . . . 0 N--CA 1.452 -0.339 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . 0.503 ' O ' ' HB3' ' A' ' 134' ' ' ALA . . . -65.9 -149.45 0.09 OUTLIER Glycine 0 CA--C 1.53 0.994 0 O-C-N 124.541 1.151 . . . . 0.0 110.994 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . 0.503 ' HB3' ' O ' ' A' ' 133' ' ' GLY . . . 71.97 -157.13 0.1 Allowed 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.454 0.738 . . . . 0.0 109.317 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.523 ' CB ' ' O ' ' A' ' 161' ' ' ILE . 25.3 mp0 -148.6 76.41 1.35 Allowed 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.481 1.113 . . . . 0.0 110.379 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 76.0 m-85 -126.66 125.07 41.27 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.512 1.133 . . . . 0.0 111.021 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.528 HG13 HD13 ' A' ' 161' ' ' ILE . 7.5 m -131.84 141.26 46.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 O-C-N 124.533 1.145 . . . . 0.0 109.336 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . 0.547 ' HD2' ' CE1' ' A' ' 190' ' ' TYR . 0.8 OUTLIER -115.58 137.5 52.0 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.57 1.169 . . . . 0.0 110.261 -179.956 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.683 ' HB3' ' OD1' ' A' ' 157' ' ' ASP . . . -92.56 115.6 28.25 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.501 1.126 . . . . 0.0 109.273 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.852 HD21 ' OE2' ' A' ' 188' ' ' GLU . 0.2 OUTLIER -87.44 -8.41 56.53 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.495 1.122 . . . . 0.0 109.331 179.993 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . 0.57 ' CE1' ' HB2' ' A' ' 140' ' ' LEU . 0.4 OUTLIER -128.04 144.31 51.1 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.494 1.121 . . . . 0.0 111.004 179.991 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . 0.421 ' CB ' ' HA ' ' A' ' 154' ' ' LYS . 0.9 OUTLIER -93.3 157.39 16.27 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.55 1.156 . . . . 0.0 109.242 -179.984 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' PHE . . . . . 0.574 ' HB3' ' CZ ' ' A' ' 153' ' ' PHE . 0.0 OUTLIER -149.43 -40.03 0.15 Allowed 'General case' 0 C--N 1.326 -0.42 0 O-C-N 124.479 1.112 . . . . 0.0 111.008 -179.987 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . 0.479 ' O ' ' CE1' ' A' ' 143' ' ' PHE . 37.4 m-80 55.42 175.0 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.435 0 O-C-N 124.418 1.074 . . . . 0.0 109.295 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . 0.44 ' N ' ' HB3' ' A' ' 152' ' ' PRO . . . 162.32 -170.09 37.83 Favored Glycine 0 CA--C 1.53 0.979 0 O-C-N 124.426 1.079 . . . . 0.0 111.035 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 12.2 p-10 171.17 74.02 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.47 0.747 . . . . 0.0 109.3 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -97.3 -84.67 0.37 Allowed 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.445 1.091 . . . . 0.0 109.32 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 177.51 36.73 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.49 1.119 . . . . 0.0 110.308 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 170.07 -39.04 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.476 1.11 . . . . 0.0 110.334 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -52.18 167.37 0.13 Allowed 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.478 1.112 . . . . 0.0 109.314 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.958 HD23 HG23 ' A' ' 182' ' ' ILE . 12.5 tp -130.55 107.34 15.77 Favored Pre-proline 0 C--N 1.324 -0.51 0 O-C-N 124.496 1.122 . . . . 0.0 109.265 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . 0.44 ' HB3' ' N ' ' A' ' 145' ' ' GLY . 18.3 Cg_endo -75.0 172.02 17.18 Favored 'Trans proline' 0 C--N 1.36 1.166 0 O-C-N 124.552 1.817 . . . . 0.0 111.012 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . 0.574 ' CZ ' ' HB3' ' A' ' 143' ' ' PHE . 24.4 p90 -169.5 176.7 4.92 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.516 1.135 . . . . 0.0 111.046 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . 0.421 ' HA ' ' CB ' ' A' ' 142' ' ' ASP . 0.6 OUTLIER -119.76 -155.56 0.62 Allowed 'General case' 0 C--N 1.326 -0.438 0 O-C-N 124.479 1.112 . . . . 0.0 109.296 -179.992 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 1.1 tttp -111.96 98.78 7.6 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.473 1.108 . . . . 0.0 109.314 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . 0.645 ' N ' ' O ' ' A' ' 139' ' ' ALA . . . 115.55 25.75 3.62 Favored Glycine 0 CA--C 1.529 0.967 0 O-C-N 124.525 1.141 . . . . 0.0 111.038 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . 0.863 ' C ' HD12 ' A' ' 158' ' ' ILE . 3.4 p-10 -99.13 166.85 11.05 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.438 0.728 . . . . 0.0 109.28 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . 0.863 HD12 ' C ' ' A' ' 157' ' ' ASP . 2.1 mp -122.5 150.88 26.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 O-C-N 124.422 1.076 . . . . 0.0 109.268 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.902 HD21 ' CG ' ' A' ' 174' ' ' ASP . 0.4 OUTLIER -151.94 134.84 15.65 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.482 1.114 . . . . 0.0 109.336 179.988 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . 0.48 ' O ' ' HB1' ' A' ' 172' ' ' ALA . 0.1 OUTLIER -93.53 127.56 39.25 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.431 1.082 . . . . 0.0 110.314 -179.981 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.528 HD13 HG13 ' A' ' 137' ' ' VAL . 1.6 mp -85.67 121.49 37.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 O-C-N 124.48 1.112 . . . . 0.0 109.362 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . 0.429 ' CD ' ' HB2' ' A' ' 163' ' ' ASP . 0.2 OUTLIER -119.99 -32.21 4.26 Favored 'General case' 0 C--N 1.326 -0.431 0 O-C-N 124.425 1.078 . . . . 0.0 110.289 -179.976 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . 0.448 ' CB ' ' HB3' ' A' ' 171' ' ' ASN . 0.4 OUTLIER -139.8 171.34 14.36 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.554 1.159 . . . . 0.0 109.299 179.985 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . 0.573 ' HB2' ' CD1' ' A' ' 170' ' ' TRP . 0.5 OUTLIER -156.8 82.62 3.26 Favored Pre-proline 0 C--N 1.325 -0.476 0 O-C-N 124.496 1.123 . . . . 0.0 109.312 -179.939 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -74.9 -25.71 11.83 Favored 'Trans proline' 0 C--N 1.359 1.129 0 O-C-N 124.438 1.757 . . . . 0.0 111.075 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 9.6 mt-10 -111.64 169.01 9.11 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.464 1.102 . . . . 0.0 110.317 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -90.98 -32.04 16.1 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.544 1.153 . . . . 0.0 110.296 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . 0.437 ' HB3' ' CD1' ' A' ' 169' ' ' TRP . 6.6 mt-30 -87.3 -53.45 4.83 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.552 1.158 . . . . 0.0 110.31 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' TRP . . . . . 0.473 ' N ' ' CD1' ' A' ' 169' ' ' TRP . 1.6 m95 -104.8 148.18 26.91 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.546 1.154 . . . . 0.0 107.972 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' TRP . . . . . 0.585 ' CE2' HG21 ' A' ' 184' ' ' VAL . 36.9 m0 -125.38 159.67 31.26 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.558 1.161 . . . . 0.0 108.05 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' ASN . . . . . 0.448 ' HB3' ' CB ' ' A' ' 163' ' ' ASP . 23.6 t-20 -86.14 109.5 18.92 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.511 1.132 . . . . 0.0 109.289 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . 0.48 ' HB1' ' O ' ' A' ' 160' ' ' ARG . . . -122.82 176.92 5.71 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.457 1.098 . . . . 0.0 109.323 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . 0.5 ' CG ' ' HG2' ' A' ' 179' ' ' ARG . 7.1 mt-10 -116.36 119.74 36.64 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.453 1.096 . . . . 0.0 110.357 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . 0.902 ' CG ' HD21 ' A' ' 159' ' ' LEU . 1.7 m-20 -74.66 -175.93 2.62 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.508 1.13 . . . . 0.0 109.361 179.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 98.2 p -76.74 58.93 1.49 Allowed 'General case' 0 C--N 1.324 -0.531 0 O-C-N 124.506 1.129 . . . . 0.0 109.99 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . 0.409 ' H ' ' H ' ' A' ' 177' ' ' GLY . 0.4 OUTLIER -170.93 -2.22 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.52 0 O-C-N 124.515 1.134 . . . . 0.0 110.333 -179.986 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . 0.409 ' H ' ' H ' ' A' ' 176' ' ' GLU . . . 79.16 19.58 71.9 Favored Glycine 0 CA--C 1.53 1.012 0 O-C-N 124.524 1.14 . . . . 0.0 111.037 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 178' ' ' LYS . . . . . 0.497 ' CG ' ' HB2' ' A' ' 174' ' ' ASP . 2.1 ptpp? -91.88 121.26 33.31 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.499 0.764 . . . . 0.0 109.331 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 179' ' ' ARG . . . . . 0.5 ' HG2' ' CG ' ' A' ' 173' ' ' GLU . 21.1 mtt85 -89.81 122.44 32.88 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.475 1.109 . . . . 0.0 110.275 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . 0.649 ' CA ' HD22 ' A' ' 151' ' ' LEU . . . -152.02 167.04 31.11 Favored Glycine 0 CA--C 1.531 1.037 0 O-C-N 124.486 1.117 . . . . 0.0 110.972 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 181' ' ' MET . . . . . 0.473 ' HA ' ' O ' ' A' ' 170' ' ' TRP . 33.8 mtp -87.97 103.5 15.75 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.471 0.748 . . . . 0.0 110.988 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . 0.958 HG23 HD23 ' A' ' 151' ' ' LEU . 8.2 pt -98.7 157.12 34.79 Favored Pre-proline 0 C--N 1.324 -0.528 0 O-C-N 124.526 1.141 . . . . 0.0 109.281 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 183' ' ' PRO . . . . . 0.717 ' HG2' ' HB2' ' A' ' 186' ' ' TYR . 18.4 Cg_endo -75.0 135.27 18.85 Favored 'Trans proline' 0 C--N 1.36 1.148 0 O-C-N 124.495 1.787 . . . . 0.0 111.029 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . 0.816 ' N ' ' CD ' ' A' ' 185' ' ' PRO . 62.8 t -81.74 -32.45 0.61 Allowed Pre-proline 0 C--N 1.324 -0.501 0 O-C-N 124.547 1.155 . . . . 0.0 109.359 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 185' ' ' PRO . . . . . 0.816 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.5 Cg_endo -74.98 -25.35 11.97 Favored 'Trans proline' 0 C--N 1.36 1.159 0 O-C-N 124.508 1.794 . . . . 0.0 111.011 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 186' ' ' TYR . . . . . 0.717 ' HB2' ' HG2' ' A' ' 183' ' ' PRO . 3.8 m-85 -93.48 14.43 18.69 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.504 1.127 . . . . 0.0 111.068 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 187' ' ' VAL . . . . . 0.694 HG22 ' O ' ' A' ' 183' ' ' PRO . 21.4 m -138.22 163.69 28.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 O-C-N 124.525 1.14 . . . . 0.0 109.272 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . 0.852 ' OE2' HD21 ' A' ' 140' ' ' LEU . 0.0 OUTLIER -126.07 167.62 15.1 Favored 'General case' 0 C--N 1.326 -0.416 0 O-C-N 124.431 1.082 . . . . 0.0 110.335 179.958 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -87.5 125.39 34.28 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.508 1.13 . . . . 0.0 109.251 -179.9 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 190' ' ' TYR . . . . . 0.547 ' CE1' ' HD2' ' A' ' 138' ' ' ARG . 0.1 OUTLIER -109.32 81.61 1.47 Allowed 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.444 1.09 . . . . 0.0 111.034 179.948 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . 0.466 ' O ' ' O ' ' A' ' 132' ' ' CYS . . . . . . . . 0 CA--C 1.531 1.048 0 O-C-N 124.443 1.089 . . . . 0.0 110.93 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' CYS . . . . . . . . . . . . . 5.8 t . . . . . 0 N--CA 1.452 -0.342 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -127.4 149.88 17.98 Favored Glycine 0 CA--C 1.53 1.022 0 O-C-N 124.474 1.109 . . . . 0.0 110.976 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . 48.73 -157.2 0.07 Allowed 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.449 0.735 . . . . 0.0 109.297 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.442 ' HB2' ' HB ' ' A' ' 161' ' ' ILE . 0.2 OUTLIER -120.16 60.65 0.87 Allowed 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.492 1.12 . . . . 0.0 110.294 179.981 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . 0.582 ' C ' ' CD1' ' A' ' 136' ' ' TYR . 0.4 OUTLIER -121.97 143.0 49.73 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.493 1.121 . . . . 0.0 110.978 179.998 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.834 HG22 ' O ' ' A' ' 159' ' ' LEU . 35.1 m -145.03 137.45 21.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 O-C-N 124.431 1.082 . . . . 0.0 109.243 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . 0.447 ' HB3' ' HG3' ' A' ' 188' ' ' GLU . 0.6 OUTLIER -105.07 133.98 48.93 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.466 1.104 . . . . 0.0 110.285 -179.993 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.578 ' HB2' HD11 ' A' ' 159' ' ' LEU . . . -95.97 112.57 24.27 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.56 1.163 . . . . 0.0 109.305 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.955 HD21 ' OE2' ' A' ' 188' ' ' GLU . 0.2 OUTLIER -98.5 -9.48 24.97 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.561 1.163 . . . . 0.0 109.325 -179.971 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . 0.495 ' C ' ' O ' ' A' ' 154' ' ' LYS . 14.3 m-85 -109.22 152.02 25.74 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.448 1.093 . . . . 0.0 111.062 179.906 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . 0.502 ' CA ' ' O ' ' A' ' 154' ' ' LYS . 3.3 t70 -106.9 149.53 27.36 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.551 1.157 . . . . 0.0 109.353 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' PHE . . . . . 0.579 ' HB3' ' CZ ' ' A' ' 153' ' ' PHE . 8.0 t80 -174.28 25.4 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.419 1.074 . . . . 0.0 110.965 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . 0.542 ' C ' ' HA ' ' A' ' 152' ' ' PRO . 16.9 p30 36.67 -157.5 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.563 1.165 . . . . 0.0 109.279 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . 0.473 ' N ' ' OD1' ' A' ' 144' ' ' ASN . . . 164.2 112.77 0.28 Allowed Glycine 0 CA--C 1.53 0.987 0 O-C-N 124.564 1.165 . . . . 0.0 110.988 -179.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 -159.97 52.4 0.33 Allowed 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.459 0.74 . . . . 0.0 109.316 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 60.5 m-20 -162.49 149.16 13.14 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.503 1.127 . . . . 0.0 109.336 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 42.41 35.49 0.64 Allowed 'General case' 0 C--N 1.326 -0.447 0 O-C-N 124.43 1.081 . . . . 0.0 110.344 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 60.7 47.97 7.62 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.54 1.15 . . . . 0.0 110.268 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -84.54 146.97 27.28 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.446 1.091 . . . . 0.0 109.32 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.716 HD23 ' OD1' ' A' ' 174' ' ' ASP . 1.1 mp -92.16 112.7 56.33 Favored Pre-proline 0 C--N 1.325 -0.487 0 O-C-N 124.499 1.124 . . . . 0.0 109.328 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . 0.542 ' HA ' ' C ' ' A' ' 144' ' ' ASN . 18.4 Cg_endo -74.98 138.88 23.65 Favored 'Trans proline' 0 C--N 1.359 1.104 0 O-C-N 124.505 1.792 . . . . 0.0 110.977 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . 0.579 ' CZ ' ' HB3' ' A' ' 143' ' ' PHE . 11.7 p90 -151.82 170.2 20.37 Favored 'General case' 0 C--N 1.326 -0.437 0 O-C-N 124.441 1.088 . . . . 0.0 110.922 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . 0.502 ' O ' ' CA ' ' A' ' 142' ' ' ASP . 0.0 OUTLIER -127.02 -80.73 0.6 Allowed 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.484 1.115 . . . . 0.0 109.303 -179.979 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -165.77 115.51 1.01 Allowed 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.538 1.149 . . . . 0.0 109.34 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . 0.499 ' N ' ' O ' ' A' ' 139' ' ' ALA . . . 100.38 20.83 14.27 Favored Glycine 0 CA--C 1.53 1.017 0 O-C-N 124.437 1.086 . . . . 0.0 111.049 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . 0.422 ' HB3' ' HB3' ' A' ' 139' ' ' ALA . 23.1 t70 -84.59 155.23 22.14 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.488 0.757 . . . . 0.0 109.32 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . 0.48 HG23 ' CE2' ' A' ' 136' ' ' TYR . 13.1 mm -105.1 133.78 48.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 O-C-N 124.417 1.073 . . . . 0.0 109.342 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.834 ' O ' HG22 ' A' ' 137' ' ' VAL . 0.4 OUTLIER -142.96 124.93 15.19 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.538 1.149 . . . . 0.0 109.286 -179.976 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . 0.672 ' O ' ' HA ' ' A' ' 172' ' ' ALA . 0.0 OUTLIER -94.65 141.01 29.11 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.529 1.143 . . . . 0.0 110.271 179.992 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.442 ' HB ' ' HB2' ' A' ' 135' ' ' GLU . 19.9 mm -84.28 114.71 25.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 O-C-N 124.533 1.145 . . . . 0.0 109.313 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.47 -52.59 2.75 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.491 1.119 . . . . 0.0 110.293 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 11.8 t0 -136.34 174.7 10.33 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.451 1.094 . . . . 0.0 109.284 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . 0.564 ' HB2' ' CD1' ' A' ' 170' ' ' TRP . 0.0 OUTLIER -167.1 89.16 0.75 Allowed Pre-proline 0 C--N 1.325 -0.499 0 O-C-N 124.472 1.108 . . . . 0.0 109.299 -179.99 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.04 -34.2 3.97 Favored 'Trans proline' 0 C--N 1.36 1.166 0 O-C-N 124.532 1.806 . . . . 0.0 110.952 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -107.8 170.13 8.18 Favored 'General case' 0 C--N 1.324 -0.532 0 O-C-N 124.542 1.151 . . . . 0.0 110.28 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 18.7 pt-20 -95.36 -15.56 22.98 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.471 1.107 . . . . 0.0 110.355 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . 0.445 ' HG2' ' CD1' ' A' ' 169' ' ' TRP . 20.5 tt0 -92.41 -56.29 3.09 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.502 1.126 . . . . 0.0 110.333 179.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 169' ' ' TRP . . . . . 0.445 ' CD1' ' HG2' ' A' ' 168' ' ' GLN . 32.4 m95 -105.61 140.34 38.83 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.449 1.093 . . . . 0.0 108.064 179.934 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 170' ' ' TRP . . . . . 0.712 ' CD2' HG21 ' A' ' 184' ' ' VAL . 53.1 m0 -120.02 152.78 36.99 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.523 1.139 . . . . 0.0 107.98 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 171' ' ' ASN . . . . . 0.448 ' HA ' ' O ' ' A' ' 180' ' ' GLY . 0.1 OUTLIER -88.04 97.34 10.91 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.493 1.121 . . . . 0.0 109.268 179.976 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . 0.672 ' HA ' ' O ' ' A' ' 160' ' ' ARG . . . -107.47 173.17 6.44 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.51 1.131 . . . . 0.0 109.342 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . 0.442 ' O ' ' HA ' ' A' ' 159' ' ' LEU . 18.1 mt-10 -118.94 120.08 36.21 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.517 1.136 . . . . 0.0 110.329 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . 0.716 ' OD1' HD23 ' A' ' 151' ' ' LEU . 0.1 OUTLIER -74.34 -169.92 0.89 Allowed 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.468 1.105 . . . . 0.0 109.297 -179.952 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 72.6 p -81.3 59.79 4.11 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.441 1.088 . . . . 0.0 110.004 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 177.61 25.48 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.484 1.115 . . . . 0.0 110.266 -179.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 57.79 19.2 35.2 Favored Glycine 0 CA--C 1.531 1.043 0 O-C-N 124.534 1.146 . . . . 0.0 110.997 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 178' ' ' LYS . . . . . 0.52 ' O ' HD21 ' A' ' 151' ' ' LEU . 6.6 mtmt -81.28 104.06 11.49 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.504 0.767 . . . . 0.0 109.293 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 179' ' ' ARG . . . . . 0.45 ' HA ' ' O ' ' A' ' 172' ' ' ALA . 4.7 ttp180 -90.46 118.75 30.18 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.528 1.143 . . . . 0.0 110.288 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . 0.621 ' HA3' HD13 ' A' ' 151' ' ' LEU . . . -152.25 168.86 31.47 Favored Glycine 0 CA--C 1.531 1.032 0 O-C-N 124.612 1.195 . . . . 0.0 111.04 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 181' ' ' MET . . . . . 0.461 ' HA ' ' O ' ' A' ' 170' ' ' TRP . 1.5 mmm -85.98 106.76 17.38 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.546 0.792 . . . . 0.0 110.961 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . 0.505 ' CG2' ' HB2' ' A' ' 151' ' ' LEU . 1.4 pp -110.41 162.12 21.81 Favored Pre-proline 0 C--N 1.326 -0.446 0 O-C-N 124.515 1.134 . . . . 0.0 109.278 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 183' ' ' PRO . . . . . 0.705 ' HG2' ' HB2' ' A' ' 186' ' ' TYR . 18.6 Cg_endo -74.99 132.56 15.58 Favored 'Trans proline' 0 C--N 1.36 1.162 0 O-C-N 124.508 1.794 . . . . 0.0 111.05 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . 0.807 ' N ' ' CD ' ' A' ' 185' ' ' PRO . 62.1 t -78.94 -32.45 0.79 Allowed Pre-proline 0 C--N 1.324 -0.527 0 O-C-N 124.568 1.168 . . . . 0.0 109.332 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 185' ' ' PRO . . . . . 0.807 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.4 Cg_endo -74.96 -17.44 19.65 Favored 'Trans proline' 0 C--N 1.36 1.156 0 O-C-N 124.438 1.757 . . . . 0.0 111.006 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 186' ' ' TYR . . . . . 0.705 ' HB2' ' HG2' ' A' ' 183' ' ' PRO . 3.5 m-30 -97.25 17.7 16.72 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.496 1.123 . . . . 0.0 110.972 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 187' ' ' VAL . . . . . 0.43 HG12 ' CB ' ' A' ' 139' ' ' ALA . 16.7 m -145.44 173.61 3.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 O-C-N 124.515 1.134 . . . . 0.0 109.359 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . 0.955 ' OE2' HD21 ' A' ' 140' ' ' LEU . 0.1 OUTLIER -127.95 159.6 34.47 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.504 1.127 . . . . 0.0 110.245 -179.962 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 7.4 mmmm -88.18 135.84 33.25 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.433 1.083 . . . . 0.0 109.306 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 8.9 t80 -38.54 -62.8 0.56 Allowed 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.456 1.098 . . . . 0.0 111.02 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.977 0 O-C-N 124.531 1.144 . . . . 0.0 110.962 179.981 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' CYS . . . . . . . . . . . . . 52.4 m . . . . . 0 N--CA 1.452 -0.364 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -147.04 -90.31 0.09 OUTLIER Glycine 0 CA--C 1.53 1.01 0 O-C-N 124.485 1.116 . . . . 0.0 111.022 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . 0.42 ' C ' ' HG2' ' A' ' 135' ' ' GLU . . . -156.14 -78.13 0.09 Allowed 'General case' 0 C--N 1.326 -0.443 0 O-C-N 124.558 0.799 . . . . 0.0 109.299 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.459 ' CB ' ' HB ' ' A' ' 161' ' ' ILE . 1.5 mt-10 -145.16 44.03 1.32 Allowed 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.49 1.119 . . . . 0.0 110.248 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . 0.513 ' CE1' ' HB2' ' A' ' 160' ' ' ARG . 26.0 m-85 -86.86 106.55 17.82 Favored 'General case' 0 C--N 1.324 -0.527 0 O-C-N 124.491 1.119 . . . . 0.0 110.946 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.604 ' HA ' ' O ' ' A' ' 188' ' ' GLU . 19.8 m -117.19 138.39 48.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 O-C-N 124.502 1.126 . . . . 0.0 109.301 179.943 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . 0.43 ' HG2' ' CG ' ' A' ' 188' ' ' GLU . 0.0 OUTLIER -108.27 147.01 32.03 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.532 1.145 . . . . 0.0 110.275 -179.956 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.663 ' O ' ' N ' ' A' ' 156' ' ' GLY . . . -93.88 119.89 33.41 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.506 1.128 . . . . 0.0 109.336 179.955 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.52 HD11 ' HG2' ' A' ' 188' ' ' GLU . 1.1 mt -88.51 -3.46 58.81 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.472 1.108 . . . . 0.0 109.281 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 13.8 m-85 -139.96 154.34 47.16 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.433 1.083 . . . . 0.0 110.984 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . 0.495 ' CB ' ' HA ' ' A' ' 154' ' ' LYS . 10.8 p-10 -97.36 147.48 24.14 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.495 1.122 . . . . 0.0 109.285 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' PHE . . . . . 0.569 ' HB3' ' CZ ' ' A' ' 153' ' ' PHE . 1.7 t80 177.85 67.82 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.516 1.135 . . . . 0.0 111.001 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . 0.532 ' HA ' ' HA ' ' A' ' 152' ' ' PRO . 76.6 m-20 -38.71 154.69 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.484 1.115 . . . . 0.0 109.295 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -47.19 -98.05 0.01 OUTLIER Glycine 0 CA--C 1.53 1.018 0 O-C-N 124.488 1.118 . . . . 0.0 111.045 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 9.3 p-10 -170.67 -51.1 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.474 0.749 . . . . 0.0 109.283 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -122.83 -59.59 1.59 Allowed 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.471 1.107 . . . . 0.0 109.325 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 179.29 -36.02 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.535 1.147 . . . . 0.0 110.245 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -50.91 -34.25 27.67 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.549 1.156 . . . . 0.0 110.385 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -87.23 168.69 12.99 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.479 1.112 . . . . 0.0 109.312 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.937 ' HB3' HD12 ' A' ' 182' ' ' ILE . 8.4 tp -105.12 112.37 65.12 Favored Pre-proline 0 C--N 1.325 -0.468 0 O-C-N 124.425 1.078 . . . . 0.0 109.324 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . 0.532 ' HA ' ' HA ' ' A' ' 144' ' ' ASN . 18.4 Cg_endo -74.96 148.82 36.01 Favored 'Trans proline' 0 C--N 1.36 1.149 0 O-C-N 124.506 1.792 . . . . 0.0 110.996 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . 0.596 ' CZ ' ' CG ' ' A' ' 183' ' ' PRO . 30.0 p90 -150.45 172.36 15.57 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.512 1.132 . . . . 0.0 111.072 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . 0.495 ' HA ' ' CB ' ' A' ' 142' ' ' ASP . 0.1 OUTLIER -126.1 -166.64 1.59 Allowed 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.453 1.096 . . . . 0.0 109.331 -179.985 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 6.4 ptpt -95.65 105.63 17.64 Favored 'General case' 0 C--N 1.324 -0.531 0 O-C-N 124.545 1.153 . . . . 0.0 109.329 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . 0.663 ' N ' ' O ' ' A' ' 139' ' ' ALA . . . 106.75 27.72 5.34 Favored Glycine 0 CA--C 1.53 0.999 0 O-C-N 124.434 1.084 . . . . 0.0 110.993 -180.0 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . 0.405 ' O ' ' HA ' ' A' ' 138' ' ' ARG . 16.6 t70 -97.45 165.9 11.78 Favored 'General case' 0 C--N 1.324 -0.522 0 O-C-N 124.482 0.754 . . . . 0.0 109.27 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -123.96 138.83 52.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 O-C-N 124.507 1.13 . . . . 0.0 109.268 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.989 HD22 HD13 ' A' ' 182' ' ' ILE . 0.7 OUTLIER -147.13 130.28 16.46 Favored 'General case' 0 C--N 1.324 -0.54 0 O-C-N 124.579 1.174 . . . . 0.0 109.326 179.971 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . 0.513 ' HB2' ' CE1' ' A' ' 136' ' ' TYR . 0.0 OUTLIER -93.91 132.63 38.16 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.476 1.11 . . . . 0.0 110.308 179.982 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.583 ' CD1' HG22 ' A' ' 137' ' ' VAL . 1.6 mp -89.09 132.59 33.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 O-C-N 124.519 1.137 . . . . 0.0 109.327 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -127.01 -36.59 2.16 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.522 1.139 . . . . 0.0 110.263 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -132.68 169.66 16.34 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.455 1.097 . . . . 0.0 109.242 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . 0.588 ' HB2' ' CD1' ' A' ' 170' ' ' TRP . 0.0 OUTLIER -163.36 84.48 1.38 Allowed Pre-proline 0 C--N 1.326 -0.454 0 O-C-N 124.423 1.077 . . . . 0.0 109.334 -179.988 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.94 -25.54 11.9 Favored 'Trans proline' 0 C--N 1.361 1.194 0 O-C-N 124.56 1.821 . . . . 0.0 111.022 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -113.6 174.77 5.76 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.487 1.117 . . . . 0.0 110.292 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -99.71 -19.66 16.65 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.546 1.154 . . . . 0.0 110.317 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 3.6 mt-30 -88.18 -66.69 0.89 Allowed 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.41 1.069 . . . . 0.0 110.326 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 169' ' ' TRP . . . . . . . . . . . . . 6.5 m95 -95.49 153.17 17.83 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.537 1.148 . . . . 0.0 108.025 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 170' ' ' TRP . . . . . 0.699 ' CD2' HG21 ' A' ' 184' ' ' VAL . 43.2 m0 -126.03 153.93 43.7 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 -179.925 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 171' ' ' ASN . . . . . 0.417 ' HA ' ' O ' ' A' ' 180' ' ' GLY . 0.6 OUTLIER -86.97 104.23 16.08 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.459 1.099 . . . . 0.0 109.325 179.952 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . 0.462 ' HA ' ' O ' ' A' ' 160' ' ' ARG . . . -123.0 170.74 9.84 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.514 1.134 . . . . 0.0 109.319 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . 0.404 ' HA ' ' O ' ' A' ' 178' ' ' LYS . 3.9 mt-10 -115.93 126.48 53.95 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.505 1.128 . . . . 0.0 110.319 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . 0.513 ' HB3' HD21 ' A' ' 159' ' ' LEU . 0.9 OUTLIER -78.34 -174.18 3.62 Favored 'General case' 0 C--N 1.324 -0.543 0 O-C-N 124.491 1.12 . . . . 0.0 109.298 179.986 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 80.7 p -76.19 64.48 2.01 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.514 1.134 . . . . 0.0 109.932 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -177.27 0.22 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.453 1.096 . . . . 0.0 110.345 -179.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 79.12 12.59 83.87 Favored Glycine 0 CA--C 1.53 1.006 0 O-C-N 124.575 1.172 . . . . 0.0 110.931 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 178' ' ' LYS . . . . . 0.404 ' O ' ' HA ' ' A' ' 173' ' ' GLU . 0.0 OUTLIER -83.91 109.4 17.57 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.554 0.797 . . . . 0.0 109.272 -179.977 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 179' ' ' ARG . . . . . 0.435 ' HA ' ' O ' ' A' ' 172' ' ' ALA . 2.1 ttp85 -87.99 123.19 32.45 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.495 1.122 . . . . 0.0 110.242 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . 0.643 ' N ' HD22 ' A' ' 151' ' ' LEU . . . -151.25 172.03 30.83 Favored Glycine 0 CA--C 1.53 1.022 0 O-C-N 124.486 1.116 . . . . 0.0 110.96 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 181' ' ' MET . . . . . 0.458 ' HA ' ' O ' ' A' ' 170' ' ' TRP . 0.9 OUTLIER -87.73 93.77 9.54 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.507 0.769 . . . . 0.0 111.001 -179.987 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . 0.989 HD13 HD22 ' A' ' 159' ' ' LEU . 0.0 OUTLIER -91.79 158.17 40.45 Favored Pre-proline 0 C--N 1.325 -0.497 0 O-C-N 124.459 1.099 . . . . 0.0 109.316 179.969 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 183' ' ' PRO . . . . . 0.688 ' HG2' ' HB2' ' A' ' 186' ' ' TYR . 18.2 Cg_endo -74.97 131.44 14.33 Favored 'Trans proline' 0 C--N 1.361 1.206 0 O-C-N 124.438 1.757 . . . . 0.0 111.026 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . 0.813 ' N ' ' CD ' ' A' ' 185' ' ' PRO . 85.9 t -79.96 -31.91 0.69 Allowed Pre-proline 0 C--N 1.325 -0.46 0 O-C-N 124.435 1.084 . . . . 0.0 109.265 180.0 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 185' ' ' PRO . . . . . 0.813 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.3 Cg_endo -74.99 -25.2 12.12 Favored 'Trans proline' 0 C--N 1.359 1.103 0 O-C-N 124.526 1.803 . . . . 0.0 111.002 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 186' ' ' TYR . . . . . 0.688 ' HB2' ' HG2' ' A' ' 183' ' ' PRO . 7.9 m-85 -92.83 16.64 12.01 Favored 'General case' 0 C--N 1.326 -0.431 0 O-C-N 124.498 1.124 . . . . 0.0 111.038 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 187' ' ' VAL . . . . . 0.557 HG22 ' O ' ' A' ' 183' ' ' PRO . 27.4 m -141.78 170.57 12.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 O-C-N 124.535 1.147 . . . . 0.0 109.317 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . 0.604 ' O ' ' HA ' ' A' ' 137' ' ' VAL . 0.0 OUTLIER -131.76 155.91 46.89 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.53 1.144 . . . . 0.0 110.295 -179.997 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . 0.477 ' HA ' HG12 ' A' ' 137' ' ' VAL . 0.0 OUTLIER -88.62 132.36 34.59 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.513 1.133 . . . . 0.0 109.21 -179.956 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 190' ' ' TYR . . . . . 0.565 ' CE1' ' OE2' ' A' ' 188' ' ' GLU . 0.1 OUTLIER -109.15 -61.46 1.62 Allowed 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.502 1.126 . . . . 0.0 110.977 179.964 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.919 0 O-C-N 124.533 1.146 . . . . 0.0 110.998 -179.962 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' CYS . . . . . . . . . . . . . 1.7 t . . . . . 0 N--CA 1.453 -0.322 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 150.68 -118.53 0.93 Allowed Glycine 0 CA--C 1.529 0.928 0 O-C-N 124.418 1.073 . . . . 0.0 110.996 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -168.97 -64.06 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.492 0.76 . . . . 0.0 109.275 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.801 ' HG2' HG22 ' A' ' 161' ' ' ILE . 2.4 mp0 -153.69 76.31 1.07 Allowed 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.455 1.097 . . . . 0.0 110.303 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 31.7 m-85 -126.11 131.93 51.98 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.434 1.084 . . . . 0.0 111.078 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.632 ' CG2' HG23 ' A' ' 187' ' ' VAL . 0.7 OUTLIER -132.68 127.82 56.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 O-C-N 124.516 1.135 . . . . 0.0 109.329 -179.931 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . 0.468 ' O ' ' HA ' ' A' ' 187' ' ' VAL . 0.0 OUTLIER -96.03 134.15 39.41 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.501 1.126 . . . . 0.0 110.371 -179.988 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.625 ' CB ' HG12 ' A' ' 187' ' ' VAL . . . -96.35 109.47 21.98 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.52 1.138 . . . . 0.0 109.279 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.624 HD11 ' HG2' ' A' ' 188' ' ' GLU . 0.2 OUTLIER -89.91 -31.79 17.13 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.483 1.115 . . . . 0.0 109.284 179.996 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . 0.505 ' O ' ' CD1' ' A' ' 153' ' ' PHE . 71.2 m-85 -88.53 152.62 21.74 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.529 1.143 . . . . 0.0 111.007 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . 0.507 ' HA ' ' O ' ' A' ' 154' ' ' LYS . 0.0 OUTLIER -105.86 141.44 37.27 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.497 1.123 . . . . 0.0 109.36 179.942 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' PHE . . . . . 0.644 ' HB3' ' CZ ' ' A' ' 153' ' ' PHE . 5.5 t80 179.73 57.31 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.502 1.126 . . . . 0.0 111.01 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . 0.491 ' HA ' ' CA ' ' A' ' 152' ' ' PRO . 15.9 p-10 -36.96 -49.03 0.8 Allowed 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.5 1.125 . . . . 0.0 109.294 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 91.03 -110.4 3.82 Favored Glycine 0 CA--C 1.53 1.023 0 O-C-N 124.515 1.135 . . . . 0.0 110.977 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 9.1 t30 177.08 51.5 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.498 0.764 . . . . 0.0 109.331 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . 0.416 ' O ' ' CB ' ' A' ' 148' ' ' GLU . 5.1 p-10 45.12 -161.07 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.469 1.106 . . . . 0.0 109.332 -179.92 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.416 ' CB ' ' O ' ' A' ' 147' ' ' ASP . 0.0 OUTLIER 79.68 50.98 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.527 1.142 . . . . 0.0 110.315 -179.998 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 76.75 40.79 0.19 Allowed 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.495 1.122 . . . . 0.0 110.334 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 34.0 m-20 -154.96 115.17 3.82 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.442 1.089 . . . . 0.0 109.243 -179.885 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.902 HD13 ' HA3' ' A' ' 180' ' ' GLY . 1.3 mp -78.39 119.81 78.71 Favored Pre-proline 0 C--N 1.323 -0.553 0 O-C-N 124.595 1.184 . . . . 0.0 109.264 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . 0.491 ' CA ' ' HA ' ' A' ' 144' ' ' ASN . 18.0 Cg_endo -75.07 133.8 16.91 Favored 'Trans proline' 0 C--N 1.359 1.131 0 O-C-N 124.533 1.807 . . . . 0.0 110.986 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . 0.644 ' CZ ' ' HB3' ' A' ' 143' ' ' PHE . 28.9 p90 -134.86 179.12 6.5 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.426 1.079 . . . . 0.0 111.055 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . 0.507 ' O ' ' HA ' ' A' ' 142' ' ' ASP . 5.6 ttmt -127.25 -99.51 0.37 Allowed 'General case' 0 C--N 1.324 -0.53 0 O-C-N 124.554 1.159 . . . . 0.0 109.301 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 17.2 ttpp -156.09 118.82 4.16 Favored 'General case' 0 C--N 1.326 -0.443 0 O-C-N 124.445 1.09 . . . . 0.0 109.353 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . 0.494 ' N ' ' O ' ' A' ' 139' ' ' ALA . . . 97.46 15.06 39.04 Favored Glycine 0 CA--C 1.53 1.023 0 O-C-N 124.572 1.17 . . . . 0.0 110.948 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . 0.5 ' C ' HD12 ' A' ' 158' ' ' ILE . 8.9 t0 -83.83 163.28 20.22 Favored 'General case' 0 C--N 1.324 -0.523 0 O-C-N 124.479 0.752 . . . . 0.0 109.254 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . 0.501 ' N ' HD12 ' A' ' 158' ' ' ILE . 3.5 mp -119.01 148.74 21.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 O-C-N 124.473 1.108 . . . . 0.0 109.29 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.725 HD21 ' OD1' ' A' ' 174' ' ' ASP . 0.7 OUTLIER -147.43 130.88 16.69 Favored 'General case' 0 C--N 1.326 -0.443 0 O-C-N 124.468 1.105 . . . . 0.0 109.303 -179.953 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . 0.684 ' O ' ' HA ' ' A' ' 172' ' ' ALA . 3.7 tpp180 -87.45 127.37 35.23 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.523 1.14 . . . . 0.0 110.273 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.801 HG22 ' HG2' ' A' ' 135' ' ' GLU . 1.5 mp -82.37 119.23 31.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 O-C-N 124.434 1.084 . . . . 0.0 109.305 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . 0.484 ' NH1' ' OD2' ' A' ' 163' ' ' ASP . 1.0 OUTLIER -115.25 -48.89 2.79 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.467 1.105 . . . . 0.0 110.345 179.952 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . 0.484 ' OD2' ' NH1' ' A' ' 162' ' ' ARG . 67.4 m-20 -141.54 171.34 14.2 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.485 1.116 . . . . 0.0 109.291 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . 0.591 ' HB3' ' CD1' ' A' ' 170' ' ' TRP . 14.5 mtmm -138.71 58.46 13.84 Favored Pre-proline 0 C--N 1.325 -0.486 0 O-C-N 124.521 1.138 . . . . 0.0 109.309 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . 0.541 ' HD3' ' N ' ' A' ' 164' ' ' LYS . 18.5 Cg_endo -74.99 76.41 3.4 Favored 'Trans proline' 0 C--N 1.36 1.163 0 O-C-N 124.455 1.766 . . . . 0.0 111.02 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . 0.47 ' CB ' ' O ' ' A' ' 165' ' ' PRO . 1.5 mt-10 162.77 177.24 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.547 1.155 . . . . 0.0 110.296 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -117.08 42.68 2.47 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.433 1.083 . . . . 0.0 110.277 -179.923 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER 178.29 -51.53 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.493 1.121 . . . . 0.0 110.306 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 169' ' ' TRP . . . . . . . . . . . . . 7.2 m95 -95.29 144.05 26.18 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 170' ' ' TRP . . . . . 0.789 ' CD2' HG21 ' A' ' 184' ' ' VAL . 48.6 m0 -120.45 149.82 41.78 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.474 1.109 . . . . 0.0 108.02 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 171' ' ' ASN . . . . . 0.417 ' HA ' ' O ' ' A' ' 180' ' ' GLY . 1.2 t-20 -86.6 98.99 11.4 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.428 1.08 . . . . 0.0 109.322 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . 0.684 ' HA ' ' O ' ' A' ' 160' ' ' ARG . . . -116.04 171.41 7.81 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.474 1.109 . . . . 0.0 109.239 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . 0.484 ' HG3' ' CG ' ' A' ' 179' ' ' ARG . 5.2 mt-10 -115.89 117.4 30.08 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.493 1.12 . . . . 0.0 110.326 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . 0.725 ' OD1' HD21 ' A' ' 159' ' ' LEU . 0.1 OUTLIER -68.28 -164.28 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.559 1.162 . . . . 0.0 109.355 179.969 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 88.1 p -85.09 60.03 5.99 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.444 1.09 . . . . 0.0 109.905 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -178.95 18.62 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.418 1.074 . . . . 0.0 110.286 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 63.54 14.96 56.52 Favored Glycine 0 CA--C 1.531 1.038 0 O-C-N 124.605 1.19 . . . . 0.0 110.999 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 178' ' ' LYS . . . . . 0.588 ' O ' HD21 ' A' ' 151' ' ' LEU . 1.5 mttt -80.51 105.59 11.87 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.495 0.762 . . . . 0.0 109.255 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 179' ' ' ARG . . . . . 0.484 ' CG ' ' HG3' ' A' ' 173' ' ' GLU . 0.0 OUTLIER -89.58 118.29 29.1 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.488 1.118 . . . . 0.0 110.243 -179.997 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . 0.902 ' HA3' HD13 ' A' ' 151' ' ' LEU . . . -151.55 171.09 31.09 Favored Glycine 0 CA--C 1.53 1.026 0 O-C-N 124.54 1.15 . . . . 0.0 111.004 179.938 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 181' ' ' MET . . . . . 0.451 ' CE ' ' HD2' ' A' ' 165' ' ' PRO . 0.4 OUTLIER -88.81 103.73 16.26 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.524 0.779 . . . . 0.0 110.926 -179.926 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . 0.598 HG22 ' HB2' ' A' ' 151' ' ' LEU . 0.0 OUTLIER -107.36 165.72 12.31 Favored Pre-proline 0 C--N 1.325 -0.495 0 O-C-N 124.49 1.119 . . . . 0.0 109.298 -179.998 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 183' ' ' PRO . . . . . 0.6 ' HG2' ' HB2' ' A' ' 186' ' ' TYR . 18.3 Cg_endo -75.02 131.38 14.2 Favored 'Trans proline' 0 C--N 1.359 1.088 0 O-C-N 124.534 1.807 . . . . 0.0 110.984 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . 0.803 ' N ' ' CD ' ' A' ' 185' ' ' PRO . 90.5 t -79.92 -33.64 0.8 Allowed Pre-proline 0 C--N 1.326 -0.447 0 O-C-N 124.529 1.143 . . . . 0.0 109.28 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 185' ' ' PRO . . . . . 0.803 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.3 Cg_endo -74.93 -13.87 21.46 Favored 'Trans proline' 0 C--N 1.361 1.194 0 O-C-N 124.517 1.798 . . . . 0.0 111.054 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 186' ' ' TYR . . . . . 0.6 ' HB2' ' HG2' ' A' ' 183' ' ' PRO . 8.8 m-85 -95.96 4.98 52.26 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.458 1.098 . . . . 0.0 110.983 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 187' ' ' VAL . . . . . 0.632 HG23 ' CG2' ' A' ' 137' ' ' VAL . 25.0 m -136.18 170.25 19.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 O-C-N 124.424 1.078 . . . . 0.0 109.319 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . 0.624 ' HG2' HD11 ' A' ' 140' ' ' LEU . 0.0 OUTLIER -121.82 155.27 35.69 Favored 'General case' 0 C--N 1.326 -0.432 0 O-C-N 124.426 1.079 . . . . 0.0 110.26 -179.994 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.44 126.75 35.07 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.527 1.142 . . . . 0.0 109.259 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -120.66 106.94 12.21 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.455 1.097 . . . . 0.0 111.017 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 1.005 0 O-C-N 124.551 1.157 . . . . 0.0 111.015 179.962 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.453 -0.315 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 178.96 110.38 0.28 Allowed Glycine 0 CA--C 1.53 1.001 0 O-C-N 124.493 1.121 . . . . 0.0 110.98 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -175.78 -156.98 0.05 Allowed 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.513 0.772 . . . . 0.0 109.309 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.46 ' O ' ' HA ' ' A' ' 160' ' ' ARG . 0.4 OUTLIER -119.1 63.06 0.79 Allowed 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.455 1.097 . . . . 0.0 110.33 179.978 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . 0.471 ' CE2' HG21 ' A' ' 158' ' ' ILE . 0.1 OUTLIER -127.72 113.8 16.48 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.416 1.072 . . . . 0.0 111.012 -179.973 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.511 HG13 HD13 ' A' ' 161' ' ' ILE . 16.0 m -108.17 137.18 40.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 O-C-N 124.539 1.149 . . . . 0.0 109.275 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . 0.427 ' O ' ' HA ' ' A' ' 187' ' ' VAL . 6.4 ttm180 -101.89 128.83 48.1 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.529 1.143 . . . . 0.0 110.3 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.867 ' HB3' ' HB3' ' A' ' 157' ' ' ASP . . . -88.52 103.69 16.12 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 124.557 1.16 . . . . 0.0 109.267 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.715 HD11 ' HB3' ' A' ' 188' ' ' GLU . 0.2 OUTLIER -90.41 -29.06 18.23 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.464 1.102 . . . . 0.0 109.26 179.984 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . 0.498 ' C ' ' O ' ' A' ' 154' ' ' LYS . 27.0 m-85 -92.16 151.22 20.49 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.498 1.124 . . . . 0.0 110.951 -179.907 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -98.37 143.19 29.1 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.508 1.13 . . . . 0.0 109.322 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' PHE . . . . . 0.629 ' HB3' ' CE1' ' A' ' 153' ' ' PHE . 0.3 OUTLIER -132.32 -33.92 1.26 Allowed 'General case' 0 C--N 1.324 -0.523 0 O-C-N 124.442 1.089 . . . . 0.0 111.002 -179.978 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . 0.401 ' O ' ' O ' ' A' ' 143' ' ' PHE . 40.0 t-20 62.15 134.83 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.452 1.095 . . . . 0.0 109.313 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . 0.438 ' N ' ' HB3' ' A' ' 152' ' ' PRO . . . -157.74 -179.54 32.71 Favored Glycine 0 CA--C 1.53 1.009 0 O-C-N 124.486 1.116 . . . . 0.0 110.97 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' ASN . . . . . 0.436 ' CB ' ' O ' ' A' ' 145' ' ' GLY . 3.9 m-20 161.37 66.31 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.439 0.729 . . . . 0.0 109.354 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -119.22 -85.76 0.65 Allowed 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.469 1.106 . . . . 0.0 109.275 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 168.36 46.36 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.537 1.148 . . . . 0.0 110.256 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 179.45 -46.21 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.511 1.132 . . . . 0.0 110.321 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -67.05 164.31 18.1 Favored 'General case' 0 C--N 1.326 -0.415 0 O-C-N 124.444 1.09 . . . . 0.0 109.316 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 1.038 ' CB ' HD12 ' A' ' 182' ' ' ILE . 0.6 OUTLIER -114.2 103.92 54.93 Favored Pre-proline 0 C--N 1.326 -0.434 0 O-C-N 124.557 1.161 . . . . 0.0 109.288 179.996 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . 0.438 ' HB3' ' N ' ' A' ' 145' ' ' GLY . 18.3 Cg_endo -74.93 132.72 15.85 Favored 'Trans proline' 0 C--N 1.36 1.163 0 O-C-N 124.497 1.788 . . . . 0.0 110.986 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . 0.681 ' HD2' HD11 ' A' ' 182' ' ' ILE . 20.5 p90 -149.04 174.92 11.79 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.551 1.157 . . . . 0.0 110.95 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . 0.498 ' O ' ' C ' ' A' ' 141' ' ' PHE . 1.2 ttmm -127.32 -83.73 0.61 Allowed 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.471 1.107 . . . . 0.0 109.364 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -161.46 113.52 1.81 Allowed 'General case' 0 C--N 1.326 -0.431 0 O-C-N 124.378 1.048 . . . . 0.0 109.312 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . 0.568 ' N ' ' O ' ' A' ' 139' ' ' ALA . . . 108.38 16.08 12.79 Favored Glycine 0 CA--C 1.53 1.022 0 O-C-N 124.435 1.084 . . . . 0.0 111.041 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . 0.867 ' HB3' ' HB3' ' A' ' 139' ' ' ALA . 24.6 t70 -81.27 158.06 24.93 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.55 0.794 . . . . 0.0 109.336 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . 0.471 HG21 ' CE2' ' A' ' 136' ' ' TYR . 7.5 mm -119.35 133.21 66.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 O-C-N 124.468 1.105 . . . . 0.0 109.328 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.815 HD22 HD13 ' A' ' 182' ' ' ILE . 0.1 OUTLIER -138.07 128.71 26.61 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.48 1.113 . . . . 0.0 109.316 -179.953 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . 0.59 ' O ' ' HA ' ' A' ' 172' ' ' ALA . 1.5 ttp180 -90.1 131.18 36.1 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.426 1.079 . . . . 0.0 110.271 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.511 HD13 HG13 ' A' ' 137' ' ' VAL . 1.3 mp -82.82 120.7 34.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 O-C-N 124.482 1.114 . . . . 0.0 109.353 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 3.5 mtp180 -114.41 -56.91 2.34 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.494 1.122 . . . . 0.0 110.245 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -123.83 161.41 25.34 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.478 1.111 . . . . 0.0 109.295 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . 0.628 ' CD ' ' CE2' ' A' ' 170' ' ' TRP . 2.6 ttpt -144.95 76.0 13.92 Favored Pre-proline 0 C--N 1.326 -0.451 0 O-C-N 124.506 1.128 . . . . 0.0 109.33 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.96 -33.07 4.91 Favored 'Trans proline' 0 C--N 1.36 1.145 0 O-C-N 124.527 1.804 . . . . 0.0 111.0 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . 0.406 ' O ' ' CD1' ' A' ' 170' ' ' TRP . 2.9 mt-10 -114.18 163.8 14.73 Favored 'General case' 0 C--N 1.324 -0.536 0 O-C-N 124.569 1.168 . . . . 0.0 110.282 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -88.64 -23.35 23.07 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.446 1.092 . . . . 0.0 110.283 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . 0.527 ' O ' HG23 ' A' ' 184' ' ' VAL . 3.9 mt-30 -87.03 -69.92 0.65 Allowed 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.499 1.125 . . . . 0.0 110.331 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 169' ' ' TRP . . . . . . . . . . . . . 5.8 m95 -94.1 141.35 28.64 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 170' ' ' TRP . . . . . 0.692 ' CE2' HG21 ' A' ' 184' ' ' VAL . 50.8 m0 -120.15 153.24 36.49 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.517 1.135 . . . . 0.0 107.957 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 171' ' ' ASN . . . . . 0.411 ' HA ' ' O ' ' A' ' 180' ' ' GLY . 1.3 t-20 -86.67 92.63 8.99 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.503 1.127 . . . . 0.0 109.334 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . 0.59 ' HA ' ' O ' ' A' ' 160' ' ' ARG . . . -109.21 176.66 5.01 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.507 1.129 . . . . 0.0 109.317 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . 0.406 ' HA ' ' O ' ' A' ' 178' ' ' LYS . 30.2 mt-10 -123.06 123.4 40.77 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.496 1.122 . . . . 0.0 110.331 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . 0.513 ' OD2' ' CD2' ' A' ' 151' ' ' LEU . 1.4 p30 -73.79 -171.46 1.07 Allowed 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.475 1.109 . . . . 0.0 109.369 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -83.21 64.48 7.74 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.458 1.099 . . . . 0.0 110.063 179.958 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -176.22 8.25 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.559 1.162 . . . . 0.0 110.279 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 69.03 29.26 72.41 Favored Glycine 0 CA--C 1.53 0.985 0 O-C-N 124.453 1.095 . . . . 0.0 111.03 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 178' ' ' LYS . . . . . 0.406 ' O ' ' HA ' ' A' ' 173' ' ' GLU . 8.4 mtpt -103.86 115.27 30.15 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.518 0.775 . . . . 0.0 109.346 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 179' ' ' ARG . . . . . 0.476 ' HA ' ' O ' ' A' ' 172' ' ' ALA . 8.9 ttp180 -88.95 128.03 35.68 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.5 1.125 . . . . 0.0 110.316 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . 0.568 ' CA ' HD11 ' A' ' 151' ' ' LEU . . . -151.71 170.34 31.18 Favored Glycine 0 CA--C 1.53 1.025 0 O-C-N 124.527 1.142 . . . . 0.0 110.991 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 181' ' ' MET . . . . . 0.439 ' HA ' ' O ' ' A' ' 170' ' ' TRP . 0.2 OUTLIER -92.13 99.47 12.27 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.49 0.759 . . . . 0.0 111.039 179.987 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . 1.038 HD12 ' CB ' ' A' ' 151' ' ' LEU . 0.6 OUTLIER -103.78 151.64 38.85 Favored Pre-proline 0 C--N 1.324 -0.504 0 O-C-N 124.482 1.114 . . . . 0.0 109.311 -179.976 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 183' ' ' PRO . . . . . 0.658 ' HD2' ' CG1' ' A' ' 182' ' ' ILE . 18.4 Cg_endo -74.99 134.19 17.53 Favored 'Trans proline' 0 C--N 1.359 1.109 0 O-C-N 124.441 1.759 . . . . 0.0 110.979 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . 0.858 ' N ' ' CD ' ' A' ' 185' ' ' PRO . 21.6 t -75.8 -29.14 0.79 Allowed Pre-proline 0 C--N 1.326 -0.441 0 O-C-N 124.398 1.061 . . . . 0.0 109.286 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 185' ' ' PRO . . . . . 0.858 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.5 Cg_endo -74.87 -13.68 21.65 Favored 'Trans proline' 0 C--N 1.36 1.146 0 O-C-N 124.477 1.777 . . . . 0.0 111.037 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 186' ' ' TYR . . . . . 0.635 ' HB2' ' HG2' ' A' ' 183' ' ' PRO . 8.2 m-85 -98.54 4.56 48.21 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.476 1.11 . . . . 0.0 111.009 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 187' ' ' VAL . . . . . 0.47 HG11 ' CD1' ' A' ' 159' ' ' LEU . 19.2 m -137.05 171.09 16.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 O-C-N 124.547 1.154 . . . . 0.0 109.312 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . 0.715 ' HB3' HD11 ' A' ' 140' ' ' LEU . 1.5 pp20? -125.89 176.76 6.74 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.458 1.099 . . . . 0.0 110.259 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -93.44 112.39 24.28 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.522 1.139 . . . . 0.0 109.335 179.958 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 190' ' ' TYR . . . . . 0.45 ' CD1' ' C ' ' A' ' 190' ' ' TYR . 0.8 OUTLIER -48.22 -77.96 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.53 1.144 . . . . 0.0 111.027 -179.99 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.993 0 O-C-N 124.472 1.108 . . . . 0.0 110.997 -179.963 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' CYS . . . . . 0.453 ' O ' ' O ' ' A' ' 191' ' ' GLY . 7.6 m . . . . . 0 N--CA 1.452 -0.364 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -138.32 71.87 0.45 Allowed Glycine 0 CA--C 1.53 0.993 0 O-C-N 124.466 1.104 . . . . 0.0 110.964 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . 0.453 ' C ' ' HG2' ' A' ' 135' ' ' GLU . . . -115.93 -74.72 0.6 Allowed 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.415 0.715 . . . . 0.0 109.33 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.456 ' HB2' ' O ' ' A' ' 161' ' ' ILE . 5.1 pt-20 169.76 61.37 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.502 1.126 . . . . 0.0 110.262 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . 0.433 ' CE2' ' HB3' ' A' ' 134' ' ' ALA . 95.6 m-85 -123.81 118.9 28.19 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.487 1.117 . . . . 0.0 110.99 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.645 ' HB ' HD13 ' A' ' 161' ' ' ILE . 0.9 OUTLIER -121.83 123.04 68.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 O-C-N 124.543 1.152 . . . . 0.0 109.275 -179.969 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . 0.537 ' O ' ' HA ' ' A' ' 187' ' ' VAL . 12.1 ttm180 -87.45 150.29 23.87 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.489 1.118 . . . . 0.0 110.299 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.521 ' HB2' HG12 ' A' ' 187' ' ' VAL . . . -113.75 108.48 17.16 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.499 1.125 . . . . 0.0 109.317 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.807 HD21 ' OE2' ' A' ' 188' ' ' GLU . 0.0 OUTLIER -93.5 -7.56 43.98 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.607 1.192 . . . . 0.0 109.262 -179.991 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 59.9 m-85 -113.78 164.11 14.16 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.554 1.159 . . . . 0.0 110.955 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . 0.462 ' N ' ' OD1' ' A' ' 142' ' ' ASP . 0.0 OUTLIER -115.01 148.46 38.8 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.493 1.121 . . . . 0.0 109.299 179.942 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' PHE . . . . . 0.596 ' HB3' ' CZ ' ' A' ' 153' ' ' PHE . 16.1 t80 -167.86 30.32 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.51 1.131 . . . . 0.0 111.024 -179.955 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . 0.442 ' HA ' ' HA ' ' A' ' 152' ' ' PRO . 14.8 p-10 -58.07 119.64 7.16 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.391 1.057 . . . . 0.0 109.351 180.0 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 101.18 99.0 2.35 Favored Glycine 0 CA--C 1.53 0.994 0 O-C-N 124.473 1.108 . . . . 0.0 111.038 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' ASN . . . . . 0.536 ' CG ' ' CE2' ' A' ' 143' ' ' PHE . 11.4 m-20 -146.16 -49.18 0.21 Allowed 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.479 0.752 . . . . 0.0 109.267 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 28.0 m-20 -165.09 164.72 20.32 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.588 1.18 . . . . 0.0 109.325 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -65.85 -20.12 66.13 Favored 'General case' 0 C--N 1.323 -0.557 0 O-C-N 124.571 1.169 . . . . 0.0 110.312 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -96.36 -32.19 12.49 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.462 1.101 . . . . 0.0 110.263 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . 0.466 ' CB ' ' HB2' ' A' ' 146' ' ' ASN . 0.2 OUTLIER -61.3 167.46 3.19 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.527 1.142 . . . . 0.0 109.272 179.952 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.984 HD23 ' OD1' ' A' ' 174' ' ' ASP . 1.2 tp -120.44 119.21 30.61 Favored Pre-proline 0 C--N 1.325 -0.474 0 O-C-N 124.535 1.147 . . . . 0.0 109.361 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . 0.442 ' HA ' ' HA ' ' A' ' 144' ' ' ASN . 18.2 Cg_endo -74.98 137.36 21.66 Favored 'Trans proline' 0 C--N 1.359 1.131 0 O-C-N 124.509 1.794 . . . . 0.0 110.959 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . 0.596 ' CZ ' ' HB3' ' A' ' 143' ' ' PHE . 21.8 p90 -150.41 173.75 13.68 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.49 1.119 . . . . 0.0 111.028 179.899 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . 0.417 ' HA ' ' HA ' ' A' ' 142' ' ' ASP . 1.6 tttm -132.09 -169.36 2.2 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.549 1.155 . . . . 0.0 109.319 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.498 ' CB ' ' O ' ' A' ' 140' ' ' LEU . 9.6 ptpt -89.31 111.17 21.94 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.517 1.136 . . . . 0.0 109.301 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 117.3 8.24 11.58 Favored Glycine 0 CA--C 1.529 0.96 0 O-C-N 124.486 1.116 . . . . 0.0 111.05 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . 0.432 ' CG ' ' N ' ' A' ' 158' ' ' ILE . 14.5 t0 -91.12 172.63 8.42 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.512 0.772 . . . . 0.0 109.277 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . 0.433 ' C ' ' HG ' ' A' ' 159' ' ' LEU . 3.2 mt -140.27 142.55 31.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 O-C-N 124.547 1.154 . . . . 0.0 109.332 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.588 ' CD1' HG11 ' A' ' 187' ' ' VAL . 0.1 OUTLIER -136.93 141.23 42.67 Favored 'General case' 0 C--N 1.324 -0.533 0 O-C-N 124.555 1.159 . . . . 0.0 109.328 179.997 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . 0.481 ' O ' ' HA ' ' A' ' 172' ' ' ALA . 15.2 ttm105 -87.86 134.91 33.6 Favored 'General case' 0 C--N 1.326 -0.437 0 O-C-N 124.581 1.176 . . . . 0.0 110.333 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.645 HD13 ' HB ' ' A' ' 137' ' ' VAL . 1.0 OUTLIER -83.53 109.81 17.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 O-C-N 124.536 1.148 . . . . 0.0 109.321 179.969 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . 0.452 ' HG3' ' CG ' ' A' ' 179' ' ' ARG . 20.8 mmm180 -90.68 -59.34 2.2 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.546 1.154 . . . . 0.0 110.303 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . 0.515 ' N ' ' OD1' ' A' ' 171' ' ' ASN . 0.7 OUTLIER -151.34 144.53 24.69 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.481 1.113 . . . . 0.0 109.32 179.963 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . 0.598 ' CB ' ' CG ' ' A' ' 170' ' ' TRP . 0.6 OUTLIER -128.02 78.38 75.36 Favored Pre-proline 0 C--N 1.325 -0.475 0 O-C-N 124.494 1.121 . . . . 0.0 109.307 -179.942 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.03 -48.08 0.18 Allowed 'Trans proline' 0 C--N 1.359 1.116 0 O-C-N 124.51 1.795 . . . . 0.0 110.914 -179.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 13.7 mp0 -69.68 176.23 3.7 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.402 1.064 . . . . 0.0 110.322 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -115.24 51.44 0.92 Allowed 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.547 1.154 . . . . 0.0 110.29 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . 0.476 ' HB3' ' CD1' ' A' ' 169' ' ' TRP . 3.3 mt-30 -179.25 -55.58 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.582 1.176 . . . . 0.0 110.278 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 169' ' ' TRP . . . . . 0.476 ' CD1' ' HB3' ' A' ' 168' ' ' GLN . 12.2 m95 -108.91 133.05 53.44 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.491 1.12 . . . . 0.0 107.995 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 170' ' ' TRP . . . . . 0.743 ' CE2' HG21 ' A' ' 184' ' ' VAL . 26.6 m0 -120.8 154.66 35.43 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 171' ' ' ASN . . . . . 0.515 ' OD1' ' N ' ' A' ' 163' ' ' ASP . 6.0 p30 -87.16 108.9 19.11 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.46 1.1 . . . . 0.0 109.265 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . 0.513 ' O ' ' HA ' ' A' ' 179' ' ' ARG . . . -117.35 174.63 6.02 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.511 1.132 . . . . 0.0 109.331 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -116.34 116.69 28.19 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.406 1.066 . . . . 0.0 110.278 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . 0.984 ' OD1' HD23 ' A' ' 151' ' ' LEU . 0.4 OUTLIER -74.43 -176.88 2.86 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.56 1.163 . . . . 0.0 109.316 -179.993 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 37.6 t -76.01 61.91 1.58 Allowed 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.53 1.144 . . . . 0.0 109.969 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -173.79 8.11 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.415 1.072 . . . . 0.0 110.319 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 67.88 20.91 72.94 Favored Glycine 0 CA--C 1.53 1.014 0 O-C-N 124.58 1.175 . . . . 0.0 110.998 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 178' ' ' LYS . . . . . 0.64 ' O ' HD21 ' A' ' 151' ' ' LEU . 0.0 OUTLIER -95.06 115.63 27.68 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.481 0.754 . . . . 0.0 109.329 -179.986 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 179' ' ' ARG . . . . . 0.513 ' HA ' ' O ' ' A' ' 172' ' ' ALA . 0.1 OUTLIER -90.13 122.53 33.17 Favored 'General case' 0 C--N 1.326 -0.442 0 O-C-N 124.459 1.099 . . . . 0.0 110.286 -179.958 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . 0.524 ' HA3' HD13 ' A' ' 151' ' ' LEU . . . -151.34 165.9 30.5 Favored Glycine 0 CA--C 1.53 0.971 0 O-C-N 124.487 1.117 . . . . 0.0 111.001 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 181' ' ' MET . . . . . 0.437 ' HA ' ' O ' ' A' ' 170' ' ' TRP . 0.4 OUTLIER -84.5 103.7 13.86 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.503 0.766 . . . . 0.0 111.035 179.943 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . 0.452 ' HB ' ' HD2' ' A' ' 183' ' ' PRO . 2.2 pp -106.93 161.11 23.94 Favored Pre-proline 0 C--N 1.325 -0.493 0 O-C-N 124.498 1.124 . . . . 0.0 109.267 -179.952 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 183' ' ' PRO . . . . . 0.642 ' HG2' ' HB2' ' A' ' 186' ' ' TYR . 18.4 Cg_endo -74.98 135.37 19.02 Favored 'Trans proline' 0 C--N 1.361 1.214 0 O-C-N 124.505 1.792 . . . . 0.0 110.989 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . 0.843 ' N ' ' CD ' ' A' ' 185' ' ' PRO . 58.0 t -80.1 -30.28 0.6 Allowed Pre-proline 0 C--N 1.326 -0.427 0 O-C-N 124.467 1.105 . . . . 0.0 109.28 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 185' ' ' PRO . . . . . 0.843 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.2 Cg_endo -75.05 -15.53 20.58 Favored 'Trans proline' 0 C--N 1.36 1.154 0 O-C-N 124.482 1.78 . . . . 0.0 110.973 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 186' ' ' TYR . . . . . 0.642 ' HB2' ' HG2' ' A' ' 183' ' ' PRO . 4.5 m-85 -94.95 5.91 50.58 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.492 1.12 . . . . 0.0 111.056 179.923 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 187' ' ' VAL . . . . . 0.588 HG11 ' CD1' ' A' ' 159' ' ' LEU . 35.4 m -136.94 164.48 30.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 O-C-N 124.475 1.11 . . . . 0.0 109.314 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . 0.807 ' OE2' HD21 ' A' ' 140' ' ' LEU . 0.0 OUTLIER -120.49 165.75 14.54 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.487 1.117 . . . . 0.0 110.262 -180.0 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . 0.453 ' CD ' ' H ' ' A' ' 189' ' ' LYS . 0.0 OUTLIER -89.33 126.54 35.57 Favored 'General case' 0 C--N 1.326 -0.439 0 O-C-N 124.455 1.097 . . . . 0.0 109.366 179.969 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 190' ' ' TYR . . . . . 0.436 ' CD1' ' OE1' ' A' ' 188' ' ' GLU . 0.1 OUTLIER -120.38 179.49 4.29 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.528 1.143 . . . . 0.0 110.98 -179.968 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . 0.453 ' O ' ' O ' ' A' ' 132' ' ' CYS . . . . . . . . 0 CA--C 1.531 1.038 0 O-C-N 124.494 1.121 . . . . 0.0 110.994 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' CYS . . . . . 0.418 ' O ' ' C ' ' A' ' 133' ' ' GLY . 28.5 p . . . . . 0 N--CA 1.452 -0.338 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . 0.418 ' C ' ' O ' ' A' ' 132' ' ' CYS . . . 35.2 86.05 0.01 OUTLIER Glycine 0 CA--C 1.53 0.983 0 O-C-N 124.471 1.107 . . . . 0.0 111.019 -179.941 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -175.17 -149.8 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.468 0.746 . . . . 0.0 109.354 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -137.43 70.56 1.4 Allowed 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.454 1.097 . . . . 0.0 110.321 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . 0.529 ' CE2' ' HD2' ' A' ' 160' ' ' ARG . 36.6 m-85 -126.62 130.88 51.33 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.547 1.154 . . . . 0.0 110.982 -179.969 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.716 HG12 ' O ' ' A' ' 159' ' ' LEU . 2.9 p -125.75 155.83 35.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 O-C-N 124.491 1.119 . . . . 0.0 109.273 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . 0.455 ' HB3' ' HG3' ' A' ' 188' ' ' GLU . 0.0 OUTLIER -126.08 133.03 51.8 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.501 1.125 . . . . 0.0 110.338 179.98 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.519 ' HB3' ' HB3' ' A' ' 157' ' ' ASP . . . -97.06 110.64 23.14 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.514 1.134 . . . . 0.0 109.316 -179.965 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.672 HD11 ' HG2' ' A' ' 188' ' ' GLU . 0.2 OUTLIER -95.33 -22.39 17.78 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.555 1.159 . . . . 0.0 109.344 179.948 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . 0.476 ' C ' ' O ' ' A' ' 154' ' ' LYS . 12.1 m-85 -94.62 150.31 20.36 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.474 1.109 . . . . 0.0 111.031 179.939 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . 0.431 ' CA ' ' O ' ' A' ' 154' ' ' LYS . 0.1 OUTLIER -103.48 145.8 29.47 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.538 1.149 . . . . 0.0 109.322 -179.969 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' PHE . . . . . 0.619 ' HB3' ' CE1' ' A' ' 153' ' ' PHE . 54.9 t80 -151.85 -43.94 0.11 Allowed 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.51 1.131 . . . . 0.0 111.008 -179.949 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . 0.423 ' O ' ' O ' ' A' ' 143' ' ' PHE . 8.3 t-20 51.4 100.44 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.411 0 O-C-N 124.435 1.085 . . . . 0.0 109.352 -179.93 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -174.01 108.07 0.26 Allowed Glycine 0 CA--C 1.529 0.926 0 O-C-N 124.479 1.112 . . . . 0.0 111.024 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' ASN . . . . . 0.499 ' O ' ' N ' ' A' ' 148' ' ' GLU . 1.2 p30 -104.52 -50.81 3.22 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.459 0.741 . . . . 0.0 109.343 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 66.64 -66.26 0.18 Allowed 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.575 1.172 . . . . 0.0 109.309 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.499 ' N ' ' O ' ' A' ' 146' ' ' ASN . 0.1 OUTLIER 169.91 40.51 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.454 1.097 . . . . 0.0 110.277 179.994 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 172.71 -33.29 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.561 1.163 . . . . 0.0 110.289 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -74.49 171.75 13.22 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.484 1.115 . . . . 0.0 109.328 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.614 HD21 ' HB2' ' A' ' 174' ' ' ASP . 1.4 tp -125.66 119.04 24.39 Favored Pre-proline 0 C--N 1.325 -0.493 0 O-C-N 124.577 1.173 . . . . 0.0 109.347 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -74.97 142.96 28.6 Favored 'Trans proline' 0 C--N 1.361 1.208 0 O-C-N 124.434 1.755 . . . . 0.0 111.004 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . 0.619 ' CE1' ' HB3' ' A' ' 143' ' ' PHE . 14.9 p90 -151.64 173.12 15.05 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.42 1.075 . . . . 0.0 111.006 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . 0.476 ' O ' ' C ' ' A' ' 141' ' ' PHE . 0.0 OUTLIER -125.86 -84.99 0.63 Allowed 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.488 1.118 . . . . 0.0 109.233 -179.984 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -165.58 113.14 0.96 Allowed 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.501 1.126 . . . . 0.0 109.252 -179.949 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . 0.402 ' N ' ' O ' ' A' ' 139' ' ' ALA . . . 108.84 14.07 16.47 Favored Glycine 0 CA--C 1.53 1.003 0 O-C-N 124.391 1.057 . . . . 0.0 111.016 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . 0.519 ' HB3' ' HB3' ' A' ' 139' ' ' ALA . 6.9 t0 -82.72 158.26 22.96 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.532 0.783 . . . . 0.0 109.27 -179.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . 0.53 ' N ' HD12 ' A' ' 158' ' ' ILE . 3.9 mp -119.79 141.19 41.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 O-C-N 124.571 1.169 . . . . 0.0 109.266 -179.945 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.816 ' CD2' HG21 ' A' ' 182' ' ' ILE . 2.9 mp -142.04 126.79 18.07 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.42 1.075 . . . . 0.0 109.345 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . 0.685 ' O ' ' HA ' ' A' ' 172' ' ' ALA . 0.0 OUTLIER -88.26 132.87 34.21 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.545 1.153 . . . . 0.0 110.328 179.997 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 14.3 mm -82.15 117.14 27.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 O-C-N 124.42 1.075 . . . . 0.0 109.312 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . 0.47 ' HG3' ' N ' ' A' ' 163' ' ' ASP . 0.8 OUTLIER -118.22 -32.58 4.65 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.537 1.148 . . . . 0.0 110.368 179.943 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . 0.47 ' N ' ' HG3' ' A' ' 162' ' ' ARG . 0.9 OUTLIER -146.35 155.25 42.48 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.486 1.116 . . . . 0.0 109.338 179.949 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . 0.575 ' HB3' ' CD1' ' A' ' 170' ' ' TRP . 1.4 mtmp? -148.25 71.93 11.01 Favored Pre-proline 0 C--N 1.324 -0.519 0 O-C-N 124.522 1.139 . . . . 0.0 109.234 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.96 -29.06 8.7 Favored 'Trans proline' 0 C--N 1.359 1.105 0 O-C-N 124.539 1.81 . . . . 0.0 110.999 179.922 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . 0.517 ' O ' ' CD1' ' A' ' 170' ' ' TRP . 3.0 mm-40 -105.26 166.02 10.7 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.446 1.091 . . . . 0.0 110.296 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 13.3 mt-10 -96.38 -27.82 14.75 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.463 1.102 . . . . 0.0 110.309 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . 0.452 ' O ' HG23 ' A' ' 184' ' ' VAL . 11.4 tt0 -82.35 -58.68 2.83 Favored 'General case' 0 C--N 1.324 -0.536 0 O-C-N 124.533 1.146 . . . . 0.0 110.284 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 169' ' ' TRP . . . . . 0.581 ' CZ3' ' HD3' ' A' ' 183' ' ' PRO . 9.9 m0 -109.7 163.26 13.66 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.501 1.126 . . . . 0.0 107.968 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 170' ' ' TRP . . . . . 0.698 ' CH2' HG11 ' A' ' 184' ' ' VAL . 30.9 m0 -139.57 157.11 46.36 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.525 1.141 . . . . 0.0 107.951 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 4.6 t30 -88.55 107.6 18.98 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.472 1.107 . . . . 0.0 109.291 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . 0.685 ' HA ' ' O ' ' A' ' 160' ' ' ARG . . . -121.78 178.45 4.85 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.454 1.096 . . . . 0.0 109.312 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . 0.47 ' CG ' ' HG3' ' A' ' 179' ' ' ARG . 17.9 mt-10 -116.49 115.95 26.74 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.548 1.155 . . . . 0.0 110.201 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . 0.614 ' HB2' HD21 ' A' ' 151' ' ' LEU . 0.4 OUTLIER -64.51 -164.91 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.498 1.124 . . . . 0.0 109.239 179.994 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -88.36 60.0 5.48 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.439 1.087 . . . . 0.0 110.016 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . 0.4 ' H ' ' H ' ' A' ' 177' ' ' GLY . 4.2 mt-10 174.16 22.58 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.455 1.097 . . . . 0.0 110.362 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . 0.4 ' H ' ' H ' ' A' ' 176' ' ' GLU . . . 67.75 15.52 66.77 Favored Glycine 0 CA--C 1.531 1.035 0 O-C-N 124.464 1.102 . . . . 0.0 111.023 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 178' ' ' LYS . . . . . 0.421 ' HB3' HD11 ' A' ' 151' ' ' LEU . 8.0 mttt -70.9 101.77 2.23 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.505 0.768 . . . . 0.0 109.325 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 179' ' ' ARG . . . . . 0.47 ' HG3' ' CG ' ' A' ' 173' ' ' GLU . 11.3 mtt85 -87.68 105.76 17.58 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.494 1.121 . . . . 0.0 110.255 -179.914 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . 0.412 ' HA3' HD13 ' A' ' 151' ' ' LEU . . . -151.87 169.45 31.26 Favored Glycine 0 CA--C 1.53 0.983 0 O-C-N 124.507 1.129 . . . . 0.0 111.033 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 181' ' ' MET . . . . . 0.44 ' HA ' ' O ' ' A' ' 170' ' ' TRP . 4.9 mmm -87.68 116.89 26.13 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.52 0.776 . . . . 0.0 111.064 179.904 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . 0.816 HG21 ' CD2' ' A' ' 159' ' ' LEU . 1.0 OUTLIER -112.91 161.85 24.62 Favored Pre-proline 0 C--N 1.325 -0.484 0 O-C-N 124.504 1.127 . . . . 0.0 109.252 -179.967 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 183' ' ' PRO . . . . . 0.738 ' HG2' ' HB2' ' A' ' 186' ' ' TYR . 18.2 Cg_endo -75.0 134.05 17.35 Favored 'Trans proline' 0 C--N 1.36 1.151 0 O-C-N 124.502 1.79 . . . . 0.0 110.979 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . 0.834 ' N ' ' CD ' ' A' ' 185' ' ' PRO . 38.7 t -79.96 -31.1 0.64 Allowed Pre-proline 0 C--N 1.325 -0.467 0 O-C-N 124.429 1.081 . . . . 0.0 109.275 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 185' ' ' PRO . . . . . 0.834 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.5 Cg_endo -74.99 -25.26 12.06 Favored 'Trans proline' 0 C--N 1.36 1.135 0 O-C-N 124.504 1.792 . . . . 0.0 111.059 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 186' ' ' TYR . . . . . 0.738 ' HB2' ' HG2' ' A' ' 183' ' ' PRO . 3.5 m-85 -93.82 22.84 5.23 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.522 1.139 . . . . 0.0 110.988 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 187' ' ' VAL . . . . . 0.64 ' HB ' HG22 ' A' ' 137' ' ' VAL . 26.2 m -146.53 169.52 5.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 O-C-N 124.475 1.109 . . . . 0.0 109.369 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . 0.672 ' HG2' HD11 ' A' ' 140' ' ' LEU . 0.0 OUTLIER -126.82 160.47 30.81 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.543 1.152 . . . . 0.0 110.255 -179.976 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 24.6 mmmt -85.04 127.19 34.11 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.573 1.171 . . . . 0.0 109.259 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 190' ' ' TYR . . . . . 0.498 ' O ' ' O ' ' A' ' 191' ' ' GLY . 0.1 OUTLIER -109.47 142.94 39.77 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.516 1.135 . . . . 0.0 111.012 179.945 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . 0.498 ' O ' ' O ' ' A' ' 190' ' ' TYR . . . . . . . . 0 CA--C 1.531 1.037 0 O-C-N 124.483 1.114 . . . . 0.0 110.929 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.453 -0.317 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 108.1 -74.05 0.21 Allowed Glycine 0 CA--C 1.531 1.052 0 O-C-N 124.509 1.131 . . . . 0.0 110.98 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -91.21 -166.98 1.69 Allowed 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.556 0.797 . . . . 0.0 109.31 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.512 ' O ' ' HG2' ' A' ' 160' ' ' ARG . 0.7 OUTLIER -118.11 61.13 0.77 Allowed 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.554 1.159 . . . . 0.0 110.282 179.955 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -112.03 128.71 56.26 Favored 'General case' 0 C--N 1.324 -0.522 0 O-C-N 124.531 1.145 . . . . 0.0 111.037 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.774 HG22 ' O ' ' A' ' 188' ' ' GLU . 0.4 OUTLIER -119.35 174.98 4.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 O-C-N 124.471 1.107 . . . . 0.0 109.332 179.988 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . 0.673 HH21 HD11 ' A' ' 158' ' ' ILE . 14.0 ttm180 -144.69 146.73 32.36 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.535 1.147 . . . . 0.0 110.289 -179.958 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.597 ' HB3' ' HB3' ' A' ' 157' ' ' ASP . . . -107.72 109.83 21.52 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.456 1.098 . . . . 0.0 109.306 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.64 HD11 ' HG2' ' A' ' 188' ' ' GLU . 1.0 OUTLIER -88.86 -7.15 56.66 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.52 1.138 . . . . 0.0 109.361 179.977 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 18.6 m-85 -120.67 158.24 27.86 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.576 1.173 . . . . 0.0 110.966 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . 0.487 ' HB3' ' HG2' ' A' ' 154' ' ' LYS . 2.0 p-10 -108.27 147.07 31.96 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.492 1.12 . . . . 0.0 109.339 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' PHE . . . . . 0.624 ' HB3' ' CE1' ' A' ' 153' ' ' PHE . 31.6 t80 -179.22 69.53 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.546 1.154 . . . . 0.0 110.986 179.958 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . 0.445 ' CG ' ' HB3' ' A' ' 152' ' ' PRO . 14.2 t-20 -38.64 145.08 0.09 Allowed 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.488 1.118 . . . . 0.0 109.266 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -58.63 99.87 0.14 Allowed Glycine 0 CA--C 1.529 0.964 0 O-C-N 124.49 1.119 . . . . 0.0 111.025 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 13.3 t-20 -83.93 -47.28 11.19 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.444 0.732 . . . . 0.0 109.331 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -70.13 168.96 14.51 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.574 1.171 . . . . 0.0 109.325 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -92.65 47.99 1.34 Allowed 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.51 1.131 . . . . 0.0 110.326 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -178.39 55.68 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.512 1.133 . . . . 0.0 110.276 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 29.7 p30 -163.14 165.29 24.73 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.501 1.125 . . . . 0.0 109.315 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.942 HD13 ' OD2' ' A' ' 174' ' ' ASP . 2.1 pp -113.05 140.0 23.66 Favored Pre-proline 0 C--N 1.325 -0.465 0 O-C-N 124.509 1.131 . . . . 0.0 109.3 -179.993 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . 0.445 ' HB3' ' CG ' ' A' ' 144' ' ' ASN . 18.3 Cg_endo -74.97 134.68 18.16 Favored 'Trans proline' 0 C--N 1.36 1.161 0 O-C-N 124.518 1.799 . . . . 0.0 111.022 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . 0.624 ' CE1' ' HB3' ' A' ' 143' ' ' PHE . 13.4 p90 -145.49 169.61 18.02 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.53 1.143 . . . . 0.0 111.064 179.912 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . 0.487 ' HG2' ' HB3' ' A' ' 142' ' ' ASP . 1.0 OUTLIER -127.98 -158.86 0.9 Allowed 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.434 1.084 . . . . 0.0 109.255 -179.937 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.43 108.31 20.98 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.466 1.104 . . . . 0.0 109.29 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 114.51 17.9 6.85 Favored Glycine 0 CA--C 1.53 0.974 0 O-C-N 124.433 1.083 . . . . 0.0 111.041 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . 0.968 ' C ' HD12 ' A' ' 158' ' ' ILE . 8.9 t70 -87.5 168.68 12.87 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.488 0.758 . . . . 0.0 109.366 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . 0.968 HD12 ' C ' ' A' ' 157' ' ' ASP . 2.3 mp -128.56 143.98 39.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 O-C-N 124.559 1.162 . . . . 0.0 109.31 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.911 HD13 HD13 ' A' ' 182' ' ' ILE . 0.3 OUTLIER -149.27 128.47 12.84 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.467 1.104 . . . . 0.0 109.29 -179.913 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . 0.573 ' O ' ' HA ' ' A' ' 172' ' ' ALA . 0.0 OUTLIER -84.57 138.32 32.81 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.515 1.134 . . . . 0.0 110.26 -179.994 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.461 ' HB ' ' HB2' ' A' ' 135' ' ' GLU . 43.9 mm -84.77 112.65 22.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 O-C-N 124.482 1.114 . . . . 0.0 109.306 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.45 -56.0 2.4 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.424 1.077 . . . . 0.0 110.309 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -134.88 167.01 21.69 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.464 1.103 . . . . 0.0 109.282 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . 0.585 ' HB3' ' CD1' ' A' ' 170' ' ' TRP . 23.3 mtmt -144.44 83.13 10.06 Favored Pre-proline 0 C--N 1.325 -0.492 0 O-C-N 124.531 1.144 . . . . 0.0 109.296 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.03 -27.48 9.93 Favored 'Trans proline' 0 C--N 1.36 1.152 0 O-C-N 124.523 1.802 . . . . 0.0 110.99 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . 0.492 ' O ' ' CD1' ' A' ' 170' ' ' TRP . 2.7 mt-10 -121.03 172.75 7.72 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.501 1.126 . . . . 0.0 110.284 -179.941 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -95.56 -29.8 14.16 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.516 1.135 . . . . 0.0 110.319 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . 0.654 ' O ' HG23 ' A' ' 184' ' ' VAL . 6.8 tt0 -79.11 -60.19 2.47 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.473 1.108 . . . . 0.0 110.287 -179.954 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 169' ' ' TRP . . . . . 0.42 ' O ' ' CD1' ' A' ' 170' ' ' TRP . 11.2 m0 -104.96 157.74 17.01 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 170' ' ' TRP . . . . . 0.585 ' CD1' ' HB3' ' A' ' 164' ' ' LYS . 39.9 m0 -136.13 155.61 49.92 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.467 1.104 . . . . 0.0 108.055 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 171' ' ' ASN . . . . . 0.426 ' HA ' ' O ' ' A' ' 180' ' ' GLY . 42.1 t-20 -88.37 99.2 12.08 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.525 1.141 . . . . 0.0 109.266 -179.947 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . 0.573 ' HA ' ' O ' ' A' ' 160' ' ' ARG . . . -109.41 174.77 5.72 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.514 1.134 . . . . 0.0 109.342 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . 0.472 ' C ' HD23 ' A' ' 159' ' ' LEU . 8.0 mt-10 -119.39 117.19 27.84 Favored 'General case' 0 C--N 1.326 -0.437 0 O-C-N 124.475 1.109 . . . . 0.0 110.315 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . 0.942 ' OD2' HD13 ' A' ' 151' ' ' LEU . 3.7 m-20 -67.2 -176.39 0.55 Allowed 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.471 1.107 . . . . 0.0 109.273 -179.952 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 73.4 p -79.24 60.17 3.0 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.528 1.142 . . . . 0.0 110.002 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . 0.414 ' H ' ' H ' ' A' ' 177' ' ' GLY . 0.2 OUTLIER -176.54 7.56 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.428 0 O-C-N 124.485 1.116 . . . . 0.0 110.292 -179.996 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . 0.414 ' H ' ' H ' ' A' ' 176' ' ' GLU . . . 75.66 18.23 79.81 Favored Glycine 0 CA--C 1.529 0.959 0 O-C-N 124.495 1.122 . . . . 0.0 110.985 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 14.1 mtmm -83.92 106.25 15.44 Favored 'General case' 0 C--N 1.326 -0.435 0 O-C-N 124.41 0.712 . . . . 0.0 109.277 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 179' ' ' ARG . . . . . 0.403 ' HD3' ' OE2' ' A' ' 173' ' ' GLU . 4.1 ttp180 -88.51 118.04 27.88 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.444 1.09 . . . . 0.0 110.265 -179.936 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . 0.467 ' HA3' HD23 ' A' ' 151' ' ' LEU . . . -151.57 166.86 30.83 Favored Glycine 0 CA--C 1.53 1.002 0 O-C-N 124.501 1.126 . . . . 0.0 110.979 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 181' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -87.61 114.43 24.22 Favored 'General case' 0 C--N 1.324 -0.528 0 O-C-N 124.497 0.763 . . . . 0.0 110.939 -179.957 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . 0.911 HD13 HD13 ' A' ' 159' ' ' LEU . 2.1 pt -116.02 163.44 21.35 Favored Pre-proline 0 C--N 1.325 -0.487 0 O-C-N 124.492 1.12 . . . . 0.0 109.256 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 183' ' ' PRO . . . . . 0.775 ' HG2' ' HB2' ' A' ' 186' ' ' TYR . 18.0 Cg_endo -75.02 135.63 19.3 Favored 'Trans proline' 0 C--N 1.361 1.199 0 O-C-N 124.52 1.8 . . . . 0.0 110.946 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . 0.82 ' N ' ' CD ' ' A' ' 185' ' ' PRO . 50.6 t -80.17 -31.98 0.68 Allowed Pre-proline 0 C--N 1.325 -0.469 0 O-C-N 124.486 1.117 . . . . 0.0 109.299 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 185' ' ' PRO . . . . . 0.82 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.3 Cg_endo -75.0 -23.09 14.13 Favored 'Trans proline' 0 C--N 1.361 1.214 0 O-C-N 124.541 1.811 . . . . 0.0 110.985 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 186' ' ' TYR . . . . . 0.775 ' HB2' ' HG2' ' A' ' 183' ' ' PRO . 3.8 m-85 -93.66 16.02 14.86 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.503 1.127 . . . . 0.0 111.037 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 187' ' ' VAL . . . . . 0.601 ' HA ' ' O ' ' A' ' 138' ' ' ARG . 6.0 m -145.49 165.58 10.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 O-C-N 124.449 1.093 . . . . 0.0 109.305 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . 0.774 ' O ' HG22 ' A' ' 137' ' ' VAL . 0.0 OUTLIER -130.16 166.05 21.05 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.47 1.106 . . . . 0.0 110.371 -179.971 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.65 121.85 32.92 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.462 1.101 . . . . 0.0 109.369 179.911 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -42.18 -50.94 4.8 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.543 1.152 . . . . 0.0 110.991 -179.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.962 0 O-C-N 124.456 1.097 . . . . 0.0 111.009 -179.987 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' CYS . . . . . . . . . . . . . 18.0 p . . . . . 0 N--CA 1.453 -0.319 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -163.32 -126.5 0.82 Allowed Glycine 0 CA--C 1.529 0.909 0 O-C-N 124.503 1.127 . . . . 0.0 110.989 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -70.16 -134.51 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.431 0.724 . . . . 0.0 109.273 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.437 ' O ' ' HA ' ' A' ' 160' ' ' ARG . 0.0 OUTLIER -114.57 61.3 0.67 Allowed 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.491 1.119 . . . . 0.0 110.301 -179.988 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -128.08 116.68 20.35 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 124.518 1.136 . . . . 0.0 110.967 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.593 HG13 HD13 ' A' ' 161' ' ' ILE . 32.4 m -107.77 165.02 4.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 O-C-N 124.542 1.151 . . . . 0.0 109.36 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . 0.473 ' O ' ' HA ' ' A' ' 187' ' ' VAL . 2.7 tpp85 -125.12 132.18 53.15 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.445 1.091 . . . . 0.0 110.306 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.578 ' O ' ' N ' ' A' ' 156' ' ' GLY . . . -98.22 112.94 24.74 Favored 'General case' 0 C--N 1.326 -0.444 0 O-C-N 124.474 1.109 . . . . 0.0 109.307 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.881 HD21 ' OE2' ' A' ' 188' ' ' GLU . 0.1 OUTLIER -92.71 -12.02 32.5 Favored 'General case' 0 C--N 1.326 -0.437 0 O-C-N 124.448 1.092 . . . . 0.0 109.302 -179.953 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -121.73 156.69 32.56 Favored 'General case' 0 C--N 1.326 -0.416 0 O-C-N 124.507 1.129 . . . . 0.0 110.966 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . 0.464 ' OD1' ' N ' ' A' ' 155' ' ' LYS . 0.0 OUTLIER -102.68 138.41 39.61 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.439 1.087 . . . . 0.0 109.316 -179.954 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' PHE . . . . . 0.629 ' HB3' ' CZ ' ' A' ' 153' ' ' PHE . 5.8 t80 -150.16 7.94 0.62 Allowed 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.456 1.098 . . . . 0.0 111.012 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . 0.46 ' C ' ' O ' ' A' ' 143' ' ' PHE . 0.8 OUTLIER 36.06 -153.47 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.499 1.125 . . . . 0.0 109.304 -179.995 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . 0.477 ' N ' ' HB3' ' A' ' 152' ' ' PRO . . . -175.21 -145.85 5.56 Favored Glycine 0 CA--C 1.53 1.016 0 O-C-N 124.576 1.172 . . . . 0.0 110.946 -179.955 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' ASN . . . . . 0.428 ' O ' ' CG ' ' A' ' 147' ' ' ASP . 26.6 t-20 175.52 57.84 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.453 0.737 . . . . 0.0 109.379 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . 0.482 ' O ' ' N ' ' A' ' 150' ' ' ASP . 2.3 p-10 46.17 -114.46 0.49 Allowed 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.524 1.14 . . . . 0.0 109.325 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.447 ' C ' ' O ' ' A' ' 147' ' ' ASP . 2.0 pt-20 35.52 46.51 0.29 Allowed 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.495 1.122 . . . . 0.0 110.259 179.939 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 8.3 tt0 67.04 47.13 1.42 Allowed 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.486 1.117 . . . . 0.0 110.278 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . 0.482 ' N ' ' O ' ' A' ' 147' ' ' ASP . 0.0 OUTLIER -155.52 159.21 39.56 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.465 1.103 . . . . 0.0 109.308 179.997 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.945 HD12 ' CG ' ' A' ' 174' ' ' ASP . 1.2 pt? -128.75 127.78 23.49 Favored Pre-proline 0 C--N 1.325 -0.466 0 O-C-N 124.484 1.115 . . . . 0.0 109.329 179.95 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . 0.477 ' HB3' ' N ' ' A' ' 145' ' ' GLY . 18.4 Cg_endo -74.98 148.69 35.71 Favored 'Trans proline' 0 C--N 1.359 1.128 0 O-C-N 124.444 1.76 . . . . 0.0 111.021 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . 0.629 ' CZ ' ' HB3' ' A' ' 143' ' ' PHE . 52.2 p90 -150.66 169.35 21.81 Favored 'General case' 0 C--N 1.326 -0.437 0 O-C-N 124.456 1.098 . . . . 0.0 110.967 -179.935 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . 0.435 ' HA ' ' HB3' ' A' ' 142' ' ' ASP . 2.9 tttm -128.92 -161.75 1.14 Allowed 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.528 1.143 . . . . 0.0 109.273 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.464 ' N ' ' OD1' ' A' ' 142' ' ' ASP . 0.0 OUTLIER -91.64 101.12 13.74 Favored 'General case' 0 C--N 1.324 -0.522 0 O-C-N 124.507 1.129 . . . . 0.0 109.302 -179.987 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . 0.578 ' N ' ' O ' ' A' ' 139' ' ' ALA . . . 114.47 27.64 3.27 Favored Glycine 0 CA--C 1.53 0.981 0 O-C-N 124.491 1.12 . . . . 0.0 111.023 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . 0.46 ' O ' ' HD3' ' A' ' 138' ' ' ARG . 2.5 t70 -105.08 163.47 12.53 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.555 0.797 . . . . 0.0 109.299 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . 0.433 HG12 ' HD3' ' A' ' 138' ' ' ARG . 4.4 mt -119.59 149.08 22.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 O-C-N 124.47 1.107 . . . . 0.0 109.297 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.643 ' N ' HD12 ' A' ' 159' ' ' LEU . 0.0 OUTLIER -147.5 137.45 22.93 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 124.515 1.135 . . . . 0.0 109.279 -179.969 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . 0.702 ' O ' ' HB1' ' A' ' 172' ' ' ALA . 7.3 ttt180 -88.25 136.29 33.05 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.522 1.139 . . . . 0.0 110.325 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.593 HD13 HG13 ' A' ' 137' ' ' VAL . 0.9 OUTLIER -83.68 110.3 18.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 O-C-N 124.44 1.087 . . . . 0.0 109.324 -179.948 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . 0.43 ' HB3' ' ND2' ' A' ' 171' ' ' ASN . 2.5 tpt85 -88.33 -59.6 2.19 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.483 1.114 . . . . 0.0 110.353 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . 0.429 ' O ' ' HB3' ' A' ' 170' ' ' TRP . 20.3 t0 -149.19 149.68 31.4 Favored 'General case' 0 C--N 1.324 -0.526 0 O-C-N 124.515 1.134 . . . . 0.0 109.34 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . 0.542 ' HB2' ' CE2' ' A' ' 170' ' ' TRP . 0.4 OUTLIER -132.76 76.51 70.9 Favored Pre-proline 0 C--N 1.325 -0.496 0 O-C-N 124.474 1.109 . . . . 0.0 109.324 -179.987 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -75.14 -44.89 0.3 Allowed 'Trans proline' 0 C--N 1.361 1.207 0 O-C-N 124.426 1.75 . . . . 0.0 110.959 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 -78.97 175.5 10.51 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.457 1.098 . . . . 0.0 110.303 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 32.6 mm-40 -114.03 54.12 0.76 Allowed 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.464 1.102 . . . . 0.0 110.322 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . 0.524 ' O ' HG23 ' A' ' 184' ' ' VAL . 0.0 OUTLIER -178.5 -57.63 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.432 0 O-C-N 124.464 1.103 . . . . 0.0 110.261 -179.971 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 169' ' ' TRP . . . . . 0.563 ' CH2' ' HD3' ' A' ' 183' ' ' PRO . 14.0 m95 -109.8 142.13 41.49 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 107.961 -1.125 . . . . 0.0 107.961 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 170' ' ' TRP . . . . . 0.671 ' CD2' HG21 ' A' ' 184' ' ' VAL . 22.8 m0 -133.91 161.39 34.91 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.518 1.136 . . . . 0.0 108.011 179.964 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 171' ' ' ASN . . . . . 0.43 ' ND2' ' HB3' ' A' ' 162' ' ' ARG . 5.3 p-10 -94.08 111.26 22.96 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.556 1.16 . . . . 0.0 109.296 179.986 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . 0.702 ' HB1' ' O ' ' A' ' 160' ' ' ARG . . . -117.34 -176.79 3.08 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.499 1.125 . . . . 0.0 109.308 179.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . 0.435 ' OE2' ' CD ' ' A' ' 179' ' ' ARG . 40.2 mt-10 -128.09 124.27 36.59 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.439 1.087 . . . . 0.0 110.338 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . 0.945 ' CG ' HD12 ' A' ' 151' ' ' LEU . 0.9 OUTLIER -75.99 -172.65 2.06 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.407 1.067 . . . . 0.0 109.278 -179.954 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 1.4 m -82.35 61.59 5.62 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.55 1.156 . . . . 0.0 110.028 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -177.16 9.95 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.451 1.094 . . . . 0.0 110.312 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 74.07 17.25 79.45 Favored Glycine 0 CA--C 1.531 1.034 0 O-C-N 124.51 1.132 . . . . 0.0 111.029 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 178' ' ' LYS . . . . . 0.415 ' O ' ' HA ' ' A' ' 173' ' ' GLU . 0.8 OUTLIER -82.8 101.38 10.9 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.544 0.79 . . . . 0.0 109.262 -179.97 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 179' ' ' ARG . . . . . 0.531 ' HA ' ' O ' ' A' ' 172' ' ' ALA . 0.0 OUTLIER -91.42 115.42 28.02 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.528 1.142 . . . . 0.0 110.275 -179.968 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . 0.552 ' H ' HD22 ' A' ' 151' ' ' LEU . . . -150.96 169.0 30.7 Favored Glycine 0 CA--C 1.53 1.005 0 O-C-N 124.457 1.098 . . . . 0.0 110.998 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 181' ' ' MET . . . . . 0.496 ' HG3' ' HB3' ' A' ' 169' ' ' TRP . 1.4 ttm -87.75 111.95 21.88 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.44 0.729 . . . . 0.0 110.99 -179.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . 0.557 ' HA ' ' CZ3' ' A' ' 169' ' ' TRP . 1.5 pp -115.27 166.88 10.94 Favored Pre-proline 0 C--N 1.325 -0.472 0 O-C-N 124.538 1.149 . . . . 0.0 109.263 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 183' ' ' PRO . . . . . 0.607 ' HG2' ' CB ' ' A' ' 186' ' ' TYR . 18.3 Cg_endo -75.02 135.11 18.61 Favored 'Trans proline' 0 C--N 1.36 1.145 0 O-C-N 124.471 1.774 . . . . 0.0 110.973 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . 0.811 ' N ' ' CD ' ' A' ' 185' ' ' PRO . 86.9 t -79.98 -32.3 0.71 Allowed Pre-proline 0 C--N 1.325 -0.467 0 O-C-N 124.482 1.114 . . . . 0.0 109.293 179.986 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 185' ' ' PRO . . . . . 0.811 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.3 Cg_endo -74.99 -11.38 21.49 Favored 'Trans proline' 0 C--N 1.359 1.124 0 O-C-N 124.48 1.779 . . . . 0.0 110.999 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 186' ' ' TYR . . . . . 0.607 ' CB ' ' HG2' ' A' ' 183' ' ' PRO . 6.8 m-85 -93.97 -1.98 53.82 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.501 1.126 . . . . 0.0 111.022 -179.979 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 187' ' ' VAL . . . . . 0.473 ' HA ' ' O ' ' A' ' 138' ' ' ARG . 14.4 m -133.22 174.03 13.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 O-C-N 124.477 1.111 . . . . 0.0 109.307 179.963 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . 0.881 ' OE2' HD21 ' A' ' 140' ' ' LEU . 0.0 OUTLIER -135.53 172.51 12.9 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.457 1.098 . . . . 0.0 110.307 179.991 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.8 126.07 34.8 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.454 1.096 . . . . 0.0 109.288 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 72.2 t80 -43.54 -72.2 0.06 Allowed 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.47 1.106 . . . . 0.0 110.953 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.979 0 O-C-N 124.552 1.157 . . . . 0.0 111.019 179.984 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' CYS . . . . . . . . . . . . . 4.9 t . . . . . 0 N--CA 1.452 -0.325 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . 0.454 ' O ' ' HB2' ' A' ' 134' ' ' ALA . . . 118.7 48.23 0.38 Allowed Glycine 0 CA--C 1.529 0.956 0 O-C-N 124.521 1.138 . . . . 0.0 111.063 -179.943 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . 0.454 ' HB2' ' O ' ' A' ' 133' ' ' GLY . . . 177.87 -104.64 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.492 0.76 . . . . 0.0 109.292 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.442 ' HB2' ' O ' ' A' ' 161' ' ' ILE . 1.2 pt-20 165.79 63.46 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.434 0 O-C-N 124.429 1.08 . . . . 0.0 110.32 -179.942 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 7.3 m-85 -124.19 117.06 23.75 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.489 1.118 . . . . 0.0 110.957 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.516 ' CG2' ' O ' ' A' ' 188' ' ' GLU . 0.4 OUTLIER -119.41 132.54 68.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 O-C-N 124.544 1.153 . . . . 0.0 109.309 179.973 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . 0.617 HH21 HD11 ' A' ' 158' ' ' ILE . 12.7 ttm180 -95.2 148.37 22.47 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.525 1.14 . . . . 0.0 110.373 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.671 ' HB3' ' HB3' ' A' ' 157' ' ' ASP . . . -105.91 110.66 23.01 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.512 1.132 . . . . 0.0 109.268 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.572 HD11 ' HG2' ' A' ' 188' ' ' GLU . 0.3 OUTLIER -93.89 -7.9 41.82 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.456 1.098 . . . . 0.0 109.274 179.965 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . 0.456 ' C ' ' O ' ' A' ' 154' ' ' LYS . 14.7 m-85 -104.61 158.73 16.3 Favored 'General case' 0 C--N 1.324 -0.524 0 O-C-N 124.525 1.141 . . . . 0.0 110.976 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . 0.57 ' CA ' ' O ' ' A' ' 154' ' ' LYS . 0.0 OUTLIER -122.0 115.96 23.45 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.449 1.093 . . . . 0.0 109.276 -179.942 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' PHE . . . . . 0.498 ' O ' ' CG ' ' A' ' 143' ' ' PHE . 50.4 t80 -154.07 9.66 0.38 Allowed 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.46 1.1 . . . . 0.0 110.977 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . 0.503 ' OD1' ' N ' ' A' ' 145' ' ' GLY . 18.4 p30 35.13 -154.79 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.512 1.132 . . . . 0.0 109.321 -179.95 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . 0.503 ' N ' ' OD1' ' A' ' 144' ' ' ASN . . . -135.05 142.76 14.25 Favored Glycine 0 CA--C 1.53 1.016 0 O-C-N 124.464 1.102 . . . . 0.0 110.988 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 20.0 p30 178.93 58.09 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.6 0.823 . . . . 0.0 109.272 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -139.9 -59.3 0.55 Allowed 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.471 1.107 . . . . 0.0 109.388 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -170.42 58.77 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.552 1.158 . . . . 0.0 110.326 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 70.05 51.9 0.4 Allowed 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.521 1.138 . . . . 0.0 110.335 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -92.7 136.5 33.17 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.555 1.159 . . . . 0.0 109.301 -179.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 1.061 HD23 HD22 ' A' ' 159' ' ' LEU . 1.0 OUTLIER -50.9 106.74 0.69 Allowed Pre-proline 0 C--N 1.325 -0.485 0 O-C-N 124.583 1.177 . . . . 0.0 109.358 179.987 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . 0.409 ' HD2' ' OD2' ' A' ' 174' ' ' ASP . 18.3 Cg_endo -74.98 131.93 14.87 Favored 'Trans proline' 0 C--N 1.36 1.179 0 O-C-N 124.509 1.794 . . . . 0.0 110.996 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . 0.565 ' CD1' ' N ' ' A' ' 153' ' ' PHE . 0.0 OUTLIER -145.22 166.29 25.89 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.5 1.125 . . . . 0.0 110.971 -179.975 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . 0.57 ' O ' ' CA ' ' A' ' 142' ' ' ASP . 0.0 OUTLIER -127.0 -75.37 0.58 Allowed 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.5 1.125 . . . . 0.0 109.258 179.97 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.511 ' CD ' ' O ' ' A' ' 140' ' ' LEU . 0.0 OUTLIER -165.26 109.64 0.88 Allowed 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.54 1.15 . . . . 0.0 109.278 -179.97 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . 0.51 ' N ' ' O ' ' A' ' 139' ' ' ALA . . . 93.45 29.88 9.7 Favored Glycine 0 CA--C 1.531 1.042 0 O-C-N 124.593 1.183 . . . . 0.0 110.98 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . 0.887 ' C ' HD12 ' A' ' 158' ' ' ILE . 0.4 OUTLIER -88.66 158.65 18.16 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.482 0.754 . . . . 0.0 109.285 179.995 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . 0.887 HD12 ' C ' ' A' ' 157' ' ' ASP . 1.5 mp -116.38 136.34 53.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 O-C-N 124.492 1.12 . . . . 0.0 109.278 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 1.061 HD22 HD23 ' A' ' 151' ' ' LEU . 0.6 OUTLIER -138.09 126.22 22.9 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.51 1.131 . . . . 0.0 109.3 -179.971 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . 0.525 ' O ' ' HA ' ' A' ' 172' ' ' ALA . 0.0 OUTLIER -86.84 126.28 34.54 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.535 1.147 . . . . 0.0 110.299 -179.98 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.659 HG21 ' CE ' ' A' ' 164' ' ' LYS . 12.4 mm -81.77 122.56 36.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 O-C-N 124.502 1.127 . . . . 0.0 109.336 179.998 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . 0.463 ' HG3' ' N ' ' A' ' 163' ' ' ASP . 0.0 OUTLIER -122.53 -29.55 4.06 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.526 1.141 . . . . 0.0 110.276 179.989 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . 0.463 ' N ' ' HG3' ' A' ' 162' ' ' ARG . 0.8 OUTLIER -135.99 146.0 46.73 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.477 1.111 . . . . 0.0 109.312 -179.949 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . 0.659 ' CE ' HG21 ' A' ' 161' ' ' ILE . 15.9 mtpt -146.84 62.64 7.7 Favored Pre-proline 0 C--N 1.324 -0.506 0 O-C-N 124.459 1.099 . . . . 0.0 109.342 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . 0.443 ' HD3' ' N ' ' A' ' 164' ' ' LYS . 18.1 Cg_endo -75.04 -73.54 0.01 OUTLIER 'Trans proline' 0 C--N 1.361 1.218 0 O-C-N 124.474 1.776 . . . . 0.0 110.976 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -50.69 160.06 0.47 Allowed 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.523 1.139 . . . . 0.0 110.293 -179.967 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -100.91 35.21 2.25 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.477 1.11 . . . . 0.0 110.271 -179.938 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -157.75 -51.35 0.07 Allowed 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.417 1.073 . . . . 0.0 110.353 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 169' ' ' TRP . . . . . . . . . . . . . 13.0 m95 -103.79 140.53 37.5 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.607 1.192 . . . . 0.0 108.039 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 170' ' ' TRP . . . . . 0.62 ' CE3' ' CE ' ' A' ' 164' ' ' LYS . 50.5 m0 -121.0 147.35 45.61 Favored 'General case' 0 C--N 1.324 -0.53 0 O-C-N 124.511 1.132 . . . . 0.0 107.975 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 16.4 t30 -87.47 98.06 11.18 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.473 1.108 . . . . 0.0 109.233 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . 0.566 ' HB3' HD11 ' A' ' 182' ' ' ILE . . . -107.77 173.54 6.28 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.43 1.081 . . . . 0.0 109.334 179.909 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . 0.51 ' CG ' ' HG2' ' A' ' 179' ' ' ARG . 23.9 mt-10 -118.95 120.24 36.7 Favored 'General case' 0 C--N 1.326 -0.439 0 O-C-N 124.479 1.112 . . . . 0.0 110.268 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . 0.756 ' HA ' HD23 ' A' ' 159' ' ' LEU . 0.4 OUTLIER -73.92 -169.55 0.76 Allowed 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.489 1.118 . . . . 0.0 109.307 179.944 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 27.6 t -83.69 63.98 7.73 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.496 1.122 . . . . 0.0 110.038 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . 0.457 ' H ' ' H ' ' A' ' 177' ' ' GLY . 1.3 mt-10 -176.33 7.23 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.511 1.132 . . . . 0.0 110.341 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . 0.457 ' H ' ' H ' ' A' ' 176' ' ' GLU . . . 70.68 22.46 78.04 Favored Glycine 0 CA--C 1.53 0.984 0 O-C-N 124.492 1.12 . . . . 0.0 111.005 -179.969 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 178' ' ' LYS . . . . . 0.772 ' O ' HD11 ' A' ' 151' ' ' LEU . 4.6 ptpp? -94.4 115.45 27.66 Favored 'General case' 0 C--N 1.324 -0.53 0 O-C-N 124.454 0.738 . . . . 0.0 109.29 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 179' ' ' ARG . . . . . 0.51 ' HG2' ' CG ' ' A' ' 173' ' ' GLU . 1.3 mtt180 -92.87 123.63 36.27 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.579 1.175 . . . . 0.0 110.331 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -151.04 160.49 28.66 Favored Glycine 0 CA--C 1.53 1.001 0 O-C-N 124.48 1.112 . . . . 0.0 110.996 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 181' ' ' MET . . . . . 0.431 ' HA ' ' O ' ' A' ' 170' ' ' TRP . 4.7 mmm -88.6 107.13 18.75 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.472 0.748 . . . . 0.0 110.997 -179.966 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . 0.566 HD11 ' HB3' ' A' ' 172' ' ' ALA . 1.0 OUTLIER -112.32 170.12 5.62 Favored Pre-proline 0 C--N 1.325 -0.474 0 O-C-N 124.41 1.069 . . . . 0.0 109.338 179.969 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 183' ' ' PRO . . . . . 0.599 ' HG2' ' CB ' ' A' ' 186' ' ' TYR . 18.5 Cg_endo -74.98 132.82 15.88 Favored 'Trans proline' 0 C--N 1.36 1.132 0 O-C-N 124.425 1.75 . . . . 0.0 111.022 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . 0.819 ' N ' ' CD ' ' A' ' 185' ' ' PRO . 84.5 t -76.62 -31.68 0.96 Allowed Pre-proline 0 C--N 1.326 -0.456 0 O-C-N 124.577 1.173 . . . . 0.0 109.282 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 185' ' ' PRO . . . . . 0.819 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.4 Cg_endo -74.9 -8.72 20.44 Favored 'Trans proline' 0 C--N 1.36 1.153 0 O-C-N 124.454 1.765 . . . . 0.0 111.057 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 186' ' ' TYR . . . . . 0.599 ' CB ' ' HG2' ' A' ' 183' ' ' PRO . 3.4 m-85 -99.7 6.68 45.53 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.459 1.1 . . . . 0.0 110.941 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 187' ' ' VAL . . . . . 0.504 ' HA ' ' O ' ' A' ' 138' ' ' ARG . 34.5 m -136.92 174.5 11.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 O-C-N 124.506 1.129 . . . . 0.0 109.252 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . 0.572 ' HG2' HD11 ' A' ' 140' ' ' LEU . 0.0 OUTLIER -131.58 163.69 27.5 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.558 1.161 . . . . 0.0 110.302 179.986 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.53 124.14 35.47 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.461 1.101 . . . . 0.0 109.288 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 190' ' ' TYR . . . . . 0.499 ' OH ' ' CZ ' ' A' ' 138' ' ' ARG . 0.1 OUTLIER -98.94 77.96 2.24 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.448 1.093 . . . . 0.0 111.049 179.967 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . 0.4 ' O ' ' O ' ' A' ' 190' ' ' TYR . . . . . . . . 0 CA--C 1.531 1.039 0 O-C-N 124.52 1.138 . . . . 0.0 110.992 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' CYS . . . . . 0.494 ' O ' ' C ' ' A' ' 133' ' ' GLY . 76.5 m . . . . . 0 N--CA 1.452 -0.33 0 N-CA-C 108.358 -0.978 . . . . 0.0 108.358 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . 0.494 ' C ' ' O ' ' A' ' 132' ' ' CYS . . . -29.13 -82.92 0.01 OUTLIER Glycine 0 CA--C 1.531 1.048 0 O-C-N 124.492 1.12 . . . . 0.0 111.019 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . 0.489 ' O ' ' CG ' ' A' ' 135' ' ' GLU . . . -80.92 -105.37 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.54 0.788 . . . . 0.0 109.294 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.489 ' CG ' ' O ' ' A' ' 134' ' ' ALA . 5.5 mp0 -166.82 75.96 0.17 Allowed 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.482 1.114 . . . . 0.0 110.268 179.966 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . 0.584 ' CD1' ' HG2' ' A' ' 160' ' ' ARG . 86.2 m-85 -128.33 140.11 52.04 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.549 1.155 . . . . 0.0 110.956 -179.965 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.531 ' CG2' HD11 ' A' ' 161' ' ' ILE . 29.1 m -138.1 149.64 24.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 124.514 1.134 . . . . 0.0 109.335 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . 0.433 ' HB3' ' CD ' ' A' ' 188' ' ' GLU . 1.2 ttm180 -107.54 130.02 54.91 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.495 1.122 . . . . 0.0 110.275 -179.948 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.659 ' O ' ' N ' ' A' ' 156' ' ' GLY . . . -89.25 103.37 16.0 Favored 'General case' 0 C--N 1.326 -0.443 0 O-C-N 124.461 1.1 . . . . 0.0 109.281 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.468 HD11 ' HB3' ' A' ' 188' ' ' GLU . 0.2 OUTLIER -86.85 -2.8 58.86 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.521 1.138 . . . . 0.0 109.345 179.933 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 46.7 m-85 -128.92 157.63 41.06 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.5 1.125 . . . . 0.0 111.009 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . 0.465 ' HB2' ' HA ' ' A' ' 154' ' ' LYS . 1.5 t70 -112.28 156.89 21.66 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.388 1.055 . . . . 0.0 109.266 -179.928 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' PHE . . . . . 0.619 ' HB3' ' CZ ' ' A' ' 153' ' ' PHE . 11.7 t80 -178.99 41.89 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.434 1.084 . . . . 0.0 110.955 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . 0.489 ' HA ' ' HA ' ' A' ' 152' ' ' PRO . 71.9 m-80 -49.23 161.68 0.16 Allowed 'General case' 0 C--N 1.323 -0.549 0 O-C-N 124.529 1.143 . . . . 0.0 109.254 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . 0.404 ' O ' ' OD1' ' A' ' 146' ' ' ASN . . . -145.8 -125.18 1.71 Allowed Glycine 0 CA--C 1.53 0.991 0 O-C-N 124.525 1.141 . . . . 0.0 110.999 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' ASN . . . . . 0.404 ' OD1' ' O ' ' A' ' 145' ' ' GLY . 0.7 OUTLIER 162.74 77.44 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.506 0.769 . . . . 0.0 109.324 -179.99 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -171.4 164.69 7.04 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.481 1.113 . . . . 0.0 109.312 -179.945 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -92.77 55.62 2.46 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.558 1.161 . . . . 0.0 110.315 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 9.8 tt0 -149.44 -45.27 0.14 Allowed 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.499 1.124 . . . . 0.0 110.291 179.935 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 29.2 t0 -105.43 169.92 8.18 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.514 1.134 . . . . 0.0 109.31 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.933 HD21 ' OD2' ' A' ' 174' ' ' ASP . 0.2 OUTLIER -119.41 126.18 27.14 Favored Pre-proline 0 C--N 1.326 -0.452 0 O-C-N 124.479 1.112 . . . . 0.0 109.247 -179.96 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . 0.489 ' HA ' ' HA ' ' A' ' 144' ' ' ASN . 18.5 Cg_endo -74.94 135.25 18.94 Favored 'Trans proline' 0 C--N 1.36 1.136 0 O-C-N 124.513 1.796 . . . . 0.0 110.991 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . 0.619 ' CZ ' ' HB3' ' A' ' 143' ' ' PHE . 8.4 p90 -154.51 170.54 21.19 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.472 1.108 . . . . 0.0 111.003 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . 0.465 ' HA ' ' HB2' ' A' ' 142' ' ' ASP . 6.8 tttt -128.49 -164.9 1.43 Allowed 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.441 1.088 . . . . 0.0 109.272 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 35.4 tttt -92.94 106.47 18.43 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.483 1.114 . . . . 0.0 109.293 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . 0.659 ' N ' ' O ' ' A' ' 139' ' ' ALA . . . 109.86 29.01 3.97 Favored Glycine 0 CA--C 1.531 1.034 0 O-C-N 124.496 1.123 . . . . 0.0 111.004 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . 0.494 ' HB3' ' HB3' ' A' ' 139' ' ' ALA . 22.8 t70 -97.39 167.05 11.24 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.482 0.754 . . . . 0.0 109.352 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . 0.43 HD13 ' O ' ' A' ' 157' ' ' ASP . 18.0 mm -121.46 136.78 57.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 O-C-N 124.52 1.137 . . . . 0.0 109.306 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.6 HD22 HD13 ' A' ' 182' ' ' ILE . 0.8 OUTLIER -141.48 136.63 31.44 Favored 'General case' 0 C--N 1.326 -0.427 0 O-C-N 124.495 1.122 . . . . 0.0 109.325 -179.97 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . 0.584 ' HG2' ' CD1' ' A' ' 136' ' ' TYR . 0.0 OUTLIER -97.33 134.98 39.88 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.528 1.143 . . . . 0.0 110.347 179.96 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.531 HD11 ' CG2' ' A' ' 137' ' ' VAL . 1.7 mp -87.19 125.22 41.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 O-C-N 124.501 1.126 . . . . 0.0 109.346 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . 0.482 ' CG ' ' N ' ' A' ' 163' ' ' ASP . 0.8 OUTLIER -118.63 -41.03 2.83 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 124.5 1.125 . . . . 0.0 110.291 -179.953 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . 0.482 ' N ' ' CG ' ' A' ' 162' ' ' ARG . 13.7 m-20 -148.78 176.99 9.91 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.492 1.12 . . . . 0.0 109.34 -179.987 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . 0.592 ' HB3' ' CD1' ' A' ' 170' ' ' TRP . 6.9 mtmm -144.88 65.45 12.24 Favored Pre-proline 0 C--N 1.325 -0.478 0 O-C-N 124.564 1.165 . . . . 0.0 109.283 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . 0.514 ' O ' ' CB ' ' A' ' 166' ' ' GLU . 18.5 Cg_endo -74.92 73.29 4.32 Favored 'Trans proline' 0 C--N 1.361 1.212 0 O-C-N 124.507 1.793 . . . . 0.0 110.997 179.966 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . 0.535 ' OE1' ' HE2' ' A' ' 181' ' ' MET . 2.5 mt-10 159.93 179.35 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.528 1.142 . . . . 0.0 110.325 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -118.16 46.11 1.85 Allowed 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.513 1.133 . . . . 0.0 110.318 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -178.83 -54.35 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.484 1.115 . . . . 0.0 110.322 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 169' ' ' TRP . . . . . . . . . . . . . 10.2 m95 -95.52 144.35 26.07 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.539 1.149 . . . . 0.0 107.991 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 170' ' ' TRP . . . . . 0.592 ' CD1' ' HB3' ' A' ' 164' ' ' LYS . 53.2 m0 -118.71 148.38 42.83 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 -179.963 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 171' ' ' ASN . . . . . 0.458 ' HB2' ' CD ' ' A' ' 165' ' ' PRO . 5.4 t-20 -87.58 107.73 18.73 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.555 1.16 . . . . 0.0 109.366 179.903 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . 0.576 ' HA ' ' O ' ' A' ' 160' ' ' ARG . . . -119.28 174.88 6.09 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.511 1.132 . . . . 0.0 109.31 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . 0.514 ' HG3' ' CG ' ' A' ' 179' ' ' ARG . 3.8 mt-10 -118.17 119.92 36.16 Favored 'General case' 0 C--N 1.326 -0.427 0 O-C-N 124.543 1.152 . . . . 0.0 110.262 -179.947 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . 0.933 ' OD2' HD21 ' A' ' 151' ' ' LEU . 0.8 OUTLIER -76.19 -173.7 2.5 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.411 1.069 . . . . 0.0 109.319 -179.943 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 40.6 t -75.82 63.89 1.73 Allowed 'General case' 0 C--N 1.324 -0.539 0 O-C-N 124.591 1.182 . . . . 0.0 110.079 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . 0.442 ' H ' ' H ' ' A' ' 177' ' ' GLY . 0.9 OUTLIER -177.56 1.53 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.55 1.156 . . . . 0.0 110.276 -179.921 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . 0.442 ' H ' ' H ' ' A' ' 176' ' ' GLU . . . 74.94 15.47 80.98 Favored Glycine 0 CA--C 1.53 0.998 0 O-C-N 124.522 1.139 . . . . 0.0 111.019 -179.954 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 178' ' ' LYS . . . . . 0.407 ' O ' ' HA ' ' A' ' 173' ' ' GLU . 0.0 OUTLIER -84.91 117.59 24.01 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.506 0.768 . . . . 0.0 109.38 179.986 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 179' ' ' ARG . . . . . 0.514 ' CG ' ' HG3' ' A' ' 173' ' ' GLU . 3.3 mtt85 -90.18 123.34 33.92 Favored 'General case' 0 C--N 1.326 -0.441 0 O-C-N 124.498 1.124 . . . . 0.0 110.294 -179.949 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . 0.549 ' HA3' HD12 ' A' ' 151' ' ' LEU . . . -152.21 164.57 30.56 Favored Glycine 0 CA--C 1.53 1.011 0 O-C-N 124.471 1.107 . . . . 0.0 111.017 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 181' ' ' MET . . . . . 0.535 ' HE2' ' OE1' ' A' ' 166' ' ' GLU . 21.7 mtp -86.37 101.77 13.41 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.528 0.781 . . . . 0.0 110.95 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . 0.6 HD13 HD22 ' A' ' 159' ' ' LEU . 23.3 pt -99.2 158.12 32.82 Favored Pre-proline 0 C--N 1.326 -0.452 0 O-C-N 124.492 1.12 . . . . 0.0 109.301 179.922 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 183' ' ' PRO . . . . . 0.754 ' HG2' ' HB2' ' A' ' 186' ' ' TYR . 18.4 Cg_endo -74.96 134.13 17.5 Favored 'Trans proline' 0 C--N 1.36 1.159 0 O-C-N 124.404 1.739 . . . . 0.0 110.947 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . 0.807 ' N ' ' CD ' ' A' ' 185' ' ' PRO . 73.9 t -77.43 -33.36 1.04 Allowed Pre-proline 0 C--N 1.325 -0.46 0 O-C-N 124.578 1.174 . . . . 0.0 109.271 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 185' ' ' PRO . . . . . 0.807 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.3 Cg_endo -74.96 -14.7 21.15 Favored 'Trans proline' 0 C--N 1.361 1.191 0 O-C-N 124.5 1.789 . . . . 0.0 111.026 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 186' ' ' TYR . . . . . 0.754 ' HB2' ' HG2' ' A' ' 183' ' ' PRO . 3.3 m-85 -96.59 0.31 49.78 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.508 1.13 . . . . 0.0 111.057 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 4.1 m -135.4 164.49 32.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 O-C-N 124.463 1.102 . . . . 0.0 109.271 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . 0.474 ' O ' ' HA ' ' A' ' 137' ' ' VAL . 0.0 OUTLIER -122.46 166.92 13.99 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.52 1.137 . . . . 0.0 110.293 179.963 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -87.69 135.59 33.31 Favored 'General case' 0 C--N 1.326 -0.422 0 O-C-N 124.492 1.12 . . . . 0.0 109.288 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -129.39 91.61 3.21 Favored 'General case' 0 C--N 1.326 -0.423 0 O-C-N 124.447 1.092 . . . . 0.0 110.948 -179.957 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.075 0 O-C-N 124.586 1.179 . . . . 0.0 110.952 179.931 . . . . . . . . 0 0 . 1 stop_ save_